data_1pkt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pkt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 16.9 m-85 -137.71 145.98 43.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -1.157 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.529 ' CG ' HG21 ' A' ' 31' ' ' THR . 0.5 OUTLIER -137.79 121.17 17.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.91 172.79 7.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.306 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 21.3 mtt180 -117.57 139.46 50.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . . . -83.17 105.28 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.737 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.539 HD13 ' CA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -71.73 -36.42 70.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.064 -1.023 . . . . 0.0 108.977 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 34.3 m-85 -106.07 -177.78 3.46 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -113.71 141.02 47.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.834 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.522 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 55.5 t80 -132.17 158.4 41.79 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -111.19 -63.66 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.773 -1.204 . . . . 0.0 110.13 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 15' ' ' LYS . 14.3 tttm 153.68 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.492 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 2.2 tt0 -93.57 -54.18 3.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.024 -1.047 . . . . 0.0 109.192 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -69.75 159.32 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.214 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.38 25.85 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.214 -0.929 . . . . 0.0 111.402 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' OE2' ' HA ' ' A' ' 20' ' ' GLU . 3.6 mm-40 -149.05 13.98 0.89 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.669 -1.27 . . . . 0.0 109.539 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -91.17 161.74 14.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.675 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -117.56 143.8 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 7.9 m-20 -49.15 109.68 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.336 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.579 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -103.69 154.71 19.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -154.25 142.34 20.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.96 -1.088 . . . . 0.0 109.634 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 11' ' ' LEU . 4.6 tt -47.32 135.08 10.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.71 5.9 73.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 0.4 OUTLIER -90.24 136.01 33.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 109.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 7.3 mm -94.85 140.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.071 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.627 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.4 mp -125.76 111.26 14.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.055 -1.028 . . . . 0.0 109.8 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.529 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -85.52 93.34 8.76 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 HG23 ' CA ' ' A' ' 58' ' ' GLY . 89.5 t -99.89 115.92 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.083 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.8 167.21 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.99 . . . . 0.0 109.012 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' C ' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -90.03 0.6 57.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.5 -56.47 1.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.98 -31.85 1.44 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -1.105 . . . . 0.0 109.978 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' CD1' HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.86 -39.98 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.079 -1.013 . . . . 0.0 109.98 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 56.8 t -76.39 1.62 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.37 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -97.6 -25.71 15.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' PHE . . . 120.93 22.13 3.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.58 ' CE2' HG22 ' A' ' 53' ' ' ILE . 14.7 m-85 -44.49 147.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.251 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.56 165.37 23.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -67.0 118.79 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.12 53.1 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.21 -32.23 73.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -67.91 -21.2 65.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -74.71 -9.57 58.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.34 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.498 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -119.14 75.8 15.32 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 108.897 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 53' ' ' ILE . 6.1 Cg_exo -56.67 -48.79 17.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.497 2.131 . . . . 0.0 110.73 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.88 -25.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.5 tt0 -114.12 50.48 0.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' CE2' ' A' ' 42' ' ' PHE . 7.5 mt -134.91 -45.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.56 -77.6 0.28 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.444 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 17.4 m95 -139.64 143.97 37.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.433 -1.039 . . . . 0.0 109.336 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -131.96 147.88 52.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.914 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' C ' HG23 ' A' ' 32' ' ' VAL . 17.8 t-20 -114.18 109.39 18.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.543 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -132.13 -158.1 8.87 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.601 -1.285 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 72.9 t80 -120.26 116.91 26.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.42 -1.047 . . . . 0.0 109.801 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m-20 -79.45 76.67 6.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.435 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -48.28 -34.87 11.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.787 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 31.7 m -49.11 -48.48 44.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 60' ' ' ASN . 9.4 t -101.7 2.92 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.689 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.83 45.83 95.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.577 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 17.8 mm-40 -138.62 -174.75 3.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.172 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -152.65 150.05 29.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.083 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 171.12 -164.77 37.86 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -100.44 166.31 11.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.984 . . . . 0.0 109.565 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.627 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.5 p90 -169.07 156.36 6.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.71 126.56 20.1 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.108 1.872 . . . . 0.0 109.806 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -73.74 -22.11 78.6 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -73.07 -4.93 35.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.242 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.7 m-85 -101.93 -5.43 24.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CA ' HD13 ' A' ' 11' ' ' LEU . 1.7 m -116.48 -171.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.064 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.508 ' HB3' HD22 ' A' ' 11' ' ' LEU . 11.0 pt-20 -157.51 92.82 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.624 ' CE1' ' N ' ' A' ' 78' ' ' GLY . 55.4 t80 -48.04 139.43 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 109.668 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -132.99 -0.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.982 . . . . 0.0 109.638 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.624 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 140.1 169.65 11.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 27.0 m-85 -78.92 139.15 38.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.986 . . . . 0.0 109.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.44 ' HG2' HG22 ' A' ' 31' ' ' THR . 21.1 mt-30 -129.54 126.09 37.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.104 -0.997 . . . . 0.0 109.845 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.87 177.32 5.54 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.531 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -117.78 138.11 52.28 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -70.44 103.5 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.0 110.675 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -68.5 -32.24 72.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 108.586 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 5.9 m-85 -129.75 -169.02 2.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.64 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -117.95 171.19 8.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 109.933 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.526 ' HB3' ' CG ' ' A' ' 24' ' ' LEU . 54.8 t80 -173.42 118.17 0.29 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 3.6 tttm -79.64 117.53 20.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 18.0 pttt -42.7 109.26 0.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.676 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -67.13 -66.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.252 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' OD2' ' A' ' 21' ' ' ASP . 15.9 mtm180 -90.29 174.34 7.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 2.09 12.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.69 -6.45 29.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 109.891 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -105.11 166.31 10.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.158 -0.964 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 67' ' ' GLY . 1.1 pt -114.94 163.15 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.0 m-20 -87.43 105.67 17.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' CG ' ' HB3' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -102.75 154.6 19.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -152.49 154.6 35.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 26.5 tp -46.6 135.32 8.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.94 9.62 86.05 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 16.2 t0 -91.17 110.98 22.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -1.127 . . . . 0.0 109.966 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.7 mp -79.68 141.85 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.936 -1.102 . . . . 0.0 109.79 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.668 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.9 mp -123.38 140.03 53.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.44 HG22 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -109.86 86.19 2.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 109.285 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.531 HG23 ' CA ' ' A' ' 58' ' ' GLY . 53.9 t -90.58 108.68 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.453 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 30.2 m120 -50.49 161.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 109.722 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 53.84 2.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.89 -59.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 m -61.73 -20.37 63.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.341 -1.093 . . . . 0.0 109.255 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.514 ' HB2' ' CG1' ' A' ' 32' ' ' VAL . 8.2 tp -90.35 -24.14 20.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 HG21 ' CG ' ' A' ' 47' ' ' GLU . 5.0 t -90.81 -4.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.065 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.02 -4.14 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 7.4 mt -80.82 -30.17 35.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.49 7.35 5.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 23.1 m-85 -59.94 -172.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 109.751 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.62 -171.41 1.92 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 108.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.96 84.48 6.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.724 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.76 2.17 3.98 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.169 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -80.86 -14.94 57.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.962 -1.316 . . . . 0.0 109.851 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 26.5 mt-10 -62.58 -40.17 96.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . -61.67 -9.57 6.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.208 -0.932 . . . . 0.0 110.367 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mmm180 -113.59 80.59 4.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.872 -1.142 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.578 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.63 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.325 2.017 . . . . 0.0 110.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 54.4 tt0 -41.06 -29.8 0.12 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.253 -0.905 . . . . 0.0 109.071 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -98.64 47.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.585 HG12 ' CZ ' ' A' ' 42' ' ' PHE . 4.0 mt -146.89 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -63.0 0.28 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 33.7 m95 -146.91 148.9 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -1.11 . . . . 0.0 109.289 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 2.6 mp -137.42 152.3 49.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.696 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 1.2 t-20 -110.54 107.51 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.531 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -134.28 -160.04 9.07 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -116.54 117.55 30.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.526 -0.985 . . . . 0.0 110.231 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 64' ' ' GLY . 2.5 t-20 -79.4 76.38 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.531 -0.731 . . . . 0.0 109.234 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.94 -37.32 71.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.799 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.423 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 19.4 m -60.3 -33.45 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.019 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -121.76 18.26 11.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 40.19 54.16 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.28 113.1 8.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -1.227 . . . . 0.0 109.486 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 9.1 ttp-105 -91.24 140.47 29.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.513 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 166.09 -165.19 38.01 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -93.57 166.22 12.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.484 -1.009 . . . . 0.0 109.779 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -168.1 153.91 6.91 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' HD23 ' A' ' 24' ' ' LEU . 5.8 Cg_exo -58.11 116.58 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.195 1.93 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.59 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -66.6 -28.26 73.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 1.3 p -63.63 -28.0 69.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.576 -1.543 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.437 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 19.4 m-30 -85.41 24.91 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.02 -1.05 . . . . 0.0 110.419 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.578 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 35.5 m -140.36 172.93 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.135 -0.978 . . . . 0.0 109.347 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 13.0 pt-20 -148.95 89.65 1.69 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.835 . . . . 0.0 109.177 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.557 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 75.6 t80 -41.56 133.13 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.718 . . . . 0.0 109.133 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 17.5 mm -123.37 -2.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 140.65 -174.01 22.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.355 -1.085 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 34.7 m-85 -79.88 115.17 19.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -1.086 . . . . 0.0 109.353 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.478 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 3.2 mt-30 -98.67 128.12 44.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.18 176.06 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.034 -1.041 . . . . 0.0 109.692 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -118.0 117.6 29.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.522 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . . . -61.94 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.559 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.632 ' HB2' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -46.12 -50.45 15.41 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.057 -1.027 . . . . 0.0 109.782 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -111.24 170.68 7.95 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.574 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.36 -170.41 3.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.387 -0.821 . . . . 0.0 109.879 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 7.2 t80 179.75 115.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.236 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' GLU . 8.2 pttp -79.46 109.42 13.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.144 -0.972 . . . . 0.0 109.036 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -39.69 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.255 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' LYS . 48.0 mt-10 -63.33 -59.92 4.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 63.1 mtp85 -90.1 155.2 19.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.346 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.98 -9.15 19.32 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -84.02 -21.75 31.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 0.0 109.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' CA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -100.11 156.98 16.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.404 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.459 HD13 ' HB3' ' A' ' 69' ' ' PHE . 1.1 pp -109.35 175.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.933 . . . . 0.0 109.668 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 1.8 m-20 -75.66 151.48 37.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 1.1 tp -136.91 150.07 48.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.353 -0.842 . . . . 0.0 109.096 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.534 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 146.13 16.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.99 . . . . 0.0 109.672 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 43.5 tp -51.11 136.06 24.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.49 -0.756 . . . . 0.0 109.973 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.26 -2.48 78.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.447 ' OD2' ' HB ' ' A' ' 62' ' ' THR . 11.4 t0 -90.05 144.92 25.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -1.169 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.9 mp -108.65 146.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.607 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.6 mp -124.89 112.43 16.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 0.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.478 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.51 91.91 7.97 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 109.376 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.54 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 53.8 t -93.81 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.703 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -57.24 156.61 7.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -76.2 -16.54 59.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.633 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.65 -50.51 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 p -54.52 -30.28 53.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -1.113 . . . . 0.0 110.025 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 8.7 tp -90.31 -32.32 16.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 77.2 t -90.21 2.96 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.941 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.53 -7.46 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.827 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -105.36 17.55 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.69 42.88 45.29 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 9.8 m-85 -67.26 -168.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 109.441 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.29 136.38 52.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 122.9 6.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.501 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -62.46 -25.29 67.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -1.144 . . . . 0.0 109.409 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 2.4 mp0 -61.86 -32.76 73.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.967 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 76' ' ' TYR . . . -87.41 20.54 2.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.1 tpp180 -138.78 74.86 37.74 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 6.2 Cg_exo -55.67 -48.77 18.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.443 2.095 . . . . 0.0 111.15 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 4.7 pm0 -44.11 -26.96 0.34 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.031 -1.043 . . . . 0.0 109.218 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.75 51.53 0.85 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.398 -0.814 . . . . 0.0 109.066 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 ' CD2' ' A' ' 56' ' ' LEU . 24.2 mt -141.49 -39.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.47 -78.47 0.24 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.419 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 24.3 m95 -137.66 144.82 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -1.091 . . . . 0.0 109.192 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -134.77 154.3 51.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -109.92 108.16 18.33 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -130.66 -171.21 12.86 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.454 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 68.8 t80 -116.35 118.32 32.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.545 -0.973 . . . . 0.0 110.026 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 6.2 m-80 -84.53 64.82 8.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.105 -0.997 . . . . 0.0 109.009 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -43.67 -30.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.419 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.447 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 16.5 m -49.35 -54.47 17.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.234 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.93 10.96 39.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.445 -0.784 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.71 47.11 91.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.21 178.46 5.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -1.176 . . . . 0.0 109.582 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -159.66 138.52 10.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.93 -162.19 35.99 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-20 -94.92 167.49 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.499 -1.001 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.607 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -169.84 158.89 6.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -62.13 125.37 16.27 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.187 1.924 . . . . 0.0 110.086 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.519 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -73.34 -26.3 70.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -69.65 -7.44 39.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.951 -1.323 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.5 m-85 -99.32 -0.73 40.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.987 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -124.98 164.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 121.714 0.769 . . . . 0.0 110.422 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 18.6 pt-20 -139.79 109.74 6.42 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 83.2 t80 -37.56 113.39 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -105.11 9.77 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.519 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.569 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 104.33 -149.01 16.95 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 79.2 m-85 -160.1 124.79 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.476 -1.014 . . . . 0.0 108.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.1 mt-30 -129.51 122.29 28.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.016 -1.052 . . . . 0.0 110.196 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.662 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -116.92 -178.08 3.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.06 -1.025 . . . . 0.0 109.51 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.36 165.29 13.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -88.79 123.6 33.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 11.8 mt -104.3 -33.19 8.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 10.6 m-85 -128.18 -158.72 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.814 . . . . 0.0 109.902 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -126.66 172.65 10.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.736 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 75.3 t80 -171.49 113.79 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.297 -0.877 . . . . 0.0 108.809 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -79.29 156.39 28.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.983 -1.073 . . . . 0.0 110.052 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.7 tttt -55.08 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 109.663 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mt-10 -88.73 -62.91 1.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.216 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 6.6 ttm-85 -90.16 157.44 17.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.95 -4.4 16.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.174 -0.954 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 -9.86 15.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.079 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -85.33 171.45 11.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 109.528 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.497 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -130.62 158.19 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.528 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -60.04 134.01 56.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 1.2 mm? -133.47 146.15 50.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.06 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.2 147.76 19.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 109.27 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 10' ' ' ALA . 50.4 tp -51.48 145.1 9.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.11 -10.63 67.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' OD2' ' HB ' ' A' ' 62' ' ' THR . 0.9 OUTLIER -85.98 147.68 26.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -1.176 . . . . 0.0 109.565 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.6 mp -107.38 146.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.3 mp -122.75 123.27 40.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.093 -1.004 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -98.64 92.05 5.42 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.622 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 53.5 t -88.43 113.77 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.22 -165.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -0.925 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -70.98 0.62 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.23 -36.61 83.53 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -53.71 -30.35 43.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.028 -1.278 . . . . 0.0 110.064 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 3.1 tt -90.73 -42.67 10.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.707 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 38' ' ' VAL . 99.2 t -79.27 1.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 110.029 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' C ' HD11 ' A' ' 40' ' ' LEU . . . -63.04 -12.65 27.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.322 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -106.22 27.09 9.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.63 48.68 84.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 7.1 m-85 -67.21 -168.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.639 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.1 m -133.75 143.74 48.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.486 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -59.15 122.73 14.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.0 -33.3 6.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.456 ' O ' HD13 ' A' ' 53' ' ' ILE . 5.0 mt-30 -78.36 -2.65 39.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -1.194 . . . . 0.0 109.712 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 1.3 pt-20 -69.52 -37.23 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -87.2 15.13 6.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -123.6 67.69 39.54 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 109.127 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.585 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.35 -51.01 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.219 1.946 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.4 tt0 -59.14 -33.36 70.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.012 . . . . 0.0 108.741 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 7.2 tp10 -99.28 34.06 2.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 108.689 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.531 HG22 ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -119.32 -37.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.24 -76.8 0.24 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.421 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 74.9 m95 -142.74 139.71 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.092 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.587 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -129.74 153.32 48.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.767 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 2.7 t-20 -108.7 112.21 24.4 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -132.97 -169.25 12.16 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -120.29 107.98 13.62 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.897 -0.767 . . . . 0.0 109.725 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.479 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 6.9 m-80 -79.57 90.19 5.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -36.4 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 34.1 m -53.82 -36.92 63.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 1.3 p -111.44 5.61 19.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.74 45.67 24.55 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 63' ' ' THR . 33.1 mt-10 -129.38 155.6 45.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.694 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' C ' HG23 ' A' ' 22' ' ' ILE . 2.6 tpp180 -126.61 132.01 51.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 108.893 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.497 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 177.68 -158.48 23.71 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -104.59 166.03 10.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -1.028 . . . . 0.0 110.062 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.637 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.9 p90 -163.65 158.96 17.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.447 -0.783 . . . . 0.0 109.307 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.28 127.27 21.51 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.136 1.891 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -71.3 -36.42 63.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.535 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.4 p -65.2 -9.96 27.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -1.197 . . . . 0.0 109.265 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.6 m-85 -99.82 18.37 18.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.443 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 34.8 m -134.08 -168.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.093 -1.004 . . . . 0.0 110.092 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 9' ' ' ARG . 10.3 pt-20 -154.84 87.15 1.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.537 -0.727 . . . . 0.0 109.818 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 81.8 t80 -45.73 139.64 3.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.174 -0.954 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -125.38 -4.99 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 109.127 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 116.29 -173.11 14.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.462 ' OXT' ' HA ' ' A' ' 6' ' ' TYR . 73.4 mtp180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLN . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 14.8 m-85 -79.81 102.57 9.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -1.124 . . . . 0.0 109.088 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.464 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -99.93 128.88 45.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.432 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -121.84 176.3 5.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.124 -0.985 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.5 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.2 mmm180 -118.35 122.53 43.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . . . -70.97 93.02 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.793 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 64.2 mt -58.4 -49.4 77.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -104.12 176.77 5.05 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.432 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.525 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 43.1 p-10 -107.25 -173.86 2.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 14.0 t80 -162.31 140.22 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -91.89 132.91 36.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.983 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -55.8 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.718 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' LYS . 9.3 tp10 -95.43 -54.89 3.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.212 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.1 mmp_? -81.76 136.82 35.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.68 -19.3 0.89 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.109 -0.994 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 mm-40 -97.44 -33.34 11.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -66.36 157.97 30.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.67 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -120.32 169.85 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 109.375 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 2.9 m-20 -78.99 112.41 16.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.842 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.571 ' CD2' ' CD1' ' A' ' 22' ' ' ILE . 3.1 mm? -88.5 166.29 14.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 108.426 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.628 ' CE1' ' CG2' ' A' ' 63' ' ' THR . 0.0 OUTLIER -157.99 135.15 10.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.853 -1.154 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 11' ' ' LEU . 12.1 tp -50.57 140.15 14.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.512 -0.743 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 5.8 t0 -87.93 146.43 25.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.18 -1.188 . . . . 0.0 109.084 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 30' ' ' LEU . 24.2 mm -91.59 142.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 29' ' ' ILE . 3.8 mm? -122.11 129.47 52.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -117.24 82.75 1.86 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.806 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 t -92.69 115.08 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.148 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -171.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.725 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 4.6 mtmp? -90.04 -52.15 5.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.267 -0.896 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 36' ' ' SER . . . -67.51 -46.94 65.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -42.3 -33.87 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -1.144 . . . . 0.0 109.833 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 42' ' ' PHE . 5.1 tt -90.33 -32.67 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.512 ' CG2' ' OE2' ' A' ' 47' ' ' GLU . 95.0 t -80.09 0.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.45 -12.96 16.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -105.99 27.71 8.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.44 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.19 48.93 83.69 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 37' ' ' LEU . 8.0 m-85 -69.66 -168.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.3 p -126.4 158.51 35.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.323 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.07 119.15 12.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.4 -20.03 38.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.25 15.69 9.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 4.6 mm-40 -90.33 -35.44 15.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -89.88 28.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -128.41 65.08 70.0 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB3' HD12 ' A' ' 56' ' ' LEU . 4.5 Cg_exo -57.61 -46.64 25.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.424 2.083 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.8 -19.02 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.6 -3.47 10.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 0.0 110.028 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 49' ' ' ARG . 14.1 mt -80.27 -50.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.079 -1.013 . . . . 0.0 109.128 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.72 -69.22 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.81 148.15 41.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -1.051 . . . . 0.0 109.509 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.9 t-20 -111.56 104.04 12.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -138.75 -140.87 4.04 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 64' ' ' GLY . 72.2 t80 -131.2 125.78 33.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.981 . . . . 0.0 110.363 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' HD12 ' A' ' 24' ' ' LEU . 3.3 m120 -86.43 85.17 7.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -42.85 -48.44 5.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.795 . . . . 0.0 110.867 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 4.0 m -41.26 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.0 110.234 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.628 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 39.8 p -83.3 13.09 4.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.068 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 59' ' ' TYR . . . 45.76 45.34 13.21 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -119.75 117.16 27.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 0.0 109.234 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.63 156.33 18.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 156.93 -163.71 32.4 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.122 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.2 p-10 -104.71 154.1 20.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.811 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -155.88 159.68 31.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.1 Cg_exo -59.72 130.12 33.77 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.17 1.914 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -73.6 -29.72 63.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -69.43 -5.75 25.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.364 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.5 m-85 -100.04 -4.3 30.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.66 -176.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 21.1 pt-20 -153.48 96.45 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.556 ' CE1' ' HD3' ' A' ' 79' ' ' ARG . 9.8 t80 -37.67 110.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -135.35 14.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 7' ' ' GLN . . . -130.65 110.41 1.01 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HD3' ' CE1' ' A' ' 76' ' ' TYR . 3.3 ttp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 32' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 m-85 -78.6 119.8 22.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.121 -1.223 . . . . 0.0 108.617 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 78' ' ' GLY . 30.6 mt-30 -106.78 122.91 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.141 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.79 173.77 6.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 109.64 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 8.5 mpt_? -107.86 137.44 45.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.403 -0.811 . . . . 0.0 108.846 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -66.02 99.12 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 110.241 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.5 mt -65.39 -30.51 71.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.147 -0.971 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.588 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.5 m-85 -127.94 -163.59 1.28 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.78 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.04 122.95 26.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.751 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 4.1 t80 -103.39 139.68 38.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.286 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 pttt -95.53 15.95 18.41 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.995 -1.065 . . . . 0.0 109.619 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 ttmm 64.19 92.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.658 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 4.8 tp10 -86.02 -80.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.229 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.507 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 77.8 mtm-85 -67.93 165.33 17.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.311 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -74.73 2.21 10.57 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.41 2.46 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.033 . . . . 0.0 109.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -109.37 172.43 6.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.508 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' HA3' ' A' ' 67' ' ' GLY . 6.3 pt -125.23 175.95 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.583 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -84.75 105.31 15.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.686 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 1.7 mm? -91.81 152.64 20.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.6 m80 -152.22 135.86 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.338 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 4.5 tt -55.02 137.5 46.14 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.157 -0.965 . . . . 0.0 109.605 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.66 -9.12 71.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.486 ' OD1' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -90.31 162.39 15.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 3.3 mm -115.62 147.82 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.638 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 7.4 mp -120.76 111.8 18.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.226 -0.921 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.457 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -86.52 93.57 9.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.74 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.649 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 46.9 t -92.35 121.27 42.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.117 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.5 m-80 -47.79 178.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -87.4 -71.31 0.57 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.87 -30.33 59.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 45.5 t -47.68 -33.85 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.237 . . . . 0.0 110.156 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.74 -40.55 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 88.6 t -78.57 3.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.82 20.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm? -107.8 -7.34 16.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.53 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 95.2 33.5 6.54 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 9.8 m-85 -53.81 -168.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -1.048 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 p -139.76 160.93 38.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.561 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -59.58 115.27 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.61 -34.09 4.67 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 15.9 mm-40 -68.39 -33.16 73.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.183 -1.187 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -64.23 -31.44 72.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -82.67 -14.57 54.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.1 mmm180 -112.05 80.17 3.06 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.033 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.597 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.7 Cg_exo -54.48 -57.4 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.304 2.003 . . . . 0.0 110.434 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 15.5 tt0 -44.0 -36.08 2.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.733 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.7 43.92 1.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 56' ' ' LEU . 21.8 mt -136.68 -40.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.122 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -78.72 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 14.6 m95 -145.02 143.83 30.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.101 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.582 HD11 ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -130.82 160.92 32.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 109.669 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.465 ' OD1' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -110.99 117.24 32.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.494 ' HA3' HG21 ' A' ' 32' ' ' VAL . . . -138.28 -176.16 14.37 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.5 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 70.7 t80 -117.55 111.87 19.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.876 -0.779 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.8 m-80 -79.3 78.72 5.78 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 108.79 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -48.19 -38.41 18.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.85 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 16.0 m -48.01 -46.74 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' GLY . 53.3 p -117.4 17.72 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.04 50.93 6.13 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' OE1' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.87 109.93 15.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.301 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' C ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.0 150.54 20.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 109.398 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.537 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 153.98 -160.05 29.15 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.07 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -99.29 166.3 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.36 -1.083 . . . . 0.0 109.61 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -164.63 158.93 15.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.1 Cg_exo -60.47 116.54 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.014 1.809 . . . . 0.0 109.798 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.543 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.16 -37.69 91.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 18.5 p -56.31 -23.39 36.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.902 -1.352 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 6.9 m-30 -92.49 28.23 2.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.597 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 32.7 m -137.27 170.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.101 -1.0 . . . . 0.0 109.921 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.526 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.1 pt-20 -138.66 89.66 2.39 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.501 -0.75 . . . . 0.0 109.054 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 50.6 t80 -37.75 115.78 0.44 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.641 -0.662 . . . . 0.0 110.639 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 67.6 mt -149.37 28.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -136.79 125.67 3.5 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.074 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 8.5 tpt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 72.7 m-85 -140.32 121.46 14.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -1.009 . . . . 0.0 108.863 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.466 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 2.3 tt0 -130.28 133.56 46.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.085 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -128.66 178.57 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.479 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 15.9 ttp180 -118.99 121.29 39.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -44.92 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.871 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.642 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -74.39 -64.62 0.99 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.642 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -96.71 -160.63 0.81 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -123.14 126.06 46.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.217 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 15' ' ' LYS . 92.7 t80 -128.28 131.68 48.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 12.9 mmtt -79.69 178.43 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' CG ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -98.71 68.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.956 . . . . 0.0 109.243 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -68.23 -84.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 9.2 mtm-85 -43.61 145.65 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.62 -5.62 21.06 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.257 -0.902 . . . . 0.0 109.896 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.13 7.77 25.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 109.8 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 44.4 p30 -106.16 159.39 16.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.0 109.534 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -119.44 161.21 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.354 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD2' ' CG ' ' A' ' 16' ' ' LYS . 2.7 m-20 -56.16 154.25 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 109.7 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -152.66 137.96 17.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.79 137.77 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 26.4 tp -42.81 151.07 0.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.608 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 87.31 -16.12 50.39 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 3.1 t70 -90.2 160.69 16.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -1.094 . . . . 0.0 109.168 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 4.8 mm -118.91 149.74 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 69' ' ' PHE . 8.3 mp -124.79 108.98 12.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 108.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.466 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -89.23 91.44 8.77 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.101 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.541 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 40.6 t -87.2 101.77 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.81 152.65 44.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 176.56 1.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -59.47 4.61 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -71.34 -31.74 67.72 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.357 -1.084 . . . . 0.0 109.022 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 4.9 tp -89.51 -28.54 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' CG2' ' OE2' ' A' ' 47' ' ' GLU . 55.0 t -90.17 -1.93 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.72 -12.87 18.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.555 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? -93.29 -28.24 16.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.472 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 120.83 19.1 3.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 75.6 m-85 -55.75 -168.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -1.199 . . . . 0.0 109.47 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -151.18 156.79 41.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.285 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.8 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.44 -37.0 1.67 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -87.92 -12.5 44.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.192 -1.181 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 28.2 mt-10 -83.72 12.3 6.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.898 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.573 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -107.81 -10.33 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.1 mmt180 -117.43 77.31 10.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB2' ' CA ' ' A' ' 71' ' ' GLY . 2.3 Cg_endo -61.24 -21.44 71.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.211 1.941 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -56.32 -20.55 19.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 109.357 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 mt-10 -123.83 1.42 8.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.705 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.521 HD11 ' CD2' ' A' ' 56' ' ' LEU . 9.6 mt -79.54 -30.27 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 107.62 -77.73 0.23 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 10.3 m95 -147.68 136.4 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -1.091 . . . . 0.0 109.527 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -124.03 138.3 54.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 22.6 t-20 -93.66 109.7 21.34 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -123.99 -176.62 14.76 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.14 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -114.16 110.31 19.79 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.657 -0.907 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.482 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 75.2 m-20 -78.03 82.8 4.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.983 -1.073 . . . . 0.0 108.909 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -53.36 -34.42 57.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.463 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 49.6 m -50.54 -41.67 54.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.425 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.472 HG23 ' HB3' ' A' ' 60' ' ' ASN . 1.6 t -108.35 2.68 22.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.08 47.46 89.05 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 63' ' ' THR . 73.8 mm-40 -137.02 169.68 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -1.125 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.52 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 1.1 ttt180 -140.15 156.94 46.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 22' ' ' ILE . . . 160.64 -173.18 37.14 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 5.3 t0 -97.07 160.4 14.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -1.083 . . . . 0.0 109.602 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD2' HD22 ' A' ' 30' ' ' LEU . 1.4 p90 -158.51 162.21 27.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.568 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -60.01 128.16 25.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.958 1.772 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 50' ' ' PRO . . . -71.35 -32.79 64.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' ' HA ' ' A' ' 51' ' ' GLU . 32.8 p -68.27 -7.79 33.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.985 -1.303 . . . . 0.0 109.533 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.1 m-85 -99.68 6.94 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.477 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 10.6 m -127.32 164.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.136 -0.978 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.1 pt-20 -129.22 89.0 2.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.554 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 51.8 t80 -41.02 142.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.509 -0.744 . . . . 0.0 109.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -135.25 3.73 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.456 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 135.87 -177.69 19.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.32 -1.106 . . . . 0.0 109.5 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 3.9 m-85 -79.69 81.65 5.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.335 -1.097 . . . . 0.0 108.827 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 8.8 mt-30 -84.28 141.34 31.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.276 0.56 . . . . 0.0 110.04 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -120.51 173.0 7.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.03 120.93 41.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -48.74 133.05 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.897 . . . . 0.0 110.656 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.0 mt -117.86 -39.37 3.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 19.7 m-85 -123.75 -159.02 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.594 -0.691 . . . . 0.0 109.758 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -135.38 132.46 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 109.766 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 28.3 t80 -123.9 126.97 47.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.096 -1.002 . . . . 0.0 109.547 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 24.3 ttpp -66.05 86.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -77.57 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.338 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 50.8 mtt-85 -89.0 146.08 25.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.79 -19.65 6.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -0.922 . . . . 0.0 110.017 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 3.3 pt-20 -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -90.97 169.84 10.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.361 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 67' ' ' GLY . 1.9 pt -126.79 179.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 3.3 m-20 -78.83 164.83 24.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.616 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 14.5 mt -154.15 148.6 26.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 108.714 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.9 m80 -156.06 132.66 10.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 109.823 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 11' ' ' LEU . 2.8 tt -50.8 139.27 17.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.55 -10.65 68.91 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.486 ' OD2' ' CB ' ' A' ' 25' ' ' HIS . 67.2 m-20 -79.31 -175.78 4.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -1.09 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.8 mm -133.57 125.47 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 108.946 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 20.5 mt -101.96 148.69 25.05 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.17 -0.956 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.49 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -133.25 82.56 2.0 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.882 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 8' ' ' TYR . 9.7 t -79.63 116.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.966 -1.084 . . . . 0.0 108.155 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.89 154.49 12.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.979 -1.075 . . . . 0.0 110.049 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -68.12 145.52 54.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.464 -0.772 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 -57.14 4.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -20.9 2.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.223 -1.163 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -90.11 -35.15 15.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.514 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 38.5 t -90.28 1.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.07 4.53 9.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.913 . . . . 0.0 109.98 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.602 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.7 mt -96.36 -28.99 14.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.114 -0.991 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 125.34 9.11 5.16 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.602 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 23.2 m-85 -54.64 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -1.211 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 80.3 p -125.15 -165.25 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.22 69.75 7.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.556 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.09 -31.76 0.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CG ' ' OG ' ' A' ' 43' ' ' SER . 41.4 mm-40 -68.96 -30.28 68.68 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.219 -1.165 . . . . 0.0 109.832 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -43.8 -35.92 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.97 . . . . 0.0 109.54 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.57 40.9 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -143.77 64.93 13.77 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.167 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.1 Cg_exo -58.82 -42.35 53.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.188 1.925 . . . . 0.0 110.436 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 10.1 pt-20 -61.09 -34.67 75.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -98.42 -3.52 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.53 HD11 ' CD2' ' A' ' 56' ' ' LEU . 4.3 mt -79.92 -50.42 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 108.998 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 121.62 -71.26 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.0 m95 -146.42 127.24 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.423 -1.045 . . . . 0.0 109.709 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.584 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 1.2 mp -116.21 143.7 45.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -101.63 111.69 24.01 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.561 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -138.62 -162.52 9.2 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.652 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' O ' ' OG1' ' A' ' 31' ' ' THR . 36.6 t80 -124.07 104.54 8.93 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.708 -0.877 . . . . 0.0 110.359 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -79.2 96.87 6.01 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -58.63 -33.64 70.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -0.871 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 11.6 m -49.01 -29.16 4.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 109.597 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 65' ' ' GLU . 7.8 t -127.06 5.79 6.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 59' ' ' TYR . . . 52.08 49.6 48.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' A' ' 63' ' ' THR . 35.3 mm-40 -124.98 145.43 49.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.575 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -126.1 125.59 42.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.258 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.512 ' N ' HD11 ' A' ' 22' ' ' ILE . . . 176.88 -165.85 36.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -94.41 159.93 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -1.062 . . . . 0.0 109.529 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.8 p90 -164.51 160.34 15.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.0 Cg_exo -59.98 116.5 3.35 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.102 1.868 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.584 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -66.23 -21.63 70.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.553 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 1.7 p -64.95 -16.92 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.975 -1.309 . . . . 0.0 109.81 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 9.1 m-30 -99.75 18.09 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.013 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.561 ' CG1' ' CD1' ' A' ' 30' ' ' LEU . 11.3 m -134.69 161.41 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.539 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 8.2 pt-20 -134.11 90.35 2.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.861 -1.15 . . . . 0.0 109.236 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 85.4 t80 -38.48 137.91 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -136.45 10.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 109.136 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 91.91 -106.15 3.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 0.0 109.386 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.485 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.569 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 22.5 m-85 -132.0 139.03 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -1.016 . . . . 0.0 109.039 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.17 122.47 18.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.57 177.11 4.95 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.114 -0.991 . . . . 0.0 109.854 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.1 123.09 45.94 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -49.02 106.21 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.5 mt -83.5 -29.52 27.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.888 . . . . 0.0 108.858 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -127.3 -175.48 3.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.455 -0.778 . . . . 0.0 109.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.28 179.49 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 18.0 t80 -175.0 113.1 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.353 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 146.72 30.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 18.4 tttp -53.14 112.47 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.62 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -114.5 -82.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -73.53 159.61 32.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.121 -0.987 . . . . 0.0 109.586 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -0.4 15.33 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.9 mt-10 -105.72 -4.96 20.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 18' ' ' ARG . 2.7 p-10 -112.14 167.6 10.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 67' ' ' GLY . 7.2 pt -128.0 177.59 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.6 m-20 -69.28 163.85 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -161.15 147.71 14.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.362 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.6 m80 -156.87 146.12 20.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 33.7 tp -53.04 143.2 18.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.765 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 29' ' ' ILE . . . 91.99 -31.8 5.74 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 2.2 t70 -58.52 158.76 7.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -1.088 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.5 mp -115.64 137.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 108.991 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.645 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.6 mp -117.45 125.99 51.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 109.907 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.518 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -102.46 92.94 4.89 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' CG2' ' HA3' ' A' ' 58' ' ' GLY . 91.0 t -101.57 112.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 9.4 p-10 -51.5 -177.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.159 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -86.88 -28.56 22.76 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . -67.66 -56.74 10.37 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 9.9 t -43.88 -25.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -1.183 . . . . 0.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -87.84 -40.11 14.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -0.972 . . . . 0.0 109.337 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 38' ' ' VAL . 77.3 t -77.91 -2.56 4.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.14 -34.67 14.73 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -81.14 -45.48 16.35 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.25 29.16 6.48 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.79 -79.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.714 -1.462 . . . . 0.0 108.099 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.61 157.07 24.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -84.34 68.73 10.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 108.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.03 -28.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG2' ' NE ' ' A' ' 49' ' ' ARG . 2.3 mt-30 -85.93 41.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -1.217 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 2.5 pm0 -90.1 1.87 55.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -113.15 39.81 2.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.658 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -160.2 62.78 1.87 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.9 -18.12 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.408 2.072 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.82 -35.81 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.607 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -101.49 -0.85 34.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' CG1' ' HA ' ' A' ' 50' ' ' PRO . 21.6 mt -79.87 -33.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -76.34 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.466 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 23.0 m95 -137.01 157.28 47.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -1.066 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.589 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 3.4 mp -143.39 154.75 44.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.845 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB3' ' OG ' ' A' ' 36' ' ' SER . 17.9 t-20 -114.37 109.67 18.7 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.535 ' HA3' ' CG2' ' A' ' 32' ' ' VAL . . . -133.61 -161.32 9.68 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.45 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 52.6 t80 -120.9 112.63 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.657 -0.907 . . . . 0.0 110.027 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 37.3 m-20 -79.79 80.37 6.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -40.8 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 91.2 m -57.36 -43.03 83.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 3.7 p -93.35 0.96 57.09 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.312 -0.868 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.47 44.34 67.03 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 63' ' ' THR . 26.7 mt-10 -141.09 179.09 6.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -1.193 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -152.49 146.18 25.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 109.505 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.517 ' N ' HD12 ' A' ' 22' ' ' ILE . . . 163.4 -159.6 32.2 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.972 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -92.43 166.14 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -1.046 . . . . 0.0 109.661 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 7.2 p90 -171.1 159.51 5.32 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.835 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -57.86 120.27 8.07 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.084 1.856 . . . . 0.0 110.116 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.589 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -69.67 -31.99 70.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -63.19 -18.99 64.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.908 -1.348 . . . . 0.0 109.372 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.562 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 10.7 m-30 -92.57 30.21 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.005 . . . . 0.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 35.3 m -143.8 167.32 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 5.9 pt-20 -140.49 87.53 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.25 -0.906 . . . . 0.0 109.745 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.586 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 42.1 t80 -47.88 137.66 9.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 108.746 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 70.5 mt -144.23 9.06 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . 159.27 -172.41 35.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' OXT' ' HB2' ' A' ' 7' ' ' GLN . 7.3 mtp180 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -1.072 . . . . 0.0 109.437 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.635 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 25.7 m-85 -80.23 133.25 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 109.616 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -119.14 113.57 21.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -0.795 . . . . 0.0 109.389 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.691 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.07 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.078 -1.014 . . . . 0.0 108.963 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.542 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.7 mtt85 -120.55 137.89 54.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.0 108.871 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -56.77 109.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 110.241 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -93.68 -29.71 15.29 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -128.2 -169.64 2.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.952 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 57.3 p-10 -114.93 178.35 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 67.1 t80 172.92 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.279 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 7.0 tttp -79.76 153.39 29.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.471 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' CD ' ' OD1' ' A' ' 23' ' ' ASP . 2.3 pttt -77.51 78.16 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.562 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.02 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.202 -0.936 . . . . 0.0 109.249 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -54.97 142.74 28.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -57.72 -15.67 8.63 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.06 -32.49 33.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 109.9 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -88.29 146.54 25.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.109 -0.994 . . . . 0.0 109.274 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 HD13 ' ND2' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -107.59 -169.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.671 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -73.64 153.33 40.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.848 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -141.31 129.92 22.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -147.87 133.25 18.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 3.8 tt -51.67 151.34 3.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.865 . . . . 0.0 109.721 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.16 -10.95 71.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 2.2 m-20 -90.27 -170.26 2.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.504 HG21 ' N ' ' A' ' 30' ' ' LEU . 5.0 mt -148.53 151.32 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.597 HD21 ' CE2' ' A' ' 69' ' ' PHE . 3.7 mp -134.67 130.24 36.03 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.049 -1.032 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -97.84 96.45 8.22 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 8' ' ' TYR . 51.3 t -101.46 116.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.884 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 8.1 t30 -53.12 147.41 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 108.95 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -2.77 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.138 -0.976 . . . . 0.0 109.797 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.94 -53.97 1.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 p -48.59 -22.5 0.77 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -1.132 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.559 HD23 ' CD2' ' A' ' 42' ' ' PHE . 5.4 tt -90.31 -34.86 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 0.0 109.557 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 53.8 t -87.71 0.78 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.628 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.15 -13.75 13.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.1 mm? -96.12 -23.17 16.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.583 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 118.27 23.12 3.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.559 ' CD2' HD23 ' A' ' 37' ' ' LEU . 12.0 m-85 -46.97 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -1.096 . . . . 0.0 109.612 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 t -94.56 162.88 13.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.64 96.25 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.94 -8.13 9.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.92 0.19 57.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -1.183 . . . . 0.0 109.612 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.635 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 3.1 mp0 -90.4 21.02 4.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.56 -2.46 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -126.66 86.28 58.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.5 Cg_endo -61.2 -38.22 68.06 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.248 1.966 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.9 pm0 -59.15 -17.55 27.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.145 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.8 -11.39 14.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 49' ' ' ARG . 32.6 mt -79.75 -50.17 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.43 -72.67 0.39 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.429 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 15.3 m95 -139.9 143.08 36.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -1.002 . . . . 0.0 109.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -135.86 152.27 50.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 13.1 t-20 -115.28 111.2 20.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 32' ' ' VAL . . . -134.88 -152.24 6.5 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.704 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -126.63 110.81 13.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.777 -0.837 . . . . 0.0 110.203 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' HD13 ' A' ' 22' ' ' ILE . 4.9 m-80 -78.53 82.95 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.919 -1.113 . . . . 0.0 108.822 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -52.17 -39.78 60.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.13 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 24.6 m -54.26 -46.33 72.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 109.787 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -105.93 13.29 29.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 39.81 54.43 2.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 65' ' ' GLU . 2.8 mm-40 -136.9 120.17 16.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.503 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 22' ' ' ILE . 7.2 ttp180 -92.76 151.0 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.57 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 154.09 -168.98 32.54 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.249 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -93.09 175.7 6.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.565 -0.962 . . . . 0.0 109.668 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.8 p90 -179.24 152.04 0.67 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.245 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -59.05 123.01 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.058 1.839 . . . . 0.0 109.958 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.591 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -69.41 -29.61 71.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 4.1 p -58.53 -15.01 9.39 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.839 -1.389 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 7.5 m-30 -103.29 33.22 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.025 . . . . 0.0 110.378 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 2.1 m -147.91 -179.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 9.6 pt-20 -151.06 90.37 1.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.7 t80 -52.66 123.15 10.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 109.044 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CD1' ' CD ' ' A' ' 9' ' ' ARG . 8.6 mt -112.3 -14.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 147.96 177.62 22.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.715 ' CG ' ' OH ' ' A' ' 76' ' ' TYR . 24.2 m-85 -79.31 140.25 37.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.418 -1.048 . . . . 0.0 108.643 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.521 ' CG ' HG21 ' A' ' 31' ' ' THR . 4.1 mt-30 -147.24 125.18 11.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -120.53 177.99 4.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.542 ' CB ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -114.17 170.55 8.2 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -86.52 146.57 26.33 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 109.893 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 13.3 mt -126.84 -36.99 2.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.566 ' CD1' ' HA ' ' A' ' 73' ' ' TYR . 2.5 m-85 -118.4 -163.22 0.94 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.941 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.68 170.11 10.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.539 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -174.52 116.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -86.94 34.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.938 -1.102 . . . . 0.0 110.298 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 17.4 tttt 41.55 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 42.1 mm-40 -97.25 -49.56 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.81 149.96 36.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 41.8 tt0 -69.55 -4.11 17.65 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.161 -0.962 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE2' ' OD2' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -106.32 -15.12 14.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 110.201 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 51.4 p30 -99.09 165.56 11.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.493 HD11 ' N ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -121.29 177.07 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.499 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 1.7 m-20 -70.02 171.24 9.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 14' ' ' TYR . 10.4 mt -164.76 144.97 7.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.048 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.537 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.95 125.0 4.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.43 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -47.02 129.96 12.17 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.16 -11.81 33.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 4.4 m-20 -89.73 -170.87 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' C ' HD13 ' A' ' 30' ' ' LEU . 1.3 mp -143.81 138.23 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.66 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.2 mp -116.81 124.22 49.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.521 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -96.28 103.08 14.96 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 110.648 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' ' CA ' ' A' ' 58' ' ' GLY . 96.2 t -113.8 100.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.554 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 p30 -57.73 -166.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.005 -1.06 . . . . 0.0 109.089 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -84.04 -27.18 28.51 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.027 -1.045 . . . . 0.0 110.622 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 34' ' ' LYS . . . -81.39 -53.85 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 33' ' ' ASN . 7.1 t -50.31 -22.46 1.81 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.069 -1.254 . . . . 0.0 109.437 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -88.98 -44.36 10.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 108.683 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 97.2 t -83.33 6.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -44.9 -28.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' N ' ' C ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -100.1 -29.0 12.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 136.81 -40.07 1.56 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 8.2 m-85 38.81 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.918 . . . . 0.0 109.453 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.48 145.17 31.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.877 -1.139 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -62.97 96.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 142.04 -28.23 2.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.431 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -90.41 -6.45 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -1.099 . . . . 0.0 109.32 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 2.7 mp0 -43.01 -60.03 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.361 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -84.92 46.7 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.501 -0.75 . . . . 0.0 109.859 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.02 61.51 21.73 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_exo -54.97 -48.62 20.16 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.44 2.093 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.537 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 1.1 mp0 -67.89 -34.62 76.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.158 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 1.66 56.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.958 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.579 HG21 ' CE2' ' A' ' 42' ' ' PHE . 2.7 mt -88.95 -45.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 117.06 -70.63 0.29 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.568 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 15.5 m95 -149.19 128.76 13.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -1.025 . . . . 0.0 109.078 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 1.4 mp -119.14 140.8 49.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -94.77 101.83 13.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.584 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -118.4 179.37 16.98 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.118 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.6 t80 -104.69 117.7 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.869 -0.783 . . . . 0.0 109.352 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.452 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -78.95 77.94 5.41 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.245 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -55.97 -36.12 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.53 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 18.9 m -62.95 -31.85 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 109.949 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.453 HG23 ' CE1' ' A' ' 25' ' ' HIS . 6.9 p -119.14 19.2 12.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 40.98 54.64 3.6 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.0 179.64 5.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -1.211 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 19.7 ttp85 -160.47 123.02 3.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.493 ' N ' HD11 ' A' ' 22' ' ' ILE . . . 177.2 -167.67 39.01 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.277 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 63.1 m-20 -95.26 161.83 13.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.483 -1.01 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.66 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.7 p90 -162.31 162.99 19.12 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.619 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.562 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.9 Cg_exo -59.5 113.84 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.818 1.679 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.521 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -62.99 -35.26 91.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.537 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 28.6 p -60.65 -13.68 16.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.788 -1.419 . . . . 0.0 110.118 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.566 ' HA ' ' CD1' ' A' ' 12' ' ' TYR . 7.7 m-30 -97.54 15.78 22.29 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.976 -1.077 . . . . 0.0 112.087 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 71' ' ' GLY . 12.2 m -126.81 -179.73 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.633 -1.292 . . . . 0.0 109.951 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HG3' ' CB ' ' A' ' 9' ' ' ARG . 4.2 pt-20 -143.72 91.67 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 109.103 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' OH ' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -31.58 162.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.256 1.027 . . . . 0.0 112.961 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 34.3 mm -155.01 14.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -118.33 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 mtt85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.52 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 31.1 m-85 -80.09 112.65 17.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -1.146 . . . . 0.0 109.548 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 2.6 mt-30 -98.98 121.34 40.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.67 175.58 5.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.016 . . . . 0.0 109.653 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 36.4 ttt180 -114.85 141.46 47.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -68.06 108.41 3.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.946 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.1 mt -82.0 -31.26 31.16 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.5 m-85 -129.77 -160.15 1.01 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.48 -0.763 . . . . 0.0 109.468 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -134.41 109.85 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.547 ' HB3' ' CG ' ' A' ' 24' ' ' LEU . 66.4 t80 -105.07 128.89 53.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.93 158.47 26.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.891 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -80.83 72.63 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.033 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.0 108.821 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB3' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -90.51 159.09 16.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.132 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HA ' ' CE ' ' A' ' 16' ' ' LYS . 32.3 tp10 -55.3 -28.75 55.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.531 ' CG ' ' HB3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -53.2 -40.6 64.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.999 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -99.93 162.5 12.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 ' CA ' ' A' ' 67' ' ' GLY . 35.6 pt -114.75 -168.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.925 . . . . 0.0 110.176 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -99.24 99.31 10.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 0.0 109.379 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -110.17 147.1 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 108.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -145.91 148.23 32.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -48.5 136.32 13.05 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.354 -0.841 . . . . 0.0 109.785 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 93.49 -5.03 73.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 6.7 t0 -90.39 145.9 24.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -1.132 . . . . 0.0 109.514 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.8 mm -96.58 132.06 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -0.923 . . . . 0.0 109.211 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.4 mp -110.34 114.56 28.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.319 -0.863 . . . . 0.0 108.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -92.16 96.86 10.56 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.902 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.585 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 64.3 t -102.59 108.05 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.885 . . . . 0.0 109.375 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 4.8 t30 -47.6 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -71.81 -62.76 1.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.54 99.7 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 33' ' ' ASN . 34.7 m -52.21 -19.8 2.23 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.351 -1.088 . . . . 0.0 109.827 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 5.6 tt -88.96 -36.08 16.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 40.2 t -90.42 1.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.28 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.17 47.88 1.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.887 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.42 56.61 14.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 3.8 m-85 -89.04 -166.89 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.467 ' HB3' ' HG2' ' A' ' 46' ' ' GLN . 7.2 t -133.65 141.9 47.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 108.984 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.35 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.63 -30.48 1.03 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.522 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -88.23 34.4 0.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.683 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE1' ' OH ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -90.14 -17.45 27.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . -126.16 14.77 7.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.2 mtt180 -121.66 74.8 34.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.1 Cg_exo -54.45 -52.79 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.197 1.931 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.2 OUTLIER -52.39 -28.21 18.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 49' ' ' ARG . 2.7 mt-10 -109.43 44.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' CG2' ' CE2' ' A' ' 42' ' ' PHE . 6.7 mt -130.98 -42.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 108.894 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 112.47 -76.52 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 32.7 m95 -147.35 131.33 17.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -1.068 . . . . 0.0 109.244 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.584 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -117.67 160.45 21.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 32' ' ' VAL . 13.8 t-20 -113.0 111.19 21.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -133.17 -170.57 12.47 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.45 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 61.4 t80 -116.78 113.22 22.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.572 -0.958 . . . . 0.0 110.188 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -79.27 77.98 5.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' A' ' 61' ' ' GLU . 3.7 tm-20 -52.92 -36.32 59.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.458 -0.776 . . . . 0.0 110.289 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 20.8 m -55.23 -38.48 68.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 109.982 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.447 HG22 ' CE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -113.01 20.48 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.48 53.88 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.79 172.08 13.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 22' ' ' ILE . 32.2 ttm-85 -156.19 144.6 19.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.53 ' CA ' HG22 ' A' ' 22' ' ' ILE . . . 159.78 -152.95 23.93 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.025 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 72.7 m-20 -100.65 162.46 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -1.025 . . . . 0.0 109.916 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.646 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.9 p90 -161.97 158.97 21.85 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.591 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -58.84 125.73 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.093 1.862 . . . . 0.0 110.146 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.549 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -68.26 -44.16 76.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.434 ' CG2' ' HA ' ' A' ' 51' ' ' GLU . 33.5 p -61.68 -12.12 14.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.998 -1.296 . . . . 0.0 109.615 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.4 m-85 -92.95 18.58 8.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.996 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 12.4 m -140.02 -176.04 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.219 -0.926 . . . . 0.0 109.793 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 77' ' ' ILE . 7.8 pt-20 -155.1 89.28 1.21 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 6' ' ' TYR . 48.8 t80 -46.14 120.68 2.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.613 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 1.1 mp -152.36 20.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.56 111.57 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.45 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 12.1 mtm105 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.13 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 25.3 m-85 -79.55 93.35 5.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -1.12 . . . . 0.0 109.75 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.9 mt-30 -89.69 129.97 36.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 0.0 108.622 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.35 179.05 4.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.924 -1.11 . . . . 0.0 109.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.38 136.33 53.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 28' ' ' ASP . . . -76.31 137.76 40.07 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 110.436 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -122.94 -32.66 3.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 4.4 m-85 -112.74 -163.13 0.83 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -137.51 112.6 9.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.965 -1.084 . . . . 0.0 110.153 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 17.2 t80 -100.42 158.33 15.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.052 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.77 149.61 30.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 0.0 109.42 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HB2' ' CG ' ' A' ' 23' ' ' ASP . 14.9 tttp -82.23 70.77 9.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -55.94 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -79.76 142.28 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -64.08 -9.75 18.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.213 -0.93 . . . . 0.0 109.935 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 3.3 mm-40 -103.82 19.7 19.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.983 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 11.6 p-10 -124.71 172.51 9.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.495 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -130.9 154.87 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -68.94 110.34 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -104.55 148.92 25.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.201 -0.937 . . . . 0.0 109.277 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -160.17 130.47 5.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.175 -0.953 . . . . 0.0 109.372 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -42.93 137.14 2.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.322 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -1.07 81.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 37.2 t0 -90.72 131.59 36.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.426 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 46.2 mm -87.99 132.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.973 -1.079 . . . . 0.0 109.284 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.66 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 9.0 mp -107.68 139.87 41.58 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.325 -0.86 . . . . 0.0 108.993 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -116.29 99.25 7.07 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.005 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.518 HG21 ' CA ' ' A' ' 58' ' ' GLY . 52.6 t -107.74 95.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 73.8 m-20 -45.42 136.1 5.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 109.953 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -70.14 160.77 31.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.44 -60.82 4.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -20.65 55.78 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.377 -1.072 . . . . 0.0 108.513 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 4.5 tp -85.68 -29.32 24.08 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.479 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 38.9 t -84.77 -1.23 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -0.41 15.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -103.98 12.75 33.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 109.648 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.74 15.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 17.2 m-85 -72.35 -168.92 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.662 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.454 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 94.9 p -125.51 166.04 17.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.835 . . . . 0.0 109.287 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -72.27 98.58 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.646 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.22 13.27 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 53' ' ' ILE . 1.6 mt-30 -89.89 -21.91 22.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -1.22 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CB ' HD22 ' A' ' 37' ' ' LEU . 3.5 pt-20 -65.7 -8.27 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.274 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.451 ' C ' ' HD3' ' A' ' 50' ' ' PRO . . . -108.11 -4.97 17.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.981 -1.074 . . . . 0.0 110.036 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.494 ' O ' HG13 ' A' ' 53' ' ' ILE . 32.5 mmt-85 -117.96 72.33 8.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.9 Cg_exo -54.2 -33.19 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.279 1.986 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' HG21 ' A' ' 72' ' ' THR . 3.0 pt-20 -64.21 -40.16 95.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.056 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 61.7 mt-10 -85.33 4.76 33.65 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 109.526 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 56' ' ' LEU . 8.6 mt -94.24 -52.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -77.04 0.3 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.428 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 14.2 m95 -134.09 147.2 50.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -1.028 . . . . 0.0 109.063 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -140.38 158.24 44.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 28.5 t-20 -113.9 109.35 18.37 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.518 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -132.74 -161.3 9.86 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.66 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 54.1 t80 -127.18 114.19 17.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 110.182 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -79.75 96.35 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.121 -0.987 . . . . 0.0 108.615 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -60.35 -40.87 92.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 22.9 m -59.28 -22.12 60.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.988 -1.07 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -120.62 6.12 10.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 45.01 37.66 5.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' OE2' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -114.76 173.86 6.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.168 . . . . 0.0 109.462 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 1.6 ttp85 -153.25 130.87 11.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.137 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 169.55 -158.04 30.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.174 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-20 -92.79 165.46 12.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -1.013 . . . . 0.0 110.0 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.66 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -171.79 153.13 3.24 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.96 123.35 12.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.025 1.817 . . . . 0.0 110.063 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.583 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -72.18 -30.3 65.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 51' ' ' GLU . 2.3 p -67.02 -7.88 25.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -1.207 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.582 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.1 m-85 -98.67 10.88 40.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' C ' ' CD2' ' A' ' 11' ' ' LEU . 2.9 m -130.9 -165.96 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.755 0.788 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.501 ' CG ' ' CB ' ' A' ' 9' ' ' ARG . 8.2 pt-20 -160.05 90.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.8 t80 -38.16 120.6 0.89 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.506 -0.747 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 9' ' ' ARG . 45.8 mm -106.62 -19.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.97 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 129.27 -130.32 6.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.26 -1.141 . . . . 0.0 109.449 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 39.1 m-85 -148.35 111.98 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -1.155 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -99.83 120.24 39.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.557 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.1 178.59 4.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.975 -1.078 . . . . 0.0 109.868 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.94 147.96 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -75.51 106.64 7.16 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 110.126 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.7 mt -84.97 -26.34 27.21 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 23.5 m-85 -135.82 -160.71 1.08 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.538 -0.726 . . . . 0.0 109.711 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 24' ' ' LEU . 10.1 p-10 -135.67 143.26 45.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.593 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 10.7 t80 -116.67 163.91 15.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.188 -0.945 . . . . 0.0 108.626 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 8.9 mmtt -104.57 -19.58 13.95 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.053 -1.03 . . . . 0.0 110.551 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER 75.24 81.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.068 . . . . 0.0 109.236 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -84.42 -54.96 4.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.731 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' CG ' ' A' ' 21' ' ' ASP . 1.1 tpt180 -87.97 162.35 16.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.71 -3.6 19.4 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 7.1 pt-20 -99.61 14.81 28.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.083 -1.011 . . . . 0.0 109.773 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -127.68 163.42 24.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.149 -0.969 . . . . 0.0 109.417 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.537 HD11 ' N ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -128.33 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 110.116 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.576 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -58.99 119.45 7.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.572 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.2 mm? -97.28 159.38 14.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 109.169 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.1 m80 -159.44 125.38 4.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.865 . . . . 0.0 109.4 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.8 tp -50.62 128.29 20.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.74 28.28 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.3 p30 -90.02 -179.9 5.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.272 . . . . 0.0 109.967 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' CG2' ' OE1' ' A' ' 7' ' ' GLN . 33.5 mm -127.54 149.2 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.599 HD22 ' CE2' ' A' ' 69' ' ' PHE . 10.3 mp -123.84 123.34 40.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.013 -1.054 . . . . 0.0 110.387 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.474 HG21 ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -99.7 86.61 3.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' CE2' ' A' ' 8' ' ' TYR . 67.7 t -96.56 116.35 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -56.52 162.83 2.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 108.475 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.7 ptmt -90.5 -25.61 20.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.01 -1.056 . . . . 0.0 110.327 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.65 -58.83 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -50.19 -22.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -1.151 . . . . 0.0 110.05 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.586 HD22 ' CE1' ' A' ' 42' ' ' PHE . 4.1 tt -90.31 -32.73 16.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 109.707 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 51.3 t -82.34 -0.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 109.751 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.2 -21.18 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.198 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.14 37.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.516 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.96 49.58 17.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' A' ' 37' ' ' LEU . 2.3 m-85 -59.38 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.177 -1.19 . . . . 0.0 109.267 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -128.56 150.79 50.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.138 -0.977 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.55 120.81 10.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.07 -33.41 6.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.504 ' O ' ' CG1' ' A' ' 53' ' ' ILE . 10.2 mt-30 -65.9 -11.93 50.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -1.147 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 14.9 mm-40 -81.13 -22.38 39.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.626 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.18 -4.96 58.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.1 mmp_? -117.14 74.13 7.27 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.7 Cg_exo -54.99 -32.17 77.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.2 1.934 . . . . 0.0 110.489 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HA ' HG21 ' A' ' 72' ' ' THR . 6.7 pt-20 -62.24 -35.98 80.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.942 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.3 mt-10 -95.57 -3.74 45.92 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.162 -0.961 . . . . 0.0 110.017 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 56' ' ' LEU . 31.6 mt -79.6 -36.92 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 109.361 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 108.15 -76.52 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m95 -143.77 132.81 22.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -1.137 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.571 ' CD1' ' HA2' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -117.42 142.3 47.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.798 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -105.97 111.77 24.55 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 32' ' ' VAL . . . -139.49 -161.27 8.66 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.413 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 67.2 t80 -115.5 114.22 24.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.626 -0.926 . . . . 0.0 110.553 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.1 m-20 -78.09 79.02 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -42.68 -44.69 4.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 3.4 m -46.57 -69.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.105 -0.997 . . . . 0.0 109.876 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.535 ' CG2' ' HG3' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -81.05 6.03 14.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.971 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.42 48.43 60.17 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.576 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 2.7 mt-10 -121.27 173.11 7.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.278 . . . . 0.0 109.282 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.58 118.0 6.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 109.341 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' ND2' ' A' ' 57' ' ' ASN . . . -176.4 -150.76 8.38 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 7.5 m-20 -108.83 165.21 11.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -1.056 . . . . 0.0 109.829 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CE2' HD22 ' A' ' 30' ' ' LEU . 1.9 p90 -165.87 161.82 13.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.385 -0.822 . . . . 0.0 109.011 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -57.92 126.92 23.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.936 1.757 . . . . 0.0 110.033 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -71.98 -33.97 62.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 51' ' ' GLU . 2.0 p -65.48 -9.03 22.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.083 -1.245 . . . . 0.0 109.218 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -98.3 16.4 21.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.899 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 6.1 m -136.49 -175.45 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.18 -0.95 . . . . 0.0 109.612 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.51 ' O ' HG13 ' A' ' 77' ' ' ILE . 11.3 pt-20 -156.61 87.26 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.87 . . . . 0.0 109.808 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.514 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 58.3 t80 -46.18 135.8 7.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.369 -0.832 . . . . 0.0 109.753 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -135.38 17.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.067 -1.021 . . . . 0.0 109.468 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA2' ' OH ' ' A' ' 76' ' ' TYR . . . 116.52 -147.17 18.91 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.455 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 87.9 m-85 -79.58 121.21 24.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.46 -1.024 . . . . 0.0 108.885 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 1.3 mt-30 -118.87 115.67 24.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.883 -1.136 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.99 -178.98 3.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.905 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -121.64 132.43 54.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -57.65 164.43 2.05 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 109.932 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 HD13 ' CG ' ' A' ' 75' ' ' GLU . 14.1 mt -138.49 -40.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 5.2 m-85 -117.3 -159.66 0.74 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.128 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 11.5 p-10 -119.71 168.18 11.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 110.275 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CB ' ' CD2' ' A' ' 24' ' ' LEU . 2.0 t80 -171.91 119.22 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.509 -0.744 . . . . 0.0 109.195 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' LYS . 16.8 mttm -93.67 49.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.833 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 9.7 ttmt 42.2 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 3.2 mt-10 -73.23 -81.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.276 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 8.1 mmt180 -88.96 150.52 22.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.0 109.388 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -47.12 -23.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.823 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.77 -48.68 68.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.965 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 34.7 p30 -82.38 173.15 12.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.53 HD13 ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -127.71 -171.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.0 m-20 -93.75 115.04 27.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -121.32 150.21 41.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.528 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -150.21 149.36 30.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.047 -1.033 . . . . 0.0 109.769 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 11' ' ' LEU . 2.1 tp -42.47 136.46 2.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 85.62 2.28 87.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 13.5 t0 -90.41 117.25 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -1.174 . . . . 0.0 109.213 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.8 mp -79.97 134.98 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 69' ' ' PHE . 6.9 mp -113.46 136.8 52.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.439 ' CG2' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -115.65 89.31 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 111.008 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CG2' ' OH ' ' A' ' 8' ' ' TYR . 1.5 t -89.4 106.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 108.841 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -50.75 157.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -73.3 156.28 38.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 -56.93 4.83 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -51.04 -23.28 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.218 -1.166 . . . . 0.0 109.66 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.632 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.49 -34.21 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 52.5 t -89.13 1.79 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.746 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.62 -8.21 25.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.76 18.62 21.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.311 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.77 38.78 60.7 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.632 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.6 m-85 -57.8 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.525 ' O ' ' C ' ' A' ' 44' ' ' ASP . 27.2 t -125.08 97.69 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.72 93.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.297 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.03 -14.76 4.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 43' ' ' SER . 5.8 mt-30 -90.68 2.14 56.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.778 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 1.3 mp0 -65.7 -23.23 66.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -103.21 19.04 20.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.526 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mmt180 -130.93 65.2 76.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.212 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.38 -33.49 97.86 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.162 1.908 . . . . 0.0 110.342 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 21.1 pt-20 -58.61 -29.8 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 109.597 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 -0.13 24.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.53 HG21 ' CE2' ' A' ' 42' ' ' PHE . 6.2 mt -79.92 -39.22 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 111.66 -73.45 0.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 11.2 m95 -148.1 140.98 24.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.467 -1.02 . . . . 0.0 109.123 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.609 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -130.8 132.9 45.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.0 110.019 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -99.82 105.37 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -131.6 -156.2 8.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.621 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -115.66 111.49 20.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.451 -1.029 . . . . 0.0 110.774 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.538 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 3.2 m-80 -79.59 80.4 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 108.603 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -44.56 -44.84 9.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -46.49 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.03 . . . . 0.0 109.957 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.489 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 14.7 p -83.36 12.71 5.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.87 43.31 6.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.473 ' OE1' HG21 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.91 117.14 25.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -1.141 . . . . 0.0 109.314 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 15.9 ttm180 -94.99 138.06 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 168.18 -174.0 43.01 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.248 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -90.02 152.82 21.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.72 -0.871 . . . . 0.0 109.859 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.5 p90 -155.36 161.16 30.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 0.0 109.121 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.581 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.67 127.42 23.54 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.929 1.753 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.544 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -72.12 -32.29 63.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -69.56 -8.66 49.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.239 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.69 -1.24 50.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 71' ' ' GLY . 5.9 m -122.73 -174.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' HD13 ' A' ' 11' ' ' LEU . 2.5 pt-20 -156.75 88.66 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 81.9 t80 -34.48 128.94 0.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.242 0.544 . . . . 0.0 109.973 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -116.78 0.86 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.946 . . . . 0.0 109.396 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 97.95 -115.02 5.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 7.3 m-85 -81.76 141.74 33.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.438 -1.037 . . . . 0.0 108.975 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.485 ' NE2' HG22 ' A' ' 31' ' ' THR . 2.9 mt-30 -144.88 116.81 8.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.662 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.94 179.78 3.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.525 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 12.6 mtm180 -114.83 168.72 9.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.328 -0.858 . . . . 0.0 108.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -90.2 97.77 11.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.604 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -67.51 -30.72 70.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.086 -1.008 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.604 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -129.47 -168.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.439 -0.788 . . . . 0.0 109.725 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -130.79 98.25 4.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 32.1 t80 -88.41 152.29 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.785 . . . . 0.0 109.323 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 151.69 20.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.953 . . . . 0.0 109.425 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.6 ttpt -72.92 85.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.408 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' CG ' ' OH ' ' A' ' 14' ' ' TYR . 1.7 pp20? -117.86 -35.22 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -71.99 138.38 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.1 tt0 -56.41 -15.89 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 3.5 tt0 -129.65 36.98 4.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 110.11 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 1.1 p-10 -122.53 161.66 23.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.062 -1.024 . . . . 0.0 109.531 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.508 HG13 ' CD2' ' A' ' 24' ' ' LEU . 1.6 pt -116.11 170.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.92 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.574 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -79.51 100.8 7.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.218 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.5 mm? -88.06 133.42 33.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.8 m80 -135.08 139.2 44.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.6 tt -56.33 123.37 14.39 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.35 -0.844 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.93 -5.56 39.71 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -90.34 167.04 12.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 109.066 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.529 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.7 mp -125.52 147.71 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 5.9 mp -122.77 127.55 49.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.237 -0.914 . . . . 0.0 108.789 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.485 HG22 ' NE2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -97.91 93.65 6.45 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 109.942 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.611 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 87.4 t -90.31 114.39 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -58.02 173.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -37.66 66.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.275 -0.89 . . . . 0.0 109.741 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.56 -44.09 8.81 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.459 ' OG ' HG11 ' A' ' 32' ' ' VAL . 79.2 p -51.83 -21.43 2.87 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 47' ' ' GLU . 1.6 tm? -85.21 -35.97 21.27 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 79.5 t -85.68 4.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.768 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.83 -5.19 11.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.664 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -100.16 -45.21 5.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 109.166 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 123.95 17.16 3.13 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.664 ' CE2' ' CD2' ' A' ' 40' ' ' LEU . 10.0 m-85 -59.37 -151.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 108.969 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.58 166.62 16.36 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.311 -0.868 . . . . 0.0 108.854 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.65 87.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.03 -17.15 1.37 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.466 ' O ' HD12 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -89.55 20.91 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.235 . . . . 0.0 109.629 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 13.1 mt-10 -89.75 -43.11 10.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.866 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.92 38.47 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -156.25 66.55 4.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.924 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' CG ' HG22 ' A' ' 74' ' ' VAL . 3.1 Cg_exo -59.64 -46.43 20.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.244 1.963 . . . . 0.0 110.413 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -44.31 -26.69 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.244 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.52 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tt0 -111.64 50.57 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.178 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 57.9 mt -141.85 -69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 142.03 -63.31 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 43.0 m95 -152.33 140.08 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -1.088 . . . . 0.0 109.38 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.585 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -131.66 159.87 37.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.938 . . . . 0.0 109.763 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.4 t-20 -114.29 110.38 19.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 32' ' ' VAL . . . -131.18 -168.85 12.29 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.203 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 40.0 t80 -111.52 114.66 27.89 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -80.63 75.21 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.028 . . . . 0.0 108.952 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.22 -33.88 21.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.5 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 16.4 m -55.39 -45.22 76.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.7 OUTLIER -113.99 18.0 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.65 39.48 4.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 11.5 mt-10 -123.7 109.04 13.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.146 . . . . 0.0 109.135 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 17.6 ptt180 -92.63 143.97 25.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.729 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' CA ' HG22 ' A' ' 22' ' ' ILE . . . 168.67 -162.24 36.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -93.87 163.4 13.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -1.042 . . . . 0.0 109.382 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.585 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 3.8 p90 -163.63 158.64 17.25 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.76 124.43 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.133 1.888 . . . . 0.0 109.973 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -68.74 -40.92 85.01 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p -65.08 -12.06 46.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -1.204 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.0 m-85 -94.2 15.25 17.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.782 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 28.1 m -132.37 179.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.525 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.4 pt-20 -151.5 88.43 1.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 38.1 t80 -45.08 122.64 3.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 74.7 mt -148.36 27.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -150.19 120.68 1.16 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.268 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.493 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 20.2 mtt85 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.464 -1.021 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 23.5 m-85 -78.1 113.52 16.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.06 . . . . 0.0 109.384 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.1 mt-30 -108.99 123.75 49.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.67 179.23 4.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.963 -1.085 . . . . 0.0 108.657 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 1.3 mtt180 -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -58.31 122.9 14.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.037 -1.039 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.8 mt -99.31 -34.07 10.47 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.0 m-85 -123.23 -166.72 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -0.807 . . . . 0.0 109.902 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 45.8 p30 -108.38 165.44 11.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.915 . . . . 0.0 109.839 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.515 ' CB ' HD21 ' A' ' 24' ' ' LEU . 7.7 t80 -173.81 106.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.405 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 12.5 ptmm? -83.57 11.58 6.95 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.649 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 69.72 115.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.223 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -90.66 -64.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.29 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.17 162.09 15.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.76 -10.87 22.06 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.96 -25.61 48.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -105.04 161.55 14.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 pp -118.84 -176.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.465 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 4.7 m-20 -73.92 -179.83 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER 172.91 152.68 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.543 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.51 144.35 18.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.2 tt -48.9 148.21 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 83.57 -7.34 69.38 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.528 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 3.0 m-20 -88.06 -175.25 5.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' N ' ' A' ' 29' ' ' ILE . 2.4 mp -137.5 146.6 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.638 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.6 mp -122.38 120.84 35.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.228 -0.92 . . . . 0.0 109.125 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.93 91.49 7.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.864 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.587 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 87.8 t -99.87 110.63 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.0 109.024 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -63.4 147.77 50.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.789 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 161.66 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.353 -0.842 . . . . 0.0 109.573 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 -59.87 4.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 m -52.66 -24.98 9.54 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.216 -1.167 . . . . 0.0 109.184 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.59 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 3.2 tt -90.27 -29.36 18.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.814 . . . . 0.0 109.347 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 96.8 t -89.2 0.56 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.34 -8.33 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' CE1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -91.99 -17.07 25.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.718 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.38 23.07 3.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.2 m-85 -57.36 -171.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -1.15 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.9 -173.67 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.377 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.36 87.36 7.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 -31.78 2.5 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -53.8 -20.38 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -49.97 -54.47 19.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.627 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -85.31 59.31 5.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.431 -0.793 . . . . 0.0 110.033 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -153.06 57.49 2.03 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 3.3 Cg_exo -49.85 -46.89 25.56 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.463 ' HA ' HG21 ' A' ' 72' ' ' THR . 8.4 pt-20 -60.2 -33.68 72.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.06 -1.025 . . . . 0.0 109.311 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' CD ' ' HG2' ' A' ' 49' ' ' ARG . 5.4 mt-10 -99.89 1.82 43.19 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 49' ' ' ARG . 2.5 mt -94.36 -34.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 108.895 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.39 -80.52 0.31 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -140.56 144.77 36.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -1.082 . . . . 0.0 109.083 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -128.77 159.83 34.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 15.6 t-20 -118.41 114.47 22.96 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.532 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -135.9 -160.01 8.71 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.291 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 44.5 t80 -126.17 110.03 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.669 -0.901 . . . . 0.0 109.787 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 1.2 m-20 -79.29 85.49 5.13 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.128 -0.982 . . . . 0.0 109.371 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.49 -34.94 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.528 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 24.4 m -51.12 -33.82 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.639 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.6 t -121.74 7.07 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.62 47.0 87.91 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -118.26 163.22 17.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -1.187 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 9.1 ttp180 -148.47 127.72 12.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 167.09 -159.42 32.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.603 -1.284 . . . . 0.0 109.952 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -96.08 167.38 11.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.804 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -165.57 159.71 13.67 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.231 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.1 Cg_exo -61.62 122.55 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.073 1.848 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -69.7 -41.83 73.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 51' ' ' GLU . 2.4 p -60.46 -12.18 8.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.316 . . . . 0.0 109.408 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.6 m-85 -98.56 22.12 10.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.127 -0.983 . . . . 0.0 110.533 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 15.4 m -138.39 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 6.4 pt-20 -148.55 84.07 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -32.54 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.758 0.79 . . . . 0.0 112.155 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 15.1 mm -129.61 -9.69 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 79' ' ' ARG . . . 81.93 -151.79 30.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.629 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 18.5 m-85 -86.45 123.28 31.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -1.135 . . . . 0.0 109.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.542 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -127.72 138.86 52.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 109.712 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -137.29 179.64 6.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.967 . . . . 0.0 109.672 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 29' ' ' ILE . 1.4 mtm-85 -111.42 161.85 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.68 102.19 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 110.502 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.599 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 2.9 mt -75.14 -39.5 60.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.1 m-85 -128.01 172.47 10.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.882 . . . . 0.0 109.855 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 9.3 p-10 -99.6 146.63 26.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 109.677 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 71.8 t80 -125.24 166.21 16.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -108.24 139.32 43.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 109.423 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 15.5 ttpp -83.3 72.87 10.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 108.928 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -90.27 153.71 20.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.152 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.41 -26.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 18' ' ' ARG . 2.0 mt-10 -53.94 -59.67 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.4 p30 -77.06 169.46 18.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.81 . . . . 0.0 109.571 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 1.3 pp -127.77 161.77 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 0.0 109.893 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 4.5 m-20 -74.17 126.44 30.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.574 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 69' ' ' PHE . 19.0 mt -115.46 160.51 19.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.538 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 2.2 m80 -156.56 149.95 24.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.52 137.52 56.19 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 109.386 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.98 -31.11 5.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 9.7 t0 -59.48 131.55 51.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -1.107 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CD1' ' HD3' ' A' ' 9' ' ' ARG . 9.8 mm -93.26 140.46 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.651 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 9.8 mp -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.134 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.5 87.09 2.47 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.437 -0.789 . . . . 0.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 8' ' ' TYR . 37.7 t -82.85 96.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -50.44 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.385 -0.822 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -86.93 154.08 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.626 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.516 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 88.43 -50.8 3.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -26.19 63.33 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.283 -1.128 . . . . 0.0 109.821 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 2.2 tt -90.14 -35.97 15.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 48.5 t -87.32 0.29 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.85 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.24 -13.99 15.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -104.05 32.2 4.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.744 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.21 51.27 55.29 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 5.5 m-85 -70.83 -176.67 1.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -116.58 158.43 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -73.51 82.91 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.25 -36.94 0.6 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.1 29.31 1.24 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -90.1 -31.3 17.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.734 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . -107.28 42.07 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.763 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.8 tpt180 -138.41 73.42 42.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.599 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 6.1 Cg_exo -56.75 -48.35 19.09 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.688 2.259 . . . . 0.0 111.878 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -56.64 -16.31 6.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.848 -1.158 . . . . 0.0 109.811 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -120.17 -5.41 9.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 109.8 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 49' ' ' ARG . 12.0 mt -79.86 -43.52 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.013 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.41 -76.39 0.26 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 30.7 m95 -143.74 132.75 22.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -1.045 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -119.87 158.61 26.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 110.027 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 21.1 t-20 -119.3 111.36 18.1 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -135.15 -151.7 6.32 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 31.0 t80 -130.73 113.36 14.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.915 -0.756 . . . . 0.0 109.978 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -80.71 82.07 6.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.0 109.17 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -49.51 -37.12 25.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.946 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -53.0 -44.39 67.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.647 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.43 ' HB ' ' OE1' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -110.43 15.86 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.75 41.49 7.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' OE1' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -106.99 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -1.139 . . . . 0.0 109.558 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.568 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 10.8 ttt180 -156.85 130.29 8.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 161.33 -162.91 34.15 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -92.9 174.74 7.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.991 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.651 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 22.3 p90 178.98 157.47 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 109.333 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.72 115.52 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.021 1.814 . . . . 0.0 109.657 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.594 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -67.84 -30.0 74.08 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 18.7 p -49.49 -20.67 0.77 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.817 -1.402 . . . . 0.0 109.935 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 18.2 m-85 -97.54 33.76 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 111.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.599 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 16.5 m -145.41 174.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.035 -1.041 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 9' ' ' ARG . 4.9 pt-20 -148.66 93.01 2.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t80 -37.34 119.57 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.372 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 14.2 mm -144.99 15.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.32 100.72 0.46 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.417 -1.049 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 28.5 m-85 -143.31 148.22 35.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.52 -0.988 . . . . 0.0 108.472 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.476 ' CG ' HG21 ' A' ' 31' ' ' THR . 9.9 mt-30 -137.63 107.58 6.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 110.074 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.668 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.47 172.87 6.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.114 -0.991 . . . . 0.0 108.651 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 23.1 ttt180 -109.22 166.3 10.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -0.972 . . . . 0.0 108.954 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -90.64 99.36 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.024 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -80.62 -35.1 34.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.147 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 26.0 m-85 -130.76 171.3 13.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.883 . . . . 0.0 109.822 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -97.88 -177.26 3.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 65.6 t80 173.6 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -80.02 143.17 34.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 14.1 pttp -59.32 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -66.18 -70.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 5.4 mtt180 -75.89 164.39 26.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.69 1.48 10.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 1.1 tp10 -104.81 -6.08 20.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.038 -1.039 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.476 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -102.35 154.31 19.18 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 109.824 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.475 ' CD1' HD22 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -108.01 -171.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 0.0 109.391 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.97 142.19 33.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.481 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 1.6 mm? -131.97 138.1 48.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.481 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -153.13 136.79 16.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -49.0 135.58 15.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 96.28 -3.69 64.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 5.1 t70 -90.12 148.97 22.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 17.6 mm -101.68 132.15 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.859 . . . . 0.0 108.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.596 HD21 ' CE2' ' A' ' 69' ' ' PHE . 6.5 mp -114.21 111.72 22.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -91.44 96.01 10.28 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.222 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 8' ' ' TYR . 78.4 t -98.32 101.1 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.0 m-80 -46.99 173.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 109.891 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 1.2 ttpm? -90.35 -27.46 19.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.04 -53.92 3.55 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -54.54 -24.51 21.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.217 -1.167 . . . . 0.0 109.664 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 tp -90.28 -40.83 11.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.512 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 47.4 t -79.93 0.38 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.907 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 -6.53 24.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -102.85 8.41 39.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.705 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.63 32.24 38.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 24.6 m-85 -58.29 -168.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.39 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.07 167.89 14.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.539 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.0 107.67 7.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.55 19.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.461 ' O ' HD12 ' A' ' 53' ' ' ILE . 11.7 mm-40 -82.19 -41.15 20.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.261 -1.14 . . . . 0.0 109.579 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 pm0 -42.51 -43.89 3.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.442 -0.786 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -85.54 43.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -151.53 62.63 5.01 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HB2' HG21 ' A' ' 74' ' ' VAL . 2.8 Cg_exo -54.64 -55.55 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.469 2.113 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -48.7 -23.45 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.032 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.0 mt-10 -121.44 48.37 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.526 ' CD1' HD22 ' A' ' 56' ' ' LEU . 4.9 mt -133.08 -43.91 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -75.65 0.26 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.521 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 48.5 m95 -144.19 123.57 13.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.378 -1.072 . . . . 0.0 109.576 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -112.95 156.47 22.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' HG23 ' A' ' 32' ' ' VAL . 14.5 t-20 -112.21 107.69 16.65 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.533 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -130.18 -163.94 11.21 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.457 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.0 t80 -122.32 113.27 19.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.767 -0.843 . . . . 0.0 110.147 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 1.2 m120 -78.96 82.71 5.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.192 -0.943 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -45.19 -41.93 8.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.067 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m -47.88 -69.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.459 HG21 ' HB2' ' A' ' 60' ' ' ASN . 1.7 t -79.76 4.91 14.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.963 . . . . 0.0 109.698 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.75 50.15 38.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -128.84 171.52 12.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -1.128 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.426 ' C ' HG22 ' A' ' 22' ' ' ILE . 12.2 ttp85 -143.21 143.8 31.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.88 -167.36 37.25 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.573 -1.298 . . . . 0.0 109.923 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 21' ' ' ASP . 4.0 p30 -91.49 171.85 8.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -1.062 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 30' ' ' LEU . 13.5 p90 -175.13 154.01 1.64 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.875 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -58.4 124.51 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.985 1.79 . . . . 0.0 109.765 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' CA ' HD12 ' A' ' 56' ' ' LEU . . . -71.62 -18.83 77.49 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -70.49 -13.85 62.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.694 -1.474 . . . . 0.0 109.68 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 10.7 m-30 -99.9 19.3 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 2.7 m -132.39 -174.02 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.81 -1.181 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.51 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.8 pt-20 -158.19 88.02 0.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.557 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 14.2 t80 -43.13 133.31 3.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.907 . . . . 0.0 109.31 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.521 HD13 ' N ' ' A' ' 9' ' ' ARG . 2.8 mp -129.06 -4.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.876 -1.14 . . . . 0.0 109.931 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 171.66 167.29 31.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.518 ' CA ' ' OH ' ' A' ' 76' ' ' TYR . 2.6 ptt-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.54 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.616 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 52.5 m-85 -84.57 121.35 27.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -1.076 . . . . 0.0 109.265 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 3.7 mt-30 -116.87 129.98 56.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.88 174.65 6.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.945 . . . . 0.0 109.926 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.536 ' HB2' ' CD1' ' A' ' 77' ' ' ILE . 1.8 ttp85 -117.11 126.71 53.26 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 28' ' ' ASP . . . -54.4 133.22 45.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.7 mt -108.93 -38.79 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.554 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 3.8 m-85 -116.48 -160.43 0.76 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -124.52 146.6 48.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.909 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.529 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 63.9 t80 -156.33 111.23 2.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.21 121.91 25.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -48.67 114.6 1.01 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HG3' ' OD2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -90.57 -72.07 0.59 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.203 -0.936 . . . . 0.0 108.612 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.67 166.06 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 109.143 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -9.62 18.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 109.883 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.59 -23.04 40.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.095 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -108.55 158.4 17.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.8 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 67' ' ' GLY . 15.4 pt -111.29 -169.54 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.564 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -106.61 109.0 20.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.824 . . . . 0.0 109.527 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -113.58 148.08 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.18 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 2.0 m80 -154.01 141.49 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 109.39 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' HIS . 2.5 tp -41.59 136.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.679 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.32 1.64 81.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 1.4 m-20 -90.42 169.18 11.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -1.156 . . . . 0.0 109.473 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 28' ' ' ASP . 2.7 mm -122.92 132.54 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.183 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.616 HD21 ' CZ ' ' A' ' 69' ' ' PHE . 10.5 mp -115.61 128.59 56.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.066 -1.021 . . . . 0.0 109.116 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.464 HG22 ' OE1' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -110.42 79.77 1.24 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.392 -0.818 . . . . 0.0 109.149 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.559 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 74.7 t -80.25 117.12 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -53.3 -173.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 37' ' ' LEU . 6.3 mtmt -90.17 -62.47 1.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.427 -0.796 . . . . 0.0 109.938 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.67 -54.49 37.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -19.7 3.56 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.213 -1.169 . . . . 0.0 109.32 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.577 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 0.5 OUTLIER -84.57 -36.85 21.82 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 21.9 t -85.02 -4.06 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.344 -0.848 . . . . 0.0 109.886 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.1 -24.1 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.055 -1.028 . . . . 0.0 108.605 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -88.78 33.19 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.624 -0.673 . . . . 0.0 109.848 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 47.51 29.55 5.61 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 53' ' ' ILE . 6.8 m-30 -47.62 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.822 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -100.86 -174.35 2.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.181 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.98 103.92 16.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.787 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 12.59 77.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 43' ' ' SER . 6.8 tt0 -90.3 29.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -1.2 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HG3' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -86.55 -13.12 46.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -79.08 4.52 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.094 -1.004 . . . . 0.0 109.396 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . 3.5 mtt180 -131.28 63.2 69.11 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 108.943 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.7 Cg_exo -59.0 -24.68 74.51 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.25 1.967 . . . . 0.0 110.397 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.543 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -69.03 -43.34 74.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.121 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.0 mt-10 -79.79 -6.79 57.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.154 -0.966 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -79.71 -42.39 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 108.697 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.8 -74.34 0.26 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 21.7 m95 -147.67 122.75 10.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -1.031 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -104.9 153.78 20.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.028 -1.045 . . . . 0.0 108.983 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' HG12 ' A' ' 32' ' ' VAL . 5.7 t-20 -122.01 121.95 38.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.522 ' CA ' ' HA ' ' A' ' 32' ' ' VAL . . . -146.88 -146.98 4.46 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -123.57 110.16 14.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.54 -0.977 . . . . 0.0 110.131 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' HB3' ' CG2' ' A' ' 63' ' ' THR . 1.0 OUTLIER -78.32 82.38 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 108.539 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -53.02 -35.04 59.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 110.122 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.495 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 19.7 m -53.38 -39.81 64.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 109.714 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 60' ' ' ASN . 14.8 t -108.93 6.59 25.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.82 48.53 56.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 63' ' ' THR . 37.1 mm-40 -135.7 171.91 13.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -1.184 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 25.1 ttt180 -141.59 146.45 36.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 159.85 -159.05 30.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -106.5 175.46 5.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.947 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CZ ' HD21 ' A' ' 30' ' ' LEU . 1.7 p90 -173.17 162.03 3.52 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 6.1 Cg_exo -58.35 119.14 6.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.929 1.753 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.14 -29.81 66.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 51' ' ' GLU . 27.9 p -69.45 -7.02 34.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -1.233 . . . . 0.0 109.15 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -100.26 -5.37 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 110.194 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 71' ' ' GLY . 28.5 m -111.29 172.87 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 6.0 pt-20 -136.25 87.55 2.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.237 -0.915 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 91.4 t80 -42.64 143.54 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 9' ' ' ARG . 3.6 mt -145.2 16.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.491 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 83.69 -122.57 5.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 109.495 179.977 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 46.0 m-85 -107.06 115.99 31.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -1.192 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 9.8 mt-30 -93.39 127.85 39.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.45 177.32 4.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.795 -1.191 . . . . 0.0 111.315 -179.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -114.23 124.85 53.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.825 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -61.3 116.66 4.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.7 mt -82.73 -36.14 26.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.571 -0.706 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 3.3 m-85 -120.83 -137.68 0.33 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.396 -0.815 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -144.16 -177.01 5.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 1.6 t80 -170.03 135.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.69 8.08 45.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 4.7 tttt 61.52 108.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 0.0 109.893 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -61.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 32.1 mtm-85 -90.41 139.63 30.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' ARG . 46.0 tt0 -40.93 -35.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.454 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -54.51 -59.53 4.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -64.52 165.34 10.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 110.022 -179.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.501 HD13 ' ND2' ' A' ' 60' ' ' ASN . 1.6 pt -129.53 172.33 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.65 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.2 m-20 -69.62 115.91 9.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.9 . . . . 0.0 109.921 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -104.94 157.88 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -160.1 143.14 13.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.665 -1.272 . . . . 0.0 110.204 -179.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -55.49 139.25 44.36 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.232 -0.918 . . . . 0.0 109.394 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -33.07 4.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 25' ' ' HIS . 7.6 t0 -68.38 121.25 15.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -1.066 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 30' ' ' LEU . 2.9 mp -88.37 165.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.687 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.78 147.43 42.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.049 -1.032 . . . . 0.0 108.235 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.472 HG21 ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -108.25 93.21 4.41 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.679 -0.638 . . . . 0.0 109.764 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 47.3 t -92.89 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.117 -0.99 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.429 ' O ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -54.65 138.7 40.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.855 . . . . 0.0 109.682 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 6.5 pttt -59.01 144.54 44.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.295 -0.878 . . . . 0.0 108.995 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.14 -58.5 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 33' ' ' ASN . 2.6 p -46.6 -26.01 0.82 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.152 -1.205 . . . . 0.0 108.747 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.597 ' CB ' ' CG ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -85.25 -40.61 16.43 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 39' ' ' ALA . 21.4 t -70.96 -4.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -82.53 -54.94 4.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.01 20.02 4.2 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -56.77 -68.28 0.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.571 -1.546 . . . . 0.0 108.143 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 13.8 t -158.2 130.91 7.21 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.13 117.95 9.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 0.0 109.669 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.76 -1.47 55.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 1.8 tt0 -86.39 30.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.095 -1.238 . . . . 0.0 110.076 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CB ' ' CD2' ' A' ' 6' ' ' TYR . 8.1 mt-10 -88.14 20.53 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -105.24 -21.8 13.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -113.72 82.01 6.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 4.2 Cg_exo -59.62 -52.58 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -44.79 -27.47 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -105.51 47.03 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.578 ' CD1' ' CD2' ' A' ' 37' ' ' LEU . 58.7 mt -144.18 -49.69 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.5 -70.33 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 31.6 m95 -143.84 152.65 41.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.614 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -135.94 144.29 45.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.465 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 16.9 t-20 -110.34 106.19 15.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.533 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -132.31 -163.88 10.82 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.036 -1.554 . . . . 0.0 111.296 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 122.161 -0.611 . . . . 0.0 109.857 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.501 ' ND2' HD13 ' A' ' 22' ' ' ILE . 4.3 m-80 -77.04 91.12 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.838 -1.164 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.38 -37.29 62.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 10.7 m -51.71 -45.36 63.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.197 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 64' ' ' GLY . 2.5 t -107.25 9.57 30.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.52 53.61 5.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -129.51 151.85 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -1.196 . . . . 0.0 109.806 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.416 ' C ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -123.38 124.91 43.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 108.948 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -179.2 -166.64 35.4 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.471 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -104.22 166.93 10.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.966 . . . . 0.0 109.852 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CE2' ' CD1' ' A' ' 30' ' ' LEU . 5.0 p90 -167.95 160.03 9.55 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -59.85 128.6 27.36 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.221 1.947 . . . . 0.0 110.61 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.18 -36.26 60.24 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -64.85 -9.82 23.75 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.031 -1.276 . . . . 0.0 109.242 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.6 m-85 -96.41 15.36 21.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.968 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.469 HG21 ' HG2' ' A' ' 50' ' ' PRO . 29.6 m -139.74 -177.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 76' ' ' TYR . 15.5 pt-20 -156.43 89.92 1.15 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.57 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.7 t80 -36.9 132.92 0.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.619 -0.675 . . . . 0.0 109.527 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.481 HG22 ' NH1' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -119.13 -15.55 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.994 . . . . 0.0 109.509 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 -124.31 5.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.481 ' O ' ' NE2' ' A' ' 7' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.085 -1.244 . . . . 0.0 109.505 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.643 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 2.5 m-85 -99.69 136.82 39.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -1.146 . . . . 0.0 109.392 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 78' ' ' GLY . 1.2 mt-30 -129.94 108.74 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 108.941 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -101.82 -178.94 3.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.001 -1.062 . . . . 0.0 110.483 -179.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -123.51 139.77 53.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.56 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . . . -64.31 98.67 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.016 -1.053 . . . . 0.0 110.562 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.634 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 4.6 mt -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 108.588 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.634 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 28.6 m-85 -140.11 -164.13 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' HD22 ' A' ' 24' ' ' LEU . 5.3 p30 -115.67 148.2 39.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' N ' HD21 ' A' ' 24' ' ' LEU . 45.1 t80 -150.64 108.92 3.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 17' ' ' GLU . 19.4 tptt -79.8 149.37 31.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 2.1 tttp -52.55 89.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' LYS . 42.5 mm-40 -77.97 -68.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.0 mtt180 -89.6 164.65 14.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.277 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.48 2.2 10.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.232 -0.918 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -106.07 -2.71 22.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.067 -1.02 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.492 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 p-10 -115.17 167.64 10.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.977 -1.077 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.489 HD13 ' ND2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -111.92 -171.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.663 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -103.4 98.38 8.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -0.814 . . . . 0.0 109.348 179.918 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -96.87 161.99 13.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 3.0 m80 -156.33 149.75 24.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.146 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 6.4 tt -54.02 140.77 30.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.933 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -30.25 6.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.56 ' OD1' ' CB ' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.73 166.72 12.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 109.606 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' HA ' HD11 ' A' ' 29' ' ' ILE . 7.4 mm -119.29 141.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.598 HD21 ' CZ ' ' A' ' 69' ' ' PHE . 10.4 mp -110.43 123.64 50.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.414 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -104.3 88.63 3.02 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 -179.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.59 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 74.3 t -96.55 95.5 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.468 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' VAL . 2.2 m120 -42.0 165.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 109.948 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.26 150.69 23.72 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.338 -0.851 . . . . 0.0 109.408 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.27 -61.72 2.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -55.61 -19.52 10.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.299 -1.118 . . . . 0.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.526 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -89.71 -30.62 17.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.47 -0.769 . . . . 0.0 109.409 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.534 HG21 ' CG ' ' A' ' 47' ' ' GLU . 18.8 t -87.87 -2.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -3.93 20.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.9 mt -84.26 -25.68 29.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 122.06 4.2 9.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CZ ' ' CG2' ' A' ' 53' ' ' ILE . 20.0 m-85 -53.08 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.602 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.536 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -116.58 118.36 32.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 43' ' ' SER . 11.1 t70 -24.3 88.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.303 0.573 . . . . 0.0 111.259 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 139.53 -7.73 3.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' HD12 ' A' ' 53' ' ' ILE . 1.1 tp60 -90.51 -0.89 57.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.296 . . . . 0.0 110.04 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 22.1 mt-10 -66.92 -10.0 44.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 0.0 109.57 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.36 19.2 16.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.518 ' CG ' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -128.72 61.69 56.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.0 Cg_exo -57.62 -38.96 91.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.228 1.952 . . . . 0.0 110.323 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -64.37 -28.33 69.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 16.9 mm-40 -101.64 -5.24 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 18.6 mt -83.44 -88.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.283 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 155.8 -55.05 0.41 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.2 m95 -153.27 138.4 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -1.046 . . . . 0.0 109.395 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -135.01 143.04 46.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.795 -179.964 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -94.51 102.98 14.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.553 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -118.98 175.93 15.89 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.723 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.5 t80 -109.25 106.92 16.97 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.815 -0.815 . . . . 0.0 109.519 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.489 ' ND2' HD13 ' A' ' 22' ' ' ILE . 1.6 m-80 -78.12 89.31 4.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 108.971 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -57.63 -36.86 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.004 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m -49.47 -33.04 13.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 6.6 9.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.2 39.41 70.92 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -107.7 157.02 18.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.49 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 13.0 tpt180 -139.16 114.43 9.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 108.868 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -175.4 -165.35 31.39 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.046 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.556 ' OD2' ' CE3' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -97.81 164.31 12.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -1.01 . . . . 0.0 109.783 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CZ ' HD21 ' A' ' 30' ' ' LEU . 1.2 p90 -160.07 162.66 23.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.46 124.89 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.922 1.748 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -71.45 -33.73 63.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -68.09 -8.2 36.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.984 -1.304 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.0 m-85 -99.06 -7.75 26.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.114 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 71' ' ' GLY . 24.1 m -109.34 176.11 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.526 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 5.7 pt-20 -142.11 89.33 2.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.437 -0.79 . . . . 0.0 108.957 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.612 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 60.4 t80 -38.71 125.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.549 -0.72 . . . . 0.0 109.921 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.577 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -152.57 17.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -121.38 105.1 0.99 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 10.4 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 21.6 m-85 -137.53 105.04 5.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.92 . . . . 0.0 108.691 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 10.2 mt-30 -99.64 123.12 43.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 110.047 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -112.91 170.19 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.071 -1.018 . . . . 0.0 108.967 179.878 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 13.3 ttp180 -105.68 145.47 31.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 108.97 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -74.13 96.95 2.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.923 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 18.6 mt -64.26 -29.75 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 6.5 m-85 -130.01 -159.34 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.139 -0.976 . . . . 0.0 110.16 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -117.59 -167.81 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -176.44 156.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.893 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -119.33 27.11 9.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 0.0 110.399 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.532 ' CB ' ' OD1' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 42.26 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.105 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 18' ' ' ARG . 17.4 mt-10 -126.9 -50.2 1.46 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.053 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 55' ' ' TRP . 0.2 OUTLIER -39.79 161.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.542 -0.724 . . . . 0.0 110.274 179.97 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -28.99 -68.25 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.595 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 5.3 mm-40 -131.16 48.68 2.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.808 -1.182 . . . . 0.0 111.005 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 56.1 p-10 -95.85 154.99 16.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.164 . . . . 0.0 108.853 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 23' ' ' ASP . 1.2 pp -104.09 171.35 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 110.042 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -64.82 170.3 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -153.27 146.84 25.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.528 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -156.25 138.98 15.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.681 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -55.35 122.27 10.79 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.43 -5.36 28.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.522 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 1.2 m-20 -90.24 163.63 14.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -1.166 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 14.1 mm -119.24 140.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.597 HD21 ' CE2' ' A' ' 69' ' ' PHE . 5.8 mp -118.9 113.85 21.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.09 105.78 17.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.561 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 71.7 t -115.75 91.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.699 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t-20 -42.82 159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.931 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -83.75 145.43 28.72 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 98.79 -55.4 1.01 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -45.85 -27.36 0.85 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.267 -1.137 . . . . 0.0 108.877 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.543 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 0.6 OUTLIER -90.06 -35.72 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 42.0 t -79.23 3.89 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 109.659 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.35 -13.2 17.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.2 mm? -96.85 -19.72 18.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.089 -1.007 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 117.77 25.32 3.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.543 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 5.9 m-85 -51.65 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -1.042 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -160.5 -162.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.147 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 11.4 t70 -90.14 62.39 5.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.177 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 34.68 2.57 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -82.42 6.66 16.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 109.557 -179.958 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' OE2' ' CZ ' ' A' ' 8' ' ' TYR . 3.9 tm-20 -67.7 -7.01 23.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -84.99 16.96 3.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.988 -1.07 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -125.69 59.36 26.7 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.126 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HB3' ' CG2' ' A' ' 74' ' ' VAL . 3.0 Cg_exo -50.13 -59.78 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.153 1.902 . . . . 0.0 110.337 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 4.2 tt0 -66.65 -17.15 64.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 108.679 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.2 mm-40 -108.67 22.69 15.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 49' ' ' ARG . 5.5 mt -118.39 -45.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 108.945 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.97 -74.32 0.29 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.574 ' CZ2' ' HG3' ' A' ' 18' ' ' ARG . 12.5 m95 -141.78 147.02 36.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -1.084 . . . . 0.0 109.121 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.589 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -136.89 159.58 41.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -180.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 67' ' ' GLY . 3.1 t-20 -111.76 100.79 9.22 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.54 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -119.62 178.46 16.55 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.598 ' CG ' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -112.43 113.27 25.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.654 -0.909 . . . . 0.0 109.893 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 37.0 m-80 -89.44 64.43 6.75 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 62' ' ' THR . 4.1 mt-10 -45.94 -28.3 1.1 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.023 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.522 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 8.3 m -47.19 -54.97 9.39 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.8 t -87.3 -10.21 52.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.67 40.29 11.04 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 8.2 mm-40 -138.89 164.88 28.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.057 -1.261 . . . . 0.0 109.257 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.598 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 52.2 ttp85 -145.69 115.3 7.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . -162.63 -159.07 10.06 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -87.81 165.63 15.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.945 . . . . 0.0 110.091 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.597 ' CE2' HD21 ' A' ' 30' ' ' LEU . 2.7 p90 -172.13 159.23 4.33 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.802 . . . . 0.0 109.313 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.7 Cg_exo -61.44 126.05 18.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.176 1.918 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.589 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -71.68 -32.94 63.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 1.6 p -64.84 -9.94 24.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.083 -1.245 . . . . 0.0 109.43 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.9 m-85 -98.73 15.95 23.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 50' ' ' PRO . 18.1 m -134.94 -177.94 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.085 -1.009 . . . . 0.0 110.534 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 4.5 pt-20 -147.03 89.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 33.3 t80 -49.65 123.88 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.44 ' O ' HG21 ' A' ' 77' ' ' ILE . 9.6 mt -113.58 -16.8 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.985 . . . . 0.0 109.649 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 111.65 -160.48 13.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.56 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.577 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 60.0 m-85 -158.75 141.21 14.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.494 -1.004 . . . . 0.0 108.959 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.507 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.1 tt0 -154.81 114.36 3.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 109.43 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -109.8 170.93 7.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 1.6 tpp180 -112.83 116.7 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 9' ' ' ARG . . . -43.44 158.02 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.68 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.5 mt -135.92 -41.17 0.67 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 12.3 m-85 -125.33 169.96 11.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.548 -0.72 . . . . 0.0 109.765 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p30 -102.87 139.39 38.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.559 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 34.4 t80 -134.78 131.33 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.213 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.99 120.43 24.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.556 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.1 pttt -56.29 91.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.824 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -55.72 -68.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.33 159.33 16.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.157 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.31 -12.98 10.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.075 -1.016 . . . . 0.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -31.24 62.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -96.01 149.29 21.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 109.5 -179.989 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.517 HD11 ' N ' ' A' ' 23' ' ' ASP . 1.4 pp -105.37 175.84 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.579 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 4.0 m-20 -80.18 115.8 19.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 109.894 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -94.08 147.01 23.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 108.725 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -152.49 127.57 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.536 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 5.5 tt -43.64 141.19 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.97 1.11 88.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 29' ' ' ILE . 12.5 t0 -82.32 152.45 26.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 6.4 mm -104.37 124.57 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.035 . . . . 0.0 109.071 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.642 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.8 mp -111.81 106.78 15.63 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 109.555 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -88.93 95.82 10.47 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.262 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 40.7 t -93.65 116.02 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.467 -0.771 . . . . 0.0 109.451 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -87.36 -179.31 6.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 146.95 31.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.06 -62.38 2.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -21.07 29.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.28 -1.129 . . . . 0.0 108.949 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.588 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -90.09 -35.3 15.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.284 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 40.0 t -77.17 2.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' C ' HD11 ' A' ' 40' ' ' LEU . . . -60.89 -11.93 9.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -102.64 36.63 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.001 -1.062 . . . . 0.0 109.39 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 48.3 25.09 4.02 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.614 ' CZ ' ' CG2' ' A' ' 53' ' ' ILE . 6.1 m-30 -48.4 -178.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.572 -0.957 . . . . 0.0 109.858 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -122.83 106.12 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 43' ' ' SER . 13.4 t0 -27.72 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.312 0.577 . . . . 0.0 110.97 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 147.46 -23.07 1.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -89.96 -2.94 58.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.12 -1.224 . . . . 0.0 110.309 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CB ' ' CE1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -42.99 -49.79 5.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.435 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.26 46.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.09 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.53 ' CD ' ' HB3' ' A' ' 52' ' ' GLU . 55.5 ttt180 -151.34 59.37 3.25 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.078 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 3.0 Cg_endo -60.03 -47.49 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.268 1.979 . . . . 0.0 110.453 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 52' ' ' GLU . 24.1 pt-20 -47.89 -46.87 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.53 ' HB3' ' CD ' ' A' ' 49' ' ' ARG . 1.4 tt0 -99.5 47.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.181 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.614 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -130.56 -39.58 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.953 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.4 -79.41 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -138.6 137.32 36.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 1.2 mp -121.78 168.21 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 109.794 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.6 119.49 33.9 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 32' ' ' VAL . . . -144.43 -172.94 15.37 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.088 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -114.85 109.11 17.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.465 -1.021 . . . . 0.0 109.763 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' OD1' ' CD1' ' A' ' 22' ' ' ILE . 15.9 m120 -79.05 85.9 4.93 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.189 -0.944 . . . . 0.0 109.0 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.447 -0.783 . . . . 0.0 110.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 21.9 m -53.58 -35.88 61.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.449 HG22 ' CE1' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -116.87 10.52 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 42.44 53.95 4.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -141.93 115.32 8.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.24 136.77 32.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 109.247 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.507 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 176.96 -160.5 27.67 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.244 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 8.4 m-20 -96.33 163.98 12.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -1.06 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.642 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 p90 -164.36 158.99 15.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.879 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.3 Cg_exo -61.19 117.43 4.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.249 1.966 . . . . 0.0 109.981 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -68.12 -34.83 82.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 2.9 p -63.26 -19.99 65.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.971 -1.311 . . . . 0.0 110.03 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 7.2 m-30 -93.41 17.98 10.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.598 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 30.7 m -131.02 170.12 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.097 -1.002 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 7.6 pt-20 -137.6 87.38 2.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.282 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CE2' ' N ' ' A' ' 78' ' ' GLY . 65.8 t80 -41.04 141.11 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 9' ' ' ARG . 3.3 mt -139.36 8.99 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 97.33 -140.33 14.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.408 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 28.7 m-85 -80.02 106.35 11.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -1.083 . . . . 0.0 109.753 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.468 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.3 mt-30 -102.56 128.04 49.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.31 173.15 6.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 0.0 109.972 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.87 142.26 46.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -64.93 151.31 46.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.896 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 75' ' ' GLU . 13.3 mt -134.2 -41.8 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.0 m-85 -118.77 -142.8 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.554 -0.717 . . . . 0.0 109.541 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -144.77 173.96 11.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.89 -1.132 . . . . 0.0 109.957 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 47.6 t80 -173.59 141.51 0.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.4 -0.813 . . . . 0.0 108.911 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' GLU . 1.4 mttt -101.94 133.44 46.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.03 -1.043 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -58.63 88.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 109.528 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 15' ' ' LYS . 60.8 tt0 -90.1 -73.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.1 mtt180 -61.66 157.9 16.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 26.2 tp10 -74.75 1.95 11.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.117 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.38 -1.06 16.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.061 -1.024 . . . . 0.0 110.042 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 52.3 p30 -110.99 164.63 12.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.997 -1.064 . . . . 0.0 109.6 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 67' ' ' GLY . 2.1 pt -126.38 -170.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 1.2 m-20 -84.9 134.5 34.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.634 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -128.12 138.28 52.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.076 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -153.46 138.75 17.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.062 -1.024 . . . . 0.0 109.62 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 tt -54.21 147.55 12.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.35 -0.844 . . . . 0.0 109.779 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 90.65 -9.89 76.29 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.8 m-20 -86.54 178.12 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.163 . . . . 0.0 109.83 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 5.7 mm -129.5 140.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.115 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.652 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.8 mp -121.42 130.13 53.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.971 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.468 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -106.94 93.82 4.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.884 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 8' ' ' TYR . 56.4 t -101.11 115.03 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -68.47 160.95 28.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.05 2.55 17.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.886 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.58 -49.6 0.47 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -54.84 -25.69 30.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -1.168 . . . . 0.0 109.641 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.591 ' CD2' ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -90.38 -34.08 15.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' CG2' ' OE2' ' A' ' 47' ' ' GLU . 71.4 t -80.75 2.27 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.066 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.5 4.23 7.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 109.988 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -111.44 5.1 19.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.047 . . . . 0.0 109.975 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.09 34.26 6.87 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CE1' ' CD2' ' A' ' 37' ' ' LEU . 14.9 m-85 -69.88 -169.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.81 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.524 ' O ' ' C ' ' A' ' 44' ' ' ASP . 58.8 m -125.93 90.11 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.913 0.864 . . . . 0.0 109.198 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.74 87.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.409 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 148.61 -23.95 1.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -90.33 -12.39 37.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.058 -1.26 . . . . 0.0 110.01 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' OE2' ' CG2' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -43.37 -39.76 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.933 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.59 40.94 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.522 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -148.08 60.34 5.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 5.0 Cg_exo -59.0 -41.93 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.358 2.039 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HA ' HG21 ' A' ' 72' ' ' THR . 16.8 pt-20 -57.01 -16.5 7.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.07 -5.75 10.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.895 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 56' ' ' LEU . 3.2 mt -79.6 -34.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 109.161 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 -71.6 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -141.5 124.93 16.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -1.046 . . . . 0.0 109.407 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.578 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -113.82 156.44 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.816 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -113.05 106.92 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.529 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -130.52 -158.65 9.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.588 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 38.8 t80 -124.8 108.72 12.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.674 -0.897 . . . . 0.0 109.863 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -79.4 90.83 5.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.302 -0.874 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.06 -37.93 67.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 96.5 m -57.51 -45.77 84.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.326 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.4 p -93.81 4.89 53.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.68 48.75 8.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -140.2 166.35 24.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.621 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.4 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 30.9 ttp180 -134.11 140.87 46.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.512 ' N ' HD12 ' A' ' 22' ' ' ILE . . . 165.6 -163.24 36.51 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.232 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 43.6 m-20 -94.19 170.74 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.976 . . . . 0.0 109.784 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.652 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 9.9 p90 -172.77 158.59 3.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.354 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.83 121.39 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.15 1.9 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.57 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -72.08 -34.37 61.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 51' ' ' GLU . 17.0 p -66.3 -8.97 28.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.304 . . . . 0.0 109.048 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.54 9.56 39.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 4.5 m -128.06 -174.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.9 pt-20 -160.21 92.74 1.01 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.604 -0.685 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 75' ' ' GLU . 5.1 t80 -33.19 115.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.569 0.7 . . . . 0.0 110.547 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.579 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 10.4 mm -144.11 16.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -129.35 115.22 1.89 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.251 -1.147 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 26.3 m-85 -80.91 123.74 28.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 31' ' ' THR . 16.7 mt-30 -115.56 115.65 26.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -104.96 175.56 5.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.062 -1.024 . . . . 0.0 109.093 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.53 174.35 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 108.849 179.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.37 152.42 21.01 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.2 mt -137.79 -38.56 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.566 ' HB2' ' CG ' ' A' ' 73' ' ' TYR . 4.5 m-85 -122.82 176.02 6.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.383 -0.823 . . . . 0.0 109.78 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -100.63 171.86 7.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 3.1 t80 -161.96 146.75 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.6 ttpt -107.99 17.95 21.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 21' ' ' ASP . 16.1 ttmt 59.5 71.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.806 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.5 tp10 -72.4 -73.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.7 mtp85 -53.8 144.23 18.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.35 -7.66 10.43 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -103.68 -22.76 13.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.006 -1.059 . . . . 0.0 110.441 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 16' ' ' LYS . 48.1 p30 -73.77 -179.82 3.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 0.0 109.82 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.467 ' CG2' ' HA3' ' A' ' 67' ' ' GLY . 1.3 pp -138.11 159.4 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.2 m-20 -60.24 145.0 48.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.551 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 10.2 mt -135.4 157.75 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.868 . . . . 0.0 109.37 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CE1' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -160.01 128.87 5.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 109.151 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.94 124.77 7.92 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.33 -18.79 11.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.54 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 1.1 m-20 -90.3 160.58 16.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.504 HG21 ' N ' ' A' ' 30' ' ' LEU . 6.5 mt -115.96 157.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.661 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 3.2 mp -130.77 121.41 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.279 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.44 HG21 ' HG2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -93.16 102.62 14.93 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.779 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.582 HG23 ' CE2' ' A' ' 8' ' ' TYR . 75.6 t -102.32 117.91 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -50.59 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 12.7 mtpt -90.29 -73.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.58 -24.21 30.96 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.82 -40.74 85.05 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.081 -1.246 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 10.8 tp -90.09 -29.52 18.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 58.3 t -90.15 3.16 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.908 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.53 -7.67 21.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.37 15.63 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.096 -1.003 . . . . 0.0 109.773 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.4 41.61 25.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 5.1 m-85 -64.77 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -139.27 156.21 47.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.34 120.75 10.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.61 -31.77 6.42 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.515 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 2.3 mp0 -76.48 -40.08 51.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -1.169 . . . . 0.0 109.462 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CB ' HD22 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.86 -27.05 66.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -84.71 -19.7 32.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -113.55 77.87 3.44 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.329 179.968 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.495 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 4.2 Cg_exo -57.73 -32.71 95.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.096 1.864 . . . . 0.0 110.238 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 24.7 tt0 -60.39 -32.43 71.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.018 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.37 -6.64 43.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 42' ' ' PHE . 16.2 mt -79.71 -54.34 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.71 -69.69 0.52 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.417 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 23.9 m95 -144.18 141.27 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.55 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.62 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -138.68 139.83 38.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -90.25 99.21 12.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.852 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.532 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -112.38 166.29 12.17 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.346 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -101.95 106.58 17.53 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.764 -0.845 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 3.2 m120 -78.48 78.45 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -49.27 -36.56 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.814 . . . . 0.0 109.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.54 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 20.4 m -51.51 -61.08 2.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.379 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 25' ' ' HIS . 1.9 p -91.69 13.18 18.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.53 54.35 4.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 18.4 pt-20 -139.23 121.81 16.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.646 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.426 ' C ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -96.64 128.43 43.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . -174.39 -179.53 45.06 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -88.94 165.02 14.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 109.59 180.0 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.661 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.8 p90 -165.67 162.84 13.05 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.644 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 2.2 Cg_endo -63.71 120.55 7.98 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.86 1.707 . . . . 0.0 109.254 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.545 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -64.35 -19.18 64.03 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 1.7 p -72.57 -20.03 61.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.902 -1.352 . . . . 0.0 109.927 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 7.3 m-30 -92.92 7.36 44.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 0.0 110.584 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 50' ' ' PRO . 13.3 m -118.4 -172.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.946 -1.097 . . . . 0.0 109.621 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 10.5 pt-20 -155.74 86.16 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.4 t80 -40.37 136.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 9' ' ' ARG . 5.1 mt -119.78 -4.28 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 109.859 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.583 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 130.48 -162.48 23.27 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 56.4 m-85 -80.43 110.36 15.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.584 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.2 mt-30 -87.48 124.42 33.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.584 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -104.58 -177.11 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.01 -1.057 . . . . 0.0 110.131 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.552 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 3.8 ttm180 -126.32 130.96 51.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -65.48 123.5 19.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.778 -1.201 . . . . 0.0 110.056 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -99.79 -42.41 6.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 7.2 m-85 -124.12 -158.68 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.503 -0.748 . . . . 0.0 109.566 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 6.2 p-10 -123.37 171.97 9.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.686 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.496 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 26.1 t80 -167.76 113.54 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.8 mmtp -80.21 132.81 35.94 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.062 -1.024 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 4.4 mtpm? -41.87 106.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.853 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -133.2 -33.96 1.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -75.55 145.6 41.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.85 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' HG3' ' OE1' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -41.96 -33.63 0.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.697 -0.627 . . . . 0.0 110.743 -179.98 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.459 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -137.35 58.06 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.924 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 p-10 -119.2 173.48 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.916 -1.115 . . . . 0.0 108.92 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -126.0 179.05 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 109.95 179.982 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.577 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 1.2 m-20 -85.91 108.82 18.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.3 mm? -95.07 144.13 25.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -155.18 128.4 8.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.11 -0.994 . . . . 0.0 109.66 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 11' ' ' LEU . 3.2 tt -52.14 137.93 26.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.741 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -18.52 39.46 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD1' ' CG2' ' A' ' 62' ' ' THR . 16.7 m-20 -90.21 172.35 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -1.191 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.469 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 19.2 mm -117.83 144.72 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.522 ' CD1' HG13 ' A' ' 74' ' ' VAL . 10.3 mt -108.53 146.79 32.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -129.91 87.19 2.49 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.757 179.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.584 HG22 ' CE2' ' A' ' 8' ' ' TYR . 29.5 t -97.51 116.25 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -57.19 122.36 12.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.44 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.527 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.472 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 144.18 -56.95 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -48.21 -51.28 26.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.141 . . . . 0.0 110.122 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.555 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -81.39 -15.76 54.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.115 -0.99 . . . . 0.0 109.195 -179.92 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.54 ' CG2' ' OE1' ' A' ' 47' ' ' GLU . 1.4 t -77.84 -10.79 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.55 -9.15 23.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.0 109.336 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 42' ' ' PHE . 14.6 mt -67.92 -27.63 66.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.03 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.17 3.03 6.94 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 53' ' ' ILE . 19.8 m-85 -58.82 178.08 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -1.145 . . . . 0.0 109.631 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -119.53 135.74 54.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 108.75 179.963 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 43' ' ' SER . 10.5 t70 -31.88 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.317 0.579 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 129.49 -3.64 6.2 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 4.6 mt-30 -91.14 -25.02 19.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.102 -1.234 . . . . 0.0 109.632 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 1.1 tt0 -59.05 -47.97 83.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -56.19 -15.8 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.11 80.45 5.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 109.587 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -65.04 -47.12 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.166 1.911 . . . . 0.0 110.451 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' PRO . 7.6 pt-20 -43.17 -42.15 4.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.25 51.71 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.593 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.3 mt -138.89 -41.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.72 -77.18 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.412 ' CZ2' ' HD2' ' A' ' 18' ' ' ARG . 34.4 m95 -137.91 147.13 44.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -1.037 . . . . 0.0 109.121 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.625 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -138.76 137.22 36.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.147 -0.971 . . . . 0.0 110.125 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -88.33 95.69 10.29 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.567 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -115.33 173.74 14.92 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.355 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' O ' ' OG1' ' A' ' 31' ' ' THR . 46.8 t80 -115.7 107.81 15.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.648 -0.913 . . . . 0.0 109.76 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' HD13 ' A' ' 22' ' ' ILE . 4.1 m-80 -77.97 96.7 5.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 108.873 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.469 ' OE1' ' HB ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -54.17 -39.5 66.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.001 -179.918 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.524 ' CG2' ' OD1' ' A' ' 28' ' ' ASP . 17.9 m -49.08 -64.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.9 p -85.41 6.95 24.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.554 -0.716 . . . . 0.0 109.66 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.86 54.16 5.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' HB3' HG23 ' A' ' 22' ' ' ILE . 56.4 mm-40 -131.88 142.25 49.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -1.098 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.437 ' C ' HG22 ' A' ' 22' ' ' ILE . 5.3 tmm_? -113.47 135.43 53.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 174.07 -167.91 40.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -102.13 163.96 11.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.1 p90 -163.13 162.23 18.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 Cg_endo -62.14 123.89 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.867 1.712 . . . . 0.0 109.827 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.531 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -67.61 -32.92 79.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -66.97 -9.41 38.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.035 -1.274 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.587 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.9 m-85 -95.8 -13.14 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.522 HG13 ' CD1' ' A' ' 30' ' ' LEU . 32.7 m -107.69 175.03 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 18.6 pt-20 -149.88 90.66 1.71 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.189 -0.944 . . . . 0.0 108.715 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 76.3 t80 -38.63 123.91 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.847 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 9.7 mm -111.38 -2.6 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 132.87 -164.43 24.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.108 . . . . 0.0 109.503 179.996 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.557 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 66.8 m-85 -79.37 134.13 36.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.142 . . . . 0.0 108.459 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 3.3 mt-30 -143.65 117.84 9.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.054 -1.029 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -113.78 178.66 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.359 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.498 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -112.38 155.44 24.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -91.65 121.07 32.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -104.88 -24.62 12.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.015 . . . . 0.0 108.619 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.536 ' CB ' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -119.57 176.62 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -112.27 163.02 14.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.172 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HB3' HD21 ' A' ' 24' ' ' LEU . 71.7 t80 -166.41 114.62 0.89 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.085 -1.009 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -79.46 107.41 12.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.931 . . . . 0.0 108.587 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -41.44 115.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.845 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -69.65 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.457 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.17 146.84 23.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.878 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.0 mt-10 -43.53 -24.79 0.12 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.131 -0.981 . . . . 0.0 110.038 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -60.7 -58.07 10.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.113 -0.992 . . . . 0.0 109.971 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 2.0 p30 -72.04 162.7 29.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.945 . . . . 0.0 109.87 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -122.16 162.06 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.377 -0.827 . . . . 0.0 109.378 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CD ' ' A' ' 16' ' ' LYS . 1.7 m-20 -79.22 103.69 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.901 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.568 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -102.28 153.46 19.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -150.79 141.21 22.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.048 . . . . 0.0 109.878 -179.955 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.1 tp -42.56 143.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 82.04 0.61 89.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.1 m-20 -90.42 159.13 16.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 109.746 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 28.2 mm -113.34 128.74 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 0.0 109.175 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.9 mp -109.76 105.93 15.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.915 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.484 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.95 91.33 8.03 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.547 -0.72 . . . . 0.0 110.328 -179.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 29.0 t -86.76 96.85 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 33' ' ' ASN . 6.1 p30 -51.45 152.82 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 110.385 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 34' ' ' LYS . 6.0 pttp -69.19 113.6 6.7 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.56 -54.66 0.76 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 48.4 t -56.78 -26.34 57.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.175 -1.191 . . . . 0.0 108.93 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 15.4 tp -90.55 -33.57 15.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 84.7 t -90.31 2.78 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.099 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.82 -11.81 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -107.94 34.99 3.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.708 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.1 52.4 40.26 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 5.5 m-85 -71.95 -167.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.09 143.38 50.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.13 87.89 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.34 -43.08 0.57 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' GLU . 23.2 mm-40 -73.01 -30.22 63.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.242 -1.152 . . . . 0.0 109.409 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.557 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 1.5 pt-20 -42.51 -41.99 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -85.39 44.53 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -159.85 62.72 1.96 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.6 Cg_exo -57.75 -13.61 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.341 2.027 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -70.77 -31.15 67.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.997 -1.065 . . . . 0.0 109.298 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 tp10 -110.71 1.72 18.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.9 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.533 HD11 ' CD2' ' A' ' 56' ' ' LEU . 6.6 mt -79.45 -31.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.108 -0.995 . . . . 0.0 109.082 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 -78.18 0.29 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.456 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 11.2 m95 -140.68 154.23 46.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -1.11 . . . . 0.0 109.033 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mp -143.07 158.91 43.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.989 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.425 ' HB3' ' OG ' ' A' ' 36' ' ' SER . 6.6 t-20 -117.79 117.68 29.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.535 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -138.93 -167.73 11.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 58.7 t80 -115.59 114.12 24.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -1.051 . . . . 0.0 109.96 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 17.6 m-20 -79.31 79.88 5.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 108.64 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.19 -39.38 13.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.52 -0.738 . . . . 0.0 109.833 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 18.7 m -48.51 -53.32 18.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.922 . . . . 0.0 109.658 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.5 p -108.15 17.02 22.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 41.33 54.61 3.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.47 111.9 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -1.214 . . . . 0.0 109.935 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -90.74 129.44 36.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 109.194 179.938 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' CA ' ' CG1' ' A' ' 22' ' ' ILE . . . -178.86 -165.5 33.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -95.35 168.24 10.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.376 -1.073 . . . . 0.0 109.742 179.984 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -168.51 158.57 8.41 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -60.05 125.4 17.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.253 1.969 . . . . 0.0 110.196 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -69.7 -39.9 76.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 12.0 p -64.78 -11.02 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.249 . . . . 0.0 109.636 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.8 m-85 -95.49 15.54 19.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 109.83 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 18.9 m -134.71 -169.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.83 . . . . 0.0 110.044 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.531 ' CG ' HD23 ' A' ' 11' ' ' LEU . 11.9 pt-20 -158.26 89.03 0.97 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 56.6 t80 -36.87 136.24 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.653 . . . . 0.0 110.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 75' ' ' GLU . 29.7 mm -126.32 -8.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.537 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 113.21 -109.0 2.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.421 ' OXT' ' HG3' ' A' ' 79' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.247 -1.149 . . . . 0.0 109.61 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 4.0 m-85 -79.83 118.82 21.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -1.142 . . . . 0.0 109.098 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 3.7 mp0 -102.11 118.09 36.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 109.899 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -99.62 173.01 6.92 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 0.0 108.983 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -117.9 116.53 27.13 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.801 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -47.54 109.93 0.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 110.299 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 8.9 mt -90.93 -38.39 12.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.7 m-85 -126.46 -161.02 1.03 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.592 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -123.68 -175.28 3.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 109.732 179.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 27.5 t80 167.81 123.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 108.943 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 15.3 mmtp -79.47 156.27 27.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.988 -1.07 . . . . 0.0 109.914 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 25.0 mtpt -70.06 88.77 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -71.82 -72.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.926 . . . . 0.0 109.291 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -69.81 156.52 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -77.56 70.4 3.94 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.947 0.88 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.79 -26.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 4.0 p30 -71.54 170.36 13.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -121.02 167.64 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.543 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 3.2 m-20 -73.56 111.38 8.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 14' ' ' TYR . 2.9 mm? -97.96 144.49 27.45 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 0.0 109.086 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.699 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -159.99 138.18 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.035 -179.966 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -57.51 133.57 55.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.189 -0.945 . . . . 0.0 109.498 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.8 -25.99 24.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 25' ' ' HIS . 1.1 m-20 -74.54 171.56 13.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.634 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 18.9 mm -123.53 155.15 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.651 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 7.2 mp -127.15 123.53 36.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.146 -0.971 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -101.69 92.71 4.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.412 179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.553 HG21 ' CA ' ' A' ' 58' ' ' GLY . 77.9 t -90.82 118.5 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 108.979 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 9.1 m-80 -48.01 176.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 109.284 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -83.0 -72.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.016 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . -61.61 -23.05 62.42 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 33' ' ' ASN . 16.6 t -59.07 -29.05 67.04 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.135 -1.215 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.528 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.1 tt -90.74 -47.76 7.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 95.7 t -80.0 4.42 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.93 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.28 -9.06 15.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.949 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -104.62 -11.69 16.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 0.0 110.006 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 105.95 29.21 5.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 53' ' ' ILE . 10.5 m-85 -50.97 -175.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.521 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.68 157.5 44.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 109.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -56.95 123.31 14.7 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.72 -36.28 4.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' ILE . 2.6 mt-30 -81.25 -32.45 33.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.304 -1.115 . . . . 0.0 109.376 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.8 pt-20 -64.26 -15.78 60.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.883 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -106.5 -13.95 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.737 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.6 mmt180 -113.87 80.09 5.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.2 Cg_endo -61.05 -31.74 91.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.215 1.943 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 9.1 pt-20 -60.07 -25.86 65.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 6.7 tt0 -104.81 -5.46 21.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.577 HG22 ' CE2' ' A' ' 42' ' ' PHE . 9.5 mt -79.44 -28.97 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.182 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 99.86 -77.05 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CH2' ' HD3' ' A' ' 70' ' ' PRO . 25.7 m95 -144.18 143.37 31.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 109.412 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.595 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -129.64 158.32 39.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -113.26 112.1 23.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.553 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -134.49 -171.48 12.53 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.48 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -120.6 109.64 15.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.975 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 8.4 m-20 -79.31 97.97 6.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.907 -1.121 . . . . 0.0 108.89 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.41 -36.19 81.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.817 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.534 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 37.9 m -50.05 -21.8 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 60' ' ' ASN . 12.0 t -127.76 -3.3 5.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.523 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.44 46.42 93.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -136.63 161.01 37.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.498 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 4.9 ttm180 -132.52 153.79 50.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 162.68 -171.2 38.45 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.663 -1.256 . . . . 0.0 109.962 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' ASP . 4.8 p30 -91.14 169.55 10.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.992 . . . . 0.0 109.655 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.651 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 10.4 p90 -174.33 143.86 0.91 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.164 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HD3' ' CH2' ' A' ' 55' ' ' TRP . 2.9 Cg_exo -55.45 118.19 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.801 1.668 . . . . 0.0 109.914 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.595 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -63.24 -23.84 66.71 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 51' ' ' GLU . 9.6 p -58.57 -19.54 39.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.891 -1.358 . . . . 0.0 109.881 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 17.9 m-85 -102.57 29.11 5.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 3.0 m -141.32 168.05 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 5.9 pt-20 -138.87 88.7 2.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 109.985 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.572 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 57.5 t80 -38.53 124.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 109.772 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -122.67 5.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.572 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 82.56 -100.84 2.2 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.442 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.613 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 5.2 m-30 -78.41 105.18 9.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.691 -0.888 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.454 ' HG3' HG21 ' A' ' 31' ' ' THR . 1.6 mt-30 -106.01 114.52 28.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.676 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -104.65 175.95 5.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 108.662 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 8.2 ttm180 -113.71 150.36 33.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.803 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -73.72 111.91 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.6 mt -89.1 -31.72 17.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.905 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 9.4 m-85 -132.61 -163.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.844 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 73' ' ' TYR . 12.2 p-10 -123.76 172.74 8.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 109.762 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 24.8 t80 -164.57 118.37 1.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' GLU . 29.6 tttp -80.11 136.38 36.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.882 -1.136 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 8.2 ttmt -42.94 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.499 -0.751 . . . . 0.0 109.734 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -95.55 -64.96 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -81.51 145.8 30.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.918 . . . . 0.0 109.517 -179.984 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.83 -13.6 6.65 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 11.2 pm0 -110.54 33.68 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.016 -1.052 . . . . 0.0 110.199 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -125.45 177.59 6.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.265 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 67' ' ' GLY . 2.9 pt -136.08 157.63 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -70.23 113.81 7.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.811 . . . . 0.0 109.6 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 2.4 mm? -101.32 154.09 19.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.042 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -159.96 133.18 6.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 109.423 179.997 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -52.0 141.4 18.09 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.597 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.506 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 97.35 -17.55 58.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 2.7 m-20 -83.73 174.54 10.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.528 HD11 ' N ' ' A' ' 29' ' ' ILE . 1.7 mp -125.45 137.14 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.0 mp -109.28 119.43 39.48 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.22 -0.925 . . . . 0.0 109.138 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -97.76 100.19 11.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.589 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 43.2 t -116.43 109.63 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.546 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 m120 -45.64 171.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.49 -0.756 . . . . 0.0 109.78 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -71.88 -70.7 0.31 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.744 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.91 98.42 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 33' ' ' ASN . 46.3 m -44.58 -25.14 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -1.142 . . . . 0.0 109.863 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.489 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 4.0 tt -90.28 -40.97 11.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 62.6 t -74.66 0.0 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 0.0 109.887 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.29 -12.37 13.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 109.763 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 42' ' ' PHE . 3.1 mt -91.58 17.43 8.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.983 . . . . 0.0 109.761 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 72.92 17.91 78.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 53' ' ' ILE . 14.9 m-85 -54.62 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.037 -1.272 . . . . 0.0 109.511 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -121.08 149.95 41.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.212 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -50.94 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.568 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 136.65 -46.04 1.04 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.23 -16.22 52.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.7 pt-20 -62.26 -38.15 88.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.566 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -91.11 26.6 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 109.673 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.6 mtp180 -128.67 64.84 70.5 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.309 -0.869 . . . . 0.0 108.875 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 6.3 Cg_exo -57.09 -38.68 95.08 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.267 1.978 . . . . 0.0 110.381 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG2' ' N ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.6 -27.09 68.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.504 ' N ' ' HG2' ' A' ' 51' ' ' GLU . 2.1 mt-10 -104.87 -2.81 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -82.28 -84.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.042 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' CG2' ' A' ' 53' ' ' ILE . . . 151.15 -61.32 0.41 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.456 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . 28.8 m95 -148.53 134.24 18.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -1.055 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -133.57 164.0 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 31.4 t-20 -115.72 115.64 26.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -133.06 -169.0 12.08 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 36.3 t80 -122.66 105.95 10.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.617 -0.931 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 4.5 m-80 -79.9 88.26 5.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.254 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.84 -36.77 67.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.86 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 6.2 m -52.33 -37.15 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.146 -0.971 . . . . 0.0 109.347 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -116.85 9.98 14.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.51 52.73 6.22 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.95 119.72 21.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -1.178 . . . . 0.0 109.724 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.509 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 2.8 ttt85 -101.63 134.51 44.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.16 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 170.44 -165.2 38.48 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.255 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -90.36 173.69 7.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.412 -1.052 . . . . 0.0 109.71 -179.936 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 18.1 p90 -177.58 159.57 1.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.858 . . . . 0.0 109.22 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -61.53 126.03 18.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.075 1.85 . . . . 0.0 110.015 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.553 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -69.61 -40.37 77.57 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 25.6 p -58.21 -14.0 6.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.029 -1.277 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.4 m-85 -93.15 23.21 4.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 110.155 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 29.9 m -142.59 -173.49 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.153 -0.967 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.6 pt-20 -156.42 87.32 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 109.577 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.613 ' CE2' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t80 -37.33 135.2 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.635 -0.666 . . . . 0.0 110.494 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 9' ' ' ARG . 2.7 mp -131.56 -2.89 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 87.34 -139.77 16.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -1.189 . . . . 0.0 109.286 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' O ' ' CG ' ' A' ' 34' ' ' LYS . 1.5 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . -104.81 -159.15 23.62 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.584 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 16.9 m-85 -137.71 145.98 43.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -1.157 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' CG ' HG21 ' A' ' 31' ' ' THR . 0.5 OUTLIER -137.79 121.17 17.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.91 172.79 7.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.306 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 21.3 mtt180 -117.57 139.46 50.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . . . -83.17 105.28 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.737 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.539 HD13 ' CA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -71.73 -36.42 70.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.064 -1.023 . . . . 0.0 108.977 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 34.3 m-85 -106.07 -177.78 3.46 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -113.71 141.02 47.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.834 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.522 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 55.5 t80 -132.17 158.4 41.79 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -111.19 -63.66 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.773 -1.204 . . . . 0.0 110.13 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 15' ' ' LYS . 14.3 tttm 153.68 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.492 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 2.2 tt0 -93.57 -54.18 3.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.024 -1.047 . . . . 0.0 109.192 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -69.75 159.32 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.214 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.38 25.85 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.214 -0.929 . . . . 0.0 111.402 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' OE2' ' HA ' ' A' ' 20' ' ' GLU . 3.6 mm-40 -149.05 13.98 0.89 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.669 -1.27 . . . . 0.0 109.539 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -91.17 161.74 14.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.675 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -117.56 143.8 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 7.9 m-20 -49.15 109.68 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.336 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.579 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -103.69 154.71 19.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -154.25 142.34 20.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.96 -1.088 . . . . 0.0 109.634 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 11' ' ' LEU . 4.6 tt -47.32 135.08 10.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.71 5.9 73.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 0.4 OUTLIER -90.24 136.01 33.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 109.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 7.3 mm -94.85 140.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.071 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.627 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.4 mp -125.76 111.26 14.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.055 -1.028 . . . . 0.0 109.8 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.529 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -85.52 93.34 8.76 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 HG23 ' CA ' ' A' ' 58' ' ' GLY . 89.5 t -99.89 115.92 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.083 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.8 167.21 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.99 . . . . 0.0 109.012 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' C ' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -90.03 0.6 57.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.5 -56.47 1.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.98 -31.85 1.44 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -1.105 . . . . 0.0 109.978 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' CD1' HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.86 -39.98 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.079 -1.013 . . . . 0.0 109.98 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 56.8 t -76.39 1.62 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.37 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -97.6 -25.71 15.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' PHE . . . 120.93 22.13 3.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.58 ' CE2' HG22 ' A' ' 53' ' ' ILE . 14.7 m-85 -44.49 147.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.251 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.56 165.37 23.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -67.0 118.79 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.12 53.1 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.21 -32.23 73.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -67.91 -21.2 65.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.615 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -74.71 -9.57 58.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.34 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.498 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -119.14 75.8 15.32 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 108.897 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 53' ' ' ILE . 6.1 Cg_exo -56.67 -48.79 17.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.497 2.131 . . . . 0.0 110.73 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.88 -25.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.5 tt0 -114.12 50.48 0.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' CE2' ' A' ' 42' ' ' PHE . 7.5 mt -134.91 -45.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.56 -77.6 0.28 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.444 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 17.4 m95 -139.64 143.97 37.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.433 -1.039 . . . . 0.0 109.336 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -131.96 147.88 52.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.914 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' C ' HG23 ' A' ' 32' ' ' VAL . 17.8 t-20 -114.18 109.39 18.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.543 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -132.13 -158.1 8.87 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.601 -1.285 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 72.9 t80 -120.26 116.91 26.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.42 -1.047 . . . . 0.0 109.801 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.2 m-20 -79.45 76.67 6.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -48.28 -34.87 11.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.787 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 31.7 m -49.11 -48.48 44.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 60' ' ' ASN . 9.4 t -101.7 2.92 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.689 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.83 45.83 95.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.577 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 17.8 mm-40 -138.62 -174.75 3.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.172 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -152.65 150.05 29.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.083 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 171.12 -164.77 37.86 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -100.44 166.31 11.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.984 . . . . 0.0 109.565 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.627 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.5 p90 -169.07 156.36 6.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.71 126.56 20.1 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.108 1.872 . . . . 0.0 109.806 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -73.74 -22.11 78.6 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -73.07 -4.93 35.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.242 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.565 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.7 m-85 -101.93 -5.43 24.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CA ' HD13 ' A' ' 11' ' ' LEU . 1.7 m -116.48 -171.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.064 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.508 ' HB3' HD22 ' A' ' 11' ' ' LEU . 11.0 pt-20 -157.51 92.82 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.624 ' CE1' ' N ' ' A' ' 78' ' ' GLY . 55.4 t80 -48.04 139.43 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 109.668 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -132.99 -0.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.982 . . . . 0.0 109.638 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.624 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 140.1 169.65 11.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 101.65 -152.97 18.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 27.0 m-85 -78.92 139.15 38.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.986 . . . . 0.0 109.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' HG2' HG22 ' A' ' 31' ' ' THR . 21.1 mt-30 -129.54 126.09 37.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.104 -0.997 . . . . 0.0 109.845 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.87 177.32 5.54 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.531 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -117.78 138.11 52.28 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -70.44 103.5 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.0 110.675 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -68.5 -32.24 72.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 108.586 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 5.9 m-85 -129.75 -169.02 2.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.64 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -117.95 171.19 8.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 109.933 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.526 ' HB3' ' CG ' ' A' ' 24' ' ' LEU . 54.8 t80 -173.42 118.17 0.29 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 3.6 tttm -79.64 117.53 20.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 18.0 pttt -42.7 109.26 0.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.676 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -67.13 -66.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.252 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' OD2' ' A' ' 21' ' ' ASP . 15.9 mtm180 -90.29 174.34 7.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 2.09 12.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.69 -6.45 29.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 109.891 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -105.11 166.31 10.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.158 -0.964 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 67' ' ' GLY . 1.1 pt -114.94 163.15 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.0 m-20 -87.43 105.67 17.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' CG ' ' HB3' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -102.75 154.6 19.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -152.49 154.6 35.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 26.5 tp -46.6 135.32 8.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.94 9.62 86.05 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 16.2 t0 -91.17 110.98 22.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -1.127 . . . . 0.0 109.966 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.7 mp -79.68 141.85 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.936 -1.102 . . . . 0.0 109.79 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.668 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.9 mp -123.38 140.03 53.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.44 HG22 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -109.86 86.19 2.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 109.285 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.531 HG23 ' CA ' ' A' ' 58' ' ' GLY . 53.9 t -90.58 108.68 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 30.2 m120 -50.49 161.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 109.722 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 53.84 2.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.89 -59.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 m -61.73 -20.37 63.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.341 -1.093 . . . . 0.0 109.255 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.514 ' HB2' ' CG1' ' A' ' 32' ' ' VAL . 8.2 tp -90.35 -24.14 20.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 HG21 ' CG ' ' A' ' 47' ' ' GLU . 5.0 t -90.81 -4.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.065 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.02 -4.14 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.647 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 7.4 mt -80.82 -30.17 35.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.49 7.35 5.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 23.1 m-85 -59.94 -172.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 109.751 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.62 -171.41 1.92 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 108.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.96 84.48 6.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.724 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.76 2.17 3.98 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.169 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -80.86 -14.94 57.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.962 -1.316 . . . . 0.0 109.851 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 26.5 mt-10 -62.58 -40.17 96.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . -61.67 -9.57 6.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.208 -0.932 . . . . 0.0 110.367 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mmm180 -113.59 80.59 4.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.872 -1.142 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.578 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.63 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.325 2.017 . . . . 0.0 110.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 54.4 tt0 -41.06 -29.8 0.12 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.253 -0.905 . . . . 0.0 109.071 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -98.64 47.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.585 HG12 ' CZ ' ' A' ' 42' ' ' PHE . 4.0 mt -146.89 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -63.0 0.28 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 33.7 m95 -146.91 148.9 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -1.11 . . . . 0.0 109.289 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 2.6 mp -137.42 152.3 49.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.696 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 1.2 t-20 -110.54 107.51 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.531 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -134.28 -160.04 9.07 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -116.54 117.55 30.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.526 -0.985 . . . . 0.0 110.231 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 64' ' ' GLY . 2.5 t-20 -79.4 76.38 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.531 -0.731 . . . . 0.0 109.234 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.94 -37.32 71.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.799 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.423 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 19.4 m -60.3 -33.45 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.019 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -121.76 18.26 11.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 40.19 54.16 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.28 113.1 8.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -1.227 . . . . 0.0 109.486 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 9.1 ttp-105 -91.24 140.47 29.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.513 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 166.09 -165.19 38.01 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -93.57 166.22 12.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.484 -1.009 . . . . 0.0 109.779 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -168.1 153.91 6.91 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' HD23 ' A' ' 24' ' ' LEU . 5.8 Cg_exo -58.11 116.58 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.195 1.93 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.59 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -66.6 -28.26 73.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 1.3 p -63.63 -28.0 69.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.576 -1.543 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.437 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 19.4 m-30 -85.41 24.91 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.02 -1.05 . . . . 0.0 110.419 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.578 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 35.5 m -140.36 172.93 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.135 -0.978 . . . . 0.0 109.347 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 13.0 pt-20 -148.95 89.65 1.69 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.835 . . . . 0.0 109.177 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.557 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 75.6 t80 -41.56 133.13 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.718 . . . . 0.0 109.133 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 17.5 mm -123.37 -2.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 140.65 -174.01 22.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.355 -1.085 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 167.85 136.72 2.09 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 34.7 m-85 -79.88 115.17 19.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -1.086 . . . . 0.0 109.353 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 3.2 mt-30 -98.67 128.12 44.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.18 176.06 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.034 -1.041 . . . . 0.0 109.692 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -118.0 117.6 29.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.522 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . . . -61.94 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.559 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.632 ' HB2' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -46.12 -50.45 15.41 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.057 -1.027 . . . . 0.0 109.782 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -111.24 170.68 7.95 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.574 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.36 -170.41 3.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.387 -0.821 . . . . 0.0 109.879 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 7.2 t80 179.75 115.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.236 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' GLU . 8.2 pttp -79.46 109.42 13.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.144 -0.972 . . . . 0.0 109.036 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -39.69 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.255 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' LYS . 48.0 mt-10 -63.33 -59.92 4.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 63.1 mtp85 -90.1 155.2 19.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.346 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.98 -9.15 19.32 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -84.02 -21.75 31.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 0.0 109.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' CA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -100.11 156.98 16.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.404 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.459 HD13 ' HB3' ' A' ' 69' ' ' PHE . 1.1 pp -109.35 175.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.933 . . . . 0.0 109.668 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 1.8 m-20 -75.66 151.48 37.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 1.1 tp -136.91 150.07 48.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.353 -0.842 . . . . 0.0 109.096 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.534 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 146.13 16.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.99 . . . . 0.0 109.672 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 43.5 tp -51.11 136.06 24.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.49 -0.756 . . . . 0.0 109.973 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.26 -2.48 78.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.447 ' OD2' ' HB ' ' A' ' 62' ' ' THR . 11.4 t0 -90.05 144.92 25.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -1.169 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.9 mp -108.65 146.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.607 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.6 mp -124.89 112.43 16.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 0.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.478 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.51 91.91 7.97 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 109.376 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.54 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 53.8 t -93.81 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.703 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -57.24 156.61 7.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -76.2 -16.54 59.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.633 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.65 -50.51 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 p -54.52 -30.28 53.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -1.113 . . . . 0.0 110.025 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 8.7 tp -90.31 -32.32 16.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 77.2 t -90.21 2.96 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.941 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.53 -7.46 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.827 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -105.36 17.55 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.69 42.88 45.29 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 9.8 m-85 -67.26 -168.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 109.441 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.29 136.38 52.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 122.9 6.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.501 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -62.46 -25.29 67.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -1.144 . . . . 0.0 109.409 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 2.4 mp0 -61.86 -32.76 73.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.967 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 76' ' ' TYR . . . -87.41 20.54 2.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.1 tpp180 -138.78 74.86 37.74 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 6.2 Cg_exo -55.67 -48.77 18.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.443 2.095 . . . . 0.0 111.15 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 4.7 pm0 -44.11 -26.96 0.34 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.031 -1.043 . . . . 0.0 109.218 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.75 51.53 0.85 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.398 -0.814 . . . . 0.0 109.066 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 ' CD2' ' A' ' 56' ' ' LEU . 24.2 mt -141.49 -39.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.47 -78.47 0.24 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.419 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 24.3 m95 -137.66 144.82 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -1.091 . . . . 0.0 109.192 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -134.77 154.3 51.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -109.92 108.16 18.33 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -130.66 -171.21 12.86 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 68.8 t80 -116.35 118.32 32.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.545 -0.973 . . . . 0.0 110.026 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 6.2 m-80 -84.53 64.82 8.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.105 -0.997 . . . . 0.0 109.009 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -43.67 -30.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.419 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.447 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 16.5 m -49.35 -54.47 17.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.234 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.93 10.96 39.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.445 -0.784 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.71 47.11 91.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.21 178.46 5.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -1.176 . . . . 0.0 109.582 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -159.66 138.52 10.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.93 -162.19 35.99 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-20 -94.92 167.49 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.499 -1.001 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.607 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -169.84 158.89 6.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -62.13 125.37 16.27 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.187 1.924 . . . . 0.0 110.086 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -73.34 -26.3 70.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -69.65 -7.44 39.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.951 -1.323 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.5 m-85 -99.32 -0.73 40.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.987 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -124.98 164.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 121.714 0.769 . . . . 0.0 110.422 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 18.6 pt-20 -139.79 109.74 6.42 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 83.2 t80 -37.56 113.39 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -105.11 9.77 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.519 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.569 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 104.33 -149.01 16.95 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . -71.98 -153.88 1.84 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 79.2 m-85 -160.1 124.79 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.476 -1.014 . . . . 0.0 108.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.1 mt-30 -129.51 122.29 28.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.016 -1.052 . . . . 0.0 110.196 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.662 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -116.92 -178.08 3.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.06 -1.025 . . . . 0.0 109.51 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.467 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.36 165.29 13.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -88.79 123.6 33.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 11.8 mt -104.3 -33.19 8.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 10.6 m-85 -128.18 -158.72 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.814 . . . . 0.0 109.902 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -126.66 172.65 10.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.736 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 75.3 t80 -171.49 113.79 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.297 -0.877 . . . . 0.0 108.809 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -79.29 156.39 28.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.983 -1.073 . . . . 0.0 110.052 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.7 tttt -55.08 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 109.663 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mt-10 -88.73 -62.91 1.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.216 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 6.6 ttm-85 -90.16 157.44 17.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.95 -4.4 16.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.174 -0.954 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 -9.86 15.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.079 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -85.33 171.45 11.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 109.528 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.497 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -130.62 158.19 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.528 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -60.04 134.01 56.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 1.2 mm? -133.47 146.15 50.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.06 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.2 147.76 19.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 109.27 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 10' ' ' ALA . 50.4 tp -51.48 145.1 9.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.11 -10.63 67.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' OD2' ' HB ' ' A' ' 62' ' ' THR . 0.9 OUTLIER -85.98 147.68 26.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -1.176 . . . . 0.0 109.565 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.6 mp -107.38 146.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.3 mp -122.75 123.27 40.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.093 -1.004 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -98.64 92.05 5.42 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.622 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 53.5 t -88.43 113.77 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.22 -165.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -0.925 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -70.98 0.62 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.23 -36.61 83.53 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -53.71 -30.35 43.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.028 -1.278 . . . . 0.0 110.064 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 3.1 tt -90.73 -42.67 10.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.707 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 38' ' ' VAL . 99.2 t -79.27 1.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 110.029 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' C ' HD11 ' A' ' 40' ' ' LEU . . . -63.04 -12.65 27.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.322 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -106.22 27.09 9.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.63 48.68 84.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 7.1 m-85 -67.21 -168.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.639 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.1 m -133.75 143.74 48.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.486 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -59.15 122.73 14.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.0 -33.3 6.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.456 ' O ' HD13 ' A' ' 53' ' ' ILE . 5.0 mt-30 -78.36 -2.65 39.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -1.194 . . . . 0.0 109.712 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 1.3 pt-20 -69.52 -37.23 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -87.2 15.13 6.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -123.6 67.69 39.54 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 109.127 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.585 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.35 -51.01 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.219 1.946 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.4 tt0 -59.14 -33.36 70.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.012 . . . . 0.0 108.741 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 7.2 tp10 -99.28 34.06 2.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 108.689 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.531 HG22 ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -119.32 -37.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.24 -76.8 0.24 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.421 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 74.9 m95 -142.74 139.71 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.092 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.587 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -129.74 153.32 48.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.767 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 2.7 t-20 -108.7 112.21 24.4 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -132.97 -169.25 12.16 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -120.29 107.98 13.62 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.897 -0.767 . . . . 0.0 109.725 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.479 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 6.9 m-80 -79.57 90.19 5.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -36.4 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 34.1 m -53.82 -36.92 63.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 1.3 p -111.44 5.61 19.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.74 45.67 24.55 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 63' ' ' THR . 33.1 mt-10 -129.38 155.6 45.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.694 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' C ' HG23 ' A' ' 22' ' ' ILE . 2.6 tpp180 -126.61 132.01 51.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 108.893 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.497 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 177.68 -158.48 23.71 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -104.59 166.03 10.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -1.028 . . . . 0.0 110.062 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.637 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.9 p90 -163.65 158.96 17.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.447 -0.783 . . . . 0.0 109.307 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.565 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.28 127.27 21.51 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.136 1.891 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -71.3 -36.42 63.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.535 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.4 p -65.2 -9.96 27.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -1.197 . . . . 0.0 109.265 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.6 m-85 -99.82 18.37 18.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.443 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.585 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 34.8 m -134.08 -168.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.093 -1.004 . . . . 0.0 110.092 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 9' ' ' ARG . 10.3 pt-20 -154.84 87.15 1.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.537 -0.727 . . . . 0.0 109.818 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.592 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 81.8 t80 -45.73 139.64 3.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.174 -0.954 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -125.38 -4.99 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 109.127 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.592 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 116.29 -173.11 14.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' OXT' ' HA ' ' A' ' 6' ' ' TYR . 73.4 mtp180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 7' ' ' GLN . 1.3 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLN . . . 95.01 173.25 37.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 14.8 m-85 -79.81 102.57 9.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -1.124 . . . . 0.0 109.088 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -99.93 128.88 45.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.432 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -121.84 176.3 5.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.124 -0.985 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.5 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.2 mmm180 -118.35 122.53 43.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 24' ' ' LEU . . . -70.97 93.02 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.793 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 64.2 mt -58.4 -49.4 77.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -104.12 176.77 5.05 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.432 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.525 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 43.1 p-10 -107.25 -173.86 2.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 14.0 t80 -162.31 140.22 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -91.89 132.91 36.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.983 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -55.8 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.718 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' LYS . 9.3 tp10 -95.43 -54.89 3.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.212 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.1 mmp_? -81.76 136.82 35.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.68 -19.3 0.89 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.109 -0.994 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 mm-40 -97.44 -33.34 11.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -66.36 157.97 30.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.67 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -120.32 169.85 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 109.375 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 2.9 m-20 -78.99 112.41 16.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.842 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.571 ' CD2' ' CD1' ' A' ' 22' ' ' ILE . 3.1 mm? -88.5 166.29 14.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 108.426 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.628 ' CE1' ' CG2' ' A' ' 63' ' ' THR . 0.0 OUTLIER -157.99 135.15 10.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.853 -1.154 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 11' ' ' LEU . 12.1 tp -50.57 140.15 14.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.512 -0.743 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 5.8 t0 -87.93 146.43 25.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.18 -1.188 . . . . 0.0 109.084 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 30' ' ' LEU . 24.2 mm -91.59 142.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 29' ' ' ILE . 3.8 mm? -122.11 129.47 52.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -117.24 82.75 1.86 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.806 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 8' ' ' TYR . 40.8 t -92.69 115.08 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.148 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.21 -171.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.725 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 4.6 mtmp? -90.04 -52.15 5.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.267 -0.896 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 36' ' ' SER . . . -67.51 -46.94 65.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -42.3 -33.87 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -1.144 . . . . 0.0 109.833 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 42' ' ' PHE . 5.1 tt -90.33 -32.67 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.512 ' CG2' ' OE2' ' A' ' 47' ' ' GLU . 95.0 t -80.09 0.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.45 -12.96 16.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -105.99 27.71 8.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.44 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.19 48.93 83.69 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 37' ' ' LEU . 8.0 m-85 -69.66 -168.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.3 p -126.4 158.51 35.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.323 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.07 119.15 12.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.4 -20.03 38.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.25 15.69 9.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 4.6 mm-40 -90.33 -35.44 15.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -89.88 28.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -128.41 65.08 70.0 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB3' HD12 ' A' ' 56' ' ' LEU . 4.5 Cg_exo -57.61 -46.64 25.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.424 2.083 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.8 -19.02 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.6 -3.47 10.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 0.0 110.028 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 49' ' ' ARG . 14.1 mt -80.27 -50.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.079 -1.013 . . . . 0.0 109.128 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.72 -69.22 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.81 148.15 41.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -1.051 . . . . 0.0 109.509 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.9 t-20 -111.56 104.04 12.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -138.75 -140.87 4.04 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 64' ' ' GLY . 72.2 t80 -131.2 125.78 33.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.981 . . . . 0.0 110.363 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' HD12 ' A' ' 24' ' ' LEU . 3.3 m120 -86.43 85.17 7.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -42.85 -48.44 5.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.795 . . . . 0.0 110.867 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 4.0 m -41.26 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.0 110.234 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.628 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 39.8 p -83.3 13.09 4.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.068 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 59' ' ' TYR . . . 45.76 45.34 13.21 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -119.75 117.16 27.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 0.0 109.234 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.63 156.33 18.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 156.93 -163.71 32.4 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.122 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.2 p-10 -104.71 154.1 20.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.811 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -155.88 159.68 31.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.1 Cg_exo -59.72 130.12 33.77 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.17 1.914 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -73.6 -29.72 63.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -69.43 -5.75 25.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.364 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.5 m-85 -100.04 -4.3 30.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.66 -176.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 21.1 pt-20 -153.48 96.45 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.556 ' CE1' ' HD3' ' A' ' 79' ' ' ARG . 9.8 t80 -37.67 110.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -135.35 14.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 7' ' ' GLN . . . -130.65 110.41 1.01 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HD3' ' CE1' ' A' ' 76' ' ' TYR . 3.3 ttp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 32' ' ' VAL . . . 108.0 -168.89 14.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 m-85 -78.6 119.8 22.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.121 -1.223 . . . . 0.0 108.617 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 78' ' ' GLY . 30.6 mt-30 -106.78 122.91 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.141 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.79 173.77 6.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 109.64 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 8.5 mpt_? -107.86 137.44 45.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.403 -0.811 . . . . 0.0 108.846 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -66.02 99.12 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 110.241 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.5 mt -65.39 -30.51 71.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.147 -0.971 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.588 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.5 m-85 -127.94 -163.59 1.28 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.78 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.04 122.95 26.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.751 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 4.1 t80 -103.39 139.68 38.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.286 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 pttt -95.53 15.95 18.41 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.995 -1.065 . . . . 0.0 109.619 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 ttmm 64.19 92.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.658 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 4.8 tp10 -86.02 -80.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.229 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 77.8 mtm-85 -67.93 165.33 17.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.311 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -74.73 2.21 10.57 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.41 2.46 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.033 . . . . 0.0 109.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -109.37 172.43 6.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.508 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG2' ' HA3' ' A' ' 67' ' ' GLY . 6.3 pt -125.23 175.95 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.583 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -84.75 105.31 15.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.686 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 1.7 mm? -91.81 152.64 20.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.583 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.6 m80 -152.22 135.86 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.338 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 4.5 tt -55.02 137.5 46.14 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.157 -0.965 . . . . 0.0 109.605 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.66 -9.12 71.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.486 ' OD1' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -90.31 162.39 15.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 3.3 mm -115.62 147.82 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.638 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 7.4 mp -120.76 111.8 18.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.226 -0.921 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.457 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -86.52 93.57 9.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.74 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.649 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 46.9 t -92.35 121.27 42.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.117 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.5 m-80 -47.79 178.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -87.4 -71.31 0.57 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.87 -30.33 59.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 45.5 t -47.68 -33.85 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.237 . . . . 0.0 110.156 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.74 -40.55 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 88.6 t -78.57 3.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.82 20.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm? -107.8 -7.34 16.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.53 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 95.2 33.5 6.54 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.527 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 9.8 m-85 -53.81 -168.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -1.048 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 p -139.76 160.93 38.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.561 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -59.58 115.27 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.61 -34.09 4.67 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 15.9 mm-40 -68.39 -33.16 73.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.183 -1.187 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -64.23 -31.44 72.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -82.67 -14.57 54.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.1 mmm180 -112.05 80.17 3.06 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.033 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.597 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.7 Cg_exo -54.48 -57.4 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.304 2.003 . . . . 0.0 110.434 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 15.5 tt0 -44.0 -36.08 2.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.733 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.7 43.92 1.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 56' ' ' LEU . 21.8 mt -136.68 -40.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.122 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -78.72 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 14.6 m95 -145.02 143.83 30.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.101 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.582 HD11 ' CE2' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -130.82 160.92 32.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 109.669 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.465 ' OD1' ' OD1' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -110.99 117.24 32.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' HA3' HG21 ' A' ' 32' ' ' VAL . . . -138.28 -176.16 14.37 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.5 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 70.7 t80 -117.55 111.87 19.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.876 -0.779 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.8 m-80 -79.3 78.72 5.78 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 108.79 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -48.19 -38.41 18.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.85 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 16.0 m -48.01 -46.74 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' GLY . 53.3 p -117.4 17.72 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.04 50.93 6.13 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' OE1' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.87 109.93 15.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.301 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' C ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.0 150.54 20.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 109.398 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.537 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 153.98 -160.05 29.15 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.07 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -99.29 166.3 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.36 -1.083 . . . . 0.0 109.61 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -164.63 158.93 15.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.1 Cg_exo -60.47 116.54 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.014 1.809 . . . . 0.0 109.798 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.543 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.16 -37.69 91.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 18.5 p -56.31 -23.39 36.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.902 -1.352 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 6.9 m-30 -92.49 28.23 2.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.597 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 32.7 m -137.27 170.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.101 -1.0 . . . . 0.0 109.921 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.526 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.1 pt-20 -138.66 89.66 2.39 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.501 -0.75 . . . . 0.0 109.054 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.585 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 50.6 t80 -37.75 115.78 0.44 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.641 -0.662 . . . . 0.0 110.639 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 67.6 mt -149.37 28.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -136.79 125.67 3.5 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.074 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 8.5 tpt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.43 -170.22 31.99 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 72.7 m-85 -140.32 121.46 14.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -1.009 . . . . 0.0 108.863 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.466 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 2.3 tt0 -130.28 133.56 46.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.085 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -128.66 178.57 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 15.9 ttp180 -118.99 121.29 39.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -44.92 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.871 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.642 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -74.39 -64.62 0.99 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.642 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -96.71 -160.63 0.81 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -123.14 126.06 46.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.217 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 15' ' ' LYS . 92.7 t80 -128.28 131.68 48.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 12.9 mmtt -79.69 178.43 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' CG ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -98.71 68.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.956 . . . . 0.0 109.243 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -68.23 -84.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 9.2 mtm-85 -43.61 145.65 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.62 -5.62 21.06 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.257 -0.902 . . . . 0.0 109.896 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.13 7.77 25.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 109.8 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 44.4 p30 -106.16 159.39 16.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.0 109.534 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -119.44 161.21 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.354 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD2' ' CG ' ' A' ' 16' ' ' LYS . 2.7 m-20 -56.16 154.25 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 109.7 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -152.66 137.96 17.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.79 137.77 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 26.4 tp -42.81 151.07 0.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.608 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 87.31 -16.12 50.39 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 3.1 t70 -90.2 160.69 16.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -1.094 . . . . 0.0 109.168 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 4.8 mm -118.91 149.74 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 69' ' ' PHE . 8.3 mp -124.79 108.98 12.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 108.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.466 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -89.23 91.44 8.77 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.101 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.541 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 40.6 t -87.2 101.77 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.81 152.65 44.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 176.56 1.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -59.47 4.61 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -71.34 -31.74 67.72 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.357 -1.084 . . . . 0.0 109.022 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 4.9 tp -89.51 -28.54 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' CG2' ' OE2' ' A' ' 47' ' ' GLU . 55.0 t -90.17 -1.93 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.72 -12.87 18.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.555 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? -93.29 -28.24 16.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.472 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 120.83 19.1 3.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 75.6 m-85 -55.75 -168.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -1.199 . . . . 0.0 109.47 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -151.18 156.79 41.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.285 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.8 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.44 -37.0 1.67 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -87.92 -12.5 44.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.192 -1.181 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 28.2 mt-10 -83.72 12.3 6.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.898 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.573 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -107.81 -10.33 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.1 mmt180 -117.43 77.31 10.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB2' ' CA ' ' A' ' 71' ' ' GLY . 2.3 Cg_endo -61.24 -21.44 71.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.211 1.941 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -56.32 -20.55 19.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 109.357 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 mt-10 -123.83 1.42 8.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.705 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.521 HD11 ' CD2' ' A' ' 56' ' ' LEU . 9.6 mt -79.54 -30.27 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 107.62 -77.73 0.23 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 10.3 m95 -147.68 136.4 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -1.091 . . . . 0.0 109.527 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -124.03 138.3 54.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 22.6 t-20 -93.66 109.7 21.34 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -123.99 -176.62 14.76 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.14 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -114.16 110.31 19.79 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.657 -0.907 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.482 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 75.2 m-20 -78.03 82.8 4.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.983 -1.073 . . . . 0.0 108.909 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -53.36 -34.42 57.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 49.6 m -50.54 -41.67 54.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.425 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.472 HG23 ' HB3' ' A' ' 60' ' ' ASN . 1.6 t -108.35 2.68 22.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.08 47.46 89.05 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 63' ' ' THR . 73.8 mm-40 -137.02 169.68 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -1.125 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 1.1 ttt180 -140.15 156.94 46.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 22' ' ' ILE . . . 160.64 -173.18 37.14 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 5.3 t0 -97.07 160.4 14.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -1.083 . . . . 0.0 109.602 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD2' HD22 ' A' ' 30' ' ' LEU . 1.4 p90 -158.51 162.21 27.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.568 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -60.01 128.16 25.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.958 1.772 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 50' ' ' PRO . . . -71.35 -32.79 64.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' ' HA ' ' A' ' 51' ' ' GLU . 32.8 p -68.27 -7.79 33.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.985 -1.303 . . . . 0.0 109.533 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.1 m-85 -99.68 6.94 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' CG2' ' HG2' ' A' ' 50' ' ' PRO . 10.6 m -127.32 164.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.136 -0.978 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.1 pt-20 -129.22 89.0 2.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.554 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 51.8 t80 -41.02 142.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.509 -0.744 . . . . 0.0 109.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -135.25 3.73 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.456 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 135.87 -177.69 19.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.32 -1.106 . . . . 0.0 109.5 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' CD ' ' A' ' 4' ' ' GLU . 2.8 pp20? . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.59 145.21 7.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 3.9 m-85 -79.69 81.65 5.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.335 -1.097 . . . . 0.0 108.827 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 8.8 mt-30 -84.28 141.34 31.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.276 0.56 . . . . 0.0 110.04 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -120.51 173.0 7.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.03 120.93 41.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -48.74 133.05 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.897 . . . . 0.0 110.656 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.0 mt -117.86 -39.37 3.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 19.7 m-85 -123.75 -159.02 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.594 -0.691 . . . . 0.0 109.758 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -135.38 132.46 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 109.766 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 28.3 t80 -123.9 126.97 47.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.096 -1.002 . . . . 0.0 109.547 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 24.3 ttpp -66.05 86.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -77.57 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.338 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 50.8 mtt-85 -89.0 146.08 25.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.79 -19.65 6.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -0.922 . . . . 0.0 110.017 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 3.3 pt-20 -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -90.97 169.84 10.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.361 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 67' ' ' GLY . 1.9 pt -126.79 179.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 3.3 m-20 -78.83 164.83 24.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.616 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 14.5 mt -154.15 148.6 26.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 108.714 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.9 m80 -156.06 132.66 10.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 109.823 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 11' ' ' LEU . 2.8 tt -50.8 139.27 17.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.55 -10.65 68.91 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.486 ' OD2' ' CB ' ' A' ' 25' ' ' HIS . 67.2 m-20 -79.31 -175.78 4.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -1.09 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.8 mm -133.57 125.47 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 108.946 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 20.5 mt -101.96 148.69 25.05 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.17 -0.956 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.49 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -133.25 82.56 2.0 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.882 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 8' ' ' TYR . 9.7 t -79.63 116.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.966 -1.084 . . . . 0.0 108.155 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.89 154.49 12.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.979 -1.075 . . . . 0.0 110.049 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -68.12 145.52 54.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.464 -0.772 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 -57.14 4.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -20.9 2.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.223 -1.163 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -90.11 -35.15 15.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 38.5 t -90.28 1.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.07 4.53 9.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.913 . . . . 0.0 109.98 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.602 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 3.7 mt -96.36 -28.99 14.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.114 -0.991 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 125.34 9.11 5.16 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.602 ' CE2' ' CD1' ' A' ' 40' ' ' LEU . 23.2 m-85 -54.64 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -1.211 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 80.3 p -125.15 -165.25 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.22 69.75 7.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.556 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.09 -31.76 0.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CG ' ' OG ' ' A' ' 43' ' ' SER . 41.4 mm-40 -68.96 -30.28 68.68 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.219 -1.165 . . . . 0.0 109.832 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -43.8 -35.92 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.97 . . . . 0.0 109.54 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.57 40.9 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -143.77 64.93 13.77 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.167 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.1 Cg_exo -58.82 -42.35 53.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.188 1.925 . . . . 0.0 110.436 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 10.1 pt-20 -61.09 -34.67 75.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -98.42 -3.52 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.53 HD11 ' CD2' ' A' ' 56' ' ' LEU . 4.3 mt -79.92 -50.42 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 108.998 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 121.62 -71.26 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.0 m95 -146.42 127.24 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.423 -1.045 . . . . 0.0 109.709 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.584 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 1.2 mp -116.21 143.7 45.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -101.63 111.69 24.01 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.561 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -138.62 -162.52 9.2 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.652 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' O ' ' OG1' ' A' ' 31' ' ' THR . 36.6 t80 -124.07 104.54 8.93 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.708 -0.877 . . . . 0.0 110.359 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -79.2 96.87 6.01 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -58.63 -33.64 70.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -0.871 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 11.6 m -49.01 -29.16 4.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 109.597 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 65' ' ' GLU . 7.8 t -127.06 5.79 6.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 59' ' ' TYR . . . 52.08 49.6 48.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' A' ' 63' ' ' THR . 35.3 mm-40 -124.98 145.43 49.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.575 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -126.1 125.59 42.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.258 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.512 ' N ' HD11 ' A' ' 22' ' ' ILE . . . 176.88 -165.85 36.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -94.41 159.93 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -1.062 . . . . 0.0 109.529 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.8 p90 -164.51 160.34 15.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.0 Cg_exo -59.98 116.5 3.35 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.102 1.868 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.584 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -66.23 -21.63 70.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.553 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 1.7 p -64.95 -16.92 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.975 -1.309 . . . . 0.0 109.81 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 9.1 m-30 -99.75 18.09 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.013 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.561 ' CG1' ' CD1' ' A' ' 30' ' ' LEU . 11.3 m -134.69 161.41 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.539 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 8.2 pt-20 -134.11 90.35 2.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.861 -1.15 . . . . 0.0 109.236 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 85.4 t80 -38.48 137.91 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -136.45 10.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 109.136 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 91.91 -106.15 3.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 0.0 109.386 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.485 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 178.37 -146.92 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.569 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 22.5 m-85 -132.0 139.03 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -1.016 . . . . 0.0 109.039 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.17 122.47 18.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.57 177.11 4.95 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.114 -0.991 . . . . 0.0 109.854 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.1 123.09 45.94 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -49.02 106.21 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.5 mt -83.5 -29.52 27.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.888 . . . . 0.0 108.858 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -127.3 -175.48 3.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.455 -0.778 . . . . 0.0 109.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.28 179.49 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 18.0 t80 -175.0 113.1 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.353 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 146.72 30.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 18.4 tttp -53.14 112.47 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.62 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -114.5 -82.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -73.53 159.61 32.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.121 -0.987 . . . . 0.0 109.586 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -0.4 15.33 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.9 mt-10 -105.72 -4.96 20.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 18' ' ' ARG . 2.7 p-10 -112.14 167.6 10.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 67' ' ' GLY . 7.2 pt -128.0 177.59 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.6 m-20 -69.28 163.85 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -161.15 147.71 14.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.362 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.6 m80 -156.87 146.12 20.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 33.7 tp -53.04 143.2 18.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.765 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 29' ' ' ILE . . . 91.99 -31.8 5.74 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 2.2 t70 -58.52 158.76 7.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -1.088 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.5 mp -115.64 137.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 108.991 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.645 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.6 mp -117.45 125.99 51.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 109.907 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.518 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -102.46 92.94 4.89 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' CG2' ' HA3' ' A' ' 58' ' ' GLY . 91.0 t -101.57 112.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 9.4 p-10 -51.5 -177.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.159 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -86.88 -28.56 22.76 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . -67.66 -56.74 10.37 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 9.9 t -43.88 -25.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -1.183 . . . . 0.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' O ' ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -87.84 -40.11 14.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -0.972 . . . . 0.0 109.337 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 38' ' ' VAL . 77.3 t -77.91 -2.56 4.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.14 -34.67 14.73 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -81.14 -45.48 16.35 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.25 29.16 6.48 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.79 -79.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.714 -1.462 . . . . 0.0 108.099 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.61 157.07 24.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -84.34 68.73 10.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 108.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.03 -28.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG2' ' NE ' ' A' ' 49' ' ' ARG . 2.3 mt-30 -85.93 41.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -1.217 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 2.5 pm0 -90.1 1.87 55.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -113.15 39.81 2.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.658 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -160.2 62.78 1.87 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.9 -18.12 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.408 2.072 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.82 -35.81 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.607 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -101.49 -0.85 34.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' CG1' ' HA ' ' A' ' 50' ' ' PRO . 21.6 mt -79.87 -33.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -76.34 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.466 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 23.0 m95 -137.01 157.28 47.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -1.066 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.589 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 3.4 mp -143.39 154.75 44.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.845 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB3' ' OG ' ' A' ' 36' ' ' SER . 17.9 t-20 -114.37 109.67 18.7 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.535 ' HA3' ' CG2' ' A' ' 32' ' ' VAL . . . -133.61 -161.32 9.68 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.45 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 52.6 t80 -120.9 112.63 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.657 -0.907 . . . . 0.0 110.027 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 37.3 m-20 -79.79 80.37 6.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -40.8 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 91.2 m -57.36 -43.03 83.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 3.7 p -93.35 0.96 57.09 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.312 -0.868 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.47 44.34 67.03 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 63' ' ' THR . 26.7 mt-10 -141.09 179.09 6.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -1.193 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -152.49 146.18 25.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 109.505 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.517 ' N ' HD12 ' A' ' 22' ' ' ILE . . . 163.4 -159.6 32.2 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.972 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -92.43 166.14 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -1.046 . . . . 0.0 109.661 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 7.2 p90 -171.1 159.51 5.32 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.835 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -57.86 120.27 8.07 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.084 1.856 . . . . 0.0 110.116 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.589 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -69.67 -31.99 70.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -63.19 -18.99 64.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.908 -1.348 . . . . 0.0 109.372 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.562 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 10.7 m-30 -92.57 30.21 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.005 . . . . 0.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 35.3 m -143.8 167.32 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 5.9 pt-20 -140.49 87.53 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.25 -0.906 . . . . 0.0 109.745 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.586 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 42.1 t80 -47.88 137.66 9.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 108.746 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 70.5 mt -144.23 9.06 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . 159.27 -172.41 35.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' OXT' ' HB2' ' A' ' 7' ' ' GLN . 7.3 mtp180 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -1.072 . . . . 0.0 109.437 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.3 0.572 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 79' ' ' ARG . . . -89.52 -178.01 45.46 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.635 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 25.7 m-85 -80.23 133.25 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 109.616 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -119.14 113.57 21.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -0.795 . . . . 0.0 109.389 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.691 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.07 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.078 -1.014 . . . . 0.0 108.963 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.7 mtt85 -120.55 137.89 54.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.0 108.871 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -56.77 109.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 110.241 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -93.68 -29.71 15.29 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -128.2 -169.64 2.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.952 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 57.3 p-10 -114.93 178.35 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 67.1 t80 172.92 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.279 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 7.0 tttp -79.76 153.39 29.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.471 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' CD ' ' OD1' ' A' ' 23' ' ' ASP . 2.3 pttt -77.51 78.16 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.562 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.02 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.202 -0.936 . . . . 0.0 109.249 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -54.97 142.74 28.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -57.72 -15.67 8.63 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.06 -32.49 33.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 109.9 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -88.29 146.54 25.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.109 -0.994 . . . . 0.0 109.274 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 HD13 ' ND2' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -107.59 -169.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.671 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.6 OUTLIER -73.64 153.33 40.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.848 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -141.31 129.92 22.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -147.87 133.25 18.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 3.8 tt -51.67 151.34 3.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.865 . . . . 0.0 109.721 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.16 -10.95 71.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 2.2 m-20 -90.27 -170.26 2.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.504 HG21 ' N ' ' A' ' 30' ' ' LEU . 5.0 mt -148.53 151.32 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.597 HD21 ' CE2' ' A' ' 69' ' ' PHE . 3.7 mp -134.67 130.24 36.03 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.049 -1.032 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -97.84 96.45 8.22 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 8' ' ' TYR . 51.3 t -101.46 116.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.884 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 8.1 t30 -53.12 147.41 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 108.95 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -2.77 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.138 -0.976 . . . . 0.0 109.797 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.94 -53.97 1.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 p -48.59 -22.5 0.77 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -1.132 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.559 HD23 ' CD2' ' A' ' 42' ' ' PHE . 5.4 tt -90.31 -34.86 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 0.0 109.557 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 53.8 t -87.71 0.78 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.628 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.15 -13.75 13.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.1 mm? -96.12 -23.17 16.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.583 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 118.27 23.12 3.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.559 ' CD2' HD23 ' A' ' 37' ' ' LEU . 12.0 m-85 -46.97 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -1.096 . . . . 0.0 109.612 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 t -94.56 162.88 13.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.64 96.25 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.94 -8.13 9.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.92 0.19 57.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -1.183 . . . . 0.0 109.612 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.635 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 3.1 mp0 -90.4 21.02 4.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.56 -2.46 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -126.66 86.28 58.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.5 Cg_endo -61.2 -38.22 68.06 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.248 1.966 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.9 pm0 -59.15 -17.55 27.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.145 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.8 -11.39 14.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 49' ' ' ARG . 32.6 mt -79.75 -50.17 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.43 -72.67 0.39 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.429 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 15.3 m95 -139.9 143.08 36.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -1.002 . . . . 0.0 109.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -135.86 152.27 50.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 13.1 t-20 -115.28 111.2 20.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 32' ' ' VAL . . . -134.88 -152.24 6.5 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.704 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -126.63 110.81 13.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.777 -0.837 . . . . 0.0 110.203 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' HD13 ' A' ' 22' ' ' ILE . 4.9 m-80 -78.53 82.95 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.919 -1.113 . . . . 0.0 108.822 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -52.17 -39.78 60.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.13 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 24.6 m -54.26 -46.33 72.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 109.787 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -105.93 13.29 29.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 39.81 54.43 2.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 65' ' ' GLU . 2.8 mm-40 -136.9 120.17 16.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.503 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 22' ' ' ILE . 7.2 ttp180 -92.76 151.0 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.57 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 154.09 -168.98 32.54 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.249 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -93.09 175.7 6.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.565 -0.962 . . . . 0.0 109.668 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.8 p90 -179.24 152.04 0.67 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.245 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -59.05 123.01 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.058 1.839 . . . . 0.0 109.958 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.591 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -69.41 -29.61 71.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 4.1 p -58.53 -15.01 9.39 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.839 -1.389 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 7.5 m-30 -103.29 33.22 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.025 . . . . 0.0 110.378 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 2.1 m -147.91 -179.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 9.6 pt-20 -151.06 90.37 1.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.7 t80 -52.66 123.15 10.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 109.044 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CD1' ' CD ' ' A' ' 9' ' ' ARG . 8.6 mt -112.3 -14.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 147.96 177.62 22.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 119.45 -138.67 13.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.715 ' CG ' ' OH ' ' A' ' 76' ' ' TYR . 24.2 m-85 -79.31 140.25 37.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.418 -1.048 . . . . 0.0 108.643 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.521 ' CG ' HG21 ' A' ' 31' ' ' THR . 4.1 mt-30 -147.24 125.18 11.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -120.53 177.99 4.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' CB ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -114.17 170.55 8.2 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -86.52 146.57 26.33 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 109.893 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 13.3 mt -126.84 -36.99 2.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.566 ' CD1' ' HA ' ' A' ' 73' ' ' TYR . 2.5 m-85 -118.4 -163.22 0.94 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.941 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.68 170.11 10.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.539 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -174.52 116.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -86.94 34.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.938 -1.102 . . . . 0.0 110.298 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 17.4 tttt 41.55 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 42.1 mm-40 -97.25 -49.56 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.81 149.96 36.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 41.8 tt0 -69.55 -4.11 17.65 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.161 -0.962 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE2' ' OD2' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -106.32 -15.12 14.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 110.201 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 51.4 p30 -99.09 165.56 11.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.493 HD11 ' N ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -121.29 177.07 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.499 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 1.7 m-20 -70.02 171.24 9.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 14' ' ' TYR . 10.4 mt -164.76 144.97 7.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.048 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.537 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.95 125.0 4.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.43 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -47.02 129.96 12.17 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.16 -11.81 33.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 4.4 m-20 -89.73 -170.87 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' C ' HD13 ' A' ' 30' ' ' LEU . 1.3 mp -143.81 138.23 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.66 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.2 mp -116.81 124.22 49.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.521 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -96.28 103.08 14.96 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 110.648 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.584 ' CG2' ' CA ' ' A' ' 58' ' ' GLY . 96.2 t -113.8 100.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.554 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 p30 -57.73 -166.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.005 -1.06 . . . . 0.0 109.089 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -84.04 -27.18 28.51 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.027 -1.045 . . . . 0.0 110.622 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 34' ' ' LYS . . . -81.39 -53.85 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 33' ' ' ASN . 7.1 t -50.31 -22.46 1.81 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.069 -1.254 . . . . 0.0 109.437 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -88.98 -44.36 10.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 108.683 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 97.2 t -83.33 6.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -44.9 -28.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' N ' ' C ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -100.1 -29.0 12.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 136.81 -40.07 1.56 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 8.2 m-85 38.81 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.918 . . . . 0.0 109.453 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.48 145.17 31.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.877 -1.139 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -62.97 96.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 142.04 -28.23 2.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.431 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -90.41 -6.45 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -1.099 . . . . 0.0 109.32 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 2.7 mp0 -43.01 -60.03 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.361 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -84.92 46.7 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.501 -0.75 . . . . 0.0 109.859 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.02 61.51 21.73 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_exo -54.97 -48.62 20.16 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.44 2.093 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.537 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 1.1 mp0 -67.89 -34.62 76.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.158 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 1.66 56.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.958 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.579 HG21 ' CE2' ' A' ' 42' ' ' PHE . 2.7 mt -88.95 -45.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 117.06 -70.63 0.29 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.568 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 15.5 m95 -149.19 128.76 13.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -1.025 . . . . 0.0 109.078 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 1.4 mp -119.14 140.8 49.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -94.77 101.83 13.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.584 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -118.4 179.37 16.98 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.118 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.6 t80 -104.69 117.7 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.869 -0.783 . . . . 0.0 109.352 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -78.95 77.94 5.41 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.245 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -55.97 -36.12 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.53 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 18.9 m -62.95 -31.85 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 109.949 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.453 HG23 ' CE1' ' A' ' 25' ' ' HIS . 6.9 p -119.14 19.2 12.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 40.98 54.64 3.6 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.0 179.64 5.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -1.211 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 19.7 ttp85 -160.47 123.02 3.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.493 ' N ' HD11 ' A' ' 22' ' ' ILE . . . 177.2 -167.67 39.01 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.277 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 63.1 m-20 -95.26 161.83 13.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.483 -1.01 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.66 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.7 p90 -162.31 162.99 19.12 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.619 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.562 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.9 Cg_exo -59.5 113.84 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.818 1.679 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -62.99 -35.26 91.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.537 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 28.6 p -60.65 -13.68 16.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.788 -1.419 . . . . 0.0 110.118 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.566 ' HA ' ' CD1' ' A' ' 12' ' ' TYR . 7.7 m-30 -97.54 15.78 22.29 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.976 -1.077 . . . . 0.0 112.087 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 71' ' ' GLY . 12.2 m -126.81 -179.73 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.633 -1.292 . . . . 0.0 109.951 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HG3' ' CB ' ' A' ' 9' ' ' ARG . 4.2 pt-20 -143.72 91.67 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 109.103 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' OH ' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -31.58 162.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.256 1.027 . . . . 0.0 112.961 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 34.3 mm -155.01 14.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -118.33 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 mtt85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 7.0 pt-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . -178.61 -166.96 35.61 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.52 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 31.1 m-85 -80.09 112.65 17.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -1.146 . . . . 0.0 109.548 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 2.6 mt-30 -98.98 121.34 40.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.67 175.58 5.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.016 . . . . 0.0 109.653 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 36.4 ttt180 -114.85 141.46 47.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -68.06 108.41 3.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.946 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.1 mt -82.0 -31.26 31.16 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.5 m-85 -129.77 -160.15 1.01 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.48 -0.763 . . . . 0.0 109.468 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -134.41 109.85 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.547 ' HB3' ' CG ' ' A' ' 24' ' ' LEU . 66.4 t80 -105.07 128.89 53.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.93 158.47 26.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.891 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -80.83 72.63 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.033 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.0 108.821 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB3' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -90.51 159.09 16.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.132 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HA ' ' CE ' ' A' ' 16' ' ' LYS . 32.3 tp10 -55.3 -28.75 55.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.531 ' CG ' ' HB3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -53.2 -40.6 64.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.999 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -99.93 162.5 12.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 ' CA ' ' A' ' 67' ' ' GLY . 35.6 pt -114.75 -168.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.925 . . . . 0.0 110.176 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -99.24 99.31 10.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 0.0 109.379 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -110.17 147.1 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 108.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -145.91 148.23 32.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -48.5 136.32 13.05 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.354 -0.841 . . . . 0.0 109.785 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 93.49 -5.03 73.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 6.7 t0 -90.39 145.9 24.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -1.132 . . . . 0.0 109.514 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.8 mm -96.58 132.06 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -0.923 . . . . 0.0 109.211 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.4 mp -110.34 114.56 28.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.319 -0.863 . . . . 0.0 108.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -92.16 96.86 10.56 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.902 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.585 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 64.3 t -102.59 108.05 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.885 . . . . 0.0 109.375 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 4.8 t30 -47.6 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -71.81 -62.76 1.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.54 99.7 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 33' ' ' ASN . 34.7 m -52.21 -19.8 2.23 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.351 -1.088 . . . . 0.0 109.827 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 5.6 tt -88.96 -36.08 16.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 40.2 t -90.42 1.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.28 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.17 47.88 1.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.887 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.42 56.61 14.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 3.8 m-85 -89.04 -166.89 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.467 ' HB3' ' HG2' ' A' ' 46' ' ' GLN . 7.2 t -133.65 141.9 47.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 108.984 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.35 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.63 -30.48 1.03 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.522 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -88.23 34.4 0.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.683 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE1' ' OH ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -90.14 -17.45 27.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . -126.16 14.77 7.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.2 mtt180 -121.66 74.8 34.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.1 Cg_exo -54.45 -52.79 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.197 1.931 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.2 OUTLIER -52.39 -28.21 18.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 49' ' ' ARG . 2.7 mt-10 -109.43 44.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' CG2' ' CE2' ' A' ' 42' ' ' PHE . 6.7 mt -130.98 -42.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 108.894 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 112.47 -76.52 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 32.7 m95 -147.35 131.33 17.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -1.068 . . . . 0.0 109.244 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.584 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -117.67 160.45 21.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 32' ' ' VAL . 13.8 t-20 -113.0 111.19 21.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -133.17 -170.57 12.47 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.45 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 61.4 t80 -116.78 113.22 22.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.572 -0.958 . . . . 0.0 110.188 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -79.27 77.98 5.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' A' ' 61' ' ' GLU . 3.7 tm-20 -52.92 -36.32 59.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.458 -0.776 . . . . 0.0 110.289 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 20.8 m -55.23 -38.48 68.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 109.982 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.447 HG22 ' CE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -113.01 20.48 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.48 53.88 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.79 172.08 13.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 22' ' ' ILE . 32.2 ttm-85 -156.19 144.6 19.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.53 ' CA ' HG22 ' A' ' 22' ' ' ILE . . . 159.78 -152.95 23.93 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.025 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 72.7 m-20 -100.65 162.46 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -1.025 . . . . 0.0 109.916 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.646 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.9 p90 -161.97 158.97 21.85 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.591 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -58.84 125.73 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.093 1.862 . . . . 0.0 110.146 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.549 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -68.26 -44.16 76.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.434 ' CG2' ' HA ' ' A' ' 51' ' ' GLU . 33.5 p -61.68 -12.12 14.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.998 -1.296 . . . . 0.0 109.615 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.4 m-85 -92.95 18.58 8.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.996 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 12.4 m -140.02 -176.04 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.219 -0.926 . . . . 0.0 109.793 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' A' ' 77' ' ' ILE . 7.8 pt-20 -155.1 89.28 1.21 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 6' ' ' TYR . 48.8 t80 -46.14 120.68 2.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.613 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 1.1 mp -152.36 20.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.56 111.57 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.45 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 12.1 mtm105 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.13 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 120.82 -167.69 13.96 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 25.3 m-85 -79.55 93.35 5.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -1.12 . . . . 0.0 109.75 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.52 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.9 mt-30 -89.69 129.97 36.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 0.0 108.622 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.35 179.05 4.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.924 -1.11 . . . . 0.0 109.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 0.2 OUTLIER -117.38 136.33 53.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 28' ' ' ASP . . . -76.31 137.76 40.07 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 110.436 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -122.94 -32.66 3.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 4.4 m-85 -112.74 -163.13 0.83 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -137.51 112.6 9.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.965 -1.084 . . . . 0.0 110.153 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 17.2 t80 -100.42 158.33 15.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.052 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.77 149.61 30.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 0.0 109.42 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HB2' ' CG ' ' A' ' 23' ' ' ASP . 14.9 tttp -82.23 70.77 9.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -55.94 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -79.76 142.28 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -64.08 -9.75 18.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.213 -0.93 . . . . 0.0 109.935 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 3.3 mm-40 -103.82 19.7 19.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.983 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 11.6 p-10 -124.71 172.51 9.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.495 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -130.9 154.87 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -68.94 110.34 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -104.55 148.92 25.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.201 -0.937 . . . . 0.0 109.277 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -160.17 130.47 5.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.175 -0.953 . . . . 0.0 109.372 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -42.93 137.14 2.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.322 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -1.07 81.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 37.2 t0 -90.72 131.59 36.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.426 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 46.2 mm -87.99 132.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.973 -1.079 . . . . 0.0 109.284 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.66 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 9.0 mp -107.68 139.87 41.58 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.325 -0.86 . . . . 0.0 108.993 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -116.29 99.25 7.07 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.005 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.518 HG21 ' CA ' ' A' ' 58' ' ' GLY . 52.6 t -107.74 95.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 73.8 m-20 -45.42 136.1 5.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 109.953 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -70.14 160.77 31.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.44 -60.82 4.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -20.65 55.78 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.377 -1.072 . . . . 0.0 108.513 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 4.5 tp -85.68 -29.32 24.08 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.479 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 38.9 t -84.77 -1.23 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -0.41 15.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -103.98 12.75 33.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 109.648 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.74 15.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 17.2 m-85 -72.35 -168.92 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.662 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.454 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 94.9 p -125.51 166.04 17.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.835 . . . . 0.0 109.287 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -72.27 98.58 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.646 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.22 13.27 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 53' ' ' ILE . 1.6 mt-30 -89.89 -21.91 22.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -1.22 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CB ' HD22 ' A' ' 37' ' ' LEU . 3.5 pt-20 -65.7 -8.27 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.274 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.451 ' C ' ' HD3' ' A' ' 50' ' ' PRO . . . -108.11 -4.97 17.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.981 -1.074 . . . . 0.0 110.036 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.494 ' O ' HG13 ' A' ' 53' ' ' ILE . 32.5 mmt-85 -117.96 72.33 8.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.9 Cg_exo -54.2 -33.19 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.279 1.986 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' HG21 ' A' ' 72' ' ' THR . 3.0 pt-20 -64.21 -40.16 95.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.056 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 61.7 mt-10 -85.33 4.76 33.65 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 109.526 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.525 HD11 ' CD2' ' A' ' 56' ' ' LEU . 8.6 mt -94.24 -52.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -77.04 0.3 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.428 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 14.2 m95 -134.09 147.2 50.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -1.028 . . . . 0.0 109.063 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -140.38 158.24 44.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 28.5 t-20 -113.9 109.35 18.37 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.518 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -132.74 -161.3 9.86 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.66 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 54.1 t80 -127.18 114.19 17.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 110.182 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -79.75 96.35 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.121 -0.987 . . . . 0.0 108.615 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -60.35 -40.87 92.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 22.9 m -59.28 -22.12 60.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.988 -1.07 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -120.62 6.12 10.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 45.01 37.66 5.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' OE2' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -114.76 173.86 6.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.168 . . . . 0.0 109.462 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 1.6 ttp85 -153.25 130.87 11.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.137 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 169.55 -158.04 30.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.174 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.465 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-20 -92.79 165.46 12.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -1.013 . . . . 0.0 110.0 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.66 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -171.79 153.13 3.24 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.96 123.35 12.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.025 1.817 . . . . 0.0 110.063 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -72.18 -30.3 65.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 51' ' ' GLU . 2.3 p -67.02 -7.88 25.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -1.207 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.582 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.1 m-85 -98.67 10.88 40.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' C ' ' CD2' ' A' ' 11' ' ' LEU . 2.9 m -130.9 -165.96 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.755 0.788 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' CG ' ' CB ' ' A' ' 9' ' ' ARG . 8.2 pt-20 -160.05 90.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.8 t80 -38.16 120.6 0.89 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.506 -0.747 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 9' ' ' ARG . 45.8 mm -106.62 -19.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.97 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 129.27 -130.32 6.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.26 -1.141 . . . . 0.0 109.449 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' OE1' ' HD3' ' A' ' 34' ' ' LYS . 6.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 137.98 -170.52 23.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 39.1 m-85 -148.35 111.98 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -1.155 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -99.83 120.24 39.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.557 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.1 178.59 4.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.975 -1.078 . . . . 0.0 109.868 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.94 147.96 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -75.51 106.64 7.16 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 110.126 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.7 mt -84.97 -26.34 27.21 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 23.5 m-85 -135.82 -160.71 1.08 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.538 -0.726 . . . . 0.0 109.711 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 24' ' ' LEU . 10.1 p-10 -135.67 143.26 45.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.593 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 10.7 t80 -116.67 163.91 15.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.188 -0.945 . . . . 0.0 108.626 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 8.9 mmtt -104.57 -19.58 13.95 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.053 -1.03 . . . . 0.0 110.551 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER 75.24 81.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.068 . . . . 0.0 109.236 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -84.42 -54.96 4.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.731 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' O ' ' CG ' ' A' ' 21' ' ' ASP . 1.1 tpt180 -87.97 162.35 16.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.71 -3.6 19.4 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 7.1 pt-20 -99.61 14.81 28.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.083 -1.011 . . . . 0.0 109.773 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -127.68 163.42 24.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.149 -0.969 . . . . 0.0 109.417 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.537 HD11 ' N ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -128.33 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 110.116 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.576 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -58.99 119.45 7.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.572 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.2 mm? -97.28 159.38 14.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 109.169 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.1 m80 -159.44 125.38 4.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.865 . . . . 0.0 109.4 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.8 tp -50.62 128.29 20.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.74 28.28 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.3 p30 -90.02 -179.9 5.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.272 . . . . 0.0 109.967 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' CG2' ' OE1' ' A' ' 7' ' ' GLN . 33.5 mm -127.54 149.2 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.599 HD22 ' CE2' ' A' ' 69' ' ' PHE . 10.3 mp -123.84 123.34 40.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.013 -1.054 . . . . 0.0 110.387 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.474 HG21 ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -99.7 86.61 3.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.586 HG22 ' CE2' ' A' ' 8' ' ' TYR . 67.7 t -96.56 116.35 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -56.52 162.83 2.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 108.475 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HD3' ' OE1' ' A' ' 4' ' ' GLU . 11.7 ptmt -90.5 -25.61 20.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.01 -1.056 . . . . 0.0 110.327 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.65 -58.83 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -50.19 -22.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -1.151 . . . . 0.0 110.05 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.586 HD22 ' CE1' ' A' ' 42' ' ' PHE . 4.1 tt -90.31 -32.73 16.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 109.707 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 51.3 t -82.34 -0.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 109.751 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.2 -21.18 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.198 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.14 37.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.516 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.96 49.58 17.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' A' ' 37' ' ' LEU . 2.3 m-85 -59.38 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.177 -1.19 . . . . 0.0 109.267 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -128.56 150.79 50.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.138 -0.977 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.55 120.81 10.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.07 -33.41 6.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.504 ' O ' ' CG1' ' A' ' 53' ' ' ILE . 10.2 mt-30 -65.9 -11.93 50.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -1.147 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 14.9 mm-40 -81.13 -22.38 39.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.626 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.18 -4.96 58.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.1 mmp_? -117.14 74.13 7.27 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' HD11 ' A' ' 53' ' ' ILE . 5.7 Cg_exo -54.99 -32.17 77.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.2 1.934 . . . . 0.0 110.489 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HA ' HG21 ' A' ' 72' ' ' THR . 6.7 pt-20 -62.24 -35.98 80.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.942 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.3 mt-10 -95.57 -3.74 45.92 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.162 -0.961 . . . . 0.0 110.017 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 56' ' ' LEU . 31.6 mt -79.6 -36.92 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 109.361 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 108.15 -76.52 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m95 -143.77 132.81 22.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -1.137 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.571 ' CD1' ' HA2' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -117.42 142.3 47.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.798 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -105.97 111.77 24.55 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.524 ' N ' HG23 ' A' ' 32' ' ' VAL . . . -139.49 -161.27 8.66 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.413 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 67.2 t80 -115.5 114.22 24.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.626 -0.926 . . . . 0.0 110.553 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.1 m-20 -78.09 79.02 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -42.68 -44.69 4.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 3.4 m -46.57 -69.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.105 -0.997 . . . . 0.0 109.876 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.535 ' CG2' ' HG3' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -81.05 6.03 14.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.971 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.42 48.43 60.17 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.576 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 2.7 mt-10 -121.27 173.11 7.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.278 . . . . 0.0 109.282 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.58 118.0 6.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 109.341 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' ND2' ' A' ' 57' ' ' ASN . . . -176.4 -150.76 8.38 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 7.5 m-20 -108.83 165.21 11.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -1.056 . . . . 0.0 109.829 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CE2' HD22 ' A' ' 30' ' ' LEU . 1.9 p90 -165.87 161.82 13.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.385 -0.822 . . . . 0.0 109.011 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -57.92 126.92 23.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.936 1.757 . . . . 0.0 110.033 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -71.98 -33.97 62.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 51' ' ' GLU . 2.0 p -65.48 -9.03 22.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.083 -1.245 . . . . 0.0 109.218 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -98.3 16.4 21.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.899 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 6.1 m -136.49 -175.45 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.18 -0.95 . . . . 0.0 109.612 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' O ' HG13 ' A' ' 77' ' ' ILE . 11.3 pt-20 -156.61 87.26 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.87 . . . . 0.0 109.808 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.514 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 58.3 t80 -46.18 135.8 7.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.369 -0.832 . . . . 0.0 109.753 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -135.38 17.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.067 -1.021 . . . . 0.0 109.468 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.461 ' HA2' ' OH ' ' A' ' 76' ' ' TYR . . . 116.52 -147.17 18.91 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.455 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 124.85 178.56 15.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 87.9 m-85 -79.58 121.21 24.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.46 -1.024 . . . . 0.0 108.885 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 1.3 mt-30 -118.87 115.67 24.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.883 -1.136 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.99 -178.98 3.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.905 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -121.64 132.43 54.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -57.65 164.43 2.05 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 109.932 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD13 ' CG ' ' A' ' 75' ' ' GLU . 14.1 mt -138.49 -40.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 5.2 m-85 -117.3 -159.66 0.74 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.128 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 11.5 p-10 -119.71 168.18 11.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 110.275 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CB ' ' CD2' ' A' ' 24' ' ' LEU . 2.0 t80 -171.91 119.22 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.509 -0.744 . . . . 0.0 109.195 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' LYS . 16.8 mttm -93.67 49.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.833 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 9.7 ttmt 42.2 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 3.2 mt-10 -73.23 -81.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.276 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 8.1 mmt180 -88.96 150.52 22.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.0 109.388 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -47.12 -23.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.823 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.77 -48.68 68.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.965 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 34.7 p30 -82.38 173.15 12.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.53 HD13 ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -127.71 -171.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.0 m-20 -93.75 115.04 27.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -121.32 150.21 41.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.528 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -150.21 149.36 30.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.047 -1.033 . . . . 0.0 109.769 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 11' ' ' LEU . 2.1 tp -42.47 136.46 2.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 85.62 2.28 87.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 13.5 t0 -90.41 117.25 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -1.174 . . . . 0.0 109.213 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.8 mp -79.97 134.98 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 69' ' ' PHE . 6.9 mp -113.46 136.8 52.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.439 ' CG2' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -115.65 89.31 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 111.008 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CG2' ' OH ' ' A' ' 8' ' ' TYR . 1.5 t -89.4 106.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 108.841 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -50.75 157.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -73.3 156.28 38.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 -56.93 4.83 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -51.04 -23.28 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.218 -1.166 . . . . 0.0 109.66 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.632 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.49 -34.21 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 52.5 t -89.13 1.79 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.746 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.62 -8.21 25.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.76 18.62 21.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.311 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.77 38.78 60.7 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.632 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.6 m-85 -57.8 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.525 ' O ' ' C ' ' A' ' 44' ' ' ASP . 27.2 t -125.08 97.69 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.72 93.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.297 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.03 -14.76 4.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 43' ' ' SER . 5.8 mt-30 -90.68 2.14 56.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.778 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 1.3 mp0 -65.7 -23.23 66.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -103.21 19.04 20.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.526 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mmt180 -130.93 65.2 76.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.212 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.38 -33.49 97.86 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.162 1.908 . . . . 0.0 110.342 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 21.1 pt-20 -58.61 -29.8 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 109.597 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 -0.13 24.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.53 HG21 ' CE2' ' A' ' 42' ' ' PHE . 6.2 mt -79.92 -39.22 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 111.66 -73.45 0.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 11.2 m95 -148.1 140.98 24.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.467 -1.02 . . . . 0.0 109.123 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.609 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -130.8 132.9 45.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.0 110.019 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -99.82 105.37 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -131.6 -156.2 8.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.621 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -115.66 111.49 20.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.451 -1.029 . . . . 0.0 110.774 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.538 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 3.2 m-80 -79.59 80.4 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 108.603 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -44.56 -44.84 9.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -46.49 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.03 . . . . 0.0 109.957 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.489 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 14.7 p -83.36 12.71 5.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.87 43.31 6.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.473 ' OE1' HG21 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.91 117.14 25.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -1.141 . . . . 0.0 109.314 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 15.9 ttm180 -94.99 138.06 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 168.18 -174.0 43.01 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.248 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -90.02 152.82 21.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.72 -0.871 . . . . 0.0 109.859 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.5 p90 -155.36 161.16 30.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 0.0 109.121 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.581 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.67 127.42 23.54 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.929 1.753 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.544 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -72.12 -32.29 63.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -69.56 -8.66 49.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.239 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.69 -1.24 50.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 71' ' ' GLY . 5.9 m -122.73 -174.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.522 ' CG ' HD13 ' A' ' 11' ' ' LEU . 2.5 pt-20 -156.75 88.66 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 81.9 t80 -34.48 128.94 0.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.242 0.544 . . . . 0.0 109.973 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -116.78 0.86 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.946 . . . . 0.0 109.396 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 97.95 -115.02 5.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . -160.79 156.28 27.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 7.3 m-85 -81.76 141.74 33.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.438 -1.037 . . . . 0.0 108.975 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' NE2' HG22 ' A' ' 31' ' ' THR . 2.9 mt-30 -144.88 116.81 8.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.662 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.94 179.78 3.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.525 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 12.6 mtm180 -114.83 168.72 9.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.328 -0.858 . . . . 0.0 108.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -90.2 97.77 11.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.604 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -67.51 -30.72 70.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.086 -1.008 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.604 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -129.47 -168.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.439 -0.788 . . . . 0.0 109.725 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -130.79 98.25 4.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 32.1 t80 -88.41 152.29 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.785 . . . . 0.0 109.323 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 151.69 20.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.953 . . . . 0.0 109.425 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.6 ttpt -72.92 85.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.408 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' CG ' ' OH ' ' A' ' 14' ' ' TYR . 1.7 pp20? -117.86 -35.22 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -71.99 138.38 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.1 tt0 -56.41 -15.89 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 3.5 tt0 -129.65 36.98 4.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 110.11 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 1.1 p-10 -122.53 161.66 23.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.062 -1.024 . . . . 0.0 109.531 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.508 HG13 ' CD2' ' A' ' 24' ' ' LEU . 1.6 pt -116.11 170.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.92 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.574 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -79.51 100.8 7.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.218 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.5 mm? -88.06 133.42 33.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.8 m80 -135.08 139.2 44.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.6 tt -56.33 123.37 14.39 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.35 -0.844 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.93 -5.56 39.71 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -90.34 167.04 12.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 109.066 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.529 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 2.7 mp -125.52 147.71 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 5.9 mp -122.77 127.55 49.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.237 -0.914 . . . . 0.0 108.789 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.485 HG22 ' NE2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -97.91 93.65 6.45 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 109.942 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.611 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 87.4 t -90.31 114.39 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -58.02 173.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -37.66 66.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.275 -0.89 . . . . 0.0 109.741 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.56 -44.09 8.81 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.459 ' OG ' HG11 ' A' ' 32' ' ' VAL . 79.2 p -51.83 -21.43 2.87 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 47' ' ' GLU . 1.6 tm? -85.21 -35.97 21.27 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 79.5 t -85.68 4.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.768 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.83 -5.19 11.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.664 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -100.16 -45.21 5.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 109.166 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 123.95 17.16 3.13 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.664 ' CE2' ' CD2' ' A' ' 40' ' ' LEU . 10.0 m-85 -59.37 -151.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 108.969 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.58 166.62 16.36 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.311 -0.868 . . . . 0.0 108.854 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.65 87.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.03 -17.15 1.37 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.466 ' O ' HD12 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -89.55 20.91 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.235 . . . . 0.0 109.629 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 13.1 mt-10 -89.75 -43.11 10.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.866 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.92 38.47 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -156.25 66.55 4.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.924 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' CG ' HG22 ' A' ' 74' ' ' VAL . 3.1 Cg_exo -59.64 -46.43 20.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.244 1.963 . . . . 0.0 110.413 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -44.31 -26.69 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.244 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.52 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tt0 -111.64 50.57 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.178 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 57.9 mt -141.85 -69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 142.03 -63.31 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 43.0 m95 -152.33 140.08 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -1.088 . . . . 0.0 109.38 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.585 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -131.66 159.87 37.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.938 . . . . 0.0 109.763 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.4 t-20 -114.29 110.38 19.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 32' ' ' VAL . . . -131.18 -168.85 12.29 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.203 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 40.0 t80 -111.52 114.66 27.89 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -80.63 75.21 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.028 . . . . 0.0 108.952 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.22 -33.88 21.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.5 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 16.4 m -55.39 -45.22 76.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.7 OUTLIER -113.99 18.0 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.65 39.48 4.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 11.5 mt-10 -123.7 109.04 13.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.146 . . . . 0.0 109.135 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 17.6 ptt180 -92.63 143.97 25.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.729 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' CA ' HG22 ' A' ' 22' ' ' ILE . . . 168.67 -162.24 36.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -93.87 163.4 13.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -1.042 . . . . 0.0 109.382 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.585 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 3.8 p90 -163.63 158.64 17.25 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.76 124.43 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.133 1.888 . . . . 0.0 109.973 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -68.74 -40.92 85.01 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p -65.08 -12.06 46.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -1.204 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.0 m-85 -94.2 15.25 17.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.782 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 28.1 m -132.37 179.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.525 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.4 pt-20 -151.5 88.43 1.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 38.1 t80 -45.08 122.64 3.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 74.7 mt -148.36 27.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -150.19 120.68 1.16 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.268 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.493 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 20.2 mtt85 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.464 -1.021 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . -163.57 -161.54 12.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 23.5 m-85 -78.1 113.52 16.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.06 . . . . 0.0 109.384 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.1 mt-30 -108.99 123.75 49.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.67 179.23 4.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.963 -1.085 . . . . 0.0 108.657 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 1.3 mtt180 -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -58.31 122.9 14.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.037 -1.039 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.8 mt -99.31 -34.07 10.47 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.0 m-85 -123.23 -166.72 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -0.807 . . . . 0.0 109.902 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 45.8 p30 -108.38 165.44 11.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.915 . . . . 0.0 109.839 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.515 ' CB ' HD21 ' A' ' 24' ' ' LEU . 7.7 t80 -173.81 106.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.405 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 12.5 ptmm? -83.57 11.58 6.95 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.649 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 69.72 115.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.223 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -90.66 -64.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.29 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.17 162.09 15.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.76 -10.87 22.06 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.96 -25.61 48.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -105.04 161.55 14.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 1.4 pp -118.84 -176.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.465 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 4.7 m-20 -73.92 -179.83 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER 172.91 152.68 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.543 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.51 144.35 18.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.2 tt -48.9 148.21 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 83.57 -7.34 69.38 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 3.0 m-20 -88.06 -175.25 5.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' N ' ' A' ' 29' ' ' ILE . 2.4 mp -137.5 146.6 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.638 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.6 mp -122.38 120.84 35.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.228 -0.92 . . . . 0.0 109.125 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.93 91.49 7.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.864 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.587 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 87.8 t -99.87 110.63 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.0 109.024 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -63.4 147.77 50.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.789 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 161.66 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.353 -0.842 . . . . 0.0 109.573 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 -59.87 4.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 m -52.66 -24.98 9.54 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.216 -1.167 . . . . 0.0 109.184 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.59 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 3.2 tt -90.27 -29.36 18.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.814 . . . . 0.0 109.347 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 96.8 t -89.2 0.56 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.34 -8.33 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.578 HD11 ' CE1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -91.99 -17.07 25.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.718 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.38 23.07 3.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.2 m-85 -57.36 -171.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -1.15 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.9 -173.67 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.377 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.36 87.36 7.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 -31.78 2.5 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -53.8 -20.38 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -49.97 -54.47 19.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.627 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -85.31 59.31 5.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.431 -0.793 . . . . 0.0 110.033 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -153.06 57.49 2.03 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 3.3 Cg_exo -49.85 -46.89 25.56 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.463 ' HA ' HG21 ' A' ' 72' ' ' THR . 8.4 pt-20 -60.2 -33.68 72.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.06 -1.025 . . . . 0.0 109.311 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' CD ' ' HG2' ' A' ' 49' ' ' ARG . 5.4 mt-10 -99.89 1.82 43.19 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 49' ' ' ARG . 2.5 mt -94.36 -34.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 108.895 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.39 -80.52 0.31 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -140.56 144.77 36.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -1.082 . . . . 0.0 109.083 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -128.77 159.83 34.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 15.6 t-20 -118.41 114.47 22.96 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.532 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -135.9 -160.01 8.71 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.291 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 44.5 t80 -126.17 110.03 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.669 -0.901 . . . . 0.0 109.787 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 1.2 m-20 -79.29 85.49 5.13 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.128 -0.982 . . . . 0.0 109.371 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.49 -34.94 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.528 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 24.4 m -51.12 -33.82 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.639 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.6 t -121.74 7.07 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.62 47.0 87.91 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -118.26 163.22 17.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -1.187 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 9.1 ttp180 -148.47 127.72 12.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 167.09 -159.42 32.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.603 -1.284 . . . . 0.0 109.952 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -96.08 167.38 11.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.804 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -165.57 159.71 13.67 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.231 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.1 Cg_exo -61.62 122.55 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.073 1.848 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -69.7 -41.83 73.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 51' ' ' GLU . 2.4 p -60.46 -12.18 8.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.316 . . . . 0.0 109.408 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.6 m-85 -98.56 22.12 10.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.127 -0.983 . . . . 0.0 110.533 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 15.4 m -138.39 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 6.4 pt-20 -148.55 84.07 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -32.54 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.758 0.79 . . . . 0.0 112.155 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 15.1 mm -129.61 -9.69 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 79' ' ' ARG . . . 81.93 -151.79 30.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.629 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.33 141.44 42.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 18.5 m-85 -86.45 123.28 31.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -1.135 . . . . 0.0 109.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.542 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -127.72 138.86 52.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 109.712 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -137.29 179.64 6.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.967 . . . . 0.0 109.672 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 29' ' ' ILE . 1.4 mtm-85 -111.42 161.85 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.68 102.19 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 110.502 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.599 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 2.9 mt -75.14 -39.5 60.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.1 m-85 -128.01 172.47 10.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.882 . . . . 0.0 109.855 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 9.3 p-10 -99.6 146.63 26.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 109.677 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 71.8 t80 -125.24 166.21 16.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -108.24 139.32 43.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 109.423 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 15.5 ttpp -83.3 72.87 10.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 108.928 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -90.27 153.71 20.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.152 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.41 -26.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 18' ' ' ARG . 2.0 mt-10 -53.94 -59.67 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.4 p30 -77.06 169.46 18.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.81 . . . . 0.0 109.571 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 69' ' ' PHE . 1.3 pp -127.77 161.77 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 0.0 109.893 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 4.5 m-20 -74.17 126.44 30.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.574 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.581 HD12 ' CD2' ' A' ' 69' ' ' PHE . 19.0 mt -115.46 160.51 19.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.538 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 2.2 m80 -156.56 149.95 24.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.52 137.52 56.19 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 109.386 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.98 -31.11 5.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 9.7 t0 -59.48 131.55 51.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -1.107 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CD1' ' HD3' ' A' ' 9' ' ' ARG . 9.8 mm -93.26 140.46 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.651 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 9.8 mp -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.134 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.5 87.09 2.47 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.437 -0.789 . . . . 0.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 8' ' ' TYR . 37.7 t -82.85 96.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -50.44 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.385 -0.822 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -86.93 154.08 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.626 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.516 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 88.43 -50.8 3.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -26.19 63.33 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.283 -1.128 . . . . 0.0 109.821 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 2.2 tt -90.14 -35.97 15.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 48.5 t -87.32 0.29 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.85 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.24 -13.99 15.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -104.05 32.2 4.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.744 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.21 51.27 55.29 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 5.5 m-85 -70.83 -176.67 1.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -116.58 158.43 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -73.51 82.91 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.25 -36.94 0.6 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.1 29.31 1.24 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -90.1 -31.3 17.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.734 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . -107.28 42.07 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.763 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.8 tpt180 -138.41 73.42 42.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.599 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 6.1 Cg_exo -56.75 -48.35 19.09 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.688 2.259 . . . . 0.0 111.878 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -56.64 -16.31 6.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.848 -1.158 . . . . 0.0 109.811 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -120.17 -5.41 9.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 109.8 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 49' ' ' ARG . 12.0 mt -79.86 -43.52 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.013 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.41 -76.39 0.26 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 30.7 m95 -143.74 132.75 22.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -1.045 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.594 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -119.87 158.61 26.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 110.027 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 21.1 t-20 -119.3 111.36 18.1 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -135.15 -151.7 6.32 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 31.0 t80 -130.73 113.36 14.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.915 -0.756 . . . . 0.0 109.978 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -80.71 82.07 6.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.0 109.17 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -49.51 -37.12 25.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.946 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -53.0 -44.39 67.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.647 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.43 ' HB ' ' OE1' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -110.43 15.86 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.75 41.49 7.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' OE1' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -106.99 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -1.139 . . . . 0.0 109.558 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.568 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 10.8 ttt180 -156.85 130.29 8.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 161.33 -162.91 34.15 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -92.9 174.74 7.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.991 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.651 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 22.3 p90 178.98 157.47 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 109.333 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.72 115.52 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.021 1.814 . . . . 0.0 109.657 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.594 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -67.84 -30.0 74.08 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 18.7 p -49.49 -20.67 0.77 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.817 -1.402 . . . . 0.0 109.935 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 18.2 m-85 -97.54 33.76 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 111.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.599 ' CG2' ' CB ' ' A' ' 50' ' ' PRO . 16.5 m -145.41 174.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.035 -1.041 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 9' ' ' ARG . 4.9 pt-20 -148.66 93.01 2.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t80 -37.34 119.57 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.372 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 14.2 mm -144.99 15.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.32 100.72 0.46 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.417 -1.049 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 147.64 -119.22 1.08 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 28.5 m-85 -143.31 148.22 35.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.52 -0.988 . . . . 0.0 108.472 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.476 ' CG ' HG21 ' A' ' 31' ' ' THR . 9.9 mt-30 -137.63 107.58 6.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 110.074 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.668 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.47 172.87 6.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.114 -0.991 . . . . 0.0 108.651 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 23.1 ttt180 -109.22 166.3 10.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -0.972 . . . . 0.0 108.954 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -90.64 99.36 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.024 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -80.62 -35.1 34.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.147 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 26.0 m-85 -130.76 171.3 13.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.883 . . . . 0.0 109.822 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -97.88 -177.26 3.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 13' ' ' ASP . 65.6 t80 173.6 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -80.02 143.17 34.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 14.1 pttp -59.32 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -66.18 -70.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 5.4 mtt180 -75.89 164.39 26.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.69 1.48 10.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 1.1 tp10 -104.81 -6.08 20.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.038 -1.039 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.476 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -102.35 154.31 19.18 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 109.824 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.475 ' CD1' HD22 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -108.01 -171.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 0.0 109.391 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.97 142.19 33.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.481 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 1.6 mm? -131.97 138.1 48.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.481 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -153.13 136.79 16.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -49.0 135.58 15.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 96.28 -3.69 64.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 5.1 t70 -90.12 148.97 22.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 17.6 mm -101.68 132.15 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.859 . . . . 0.0 108.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.596 HD21 ' CE2' ' A' ' 69' ' ' PHE . 6.5 mp -114.21 111.72 22.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -91.44 96.01 10.28 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.222 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 8' ' ' TYR . 78.4 t -98.32 101.1 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.0 m-80 -46.99 173.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 109.891 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 1.2 ttpm? -90.35 -27.46 19.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.04 -53.92 3.55 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -54.54 -24.51 21.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.217 -1.167 . . . . 0.0 109.664 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 tp -90.28 -40.83 11.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.512 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 47.4 t -79.93 0.38 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.907 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 -6.53 24.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -102.85 8.41 39.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.705 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.63 32.24 38.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 24.6 m-85 -58.29 -168.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.39 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.07 167.89 14.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.539 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.0 107.67 7.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.55 19.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.461 ' O ' HD12 ' A' ' 53' ' ' ILE . 11.7 mm-40 -82.19 -41.15 20.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.261 -1.14 . . . . 0.0 109.579 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 pm0 -42.51 -43.89 3.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.442 -0.786 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -85.54 43.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.474 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -151.53 62.63 5.01 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HB2' HG21 ' A' ' 74' ' ' VAL . 2.8 Cg_exo -54.64 -55.55 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.469 2.113 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -48.7 -23.45 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.032 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.0 mt-10 -121.44 48.37 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.526 ' CD1' HD22 ' A' ' 56' ' ' LEU . 4.9 mt -133.08 -43.91 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -75.65 0.26 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.521 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 48.5 m95 -144.19 123.57 13.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.378 -1.072 . . . . 0.0 109.576 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -112.95 156.47 22.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.444 ' C ' HG23 ' A' ' 32' ' ' VAL . 14.5 t-20 -112.21 107.69 16.65 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.533 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -130.18 -163.94 11.21 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.457 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.0 t80 -122.32 113.27 19.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.767 -0.843 . . . . 0.0 110.147 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 1.2 m120 -78.96 82.71 5.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.192 -0.943 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -45.19 -41.93 8.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.067 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m -47.88 -69.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.459 HG21 ' HB2' ' A' ' 60' ' ' ASN . 1.7 t -79.76 4.91 14.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.963 . . . . 0.0 109.698 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.75 50.15 38.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -128.84 171.52 12.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -1.128 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.426 ' C ' HG22 ' A' ' 22' ' ' ILE . 12.2 ttp85 -143.21 143.8 31.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.88 -167.36 37.25 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.573 -1.298 . . . . 0.0 109.923 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 21' ' ' ASP . 4.0 p30 -91.49 171.85 8.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -1.062 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 30' ' ' LEU . 13.5 p90 -175.13 154.01 1.64 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.875 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -58.4 124.51 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.985 1.79 . . . . 0.0 109.765 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' CA ' HD12 ' A' ' 56' ' ' LEU . . . -71.62 -18.83 77.49 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -70.49 -13.85 62.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.694 -1.474 . . . . 0.0 109.68 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 10.7 m-30 -99.9 19.3 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 9' ' ' ARG . 2.7 m -132.39 -174.02 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.81 -1.181 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.8 pt-20 -158.19 88.02 0.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.557 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 14.2 t80 -43.13 133.31 3.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.907 . . . . 0.0 109.31 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.521 HD13 ' N ' ' A' ' 9' ' ' ARG . 2.8 mp -129.06 -4.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.876 -1.14 . . . . 0.0 109.931 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 171.66 167.29 31.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.518 ' CA ' ' OH ' ' A' ' 76' ' ' TYR . 2.6 ptt-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.54 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.34 148.84 17.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.616 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 52.5 m-85 -84.57 121.35 27.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -1.076 . . . . 0.0 109.265 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 3.7 mt-30 -116.87 129.98 56.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.88 174.65 6.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.945 . . . . 0.0 109.926 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.536 ' HB2' ' CD1' ' A' ' 77' ' ' ILE . 1.8 ttp85 -117.11 126.71 53.26 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 28' ' ' ASP . . . -54.4 133.22 45.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.7 mt -108.93 -38.79 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.554 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 3.8 m-85 -116.48 -160.43 0.76 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -124.52 146.6 48.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.909 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.529 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 63.9 t80 -156.33 111.23 2.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.21 121.91 25.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -48.67 114.6 1.01 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HG3' ' OD2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -90.57 -72.07 0.59 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.203 -0.936 . . . . 0.0 108.612 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.67 166.06 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 109.143 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -9.62 18.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 109.883 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.59 -23.04 40.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.095 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -108.55 158.4 17.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.8 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 67' ' ' GLY . 15.4 pt -111.29 -169.54 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.564 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -106.61 109.0 20.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.824 . . . . 0.0 109.527 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -113.58 148.08 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.18 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 2.0 m80 -154.01 141.49 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 109.39 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' HIS . 2.5 tp -41.59 136.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.679 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.32 1.64 81.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 1.4 m-20 -90.42 169.18 11.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -1.156 . . . . 0.0 109.473 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 28' ' ' ASP . 2.7 mm -122.92 132.54 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.183 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.616 HD21 ' CZ ' ' A' ' 69' ' ' PHE . 10.5 mp -115.61 128.59 56.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.066 -1.021 . . . . 0.0 109.116 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.464 HG22 ' OE1' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -110.42 79.77 1.24 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.392 -0.818 . . . . 0.0 109.149 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.559 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 74.7 t -80.25 117.12 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -53.3 -173.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 37' ' ' LEU . 6.3 mtmt -90.17 -62.47 1.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.427 -0.796 . . . . 0.0 109.938 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.67 -54.49 37.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -19.7 3.56 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.213 -1.169 . . . . 0.0 109.32 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.577 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 0.5 OUTLIER -84.57 -36.85 21.82 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 21.9 t -85.02 -4.06 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.344 -0.848 . . . . 0.0 109.886 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.1 -24.1 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.055 -1.028 . . . . 0.0 108.605 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -88.78 33.19 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.624 -0.673 . . . . 0.0 109.848 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 47.51 29.55 5.61 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 53' ' ' ILE . 6.8 m-30 -47.62 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.822 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -100.86 -174.35 2.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.181 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.98 103.92 16.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.787 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 12.59 77.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 43' ' ' SER . 6.8 tt0 -90.3 29.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -1.2 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HG3' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -86.55 -13.12 46.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -79.08 4.52 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.094 -1.004 . . . . 0.0 109.396 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 52' ' ' GLU . 3.5 mtt180 -131.28 63.2 69.11 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 108.943 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.7 Cg_exo -59.0 -24.68 74.51 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.25 1.967 . . . . 0.0 110.397 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.543 ' CB ' ' HA ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -69.03 -43.34 74.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.121 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.0 mt-10 -79.79 -6.79 57.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.154 -0.966 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -79.71 -42.39 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 108.697 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.8 -74.34 0.26 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 21.7 m95 -147.67 122.75 10.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -1.031 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -104.9 153.78 20.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.028 -1.045 . . . . 0.0 108.983 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' O ' HG12 ' A' ' 32' ' ' VAL . 5.7 t-20 -122.01 121.95 38.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.522 ' CA ' ' HA ' ' A' ' 32' ' ' VAL . . . -146.88 -146.98 4.46 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -123.57 110.16 14.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.54 -0.977 . . . . 0.0 110.131 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' HB3' ' CG2' ' A' ' 63' ' ' THR . 1.0 OUTLIER -78.32 82.38 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 108.539 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -53.02 -35.04 59.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 110.122 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.495 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 19.7 m -53.38 -39.81 64.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 109.714 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 60' ' ' ASN . 14.8 t -108.93 6.59 25.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.82 48.53 56.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 63' ' ' THR . 37.1 mm-40 -135.7 171.91 13.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -1.184 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 25.1 ttt180 -141.59 146.45 36.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 159.85 -159.05 30.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -106.5 175.46 5.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.947 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.616 ' CZ ' HD21 ' A' ' 30' ' ' LEU . 1.7 p90 -173.17 162.03 3.52 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 6.1 Cg_exo -58.35 119.14 6.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.929 1.753 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.14 -29.81 66.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 51' ' ' GLU . 27.9 p -69.45 -7.02 34.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -1.233 . . . . 0.0 109.15 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -100.26 -5.37 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 110.194 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 71' ' ' GLY . 28.5 m -111.29 172.87 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 6.0 pt-20 -136.25 87.55 2.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.237 -0.915 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 91.4 t80 -42.64 143.54 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 9' ' ' ARG . 3.6 mt -145.2 16.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.491 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 83.69 -122.57 5.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 109.495 179.977 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.45 156.69 5.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 46.0 m-85 -107.06 115.99 31.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -1.192 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 9.8 mt-30 -93.39 127.85 39.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.45 177.32 4.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.795 -1.191 . . . . 0.0 111.315 -179.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.481 ' NH1' HG22 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -114.23 124.85 53.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.825 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -61.3 116.66 4.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.7 mt -82.73 -36.14 26.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.571 -0.706 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 3.3 m-85 -120.83 -137.68 0.33 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.396 -0.815 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -144.16 -177.01 5.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 1.6 t80 -170.03 135.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.69 8.08 45.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.912 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 4.7 tttt 61.52 108.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 0.0 109.893 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -61.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 32.1 mtm-85 -90.41 139.63 30.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' ARG . 46.0 tt0 -40.93 -35.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.454 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -54.51 -59.53 4.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -64.52 165.34 10.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 110.022 -179.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.501 HD13 ' ND2' ' A' ' 60' ' ' ASN . 1.6 pt -129.53 172.33 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.65 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.2 m-20 -69.62 115.91 9.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.9 . . . . 0.0 109.921 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -104.94 157.88 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -160.1 143.14 13.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.665 -1.272 . . . . 0.0 110.204 -179.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -55.49 139.25 44.36 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.232 -0.918 . . . . 0.0 109.394 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -33.07 4.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 25' ' ' HIS . 7.6 t0 -68.38 121.25 15.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -1.066 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 30' ' ' LEU . 2.9 mp -88.37 165.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.687 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.78 147.43 42.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.049 -1.032 . . . . 0.0 108.235 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.472 HG21 ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -108.25 93.21 4.41 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.679 -0.638 . . . . 0.0 109.764 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 47.3 t -92.89 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.117 -0.99 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.429 ' O ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -54.65 138.7 40.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.855 . . . . 0.0 109.682 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 6.5 pttt -59.01 144.54 44.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.295 -0.878 . . . . 0.0 108.995 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.14 -58.5 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 33' ' ' ASN . 2.6 p -46.6 -26.01 0.82 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.152 -1.205 . . . . 0.0 108.747 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.597 ' CB ' ' CG ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -85.25 -40.61 16.43 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 39' ' ' ALA . 21.4 t -70.96 -4.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -82.53 -54.94 4.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.01 20.02 4.2 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -56.77 -68.28 0.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.571 -1.546 . . . . 0.0 108.143 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 13.8 t -158.2 130.91 7.21 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.13 117.95 9.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 0.0 109.669 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.76 -1.47 55.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 1.8 tt0 -86.39 30.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.095 -1.238 . . . . 0.0 110.076 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CB ' ' CD2' ' A' ' 6' ' ' TYR . 8.1 mt-10 -88.14 20.53 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.57 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -105.24 -21.8 13.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -113.72 82.01 6.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 4.2 Cg_exo -59.62 -52.58 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -44.79 -27.47 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -105.51 47.03 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.578 ' CD1' ' CD2' ' A' ' 37' ' ' LEU . 58.7 mt -144.18 -49.69 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.5 -70.33 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 31.6 m95 -143.84 152.65 41.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.614 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -135.94 144.29 45.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.465 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 16.9 t-20 -110.34 106.19 15.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.533 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -132.31 -163.88 10.82 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.036 -1.554 . . . . 0.0 111.296 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 122.161 -0.611 . . . . 0.0 109.857 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.501 ' ND2' HD13 ' A' ' 22' ' ' ILE . 4.3 m-80 -77.04 91.12 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.838 -1.164 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.38 -37.29 62.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 10.7 m -51.71 -45.36 63.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.197 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 64' ' ' GLY . 2.5 t -107.25 9.57 30.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.52 53.61 5.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -129.51 151.85 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -1.196 . . . . 0.0 109.806 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.416 ' C ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -123.38 124.91 43.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 108.948 -179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -179.2 -166.64 35.4 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.471 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -104.22 166.93 10.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.966 . . . . 0.0 109.852 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CE2' ' CD1' ' A' ' 30' ' ' LEU . 5.0 p90 -167.95 160.03 9.55 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.57 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -59.85 128.6 27.36 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.221 1.947 . . . . 0.0 110.61 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.18 -36.26 60.24 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p -64.85 -9.82 23.75 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.031 -1.276 . . . . 0.0 109.242 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.6 m-85 -96.41 15.36 21.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.968 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG21 ' HG2' ' A' ' 50' ' ' PRO . 29.6 m -139.74 -177.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 76' ' ' TYR . 15.5 pt-20 -156.43 89.92 1.15 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.57 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.7 t80 -36.9 132.92 0.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.619 -0.675 . . . . 0.0 109.527 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.481 HG22 ' NH1' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -119.13 -15.55 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.994 . . . . 0.0 109.509 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 -124.31 5.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.481 ' O ' ' NE2' ' A' ' 7' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.085 -1.244 . . . . 0.0 109.505 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 34' ' ' LYS . 2.2 mt-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.344 0.592 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.92 -179.92 52.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.643 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 2.5 m-85 -99.69 136.82 39.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -1.146 . . . . 0.0 109.392 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 78' ' ' GLY . 1.2 mt-30 -129.94 108.74 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 108.941 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -101.82 -178.94 3.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.001 -1.062 . . . . 0.0 110.483 -179.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -123.51 139.77 53.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.56 ' CB ' ' OD1' ' A' ' 28' ' ' ASP . . . -64.31 98.67 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.016 -1.053 . . . . 0.0 110.562 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.634 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 4.6 mt -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 108.588 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.634 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 28.6 m-85 -140.11 -164.13 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' HD22 ' A' ' 24' ' ' LEU . 5.3 p30 -115.67 148.2 39.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' N ' HD21 ' A' ' 24' ' ' LEU . 45.1 t80 -150.64 108.92 3.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 17' ' ' GLU . 19.4 tptt -79.8 149.37 31.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 2.1 tttp -52.55 89.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' LYS . 42.5 mm-40 -77.97 -68.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.0 mtt180 -89.6 164.65 14.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.277 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.48 2.2 10.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.232 -0.918 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -106.07 -2.71 22.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.067 -1.02 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 p-10 -115.17 167.64 10.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.977 -1.077 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.489 HD13 ' ND2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -111.92 -171.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.663 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -103.4 98.38 8.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -0.814 . . . . 0.0 109.348 179.918 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -96.87 161.99 13.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 3.0 m80 -156.33 149.75 24.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.146 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 6.4 tt -54.02 140.77 30.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.933 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -30.25 6.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.56 ' OD1' ' CB ' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.73 166.72 12.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 109.606 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' HA ' HD11 ' A' ' 29' ' ' ILE . 7.4 mm -119.29 141.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.598 HD21 ' CZ ' ' A' ' 69' ' ' PHE . 10.4 mp -110.43 123.64 50.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.414 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -104.3 88.63 3.02 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 -179.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.59 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 74.3 t -96.55 95.5 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.468 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' VAL . 2.2 m120 -42.0 165.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 109.948 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -87.26 150.69 23.72 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.338 -0.851 . . . . 0.0 109.408 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.27 -61.72 2.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -55.61 -19.52 10.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.299 -1.118 . . . . 0.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -89.71 -30.62 17.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.47 -0.769 . . . . 0.0 109.409 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.534 HG21 ' CG ' ' A' ' 47' ' ' GLU . 18.8 t -87.87 -2.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -3.93 20.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.612 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.9 mt -84.26 -25.68 29.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 122.06 4.2 9.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CZ ' ' CG2' ' A' ' 53' ' ' ILE . 20.0 m-85 -53.08 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.602 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.536 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -116.58 118.36 32.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 43' ' ' SER . 11.1 t70 -24.3 88.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.303 0.573 . . . . 0.0 111.259 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 139.53 -7.73 3.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' HD12 ' A' ' 53' ' ' ILE . 1.1 tp60 -90.51 -0.89 57.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.296 . . . . 0.0 110.04 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 22.1 mt-10 -66.92 -10.0 44.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 0.0 109.57 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.36 19.2 16.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.518 ' CG ' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -128.72 61.69 56.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.0 Cg_exo -57.62 -38.96 91.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.228 1.952 . . . . 0.0 110.323 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -64.37 -28.33 69.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 16.9 mm-40 -101.64 -5.24 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 18.6 mt -83.44 -88.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.283 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 155.8 -55.05 0.41 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.2 m95 -153.27 138.4 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -1.046 . . . . 0.0 109.395 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -135.01 143.04 46.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.795 -179.964 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -94.51 102.98 14.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.553 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -118.98 175.93 15.89 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.723 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.5 t80 -109.25 106.92 16.97 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.815 -0.815 . . . . 0.0 109.519 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.489 ' ND2' HD13 ' A' ' 22' ' ' ILE . 1.6 m-80 -78.12 89.31 4.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 108.971 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -57.63 -36.86 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.004 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m -49.47 -33.04 13.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 6.6 9.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.2 39.41 70.92 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -107.7 157.02 18.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.49 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 13.0 tpt180 -139.16 114.43 9.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 108.868 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -175.4 -165.35 31.39 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.046 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.556 ' OD2' ' CE3' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -97.81 164.31 12.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -1.01 . . . . 0.0 109.783 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CZ ' HD21 ' A' ' 30' ' ' LEU . 1.2 p90 -160.07 162.66 23.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.46 124.89 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.922 1.748 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.481 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -71.45 -33.73 63.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -68.09 -8.2 36.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.984 -1.304 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.59 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.0 m-85 -99.06 -7.75 26.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.114 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 71' ' ' GLY . 24.1 m -109.34 176.11 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.526 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 5.7 pt-20 -142.11 89.33 2.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.437 -0.79 . . . . 0.0 108.957 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.612 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 60.4 t80 -38.71 125.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.549 -0.72 . . . . 0.0 109.921 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.577 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -152.57 17.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -121.38 105.1 0.99 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 10.4 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 4.6 tm-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . -169.23 -51.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 21.6 m-85 -137.53 105.04 5.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.92 . . . . 0.0 108.691 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 10.2 mt-30 -99.64 123.12 43.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 110.047 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -112.91 170.19 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.071 -1.018 . . . . 0.0 108.967 179.878 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 13.3 ttp180 -105.68 145.47 31.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 108.97 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -74.13 96.95 2.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.923 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 18.6 mt -64.26 -29.75 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 6.5 m-85 -130.01 -159.34 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.139 -0.976 . . . . 0.0 110.16 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -117.59 -167.81 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -176.44 156.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.893 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -119.33 27.11 9.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 0.0 110.399 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.532 ' CB ' ' OD1' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 42.26 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.105 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 18' ' ' ARG . 17.4 mt-10 -126.9 -50.2 1.46 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.053 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 55' ' ' TRP . 0.2 OUTLIER -39.79 161.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.542 -0.724 . . . . 0.0 110.274 179.97 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -28.99 -68.25 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.595 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 5.3 mm-40 -131.16 48.68 2.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.808 -1.182 . . . . 0.0 111.005 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 56.1 p-10 -95.85 154.99 16.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.164 . . . . 0.0 108.853 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 23' ' ' ASP . 1.2 pp -104.09 171.35 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 110.042 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -64.82 170.3 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -153.27 146.84 25.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.528 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -156.25 138.98 15.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.681 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -55.35 122.27 10.79 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.43 -5.36 28.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 1.2 m-20 -90.24 163.63 14.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -1.166 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 14.1 mm -119.24 140.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.597 HD21 ' CE2' ' A' ' 69' ' ' PHE . 5.8 mp -118.9 113.85 21.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.09 105.78 17.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.561 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 71.7 t -115.75 91.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.699 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' HA ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t-20 -42.82 159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.931 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -83.75 145.43 28.72 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 98.79 -55.4 1.01 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -45.85 -27.36 0.85 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.267 -1.137 . . . . 0.0 108.877 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.543 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 0.6 OUTLIER -90.06 -35.72 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 42.0 t -79.23 3.89 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 109.659 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.35 -13.2 17.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' CD2' ' N ' ' A' ' 40' ' ' LEU . 1.2 mm? -96.85 -19.72 18.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.089 -1.007 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 117.77 25.32 3.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.543 ' CD2' ' CD2' ' A' ' 37' ' ' LEU . 5.9 m-85 -51.65 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -1.042 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -160.5 -162.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.147 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 11.4 t70 -90.14 62.39 5.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.177 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 34.68 2.57 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -82.42 6.66 16.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 109.557 -179.958 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' OE2' ' CZ ' ' A' ' 8' ' ' TYR . 3.9 tm-20 -67.7 -7.01 23.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -84.99 16.96 3.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.988 -1.07 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -125.69 59.36 26.7 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.126 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HB3' ' CG2' ' A' ' 74' ' ' VAL . 3.0 Cg_exo -50.13 -59.78 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.153 1.902 . . . . 0.0 110.337 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 4.2 tt0 -66.65 -17.15 64.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 108.679 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.2 mm-40 -108.67 22.69 15.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 49' ' ' ARG . 5.5 mt -118.39 -45.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 108.945 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.97 -74.32 0.29 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.574 ' CZ2' ' HG3' ' A' ' 18' ' ' ARG . 12.5 m95 -141.78 147.02 36.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -1.084 . . . . 0.0 109.121 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.589 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -136.89 159.58 41.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -180.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 67' ' ' GLY . 3.1 t-20 -111.76 100.79 9.22 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.54 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -119.62 178.46 16.55 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.598 ' CG ' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -112.43 113.27 25.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.654 -0.909 . . . . 0.0 109.893 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 37.0 m-80 -89.44 64.43 6.75 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 62' ' ' THR . 4.1 mt-10 -45.94 -28.3 1.1 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.023 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 8.3 m -47.19 -54.97 9.39 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.8 t -87.3 -10.21 52.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.67 40.29 11.04 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 8.2 mm-40 -138.89 164.88 28.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.057 -1.261 . . . . 0.0 109.257 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.598 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 52.2 ttp85 -145.69 115.3 7.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . -162.63 -159.07 10.06 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -87.81 165.63 15.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.945 . . . . 0.0 110.091 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.597 ' CE2' HD21 ' A' ' 30' ' ' LEU . 2.7 p90 -172.13 159.23 4.33 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.802 . . . . 0.0 109.313 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.7 Cg_exo -61.44 126.05 18.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.176 1.918 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.589 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -71.68 -32.94 63.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 1.6 p -64.84 -9.94 24.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.083 -1.245 . . . . 0.0 109.43 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.9 m-85 -98.73 15.95 23.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 50' ' ' PRO . 18.1 m -134.94 -177.94 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.085 -1.009 . . . . 0.0 110.534 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 4.5 pt-20 -147.03 89.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 33.3 t80 -49.65 123.88 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.44 ' O ' HG21 ' A' ' 77' ' ' ILE . 9.6 mt -113.58 -16.8 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.985 . . . . 0.0 109.649 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 111.65 -160.48 13.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.56 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.577 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . 178.6 -143.39 5.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CE1' ' CB ' ' A' ' 47' ' ' GLU . 60.0 m-85 -158.75 141.21 14.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.494 -1.004 . . . . 0.0 108.959 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.507 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.1 tt0 -154.81 114.36 3.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 109.43 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -109.8 170.93 7.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 1.6 tpp180 -112.83 116.7 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 9' ' ' ARG . . . -43.44 158.02 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.68 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.5 mt -135.92 -41.17 0.67 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 12.3 m-85 -125.33 169.96 11.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.548 -0.72 . . . . 0.0 109.765 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p30 -102.87 139.39 38.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.559 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 34.4 t80 -134.78 131.33 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.213 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.99 120.43 24.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.556 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.1 pttt -56.29 91.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.824 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -55.72 -68.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.33 159.33 16.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.157 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.31 -12.98 10.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.075 -1.016 . . . . 0.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -31.24 62.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -96.01 149.29 21.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 109.5 -179.989 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.517 HD11 ' N ' ' A' ' 23' ' ' ASP . 1.4 pp -105.37 175.84 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.579 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 4.0 m-20 -80.18 115.8 19.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 109.894 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -94.08 147.01 23.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 108.725 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -152.49 127.57 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.536 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 5.5 tt -43.64 141.19 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.97 1.11 88.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 29' ' ' ILE . 12.5 t0 -82.32 152.45 26.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 6.4 mm -104.37 124.57 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.035 . . . . 0.0 109.071 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.642 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.8 mp -111.81 106.78 15.63 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 109.555 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -88.93 95.82 10.47 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.262 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 8' ' ' TYR . 40.7 t -93.65 116.02 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.467 -0.771 . . . . 0.0 109.451 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -87.36 -179.31 6.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 146.95 31.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.06 -62.38 2.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -21.07 29.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.28 -1.129 . . . . 0.0 108.949 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.588 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -90.09 -35.3 15.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.284 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 40.0 t -77.17 2.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' C ' HD11 ' A' ' 40' ' ' LEU . . . -60.89 -11.93 9.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -102.64 36.63 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.001 -1.062 . . . . 0.0 109.39 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 48.3 25.09 4.02 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.614 ' CZ ' ' CG2' ' A' ' 53' ' ' ILE . 6.1 m-30 -48.4 -178.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.572 -0.957 . . . . 0.0 109.858 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -122.83 106.12 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 43' ' ' SER . 13.4 t0 -27.72 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.312 0.577 . . . . 0.0 110.97 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 147.46 -23.07 1.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -89.96 -2.94 58.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.12 -1.224 . . . . 0.0 110.309 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CB ' ' CE1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -42.99 -49.79 5.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.435 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.26 46.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.09 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.53 ' CD ' ' HB3' ' A' ' 52' ' ' GLU . 55.5 ttt180 -151.34 59.37 3.25 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.078 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 3.0 Cg_endo -60.03 -47.49 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.268 1.979 . . . . 0.0 110.453 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 52' ' ' GLU . 24.1 pt-20 -47.89 -46.87 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.53 ' HB3' ' CD ' ' A' ' 49' ' ' ARG . 1.4 tt0 -99.5 47.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.181 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.614 ' CG2' ' CZ ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -130.56 -39.58 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.953 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.4 -79.41 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -138.6 137.32 36.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 1.2 mp -121.78 168.21 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 109.794 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.6 119.49 33.9 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA3' HG21 ' A' ' 32' ' ' VAL . . . -144.43 -172.94 15.37 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.088 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -114.85 109.11 17.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.465 -1.021 . . . . 0.0 109.763 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' OD1' ' CD1' ' A' ' 22' ' ' ILE . 15.9 m120 -79.05 85.9 4.93 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.189 -0.944 . . . . 0.0 109.0 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.447 -0.783 . . . . 0.0 110.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 21.9 m -53.58 -35.88 61.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.449 HG22 ' CE1' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -116.87 10.52 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 42.44 53.95 4.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -141.93 115.32 8.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.24 136.77 32.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 109.247 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.507 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 176.96 -160.5 27.67 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.244 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 8.4 m-20 -96.33 163.98 12.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -1.06 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.642 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 p90 -164.36 158.99 15.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.879 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.3 Cg_exo -61.19 117.43 4.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.249 1.966 . . . . 0.0 109.981 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -68.12 -34.83 82.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 2.9 p -63.26 -19.99 65.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.971 -1.311 . . . . 0.0 110.03 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 7.2 m-30 -93.41 17.98 10.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.598 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 30.7 m -131.02 170.12 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.097 -1.002 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 7.6 pt-20 -137.6 87.38 2.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.282 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CE2' ' N ' ' A' ' 78' ' ' GLY . 65.8 t80 -41.04 141.11 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 9' ' ' ARG . 3.3 mt -139.36 8.99 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 97.33 -140.33 14.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.408 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.61 -168.13 19.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 28.7 m-85 -80.02 106.35 11.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -1.083 . . . . 0.0 109.753 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.468 ' CG ' HG21 ' A' ' 31' ' ' THR . 1.3 mt-30 -102.56 128.04 49.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.31 173.15 6.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 0.0 109.972 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HB3' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.87 142.26 46.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -64.93 151.31 46.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.896 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 75' ' ' GLU . 13.3 mt -134.2 -41.8 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.0 m-85 -118.77 -142.8 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.554 -0.717 . . . . 0.0 109.541 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -144.77 173.96 11.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.89 -1.132 . . . . 0.0 109.957 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 47.6 t80 -173.59 141.51 0.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.4 -0.813 . . . . 0.0 108.911 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' GLU . 1.4 mttt -101.94 133.44 46.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.03 -1.043 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -58.63 88.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 109.528 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 15' ' ' LYS . 60.8 tt0 -90.1 -73.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.1 mtt180 -61.66 157.9 16.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 26.2 tp10 -74.75 1.95 11.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.117 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.38 -1.06 16.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.061 -1.024 . . . . 0.0 110.042 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 52.3 p30 -110.99 164.63 12.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.997 -1.064 . . . . 0.0 109.6 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 67' ' ' GLY . 2.1 pt -126.38 -170.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 1.2 m-20 -84.9 134.5 34.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.634 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -128.12 138.28 52.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.076 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -153.46 138.75 17.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.062 -1.024 . . . . 0.0 109.62 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 tt -54.21 147.55 12.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.35 -0.844 . . . . 0.0 109.779 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 90.65 -9.89 76.29 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.8 m-20 -86.54 178.12 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.163 . . . . 0.0 109.83 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 5.7 mm -129.5 140.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.115 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.652 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.8 mp -121.42 130.13 53.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.971 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.468 HG21 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -106.94 93.82 4.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.884 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 8' ' ' TYR . 56.4 t -101.11 115.03 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -68.47 160.95 28.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.05 2.55 17.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.886 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.58 -49.6 0.47 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -54.84 -25.69 30.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -1.168 . . . . 0.0 109.641 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.591 ' CD2' ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -90.38 -34.08 15.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' CG2' ' OE2' ' A' ' 47' ' ' GLU . 71.4 t -80.75 2.27 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.066 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.5 4.23 7.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 109.988 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -111.44 5.1 19.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.047 . . . . 0.0 109.975 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.09 34.26 6.87 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CE1' ' CD2' ' A' ' 37' ' ' LEU . 14.9 m-85 -69.88 -169.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.81 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.524 ' O ' ' C ' ' A' ' 44' ' ' ASP . 58.8 m -125.93 90.11 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.913 0.864 . . . . 0.0 109.198 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.74 87.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.409 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 148.61 -23.95 1.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -90.33 -12.39 37.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.058 -1.26 . . . . 0.0 110.01 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' OE2' ' CG2' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -43.37 -39.76 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.933 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.59 40.94 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.522 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -148.08 60.34 5.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 5.0 Cg_exo -59.0 -41.93 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.358 2.039 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HA ' HG21 ' A' ' 72' ' ' THR . 16.8 pt-20 -57.01 -16.5 7.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -120.07 -5.75 10.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.895 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 56' ' ' LEU . 3.2 mt -79.6 -34.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 109.161 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 -71.6 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -141.5 124.93 16.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -1.046 . . . . 0.0 109.407 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.578 ' O ' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -113.82 156.44 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.816 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -113.05 106.92 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.529 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -130.52 -158.65 9.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.588 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 38.8 t80 -124.8 108.72 12.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.674 -0.897 . . . . 0.0 109.863 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -79.4 90.83 5.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.302 -0.874 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.06 -37.93 67.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 96.5 m -57.51 -45.77 84.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.326 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.4 p -93.81 4.89 53.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.68 48.75 8.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -140.2 166.35 24.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.621 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 30.9 ttp180 -134.11 140.87 46.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.512 ' N ' HD12 ' A' ' 22' ' ' ILE . . . 165.6 -163.24 36.51 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.232 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 43.6 m-20 -94.19 170.74 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.976 . . . . 0.0 109.784 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.652 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 9.9 p90 -172.77 158.59 3.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.354 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.83 121.39 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.15 1.9 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.57 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -72.08 -34.37 61.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 51' ' ' GLU . 17.0 p -66.3 -8.97 28.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.304 . . . . 0.0 109.048 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.54 9.56 39.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 4.5 m -128.06 -174.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.9 pt-20 -160.21 92.74 1.01 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.604 -0.685 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 75' ' ' GLU . 5.1 t80 -33.19 115.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.569 0.7 . . . . 0.0 110.547 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.579 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 10.4 mm -144.11 16.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -129.35 115.22 1.89 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.251 -1.147 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.93 163.1 11.88 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 26.3 m-85 -80.91 123.74 28.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 31' ' ' THR . 16.7 mt-30 -115.56 115.65 26.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -104.96 175.56 5.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.062 -1.024 . . . . 0.0 109.093 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.53 174.35 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 108.849 179.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.37 152.42 21.01 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.2 mt -137.79 -38.56 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.566 ' HB2' ' CG ' ' A' ' 73' ' ' TYR . 4.5 m-85 -122.82 176.02 6.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.383 -0.823 . . . . 0.0 109.78 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -100.63 171.86 7.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 3.1 t80 -161.96 146.75 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.6 ttpt -107.99 17.95 21.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 21' ' ' ASP . 16.1 ttmt 59.5 71.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.806 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.5 tp10 -72.4 -73.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.7 mtp85 -53.8 144.23 18.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.35 -7.66 10.43 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -103.68 -22.76 13.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.006 -1.059 . . . . 0.0 110.441 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 16' ' ' LYS . 48.1 p30 -73.77 -179.82 3.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 0.0 109.82 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.467 ' CG2' ' HA3' ' A' ' 67' ' ' GLY . 1.3 pp -138.11 159.4 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.2 m-20 -60.24 145.0 48.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.551 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 10.2 mt -135.4 157.75 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.868 . . . . 0.0 109.37 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CE1' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -160.01 128.87 5.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 109.151 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.94 124.77 7.92 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.33 -18.79 11.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.54 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 1.1 m-20 -90.3 160.58 16.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.504 HG21 ' N ' ' A' ' 30' ' ' LEU . 6.5 mt -115.96 157.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.661 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 3.2 mp -130.77 121.41 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.279 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.44 HG21 ' HG2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -93.16 102.62 14.93 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.779 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.582 HG23 ' CE2' ' A' ' 8' ' ' TYR . 75.6 t -102.32 117.91 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -50.59 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 12.7 mtpt -90.29 -73.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.58 -24.21 30.96 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.82 -40.74 85.05 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.081 -1.246 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 10.8 tp -90.09 -29.52 18.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 58.3 t -90.15 3.16 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.908 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.53 -7.67 21.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.37 15.63 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.096 -1.003 . . . . 0.0 109.773 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.4 41.61 25.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 5.1 m-85 -64.77 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -139.27 156.21 47.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.34 120.75 10.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.61 -31.77 6.42 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.515 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 2.3 mp0 -76.48 -40.08 51.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -1.169 . . . . 0.0 109.462 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CB ' HD22 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.86 -27.05 66.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -84.71 -19.7 32.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -113.55 77.87 3.44 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.329 179.968 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.495 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 4.2 Cg_exo -57.73 -32.71 95.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.096 1.864 . . . . 0.0 110.238 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 72' ' ' THR . 24.7 tt0 -60.39 -32.43 71.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.018 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.37 -6.64 43.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 42' ' ' PHE . 16.2 mt -79.71 -54.34 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.71 -69.69 0.52 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.417 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 23.9 m95 -144.18 141.27 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.55 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.62 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -138.68 139.83 38.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -90.25 99.21 12.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.852 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.532 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -112.38 166.29 12.17 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.346 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -101.95 106.58 17.53 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.764 -0.845 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 3.2 m120 -78.48 78.45 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -49.27 -36.56 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.814 . . . . 0.0 109.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.54 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 20.4 m -51.51 -61.08 2.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.379 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 25' ' ' HIS . 1.9 p -91.69 13.18 18.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.53 54.35 4.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 18.4 pt-20 -139.23 121.81 16.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.646 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.426 ' C ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -96.64 128.43 43.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . -174.39 -179.53 45.06 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -88.94 165.02 14.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 109.59 180.0 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.661 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.8 p90 -165.67 162.84 13.05 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.644 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 2.2 Cg_endo -63.71 120.55 7.98 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.86 1.707 . . . . 0.0 109.254 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.545 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -64.35 -19.18 64.03 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 1.7 p -72.57 -20.03 61.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.902 -1.352 . . . . 0.0 109.927 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 7.3 m-30 -92.92 7.36 44.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 0.0 110.584 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 50' ' ' PRO . 13.3 m -118.4 -172.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.946 -1.097 . . . . 0.0 109.621 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 10.5 pt-20 -155.74 86.16 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.4 t80 -40.37 136.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 9' ' ' ARG . 5.1 mt -119.78 -4.28 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 109.859 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.583 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 130.48 -162.48 23.27 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.83 -165.63 11.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 56.4 m-85 -80.43 110.36 15.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.584 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.2 mt-30 -87.48 124.42 33.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.584 ' CE2' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -104.58 -177.11 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.01 -1.057 . . . . 0.0 110.131 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.552 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 3.8 ttm180 -126.32 130.96 51.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -65.48 123.5 19.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.778 -1.201 . . . . 0.0 110.056 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.588 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -99.79 -42.41 6.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 7.2 m-85 -124.12 -158.68 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.503 -0.748 . . . . 0.0 109.566 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 6.2 p-10 -123.37 171.97 9.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.686 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.496 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 26.1 t80 -167.76 113.54 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.8 mmtp -80.21 132.81 35.94 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.062 -1.024 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 4.4 mtpm? -41.87 106.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.853 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -133.2 -33.96 1.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -75.55 145.6 41.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.85 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' HG3' ' OE1' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -41.96 -33.63 0.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.697 -0.627 . . . . 0.0 110.743 -179.98 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.459 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -137.35 58.06 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.924 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 p-10 -119.2 173.48 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.916 -1.115 . . . . 0.0 108.92 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -126.0 179.05 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 109.95 179.982 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.577 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 1.2 m-20 -85.91 108.82 18.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.3 mm? -95.07 144.13 25.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -155.18 128.4 8.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.11 -0.994 . . . . 0.0 109.66 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 11' ' ' LEU . 3.2 tt -52.14 137.93 26.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.741 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -18.52 39.46 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD1' ' CG2' ' A' ' 62' ' ' THR . 16.7 m-20 -90.21 172.35 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -1.191 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.469 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 19.2 mm -117.83 144.72 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.522 ' CD1' HG13 ' A' ' 74' ' ' VAL . 10.3 mt -108.53 146.79 32.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -129.91 87.19 2.49 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.757 179.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.584 HG22 ' CE2' ' A' ' 8' ' ' TYR . 29.5 t -97.51 116.25 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -57.19 122.36 12.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.44 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.527 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.472 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 144.18 -56.95 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -48.21 -51.28 26.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.141 . . . . 0.0 110.122 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.555 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -81.39 -15.76 54.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.115 -0.99 . . . . 0.0 109.195 -179.92 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.54 ' CG2' ' OE1' ' A' ' 47' ' ' GLU . 1.4 t -77.84 -10.79 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.55 -9.15 23.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.0 109.336 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.561 HD13 ' CE2' ' A' ' 42' ' ' PHE . 14.6 mt -67.92 -27.63 66.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.03 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.17 3.03 6.94 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 53' ' ' ILE . 19.8 m-85 -58.82 178.08 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -1.145 . . . . 0.0 109.631 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -119.53 135.74 54.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 108.75 179.963 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 43' ' ' SER . 10.5 t70 -31.88 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.317 0.579 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 129.49 -3.64 6.2 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 42' ' ' PHE . 4.6 mt-30 -91.14 -25.02 19.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.102 -1.234 . . . . 0.0 109.632 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 1.1 tt0 -59.05 -47.97 83.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -56.19 -15.8 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.11 80.45 5.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 109.587 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -65.04 -47.12 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.166 1.911 . . . . 0.0 110.451 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' PRO . 7.6 pt-20 -43.17 -42.15 4.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.25 51.71 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.593 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.3 mt -138.89 -41.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.72 -77.18 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.412 ' CZ2' ' HD2' ' A' ' 18' ' ' ARG . 34.4 m95 -137.91 147.13 44.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -1.037 . . . . 0.0 109.121 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.625 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -138.76 137.22 36.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.147 -0.971 . . . . 0.0 110.125 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -88.33 95.69 10.29 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.567 ' CA ' ' CG2' ' A' ' 32' ' ' VAL . . . -115.33 173.74 14.92 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.355 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' O ' ' OG1' ' A' ' 31' ' ' THR . 46.8 t80 -115.7 107.81 15.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.648 -0.913 . . . . 0.0 109.76 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' ND2' HD13 ' A' ' 22' ' ' ILE . 4.1 m-80 -77.97 96.7 5.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 108.873 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.469 ' OE1' ' HB ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -54.17 -39.5 66.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.001 -179.918 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.524 ' CG2' ' OD1' ' A' ' 28' ' ' ASP . 17.9 m -49.08 -64.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.9 p -85.41 6.95 24.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.554 -0.716 . . . . 0.0 109.66 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.86 54.16 5.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' HB3' HG23 ' A' ' 22' ' ' ILE . 56.4 mm-40 -131.88 142.25 49.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -1.098 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.437 ' C ' HG22 ' A' ' 22' ' ' ILE . 5.3 tmm_? -113.47 135.43 53.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.493 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 174.07 -167.91 40.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -102.13 163.96 11.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.1 p90 -163.13 162.23 18.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 Cg_endo -62.14 123.89 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.867 1.712 . . . . 0.0 109.827 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' CA ' HD13 ' A' ' 56' ' ' LEU . . . -67.61 -32.92 79.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -66.97 -9.41 38.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.035 -1.274 . . . . 0.0 109.415 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.587 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.9 m-85 -95.8 -13.14 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.522 HG13 ' CD1' ' A' ' 30' ' ' LEU . 32.7 m -107.69 175.03 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 18.6 pt-20 -149.88 90.66 1.71 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.189 -0.944 . . . . 0.0 108.715 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 76.3 t80 -38.63 123.91 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.847 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 9.7 mm -111.38 -2.6 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 132.87 -164.43 24.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.108 . . . . 0.0 109.503 179.996 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.67 150.41 7.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.557 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 66.8 m-85 -79.37 134.13 36.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.142 . . . . 0.0 108.459 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 3.3 mt-30 -143.65 117.84 9.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.054 -1.029 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -113.78 178.66 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.359 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.498 ' O ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -112.38 155.44 24.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -91.65 121.07 32.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -104.88 -24.62 12.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.015 . . . . 0.0 108.619 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.536 ' CB ' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -119.57 176.62 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.4 OUTLIER -112.27 163.02 14.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.172 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HB3' HD21 ' A' ' 24' ' ' LEU . 71.7 t80 -166.41 114.62 0.89 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.085 -1.009 . . . . 0.0 109.616 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -79.46 107.41 12.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.931 . . . . 0.0 108.587 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -41.44 115.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.845 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -69.65 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.17 146.84 23.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.878 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.0 mt-10 -43.53 -24.79 0.12 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.131 -0.981 . . . . 0.0 110.038 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -60.7 -58.07 10.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.113 -0.992 . . . . 0.0 109.971 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 2.0 p30 -72.04 162.7 29.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.945 . . . . 0.0 109.87 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -122.16 162.06 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.377 -0.827 . . . . 0.0 109.378 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CD ' ' A' ' 16' ' ' LYS . 1.7 m-20 -79.22 103.69 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.901 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.568 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -102.28 153.46 19.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -150.79 141.21 22.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.048 . . . . 0.0 109.878 -179.955 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.1 tp -42.56 143.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 82.04 0.61 89.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.1 m-20 -90.42 159.13 16.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 109.746 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 28.2 mm -113.34 128.74 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 0.0 109.175 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 6.9 mp -109.76 105.93 15.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.915 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.484 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.95 91.33 8.03 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.547 -0.72 . . . . 0.0 110.328 -179.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 29.0 t -86.76 96.85 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 33' ' ' ASN . 6.1 p30 -51.45 152.82 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 110.385 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 34' ' ' LYS . 6.0 pttp -69.19 113.6 6.7 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.56 -54.66 0.76 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 48.4 t -56.78 -26.34 57.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.175 -1.191 . . . . 0.0 108.93 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.571 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 15.4 tp -90.55 -33.57 15.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 42' ' ' PHE . 84.7 t -90.31 2.78 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.099 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.82 -11.81 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -107.94 34.99 3.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.708 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.1 52.4 40.26 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 37' ' ' LEU . 5.5 m-85 -71.95 -167.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.09 143.38 50.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.13 87.89 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.34 -43.08 0.57 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' GLU . 23.2 mm-40 -73.01 -30.22 63.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.242 -1.152 . . . . 0.0 109.409 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.557 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 1.5 pt-20 -42.51 -41.99 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -85.39 44.53 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -159.85 62.72 1.96 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.6 Cg_exo -57.75 -13.61 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.341 2.027 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -70.77 -31.15 67.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.997 -1.065 . . . . 0.0 109.298 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 tp10 -110.71 1.72 18.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.9 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.533 HD11 ' CD2' ' A' ' 56' ' ' LEU . 6.6 mt -79.45 -31.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.108 -0.995 . . . . 0.0 109.082 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 -78.18 0.29 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.456 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 11.2 m95 -140.68 154.23 46.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -1.11 . . . . 0.0 109.033 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 1.5 mp -143.07 158.91 43.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.989 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.425 ' HB3' ' OG ' ' A' ' 36' ' ' SER . 6.6 t-20 -117.79 117.68 29.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.535 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -138.93 -167.73 11.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 58.7 t80 -115.59 114.12 24.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -1.051 . . . . 0.0 109.96 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 17.6 m-20 -79.31 79.88 5.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 108.64 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.19 -39.38 13.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.52 -0.738 . . . . 0.0 109.833 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 18.7 m -48.51 -53.32 18.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.922 . . . . 0.0 109.658 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.5 p -108.15 17.02 22.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 41.33 54.61 3.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.47 111.9 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -1.214 . . . . 0.0 109.935 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -90.74 129.44 36.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 109.194 179.938 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' CA ' ' CG1' ' A' ' 22' ' ' ILE . . . -178.86 -165.5 33.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -95.35 168.24 10.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.376 -1.073 . . . . 0.0 109.742 179.984 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -168.51 158.57 8.41 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -60.05 125.4 17.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.253 1.969 . . . . 0.0 110.196 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -69.7 -39.9 76.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 12.0 p -64.78 -11.02 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.249 . . . . 0.0 109.636 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.8 m-85 -95.49 15.54 19.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 109.83 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 18.9 m -134.71 -169.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.83 . . . . 0.0 110.044 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.531 ' CG ' HD23 ' A' ' 11' ' ' LEU . 11.9 pt-20 -158.26 89.03 0.97 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 56.6 t80 -36.87 136.24 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.653 . . . . 0.0 110.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 75' ' ' GLU . 29.7 mm -126.32 -8.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.537 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 113.21 -109.0 2.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.421 ' OXT' ' HG3' ' A' ' 79' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.247 -1.149 . . . . 0.0 109.61 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.53 150.66 20.88 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 4.0 m-85 -79.83 118.82 21.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -1.142 . . . . 0.0 109.098 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 3.7 mp0 -102.11 118.09 36.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 109.899 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -99.62 173.01 6.92 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 0.0 108.983 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -117.9 116.53 27.13 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.801 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -47.54 109.93 0.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 110.299 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 8.9 mt -90.93 -38.39 12.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.7 m-85 -126.46 -161.02 1.03 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.592 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -123.68 -175.28 3.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 109.732 179.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 27.5 t80 167.81 123.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 108.943 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 15.3 mmtp -79.47 156.27 27.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.988 -1.07 . . . . 0.0 109.914 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 25.0 mtpt -70.06 88.77 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -71.82 -72.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.926 . . . . 0.0 109.291 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -69.81 156.52 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -77.56 70.4 3.94 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.947 0.88 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.79 -26.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 4.0 p30 -71.54 170.36 13.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -121.02 167.64 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.543 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 3.2 m-20 -73.56 111.38 8.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 14' ' ' TYR . 2.9 mm? -97.96 144.49 27.45 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 0.0 109.086 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.699 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -159.99 138.18 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.035 -179.966 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -57.51 133.57 55.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.189 -0.945 . . . . 0.0 109.498 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.8 -25.99 24.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 25' ' ' HIS . 1.1 m-20 -74.54 171.56 13.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.634 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 18.9 mm -123.53 155.15 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.651 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 7.2 mp -127.15 123.53 36.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.146 -0.971 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -101.69 92.71 4.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.412 179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.553 HG21 ' CA ' ' A' ' 58' ' ' GLY . 77.9 t -90.82 118.5 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 108.979 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 9.1 m-80 -48.01 176.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 109.284 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -83.0 -72.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.016 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 34' ' ' LYS . . . -61.61 -23.05 62.42 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 33' ' ' ASN . 16.6 t -59.07 -29.05 67.04 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.135 -1.215 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.1 tt -90.74 -47.76 7.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 95.7 t -80.0 4.42 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.93 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.28 -9.06 15.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.949 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -104.62 -11.69 16.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 0.0 110.006 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 105.95 29.21 5.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 53' ' ' ILE . 10.5 m-85 -50.97 -175.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.521 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.68 157.5 44.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 109.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -56.95 123.31 14.7 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.72 -36.28 4.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' ILE . 2.6 mt-30 -81.25 -32.45 33.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.304 -1.115 . . . . 0.0 109.376 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.8 pt-20 -64.26 -15.78 60.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.883 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -106.5 -13.95 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.737 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.6 mmt180 -113.87 80.09 5.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.2 Cg_endo -61.05 -31.74 91.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.215 1.943 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 9.1 pt-20 -60.07 -25.86 65.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 6.7 tt0 -104.81 -5.46 21.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG22 ' CE2' ' A' ' 42' ' ' PHE . 9.5 mt -79.44 -28.97 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.182 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 99.86 -77.05 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CH2' ' HD3' ' A' ' 70' ' ' PRO . 25.7 m95 -144.18 143.37 31.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 109.412 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.595 ' CD1' ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -129.64 158.32 39.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -113.26 112.1 23.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.553 ' CA ' HG21 ' A' ' 32' ' ' VAL . . . -134.49 -171.48 12.53 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.48 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -120.6 109.64 15.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.975 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 8.4 m-20 -79.31 97.97 6.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.907 -1.121 . . . . 0.0 108.89 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.41 -36.19 81.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.817 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.534 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 37.9 m -50.05 -21.8 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 60' ' ' ASN . 12.0 t -127.76 -3.3 5.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.523 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.44 46.42 93.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -136.63 161.01 37.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.498 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 4.9 ttm180 -132.52 153.79 50.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 162.68 -171.2 38.45 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.663 -1.256 . . . . 0.0 109.962 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' ASP . 4.8 p30 -91.14 169.55 10.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.992 . . . . 0.0 109.655 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.651 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 10.4 p90 -174.33 143.86 0.91 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.164 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HD3' ' CH2' ' A' ' 55' ' ' TRP . 2.9 Cg_exo -55.45 118.19 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.801 1.668 . . . . 0.0 109.914 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.595 ' CA ' ' CD1' ' A' ' 56' ' ' LEU . . . -63.24 -23.84 66.71 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 51' ' ' GLU . 9.6 p -58.57 -19.54 39.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.891 -1.358 . . . . 0.0 109.881 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 17.9 m-85 -102.57 29.11 5.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 3.0 m -141.32 168.05 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 5.9 pt-20 -138.87 88.7 2.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 109.985 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.572 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 57.5 t80 -38.53 124.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 109.772 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -122.67 5.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.572 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 82.56 -100.84 2.2 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.442 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 175.76 -127.77 1.3 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.613 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 5.2 m-30 -78.41 105.18 9.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.691 -0.888 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.454 ' HG3' HG21 ' A' ' 31' ' ' THR . 1.6 mt-30 -106.01 114.52 28.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.676 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -104.65 175.95 5.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 108.662 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 8.2 ttm180 -113.71 150.36 33.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.803 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -73.72 111.91 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.6 mt -89.1 -31.72 17.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.905 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 9.4 m-85 -132.61 -163.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.844 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 73' ' ' TYR . 12.2 p-10 -123.76 172.74 8.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 109.762 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 24.8 t80 -164.57 118.37 1.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' GLU . 29.6 tttp -80.11 136.38 36.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.882 -1.136 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 8.2 ttmt -42.94 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.499 -0.751 . . . . 0.0 109.734 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -95.55 -64.96 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -81.51 145.8 30.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.918 . . . . 0.0 109.517 -179.984 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.83 -13.6 6.65 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 11.2 pm0 -110.54 33.68 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.016 -1.052 . . . . 0.0 110.199 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -125.45 177.59 6.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.265 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 67' ' ' GLY . 2.9 pt -136.08 157.63 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -70.23 113.81 7.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.811 . . . . 0.0 109.6 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' C ' ' CG ' ' A' ' 25' ' ' HIS . 2.4 mm? -101.32 154.09 19.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.042 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -159.96 133.18 6.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 109.423 179.997 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -52.0 141.4 18.09 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.597 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.506 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 97.35 -17.55 58.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' OD2' ' CG2' ' A' ' 62' ' ' THR . 2.7 m-20 -83.73 174.54 10.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.528 HD11 ' N ' ' A' ' 29' ' ' ILE . 1.7 mp -125.45 137.14 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.0 mp -109.28 119.43 39.48 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.22 -0.925 . . . . 0.0 109.138 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -97.76 100.19 11.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.589 HG22 ' CZ ' ' A' ' 8' ' ' TYR . 43.2 t -116.43 109.63 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.546 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 m120 -45.64 171.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.49 -0.756 . . . . 0.0 109.78 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -71.88 -70.7 0.31 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.744 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.91 98.42 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 33' ' ' ASN . 46.3 m -44.58 -25.14 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -1.142 . . . . 0.0 109.863 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.489 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 4.0 tt -90.28 -40.97 11.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 62.6 t -74.66 0.0 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 0.0 109.887 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.29 -12.37 13.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 109.763 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 42' ' ' PHE . 3.1 mt -91.58 17.43 8.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.983 . . . . 0.0 109.761 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 72.92 17.91 78.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 53' ' ' ILE . 14.9 m-85 -54.62 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.037 -1.272 . . . . 0.0 109.511 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -121.08 149.95 41.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.212 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -50.94 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.568 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 136.65 -46.04 1.04 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.23 -16.22 52.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.7 pt-20 -62.26 -38.15 88.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.566 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -91.11 26.6 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 109.673 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.6 mtp180 -128.67 64.84 70.5 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.309 -0.869 . . . . 0.0 108.875 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 6.3 Cg_exo -57.09 -38.68 95.08 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.267 1.978 . . . . 0.0 110.381 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG2' ' N ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.6 -27.09 68.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' N ' ' HG2' ' A' ' 51' ' ' GLU . 2.1 mt-10 -104.87 -2.81 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -82.28 -84.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.042 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' CG2' ' A' ' 53' ' ' ILE . . . 151.15 -61.32 0.41 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.456 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . 28.8 m95 -148.53 134.24 18.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -1.055 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -133.57 164.0 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 31.4 t-20 -115.72 115.64 26.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' HG23 ' A' ' 32' ' ' VAL . . . -133.06 -169.0 12.08 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 36.3 t80 -122.66 105.95 10.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.617 -0.931 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 4.5 m-80 -79.9 88.26 5.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.254 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.84 -36.77 67.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.86 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' OD2' ' A' ' 28' ' ' ASP . 6.2 m -52.33 -37.15 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.146 -0.971 . . . . 0.0 109.347 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.449 ' O ' ' OE1' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -116.85 9.98 14.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.51 52.73 6.22 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.95 119.72 21.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -1.178 . . . . 0.0 109.724 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 2.8 ttt85 -101.63 134.51 44.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.16 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 22' ' ' ILE . . . 170.44 -165.2 38.48 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.255 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -90.36 173.69 7.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.412 -1.052 . . . . 0.0 109.71 -179.936 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 18.1 p90 -177.58 159.57 1.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.858 . . . . 0.0 109.22 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -61.53 126.03 18.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.075 1.85 . . . . 0.0 110.015 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.553 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -69.61 -40.37 77.57 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 25.6 p -58.21 -14.0 6.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.029 -1.277 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.4 m-85 -93.15 23.21 4.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 110.155 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 71' ' ' GLY . 29.9 m -142.59 -173.49 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.153 -0.967 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.6 pt-20 -156.42 87.32 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 109.577 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.613 ' CE2' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t80 -37.33 135.2 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.635 -0.666 . . . . 0.0 110.494 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 9' ' ' ARG . 2.7 mp -131.56 -2.89 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 87.34 -139.77 16.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -1.189 . . . . 0.0 109.286 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 16.9 m-85 -137.71 145.98 43.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -1.157 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.627 HE21 HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -137.79 121.17 17.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.91 172.79 7.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.306 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 21.3 mtt180 -117.57 139.46 50.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . . . -83.17 105.28 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.737 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -71.73 -36.42 70.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.064 -1.023 . . . . 0.0 108.977 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 34.3 m-85 -106.07 -177.78 3.46 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -113.71 141.02 47.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.834 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.56 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 55.5 t80 -132.17 158.4 41.79 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -111.19 -63.66 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.773 -1.204 . . . . 0.0 110.13 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 15' ' ' LYS . 14.3 tttm 153.68 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 2.2 tt0 -93.57 -54.18 3.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.024 -1.047 . . . . 0.0 109.192 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -69.75 159.32 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.214 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.38 25.85 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.214 -0.929 . . . . 0.0 111.402 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 20' ' ' GLU . 3.6 mm-40 -149.05 13.98 0.89 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.669 -1.27 . . . . 0.0 109.539 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -91.17 161.74 14.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.675 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -117.56 143.8 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 7.9 m-20 -49.15 109.68 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.336 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -103.69 154.71 19.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -154.25 142.34 20.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.96 -1.088 . . . . 0.0 109.634 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.6 tt -47.32 135.08 10.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.71 5.9 73.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 0.4 OUTLIER -90.24 136.01 33.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 109.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.935 ' C ' HD12 ' A' ' 30' ' ' LEU . 7.3 mm -94.85 140.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.071 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.935 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -125.76 111.26 14.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.055 -1.028 . . . . 0.0 109.8 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 HE21 ' A' ' 7' ' ' GLN . 0.2 OUTLIER -85.52 93.34 8.76 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' CA ' ' A' ' 58' ' ' GLY . 89.5 t -99.89 115.92 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.083 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.8 167.21 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.99 . . . . 0.0 109.012 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' C ' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -90.03 0.6 57.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.5 -56.47 1.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.98 -31.85 1.44 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -1.105 . . . . 0.0 109.978 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.932 HD11 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.86 -39.98 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.079 -1.013 . . . . 0.0 109.98 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 38' ' ' VAL . 56.8 t -76.39 1.62 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.37 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -97.6 -25.71 15.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' PHE . . . 120.93 22.13 3.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.061 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.7 m-85 -44.49 147.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.251 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.56 165.37 23.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -67.0 118.79 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.12 53.1 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.21 -32.23 73.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.816 ' HG3' HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -67.91 -21.2 65.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -74.71 -9.57 58.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.34 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -119.14 75.8 15.32 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 108.897 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 53' ' ' ILE . 6.1 Cg_exo -56.67 -48.79 17.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.497 2.131 . . . . 0.0 110.73 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.88 -25.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.5 tt0 -114.12 50.48 0.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.061 HG23 ' CE2' ' A' ' 42' ' ' PHE . 7.5 mt -134.91 -45.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.56 -77.6 0.28 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.458 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 17.4 m95 -139.64 143.97 37.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.433 -1.039 . . . . 0.0 109.336 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.932 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -131.96 147.88 52.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.914 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 32' ' ' VAL . 17.8 t-20 -114.18 109.39 18.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.574 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.13 -158.1 8.87 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.601 -1.285 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 72.9 t80 -120.26 116.91 26.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.42 -1.047 . . . . 0.0 109.801 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.794 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.2 m-20 -79.45 76.67 6.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -48.28 -34.87 11.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.787 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 31.7 m -49.11 -48.48 44.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.794 HG22 ' HB3' ' A' ' 60' ' ' ASN . 9.4 t -101.7 2.92 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.689 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.83 45.83 95.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.577 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 17.8 mm-40 -138.62 -174.75 3.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.172 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 150.05 29.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.083 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 171.12 -164.77 37.86 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -100.44 166.31 11.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.984 . . . . 0.0 109.565 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 5.5 p90 -169.07 156.36 6.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.71 126.56 20.1 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.108 1.872 . . . . 0.0 109.806 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.822 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.74 -22.11 78.6 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.534 ' HG1' ' HD1' ' A' ' 73' ' ' TYR . 1.2 p -73.07 -4.93 35.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.242 . . . . 0.0 109.47 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.7 m-85 -101.93 -5.43 24.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.766 ' O ' HD11 ' A' ' 11' ' ' LEU . 1.7 m -116.48 -171.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.064 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD21 ' A' ' 11' ' ' LEU . 11.0 pt-20 -157.51 92.82 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.63 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 55.4 t80 -48.04 139.43 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 109.668 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -132.99 -0.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.982 . . . . 0.0 109.638 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.624 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 140.1 169.65 11.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 27.0 m-85 -78.92 139.15 38.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.986 . . . . 0.0 109.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HG2' HG23 ' A' ' 31' ' ' THR . 64.6 mt-30 -129.54 126.09 37.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.104 -0.997 . . . . 0.0 109.845 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.87 177.32 5.54 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.531 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -117.78 138.11 52.28 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -70.44 103.5 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.0 110.675 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -68.5 -32.24 72.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 108.586 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 5.9 m-85 -129.75 -169.02 2.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.64 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -117.95 171.19 8.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 109.933 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.736 ' HD2' HD21 ' A' ' 24' ' ' LEU . 54.8 t80 -173.42 118.17 0.29 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 3.6 tttm -79.64 117.53 20.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 18.0 pttt -42.7 109.26 0.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.676 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -67.13 -66.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.252 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' OD2' ' A' ' 21' ' ' ASP . 15.9 mtm180 -90.29 174.34 7.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 2.09 12.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.69 -6.45 29.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 109.891 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -105.11 166.31 10.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.158 -0.964 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.804 HD12 HD22 ' A' ' 60' ' ' ASN . 1.1 pt -114.94 163.15 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.453 ' OD1' ' HD3' ' A' ' 16' ' ' LYS . 2.0 m-20 -87.43 105.67 17.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.736 HD21 ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -102.75 154.6 19.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.1 m-70 -152.49 154.6 35.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 26.5 tp -46.6 135.32 8.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.94 9.62 86.05 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 16.2 t0 -91.17 110.98 22.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -1.127 . . . . 0.0 109.966 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.936 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -79.68 141.85 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.936 -1.102 . . . . 0.0 109.79 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.936 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.9 mp -123.38 140.03 53.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -109.86 86.19 2.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 109.285 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.606 HG22 ' CA ' ' A' ' 58' ' ' GLY . 53.9 t -90.58 108.68 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 30.2 m120 -50.49 161.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 109.722 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 53.84 2.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.89 -59.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 m -61.73 -20.37 63.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.341 -1.093 . . . . 0.0 109.255 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 47' ' ' GLU . 8.2 tp -90.35 -24.14 20.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.715 HG23 ' OE2' ' A' ' 47' ' ' GLU . 5.0 t -90.81 -4.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.065 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.02 -4.14 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.989 HD12 ' CE2' ' A' ' 42' ' ' PHE . 7.4 mt -80.82 -30.17 35.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.49 7.35 5.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.989 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.1 m-85 -59.94 -172.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 109.751 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.62 -171.41 1.92 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 108.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.96 84.48 6.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.724 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.76 2.17 3.98 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.169 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.522 ' CB ' ' HB3' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -80.86 -14.94 57.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.962 -1.316 . . . . 0.0 109.851 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.715 ' OE2' HG23 ' A' ' 38' ' ' VAL . 26.5 mt-10 -62.58 -40.17 96.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -61.67 -9.57 6.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.208 -0.932 . . . . 0.0 110.367 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mmm180 -113.59 80.59 4.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.872 -1.142 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.593 ' CG ' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.63 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.325 2.017 . . . . 0.0 110.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.4 tt0 -41.06 -29.8 0.12 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.253 -0.905 . . . . 0.0 109.071 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -98.64 47.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.835 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.0 mt -146.89 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -63.0 0.28 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 33.7 m95 -146.91 148.9 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -1.11 . . . . 0.0 109.289 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.728 HD11 ' HA3' ' A' ' 71' ' ' GLY . 2.6 mp -137.42 152.3 49.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.696 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 15.3 t30 -110.54 107.51 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.606 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.28 -160.04 9.07 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 49.2 t80 -116.54 117.55 30.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.526 -0.985 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.804 HD22 HD12 ' A' ' 22' ' ' ILE . 2.5 t-20 -79.4 76.38 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.531 -0.731 . . . . 0.0 109.234 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.94 -37.32 71.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.799 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 19.4 m -60.3 -33.45 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.019 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -121.76 18.26 11.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 40.19 54.16 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.28 113.1 8.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -1.227 . . . . 0.0 109.486 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 9.1 ttp-105 -91.24 140.47 29.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.623 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 166.09 -165.19 38.01 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -93.57 166.22 12.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.484 -1.009 . . . . 0.0 109.779 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -168.1 153.91 6.91 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -58.11 116.58 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.195 1.93 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.6 -28.26 73.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -63.63 -28.0 69.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.576 -1.543 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 19.4 m-30 -85.41 24.91 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.02 -1.05 . . . . 0.0 110.419 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.5 m -140.36 172.93 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.135 -0.978 . . . . 0.0 109.347 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD11 ' A' ' 11' ' ' LEU . 13.0 pt-20 -148.95 89.65 1.69 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.835 . . . . 0.0 109.177 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 75.6 t80 -41.56 133.13 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.718 . . . . 0.0 109.133 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 77' ' ' ILE . 17.5 mm -123.37 -2.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 140.65 -174.01 22.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.355 -1.085 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 34.7 m-85 -79.88 115.17 19.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -1.086 . . . . 0.0 109.353 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.679 ' CG ' HG23 ' A' ' 31' ' ' THR . 3.2 mt-30 -98.67 128.12 44.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.18 176.06 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.034 -1.041 . . . . 0.0 109.692 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' C ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.0 117.6 29.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -61.94 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.559 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -46.12 -50.45 15.41 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.057 -1.027 . . . . 0.0 109.782 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -111.24 170.68 7.95 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.574 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.36 -170.41 3.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.387 -0.821 . . . . 0.0 109.879 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 7.2 t80 179.75 115.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.236 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' GLU . 8.2 pttp -79.46 109.42 13.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.144 -0.972 . . . . 0.0 109.036 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -39.69 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.255 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' LYS . 48.0 mt-10 -63.33 -59.92 4.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 63.1 mtp85 -90.1 155.2 19.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.346 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.98 -9.15 19.32 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -84.02 -21.75 31.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 0.0 109.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' CA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -100.11 156.98 16.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.404 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.35 175.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.933 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.432 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 1.8 m-20 -75.66 151.48 37.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.002 HD11 HD21 ' A' ' 30' ' ' LEU . 1.1 tp -136.91 150.07 48.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.353 -0.842 . . . . 0.0 109.096 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.534 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 146.13 16.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.99 . . . . 0.0 109.672 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 43.5 tp -51.11 136.06 24.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.49 -0.756 . . . . 0.0 109.973 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.26 -2.48 78.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.655 ' C ' HD12 ' A' ' 29' ' ' ILE . 11.4 t0 -90.05 144.92 25.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -1.169 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.934 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 mp -108.65 146.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 24' ' ' LEU . 6.6 mp -124.89 112.43 16.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 0.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.679 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.51 91.91 7.97 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 109.376 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 8' ' ' TYR . 53.8 t -93.81 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.703 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -57.24 156.61 7.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -76.2 -16.54 59.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.633 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.65 -50.51 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 p -54.52 -30.28 53.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -1.113 . . . . 0.0 110.025 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.813 HD21 ' HA ' ' A' ' 47' ' ' GLU . 8.7 tp -90.31 -32.32 16.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 38' ' ' VAL . 77.2 t -90.21 2.96 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.941 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.53 -7.46 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.827 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.867 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -105.36 17.55 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.69 42.88 45.29 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.933 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -67.26 -168.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 109.441 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.29 136.38 52.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 122.9 6.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.501 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -62.46 -25.29 67.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -1.144 . . . . 0.0 109.409 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.813 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.4 mp0 -61.86 -32.76 73.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.967 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 76' ' ' TYR . . . -87.41 20.54 2.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.1 tpp180 -138.78 74.86 37.74 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 53' ' ' ILE . 6.2 Cg_exo -55.67 -48.77 18.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.443 2.095 . . . . 0.0 111.15 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 4.7 pm0 -44.11 -26.96 0.34 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.031 -1.043 . . . . 0.0 109.218 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.75 51.53 0.85 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.398 -0.814 . . . . 0.0 109.066 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 42' ' ' PHE . 24.2 mt -141.49 -39.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.47 -78.47 0.24 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.426 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 24.3 m95 -137.66 144.82 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -1.091 . . . . 0.0 109.192 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -134.77 154.3 51.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.448 ' C ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.92 108.16 18.33 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -130.66 -171.21 12.86 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 68.8 t80 -116.35 118.32 32.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.545 -0.973 . . . . 0.0 110.026 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 6.2 m-80 -84.53 64.82 8.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.105 -0.997 . . . . 0.0 109.009 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -43.67 -30.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.419 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.454 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 16.5 m -49.35 -54.47 17.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.234 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.93 10.96 39.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.445 -0.784 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.71 47.11 91.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.21 178.46 5.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -1.176 . . . . 0.0 109.582 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -159.66 138.52 10.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.93 -162.19 35.99 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-20 -94.92 167.49 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.499 -1.001 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -169.84 158.89 6.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -62.13 125.37 16.27 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.187 1.924 . . . . 0.0 110.086 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.868 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.34 -26.3 70.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -69.65 -7.44 39.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.951 -1.323 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.5 m-85 -99.32 -0.73 40.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.987 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.669 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -124.98 164.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 121.714 0.769 . . . . 0.0 110.422 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.829 ' HB3' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -139.79 109.74 6.42 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 83.2 t80 -37.56 113.39 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -105.11 9.77 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.519 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 104.33 -149.01 16.95 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 79.2 m-85 -160.1 124.79 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.476 -1.014 . . . . 0.0 108.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 31' ' ' THR . 1.1 mt-30 -129.51 122.29 28.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.016 -1.052 . . . . 0.0 110.196 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -116.92 -178.08 3.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.06 -1.025 . . . . 0.0 109.51 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.36 165.29 13.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.83 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -88.79 123.6 33.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 11.8 mt -104.3 -33.19 8.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 10.6 m-85 -128.18 -158.72 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.814 . . . . 0.0 109.902 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -126.66 172.65 10.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.736 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 75.3 t80 -171.49 113.79 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.297 -0.877 . . . . 0.0 108.809 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -79.29 156.39 28.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.983 -1.073 . . . . 0.0 110.052 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.7 tttt -55.08 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 109.663 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mt-10 -88.73 -62.91 1.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.216 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 6.6 ttm-85 -90.16 157.44 17.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.95 -4.4 16.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.174 -0.954 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 -9.86 15.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.079 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -85.33 171.45 11.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 109.528 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.492 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -130.62 158.19 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.795 ' O ' HD22 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -60.04 134.01 56.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 1.2 mm? -133.47 146.15 50.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.06 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.2 147.76 19.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 109.27 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 10' ' ' ALA . 50.4 tp -51.48 145.1 9.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.11 -10.63 67.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.711 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.98 147.68 26.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -1.176 . . . . 0.0 109.565 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.906 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.6 mp -107.38 146.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 6.3 mp -122.75 123.27 40.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.093 -1.004 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.513 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -98.64 92.05 5.42 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.622 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 8' ' ' TYR . 53.5 t -88.43 113.77 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.22 -165.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -0.925 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -70.98 0.62 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.23 -36.61 83.53 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -53.71 -30.35 43.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.028 -1.278 . . . . 0.0 110.064 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.821 HD23 ' O ' ' A' ' 37' ' ' LEU . 3.1 tt -90.73 -42.67 10.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.707 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.636 ' O ' HG12 ' A' ' 38' ' ' VAL . 99.2 t -79.27 1.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 110.029 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -63.04 -12.65 27.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.322 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.872 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -106.22 27.09 9.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.63 48.68 84.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.755 ' CE2' HD21 ' A' ' 37' ' ' LEU . 7.1 m-85 -67.21 -168.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.639 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.1 m -133.75 143.74 48.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.486 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -59.15 122.73 14.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.0 -33.3 6.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -78.36 -2.65 39.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -1.194 . . . . 0.0 109.712 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 1.3 pt-20 -69.52 -37.23 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -87.2 15.13 6.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -123.6 67.69 39.54 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 109.127 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.585 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.35 -51.01 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.219 1.946 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.4 tt0 -59.14 -33.36 70.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.012 . . . . 0.0 108.741 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HG2' ' A' ' 49' ' ' ARG . 7.2 tp10 -99.28 34.06 2.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 108.689 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.678 HG21 ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -119.32 -37.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.24 -76.8 0.24 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 74.9 m95 -142.74 139.71 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.092 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -129.74 153.32 48.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.767 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 4.0 t30 -108.7 112.21 24.4 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -132.97 -169.25 12.16 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -120.29 107.98 13.62 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.897 -0.767 . . . . 0.0 109.725 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' OD1' HD21 ' A' ' 24' ' ' LEU . 4.5 m120 -79.57 90.19 5.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -36.4 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.485 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 34.1 m -53.82 -36.92 63.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.478 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.3 p -111.44 5.61 19.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.74 45.67 24.55 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 63' ' ' THR . 33.1 mt-10 -129.38 155.6 45.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.694 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' C ' HG21 ' A' ' 22' ' ' ILE . 2.6 tpp180 -126.61 132.01 51.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 108.893 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 177.68 -158.48 23.71 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -104.59 166.03 10.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -1.028 . . . . 0.0 110.062 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.65 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.9 p90 -163.65 158.96 17.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.447 -0.783 . . . . 0.0 109.307 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.28 127.27 21.51 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.136 1.891 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.822 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -71.3 -36.42 63.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.552 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.4 p -65.2 -9.96 27.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -1.197 . . . . 0.0 109.265 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.605 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.6 m-85 -99.82 18.37 18.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.443 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 71' ' ' GLY . 34.8 m -134.08 -168.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.093 -1.004 . . . . 0.0 110.092 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 77' ' ' ILE . 10.3 pt-20 -154.84 87.15 1.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.537 -0.727 . . . . 0.0 109.818 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 81.8 t80 -45.73 139.64 3.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.174 -0.954 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.38 -4.99 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 109.127 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 116.29 -173.11 14.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.46 ' OXT' ' HA ' ' A' ' 6' ' ' TYR . 73.4 mtp180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLN . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 14.8 m-85 -79.81 102.57 9.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -1.124 . . . . 0.0 109.088 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -99.93 128.88 45.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.432 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.627 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -121.84 176.3 5.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.124 -0.985 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.2 mmm180 -118.35 122.53 43.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.706 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -70.97 93.02 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.793 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.944 HD21 ' CD ' ' A' ' 75' ' ' GLU . 64.2 mt -58.4 -49.4 77.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -104.12 176.77 5.05 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.432 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 43.1 p-10 -107.25 -173.86 2.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 14.0 t80 -162.31 140.22 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -91.89 132.91 36.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.983 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -55.8 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.718 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' LYS . 9.3 tp10 -95.43 -54.89 3.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.212 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.1 mmp_? -81.76 136.82 35.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.68 -19.3 0.89 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.109 -0.994 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 mm-40 -97.44 -33.34 11.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -66.36 157.97 30.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.67 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.667 HG21 ' O ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -120.32 169.85 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 109.375 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.727 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -78.99 112.41 16.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.842 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.706 HD12 ' CB ' ' A' ' 10' ' ' ALA . 3.1 mm? -88.5 166.29 14.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 108.426 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.727 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -157.99 135.15 10.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.853 -1.154 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 11' ' ' LEU . 12.1 tp -50.57 140.15 14.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.512 -0.743 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 5.8 t0 -87.93 146.43 25.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.18 -1.188 . . . . 0.0 109.084 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.698 ' C ' HD22 ' A' ' 30' ' ' LEU . 24.2 mm -91.59 142.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 29' ' ' ILE . 3.8 mm? -122.11 129.47 52.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -117.24 82.75 1.86 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.806 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 ' OH ' ' A' ' 8' ' ' TYR . 40.8 t -92.69 115.08 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.148 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 7.0 m-20 -56.21 -171.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.725 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 4.6 mtmp? -90.04 -52.15 5.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.267 -0.896 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 36' ' ' SER . . . -67.51 -46.94 65.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -42.3 -33.87 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -1.144 . . . . 0.0 109.833 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.784 HD23 ' O ' ' A' ' 37' ' ' LEU . 5.1 tt -90.33 -32.67 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.731 HG22 ' OE2' ' A' ' 47' ' ' GLU . 95.0 t -80.09 0.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -61.45 -12.96 16.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.856 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -105.99 27.71 8.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.44 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.19 48.93 83.69 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.866 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.0 m-85 -69.66 -168.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.3 p -126.4 158.51 35.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.323 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.07 119.15 12.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.4 -20.03 38.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.25 15.69 9.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' OE2' HG22 ' A' ' 38' ' ' VAL . 4.6 mm-40 -90.33 -35.44 15.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -89.88 28.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.477 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -128.41 65.08 70.0 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.5 Cg_exo -57.61 -46.64 25.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.424 2.083 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.8 -19.02 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.6 -3.47 10.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 0.0 110.028 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.866 HG23 ' CE2' ' A' ' 42' ' ' PHE . 14.1 mt -80.27 -50.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.079 -1.013 . . . . 0.0 109.128 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.72 -69.22 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.409 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 45.1 m95 -139.81 148.15 41.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -1.051 . . . . 0.0 109.509 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.901 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.9 t-20 -111.56 104.04 12.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 32' ' ' VAL . . . -138.75 -140.87 4.04 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 64' ' ' GLY . 72.2 t80 -131.2 125.78 33.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.981 . . . . 0.0 110.363 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.43 85.17 7.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -42.85 -48.44 5.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.795 . . . . 0.0 110.867 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.558 HG22 HG23 ' A' ' 63' ' ' THR . 4.0 m -41.26 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.0 110.234 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.558 HG23 HG22 ' A' ' 62' ' ' THR . 39.8 p -83.3 13.09 4.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.068 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 59' ' ' TYR . . . 45.76 45.34 13.21 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -119.75 117.16 27.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 0.0 109.234 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.667 ' O ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.63 156.33 18.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 156.93 -163.71 32.4 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.122 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.2 p-10 -104.71 154.1 20.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.811 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -155.88 159.68 31.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.1 Cg_exo -59.72 130.12 33.77 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.17 1.914 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -73.6 -29.72 63.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -69.43 -5.75 25.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.5 m-85 -100.04 -4.3 30.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.66 -176.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.944 ' CD ' HD21 ' A' ' 11' ' ' LEU . 21.1 pt-20 -153.48 96.45 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' HD3' ' A' ' 79' ' ' ARG . 9.8 t80 -37.67 110.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -135.35 14.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 7' ' ' GLN . . . -130.65 110.41 1.01 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.562 ' HD3' ' CE1' ' A' ' 76' ' ' TYR . 3.3 ttp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 32' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 m-85 -78.6 119.8 22.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.121 -1.223 . . . . 0.0 108.617 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 78' ' ' GLY . 8.1 mt-30 -106.78 122.91 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.141 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.941 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -115.79 173.77 6.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 109.64 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 8.5 mpt_? -107.86 137.44 45.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.403 -0.811 . . . . 0.0 108.846 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -66.02 99.12 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 110.241 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.5 mt -65.39 -30.51 71.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.147 -0.971 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.5 m-85 -127.94 -163.59 1.28 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.78 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.04 122.95 26.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.751 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.531 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 4.1 t80 -103.39 139.68 38.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.286 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 pttt -95.53 15.95 18.41 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.995 -1.065 . . . . 0.0 109.619 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 ttmm 64.19 92.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.658 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 4.8 tp10 -86.02 -80.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.229 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.507 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 77.8 mtm-85 -67.93 165.33 17.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.311 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -74.73 2.21 10.57 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.41 2.46 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.033 . . . . 0.0 109.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -109.37 172.43 6.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.508 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 HG13 ' CD2' ' A' ' 24' ' ' LEU . 6.3 pt -125.23 175.95 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.583 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -84.75 105.31 15.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.686 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.054 HD11 HD21 ' A' ' 30' ' ' LEU . 1.7 mm? -91.81 152.64 20.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' HG21 ' A' ' 63' ' ' THR . 1.6 m80 -152.22 135.86 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.338 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.5 tt -55.02 137.5 46.14 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.157 -0.965 . . . . 0.0 109.605 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.66 -9.12 71.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -90.31 162.39 15.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.3 mm -115.62 147.82 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.054 HD21 HD11 ' A' ' 24' ' ' LEU . 7.4 mp -120.76 111.8 18.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.226 -0.921 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.492 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -86.52 93.57 9.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.74 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.941 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 46.9 t -92.35 121.27 42.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.117 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 4.1 m120 -47.79 178.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -87.4 -71.31 0.57 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.87 -30.33 59.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 45.5 t -47.68 -33.85 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.237 . . . . 0.0 110.156 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.74 -40.55 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.679 ' O ' HG12 ' A' ' 38' ' ' VAL . 88.6 t -78.57 3.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.82 20.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.866 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.3 mm? -107.8 -7.34 16.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.53 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 95.2 33.5 6.54 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.722 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -53.81 -168.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -1.048 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 29.3 p -139.76 160.93 38.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -59.58 115.27 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.61 -34.09 4.67 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 15.9 mm-40 -68.39 -33.16 73.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.183 -1.187 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -64.23 -31.44 72.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -82.67 -14.57 54.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.1 mmm180 -112.05 80.17 3.06 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.033 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.7 Cg_exo -54.48 -57.4 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.304 2.003 . . . . 0.0 110.434 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 72' ' ' THR . 15.5 tt0 -44.0 -36.08 2.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.733 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.7 43.92 1.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.722 HG23 ' CE2' ' A' ' 42' ' ' PHE . 21.8 mt -136.68 -40.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.122 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -78.72 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 14.6 m95 -145.02 143.83 30.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.101 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.765 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -130.82 160.92 32.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 109.669 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -110.99 117.24 32.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.28 -176.16 14.37 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.5 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 70.7 t80 -117.55 111.87 19.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.876 -0.779 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.8 m-80 -79.3 78.72 5.78 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 108.79 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -48.19 -38.41 18.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.85 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 16.0 m -48.01 -46.74 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.599 HG21 ' CE1' ' A' ' 25' ' ' HIS . 53.3 p -117.4 17.72 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.04 50.93 6.13 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' OE1' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.87 109.93 15.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.301 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.455 ' C ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.0 150.54 20.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 109.398 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 153.98 -160.05 29.15 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.07 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.612 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -99.29 166.3 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.36 -1.083 . . . . 0.0 109.61 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.765 ' HE2' HG11 ' A' ' 74' ' ' VAL . 5.1 p90 -164.63 158.93 15.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.1 Cg_exo -60.47 116.54 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.014 1.809 . . . . 0.0 109.798 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.044 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.16 -37.69 91.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 51' ' ' GLU . 18.5 p -56.31 -23.39 36.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.902 -1.352 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 6.9 m-30 -92.49 28.23 2.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.044 HG22 ' O ' ' A' ' 71' ' ' GLY . 32.7 m -137.27 170.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.101 -1.0 . . . . 0.0 109.921 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.765 ' HG3' HD12 ' A' ' 77' ' ' ILE . 8.1 pt-20 -138.66 89.66 2.39 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.501 -0.75 . . . . 0.0 109.054 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 50.6 t80 -37.75 115.78 0.44 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.641 -0.662 . . . . 0.0 110.639 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.806 ' O ' HG22 ' A' ' 77' ' ' ILE . 67.6 mt -149.37 28.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -136.79 125.67 3.5 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.074 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 8.5 tpt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 72.7 m-85 -140.32 121.46 14.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -1.009 . . . . 0.0 108.863 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.636 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.3 tt0 -130.28 133.56 46.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.085 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.707 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -128.66 178.57 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.906 ' HB2' HD11 ' A' ' 77' ' ' ILE . 15.9 ttp180 -118.99 121.29 39.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -44.92 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.871 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.654 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -74.39 -64.62 0.99 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.654 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -96.71 -160.63 0.81 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -123.14 126.06 46.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.217 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 15' ' ' LYS . 92.7 t80 -128.28 131.68 48.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 12.9 mmtt -79.69 178.43 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' CG ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -98.71 68.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.956 . . . . 0.0 109.243 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -68.23 -84.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 9.2 mtm-85 -43.61 145.65 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.62 -5.62 21.06 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.257 -0.902 . . . . 0.0 109.896 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.13 7.77 25.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 109.8 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 44.4 p30 -106.16 159.39 16.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.0 109.534 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -119.44 161.21 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.354 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD2' ' CG ' ' A' ' 16' ' ' LYS . 2.7 m-20 -56.16 154.25 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 109.7 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -152.66 137.96 17.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.79 137.77 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 26.4 tp -42.81 151.07 0.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.608 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 87.31 -16.12 50.39 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 3.1 t70 -90.2 160.69 16.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -1.094 . . . . 0.0 109.168 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.976 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.8 mm -118.91 149.74 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.133 HD23 ' CE2' ' A' ' 69' ' ' PHE . 8.3 mp -124.79 108.98 12.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 108.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.636 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -89.23 91.44 8.77 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.101 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.707 HG21 ' OH ' ' A' ' 8' ' ' TYR . 40.6 t -87.2 101.77 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.81 152.65 44.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 176.56 1.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -59.47 4.61 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -71.34 -31.74 67.72 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.357 -1.084 . . . . 0.0 109.022 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 47' ' ' GLU . 4.9 tp -89.51 -28.54 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 38' ' ' VAL . 55.0 t -90.17 -1.93 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.72 -12.87 18.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.555 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.85 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.9 mm? -93.29 -28.24 16.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.472 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 120.83 19.1 3.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.944 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 75.6 m-85 -55.75 -168.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -1.199 . . . . 0.0 109.47 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -151.18 156.79 41.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.285 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.8 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.44 -37.0 1.67 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -87.92 -12.5 44.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.192 -1.181 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.779 ' CB ' HD21 ' A' ' 37' ' ' LEU . 28.2 mt-10 -83.72 12.3 6.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.898 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -107.81 -10.33 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.1 mmt180 -117.43 77.31 10.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.733 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.3 Cg_endo -61.24 -21.44 71.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.211 1.941 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -56.32 -20.55 19.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 109.357 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 mt-10 -123.83 1.42 8.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.705 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.944 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 9.6 mt -79.54 -30.27 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 107.62 -77.73 0.23 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 10.3 m95 -147.68 136.4 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -1.091 . . . . 0.0 109.527 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.748 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -124.03 138.3 54.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.514 ' C ' HG22 ' A' ' 32' ' ' VAL . 22.6 t-20 -93.66 109.7 21.34 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -123.99 -176.62 14.76 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.14 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -114.16 110.31 19.79 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.657 -0.907 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' HG22 ' A' ' 63' ' ' THR . 75.2 m-20 -78.03 82.8 4.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.983 -1.073 . . . . 0.0 108.909 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -53.36 -34.42 57.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.468 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 49.6 m -50.54 -41.67 54.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.425 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 60' ' ' ASN . 1.6 t -108.35 2.68 22.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.08 47.46 89.05 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 63' ' ' THR . 73.8 mm-40 -137.02 169.68 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -1.125 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HG21 ' A' ' 22' ' ' ILE . 1.1 ttt180 -140.15 156.94 46.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 22' ' ' ILE . . . 160.64 -173.18 37.14 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 5.3 t0 -97.07 160.4 14.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -1.083 . . . . 0.0 109.602 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 1.133 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.4 p90 -158.51 162.21 27.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -60.01 128.16 25.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.958 1.772 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.35 -32.79 64.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 51' ' ' GLU . 32.8 p -68.27 -7.79 33.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.985 -1.303 . . . . 0.0 109.533 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.1 m-85 -99.68 6.94 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.733 HG23 ' HG2' ' A' ' 50' ' ' PRO . 10.6 m -127.32 164.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.136 -0.978 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.1 pt-20 -129.22 89.0 2.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.554 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 51.8 t80 -41.02 142.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.509 -0.744 . . . . 0.0 109.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -135.25 3.73 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.456 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 135.87 -177.69 19.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.32 -1.106 . . . . 0.0 109.5 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 3.9 m-85 -79.69 81.65 5.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.335 -1.097 . . . . 0.0 108.827 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.654 ' CG ' HG23 ' A' ' 31' ' ' THR . 8.8 mt-30 -84.28 141.34 31.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.276 0.56 . . . . 0.0 110.04 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.841 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -120.51 173.0 7.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.03 120.93 41.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.653 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -48.74 133.05 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.897 . . . . 0.0 110.656 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.0 mt -117.86 -39.37 3.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 19.7 m-85 -123.75 -159.02 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.594 -0.691 . . . . 0.0 109.758 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -135.38 132.46 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 109.766 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 28.3 t80 -123.9 126.97 47.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.096 -1.002 . . . . 0.0 109.547 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 24.3 ttpp -66.05 86.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -77.57 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.338 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 50.8 mtt-85 -89.0 146.08 25.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.79 -19.65 6.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -0.922 . . . . 0.0 110.017 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 3.3 pt-20 -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -90.97 169.84 10.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.361 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 67' ' ' GLY . 1.9 pt -126.79 179.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 3.3 m-20 -78.83 164.83 24.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.616 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 14.5 mt -154.15 148.6 26.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 108.714 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.9 m80 -156.06 132.66 10.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 109.823 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.8 tt -50.8 139.27 17.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.55 -10.65 68.91 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.801 ' OD1' HG21 ' A' ' 62' ' ' THR . 67.2 m-20 -79.31 -175.78 4.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -1.09 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.8 mm -133.57 125.47 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 108.946 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 20.5 mt -101.96 148.69 25.05 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.17 -0.956 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.654 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -133.25 82.56 2.0 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.882 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.841 HG21 ' OH ' ' A' ' 8' ' ' TYR . 9.7 t -79.63 116.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.966 -1.084 . . . . 0.0 108.155 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.89 154.49 12.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.979 -1.075 . . . . 0.0 110.049 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -68.12 145.52 54.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.464 -0.772 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 -57.14 4.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -20.9 2.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.223 -1.163 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -90.11 -35.15 15.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.5 t -90.28 1.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.07 4.53 9.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.913 . . . . 0.0 109.98 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.7 mt -96.36 -28.99 14.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.114 -0.991 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 125.34 9.11 5.16 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.898 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.2 m-85 -54.64 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -1.211 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 80.3 p -125.15 -165.25 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.22 69.75 7.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.556 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.09 -31.76 0.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CG ' ' OG ' ' A' ' 43' ' ' SER . 41.4 mm-40 -68.96 -30.28 68.68 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.219 -1.165 . . . . 0.0 109.832 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -43.8 -35.92 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.97 . . . . 0.0 109.54 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.57 40.9 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -143.77 64.93 13.77 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.167 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.82 -42.35 53.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.188 1.925 . . . . 0.0 110.436 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 10.1 pt-20 -61.09 -34.67 75.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -98.42 -3.52 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.802 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.3 mt -79.92 -50.42 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 108.998 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 121.62 -71.26 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.0 m95 -146.42 127.24 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.423 -1.045 . . . . 0.0 109.709 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.662 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -116.21 143.7 45.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' HG22 ' A' ' 32' ' ' VAL . 3.3 t-20 -101.63 111.69 24.01 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.62 -162.52 9.2 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.652 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 64' ' ' GLY . 36.6 t80 -124.07 104.54 8.93 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.708 -0.877 . . . . 0.0 110.359 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -79.2 96.87 6.01 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -58.63 -33.64 70.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -0.871 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 ' OD1' ' A' ' 28' ' ' ASP . 11.6 m -49.01 -29.16 4.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 109.597 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' HB2' ' A' ' 65' ' ' GLU . 7.8 t -127.06 5.79 6.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 59' ' ' TYR . . . 52.08 49.6 48.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 63' ' ' THR . 35.3 mm-40 -124.98 145.43 49.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.575 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -126.1 125.59 42.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.258 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.581 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 176.88 -165.85 36.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -94.41 159.93 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -1.062 . . . . 0.0 109.529 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.8 p90 -164.51 160.34 15.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.0 Cg_exo -59.98 116.5 3.35 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.102 1.868 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.23 -21.63 70.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.553 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 1.7 p -64.95 -16.92 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.975 -1.309 . . . . 0.0 109.81 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 9.1 m-30 -99.75 18.09 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.013 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 71' ' ' GLY . 11.3 m -134.69 161.41 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 8.2 pt-20 -134.11 90.35 2.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.861 -1.15 . . . . 0.0 109.236 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 85.4 t80 -38.48 137.91 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -136.45 10.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 109.136 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 91.91 -106.15 3.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 0.0 109.386 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.485 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 22.5 m-85 -132.0 139.03 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -1.016 . . . . 0.0 109.039 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.17 122.47 18.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.57 177.11 4.95 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.114 -0.991 . . . . 0.0 109.854 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.1 123.09 45.94 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -49.02 106.21 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.5 mt -83.5 -29.52 27.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.888 . . . . 0.0 108.858 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -127.3 -175.48 3.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.455 -0.778 . . . . 0.0 109.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.28 179.49 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 18.0 t80 -175.0 113.1 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.353 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 146.72 30.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 18.4 tttp -53.14 112.47 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.62 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -114.5 -82.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -73.53 159.61 32.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.121 -0.987 . . . . 0.0 109.586 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -0.4 15.33 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.9 mt-10 -105.72 -4.96 20.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 18' ' ' ARG . 2.7 p-10 -112.14 167.6 10.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.623 HD12 HD22 ' A' ' 60' ' ' ASN . 7.2 pt -128.0 177.59 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.6 m-20 -69.28 163.85 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.55 HD11 HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -161.15 147.71 14.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.362 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.535 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 3.9 m-70 -156.87 146.12 20.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 10' ' ' ALA . 33.7 tp -53.04 143.2 18.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.765 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' H ' HD12 ' A' ' 26' ' ' LEU . . . 91.99 -31.8 5.74 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.2 t70 -58.52 158.76 7.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -1.088 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.839 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.5 mp -115.64 137.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 108.991 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.6 mp -117.45 125.99 51.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 109.907 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -102.46 92.94 4.89 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.752 HG22 ' CA ' ' A' ' 58' ' ' GLY . 91.0 t -101.57 112.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 9.4 p-10 -51.5 -177.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.159 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -86.88 -28.56 22.76 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . -67.66 -56.74 10.37 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 9.9 t -43.88 -25.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -1.183 . . . . 0.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -87.84 -40.11 14.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -0.972 . . . . 0.0 109.337 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 38' ' ' VAL . 77.3 t -77.91 -2.56 4.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.14 -34.67 14.73 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -81.14 -45.48 16.35 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.25 29.16 6.48 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.79 -79.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.714 -1.462 . . . . 0.0 108.099 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.61 157.07 24.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -84.34 68.73 10.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 108.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.03 -28.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG2' ' NE ' ' A' ' 49' ' ' ARG . 2.3 mt-30 -85.93 41.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -1.217 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 2.5 pm0 -90.1 1.87 55.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -113.15 39.81 2.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.658 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.49 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -160.2 62.78 1.87 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.9 -18.12 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.408 2.072 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.82 -35.81 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.607 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -101.49 -0.85 34.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.638 HD12 HD21 ' A' ' 56' ' ' LEU . 21.6 mt -79.87 -33.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -76.34 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.475 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 23.0 m95 -137.01 157.28 47.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -1.066 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 37' ' ' LEU . 3.4 mp -143.39 154.75 44.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.845 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 32' ' ' VAL . 17.9 t-20 -114.37 109.67 18.7 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.752 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.61 -161.32 9.68 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 52.6 t80 -120.9 112.63 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.657 -0.907 . . . . 0.0 110.027 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.623 HD22 HD12 ' A' ' 22' ' ' ILE . 37.3 m-20 -79.79 80.37 6.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -40.8 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 91.2 m -57.36 -43.03 83.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 3.7 p -93.35 0.96 57.09 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.312 -0.868 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.47 44.34 67.03 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 63' ' ' THR . 26.7 mt-10 -141.09 179.09 6.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -1.193 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 15.3 ptt85 -152.49 146.18 25.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 109.505 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 163.4 -159.6 32.2 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.972 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -92.43 166.14 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -1.046 . . . . 0.0 109.661 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.883 ' HE2' HG11 ' A' ' 74' ' ' VAL . 7.2 p90 -171.1 159.51 5.32 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.835 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.55 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -57.86 120.27 8.07 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.084 1.856 . . . . 0.0 110.116 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.973 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.67 -31.99 70.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -63.19 -18.99 64.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.908 -1.348 . . . . 0.0 109.372 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 10.7 m-30 -92.57 30.21 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.005 . . . . 0.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.3 m -143.8 167.32 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 5.9 pt-20 -140.49 87.53 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.25 -0.906 . . . . 0.0 109.745 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.601 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 42.1 t80 -47.88 137.66 9.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 108.746 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.712 ' O ' HG22 ' A' ' 77' ' ' ILE . 70.5 mt -144.23 9.06 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . 159.27 -172.41 35.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' OXT' ' HB2' ' A' ' 7' ' ' GLN . 7.3 mtp180 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -1.072 . . . . 0.0 109.437 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.635 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 25.7 m-85 -80.23 133.25 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 109.616 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.593 ' CG ' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -119.14 113.57 21.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -0.795 . . . . 0.0 109.389 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.748 ' CE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.07 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.078 -1.014 . . . . 0.0 108.963 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.7 mtt85 -120.55 137.89 54.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.0 108.871 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -56.77 109.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 110.241 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -93.68 -29.71 15.29 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -128.2 -169.64 2.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.952 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 57.3 p-10 -114.93 178.35 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 67.1 t80 172.92 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.279 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 7.0 tttp -79.76 153.39 29.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.471 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 2.3 pttt -77.51 78.16 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.562 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.02 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.202 -0.936 . . . . 0.0 109.249 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -54.97 142.74 28.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -57.72 -15.67 8.63 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.06 -32.49 33.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 109.9 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -88.29 146.54 25.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.109 -0.994 . . . . 0.0 109.274 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.705 HD11 ' OD1' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -107.59 -169.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.671 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -73.64 153.33 40.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.848 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.31 129.92 22.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.666 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -147.87 133.25 18.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.646 HD23 ' C ' ' A' ' 26' ' ' LEU . 3.8 tt -51.67 151.34 3.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.865 . . . . 0.0 109.721 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 26' ' ' LEU . . . 89.16 -10.95 71.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.744 ' CG ' HG21 ' A' ' 62' ' ' THR . 2.2 m-20 -90.27 -170.26 2.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.966 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.0 mt -148.53 151.32 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.966 HD12 ' C ' ' A' ' 29' ' ' ILE . 3.7 mp -134.67 130.24 36.03 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.049 -1.032 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -97.84 96.45 8.22 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 57' ' ' ASN . 51.3 t -101.46 116.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.884 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 8.1 t30 -53.12 147.41 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 108.95 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -2.77 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.138 -0.976 . . . . 0.0 109.797 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.94 -53.97 1.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 p -48.59 -22.5 0.77 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -1.132 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD13 ' A' ' 53' ' ' ILE . 5.4 tt -90.31 -34.86 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 0.0 109.557 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.661 ' O ' HG12 ' A' ' 38' ' ' VAL . 53.8 t -87.71 0.78 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.628 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.15 -13.75 13.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.805 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.1 mm? -96.12 -23.17 16.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.583 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 118.27 23.12 3.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.861 ' CE2' HG23 ' A' ' 53' ' ' ILE . 12.0 m-85 -46.97 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -1.096 . . . . 0.0 109.612 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 t -94.56 162.88 13.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.64 96.25 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.94 -8.13 9.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.92 0.19 57.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -1.183 . . . . 0.0 109.612 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.635 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 3.1 mp0 -90.4 21.02 4.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.56 -2.46 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -126.66 86.28 58.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.5 Cg_endo -61.2 -38.22 68.06 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.248 1.966 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.9 pm0 -59.15 -17.55 27.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.145 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.8 -11.39 14.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.076 HD13 HD11 ' A' ' 37' ' ' LEU . 32.6 mt -79.75 -50.17 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.43 -72.67 0.39 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 15.3 m95 -139.9 143.08 36.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -1.002 . . . . 0.0 109.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.865 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -135.86 152.27 50.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.732 ' O ' HG13 ' A' ' 32' ' ' VAL . 3.8 t30 -115.28 111.2 20.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.723 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.88 -152.24 6.5 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.704 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 60.0 t80 -126.63 110.81 13.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.777 -0.837 . . . . 0.0 110.203 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.705 ' OD1' HD11 ' A' ' 22' ' ' ILE . 1.4 m120 -78.53 82.95 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.919 -1.113 . . . . 0.0 108.822 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -52.17 -39.78 60.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.13 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.744 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.6 m -54.26 -46.33 72.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 109.787 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.666 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -105.93 13.29 29.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 39.81 54.43 2.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' HB3' HD13 ' A' ' 22' ' ' ILE . 2.8 mm-40 -136.9 120.17 16.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.503 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 22' ' ' ILE . 7.2 ttp180 -92.76 151.0 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.57 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.09 -168.98 32.54 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -93.09 175.7 6.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.565 -0.962 . . . . 0.0 109.668 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.8 p90 -179.24 152.04 0.67 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.245 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -59.05 123.01 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.058 1.839 . . . . 0.0 109.958 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.865 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -69.41 -29.61 71.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 4.1 p -58.53 -15.01 9.39 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.839 -1.389 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 7.5 m-30 -103.29 33.22 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.025 . . . . 0.0 110.378 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 71' ' ' GLY . 2.1 m -147.91 -179.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 9.6 pt-20 -151.06 90.37 1.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 49.7 t80 -52.66 123.15 10.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 109.044 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.825 HD12 ' CD ' ' A' ' 9' ' ' ARG . 8.6 mt -112.3 -14.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 147.96 177.62 22.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.715 ' CG ' ' OH ' ' A' ' 76' ' ' TYR . 24.2 m-85 -79.31 140.25 37.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.418 -1.048 . . . . 0.0 108.643 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 mt-30 -147.24 125.18 11.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -120.53 177.99 4.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.564 ' CB ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -114.17 170.55 8.2 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -86.52 146.57 26.33 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 109.893 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 74' ' ' VAL . 13.3 mt -126.84 -36.99 2.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 2.5 m-85 -118.4 -163.22 0.94 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.941 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.68 170.11 10.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -174.52 116.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -86.94 34.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.938 -1.102 . . . . 0.0 110.298 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 17.4 tttt 41.55 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 42.1 mm-40 -97.25 -49.56 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.81 149.96 36.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 41.8 tt0 -69.55 -4.11 17.65 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.161 -0.962 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE2' ' OD2' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -106.32 -15.12 14.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 110.201 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 51.4 p30 -99.09 165.56 11.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.771 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -121.29 177.07 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.515 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 1.7 m-20 -70.02 171.24 9.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.813 HD21 HD21 ' A' ' 30' ' ' LEU . 10.4 mt -164.76 144.97 7.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.048 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.927 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -158.95 125.0 4.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.43 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.02 129.96 12.17 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.16 -11.81 33.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.754 ' CG ' HG21 ' A' ' 62' ' ' THR . 4.4 m-20 -89.73 -170.87 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.88 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -143.81 138.23 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.211 HD23 ' CE2' ' A' ' 69' ' ' PHE . 6.2 mp -116.81 124.22 49.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.467 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -96.28 103.08 14.96 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 110.648 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 96.2 t -113.8 100.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 p30 -57.73 -166.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.005 -1.06 . . . . 0.0 109.089 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -84.04 -27.18 28.51 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.027 -1.045 . . . . 0.0 110.622 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' N ' ' HG2' ' A' ' 34' ' ' LYS . . . -81.39 -53.85 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 33' ' ' ASN . 7.1 t -50.31 -22.46 1.81 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.069 -1.254 . . . . 0.0 109.437 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.652 HD12 HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -88.98 -44.36 10.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 108.683 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 38' ' ' VAL . 97.2 t -83.33 6.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -44.9 -28.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.668 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -100.1 -29.0 12.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 136.81 -40.07 1.56 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.2 m-85 38.81 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.918 . . . . 0.0 109.453 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.48 145.17 31.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.877 -1.139 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -62.97 96.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 142.04 -28.23 2.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -90.41 -6.45 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -1.099 . . . . 0.0 109.32 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 2.7 mp0 -43.01 -60.03 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.361 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -84.92 46.7 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.501 -0.75 . . . . 0.0 109.859 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.02 61.51 21.73 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.8 Cg_exo -54.97 -48.62 20.16 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.44 2.093 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 72' ' ' THR . 1.1 mp0 -67.89 -34.62 76.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.158 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 1.66 56.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.958 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.834 HD13 HD21 ' A' ' 56' ' ' LEU . 2.7 mt -88.95 -45.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 117.06 -70.63 0.29 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 15.5 m95 -149.19 128.76 13.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -1.025 . . . . 0.0 109.078 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.834 HD21 HD13 ' A' ' 53' ' ' ILE . 1.4 mp -119.14 140.8 49.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -94.77 101.83 13.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.4 179.37 16.98 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.118 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.6 t80 -104.69 117.7 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.869 -0.783 . . . . 0.0 109.352 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -78.95 77.94 5.41 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.245 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -55.97 -36.12 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.754 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.9 m -62.95 -31.85 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 109.949 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.927 HG21 ' HE1' ' A' ' 25' ' ' HIS . 6.9 p -119.14 19.2 12.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 40.98 54.64 3.6 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.0 179.64 5.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -1.211 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 19.7 ttp85 -160.47 123.02 3.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.771 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 177.2 -167.67 39.01 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.277 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 63.1 m-20 -95.26 161.83 13.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.483 -1.01 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 1.211 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -162.31 162.99 19.12 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.619 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.9 Cg_exo -59.5 113.84 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.818 1.679 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -62.99 -35.26 91.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 51' ' ' GLU . 28.6 p -60.65 -13.68 16.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.788 -1.419 . . . . 0.0 110.118 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 7.7 m-30 -97.54 15.78 22.29 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.976 -1.077 . . . . 0.0 112.087 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.2 m -126.81 -179.73 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.633 -1.292 . . . . 0.0 109.951 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 11' ' ' LEU . 4.2 pt-20 -143.72 91.67 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 109.103 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' OH ' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -31.58 162.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.256 1.027 . . . . 0.0 112.961 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.768 ' O ' HG22 ' A' ' 77' ' ' ILE . 34.3 mm -155.01 14.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -118.33 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 mtt85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 31.1 m-85 -80.09 112.65 17.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -1.146 . . . . 0.0 109.548 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 2.6 mt-30 -98.98 121.34 40.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.68 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.67 175.58 5.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.016 . . . . 0.0 109.653 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 36.4 ttt180 -114.85 141.46 47.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -68.06 108.41 3.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.946 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.1 mt -82.0 -31.26 31.16 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.5 m-85 -129.77 -160.15 1.01 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.48 -0.763 . . . . 0.0 109.468 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -134.41 109.85 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB3' HD21 ' A' ' 24' ' ' LEU . 66.4 t80 -105.07 128.89 53.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.93 158.47 26.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.891 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' CE ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -80.83 72.63 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.033 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.0 108.821 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -90.51 159.09 16.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.132 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HA ' ' CE ' ' A' ' 16' ' ' LYS . 32.3 tp10 -55.3 -28.75 55.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -53.2 -40.6 64.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.999 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -99.93 162.5 12.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.816 HG21 ' C ' ' A' ' 66' ' ' ARG . 35.6 pt -114.75 -168.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.925 . . . . 0.0 110.176 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -99.24 99.31 10.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 0.0 109.379 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -110.17 147.1 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 108.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -145.91 148.23 32.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -48.5 136.32 13.05 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.354 -0.841 . . . . 0.0 109.785 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 93.49 -5.03 73.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 6.7 t0 -90.39 145.9 24.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -1.132 . . . . 0.0 109.514 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.8 mm -96.58 132.06 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -0.923 . . . . 0.0 109.211 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.4 mp -110.34 114.56 28.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.319 -0.863 . . . . 0.0 108.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -92.16 96.86 10.56 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.902 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.68 HG11 ' OH ' ' A' ' 8' ' ' TYR . 64.3 t -102.59 108.05 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.885 . . . . 0.0 109.375 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 4.8 t30 -47.6 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -71.81 -62.76 1.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.54 99.7 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 33' ' ' ASN . 34.7 m -52.21 -19.8 2.23 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.351 -1.088 . . . . 0.0 109.827 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 37' ' ' LEU . 5.6 tt -88.96 -36.08 16.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 38' ' ' VAL . 40.2 t -90.42 1.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.28 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.17 47.88 1.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.887 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.42 56.61 14.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.799 ' CE2' HG23 ' A' ' 53' ' ' ILE . 3.8 m-85 -89.04 -166.89 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 46' ' ' GLN . 7.2 t -133.65 141.9 47.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 108.984 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.35 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.63 -30.48 1.03 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.753 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -88.23 34.4 0.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.683 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' OE1' ' OH ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -90.14 -17.45 27.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 76' ' ' TYR . . . -126.16 14.77 7.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.2 mtt180 -121.66 74.8 34.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.609 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.45 -52.79 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.197 1.931 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -52.39 -28.21 18.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 49' ' ' ARG . 2.7 mt-10 -109.43 44.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.7 mt -130.98 -42.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 108.894 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 112.47 -76.52 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 32.7 m95 -147.35 131.33 17.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -1.068 . . . . 0.0 109.244 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.793 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -117.67 160.45 21.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 8.6 t30 -113.0 111.19 21.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.17 -170.57 12.47 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.45 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 61.4 t80 -116.78 113.22 22.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.572 -0.958 . . . . 0.0 110.188 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.622 ' ND2' HD11 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -79.27 77.98 5.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' A' ' 61' ' ' GLU . 3.7 tm-20 -52.92 -36.32 59.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.458 -0.776 . . . . 0.0 110.289 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 20.8 m -55.23 -38.48 68.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 109.982 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.444 HG21 ' NE2' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -113.01 20.48 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.48 53.88 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.79 172.08 13.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.816 ' C ' HG21 ' A' ' 22' ' ' ILE . 32.2 ttm-85 -156.19 144.6 19.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.564 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 159.78 -152.95 23.93 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.025 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 72.7 m-20 -100.65 162.46 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -1.025 . . . . 0.0 109.916 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.646 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.9 p90 -161.97 158.97 21.85 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -58.84 125.73 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.093 1.862 . . . . 0.0 110.146 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -68.26 -44.16 76.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 51' ' ' GLU . 33.5 p -61.68 -12.12 14.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.998 -1.296 . . . . 0.0 109.615 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.4 m-85 -92.95 18.58 8.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.996 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.4 m -140.02 -176.04 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.219 -0.926 . . . . 0.0 109.793 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 1.039 ' O ' HD12 ' A' ' 77' ' ' ILE . 7.8 pt-20 -155.1 89.28 1.21 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.51 ' CE1' ' HB3' ' A' ' 6' ' ' TYR . 48.8 t80 -46.14 120.68 2.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.039 HD12 ' O ' ' A' ' 75' ' ' GLU . 1.1 mp -152.36 20.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.56 111.57 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.46 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 12.1 mtm105 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.13 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 25.3 m-85 -79.55 93.35 5.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -1.12 . . . . 0.0 109.75 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.752 ' HG2' HG23 ' A' ' 31' ' ' THR . 3.4 mt-30 -89.69 129.97 36.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 0.0 108.622 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.35 179.05 4.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.924 -1.11 . . . . 0.0 109.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -117.38 136.33 53.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -76.31 137.76 40.07 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 110.436 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.975 HD21 ' C ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -122.94 -32.66 3.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.498 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 m-85 -112.74 -163.13 0.83 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -137.51 112.6 9.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.965 -1.084 . . . . 0.0 110.153 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 17.2 t80 -100.42 158.33 15.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.052 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.77 149.61 30.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 0.0 109.42 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 23' ' ' ASP . 14.9 tttp -82.23 70.77 9.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -55.94 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -79.76 142.28 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -64.08 -9.75 18.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.213 -0.93 . . . . 0.0 109.935 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 3.3 mm-40 -103.82 19.7 19.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.983 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 11.6 p-10 -124.71 172.51 9.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.881 HD12 HD21 ' A' ' 60' ' ' ASN . 0.5 OUTLIER -130.9 154.87 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.668 ' HB3' ' HE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -68.94 110.34 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.567 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -104.55 148.92 25.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.201 -0.937 . . . . 0.0 109.277 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.668 ' HE1' ' HB3' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -160.17 130.47 5.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.175 -0.953 . . . . 0.0 109.372 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -42.93 137.14 2.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.322 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -1.07 81.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.789 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 37.2 t0 -90.72 131.59 36.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.426 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 46.2 mm -87.99 132.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.973 -1.079 . . . . 0.0 109.284 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.671 HD23 ' CE2' ' A' ' 69' ' ' PHE . 9.0 mp -107.68 139.87 41.58 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.325 -0.86 . . . . 0.0 108.993 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.752 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -116.29 99.25 7.07 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.005 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 52.6 t -107.74 95.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 73.8 m-20 -45.42 136.1 5.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 109.953 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -70.14 160.77 31.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.44 -60.82 4.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -20.65 55.78 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.377 -1.072 . . . . 0.0 108.513 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 47' ' ' GLU . 4.5 tp -85.68 -29.32 24.08 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.9 t -84.77 -1.23 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -73.71 -0.41 15.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.843 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.1 mm? -103.98 12.75 33.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 109.648 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.74 15.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 53' ' ' ILE . 17.2 m-85 -72.35 -168.92 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.662 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 94.9 p -125.51 166.04 17.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.835 . . . . 0.0 109.287 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -72.27 98.58 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.646 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.22 13.27 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.464 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.6 mt-30 -89.89 -21.91 22.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -1.22 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HA ' HD21 ' A' ' 37' ' ' LEU . 3.5 pt-20 -65.7 -8.27 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.274 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' C ' ' HD3' ' A' ' 50' ' ' PRO . . . -108.11 -4.97 17.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.981 -1.074 . . . . 0.0 110.036 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.501 ' O ' HG13 ' A' ' 53' ' ' ILE . 32.5 mmt-85 -117.96 72.33 8.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.9 Cg_exo -54.2 -33.19 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.279 1.986 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 72' ' ' THR . 3.0 pt-20 -64.21 -40.16 95.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.056 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 61.7 mt-10 -85.33 4.76 33.65 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 109.526 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 56' ' ' LEU . 8.6 mt -94.24 -52.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -77.04 0.3 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 14.2 m95 -134.09 147.2 50.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -1.028 . . . . 0.0 109.063 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.812 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -140.38 158.24 44.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 28.5 t-20 -113.9 109.35 18.37 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.74 -161.3 9.86 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.66 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 54.1 t80 -127.18 114.19 17.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 110.182 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.881 HD21 HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -79.75 96.35 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.121 -0.987 . . . . 0.0 108.615 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -60.35 -40.87 92.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.439 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 22.9 m -59.28 -22.12 60.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.988 -1.07 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.62 6.12 10.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 45.01 37.66 5.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' OE2' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -114.76 173.86 6.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.168 . . . . 0.0 109.462 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 1.6 ttp85 -153.25 130.87 11.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.137 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 169.55 -158.04 30.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.174 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-20 -92.79 165.46 12.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -1.013 . . . . 0.0 110.0 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.671 ' CE2' HD23 ' A' ' 30' ' ' LEU . 4.3 p90 -171.79 153.13 3.24 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.96 123.35 12.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.025 1.817 . . . . 0.0 110.063 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.812 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -30.3 65.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.604 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.3 p -67.02 -7.88 25.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -1.207 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.1 m-85 -98.67 10.88 40.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.975 ' C ' HD21 ' A' ' 11' ' ' LEU . 2.9 m -130.9 -165.96 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.755 0.788 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' HD23 ' A' ' 11' ' ' LEU . 8.2 pt-20 -160.05 90.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.577 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.8 t80 -38.16 120.6 0.89 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.506 -0.747 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.508 ' CG1' ' HB2' ' A' ' 9' ' ' ARG . 45.8 mm -106.62 -19.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.97 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.577 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 129.27 -130.32 6.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.26 -1.141 . . . . 0.0 109.449 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 39.1 m-85 -148.35 111.98 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -1.155 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.544 ' OE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -99.83 120.24 39.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.557 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -107.1 178.59 4.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.975 -1.078 . . . . 0.0 109.868 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.94 147.96 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . . . -75.51 106.64 7.16 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 110.126 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.7 mt -84.97 -26.34 27.21 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 23.5 m-85 -135.82 -160.71 1.08 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.538 -0.726 . . . . 0.0 109.711 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HA ' ' C ' ' A' ' 24' ' ' LEU . 10.1 p-10 -135.67 143.26 45.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.593 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 10.7 t80 -116.67 163.91 15.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.188 -0.945 . . . . 0.0 108.626 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 8.9 mmtt -104.57 -19.58 13.95 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.053 -1.03 . . . . 0.0 110.551 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER 75.24 81.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.068 . . . . 0.0 109.236 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -84.42 -54.96 4.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.731 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 1.1 tpt180 -87.97 162.35 16.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.71 -3.6 19.4 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 7.1 pt-20 -99.61 14.81 28.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.083 -1.011 . . . . 0.0 109.773 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -127.68 163.42 24.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.149 -0.969 . . . . 0.0 109.417 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -128.33 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 110.116 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.576 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -58.99 119.45 7.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 30' ' ' LEU . 2.2 mm? -97.28 159.38 14.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 109.169 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.1 m80 -159.44 125.38 4.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.865 . . . . 0.0 109.4 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 10' ' ' ALA . 2.8 tp -50.62 128.29 20.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.74 28.28 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.729 ' CG ' ' HB2' ' A' ' 10' ' ' ALA . 2.3 p30 -90.02 -179.9 5.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.272 . . . . 0.0 109.967 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.858 ' C ' HD12 ' A' ' 30' ' ' LEU . 33.5 mm -127.54 149.2 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.074 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.3 mp -123.84 123.34 40.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.013 -1.054 . . . . 0.0 110.387 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -99.7 86.61 3.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 57' ' ' ASN . 67.7 t -96.56 116.35 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -56.52 162.83 2.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 108.475 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.7 ptmt -90.5 -25.61 20.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.01 -1.056 . . . . 0.0 110.327 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.65 -58.83 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -50.19 -22.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -1.151 . . . . 0.0 110.05 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' OE1' ' A' ' 47' ' ' GLU . 4.1 tt -90.31 -32.73 16.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 109.707 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 38' ' ' VAL . 51.3 t -82.34 -0.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 109.751 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.2 -21.18 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.198 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.14 37.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.516 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.96 49.58 17.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 2.3 m-85 -59.38 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.177 -1.19 . . . . 0.0 109.267 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -128.56 150.79 50.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.138 -0.977 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.55 120.81 10.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.07 -33.41 6.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.504 ' O ' ' CG1' ' A' ' 53' ' ' ILE . 10.2 mt-30 -65.9 -11.93 50.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -1.147 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 1.015 ' OE1' HD13 ' A' ' 37' ' ' LEU . 14.9 mm-40 -81.13 -22.38 39.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.626 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.18 -4.96 58.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.1 mmp_? -117.14 74.13 7.27 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.7 Cg_exo -54.99 -32.17 77.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.2 1.934 . . . . 0.0 110.489 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 6.7 pt-20 -62.24 -35.98 80.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.942 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.3 mt-10 -95.57 -3.74 45.92 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.162 -0.961 . . . . 0.0 110.017 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.717 HD12 HD21 ' A' ' 56' ' ' LEU . 31.6 mt -79.6 -36.92 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 109.361 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 108.15 -76.52 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m95 -143.77 132.81 22.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -1.137 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -117.42 142.3 47.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.798 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.687 ' O ' HG13 ' A' ' 32' ' ' VAL . 8.8 t-20 -105.97 111.77 24.55 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.568 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -139.49 -161.27 8.66 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.413 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 67.2 t80 -115.5 114.22 24.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.626 -0.926 . . . . 0.0 110.553 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.1 m-20 -78.09 79.02 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -42.68 -44.69 4.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 3.4 m -46.57 -69.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.105 -0.997 . . . . 0.0 109.876 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.543 ' CG2' ' HG3' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -81.05 6.03 14.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.971 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.42 48.43 60.17 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.576 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 2.7 mt-10 -121.27 173.11 7.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.278 . . . . 0.0 109.282 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.58 118.0 6.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 109.341 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -176.4 -150.76 8.38 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.618 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 7.5 m-20 -108.83 165.21 11.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -1.056 . . . . 0.0 109.829 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 1.074 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.9 p90 -165.87 161.82 13.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.385 -0.822 . . . . 0.0 109.011 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.595 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -57.92 126.92 23.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.936 1.757 . . . . 0.0 110.033 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.98 -33.97 62.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 72' ' ' THR . 2.0 p -65.48 -9.03 22.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.083 -1.245 . . . . 0.0 109.218 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -98.3 16.4 21.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.899 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 30' ' ' LEU . 6.1 m -136.49 -175.45 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.18 -0.95 . . . . 0.0 109.612 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 77' ' ' ILE . 11.3 pt-20 -156.61 87.26 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.87 . . . . 0.0 109.808 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.522 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 58.3 t80 -46.18 135.8 7.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.369 -0.832 . . . . 0.0 109.753 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -135.38 17.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.067 -1.021 . . . . 0.0 109.468 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.457 ' HA2' ' OH ' ' A' ' 76' ' ' TYR . . . 116.52 -147.17 18.91 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 87.9 m-85 -79.58 121.21 24.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.46 -1.024 . . . . 0.0 108.885 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.627 ' CG ' HG23 ' A' ' 31' ' ' THR . 1.3 mt-30 -118.87 115.67 24.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.883 -1.136 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.625 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -105.99 -178.98 3.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.905 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -121.64 132.43 54.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.731 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -57.65 164.43 2.05 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 109.932 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 74' ' ' VAL . 14.1 mt -138.49 -40.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.603 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -117.3 -159.66 0.74 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.128 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 11.5 p-10 -119.71 168.18 11.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 110.275 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CB ' ' CD2' ' A' ' 24' ' ' LEU . 2.0 t80 -171.91 119.22 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.509 -0.744 . . . . 0.0 109.195 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' LYS . 16.8 mttm -93.67 49.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.833 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 9.7 ttmt 42.2 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 3.2 mt-10 -73.23 -81.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.276 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 8.1 mmt180 -88.96 150.52 22.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.0 109.388 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -47.12 -23.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.823 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.77 -48.68 68.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.965 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 34.7 p30 -82.38 173.15 12.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -127.71 -171.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.0 m-20 -93.75 115.04 27.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -121.32 150.21 41.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.728 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -150.21 149.36 30.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.047 -1.033 . . . . 0.0 109.769 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.1 tp -42.47 136.46 2.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 85.62 2.28 87.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.731 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 13.5 t0 -90.41 117.25 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -1.174 . . . . 0.0 109.213 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.8 mp -79.97 134.98 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.025 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 6.9 mp -113.46 136.8 52.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -115.65 89.31 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 111.008 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 37' ' ' LEU . 1.5 t -89.4 106.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 108.841 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -50.75 157.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -73.3 156.28 38.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 -56.93 4.83 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -51.04 -23.28 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.218 -1.166 . . . . 0.0 109.66 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -90.49 -34.21 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 38' ' ' VAL . 52.5 t -89.13 1.79 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.746 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.502 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.62 -8.21 25.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.861 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.76 18.62 21.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.311 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.77 38.78 60.7 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.707 ' CE1' HD23 ' A' ' 40' ' ' LEU . 5.6 m-85 -57.8 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.525 ' O ' ' C ' ' A' ' 44' ' ' ASP . 27.2 t -125.08 97.69 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.72 93.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.297 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.03 -14.76 4.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' SER . 5.8 mt-30 -90.68 2.14 56.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.778 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 1.3 mp0 -65.7 -23.23 66.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -103.21 19.04 20.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.526 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mmt180 -130.93 65.2 76.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.212 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.38 -33.49 97.86 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.162 1.908 . . . . 0.0 110.342 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 21.1 pt-20 -58.61 -29.8 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 109.597 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 -0.13 24.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.704 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.2 mt -79.92 -39.22 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 111.66 -73.45 0.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 11.2 m95 -148.1 140.98 24.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.467 -1.02 . . . . 0.0 109.123 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -130.8 132.9 45.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.0 110.019 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 6.1 t30 -99.82 105.37 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 32' ' ' VAL . . . -131.6 -156.2 8.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.621 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -115.66 111.49 20.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.451 -1.029 . . . . 0.0 110.774 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' HD11 ' A' ' 30' ' ' LEU . 3.2 m-80 -79.59 80.4 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 108.603 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -44.56 -44.84 9.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -46.49 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.03 . . . . 0.0 109.957 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.656 HG21 ' NE2' ' A' ' 25' ' ' HIS . 14.7 p -83.36 12.71 5.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.87 43.31 6.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.91 117.14 25.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -1.141 . . . . 0.0 109.314 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 15.9 ttm180 -94.99 138.06 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.501 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 168.18 -174.0 43.01 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.248 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -90.02 152.82 21.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.72 -0.871 . . . . 0.0 109.859 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 1.025 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 2.5 p90 -155.36 161.16 30.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 0.0 109.121 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.67 127.42 23.54 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.929 1.753 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.12 -32.29 63.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -69.56 -8.66 49.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.239 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.69 -1.24 50.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.73 ' O ' HD12 ' A' ' 11' ' ' LEU . 5.9 m -122.73 -174.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 11' ' ' LEU . 2.5 pt-20 -156.75 88.66 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.59 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 81.9 t80 -34.48 128.94 0.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.242 0.544 . . . . 0.0 109.973 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -116.78 0.86 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.946 . . . . 0.0 109.396 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.59 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 97.95 -115.02 5.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 7.3 m-85 -81.76 141.74 33.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.438 -1.037 . . . . 0.0 108.975 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.635 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.9 mt-30 -144.88 116.81 8.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.803 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -110.94 179.78 3.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 12.6 mtm180 -114.83 168.72 9.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.328 -0.858 . . . . 0.0 108.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -90.2 97.77 11.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -67.51 -30.72 70.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.086 -1.008 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -129.47 -168.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.439 -0.788 . . . . 0.0 109.725 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -130.79 98.25 4.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.537 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 32.1 t80 -88.41 152.29 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.785 . . . . 0.0 109.323 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 151.69 20.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.953 . . . . 0.0 109.425 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.6 ttpt -72.92 85.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.408 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' CG ' ' OH ' ' A' ' 14' ' ' TYR . 1.7 pp20? -117.86 -35.22 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -71.99 138.38 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.1 tt0 -56.41 -15.89 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 3.5 tt0 -129.65 36.98 4.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 110.11 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 1.1 p-10 -122.53 161.66 23.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.062 -1.024 . . . . 0.0 109.531 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 24' ' ' LEU . 1.6 pt -116.11 170.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.92 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.574 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -79.51 100.8 7.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.218 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.9 HD11 HD21 ' A' ' 30' ' ' LEU . 3.5 mm? -88.06 133.42 33.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.8 m80 -135.08 139.2 44.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.6 tt -56.33 123.37 14.39 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.35 -0.844 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.93 -5.56 39.71 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -90.34 167.04 12.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 109.066 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.925 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -125.52 147.71 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 29' ' ' ILE . 5.9 mp -122.77 127.55 49.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.237 -0.914 . . . . 0.0 108.789 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.635 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -97.91 93.65 6.45 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 109.942 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 87.4 t -90.31 114.39 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -58.02 173.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -37.66 66.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.275 -0.89 . . . . 0.0 109.741 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.56 -44.09 8.81 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 79.2 p -51.83 -21.43 2.87 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 37' ' ' LEU . 1.6 tm? -85.21 -35.97 21.27 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 38' ' ' VAL . 79.5 t -85.68 4.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.768 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.83 -5.19 11.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.217 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.121 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -100.16 -45.21 5.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 109.166 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 123.95 17.16 3.13 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.121 ' CE2' HD23 ' A' ' 40' ' ' LEU . 10.0 m-85 -59.37 -151.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 108.969 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.58 166.62 16.36 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.311 -0.868 . . . . 0.0 108.854 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.65 87.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.03 -17.15 1.37 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.75 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -89.55 20.91 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.235 . . . . 0.0 109.629 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.646 ' OE2' HG23 ' A' ' 38' ' ' VAL . 13.1 mt-10 -89.75 -43.11 10.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.866 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.92 38.47 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 tpt180 -156.25 66.55 4.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HG2' HG23 ' A' ' 74' ' ' VAL . 3.1 Cg_exo -59.64 -46.43 20.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.244 1.963 . . . . 0.0 110.413 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -44.31 -26.69 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.244 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tt0 -111.64 50.57 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.178 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.75 HD11 ' O ' ' A' ' 46' ' ' GLN . 57.9 mt -141.85 -69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 142.03 -63.31 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 43.0 m95 -152.33 140.08 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -1.088 . . . . 0.0 109.38 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -131.66 159.87 37.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.938 . . . . 0.0 109.763 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.8 t30 -114.29 110.38 19.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.18 -168.85 12.29 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.203 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 40.0 t80 -111.52 114.66 27.89 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.63 75.21 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.028 . . . . 0.0 108.952 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.22 -33.88 21.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 16.4 m -55.39 -45.22 76.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.559 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -113.99 18.0 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.65 39.48 4.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 11.5 mt-10 -123.7 109.04 13.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.146 . . . . 0.0 109.135 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 17.6 ptt180 -92.63 143.97 25.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.729 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 168.67 -162.24 36.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -93.87 163.4 13.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -1.042 . . . . 0.0 109.382 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.724 ' CE2' HG11 ' A' ' 74' ' ' VAL . 3.8 p90 -163.63 158.64 17.25 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.76 124.43 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.133 1.888 . . . . 0.0 109.973 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.74 -40.92 85.01 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p -65.08 -12.06 46.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -1.204 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.0 m-85 -94.2 15.25 17.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.782 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.1 m -132.37 179.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.4 pt-20 -151.5 88.43 1.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 38.1 t80 -45.08 122.64 3.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 77' ' ' ILE . 74.7 mt -148.36 27.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -150.19 120.68 1.16 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.268 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.501 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 20.2 mtt85 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.464 -1.021 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.717 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 23.5 m-85 -78.1 113.52 16.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.06 . . . . 0.0 109.384 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.1 mt-30 -108.99 123.75 49.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.67 179.23 4.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.963 -1.085 . . . . 0.0 108.657 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 1.3 mtt180 -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -58.31 122.9 14.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.037 -1.039 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.8 mt -99.31 -34.07 10.47 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.0 m-85 -123.23 -166.72 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -0.807 . . . . 0.0 109.902 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 45.8 p30 -108.38 165.44 11.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.915 . . . . 0.0 109.839 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.807 ' HB2' HD22 ' A' ' 24' ' ' LEU . 7.7 t80 -173.81 106.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.405 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 12.5 ptmm? -83.57 11.58 6.95 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.649 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 69.72 115.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.223 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -90.66 -64.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.29 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.17 162.09 15.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.76 -10.87 22.06 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.96 -25.61 48.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -105.04 161.55 14.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 66' ' ' ARG . 1.4 pp -118.84 -176.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.465 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 4.7 m-20 -73.92 -179.83 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.807 HD22 ' HB2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 172.91 152.68 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.543 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.51 144.35 18.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.2 tt -48.9 148.21 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 83.57 -7.34 69.38 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 1.001 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.0 m-20 -88.06 -175.25 5.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.001 HD12 ' C ' ' A' ' 28' ' ' ASP . 2.4 mp -137.5 146.6 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.918 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.6 mp -122.38 120.84 35.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.228 -0.92 . . . . 0.0 109.125 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.93 91.49 7.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.864 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.672 HG11 ' OH ' ' A' ' 8' ' ' TYR . 87.8 t -99.87 110.63 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.0 109.024 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 97.0 m-20 -63.4 147.77 50.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.789 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 161.66 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.353 -0.842 . . . . 0.0 109.573 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 -59.87 4.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 m -52.66 -24.98 9.54 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.216 -1.167 . . . . 0.0 109.184 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.866 HD23 ' O ' ' A' ' 37' ' ' LEU . 3.2 tt -90.27 -29.36 18.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.814 . . . . 0.0 109.347 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 38' ' ' VAL . 96.8 t -89.2 0.56 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.34 -8.33 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -91.99 -17.07 25.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.718 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.38 23.07 3.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.2 m-85 -57.36 -171.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -1.15 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.9 -173.67 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.377 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.36 87.36 7.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 -31.78 2.5 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -53.8 -20.38 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -49.97 -54.47 19.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -85.31 59.31 5.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.431 -0.793 . . . . 0.0 110.033 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -153.06 57.49 2.03 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 3.3 Cg_exo -49.85 -46.89 25.56 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.774 ' HA ' HG22 ' A' ' 72' ' ' THR . 8.4 pt-20 -60.2 -33.68 72.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.06 -1.025 . . . . 0.0 109.311 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' CD ' ' HG2' ' A' ' 49' ' ' ARG . 5.4 mt-10 -99.89 1.82 43.19 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 50' ' ' PRO . 2.5 mt -94.36 -34.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 108.895 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.39 -80.52 0.31 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -140.56 144.77 36.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -1.082 . . . . 0.0 109.083 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.816 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -128.77 159.83 34.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.4 t30 -118.41 114.47 22.96 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -135.9 -160.01 8.71 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.291 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 44.5 t80 -126.17 110.03 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.669 -0.901 . . . . 0.0 109.787 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 1.2 m-20 -79.29 85.49 5.13 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.128 -0.982 . . . . 0.0 109.371 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.49 -34.94 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.761 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.4 m -51.12 -33.82 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.639 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 65' ' ' GLU . 5.6 t -121.74 7.07 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.621 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.62 47.0 87.91 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 63' ' ' THR . 81.5 mm-40 -118.26 163.22 17.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -1.187 . . . . 0.0 109.379 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.655 ' O ' HG21 ' A' ' 22' ' ' ILE . 9.1 ttp180 -148.47 127.72 12.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 167.09 -159.42 32.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.603 -1.284 . . . . 0.0 109.952 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -96.08 167.38 11.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.804 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -165.57 159.71 13.67 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.231 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.1 Cg_exo -61.62 122.55 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.073 1.848 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -41.83 73.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.4 p -60.46 -12.18 8.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.316 . . . . 0.0 109.408 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.6 m-85 -98.56 22.12 10.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.127 -0.983 . . . . 0.0 110.533 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 71' ' ' GLY . 15.4 m -138.39 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 6.4 pt-20 -148.55 84.07 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CZ ' ' HB3' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -32.54 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.758 0.79 . . . . 0.0 112.155 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 15.1 mm -129.61 -9.69 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 79' ' ' ARG . . . 81.93 -151.79 30.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.629 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.606 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 18.5 m-85 -86.45 123.28 31.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -1.135 . . . . 0.0 109.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.542 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -127.72 138.86 52.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 109.712 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.703 ' CE2' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -137.29 179.64 6.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.967 . . . . 0.0 109.672 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.545 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 1.4 mtm-85 -111.42 161.85 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.68 102.19 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 110.502 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 75' ' ' GLU . 2.9 mt -75.14 -39.5 60.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.1 m-85 -128.01 172.47 10.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.882 . . . . 0.0 109.855 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 9.3 p-10 -99.6 146.63 26.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 109.677 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 70' ' ' PRO . 71.8 t80 -125.24 166.21 16.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -108.24 139.32 43.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 109.423 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 15.5 ttpp -83.3 72.87 10.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 108.928 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -90.27 153.71 20.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.152 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.41 -26.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 18' ' ' ARG . 2.0 mt-10 -53.94 -59.67 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.4 p30 -77.06 169.46 18.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.81 . . . . 0.0 109.571 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.3 pp -127.77 161.77 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 0.0 109.893 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 4.5 m-20 -74.17 126.44 30.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.574 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 69' ' ' PHE . 19.0 mt -115.46 160.51 19.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.538 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 4.7 m-70 -156.56 149.95 24.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -57.52 137.52 56.19 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 109.386 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.98 -31.11 5.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 9.7 t0 -59.48 131.55 51.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -1.107 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.8 mm -93.26 140.46 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.752 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 9.8 mp -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.134 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -111.5 87.09 2.47 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.437 -0.789 . . . . 0.0 109.372 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.703 HG21 ' CE2' ' A' ' 8' ' ' TYR . 37.7 t -82.85 96.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -50.44 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.385 -0.822 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -86.93 154.08 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.626 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 88.43 -50.8 3.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -26.19 63.33 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.283 -1.128 . . . . 0.0 109.821 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 37' ' ' LEU . 2.2 tt -90.14 -35.97 15.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 38' ' ' VAL . 48.5 t -87.32 0.29 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.85 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.24 -13.99 15.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -104.05 32.2 4.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.744 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.21 51.27 55.29 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.702 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -70.83 -176.67 1.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -116.58 158.43 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -73.51 82.91 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.25 -36.94 0.6 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.1 29.31 1.24 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -90.1 -31.3 17.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.734 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -107.28 42.07 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.763 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.8 tpt180 -138.41 73.42 42.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.723 ' CG ' HG23 ' A' ' 74' ' ' VAL . 6.1 Cg_exo -56.75 -48.35 19.09 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.688 2.259 . . . . 0.0 111.878 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -56.64 -16.31 6.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.848 -1.158 . . . . 0.0 109.811 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -120.17 -5.41 9.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 109.8 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -79.86 -43.52 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.013 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.41 -76.39 0.26 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 30.7 m95 -143.74 132.75 22.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -1.045 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.853 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -119.87 158.61 26.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 110.027 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 21.1 t-20 -119.3 111.36 18.1 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -135.15 -151.7 6.32 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 31.0 t80 -130.73 113.36 14.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.915 -0.756 . . . . 0.0 109.978 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.606 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -80.71 82.07 6.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.0 109.17 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -49.51 -37.12 25.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.946 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -53.0 -44.39 67.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.647 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.503 HG21 ' NE2' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -110.43 15.86 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.75 41.49 7.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -106.99 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -1.139 . . . . 0.0 109.558 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.572 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 10.8 ttt180 -156.85 130.29 8.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 161.33 -162.91 34.15 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -92.9 174.74 7.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.991 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.76 ' HB3' HD11 ' A' ' 22' ' ' ILE . 22.3 p90 178.98 157.47 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 109.333 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.72 115.52 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.021 1.814 . . . . 0.0 109.657 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.951 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.84 -30.0 74.08 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 18.7 p -49.49 -20.67 0.77 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.817 -1.402 . . . . 0.0 109.935 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 18.2 m-85 -97.54 33.76 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 111.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 71' ' ' GLY . 16.5 m -145.41 174.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.035 -1.041 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.728 ' HB3' HD11 ' A' ' 11' ' ' LEU . 4.9 pt-20 -148.66 93.01 2.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.8 t80 -37.34 119.57 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.372 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 77' ' ' ILE . 14.2 mm -144.99 15.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.32 100.72 0.46 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.477 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.417 -1.049 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 28.5 m-85 -143.31 148.22 35.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.52 -0.988 . . . . 0.0 108.472 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' CG ' HG23 ' A' ' 31' ' ' THR . 9.9 mt-30 -137.63 107.58 6.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 110.074 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.668 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.47 172.87 6.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.114 -0.991 . . . . 0.0 108.651 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB2' HD11 ' A' ' 77' ' ' ILE . 23.1 ttt180 -109.22 166.3 10.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -0.972 . . . . 0.0 108.954 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -90.64 99.36 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.024 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.61 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -80.62 -35.1 34.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.147 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 26.0 m-85 -130.76 171.3 13.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.883 . . . . 0.0 109.822 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -97.88 -177.26 3.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 65.6 t80 173.6 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -80.02 143.17 34.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 14.1 pttp -59.32 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -66.18 -70.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.4 mtt180 -75.89 164.39 26.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.69 1.48 10.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 1.1 tp10 -104.81 -6.08 20.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.038 -1.039 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.474 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -102.35 154.31 19.18 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 109.824 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -108.01 -171.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 0.0 109.391 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.824 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.97 142.19 33.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.0 HD11 HD21 ' A' ' 30' ' ' LEU . 1.6 mm? -131.97 138.1 48.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.481 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -153.13 136.79 16.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -49.0 135.58 15.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 96.28 -3.69 64.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 5.1 t70 -90.12 148.97 22.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.495 ' C ' HD12 ' A' ' 30' ' ' LEU . 17.6 mm -101.68 132.15 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.859 . . . . 0.0 108.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 24' ' ' LEU . 6.5 mp -114.21 111.72 22.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.44 96.01 10.28 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.222 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.664 HG11 ' OH ' ' A' ' 8' ' ' TYR . 78.4 t -98.32 101.1 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.0 m-80 -46.99 173.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 109.891 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 1.2 ttpm? -90.35 -27.46 19.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.04 -53.92 3.55 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -54.54 -24.51 21.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.217 -1.167 . . . . 0.0 109.664 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 47' ' ' GLU . 19.6 tp -90.28 -40.83 11.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.652 ' O ' HG12 ' A' ' 38' ' ' VAL . 47.4 t -79.93 0.38 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.907 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.414 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -68.24 -6.53 24.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.858 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.1 mm? -102.85 8.41 39.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.705 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.63 32.24 38.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.721 ' HE2' HG23 ' A' ' 53' ' ' ILE . 24.6 m-85 -58.29 -168.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.39 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.07 167.89 14.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.539 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.0 107.67 7.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.55 19.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD11 ' A' ' 53' ' ' ILE . 11.7 mm-40 -82.19 -41.15 20.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.261 -1.14 . . . . 0.0 109.579 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.2 pm0 -42.51 -43.89 3.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.442 -0.786 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -85.54 43.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.469 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -151.53 62.63 5.01 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HB2' HG23 ' A' ' 74' ' ' VAL . 2.8 Cg_exo -54.64 -55.55 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.469 2.113 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.7 -23.45 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.032 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.0 mt-10 -121.44 48.37 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 42' ' ' PHE . 4.9 mt -133.08 -43.91 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -75.65 0.26 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 48.5 m95 -144.19 123.57 13.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.378 -1.072 . . . . 0.0 109.576 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.732 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -112.95 156.47 22.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' VAL . 14.5 t-20 -112.21 107.69 16.65 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.627 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.18 -163.94 11.21 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.0 t80 -122.32 113.27 19.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.767 -0.843 . . . . 0.0 110.147 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 1.2 m120 -78.96 82.71 5.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.192 -0.943 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -45.19 -41.93 8.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.067 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m -47.88 -69.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 t -79.76 4.91 14.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.963 . . . . 0.0 109.698 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.75 50.15 38.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -128.84 171.52 12.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -1.128 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' C ' HG21 ' A' ' 22' ' ' ILE . 12.2 ttp85 -143.21 143.8 31.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 162.88 -167.36 37.25 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.573 -1.298 . . . . 0.0 109.923 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.0 p30 -91.49 171.85 8.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -1.062 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 13.5 p90 -175.13 154.01 1.64 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.875 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -58.4 124.51 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.985 1.79 . . . . 0.0 109.765 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.732 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -71.62 -18.83 77.49 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -70.49 -13.85 62.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.694 -1.474 . . . . 0.0 109.68 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.598 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 10.7 m-30 -99.9 19.3 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 50' ' ' PRO . 2.7 m -132.39 -174.02 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.81 -1.181 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.53 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.8 pt-20 -158.19 88.02 0.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.557 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 14.2 t80 -43.13 133.31 3.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.907 . . . . 0.0 109.31 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.8 mp -129.06 -4.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.876 -1.14 . . . . 0.0 109.931 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 171.66 167.29 31.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.518 ' CA ' ' OH ' ' A' ' 76' ' ' TYR . 2.6 ptt-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.54 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.671 ' CD1' HD22 ' A' ' 37' ' ' LEU . 52.5 m-85 -84.57 121.35 27.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -1.076 . . . . 0.0 109.265 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 3.7 mt-30 -116.87 129.98 56.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.636 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -118.88 174.65 6.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.945 . . . . 0.0 109.926 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.826 ' HB2' HD11 ' A' ' 77' ' ' ILE . 1.8 ttp85 -117.11 126.71 53.26 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -54.4 133.22 45.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.573 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.7 mt -108.93 -38.79 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 3.8 m-85 -116.48 -160.43 0.76 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -124.52 146.6 48.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.909 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 24' ' ' LEU . 63.9 t80 -156.33 111.23 2.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.21 121.91 25.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -48.67 114.6 1.01 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG3' ' OD2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -90.57 -72.07 0.59 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.203 -0.936 . . . . 0.0 108.612 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.67 166.06 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 109.143 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -9.62 18.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 109.883 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.59 -23.04 40.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.095 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -108.55 158.4 17.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.8 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 60' ' ' ASN . 15.4 pt -111.29 -169.54 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.564 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -106.61 109.0 20.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.824 . . . . 0.0 109.527 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -113.58 148.08 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.18 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 2.0 m80 -154.01 141.49 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 109.39 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.5 tp -41.59 136.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.679 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.32 1.64 81.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.781 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.4 m-20 -90.42 169.18 11.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -1.156 . . . . 0.0 109.473 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.596 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mm -122.92 132.54 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.183 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.985 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.5 mp -115.61 128.59 56.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.066 -1.021 . . . . 0.0 109.116 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -110.42 79.77 1.24 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.392 -0.818 . . . . 0.0 109.149 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 37' ' ' LEU . 74.7 t -80.25 117.12 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -53.3 -173.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 37' ' ' LEU . 6.3 mtmt -90.17 -62.47 1.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.427 -0.796 . . . . 0.0 109.938 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.67 -54.49 37.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -19.7 3.56 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.213 -1.169 . . . . 0.0 109.32 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.75 HD21 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -84.57 -36.85 21.82 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 38' ' ' VAL . 21.9 t -85.02 -4.06 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.344 -0.848 . . . . 0.0 109.886 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.1 -24.1 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.055 -1.028 . . . . 0.0 108.605 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -88.78 33.19 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.624 -0.673 . . . . 0.0 109.848 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 47.51 29.55 5.61 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.658 ' CE1' HG23 ' A' ' 53' ' ' ILE . 6.8 m-30 -47.62 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.822 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -100.86 -174.35 2.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.181 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.98 103.92 16.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.787 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 12.59 77.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' SER . 6.8 tt0 -90.3 29.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -1.2 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.75 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -86.55 -13.12 46.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -79.08 4.52 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.094 -1.004 . . . . 0.0 109.396 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 mtt180 -131.28 63.2 69.11 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 108.943 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' CB ' HD11 ' A' ' 56' ' ' LEU . 4.7 Cg_exo -59.0 -24.68 74.51 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.25 1.967 . . . . 0.0 110.397 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.71 ' CA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -69.03 -43.34 74.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.121 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.0 mt-10 -79.79 -6.79 57.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.154 -0.966 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -79.71 -42.39 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 108.697 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.8 -74.34 0.26 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 21.7 m95 -147.67 122.75 10.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -1.031 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -104.9 153.78 20.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.028 -1.045 . . . . 0.0 108.983 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.666 ' O ' HG13 ' A' ' 32' ' ' VAL . 5.7 t-20 -122.01 121.95 38.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 32' ' ' VAL . . . -146.88 -146.98 4.46 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -123.57 110.16 14.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.54 -0.977 . . . . 0.0 110.131 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.965 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -78.32 82.38 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 108.539 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -53.02 -35.04 59.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 110.122 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 28' ' ' ASP . 19.7 m -53.38 -39.81 64.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 109.714 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.965 HG22 ' HB3' ' A' ' 60' ' ' ASN . 14.8 t -108.93 6.59 25.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.82 48.53 56.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 63' ' ' THR . 37.1 mm-40 -135.7 171.91 13.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -1.184 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 25.1 ttt180 -141.59 146.45 36.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 22' ' ' ILE . . . 159.85 -159.05 30.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -106.5 175.46 5.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.947 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.985 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -173.17 162.03 3.52 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 6.1 Cg_exo -58.35 119.14 6.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.929 1.753 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.14 -29.81 66.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.71 HG22 ' CA ' ' A' ' 51' ' ' GLU . 27.9 p -69.45 -7.02 34.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -1.233 . . . . 0.0 109.15 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -100.26 -5.37 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 110.194 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.5 m -111.29 172.87 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 6.0 pt-20 -136.25 87.55 2.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.237 -0.915 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.605 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 91.4 t80 -42.64 143.54 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 9' ' ' ARG . 3.6 mt -145.2 16.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 83.69 -122.57 5.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 109.495 179.977 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.617 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 46.0 m-85 -107.06 115.99 31.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -1.192 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.775 ' CG ' HG23 ' A' ' 31' ' ' THR . 28.3 mt-30 -93.39 127.85 39.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.45 177.32 4.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.795 -1.191 . . . . 0.0 111.315 -179.897 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -114.23 124.85 53.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.825 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -61.3 116.66 4.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.7 mt -82.73 -36.14 26.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.571 -0.706 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 3.3 m-85 -120.83 -137.68 0.33 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.396 -0.815 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -144.16 -177.01 5.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 1.6 t80 -170.03 135.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.69 8.08 45.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.912 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 4.7 tttt 61.52 108.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 0.0 109.893 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -61.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 32.1 mtm-85 -90.41 139.63 30.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' ARG . 46.0 tt0 -40.93 -35.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -54.51 -59.53 4.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -64.52 165.34 10.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 110.022 -179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.605 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.6 pt -129.53 172.33 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.65 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.2 m-20 -69.62 115.91 9.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.9 . . . . 0.0 109.921 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -104.94 157.88 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.677 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -160.1 143.14 13.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.665 -1.272 . . . . 0.0 110.204 -179.929 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -55.49 139.25 44.36 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.232 -0.918 . . . . 0.0 109.394 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 29' ' ' ILE . . . 89.59 -33.07 4.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 25' ' ' HIS . 7.6 t0 -68.38 121.25 15.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -1.066 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.962 ' C ' HD23 ' A' ' 30' ' ' LEU . 2.9 mp -88.37 165.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.78 147.43 42.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.049 -1.032 . . . . 0.0 108.235 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.775 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -108.25 93.21 4.41 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.679 -0.638 . . . . 0.0 109.764 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 47.3 t -92.89 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.117 -0.99 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -54.65 138.7 40.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.855 . . . . 0.0 109.682 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 6.5 pttt -59.01 144.54 44.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.295 -0.878 . . . . 0.0 108.995 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.14 -58.5 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 33' ' ' ASN . 2.6 p -46.6 -26.01 0.82 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.152 -1.205 . . . . 0.0 108.747 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.017 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -85.25 -40.61 16.43 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 38' ' ' VAL . 21.4 t -70.96 -4.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -82.53 -54.94 4.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.01 20.02 4.2 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.783 ' HE2' HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -56.77 -68.28 0.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.571 -1.546 . . . . 0.0 108.143 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 13.8 t -158.2 130.91 7.21 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.13 117.95 9.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 0.0 109.669 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.76 -1.47 55.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 1.8 tt0 -86.39 30.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.095 -1.238 . . . . 0.0 110.076 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.737 ' HA ' HD22 ' A' ' 37' ' ' LEU . 8.1 mt-10 -88.14 20.53 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -105.24 -21.8 13.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -113.72 82.01 6.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.881 ' HA ' HD12 ' A' ' 53' ' ' ILE . 4.2 Cg_exo -59.62 -52.58 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -44.79 -27.47 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -105.51 47.03 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.971 HD13 ' CD2' ' A' ' 37' ' ' LEU . 58.7 mt -144.18 -49.69 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.5 -70.33 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 31.6 m95 -143.84 152.65 41.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.94 144.29 45.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.465 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 16.9 t-20 -110.34 106.19 15.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.31 -163.88 10.82 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.036 -1.554 . . . . 0.0 111.296 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 122.161 -0.611 . . . . 0.0 109.857 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.91 ' OD1' HD22 ' A' ' 30' ' ' LEU . 4.3 m-80 -77.04 91.12 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.838 -1.164 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.38 -37.29 62.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.487 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 10.7 m -51.71 -45.36 63.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.197 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 60' ' ' ASN . 2.5 t -107.25 9.57 30.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.52 53.61 5.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -129.51 151.85 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -1.196 . . . . 0.0 109.806 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.38 124.91 43.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 108.948 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -179.2 -166.64 35.4 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.471 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -104.22 166.93 10.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.966 . . . . 0.0 109.852 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CE2' ' CD1' ' A' ' 30' ' ' LEU . 5.0 p90 -167.95 160.03 9.55 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -59.85 128.6 27.36 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.221 1.947 . . . . 0.0 110.61 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -36.26 60.24 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 2.7 p -64.85 -9.82 23.75 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.031 -1.276 . . . . 0.0 109.242 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.6 m-85 -96.41 15.36 21.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.968 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.6 m -139.74 -177.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HD21 ' A' ' 11' ' ' LEU . 15.5 pt-20 -156.43 89.92 1.15 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.7 t80 -36.9 132.92 0.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.619 -0.675 . . . . 0.0 109.527 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG21 ' NH1' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -119.13 -15.55 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.994 . . . . 0.0 109.509 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 -124.31 5.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.085 -1.244 . . . . 0.0 109.505 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.643 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 2.5 m-85 -99.69 136.82 39.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -1.146 . . . . 0.0 109.392 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 78' ' ' GLY . 1.2 mt-30 -129.94 108.74 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 108.941 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -101.82 -178.94 3.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.001 -1.062 . . . . 0.0 110.483 -179.873 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -123.51 139.77 53.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . . . -64.31 98.67 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.016 -1.053 . . . . 0.0 110.562 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.661 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 4.6 mt -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 108.588 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.661 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 28.6 m-85 -140.11 -164.13 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -115.67 148.2 39.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' HD22 ' A' ' 24' ' ' LEU . 45.1 t80 -150.64 108.92 3.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 17' ' ' GLU . 19.4 tptt -79.8 149.37 31.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 2.1 tttp -52.55 89.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' LYS . 42.5 mm-40 -77.97 -68.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.0 mtt180 -89.6 164.65 14.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.277 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.48 2.2 10.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.232 -0.918 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -106.07 -2.71 22.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.067 -1.02 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 p-10 -115.17 167.64 10.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.977 -1.077 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.528 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -111.92 -171.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.663 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -103.4 98.38 8.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -0.814 . . . . 0.0 109.348 179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.678 HD23 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -96.87 161.99 13.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.54 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 5.7 m-70 -156.33 149.75 24.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.146 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 6.4 tt -54.02 140.77 30.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.933 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -30.25 6.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.866 ' OD1' ' HB2' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.73 166.72 12.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 109.606 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 28' ' ' ASP . 7.4 mm -119.29 141.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.953 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.4 mp -110.43 123.64 50.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.3 88.63 3.02 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.784 HG22 ' CA ' ' A' ' 58' ' ' GLY . 74.3 t -96.55 95.5 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.468 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' VAL . 2.2 m120 -42.0 165.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 109.948 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.26 150.69 23.72 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.338 -0.851 . . . . 0.0 109.408 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.27 -61.72 2.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -55.61 -19.52 10.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.299 -1.118 . . . . 0.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.604 ' CD1' HG11 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -89.71 -30.62 17.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.47 -0.769 . . . . 0.0 109.409 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.574 HG23 ' CG ' ' A' ' 47' ' ' GLU . 18.8 t -87.87 -2.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -3.93 20.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 42' ' ' PHE . 5.9 mt -84.26 -25.68 29.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 122.06 4.2 9.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.038 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 20.0 m-85 -53.08 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.602 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.536 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -116.58 118.36 32.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 43' ' ' SER . 11.1 t70 -24.3 88.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.303 0.573 . . . . 0.0 111.259 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 139.53 -7.73 3.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.907 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.1 tp60 -90.51 -0.89 57.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.296 . . . . 0.0 110.04 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 22.1 mt-10 -66.92 -10.0 44.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 0.0 109.57 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.892 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -114.36 19.2 16.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -128.72 61.69 56.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.0 Cg_exo -57.62 -38.96 91.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.228 1.952 . . . . 0.0 110.323 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -64.37 -28.33 69.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 16.9 mm-40 -101.64 -5.24 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.038 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 18.6 mt -83.44 -88.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.283 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.808 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 155.8 -55.05 0.41 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 29.2 m95 -153.27 138.4 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -1.046 . . . . 0.0 109.395 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -135.01 143.04 46.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.795 -179.964 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 1.4 t-20 -94.51 102.98 14.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.784 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.98 175.93 15.89 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.723 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.5 t80 -109.25 106.92 16.97 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.815 -0.815 . . . . 0.0 109.519 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' ND2' ' CD1' ' A' ' 22' ' ' ILE . 1.6 m-80 -78.12 89.31 4.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 108.971 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -57.63 -36.86 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.004 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m -49.47 -33.04 13.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 6.6 9.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.2 39.41 70.92 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -107.7 157.02 18.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 13.0 tpt180 -139.16 114.43 9.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 108.868 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -175.4 -165.35 31.39 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.046 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.556 ' OD2' ' CE3' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -97.81 164.31 12.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -1.01 . . . . 0.0 109.783 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.953 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.2 p90 -160.07 162.66 23.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.612 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.46 124.89 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.922 1.748 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.45 -33.73 63.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -68.09 -8.2 36.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.984 -1.304 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.0 m-85 -99.06 -7.75 26.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.114 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 71' ' ' GLY . 24.1 m -109.34 176.11 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 5.7 pt-20 -142.11 89.33 2.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.437 -0.79 . . . . 0.0 108.957 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.892 ' CD2' ' HB1' ' A' ' 48' ' ' ALA . 60.4 t80 -38.71 125.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.549 -0.72 . . . . 0.0 109.921 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -152.57 17.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -121.38 105.1 0.99 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 10.4 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 21.6 m-85 -137.53 105.04 5.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.92 . . . . 0.0 108.691 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.485 ' CG ' HG23 ' A' ' 31' ' ' THR . 10.2 mt-30 -99.64 123.12 43.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 110.047 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -112.91 170.19 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.071 -1.018 . . . . 0.0 108.967 179.878 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.548 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 13.3 ttp180 -105.68 145.47 31.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 108.97 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -74.13 96.95 2.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.923 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 18.6 mt -64.26 -29.75 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.618 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 6.5 m-85 -130.01 -159.34 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.139 -0.976 . . . . 0.0 110.16 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -117.59 -167.81 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -176.44 156.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.893 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -119.33 27.11 9.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 0.0 110.399 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.532 ' CB ' ' OD1' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 42.26 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.105 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 18' ' ' ARG . 17.4 mt-10 -126.9 -50.2 1.46 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.053 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 55' ' ' TRP . 0.2 OUTLIER -39.79 161.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.542 -0.724 . . . . 0.0 110.274 179.97 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -28.99 -68.25 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.595 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 5.3 mm-40 -131.16 48.68 2.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.808 -1.182 . . . . 0.0 111.005 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 56.1 p-10 -95.85 154.99 16.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.164 . . . . 0.0 108.853 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.2 pp -104.09 171.35 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 110.042 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -64.82 170.3 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.943 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -153.27 146.84 25.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.528 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -156.25 138.98 15.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.681 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -55.35 122.27 10.79 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.43 -5.36 28.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.695 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.2 m-20 -90.24 163.63 14.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -1.166 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.706 ' C ' HD12 ' A' ' 30' ' ' LEU . 14.1 mm -119.24 140.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 24' ' ' LEU . 5.8 mp -118.9 113.85 21.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.485 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -88.09 105.78 17.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.561 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 58' ' ' GLY . 71.7 t -115.75 91.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.699 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.519 ' HA ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t-20 -42.82 159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.931 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -83.75 145.43 28.72 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 98.79 -55.4 1.01 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -45.85 -27.36 0.85 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.267 -1.137 . . . . 0.0 108.877 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 42' ' ' PHE . 0.6 OUTLIER -90.06 -35.72 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.964 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' HG12 ' A' ' 38' ' ' VAL . 42.0 t -79.23 3.89 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 109.659 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.35 -13.2 17.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.832 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.2 mm? -96.85 -19.72 18.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.089 -1.007 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 117.77 25.32 3.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.703 ' HE2' HG23 ' A' ' 53' ' ' ILE . 5.9 m-85 -51.65 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -1.042 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -160.5 -162.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.147 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 11.4 t70 -90.14 62.39 5.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.177 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 34.68 2.57 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -82.42 6.66 16.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 109.557 -179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' OE2' ' CZ ' ' A' ' 8' ' ' TYR . 3.9 tm-20 -67.7 -7.01 23.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -84.99 16.96 3.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.988 -1.07 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -125.69 59.36 26.7 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.126 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.547 ' CB ' HG23 ' A' ' 74' ' ' VAL . 3.0 Cg_exo -50.13 -59.78 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.153 1.902 . . . . 0.0 110.337 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.639 ' HA ' HG22 ' A' ' 72' ' ' THR . 4.2 tt0 -66.65 -17.15 64.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 108.679 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.2 mm-40 -108.67 22.69 15.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.703 HG23 ' HE2' ' A' ' 42' ' ' PHE . 5.5 mt -118.39 -45.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 108.945 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.97 -74.32 0.29 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 18' ' ' ARG . 12.5 m95 -141.78 147.02 36.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -1.084 . . . . 0.0 109.121 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.764 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -136.89 159.58 41.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 32' ' ' VAL . 10.8 t30 -111.76 100.79 9.22 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -119.62 178.46 16.55 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CG ' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -112.43 113.27 25.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.654 -0.909 . . . . 0.0 109.893 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 37.0 m-80 -89.44 64.43 6.75 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 62' ' ' THR . 4.1 mt-10 -45.94 -28.3 1.1 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.023 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.695 HG21 ' CG ' ' A' ' 28' ' ' ASP . 8.3 m -47.19 -54.97 9.39 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.8 t -87.3 -10.21 52.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.67 40.29 11.04 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 8.2 mm-40 -138.89 164.88 28.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.057 -1.261 . . . . 0.0 109.257 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 52.2 ttp85 -145.69 115.3 7.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.63 -159.07 10.06 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -87.81 165.63 15.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.945 . . . . 0.0 110.091 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.7 p90 -172.13 159.23 4.33 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.802 . . . . 0.0 109.313 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.7 Cg_exo -61.44 126.05 18.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.176 1.918 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -71.68 -32.94 63.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -64.84 -9.94 24.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.083 -1.245 . . . . 0.0 109.43 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.9 m-85 -98.73 15.95 23.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.789 HG11 ' HE2' ' A' ' 69' ' ' PHE . 18.1 m -134.94 -177.94 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.085 -1.009 . . . . 0.0 110.534 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 4.5 pt-20 -147.03 89.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 33.3 t80 -49.65 123.88 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.58 -16.8 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.985 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 111.65 -160.48 13.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.56 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.577 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 47' ' ' GLU . 60.0 m-85 -158.75 141.21 14.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.494 -1.004 . . . . 0.0 108.959 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -154.81 114.36 3.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 109.43 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 1.085 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -109.8 170.93 7.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.758 ' CB ' HD11 ' A' ' 77' ' ' ILE . 1.6 tpp180 -112.83 116.7 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -43.44 158.02 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.68 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.62 HD21 ' OE1' ' A' ' 75' ' ' GLU . 14.5 mt -135.92 -41.17 0.67 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 12.3 m-85 -125.33 169.96 11.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.548 -0.72 . . . . 0.0 109.765 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p30 -102.87 139.39 38.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.559 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 34.4 t80 -134.78 131.33 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.213 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.99 120.43 24.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.556 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.1 pttt -56.29 91.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.824 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -55.72 -68.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.33 159.33 16.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.157 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.31 -12.98 10.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.075 -1.016 . . . . 0.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -31.24 62.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -96.01 149.29 21.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 109.5 -179.989 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.644 HD11 ' CG ' ' A' ' 60' ' ' ASN . 1.4 pp -105.37 175.84 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.579 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 4.0 m-20 -80.18 115.8 19.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 109.894 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -94.08 147.01 23.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 108.725 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.654 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER -152.49 127.57 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.536 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.674 HD23 ' C ' ' A' ' 26' ' ' LEU . 5.5 tt -43.64 141.19 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.97 1.11 88.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.581 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 12.5 t0 -82.32 152.45 26.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 6.4 mm -104.37 124.57 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.035 . . . . 0.0 109.071 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 24' ' ' LEU . 6.8 mp -111.81 106.78 15.63 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 109.555 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.49 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -88.93 95.82 10.47 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.262 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 40.7 t -93.65 116.02 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.467 -0.771 . . . . 0.0 109.451 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -87.36 -179.31 6.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 146.95 31.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.06 -62.38 2.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -21.07 29.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.28 -1.129 . . . . 0.0 108.949 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.588 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -90.09 -35.3 15.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.284 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 38' ' ' VAL . 40.0 t -77.17 2.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.486 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -60.89 -11.93 9.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.938 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -102.64 36.63 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.001 -1.062 . . . . 0.0 109.39 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 48.3 25.09 4.02 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.938 ' CE2' HD23 ' A' ' 40' ' ' LEU . 6.1 m-30 -48.4 -178.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.572 -0.957 . . . . 0.0 109.858 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -122.83 106.12 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 43' ' ' SER . 13.4 t0 -27.72 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.312 0.577 . . . . 0.0 110.97 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 147.46 -23.07 1.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.602 ' HG2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -89.96 -2.94 58.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.12 -1.224 . . . . 0.0 110.309 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -42.99 -49.79 5.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.435 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.26 46.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.09 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.548 ' CD ' ' HB3' ' A' ' 52' ' ' GLU . 55.5 ttt180 -151.34 59.37 3.25 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.078 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 3.0 Cg_endo -60.03 -47.49 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.268 1.979 . . . . 0.0 110.453 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 52' ' ' GLU . 24.1 pt-20 -47.89 -46.87 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HB3' ' CD ' ' A' ' 49' ' ' ARG . 1.4 tt0 -99.5 47.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.181 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.825 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -130.56 -39.58 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.953 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.4 -79.41 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -138.6 137.32 36.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.631 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -121.78 168.21 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 109.794 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.679 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.3 t-20 -119.6 119.49 33.9 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.43 -172.94 15.37 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.088 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 50.1 t80 -114.85 109.11 17.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.465 -1.021 . . . . 0.0 109.763 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.644 ' CG ' HD11 ' A' ' 22' ' ' ILE . 15.9 m120 -79.05 85.9 4.93 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.189 -0.944 . . . . 0.0 109.0 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.447 -0.783 . . . . 0.0 110.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 21.9 m -53.58 -35.88 61.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.654 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -116.87 10.52 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 42.44 53.95 4.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -141.93 115.32 8.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.24 136.77 32.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 109.247 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.599 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 176.96 -160.5 27.67 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.244 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 8.4 m-20 -96.33 163.98 12.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -1.06 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.642 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 p90 -164.36 158.99 15.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.879 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.3 Cg_exo -61.19 117.43 4.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.249 1.966 . . . . 0.0 109.981 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.848 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.12 -34.83 82.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 2.9 p -63.26 -19.99 65.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.971 -1.311 . . . . 0.0 110.03 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 7.2 m-30 -93.41 17.98 10.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.598 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 71' ' ' GLY . 30.7 m -131.02 170.12 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.097 -1.002 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' OE1' HD21 ' A' ' 11' ' ' LEU . 7.6 pt-20 -137.6 87.38 2.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.282 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CE2' ' N ' ' A' ' 78' ' ' GLY . 65.8 t80 -41.04 141.11 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.758 HD11 ' CB ' ' A' ' 9' ' ' ARG . 3.3 mt -139.36 8.99 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 97.33 -140.33 14.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.408 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 28.7 m-85 -80.02 106.35 11.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -1.083 . . . . 0.0 109.753 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.753 ' HG2' HG23 ' A' ' 31' ' ' THR . 1.4 mt-30 -102.56 128.04 49.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.31 173.15 6.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 0.0 109.972 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.87 142.26 46.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -64.93 151.31 46.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.896 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.772 HD21 ' CD ' ' A' ' 75' ' ' GLU . 13.3 mt -134.2 -41.8 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.624 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.0 m-85 -118.77 -142.8 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.554 -0.717 . . . . 0.0 109.541 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -144.77 173.96 11.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.89 -1.132 . . . . 0.0 109.957 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 47.6 t80 -173.59 141.51 0.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.4 -0.813 . . . . 0.0 108.911 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' GLU . 1.4 mttt -101.94 133.44 46.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.03 -1.043 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 21' ' ' ASP . 3.7 ttpm? -58.63 88.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 109.528 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 15' ' ' LYS . 60.8 tt0 -90.1 -73.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.1 mtt180 -61.66 157.9 16.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 26.2 tp10 -74.75 1.95 11.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.117 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.418 ' HG2' ' OD2' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -111.38 -1.06 16.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.061 -1.024 . . . . 0.0 110.042 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 52.3 p30 -110.99 164.63 12.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.997 -1.064 . . . . 0.0 109.6 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.803 HD12 ' ND2' ' A' ' 60' ' ' ASN . 2.1 pt -126.38 -170.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 1.2 m-20 -84.9 134.5 34.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.634 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -128.12 138.28 52.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.076 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -153.46 138.75 17.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.062 -1.024 . . . . 0.0 109.62 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 tt -54.21 147.55 12.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.35 -0.844 . . . . 0.0 109.779 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 90.65 -9.89 76.29 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.892 ' O ' HD13 ' A' ' 29' ' ' ILE . 1.8 m-20 -86.54 178.12 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.163 . . . . 0.0 109.83 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 28' ' ' ASP . 5.7 mm -129.5 140.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.115 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -121.42 130.13 53.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.971 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.753 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -106.94 93.82 4.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.884 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.952 ' CG1' HD12 ' A' ' 37' ' ' LEU . 56.4 t -101.11 115.03 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -68.47 160.95 28.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.05 2.55 17.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.886 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.58 -49.6 0.47 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -54.84 -25.69 30.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -1.168 . . . . 0.0 109.641 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.952 HD12 ' CG1' ' A' ' 32' ' ' VAL . 1.3 tt -90.38 -34.08 15.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 38' ' ' VAL . 71.4 t -80.75 2.27 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.066 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.5 4.23 7.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 109.988 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -111.44 5.1 19.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.047 . . . . 0.0 109.975 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.09 34.26 6.87 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.774 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -69.88 -169.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.81 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.524 ' O ' ' C ' ' A' ' 44' ' ' ASP . 58.8 m -125.93 90.11 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.913 0.864 . . . . 0.0 109.198 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.74 87.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.409 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 148.61 -23.95 1.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.483 ' NE2' ' HB3' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -90.33 -12.39 37.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.058 -1.26 . . . . 0.0 110.01 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.825 ' OE1' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -43.37 -39.76 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.933 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.59 40.94 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -148.08 60.34 5.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 5.0 Cg_exo -59.0 -41.93 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.358 2.039 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HA ' HG22 ' A' ' 72' ' ' THR . 16.8 pt-20 -57.01 -16.5 7.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.7 mt-10 -120.07 -5.75 10.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.895 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.774 HG23 ' CE2' ' A' ' 42' ' ' PHE . 3.2 mt -79.6 -34.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 109.161 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 -71.6 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -141.5 124.93 16.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -1.046 . . . . 0.0 109.407 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -113.82 156.44 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.816 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.534 ' ND2' ' OD1' ' A' ' 68' ' ' ASP . 3.1 t-20 -113.05 106.92 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.604 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.52 -158.65 9.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.588 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 38.8 t80 -124.8 108.72 12.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.674 -0.897 . . . . 0.0 109.863 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.803 ' ND2' HD12 ' A' ' 22' ' ' ILE . 1.4 m-20 -79.4 90.83 5.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.302 -0.874 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.06 -37.93 67.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 96.5 m -57.51 -45.77 84.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.326 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.4 p -93.81 4.89 53.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.68 48.75 8.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -140.2 166.35 24.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.621 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.4 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 30.9 ttp180 -134.11 140.87 46.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 165.6 -163.24 36.51 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.232 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 43.6 m-20 -94.19 170.74 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.976 . . . . 0.0 109.784 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.652 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 9.9 p90 -172.77 158.59 3.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.354 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.83 121.39 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.15 1.9 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.782 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -72.08 -34.37 61.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 51' ' ' GLU . 17.0 p -66.3 -8.97 28.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.304 . . . . 0.0 109.048 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.624 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.54 9.56 39.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 30' ' ' LEU . 4.5 m -128.06 -174.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.772 ' CD ' HD21 ' A' ' 11' ' ' LEU . 15.9 pt-20 -160.21 92.74 1.01 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.604 -0.685 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 75' ' ' GLU . 5.1 t80 -33.19 115.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.569 0.7 . . . . 0.0 110.547 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 77' ' ' ILE . 10.4 mm -144.11 16.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -129.35 115.22 1.89 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.251 -1.147 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 26.3 m-85 -80.91 123.74 28.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -115.56 115.65 26.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.7 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -104.96 175.56 5.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.062 -1.024 . . . . 0.0 109.093 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -112.53 174.35 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 108.849 179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.37 152.42 21.01 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.2 mt -137.79 -38.56 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.577 ' HB2' ' CG ' ' A' ' 73' ' ' TYR . 4.5 m-85 -122.82 176.02 6.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.383 -0.823 . . . . 0.0 109.78 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -100.63 171.86 7.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 3.1 t80 -161.96 146.75 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.6 ttpt -107.99 17.95 21.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 21' ' ' ASP . 16.1 ttmt 59.5 71.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.806 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.5 tp10 -72.4 -73.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.7 mtp85 -53.8 144.23 18.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.35 -7.66 10.43 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -103.68 -22.76 13.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.006 -1.059 . . . . 0.0 110.441 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 16' ' ' LYS . 48.1 p30 -73.77 -179.82 3.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 0.0 109.82 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.622 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.3 pp -138.11 159.4 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.2 m-20 -60.24 145.0 48.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.786 HD11 ' CB ' ' A' ' 69' ' ' PHE . 10.2 mt -135.4 157.75 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.868 . . . . 0.0 109.37 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.838 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -160.01 128.87 5.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 109.151 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -47.94 124.77 7.92 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 109.737 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.33 -18.79 11.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.642 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -90.3 160.58 16.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.86 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 mt -115.96 157.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.92 HD23 ' CE2' ' A' ' 69' ' ' PHE . 3.2 mp -130.77 121.41 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.279 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 102.62 14.93 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.779 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.7 HG11 ' OH ' ' A' ' 8' ' ' TYR . 75.6 t -102.32 117.91 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -50.59 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 12.7 mtpt -90.29 -73.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -54.58 -24.21 30.96 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -58.82 -40.74 85.05 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.081 -1.246 . . . . 0.0 109.883 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.8 tp -90.09 -29.52 18.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 38' ' ' VAL . 58.3 t -90.15 3.16 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.908 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -66.53 -7.67 21.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.37 15.63 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.096 -1.003 . . . . 0.0 109.773 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.4 41.61 25.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.96 ' CE2' HG23 ' A' ' 53' ' ' ILE . 5.1 m-85 -64.77 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -139.27 156.21 47.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.34 120.75 10.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.61 -31.77 6.42 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.3 mp0 -76.48 -40.08 51.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -1.169 . . . . 0.0 109.462 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.79 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.86 -27.05 66.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -84.71 -19.7 32.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -113.55 77.87 3.44 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.329 179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.654 ' HG2' HG23 ' A' ' 74' ' ' VAL . 4.2 Cg_exo -57.73 -32.71 95.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.096 1.864 . . . . 0.0 110.238 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.7 tt0 -60.39 -32.43 71.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.018 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.37 -6.64 43.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.96 HG23 ' CE2' ' A' ' 42' ' ' PHE . 16.2 mt -79.71 -54.34 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.71 -69.69 0.52 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.421 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 23.9 m95 -144.18 141.27 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.55 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -138.68 139.83 38.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' VAL . 10.6 t30 -90.25 99.21 12.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -112.38 166.29 12.17 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.346 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -101.95 106.58 17.53 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.764 -0.845 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 2.6 m-80 -78.48 78.45 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -49.27 -36.56 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.814 . . . . 0.0 109.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.642 HG21 ' CG ' ' A' ' 28' ' ' ASP . 20.4 m -51.51 -61.08 2.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.379 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.838 HG21 ' CE1' ' A' ' 25' ' ' HIS . 1.9 p -91.69 13.18 18.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.53 54.35 4.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 18.4 pt-20 -139.23 121.81 16.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.646 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.64 128.43 43.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -174.39 -179.53 45.06 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -88.94 165.02 14.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 109.59 180.0 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.92 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.8 p90 -165.67 162.84 13.05 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.644 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 2.2 Cg_endo -63.71 120.55 7.98 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.86 1.707 . . . . 0.0 109.254 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.706 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -64.35 -19.18 64.03 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.514 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -72.57 -20.03 61.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.902 -1.352 . . . . 0.0 109.927 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.577 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 7.3 m-30 -92.92 7.36 44.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 0.0 110.584 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.654 HG23 ' HG2' ' A' ' 50' ' ' PRO . 13.3 m -118.4 -172.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.946 -1.097 . . . . 0.0 109.621 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HB3' HD11 ' A' ' 11' ' ' LEU . 10.5 pt-20 -155.74 86.16 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.4 t80 -40.37 136.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 9' ' ' ARG . 5.1 mt -119.78 -4.28 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 109.859 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 130.48 -162.48 23.27 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HD2' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.603 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 56.4 m-85 -80.43 110.36 15.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.584 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.2 mt-30 -87.48 124.42 33.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HD2' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -104.58 -177.11 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.01 -1.057 . . . . 0.0 110.131 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 3.8 ttm180 -126.32 130.96 51.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -65.48 123.5 19.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.778 -1.201 . . . . 0.0 110.056 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.625 HD21 ' CD ' ' A' ' 75' ' ' GLU . 10.5 mt -99.79 -42.41 6.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 7.2 m-85 -124.12 -158.68 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.503 -0.748 . . . . 0.0 109.566 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 6.2 p-10 -123.37 171.97 9.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.686 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 26.1 t80 -167.76 113.54 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.8 mmtp -80.21 132.81 35.94 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.062 -1.024 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 4.4 mtpm? -41.87 106.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.853 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -133.2 -33.96 1.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -75.55 145.6 41.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.85 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.477 ' HG3' ' OE1' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -41.96 -33.63 0.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.697 -0.627 . . . . 0.0 110.743 -179.98 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.477 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -137.35 58.06 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.924 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 3.4 p-10 -119.2 173.48 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.916 -1.115 . . . . 0.0 108.92 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.684 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -126.0 179.05 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 109.95 179.982 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.577 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 1.2 m-20 -85.91 108.82 18.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.3 mm? -95.07 144.13 25.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.659 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -155.18 128.4 8.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.11 -0.994 . . . . 0.0 109.66 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 3.2 tt -52.14 137.93 26.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.741 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -18.52 39.46 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.925 ' OD1' HG21 ' A' ' 62' ' ' THR . 16.7 m-20 -90.21 172.35 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -1.191 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 19.2 mm -117.83 144.72 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.722 HD22 ' ND2' ' A' ' 60' ' ' ASN . 10.3 mt -108.53 146.79 32.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 87.19 2.49 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.757 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.023 HG11 HD23 ' A' ' 37' ' ' LEU . 29.5 t -97.51 116.25 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -57.19 122.36 12.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.44 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.527 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 144.18 -56.95 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -48.21 -51.28 26.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.141 . . . . 0.0 110.122 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.023 HD23 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -81.39 -15.76 54.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.115 -0.99 . . . . 0.0 109.195 -179.92 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.094 HG23 ' OE1' ' A' ' 47' ' ' GLU . 1.4 t -77.84 -10.79 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.773 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.55 -9.15 23.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.0 109.336 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.74 HD12 ' CE2' ' A' ' 42' ' ' PHE . 14.6 mt -67.92 -27.63 66.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.03 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.17 3.03 6.94 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 40' ' ' LEU . 19.8 m-85 -58.82 178.08 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -1.145 . . . . 0.0 109.631 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -119.53 135.74 54.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 108.75 179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 43' ' ' SER . 10.5 t70 -31.88 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.317 0.579 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 129.49 -3.64 6.2 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 53' ' ' ILE . 4.6 mt-30 -91.14 -25.02 19.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.102 -1.234 . . . . 0.0 109.632 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 1.094 ' OE1' HG23 ' A' ' 38' ' ' VAL . 1.1 tt0 -59.05 -47.97 83.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -56.19 -15.8 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.11 80.45 5.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 109.587 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.608 ' CG ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -65.04 -47.12 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.166 1.911 . . . . 0.0 110.451 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' PRO . 7.6 pt-20 -43.17 -42.15 4.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.25 51.71 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.602 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 1.3 mt -138.89 -41.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.72 -77.18 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.427 ' CZ2' ' HD2' ' A' ' 18' ' ' ARG . 34.4 m95 -137.91 147.13 44.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -1.037 . . . . 0.0 109.121 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -138.76 137.22 36.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.147 -0.971 . . . . 0.0 110.125 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.607 ' ND2' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -88.33 95.69 10.29 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.662 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -115.33 173.74 14.92 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.355 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -115.7 107.81 15.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.648 -0.913 . . . . 0.0 109.76 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.722 ' ND2' HD22 ' A' ' 30' ' ' LEU . 4.1 m-80 -77.97 96.7 5.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 108.873 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' OE1' ' HB ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -54.17 -39.5 66.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.001 -179.918 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.925 HG21 ' OD1' ' A' ' 28' ' ' ASP . 17.9 m -49.08 -64.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.659 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.9 p -85.41 6.95 24.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.554 -0.716 . . . . 0.0 109.66 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.86 54.16 5.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 63' ' ' THR . 56.4 mm-40 -131.88 142.25 49.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -1.098 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -113.47 135.43 53.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.493 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.684 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 174.07 -167.91 40.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.607 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -102.13 163.96 11.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.699 ' HE1' HD13 ' A' ' 56' ' ' LEU . 2.1 p90 -163.13 162.23 18.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 Cg_endo -62.14 123.89 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.867 1.712 . . . . 0.0 109.827 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.777 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -67.61 -32.92 79.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 72' ' ' THR . 1.7 p -66.97 -9.41 38.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.035 -1.274 . . . . 0.0 109.415 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.9 m-85 -95.8 -13.14 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.608 HG23 ' CG ' ' A' ' 50' ' ' PRO . 32.7 m -107.69 175.03 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.625 ' CD ' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -149.88 90.66 1.71 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.189 -0.944 . . . . 0.0 108.715 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.557 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 76.3 t80 -38.63 123.91 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.847 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 77' ' ' ILE . 9.7 mm -111.38 -2.6 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 132.87 -164.43 24.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.108 . . . . 0.0 109.503 179.996 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 66.8 m-85 -79.37 134.13 36.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.142 . . . . 0.0 108.459 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 3.3 mt-30 -143.65 117.84 9.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.054 -1.029 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.875 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.78 178.66 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.359 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.38 155.44 24.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -91.65 121.07 32.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.882 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -104.88 -24.62 12.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.015 . . . . 0.0 108.619 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.556 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -119.57 176.62 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 163.02 14.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.172 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -166.41 114.62 0.89 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.085 -1.009 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -79.46 107.41 12.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.931 . . . . 0.0 108.587 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -41.44 115.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.845 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -69.65 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.457 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.17 146.84 23.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.878 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.0 mt-10 -43.53 -24.79 0.12 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.131 -0.981 . . . . 0.0 110.038 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -60.7 -58.07 10.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.113 -0.992 . . . . 0.0 109.971 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 2.0 p30 -72.04 162.7 29.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.945 . . . . 0.0 109.87 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -122.16 162.06 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.377 -0.827 . . . . 0.0 109.378 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CD ' ' A' ' 16' ' ' LYS . 1.7 m-20 -79.22 103.69 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.901 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -102.28 153.46 19.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.625 ' HE1' HG21 ' A' ' 63' ' ' THR . 1.0 OUTLIER -150.79 141.21 22.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.048 . . . . 0.0 109.878 -179.955 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tp -42.56 143.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 82.04 0.61 89.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.1 m-20 -90.42 159.13 16.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 109.746 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 28.2 mm -113.34 128.74 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 0.0 109.175 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.9 mp -109.76 105.93 15.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.915 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.95 91.33 8.03 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.547 -0.72 . . . . 0.0 110.328 -179.931 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.875 HG21 ' OH ' ' A' ' 8' ' ' TYR . 29.0 t -86.76 96.85 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 33' ' ' ASN . 6.1 p30 -51.45 152.82 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 110.385 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 34' ' ' LYS . 6.0 pttp -69.19 113.6 6.7 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.56 -54.66 0.76 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 48.4 t -56.78 -26.34 57.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.175 -1.191 . . . . 0.0 108.93 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.919 HD11 HD13 ' A' ' 53' ' ' ILE . 15.4 tp -90.55 -33.57 15.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 38' ' ' VAL . 84.7 t -90.31 2.78 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.099 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.82 -11.81 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -107.94 34.99 3.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.708 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.1 52.4 40.26 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.897 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -71.95 -167.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.09 143.38 50.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.13 87.89 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.34 -43.08 0.57 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' GLU . 23.2 mm-40 -73.01 -30.22 63.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.242 -1.152 . . . . 0.0 109.409 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 37' ' ' LEU . 1.5 pt-20 -42.51 -41.99 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -85.39 44.53 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.518 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -159.85 62.72 1.96 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.6 Cg_exo -57.75 -13.61 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.341 2.027 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -70.77 -31.15 67.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.997 -1.065 . . . . 0.0 109.298 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 tp10 -110.71 1.72 18.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.9 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.919 HD13 HD11 ' A' ' 37' ' ' LEU . 6.6 mt -79.45 -31.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.108 -0.995 . . . . 0.0 109.082 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 -78.18 0.29 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.465 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 11.2 m95 -140.68 154.23 46.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -1.11 . . . . 0.0 109.033 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.809 HD23 HD13 ' A' ' 37' ' ' LEU . 1.5 mp -143.07 158.91 43.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.989 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 32' ' ' VAL . 1.6 t30 -117.79 117.68 29.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -138.93 -167.73 11.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 58.7 t80 -115.59 114.12 24.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -1.051 . . . . 0.0 109.96 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 17.6 m-20 -79.31 79.88 5.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 108.64 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.19 -39.38 13.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.52 -0.738 . . . . 0.0 109.833 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 18.7 m -48.51 -53.32 18.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.922 . . . . 0.0 109.658 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.625 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.5 p -108.15 17.02 22.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 41.33 54.61 3.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.47 111.9 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -1.214 . . . . 0.0 109.935 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -90.74 129.44 36.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 109.194 179.938 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' CA ' ' CG1' ' A' ' 22' ' ' ILE . . . -178.86 -165.5 33.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -95.35 168.24 10.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.376 -1.073 . . . . 0.0 109.742 179.984 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -168.51 158.57 8.41 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -60.05 125.4 17.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.253 1.969 . . . . 0.0 110.196 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.801 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -39.9 76.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 12.0 p -64.78 -11.02 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.249 . . . . 0.0 109.636 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.8 m-85 -95.49 15.54 19.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 109.83 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.882 ' O ' HD11 ' A' ' 11' ' ' LEU . 18.9 m -134.71 -169.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.83 . . . . 0.0 110.044 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.766 ' CD ' HD22 ' A' ' 11' ' ' LEU . 11.9 pt-20 -158.26 89.03 0.97 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 56.6 t80 -36.87 136.24 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.653 . . . . 0.0 110.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 75' ' ' GLU . 29.7 mm -126.32 -8.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 113.21 -109.0 2.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.43 ' O ' ' NE2' ' A' ' 7' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.247 -1.149 . . . . 0.0 109.61 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 4.0 m-85 -79.83 118.82 21.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -1.142 . . . . 0.0 109.098 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 3.7 mp0 -102.11 118.09 36.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 109.899 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.865 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -99.62 173.01 6.92 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 0.0 108.983 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -117.9 116.53 27.13 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.801 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 25' ' ' HIS . . . -47.54 109.93 0.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 110.299 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.9 mt -90.93 -38.39 12.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.7 m-85 -126.46 -161.02 1.03 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.592 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -123.68 -175.28 3.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 109.732 179.911 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 27.5 t80 167.81 123.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 108.943 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 15.3 mmtp -79.47 156.27 27.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.988 -1.07 . . . . 0.0 109.914 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 25.0 mtpt -70.06 88.77 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -71.82 -72.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.926 . . . . 0.0 109.291 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -69.81 156.52 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -77.56 70.4 3.94 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.947 0.88 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.79 -26.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 4.0 p30 -71.54 170.36 13.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -121.02 167.64 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.543 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.727 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 3.2 m-20 -73.56 111.38 8.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 2.9 mm? -97.96 144.49 27.45 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 0.0 109.086 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.727 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -159.99 138.18 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.035 -179.966 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -57.51 133.57 55.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.189 -0.945 . . . . 0.0 109.498 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.8 -25.99 24.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.581 ' OD2' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -74.54 171.56 13.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.634 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.97 ' C ' HD12 ' A' ' 30' ' ' LEU . 18.9 mm -123.53 155.15 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.2 mp -127.15 123.53 36.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.146 -0.971 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -101.69 92.71 4.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.412 179.975 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.865 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 77.9 t -90.82 118.5 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 108.979 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 9.1 m-80 -48.01 176.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 109.284 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -83.0 -72.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.016 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -61.61 -23.05 62.42 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.516 ' CB ' ' HB2' ' A' ' 33' ' ' ASN . 16.6 t -59.07 -29.05 67.04 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.135 -1.215 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 1.1 tt -90.74 -47.76 7.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.644 ' O ' HG12 ' A' ' 38' ' ' VAL . 95.7 t -80.0 4.42 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.93 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -64.28 -9.06 15.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.949 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.3 mt -104.62 -11.69 16.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 0.0 110.006 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 105.95 29.21 5.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.847 ' CE2' HG23 ' A' ' 53' ' ' ILE . 10.5 m-85 -50.97 -175.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.521 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.68 157.5 44.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 109.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -56.95 123.31 14.7 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.72 -36.28 4.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.783 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.6 mt-30 -81.25 -32.45 33.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.304 -1.115 . . . . 0.0 109.376 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.8 pt-20 -64.26 -15.78 60.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.883 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -106.5 -13.95 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.737 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.6 mmt180 -113.87 80.09 5.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.2 Cg_endo -61.05 -31.74 91.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.215 1.943 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 9.1 pt-20 -60.07 -25.86 65.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 6.7 tt0 -104.81 -5.46 21.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.847 HG23 ' CE2' ' A' ' 42' ' ' PHE . 9.5 mt -79.44 -28.97 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.182 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 99.86 -77.05 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 70' ' ' PRO . 25.7 m95 -144.18 143.37 31.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 109.412 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.874 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -129.64 158.32 39.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.26 112.1 23.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -134.49 -171.48 12.53 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.48 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -120.6 109.64 15.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.975 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 8.4 m-20 -79.31 97.97 6.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.907 -1.121 . . . . 0.0 108.89 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.41 -36.19 81.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.817 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' OD2' ' A' ' 28' ' ' ASP . 37.9 m -50.05 -21.8 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' ASN . 12.0 t -127.76 -3.3 5.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.523 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.44 46.42 93.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -136.63 161.01 37.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.498 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 4.9 ttm180 -132.52 153.79 50.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.421 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 162.68 -171.2 38.45 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.663 -1.256 . . . . 0.0 109.962 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' ASP . 4.8 p30 -91.14 169.55 10.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.992 . . . . 0.0 109.655 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.679 ' HE2' HG11 ' A' ' 74' ' ' VAL . 10.4 p90 -174.33 143.86 0.91 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.164 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 2.9 Cg_exo -55.45 118.19 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.801 1.668 . . . . 0.0 109.914 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.874 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -63.24 -23.84 66.71 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 p -58.57 -19.54 39.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.891 -1.358 . . . . 0.0 109.881 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 17.9 m-85 -102.57 29.11 5.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' HE2' ' A' ' 69' ' ' PHE . 3.0 m -141.32 168.05 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.567 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 5.9 pt-20 -138.87 88.7 2.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 109.985 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.578 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 57.5 t80 -38.53 124.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 109.772 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -122.67 5.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 82.56 -100.84 2.2 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.442 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.61 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 5.2 m-30 -78.41 105.18 9.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.691 -0.888 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 1.6 mt-30 -106.01 114.52 28.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.763 ' OH ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -104.65 175.95 5.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 108.662 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.687 ' HB2' HD11 ' A' ' 77' ' ' ILE . 8.2 ttm180 -113.71 150.36 33.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.803 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -73.72 111.91 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 8.6 mt -89.1 -31.72 17.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.905 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 9.4 m-85 -132.61 -163.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.844 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 73' ' ' TYR . 12.2 p-10 -123.76 172.74 8.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 109.762 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 24.8 t80 -164.57 118.37 1.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' GLU . 29.6 tttp -80.11 136.38 36.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.882 -1.136 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 8.2 ttmt -42.94 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.499 -0.751 . . . . 0.0 109.734 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -95.55 -64.96 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -81.51 145.8 30.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.918 . . . . 0.0 109.517 -179.984 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.83 -13.6 6.65 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 11.2 pm0 -110.54 33.68 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.016 -1.052 . . . . 0.0 110.199 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -125.45 177.59 6.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.265 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 ' HA3' ' A' ' 67' ' ' GLY . 2.9 pt -136.08 157.63 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -70.23 113.81 7.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.811 . . . . 0.0 109.6 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 2.4 mm? -101.32 154.09 19.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.042 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.594 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -159.96 133.18 6.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 109.423 179.997 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -52.0 141.4 18.09 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.597 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 97.35 -17.55 58.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.948 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.73 174.54 10.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.7 mp -125.45 137.14 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 8.0 mp -109.28 119.43 39.48 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.22 -0.925 . . . . 0.0 109.138 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -97.76 100.19 11.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 43.2 t -116.43 109.63 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.551 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 m120 -45.64 171.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.49 -0.756 . . . . 0.0 109.78 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -71.88 -70.7 0.31 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.744 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.91 98.42 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 33' ' ' ASN . 46.3 m -44.58 -25.14 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -1.142 . . . . 0.0 109.863 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.815 HD23 ' O ' ' A' ' 37' ' ' LEU . 4.0 tt -90.28 -40.97 11.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 38' ' ' VAL . 62.6 t -74.66 0.0 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 0.0 109.887 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.29 -12.37 13.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 109.763 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.1 mt -91.58 17.43 8.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.983 . . . . 0.0 109.761 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 72.92 17.91 78.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.891 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -54.62 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.037 -1.272 . . . . 0.0 109.511 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -121.08 149.95 41.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.212 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -50.94 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.568 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 136.65 -46.04 1.04 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.23 -16.22 52.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.26 -38.15 88.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.566 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -91.11 26.6 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 109.673 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.6 mtp180 -128.67 64.84 70.5 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.309 -0.869 . . . . 0.0 108.875 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 6.3 Cg_exo -57.09 -38.68 95.08 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.267 1.978 . . . . 0.0 110.381 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.6 -27.09 68.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.503 ' N ' ' HG2' ' A' ' 51' ' ' GLU . 2.1 mt-10 -104.87 -2.81 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.891 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -82.28 -84.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.042 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.789 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 151.15 -61.32 0.41 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.462 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . 28.8 m95 -148.53 134.24 18.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -1.055 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.733 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -133.57 164.0 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 31.4 t-20 -115.72 115.64 26.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.06 -169.0 12.08 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 36.3 t80 -122.66 105.95 10.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.617 -0.931 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' HD12 ' A' ' 22' ' ' ILE . 4.5 m-80 -79.9 88.26 5.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.254 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.84 -36.77 67.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.86 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.67 HG21 ' OD1' ' A' ' 28' ' ' ASP . 6.2 m -52.33 -37.15 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.146 -0.971 . . . . 0.0 109.347 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.594 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -116.85 9.98 14.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.51 52.73 6.22 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.95 119.72 21.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -1.178 . . . . 0.0 109.724 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 2.8 ttt85 -101.63 134.51 44.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.16 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.65 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 170.44 -165.2 38.48 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.255 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -90.36 173.69 7.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.412 -1.052 . . . . 0.0 109.71 -179.936 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 18.1 p90 -177.58 159.57 1.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.858 . . . . 0.0 109.22 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -61.53 126.03 18.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.075 1.85 . . . . 0.0 110.015 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.61 -40.37 77.57 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 25.6 p -58.21 -14.0 6.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.029 -1.277 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.4 m-85 -93.15 23.21 4.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 110.155 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.9 m -142.59 -173.49 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.153 -0.967 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.6 pt-20 -156.42 87.32 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 109.577 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t80 -37.33 135.2 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.635 -0.666 . . . . 0.0 110.494 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.7 mp -131.56 -2.89 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 87.34 -139.77 16.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -1.189 . . . . 0.0 109.286 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' O ' ' CG ' ' A' ' 34' ' ' LYS . 1.5 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . -104.81 -159.15 23.62 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 16.9 m-85 -137.71 145.98 43.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -1.157 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.627 HE21 HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -137.79 121.17 17.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.91 172.79 7.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.306 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 21.3 mtt180 -117.57 139.46 50.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . . . -83.17 105.28 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.737 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -71.73 -36.42 70.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.064 -1.023 . . . . 0.0 108.977 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 34.3 m-85 -106.07 -177.78 3.46 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -113.71 141.02 47.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.834 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.56 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 55.5 t80 -132.17 158.4 41.79 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -111.19 -63.66 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.773 -1.204 . . . . 0.0 110.13 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 15' ' ' LYS . 14.3 tttm 153.68 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 2.2 tt0 -93.57 -54.18 3.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.024 -1.047 . . . . 0.0 109.192 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -69.75 159.32 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.214 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.38 25.85 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.214 -0.929 . . . . 0.0 111.402 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 20' ' ' GLU . 3.6 mm-40 -149.05 13.98 0.89 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.669 -1.27 . . . . 0.0 109.539 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -91.17 161.74 14.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.675 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -117.56 143.8 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 7.9 m-20 -49.15 109.68 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.336 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -103.69 154.71 19.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -154.25 142.34 20.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.96 -1.088 . . . . 0.0 109.634 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.6 tt -47.32 135.08 10.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.71 5.9 73.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 0.4 OUTLIER -90.24 136.01 33.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 109.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.935 ' C ' HD12 ' A' ' 30' ' ' LEU . 7.3 mm -94.85 140.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.071 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.935 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -125.76 111.26 14.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.055 -1.028 . . . . 0.0 109.8 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 HE21 ' A' ' 7' ' ' GLN . 0.2 OUTLIER -85.52 93.34 8.76 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' CA ' ' A' ' 58' ' ' GLY . 89.5 t -99.89 115.92 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.083 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.8 167.21 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.99 . . . . 0.0 109.012 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' C ' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -90.03 0.6 57.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.5 -56.47 1.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.98 -31.85 1.44 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -1.105 . . . . 0.0 109.978 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.932 HD11 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.86 -39.98 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.079 -1.013 . . . . 0.0 109.98 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 38' ' ' VAL . 56.8 t -76.39 1.62 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.37 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -97.6 -25.71 15.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' PHE . . . 120.93 22.13 3.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.061 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.7 m-85 -44.49 147.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.251 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.56 165.37 23.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -67.0 118.79 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.12 53.1 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.21 -32.23 73.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.816 ' HG3' HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -67.91 -21.2 65.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -74.71 -9.57 58.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.34 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -119.14 75.8 15.32 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 108.897 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 53' ' ' ILE . 6.1 Cg_exo -56.67 -48.79 17.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.497 2.131 . . . . 0.0 110.73 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.88 -25.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.5 tt0 -114.12 50.48 0.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.061 HG23 ' CE2' ' A' ' 42' ' ' PHE . 7.5 mt -134.91 -45.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.56 -77.6 0.28 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.458 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 17.4 m95 -139.64 143.97 37.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.433 -1.039 . . . . 0.0 109.336 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.932 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -131.96 147.88 52.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.914 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 32' ' ' VAL . 17.8 t-20 -114.18 109.39 18.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.574 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.13 -158.1 8.87 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.601 -1.285 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 72.9 t80 -120.26 116.91 26.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.42 -1.047 . . . . 0.0 109.801 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.794 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.2 m-20 -79.45 76.67 6.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -48.28 -34.87 11.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.787 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 31.7 m -49.11 -48.48 44.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.794 HG22 ' HB3' ' A' ' 60' ' ' ASN . 9.4 t -101.7 2.92 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.689 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.83 45.83 95.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.577 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 17.8 mm-40 -138.62 -174.75 3.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.172 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 150.05 29.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.083 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 171.12 -164.77 37.86 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -100.44 166.31 11.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.984 . . . . 0.0 109.565 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 5.5 p90 -169.07 156.36 6.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.71 126.56 20.1 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.108 1.872 . . . . 0.0 109.806 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.822 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.74 -22.11 78.6 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.534 ' HG1' ' HD1' ' A' ' 73' ' ' TYR . 1.2 p -73.07 -4.93 35.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.242 . . . . 0.0 109.47 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.7 m-85 -101.93 -5.43 24.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.766 ' O ' HD11 ' A' ' 11' ' ' LEU . 1.7 m -116.48 -171.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.064 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD21 ' A' ' 11' ' ' LEU . 11.0 pt-20 -157.51 92.82 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.63 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 55.4 t80 -48.04 139.43 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 109.668 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -132.99 -0.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.982 . . . . 0.0 109.638 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.624 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 140.1 169.65 11.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 101.65 -152.97 18.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 27.0 m-85 -78.92 139.15 38.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.986 . . . . 0.0 109.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HG2' HG23 ' A' ' 31' ' ' THR . 64.6 mt-30 -129.54 126.09 37.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.104 -0.997 . . . . 0.0 109.845 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.87 177.32 5.54 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.531 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -117.78 138.11 52.28 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -70.44 103.5 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.0 110.675 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -68.5 -32.24 72.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 108.586 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 5.9 m-85 -129.75 -169.02 2.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.64 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -117.95 171.19 8.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 109.933 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.736 ' HD2' HD21 ' A' ' 24' ' ' LEU . 54.8 t80 -173.42 118.17 0.29 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 3.6 tttm -79.64 117.53 20.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 18.0 pttt -42.7 109.26 0.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.676 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -67.13 -66.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.252 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' OD2' ' A' ' 21' ' ' ASP . 15.9 mtm180 -90.29 174.34 7.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 2.09 12.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.69 -6.45 29.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 109.891 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -105.11 166.31 10.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.158 -0.964 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.804 HD12 HD22 ' A' ' 60' ' ' ASN . 1.1 pt -114.94 163.15 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.453 ' OD1' ' HD3' ' A' ' 16' ' ' LYS . 2.0 m-20 -87.43 105.67 17.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.736 HD21 ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -102.75 154.6 19.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.1 m-70 -152.49 154.6 35.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 26.5 tp -46.6 135.32 8.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.94 9.62 86.05 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 16.2 t0 -91.17 110.98 22.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -1.127 . . . . 0.0 109.966 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.936 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -79.68 141.85 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.936 -1.102 . . . . 0.0 109.79 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.936 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.9 mp -123.38 140.03 53.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -109.86 86.19 2.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 109.285 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.606 HG22 ' CA ' ' A' ' 58' ' ' GLY . 53.9 t -90.58 108.68 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 30.2 m120 -50.49 161.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 109.722 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 53.84 2.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.89 -59.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 m -61.73 -20.37 63.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.341 -1.093 . . . . 0.0 109.255 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 47' ' ' GLU . 8.2 tp -90.35 -24.14 20.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.715 HG23 ' OE2' ' A' ' 47' ' ' GLU . 5.0 t -90.81 -4.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.065 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.02 -4.14 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.989 HD12 ' CE2' ' A' ' 42' ' ' PHE . 7.4 mt -80.82 -30.17 35.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.49 7.35 5.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.989 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.1 m-85 -59.94 -172.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 109.751 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.62 -171.41 1.92 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 108.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.96 84.48 6.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.724 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.76 2.17 3.98 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.169 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.522 ' CB ' ' HB3' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -80.86 -14.94 57.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.962 -1.316 . . . . 0.0 109.851 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.715 ' OE2' HG23 ' A' ' 38' ' ' VAL . 26.5 mt-10 -62.58 -40.17 96.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -61.67 -9.57 6.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.208 -0.932 . . . . 0.0 110.367 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mmm180 -113.59 80.59 4.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.872 -1.142 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.593 ' CG ' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.63 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.325 2.017 . . . . 0.0 110.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.4 tt0 -41.06 -29.8 0.12 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.253 -0.905 . . . . 0.0 109.071 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -98.64 47.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.835 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.0 mt -146.89 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -63.0 0.28 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 33.7 m95 -146.91 148.9 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -1.11 . . . . 0.0 109.289 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.728 HD11 ' HA3' ' A' ' 71' ' ' GLY . 2.6 mp -137.42 152.3 49.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.696 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 15.3 t30 -110.54 107.51 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.606 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.28 -160.04 9.07 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 49.2 t80 -116.54 117.55 30.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.526 -0.985 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.804 HD22 HD12 ' A' ' 22' ' ' ILE . 2.5 t-20 -79.4 76.38 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.531 -0.731 . . . . 0.0 109.234 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.94 -37.32 71.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.799 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 19.4 m -60.3 -33.45 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.019 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -121.76 18.26 11.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 40.19 54.16 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.28 113.1 8.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -1.227 . . . . 0.0 109.486 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 9.1 ttp-105 -91.24 140.47 29.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.623 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 166.09 -165.19 38.01 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -93.57 166.22 12.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.484 -1.009 . . . . 0.0 109.779 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -168.1 153.91 6.91 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -58.11 116.58 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.195 1.93 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.6 -28.26 73.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -63.63 -28.0 69.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.576 -1.543 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 19.4 m-30 -85.41 24.91 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.02 -1.05 . . . . 0.0 110.419 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.5 m -140.36 172.93 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.135 -0.978 . . . . 0.0 109.347 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD11 ' A' ' 11' ' ' LEU . 13.0 pt-20 -148.95 89.65 1.69 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.835 . . . . 0.0 109.177 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 75.6 t80 -41.56 133.13 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.718 . . . . 0.0 109.133 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 77' ' ' ILE . 17.5 mm -123.37 -2.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 140.65 -174.01 22.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.355 -1.085 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 167.85 136.72 2.09 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 34.7 m-85 -79.88 115.17 19.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -1.086 . . . . 0.0 109.353 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.679 ' CG ' HG23 ' A' ' 31' ' ' THR . 3.2 mt-30 -98.67 128.12 44.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.18 176.06 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.034 -1.041 . . . . 0.0 109.692 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' C ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.0 117.6 29.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -61.94 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.559 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -46.12 -50.45 15.41 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.057 -1.027 . . . . 0.0 109.782 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.722 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -111.24 170.68 7.95 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.574 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.36 -170.41 3.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.387 -0.821 . . . . 0.0 109.879 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 7.2 t80 179.75 115.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.236 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' GLU . 8.2 pttp -79.46 109.42 13.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.144 -0.972 . . . . 0.0 109.036 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -39.69 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.255 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' LYS . 48.0 mt-10 -63.33 -59.92 4.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 63.1 mtp85 -90.1 155.2 19.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.346 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.98 -9.15 19.32 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -84.02 -21.75 31.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 0.0 109.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' CA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -100.11 156.98 16.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.404 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.35 175.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.933 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 1.8 m-20 -75.66 151.48 37.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.002 HD11 HD21 ' A' ' 30' ' ' LEU . 1.1 tp -136.91 150.07 48.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.353 -0.842 . . . . 0.0 109.096 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.534 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 146.13 16.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.99 . . . . 0.0 109.672 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 43.5 tp -51.11 136.06 24.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.49 -0.756 . . . . 0.0 109.973 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.26 -2.48 78.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.655 ' C ' HD12 ' A' ' 29' ' ' ILE . 11.4 t0 -90.05 144.92 25.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -1.169 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.934 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 mp -108.65 146.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 24' ' ' LEU . 6.6 mp -124.89 112.43 16.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 0.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.679 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.51 91.91 7.97 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 109.376 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 8' ' ' TYR . 53.8 t -93.81 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.703 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -57.24 156.61 7.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -76.2 -16.54 59.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.633 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.65 -50.51 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 p -54.52 -30.28 53.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -1.113 . . . . 0.0 110.025 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.813 HD21 ' HA ' ' A' ' 47' ' ' GLU . 8.7 tp -90.31 -32.32 16.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 38' ' ' VAL . 77.2 t -90.21 2.96 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.941 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.53 -7.46 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.827 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.867 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -105.36 17.55 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.69 42.88 45.29 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.933 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -67.26 -168.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 109.441 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.29 136.38 52.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 122.9 6.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.501 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -62.46 -25.29 67.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -1.144 . . . . 0.0 109.409 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.813 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.4 mp0 -61.86 -32.76 73.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.967 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 76' ' ' TYR . . . -87.41 20.54 2.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.1 tpp180 -138.78 74.86 37.74 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 53' ' ' ILE . 6.2 Cg_exo -55.67 -48.77 18.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.443 2.095 . . . . 0.0 111.15 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 4.7 pm0 -44.11 -26.96 0.34 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.031 -1.043 . . . . 0.0 109.218 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.75 51.53 0.85 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.398 -0.814 . . . . 0.0 109.066 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 42' ' ' PHE . 24.2 mt -141.49 -39.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.47 -78.47 0.24 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.426 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 24.3 m95 -137.66 144.82 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -1.091 . . . . 0.0 109.192 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -134.77 154.3 51.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' C ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.92 108.16 18.33 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -130.66 -171.21 12.86 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 68.8 t80 -116.35 118.32 32.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.545 -0.973 . . . . 0.0 110.026 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 6.2 m-80 -84.53 64.82 8.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.105 -0.997 . . . . 0.0 109.009 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -43.67 -30.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.419 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.454 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 16.5 m -49.35 -54.47 17.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.234 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.93 10.96 39.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.445 -0.784 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.71 47.11 91.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.21 178.46 5.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -1.176 . . . . 0.0 109.582 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -159.66 138.52 10.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.93 -162.19 35.99 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-20 -94.92 167.49 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.499 -1.001 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -169.84 158.89 6.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -62.13 125.37 16.27 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.187 1.924 . . . . 0.0 110.086 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.868 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.34 -26.3 70.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -69.65 -7.44 39.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.951 -1.323 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.5 m-85 -99.32 -0.73 40.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.987 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.669 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -124.98 164.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 121.714 0.769 . . . . 0.0 110.422 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.829 ' HB3' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -139.79 109.74 6.42 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 83.2 t80 -37.56 113.39 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -105.11 9.77 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.519 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 104.33 -149.01 16.95 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . -71.98 -153.88 1.84 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 79.2 m-85 -160.1 124.79 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.476 -1.014 . . . . 0.0 108.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 31' ' ' THR . 1.1 mt-30 -129.51 122.29 28.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.016 -1.052 . . . . 0.0 110.196 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -116.92 -178.08 3.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.06 -1.025 . . . . 0.0 109.51 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.36 165.29 13.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.83 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -88.79 123.6 33.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 11.8 mt -104.3 -33.19 8.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 10.6 m-85 -128.18 -158.72 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.814 . . . . 0.0 109.902 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -126.66 172.65 10.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.736 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 75.3 t80 -171.49 113.79 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.297 -0.877 . . . . 0.0 108.809 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -79.29 156.39 28.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.983 -1.073 . . . . 0.0 110.052 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.7 tttt -55.08 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 109.663 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mt-10 -88.73 -62.91 1.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.216 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 6.6 ttm-85 -90.16 157.44 17.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.95 -4.4 16.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.174 -0.954 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 -9.86 15.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.079 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -85.33 171.45 11.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 109.528 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.492 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -130.62 158.19 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.795 ' O ' HD22 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -60.04 134.01 56.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 1.2 mm? -133.47 146.15 50.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.06 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.2 147.76 19.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 109.27 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 10' ' ' ALA . 50.4 tp -51.48 145.1 9.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.11 -10.63 67.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.711 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.98 147.68 26.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -1.176 . . . . 0.0 109.565 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.906 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.6 mp -107.38 146.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 6.3 mp -122.75 123.27 40.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.093 -1.004 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.513 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -98.64 92.05 5.42 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.622 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 8' ' ' TYR . 53.5 t -88.43 113.77 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.22 -165.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -0.925 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -70.98 0.62 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.23 -36.61 83.53 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -53.71 -30.35 43.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.028 -1.278 . . . . 0.0 110.064 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.821 HD23 ' O ' ' A' ' 37' ' ' LEU . 3.1 tt -90.73 -42.67 10.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.707 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.636 ' O ' HG12 ' A' ' 38' ' ' VAL . 99.2 t -79.27 1.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 110.029 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -63.04 -12.65 27.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.322 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.872 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -106.22 27.09 9.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.63 48.68 84.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.755 ' CE2' HD21 ' A' ' 37' ' ' LEU . 7.1 m-85 -67.21 -168.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.639 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.1 m -133.75 143.74 48.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.486 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -59.15 122.73 14.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.0 -33.3 6.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -78.36 -2.65 39.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -1.194 . . . . 0.0 109.712 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 1.3 pt-20 -69.52 -37.23 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -87.2 15.13 6.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -123.6 67.69 39.54 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 109.127 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.585 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.35 -51.01 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.219 1.946 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.4 tt0 -59.14 -33.36 70.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.012 . . . . 0.0 108.741 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HG2' ' A' ' 49' ' ' ARG . 7.2 tp10 -99.28 34.06 2.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 108.689 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.678 HG21 ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -119.32 -37.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.24 -76.8 0.24 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 74.9 m95 -142.74 139.71 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.092 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -129.74 153.32 48.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.767 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 4.0 t30 -108.7 112.21 24.4 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -132.97 -169.25 12.16 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -120.29 107.98 13.62 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.897 -0.767 . . . . 0.0 109.725 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' OD1' HD21 ' A' ' 24' ' ' LEU . 4.5 m120 -79.57 90.19 5.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -36.4 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.485 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 34.1 m -53.82 -36.92 63.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.478 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.3 p -111.44 5.61 19.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.74 45.67 24.55 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 63' ' ' THR . 33.1 mt-10 -129.38 155.6 45.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.694 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' C ' HG21 ' A' ' 22' ' ' ILE . 2.6 tpp180 -126.61 132.01 51.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 108.893 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 177.68 -158.48 23.71 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -104.59 166.03 10.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -1.028 . . . . 0.0 110.062 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.65 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.9 p90 -163.65 158.96 17.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.447 -0.783 . . . . 0.0 109.307 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.28 127.27 21.51 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.136 1.891 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.822 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -71.3 -36.42 63.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.552 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.4 p -65.2 -9.96 27.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -1.197 . . . . 0.0 109.265 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.605 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.6 m-85 -99.82 18.37 18.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.443 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 71' ' ' GLY . 34.8 m -134.08 -168.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.093 -1.004 . . . . 0.0 110.092 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 77' ' ' ILE . 10.3 pt-20 -154.84 87.15 1.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.537 -0.727 . . . . 0.0 109.818 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 81.8 t80 -45.73 139.64 3.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.174 -0.954 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.38 -4.99 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 109.127 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 116.29 -173.11 14.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.46 ' OXT' ' HA ' ' A' ' 6' ' ' TYR . 73.4 mtp180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 7' ' ' GLN . 1.3 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLN . . . 95.01 173.25 37.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 14.8 m-85 -79.81 102.57 9.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -1.124 . . . . 0.0 109.088 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -99.93 128.88 45.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.432 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.627 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -121.84 176.3 5.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.124 -0.985 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.2 mmm180 -118.35 122.53 43.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.706 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -70.97 93.02 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.793 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.944 HD21 ' CD ' ' A' ' 75' ' ' GLU . 64.2 mt -58.4 -49.4 77.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -104.12 176.77 5.05 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.432 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 43.1 p-10 -107.25 -173.86 2.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 14.0 t80 -162.31 140.22 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -91.89 132.91 36.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.983 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -55.8 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.718 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' LYS . 9.3 tp10 -95.43 -54.89 3.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.212 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.1 mmp_? -81.76 136.82 35.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.68 -19.3 0.89 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.109 -0.994 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 mm-40 -97.44 -33.34 11.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -66.36 157.97 30.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.67 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.667 HG21 ' O ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -120.32 169.85 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 109.375 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.727 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -78.99 112.41 16.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.842 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.706 HD12 ' CB ' ' A' ' 10' ' ' ALA . 3.1 mm? -88.5 166.29 14.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 108.426 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.727 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -157.99 135.15 10.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.853 -1.154 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 11' ' ' LEU . 12.1 tp -50.57 140.15 14.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.512 -0.743 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 5.8 t0 -87.93 146.43 25.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.18 -1.188 . . . . 0.0 109.084 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.698 ' C ' HD22 ' A' ' 30' ' ' LEU . 24.2 mm -91.59 142.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 29' ' ' ILE . 3.8 mm? -122.11 129.47 52.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -117.24 82.75 1.86 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.806 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 ' OH ' ' A' ' 8' ' ' TYR . 40.8 t -92.69 115.08 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.148 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 7.0 m-20 -56.21 -171.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.725 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 4.6 mtmp? -90.04 -52.15 5.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.267 -0.896 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 36' ' ' SER . . . -67.51 -46.94 65.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -42.3 -33.87 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -1.144 . . . . 0.0 109.833 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.784 HD23 ' O ' ' A' ' 37' ' ' LEU . 5.1 tt -90.33 -32.67 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.731 HG22 ' OE2' ' A' ' 47' ' ' GLU . 95.0 t -80.09 0.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -61.45 -12.96 16.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.856 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -105.99 27.71 8.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.44 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.19 48.93 83.69 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.866 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.0 m-85 -69.66 -168.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.3 p -126.4 158.51 35.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.323 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.07 119.15 12.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.4 -20.03 38.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.25 15.69 9.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' OE2' HG22 ' A' ' 38' ' ' VAL . 4.6 mm-40 -90.33 -35.44 15.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -89.88 28.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.477 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -128.41 65.08 70.0 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.5 Cg_exo -57.61 -46.64 25.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.424 2.083 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.8 -19.02 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.6 -3.47 10.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 0.0 110.028 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.866 HG23 ' CE2' ' A' ' 42' ' ' PHE . 14.1 mt -80.27 -50.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.079 -1.013 . . . . 0.0 109.128 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.72 -69.22 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.409 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 45.1 m95 -139.81 148.15 41.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -1.051 . . . . 0.0 109.509 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.901 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.9 t-20 -111.56 104.04 12.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 32' ' ' VAL . . . -138.75 -140.87 4.04 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 64' ' ' GLY . 72.2 t80 -131.2 125.78 33.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.981 . . . . 0.0 110.363 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.43 85.17 7.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -42.85 -48.44 5.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.795 . . . . 0.0 110.867 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.558 HG22 HG23 ' A' ' 63' ' ' THR . 4.0 m -41.26 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.0 110.234 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.558 HG23 HG22 ' A' ' 62' ' ' THR . 39.8 p -83.3 13.09 4.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.068 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 59' ' ' TYR . . . 45.76 45.34 13.21 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -119.75 117.16 27.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 0.0 109.234 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.667 ' O ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.63 156.33 18.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 156.93 -163.71 32.4 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.122 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.2 p-10 -104.71 154.1 20.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.811 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -155.88 159.68 31.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.1 Cg_exo -59.72 130.12 33.77 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.17 1.914 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -73.6 -29.72 63.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -69.43 -5.75 25.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.5 m-85 -100.04 -4.3 30.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.66 -176.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.944 ' CD ' HD21 ' A' ' 11' ' ' LEU . 21.1 pt-20 -153.48 96.45 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' HD3' ' A' ' 79' ' ' ARG . 9.8 t80 -37.67 110.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -135.35 14.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 7' ' ' GLN . . . -130.65 110.41 1.01 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.562 ' HD3' ' CE1' ' A' ' 76' ' ' TYR . 3.3 ttp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 32' ' ' VAL . . . 108.0 -168.89 14.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 m-85 -78.6 119.8 22.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.121 -1.223 . . . . 0.0 108.617 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 78' ' ' GLY . 8.1 mt-30 -106.78 122.91 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.141 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.941 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -115.79 173.77 6.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 109.64 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 8.5 mpt_? -107.86 137.44 45.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.403 -0.811 . . . . 0.0 108.846 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -66.02 99.12 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 110.241 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.5 mt -65.39 -30.51 71.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.147 -0.971 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.5 m-85 -127.94 -163.59 1.28 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.78 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.04 122.95 26.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.751 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.531 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 4.1 t80 -103.39 139.68 38.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.286 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 pttt -95.53 15.95 18.41 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.995 -1.065 . . . . 0.0 109.619 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 ttmm 64.19 92.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.658 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 4.8 tp10 -86.02 -80.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.229 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 77.8 mtm-85 -67.93 165.33 17.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.311 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -74.73 2.21 10.57 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.41 2.46 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.033 . . . . 0.0 109.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -109.37 172.43 6.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.508 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 HG13 ' CD2' ' A' ' 24' ' ' LEU . 6.3 pt -125.23 175.95 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.583 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -84.75 105.31 15.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.686 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.054 HD11 HD21 ' A' ' 30' ' ' LEU . 1.7 mm? -91.81 152.64 20.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' HG21 ' A' ' 63' ' ' THR . 1.6 m80 -152.22 135.86 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.338 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.5 tt -55.02 137.5 46.14 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.157 -0.965 . . . . 0.0 109.605 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.66 -9.12 71.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -90.31 162.39 15.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.3 mm -115.62 147.82 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.054 HD21 HD11 ' A' ' 24' ' ' LEU . 7.4 mp -120.76 111.8 18.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.226 -0.921 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.492 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -86.52 93.57 9.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.74 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.941 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 46.9 t -92.35 121.27 42.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.117 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 4.1 m120 -47.79 178.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -87.4 -71.31 0.57 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.87 -30.33 59.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 45.5 t -47.68 -33.85 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.237 . . . . 0.0 110.156 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.74 -40.55 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.679 ' O ' HG12 ' A' ' 38' ' ' VAL . 88.6 t -78.57 3.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.82 20.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.866 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.3 mm? -107.8 -7.34 16.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.53 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 95.2 33.5 6.54 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.722 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -53.81 -168.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -1.048 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 29.3 p -139.76 160.93 38.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -59.58 115.27 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.61 -34.09 4.67 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 15.9 mm-40 -68.39 -33.16 73.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.183 -1.187 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -64.23 -31.44 72.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -82.67 -14.57 54.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.1 mmm180 -112.05 80.17 3.06 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.033 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.7 Cg_exo -54.48 -57.4 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.304 2.003 . . . . 0.0 110.434 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 72' ' ' THR . 15.5 tt0 -44.0 -36.08 2.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.733 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.7 43.92 1.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.722 HG23 ' CE2' ' A' ' 42' ' ' PHE . 21.8 mt -136.68 -40.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.122 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -78.72 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 14.6 m95 -145.02 143.83 30.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.101 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.765 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -130.82 160.92 32.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 109.669 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -110.99 117.24 32.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.28 -176.16 14.37 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.5 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 70.7 t80 -117.55 111.87 19.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.876 -0.779 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.8 m-80 -79.3 78.72 5.78 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 108.79 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -48.19 -38.41 18.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.85 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 16.0 m -48.01 -46.74 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.599 HG21 ' CE1' ' A' ' 25' ' ' HIS . 53.3 p -117.4 17.72 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.04 50.93 6.13 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' OE1' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.87 109.93 15.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.301 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' C ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.0 150.54 20.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 109.398 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 153.98 -160.05 29.15 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.07 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.612 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -99.29 166.3 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.36 -1.083 . . . . 0.0 109.61 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.765 ' HE2' HG11 ' A' ' 74' ' ' VAL . 5.1 p90 -164.63 158.93 15.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.1 Cg_exo -60.47 116.54 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.014 1.809 . . . . 0.0 109.798 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.044 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.16 -37.69 91.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 51' ' ' GLU . 18.5 p -56.31 -23.39 36.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.902 -1.352 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 6.9 m-30 -92.49 28.23 2.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.044 HG22 ' O ' ' A' ' 71' ' ' GLY . 32.7 m -137.27 170.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.101 -1.0 . . . . 0.0 109.921 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.765 ' HG3' HD12 ' A' ' 77' ' ' ILE . 8.1 pt-20 -138.66 89.66 2.39 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.501 -0.75 . . . . 0.0 109.054 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 50.6 t80 -37.75 115.78 0.44 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.641 -0.662 . . . . 0.0 110.639 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.806 ' O ' HG22 ' A' ' 77' ' ' ILE . 67.6 mt -149.37 28.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -136.79 125.67 3.5 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.074 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 8.5 tpt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.43 -170.22 31.99 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 72.7 m-85 -140.32 121.46 14.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -1.009 . . . . 0.0 108.863 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.636 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.3 tt0 -130.28 133.56 46.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.085 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.707 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -128.66 178.57 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.906 ' HB2' HD11 ' A' ' 77' ' ' ILE . 15.9 ttp180 -118.99 121.29 39.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -44.92 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.871 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.654 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -74.39 -64.62 0.99 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.654 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -96.71 -160.63 0.81 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -123.14 126.06 46.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.217 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 15' ' ' LYS . 92.7 t80 -128.28 131.68 48.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 12.9 mmtt -79.69 178.43 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' CG ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -98.71 68.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.956 . . . . 0.0 109.243 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -68.23 -84.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 9.2 mtm-85 -43.61 145.65 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.62 -5.62 21.06 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.257 -0.902 . . . . 0.0 109.896 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.13 7.77 25.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 109.8 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 44.4 p30 -106.16 159.39 16.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.0 109.534 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -119.44 161.21 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.354 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD2' ' CG ' ' A' ' 16' ' ' LYS . 2.7 m-20 -56.16 154.25 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 109.7 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -152.66 137.96 17.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.79 137.77 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 26.4 tp -42.81 151.07 0.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.608 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 87.31 -16.12 50.39 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 3.1 t70 -90.2 160.69 16.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -1.094 . . . . 0.0 109.168 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.976 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.8 mm -118.91 149.74 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.133 HD23 ' CE2' ' A' ' 69' ' ' PHE . 8.3 mp -124.79 108.98 12.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 108.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.636 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -89.23 91.44 8.77 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.101 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.707 HG21 ' OH ' ' A' ' 8' ' ' TYR . 40.6 t -87.2 101.77 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.81 152.65 44.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 176.56 1.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -59.47 4.61 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -71.34 -31.74 67.72 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.357 -1.084 . . . . 0.0 109.022 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 47' ' ' GLU . 4.9 tp -89.51 -28.54 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 38' ' ' VAL . 55.0 t -90.17 -1.93 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.72 -12.87 18.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.555 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.85 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.9 mm? -93.29 -28.24 16.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.472 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 120.83 19.1 3.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.944 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 75.6 m-85 -55.75 -168.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -1.199 . . . . 0.0 109.47 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -151.18 156.79 41.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.285 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.8 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.44 -37.0 1.67 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -87.92 -12.5 44.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.192 -1.181 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.779 ' CB ' HD21 ' A' ' 37' ' ' LEU . 28.2 mt-10 -83.72 12.3 6.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.898 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -107.81 -10.33 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.1 mmt180 -117.43 77.31 10.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.733 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.3 Cg_endo -61.24 -21.44 71.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.211 1.941 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -56.32 -20.55 19.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 109.357 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 mt-10 -123.83 1.42 8.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.705 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.944 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 9.6 mt -79.54 -30.27 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 107.62 -77.73 0.23 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 10.3 m95 -147.68 136.4 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -1.091 . . . . 0.0 109.527 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.748 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -124.03 138.3 54.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.514 ' C ' HG22 ' A' ' 32' ' ' VAL . 22.6 t-20 -93.66 109.7 21.34 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -123.99 -176.62 14.76 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.14 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -114.16 110.31 19.79 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.657 -0.907 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' HG22 ' A' ' 63' ' ' THR . 75.2 m-20 -78.03 82.8 4.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.983 -1.073 . . . . 0.0 108.909 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -53.36 -34.42 57.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.468 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 49.6 m -50.54 -41.67 54.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.425 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 60' ' ' ASN . 1.6 t -108.35 2.68 22.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.08 47.46 89.05 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 63' ' ' THR . 73.8 mm-40 -137.02 169.68 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -1.125 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HG21 ' A' ' 22' ' ' ILE . 1.1 ttt180 -140.15 156.94 46.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 22' ' ' ILE . . . 160.64 -173.18 37.14 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 5.3 t0 -97.07 160.4 14.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -1.083 . . . . 0.0 109.602 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 1.133 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.4 p90 -158.51 162.21 27.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -60.01 128.16 25.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.958 1.772 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.35 -32.79 64.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 51' ' ' GLU . 32.8 p -68.27 -7.79 33.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.985 -1.303 . . . . 0.0 109.533 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.1 m-85 -99.68 6.94 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.733 HG23 ' HG2' ' A' ' 50' ' ' PRO . 10.6 m -127.32 164.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.136 -0.978 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.1 pt-20 -129.22 89.0 2.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.554 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 51.8 t80 -41.02 142.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.509 -0.744 . . . . 0.0 109.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -135.25 3.73 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.456 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 135.87 -177.69 19.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.32 -1.106 . . . . 0.0 109.5 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' CD ' ' A' ' 4' ' ' GLU . 2.8 pp20? . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.59 145.21 7.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 3.9 m-85 -79.69 81.65 5.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.335 -1.097 . . . . 0.0 108.827 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.654 ' CG ' HG23 ' A' ' 31' ' ' THR . 8.8 mt-30 -84.28 141.34 31.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.276 0.56 . . . . 0.0 110.04 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.841 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -120.51 173.0 7.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.03 120.93 41.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.653 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -48.74 133.05 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.897 . . . . 0.0 110.656 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.0 mt -117.86 -39.37 3.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 19.7 m-85 -123.75 -159.02 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.594 -0.691 . . . . 0.0 109.758 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -135.38 132.46 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 109.766 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 28.3 t80 -123.9 126.97 47.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.096 -1.002 . . . . 0.0 109.547 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 24.3 ttpp -66.05 86.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -77.57 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.338 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 50.8 mtt-85 -89.0 146.08 25.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.79 -19.65 6.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -0.922 . . . . 0.0 110.017 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 3.3 pt-20 -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -90.97 169.84 10.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.361 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 67' ' ' GLY . 1.9 pt -126.79 179.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 3.3 m-20 -78.83 164.83 24.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.616 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 14.5 mt -154.15 148.6 26.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 108.714 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.9 m80 -156.06 132.66 10.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 109.823 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.8 tt -50.8 139.27 17.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.55 -10.65 68.91 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.801 ' OD1' HG21 ' A' ' 62' ' ' THR . 67.2 m-20 -79.31 -175.78 4.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -1.09 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.8 mm -133.57 125.47 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 108.946 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 20.5 mt -101.96 148.69 25.05 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.17 -0.956 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.654 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -133.25 82.56 2.0 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.882 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.841 HG21 ' OH ' ' A' ' 8' ' ' TYR . 9.7 t -79.63 116.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.966 -1.084 . . . . 0.0 108.155 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.89 154.49 12.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.979 -1.075 . . . . 0.0 110.049 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -68.12 145.52 54.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.464 -0.772 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 -57.14 4.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -20.9 2.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.223 -1.163 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -90.11 -35.15 15.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.5 t -90.28 1.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.07 4.53 9.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.913 . . . . 0.0 109.98 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.7 mt -96.36 -28.99 14.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.114 -0.991 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 125.34 9.11 5.16 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.898 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.2 m-85 -54.64 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -1.211 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 80.3 p -125.15 -165.25 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.22 69.75 7.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.556 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.09 -31.76 0.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CG ' ' OG ' ' A' ' 43' ' ' SER . 41.4 mm-40 -68.96 -30.28 68.68 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.219 -1.165 . . . . 0.0 109.832 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -43.8 -35.92 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.97 . . . . 0.0 109.54 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.57 40.9 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -143.77 64.93 13.77 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.167 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.82 -42.35 53.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.188 1.925 . . . . 0.0 110.436 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 10.1 pt-20 -61.09 -34.67 75.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -98.42 -3.52 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.802 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.3 mt -79.92 -50.42 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 108.998 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 121.62 -71.26 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.0 m95 -146.42 127.24 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.423 -1.045 . . . . 0.0 109.709 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.662 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -116.21 143.7 45.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' HG22 ' A' ' 32' ' ' VAL . 3.3 t-20 -101.63 111.69 24.01 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.62 -162.52 9.2 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.652 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 64' ' ' GLY . 36.6 t80 -124.07 104.54 8.93 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.708 -0.877 . . . . 0.0 110.359 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -79.2 96.87 6.01 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -58.63 -33.64 70.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -0.871 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 ' OD1' ' A' ' 28' ' ' ASP . 11.6 m -49.01 -29.16 4.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 109.597 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' HB2' ' A' ' 65' ' ' GLU . 7.8 t -127.06 5.79 6.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 59' ' ' TYR . . . 52.08 49.6 48.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 63' ' ' THR . 35.3 mm-40 -124.98 145.43 49.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.575 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -126.1 125.59 42.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.258 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.581 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 176.88 -165.85 36.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -94.41 159.93 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -1.062 . . . . 0.0 109.529 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.8 p90 -164.51 160.34 15.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.0 Cg_exo -59.98 116.5 3.35 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.102 1.868 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.23 -21.63 70.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.553 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 1.7 p -64.95 -16.92 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.975 -1.309 . . . . 0.0 109.81 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 9.1 m-30 -99.75 18.09 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.013 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 71' ' ' GLY . 11.3 m -134.69 161.41 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 8.2 pt-20 -134.11 90.35 2.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.861 -1.15 . . . . 0.0 109.236 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 85.4 t80 -38.48 137.91 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -136.45 10.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 109.136 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 91.91 -106.15 3.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 0.0 109.386 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.485 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 178.37 -146.92 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 22.5 m-85 -132.0 139.03 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -1.016 . . . . 0.0 109.039 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.17 122.47 18.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.57 177.11 4.95 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.114 -0.991 . . . . 0.0 109.854 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.1 123.09 45.94 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -49.02 106.21 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.5 mt -83.5 -29.52 27.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.888 . . . . 0.0 108.858 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -127.3 -175.48 3.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.455 -0.778 . . . . 0.0 109.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.28 179.49 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 18.0 t80 -175.0 113.1 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.353 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 146.72 30.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 18.4 tttp -53.14 112.47 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.62 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -114.5 -82.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -73.53 159.61 32.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.121 -0.987 . . . . 0.0 109.586 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -0.4 15.33 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.9 mt-10 -105.72 -4.96 20.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 18' ' ' ARG . 2.7 p-10 -112.14 167.6 10.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.623 HD12 HD22 ' A' ' 60' ' ' ASN . 7.2 pt -128.0 177.59 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.6 m-20 -69.28 163.85 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.55 HD11 HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -161.15 147.71 14.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.362 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.535 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 3.9 m-70 -156.87 146.12 20.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 10' ' ' ALA . 33.7 tp -53.04 143.2 18.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.765 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' H ' HD12 ' A' ' 26' ' ' LEU . . . 91.99 -31.8 5.74 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.2 t70 -58.52 158.76 7.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -1.088 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.839 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.5 mp -115.64 137.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 108.991 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.6 mp -117.45 125.99 51.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 109.907 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -102.46 92.94 4.89 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.752 HG22 ' CA ' ' A' ' 58' ' ' GLY . 91.0 t -101.57 112.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 9.4 p-10 -51.5 -177.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.159 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -86.88 -28.56 22.76 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . -67.66 -56.74 10.37 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 9.9 t -43.88 -25.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -1.183 . . . . 0.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -87.84 -40.11 14.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -0.972 . . . . 0.0 109.337 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 38' ' ' VAL . 77.3 t -77.91 -2.56 4.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.14 -34.67 14.73 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -81.14 -45.48 16.35 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.25 29.16 6.48 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.79 -79.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.714 -1.462 . . . . 0.0 108.099 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.61 157.07 24.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -84.34 68.73 10.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 108.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.03 -28.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG2' ' NE ' ' A' ' 49' ' ' ARG . 2.3 mt-30 -85.93 41.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -1.217 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 2.5 pm0 -90.1 1.87 55.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -113.15 39.81 2.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.658 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.49 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -160.2 62.78 1.87 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.9 -18.12 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.408 2.072 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.82 -35.81 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.607 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -101.49 -0.85 34.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.638 HD12 HD21 ' A' ' 56' ' ' LEU . 21.6 mt -79.87 -33.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -76.34 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.475 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 23.0 m95 -137.01 157.28 47.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -1.066 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 37' ' ' LEU . 3.4 mp -143.39 154.75 44.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.845 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 32' ' ' VAL . 17.9 t-20 -114.37 109.67 18.7 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.752 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.61 -161.32 9.68 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 52.6 t80 -120.9 112.63 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.657 -0.907 . . . . 0.0 110.027 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.623 HD22 HD12 ' A' ' 22' ' ' ILE . 37.3 m-20 -79.79 80.37 6.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -40.8 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 91.2 m -57.36 -43.03 83.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 3.7 p -93.35 0.96 57.09 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.312 -0.868 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.47 44.34 67.03 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 63' ' ' THR . 26.7 mt-10 -141.09 179.09 6.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -1.193 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 15.3 ptt85 -152.49 146.18 25.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 109.505 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 163.4 -159.6 32.2 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.972 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -92.43 166.14 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -1.046 . . . . 0.0 109.661 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.883 ' HE2' HG11 ' A' ' 74' ' ' VAL . 7.2 p90 -171.1 159.51 5.32 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.835 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.55 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -57.86 120.27 8.07 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.084 1.856 . . . . 0.0 110.116 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.973 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.67 -31.99 70.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -63.19 -18.99 64.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.908 -1.348 . . . . 0.0 109.372 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 10.7 m-30 -92.57 30.21 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.005 . . . . 0.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.3 m -143.8 167.32 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 5.9 pt-20 -140.49 87.53 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.25 -0.906 . . . . 0.0 109.745 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.601 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 42.1 t80 -47.88 137.66 9.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 108.746 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.712 ' O ' HG22 ' A' ' 77' ' ' ILE . 70.5 mt -144.23 9.06 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . 159.27 -172.41 35.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' OXT' ' HB2' ' A' ' 7' ' ' GLN . 7.3 mtp180 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -1.072 . . . . 0.0 109.437 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.3 0.572 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 79' ' ' ARG . . . -89.52 -178.01 45.46 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.635 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 25.7 m-85 -80.23 133.25 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 109.616 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.593 ' CG ' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -119.14 113.57 21.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -0.795 . . . . 0.0 109.389 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.748 ' CE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.07 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.078 -1.014 . . . . 0.0 108.963 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.7 mtt85 -120.55 137.89 54.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.0 108.871 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -56.77 109.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 110.241 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -93.68 -29.71 15.29 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -128.2 -169.64 2.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.952 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 57.3 p-10 -114.93 178.35 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 67.1 t80 172.92 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.279 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 7.0 tttp -79.76 153.39 29.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.471 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 2.3 pttt -77.51 78.16 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.562 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.02 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.202 -0.936 . . . . 0.0 109.249 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -54.97 142.74 28.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -57.72 -15.67 8.63 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.06 -32.49 33.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 109.9 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -88.29 146.54 25.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.109 -0.994 . . . . 0.0 109.274 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.705 HD11 ' OD1' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -107.59 -169.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.671 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -73.64 153.33 40.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.848 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.31 129.92 22.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.666 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -147.87 133.25 18.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.646 HD23 ' C ' ' A' ' 26' ' ' LEU . 3.8 tt -51.67 151.34 3.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.865 . . . . 0.0 109.721 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 26' ' ' LEU . . . 89.16 -10.95 71.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.744 ' CG ' HG21 ' A' ' 62' ' ' THR . 2.2 m-20 -90.27 -170.26 2.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.966 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.0 mt -148.53 151.32 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.966 HD12 ' C ' ' A' ' 29' ' ' ILE . 3.7 mp -134.67 130.24 36.03 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.049 -1.032 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -97.84 96.45 8.22 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 57' ' ' ASN . 51.3 t -101.46 116.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.884 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 8.1 t30 -53.12 147.41 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 108.95 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -2.77 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.138 -0.976 . . . . 0.0 109.797 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.94 -53.97 1.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 p -48.59 -22.5 0.77 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -1.132 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD13 ' A' ' 53' ' ' ILE . 5.4 tt -90.31 -34.86 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 0.0 109.557 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.661 ' O ' HG12 ' A' ' 38' ' ' VAL . 53.8 t -87.71 0.78 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.628 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.15 -13.75 13.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.805 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.1 mm? -96.12 -23.17 16.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.583 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 118.27 23.12 3.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.861 ' CE2' HG23 ' A' ' 53' ' ' ILE . 12.0 m-85 -46.97 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -1.096 . . . . 0.0 109.612 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 t -94.56 162.88 13.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.64 96.25 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.94 -8.13 9.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.92 0.19 57.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -1.183 . . . . 0.0 109.612 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.635 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 3.1 mp0 -90.4 21.02 4.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.56 -2.46 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -126.66 86.28 58.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.5 Cg_endo -61.2 -38.22 68.06 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.248 1.966 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.9 pm0 -59.15 -17.55 27.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.145 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.8 -11.39 14.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.076 HD13 HD11 ' A' ' 37' ' ' LEU . 32.6 mt -79.75 -50.17 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.43 -72.67 0.39 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 15.3 m95 -139.9 143.08 36.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -1.002 . . . . 0.0 109.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.865 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -135.86 152.27 50.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.732 ' O ' HG13 ' A' ' 32' ' ' VAL . 3.8 t30 -115.28 111.2 20.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.723 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.88 -152.24 6.5 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.704 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 60.0 t80 -126.63 110.81 13.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.777 -0.837 . . . . 0.0 110.203 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.705 ' OD1' HD11 ' A' ' 22' ' ' ILE . 1.4 m120 -78.53 82.95 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.919 -1.113 . . . . 0.0 108.822 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -52.17 -39.78 60.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.13 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.744 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.6 m -54.26 -46.33 72.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 109.787 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.666 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -105.93 13.29 29.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 39.81 54.43 2.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' HB3' HD13 ' A' ' 22' ' ' ILE . 2.8 mm-40 -136.9 120.17 16.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.503 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 22' ' ' ILE . 7.2 ttp180 -92.76 151.0 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.57 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.09 -168.98 32.54 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -93.09 175.7 6.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.565 -0.962 . . . . 0.0 109.668 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.8 p90 -179.24 152.04 0.67 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.245 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -59.05 123.01 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.058 1.839 . . . . 0.0 109.958 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.865 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -69.41 -29.61 71.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 4.1 p -58.53 -15.01 9.39 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.839 -1.389 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 7.5 m-30 -103.29 33.22 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.025 . . . . 0.0 110.378 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 71' ' ' GLY . 2.1 m -147.91 -179.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 9.6 pt-20 -151.06 90.37 1.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 49.7 t80 -52.66 123.15 10.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 109.044 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.825 HD12 ' CD ' ' A' ' 9' ' ' ARG . 8.6 mt -112.3 -14.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 147.96 177.62 22.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 119.45 -138.67 13.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.715 ' CG ' ' OH ' ' A' ' 76' ' ' TYR . 24.2 m-85 -79.31 140.25 37.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.418 -1.048 . . . . 0.0 108.643 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 mt-30 -147.24 125.18 11.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -120.53 177.99 4.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.564 ' CB ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -114.17 170.55 8.2 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -86.52 146.57 26.33 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 109.893 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 74' ' ' VAL . 13.3 mt -126.84 -36.99 2.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 2.5 m-85 -118.4 -163.22 0.94 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.941 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.68 170.11 10.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -174.52 116.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -86.94 34.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.938 -1.102 . . . . 0.0 110.298 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 17.4 tttt 41.55 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 42.1 mm-40 -97.25 -49.56 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.81 149.96 36.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 41.8 tt0 -69.55 -4.11 17.65 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.161 -0.962 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE2' ' OD2' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -106.32 -15.12 14.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 110.201 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 51.4 p30 -99.09 165.56 11.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.771 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -121.29 177.07 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.515 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 1.7 m-20 -70.02 171.24 9.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.813 HD21 HD21 ' A' ' 30' ' ' LEU . 10.4 mt -164.76 144.97 7.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.048 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.927 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -158.95 125.0 4.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.43 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.02 129.96 12.17 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.16 -11.81 33.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.754 ' CG ' HG21 ' A' ' 62' ' ' THR . 4.4 m-20 -89.73 -170.87 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.88 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -143.81 138.23 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.211 HD23 ' CE2' ' A' ' 69' ' ' PHE . 6.2 mp -116.81 124.22 49.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.467 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -96.28 103.08 14.96 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 110.648 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 96.2 t -113.8 100.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 p30 -57.73 -166.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.005 -1.06 . . . . 0.0 109.089 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -84.04 -27.18 28.51 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.027 -1.045 . . . . 0.0 110.622 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' N ' ' HG2' ' A' ' 34' ' ' LYS . . . -81.39 -53.85 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 33' ' ' ASN . 7.1 t -50.31 -22.46 1.81 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.069 -1.254 . . . . 0.0 109.437 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.652 HD12 HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -88.98 -44.36 10.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 108.683 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 38' ' ' VAL . 97.2 t -83.33 6.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -44.9 -28.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.668 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -100.1 -29.0 12.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 136.81 -40.07 1.56 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.2 m-85 38.81 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.918 . . . . 0.0 109.453 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.48 145.17 31.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.877 -1.139 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -62.97 96.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 142.04 -28.23 2.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -90.41 -6.45 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -1.099 . . . . 0.0 109.32 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 2.7 mp0 -43.01 -60.03 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.361 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -84.92 46.7 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.501 -0.75 . . . . 0.0 109.859 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.02 61.51 21.73 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.8 Cg_exo -54.97 -48.62 20.16 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.44 2.093 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 72' ' ' THR . 1.1 mp0 -67.89 -34.62 76.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.158 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 1.66 56.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.958 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.834 HD13 HD21 ' A' ' 56' ' ' LEU . 2.7 mt -88.95 -45.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 117.06 -70.63 0.29 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 15.5 m95 -149.19 128.76 13.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -1.025 . . . . 0.0 109.078 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.834 HD21 HD13 ' A' ' 53' ' ' ILE . 1.4 mp -119.14 140.8 49.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -94.77 101.83 13.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.4 179.37 16.98 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.118 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.6 t80 -104.69 117.7 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.869 -0.783 . . . . 0.0 109.352 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -78.95 77.94 5.41 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.245 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -55.97 -36.12 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.754 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.9 m -62.95 -31.85 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 109.949 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.927 HG21 ' HE1' ' A' ' 25' ' ' HIS . 6.9 p -119.14 19.2 12.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 40.98 54.64 3.6 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.0 179.64 5.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -1.211 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 19.7 ttp85 -160.47 123.02 3.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.771 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 177.2 -167.67 39.01 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.277 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 63.1 m-20 -95.26 161.83 13.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.483 -1.01 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 1.211 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -162.31 162.99 19.12 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.619 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.9 Cg_exo -59.5 113.84 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.818 1.679 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -62.99 -35.26 91.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 51' ' ' GLU . 28.6 p -60.65 -13.68 16.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.788 -1.419 . . . . 0.0 110.118 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 7.7 m-30 -97.54 15.78 22.29 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.976 -1.077 . . . . 0.0 112.087 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.2 m -126.81 -179.73 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.633 -1.292 . . . . 0.0 109.951 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 11' ' ' LEU . 4.2 pt-20 -143.72 91.67 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 109.103 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' OH ' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -31.58 162.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.256 1.027 . . . . 0.0 112.961 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.768 ' O ' HG22 ' A' ' 77' ' ' ILE . 34.3 mm -155.01 14.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -118.33 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 mtt85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 7.0 pt-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . -178.61 -166.96 35.61 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 31.1 m-85 -80.09 112.65 17.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -1.146 . . . . 0.0 109.548 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 2.6 mt-30 -98.98 121.34 40.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.68 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.67 175.58 5.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.016 . . . . 0.0 109.653 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 36.4 ttt180 -114.85 141.46 47.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -68.06 108.41 3.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.946 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.1 mt -82.0 -31.26 31.16 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.5 m-85 -129.77 -160.15 1.01 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.48 -0.763 . . . . 0.0 109.468 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -134.41 109.85 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB3' HD21 ' A' ' 24' ' ' LEU . 66.4 t80 -105.07 128.89 53.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.93 158.47 26.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.891 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' CE ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -80.83 72.63 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.033 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.0 108.821 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -90.51 159.09 16.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.132 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HA ' ' CE ' ' A' ' 16' ' ' LYS . 32.3 tp10 -55.3 -28.75 55.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -53.2 -40.6 64.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.999 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -99.93 162.5 12.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.816 HG21 ' C ' ' A' ' 66' ' ' ARG . 35.6 pt -114.75 -168.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.925 . . . . 0.0 110.176 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -99.24 99.31 10.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 0.0 109.379 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -110.17 147.1 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 108.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -145.91 148.23 32.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -48.5 136.32 13.05 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.354 -0.841 . . . . 0.0 109.785 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 93.49 -5.03 73.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 6.7 t0 -90.39 145.9 24.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -1.132 . . . . 0.0 109.514 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.8 mm -96.58 132.06 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -0.923 . . . . 0.0 109.211 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.4 mp -110.34 114.56 28.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.319 -0.863 . . . . 0.0 108.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -92.16 96.86 10.56 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.902 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.68 HG11 ' OH ' ' A' ' 8' ' ' TYR . 64.3 t -102.59 108.05 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.885 . . . . 0.0 109.375 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 4.8 t30 -47.6 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -71.81 -62.76 1.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.54 99.7 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 33' ' ' ASN . 34.7 m -52.21 -19.8 2.23 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.351 -1.088 . . . . 0.0 109.827 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 37' ' ' LEU . 5.6 tt -88.96 -36.08 16.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 38' ' ' VAL . 40.2 t -90.42 1.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.28 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.17 47.88 1.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.887 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.42 56.61 14.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.799 ' CE2' HG23 ' A' ' 53' ' ' ILE . 3.8 m-85 -89.04 -166.89 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 46' ' ' GLN . 7.2 t -133.65 141.9 47.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 108.984 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.35 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.63 -30.48 1.03 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.753 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -88.23 34.4 0.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.683 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' OE1' ' OH ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -90.14 -17.45 27.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 76' ' ' TYR . . . -126.16 14.77 7.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.2 mtt180 -121.66 74.8 34.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.609 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.45 -52.79 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.197 1.931 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -52.39 -28.21 18.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 49' ' ' ARG . 2.7 mt-10 -109.43 44.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.7 mt -130.98 -42.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 108.894 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 112.47 -76.52 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 32.7 m95 -147.35 131.33 17.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -1.068 . . . . 0.0 109.244 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.793 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -117.67 160.45 21.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 8.6 t30 -113.0 111.19 21.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.17 -170.57 12.47 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.45 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 61.4 t80 -116.78 113.22 22.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.572 -0.958 . . . . 0.0 110.188 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.622 ' ND2' HD11 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -79.27 77.98 5.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' O ' ' CD ' ' A' ' 61' ' ' GLU . 3.7 tm-20 -52.92 -36.32 59.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.458 -0.776 . . . . 0.0 110.289 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 20.8 m -55.23 -38.48 68.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 109.982 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.444 HG21 ' NE2' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -113.01 20.48 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.48 53.88 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.79 172.08 13.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.816 ' C ' HG21 ' A' ' 22' ' ' ILE . 32.2 ttm-85 -156.19 144.6 19.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.564 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 159.78 -152.95 23.93 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.025 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 72.7 m-20 -100.65 162.46 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -1.025 . . . . 0.0 109.916 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.646 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.9 p90 -161.97 158.97 21.85 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -58.84 125.73 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.093 1.862 . . . . 0.0 110.146 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -68.26 -44.16 76.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 51' ' ' GLU . 33.5 p -61.68 -12.12 14.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.998 -1.296 . . . . 0.0 109.615 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.4 m-85 -92.95 18.58 8.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.996 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.4 m -140.02 -176.04 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.219 -0.926 . . . . 0.0 109.793 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 1.039 ' O ' HD12 ' A' ' 77' ' ' ILE . 7.8 pt-20 -155.1 89.28 1.21 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.51 ' CE1' ' HB3' ' A' ' 6' ' ' TYR . 48.8 t80 -46.14 120.68 2.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.039 HD12 ' O ' ' A' ' 75' ' ' GLU . 1.1 mp -152.36 20.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.56 111.57 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.46 ' HB2' ' NH1' ' A' ' 79' ' ' ARG . 12.1 mtm105 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.13 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 120.82 -167.69 13.96 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 25.3 m-85 -79.55 93.35 5.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -1.12 . . . . 0.0 109.75 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.752 ' HG2' HG23 ' A' ' 31' ' ' THR . 1.9 mt-30 -89.69 129.97 36.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 0.0 108.622 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.35 179.05 4.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.924 -1.11 . . . . 0.0 109.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -117.38 136.33 53.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -76.31 137.76 40.07 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 110.436 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.975 HD21 ' C ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -122.94 -32.66 3.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.498 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 m-85 -112.74 -163.13 0.83 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -137.51 112.6 9.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.965 -1.084 . . . . 0.0 110.153 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 17.2 t80 -100.42 158.33 15.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.052 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.77 149.61 30.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 0.0 109.42 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 23' ' ' ASP . 14.9 tttp -82.23 70.77 9.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -55.94 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -79.76 142.28 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -64.08 -9.75 18.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.213 -0.93 . . . . 0.0 109.935 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 3.3 mm-40 -103.82 19.7 19.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.983 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 11.6 p-10 -124.71 172.51 9.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.881 HD12 HD21 ' A' ' 60' ' ' ASN . 0.5 OUTLIER -130.9 154.87 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.668 ' HB3' ' HE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -68.94 110.34 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.567 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -104.55 148.92 25.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.201 -0.937 . . . . 0.0 109.277 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.668 ' HE1' ' HB3' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -160.17 130.47 5.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.175 -0.953 . . . . 0.0 109.372 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -42.93 137.14 2.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.322 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -1.07 81.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.789 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 37.2 t0 -90.72 131.59 36.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.426 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 46.2 mm -87.99 132.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.973 -1.079 . . . . 0.0 109.284 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.671 HD23 ' CE2' ' A' ' 69' ' ' PHE . 9.0 mp -107.68 139.87 41.58 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.325 -0.86 . . . . 0.0 108.993 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.752 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -116.29 99.25 7.07 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.005 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 52.6 t -107.74 95.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 73.8 m-20 -45.42 136.1 5.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 109.953 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -70.14 160.77 31.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.44 -60.82 4.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -20.65 55.78 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.377 -1.072 . . . . 0.0 108.513 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 47' ' ' GLU . 4.5 tp -85.68 -29.32 24.08 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 38' ' ' VAL . 38.9 t -84.77 -1.23 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -73.71 -0.41 15.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.843 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.1 mm? -103.98 12.75 33.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 109.648 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.74 15.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 53' ' ' ILE . 17.2 m-85 -72.35 -168.92 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.662 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 94.9 p -125.51 166.04 17.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.835 . . . . 0.0 109.287 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -72.27 98.58 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.646 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.22 13.27 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.464 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.6 mt-30 -89.89 -21.91 22.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -1.22 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HA ' HD21 ' A' ' 37' ' ' LEU . 3.5 pt-20 -65.7 -8.27 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.274 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' C ' ' HD3' ' A' ' 50' ' ' PRO . . . -108.11 -4.97 17.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.981 -1.074 . . . . 0.0 110.036 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.501 ' O ' HG13 ' A' ' 53' ' ' ILE . 32.5 mmt-85 -117.96 72.33 8.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.9 Cg_exo -54.2 -33.19 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.279 1.986 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 72' ' ' THR . 3.0 pt-20 -64.21 -40.16 95.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.056 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 61.7 mt-10 -85.33 4.76 33.65 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 109.526 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 56' ' ' LEU . 8.6 mt -94.24 -52.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -77.04 0.3 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 14.2 m95 -134.09 147.2 50.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -1.028 . . . . 0.0 109.063 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.812 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -140.38 158.24 44.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 28.5 t-20 -113.9 109.35 18.37 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.74 -161.3 9.86 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.66 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 54.1 t80 -127.18 114.19 17.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 110.182 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.881 HD21 HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -79.75 96.35 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.121 -0.987 . . . . 0.0 108.615 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -60.35 -40.87 92.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.439 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 22.9 m -59.28 -22.12 60.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.988 -1.07 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -120.62 6.12 10.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 45.01 37.66 5.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' OE2' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -114.76 173.86 6.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.168 . . . . 0.0 109.462 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 1.6 ttp85 -153.25 130.87 11.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.137 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 169.55 -158.04 30.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.174 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-20 -92.79 165.46 12.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -1.013 . . . . 0.0 110.0 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.671 ' CE2' HD23 ' A' ' 30' ' ' LEU . 4.3 p90 -171.79 153.13 3.24 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.96 123.35 12.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.025 1.817 . . . . 0.0 110.063 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.812 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -30.3 65.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.604 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.3 p -67.02 -7.88 25.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -1.207 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.1 m-85 -98.67 10.88 40.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.975 ' C ' HD21 ' A' ' 11' ' ' LEU . 2.9 m -130.9 -165.96 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.755 0.788 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' HD23 ' A' ' 11' ' ' LEU . 8.2 pt-20 -160.05 90.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.577 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.8 t80 -38.16 120.6 0.89 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.506 -0.747 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.508 ' CG1' ' HB2' ' A' ' 9' ' ' ARG . 45.8 mm -106.62 -19.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.97 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.577 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 129.27 -130.32 6.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.26 -1.141 . . . . 0.0 109.449 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' OE1' ' HD3' ' A' ' 34' ' ' LYS . 6.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 137.98 -170.52 23.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 39.1 m-85 -148.35 111.98 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -1.155 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.544 ' OE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -99.83 120.24 39.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.557 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -107.1 178.59 4.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.975 -1.078 . . . . 0.0 109.868 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.94 147.96 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . . . -75.51 106.64 7.16 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 110.126 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.7 mt -84.97 -26.34 27.21 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 23.5 m-85 -135.82 -160.71 1.08 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.538 -0.726 . . . . 0.0 109.711 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HA ' ' C ' ' A' ' 24' ' ' LEU . 10.1 p-10 -135.67 143.26 45.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.593 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 10.7 t80 -116.67 163.91 15.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.188 -0.945 . . . . 0.0 108.626 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 8.9 mmtt -104.57 -19.58 13.95 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.053 -1.03 . . . . 0.0 110.551 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER 75.24 81.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.068 . . . . 0.0 109.236 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -84.42 -54.96 4.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.731 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 1.1 tpt180 -87.97 162.35 16.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.71 -3.6 19.4 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 7.1 pt-20 -99.61 14.81 28.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.083 -1.011 . . . . 0.0 109.773 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -127.68 163.42 24.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.149 -0.969 . . . . 0.0 109.417 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -128.33 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 110.116 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.576 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -58.99 119.45 7.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 30' ' ' LEU . 2.2 mm? -97.28 159.38 14.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 109.169 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.1 m80 -159.44 125.38 4.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.865 . . . . 0.0 109.4 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 10' ' ' ALA . 2.8 tp -50.62 128.29 20.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.74 28.28 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.729 ' CG ' ' HB2' ' A' ' 10' ' ' ALA . 2.3 p30 -90.02 -179.9 5.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.272 . . . . 0.0 109.967 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.858 ' C ' HD12 ' A' ' 30' ' ' LEU . 33.5 mm -127.54 149.2 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.074 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.3 mp -123.84 123.34 40.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.013 -1.054 . . . . 0.0 110.387 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -99.7 86.61 3.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 57' ' ' ASN . 67.7 t -96.56 116.35 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -56.52 162.83 2.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 108.475 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 4' ' ' GLU . 11.7 ptmt -90.5 -25.61 20.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.01 -1.056 . . . . 0.0 110.327 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.65 -58.83 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -50.19 -22.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -1.151 . . . . 0.0 110.05 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' OE1' ' A' ' 47' ' ' GLU . 4.1 tt -90.31 -32.73 16.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 109.707 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 38' ' ' VAL . 51.3 t -82.34 -0.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 109.751 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.2 -21.18 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.198 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.14 37.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.516 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.96 49.58 17.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 2.3 m-85 -59.38 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.177 -1.19 . . . . 0.0 109.267 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -128.56 150.79 50.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.138 -0.977 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.55 120.81 10.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.07 -33.41 6.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.504 ' O ' ' CG1' ' A' ' 53' ' ' ILE . 10.2 mt-30 -65.9 -11.93 50.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -1.147 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 1.015 ' OE1' HD13 ' A' ' 37' ' ' LEU . 14.9 mm-40 -81.13 -22.38 39.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.626 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.18 -4.96 58.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.1 mmp_? -117.14 74.13 7.27 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.7 Cg_exo -54.99 -32.17 77.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.2 1.934 . . . . 0.0 110.489 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 6.7 pt-20 -62.24 -35.98 80.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.942 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.3 mt-10 -95.57 -3.74 45.92 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.162 -0.961 . . . . 0.0 110.017 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.717 HD12 HD21 ' A' ' 56' ' ' LEU . 31.6 mt -79.6 -36.92 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 109.361 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 108.15 -76.52 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m95 -143.77 132.81 22.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -1.137 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -117.42 142.3 47.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.798 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.687 ' O ' HG13 ' A' ' 32' ' ' VAL . 8.8 t-20 -105.97 111.77 24.55 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.568 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -139.49 -161.27 8.66 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.413 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 67.2 t80 -115.5 114.22 24.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.626 -0.926 . . . . 0.0 110.553 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.1 m-20 -78.09 79.02 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -42.68 -44.69 4.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 3.4 m -46.57 -69.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.105 -0.997 . . . . 0.0 109.876 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.543 ' CG2' ' HG3' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -81.05 6.03 14.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.971 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.42 48.43 60.17 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.576 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 2.7 mt-10 -121.27 173.11 7.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.278 . . . . 0.0 109.282 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.58 118.0 6.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 109.341 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -176.4 -150.76 8.38 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.618 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 7.5 m-20 -108.83 165.21 11.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -1.056 . . . . 0.0 109.829 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 1.074 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.9 p90 -165.87 161.82 13.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.385 -0.822 . . . . 0.0 109.011 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.595 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -57.92 126.92 23.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.936 1.757 . . . . 0.0 110.033 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.98 -33.97 62.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 72' ' ' THR . 2.0 p -65.48 -9.03 22.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.083 -1.245 . . . . 0.0 109.218 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -98.3 16.4 21.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.899 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 30' ' ' LEU . 6.1 m -136.49 -175.45 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.18 -0.95 . . . . 0.0 109.612 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 77' ' ' ILE . 11.3 pt-20 -156.61 87.26 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.87 . . . . 0.0 109.808 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.522 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 58.3 t80 -46.18 135.8 7.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.369 -0.832 . . . . 0.0 109.753 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -135.38 17.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.067 -1.021 . . . . 0.0 109.468 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' HA2' ' OH ' ' A' ' 76' ' ' TYR . . . 116.52 -147.17 18.91 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 124.85 178.56 15.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 87.9 m-85 -79.58 121.21 24.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.46 -1.024 . . . . 0.0 108.885 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.627 ' CG ' HG23 ' A' ' 31' ' ' THR . 1.3 mt-30 -118.87 115.67 24.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.883 -1.136 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -105.99 -178.98 3.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.905 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -121.64 132.43 54.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.731 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -57.65 164.43 2.05 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 109.932 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 74' ' ' VAL . 14.1 mt -138.49 -40.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.603 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -117.3 -159.66 0.74 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.128 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 11.5 p-10 -119.71 168.18 11.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 110.275 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CB ' ' CD2' ' A' ' 24' ' ' LEU . 2.0 t80 -171.91 119.22 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.509 -0.744 . . . . 0.0 109.195 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' LYS . 16.8 mttm -93.67 49.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.833 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 9.7 ttmt 42.2 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 3.2 mt-10 -73.23 -81.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.276 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 8.1 mmt180 -88.96 150.52 22.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.0 109.388 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -47.12 -23.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.823 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.77 -48.68 68.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.965 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 34.7 p30 -82.38 173.15 12.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -127.71 -171.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.0 m-20 -93.75 115.04 27.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -121.32 150.21 41.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.728 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -150.21 149.36 30.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.047 -1.033 . . . . 0.0 109.769 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.1 tp -42.47 136.46 2.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 85.62 2.28 87.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.731 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 13.5 t0 -90.41 117.25 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -1.174 . . . . 0.0 109.213 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.8 mp -79.97 134.98 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.025 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 6.9 mp -113.46 136.8 52.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -115.65 89.31 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 111.008 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 37' ' ' LEU . 1.5 t -89.4 106.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 108.841 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -50.75 157.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -73.3 156.28 38.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 -56.93 4.83 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -51.04 -23.28 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.218 -1.166 . . . . 0.0 109.66 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -90.49 -34.21 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 38' ' ' VAL . 52.5 t -89.13 1.79 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.746 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.502 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.62 -8.21 25.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.861 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.76 18.62 21.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.311 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.77 38.78 60.7 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.707 ' CE1' HD23 ' A' ' 40' ' ' LEU . 5.6 m-85 -57.8 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.525 ' O ' ' C ' ' A' ' 44' ' ' ASP . 27.2 t -125.08 97.69 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.72 93.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.297 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.03 -14.76 4.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' SER . 5.8 mt-30 -90.68 2.14 56.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.778 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 1.3 mp0 -65.7 -23.23 66.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -103.21 19.04 20.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.526 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mmt180 -130.93 65.2 76.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.212 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.38 -33.49 97.86 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.162 1.908 . . . . 0.0 110.342 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 21.1 pt-20 -58.61 -29.8 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 109.597 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 -0.13 24.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.704 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.2 mt -79.92 -39.22 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 111.66 -73.45 0.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 11.2 m95 -148.1 140.98 24.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.467 -1.02 . . . . 0.0 109.123 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -130.8 132.9 45.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.0 110.019 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 6.1 t30 -99.82 105.37 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 32' ' ' VAL . . . -131.6 -156.2 8.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.621 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -115.66 111.49 20.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.451 -1.029 . . . . 0.0 110.774 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' HD11 ' A' ' 30' ' ' LEU . 3.2 m-80 -79.59 80.4 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 108.603 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -44.56 -44.84 9.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -46.49 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.03 . . . . 0.0 109.957 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.656 HG21 ' NE2' ' A' ' 25' ' ' HIS . 14.7 p -83.36 12.71 5.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.87 43.31 6.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.91 117.14 25.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -1.141 . . . . 0.0 109.314 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 15.9 ttm180 -94.99 138.06 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.501 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 168.18 -174.0 43.01 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.248 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -90.02 152.82 21.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.72 -0.871 . . . . 0.0 109.859 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 1.025 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 2.5 p90 -155.36 161.16 30.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 0.0 109.121 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.67 127.42 23.54 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.929 1.753 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.12 -32.29 63.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -69.56 -8.66 49.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.239 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.69 -1.24 50.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.73 ' O ' HD12 ' A' ' 11' ' ' LEU . 5.9 m -122.73 -174.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 11' ' ' LEU . 2.5 pt-20 -156.75 88.66 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.59 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 81.9 t80 -34.48 128.94 0.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.242 0.544 . . . . 0.0 109.973 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -116.78 0.86 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.946 . . . . 0.0 109.396 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.59 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 97.95 -115.02 5.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . -160.79 156.28 27.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 7.3 m-85 -81.76 141.74 33.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.438 -1.037 . . . . 0.0 108.975 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.635 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.9 mt-30 -144.88 116.81 8.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.803 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -110.94 179.78 3.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 12.6 mtm180 -114.83 168.72 9.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.328 -0.858 . . . . 0.0 108.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -90.2 97.77 11.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -67.51 -30.72 70.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.086 -1.008 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -129.47 -168.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.439 -0.788 . . . . 0.0 109.725 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -130.79 98.25 4.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.537 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 32.1 t80 -88.41 152.29 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.785 . . . . 0.0 109.323 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 151.69 20.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.953 . . . . 0.0 109.425 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.6 ttpt -72.92 85.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.408 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' CG ' ' OH ' ' A' ' 14' ' ' TYR . 1.7 pp20? -117.86 -35.22 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -71.99 138.38 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.1 tt0 -56.41 -15.89 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 3.5 tt0 -129.65 36.98 4.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 110.11 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 1.1 p-10 -122.53 161.66 23.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.062 -1.024 . . . . 0.0 109.531 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 24' ' ' LEU . 1.6 pt -116.11 170.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.92 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.574 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -79.51 100.8 7.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.218 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.9 HD11 HD21 ' A' ' 30' ' ' LEU . 3.5 mm? -88.06 133.42 33.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.8 m80 -135.08 139.2 44.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.6 tt -56.33 123.37 14.39 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.35 -0.844 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.93 -5.56 39.71 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -90.34 167.04 12.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 109.066 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.925 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -125.52 147.71 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 29' ' ' ILE . 5.9 mp -122.77 127.55 49.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.237 -0.914 . . . . 0.0 108.789 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.635 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -97.91 93.65 6.45 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 109.942 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 87.4 t -90.31 114.39 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -58.02 173.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -37.66 66.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.275 -0.89 . . . . 0.0 109.741 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.56 -44.09 8.81 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 79.2 p -51.83 -21.43 2.87 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 37' ' ' LEU . 1.6 tm? -85.21 -35.97 21.27 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 38' ' ' VAL . 79.5 t -85.68 4.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.768 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.83 -5.19 11.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.217 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.121 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -100.16 -45.21 5.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 109.166 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 123.95 17.16 3.13 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.121 ' CE2' HD23 ' A' ' 40' ' ' LEU . 10.0 m-85 -59.37 -151.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 108.969 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.58 166.62 16.36 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.311 -0.868 . . . . 0.0 108.854 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.65 87.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.03 -17.15 1.37 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.75 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -89.55 20.91 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.235 . . . . 0.0 109.629 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.646 ' OE2' HG23 ' A' ' 38' ' ' VAL . 13.1 mt-10 -89.75 -43.11 10.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.866 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.92 38.47 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 tpt180 -156.25 66.55 4.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HG2' HG23 ' A' ' 74' ' ' VAL . 3.1 Cg_exo -59.64 -46.43 20.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.244 1.963 . . . . 0.0 110.413 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -44.31 -26.69 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.244 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tt0 -111.64 50.57 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.178 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.75 HD11 ' O ' ' A' ' 46' ' ' GLN . 57.9 mt -141.85 -69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 142.03 -63.31 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 43.0 m95 -152.33 140.08 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -1.088 . . . . 0.0 109.38 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -131.66 159.87 37.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.938 . . . . 0.0 109.763 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.8 t30 -114.29 110.38 19.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.18 -168.85 12.29 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.203 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 40.0 t80 -111.52 114.66 27.89 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.63 75.21 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.028 . . . . 0.0 108.952 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.22 -33.88 21.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 16.4 m -55.39 -45.22 76.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.559 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -113.99 18.0 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.65 39.48 4.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 11.5 mt-10 -123.7 109.04 13.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.146 . . . . 0.0 109.135 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 17.6 ptt180 -92.63 143.97 25.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.729 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 168.67 -162.24 36.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -93.87 163.4 13.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -1.042 . . . . 0.0 109.382 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.724 ' CE2' HG11 ' A' ' 74' ' ' VAL . 3.8 p90 -163.63 158.64 17.25 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.76 124.43 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.133 1.888 . . . . 0.0 109.973 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.74 -40.92 85.01 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p -65.08 -12.06 46.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -1.204 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.0 m-85 -94.2 15.25 17.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.782 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.1 m -132.37 179.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.4 pt-20 -151.5 88.43 1.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 38.1 t80 -45.08 122.64 3.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 77' ' ' ILE . 74.7 mt -148.36 27.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -150.19 120.68 1.16 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.268 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.501 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 20.2 mtt85 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.464 -1.021 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . -163.57 -161.54 12.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.717 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 23.5 m-85 -78.1 113.52 16.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.06 . . . . 0.0 109.384 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.1 mt-30 -108.99 123.75 49.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.67 179.23 4.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.963 -1.085 . . . . 0.0 108.657 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 1.3 mtt180 -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -58.31 122.9 14.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.037 -1.039 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.8 mt -99.31 -34.07 10.47 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.0 m-85 -123.23 -166.72 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -0.807 . . . . 0.0 109.902 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 45.8 p30 -108.38 165.44 11.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.915 . . . . 0.0 109.839 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.807 ' HB2' HD22 ' A' ' 24' ' ' LEU . 7.7 t80 -173.81 106.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.405 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 12.5 ptmm? -83.57 11.58 6.95 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.649 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 69.72 115.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.223 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -90.66 -64.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.29 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.17 162.09 15.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.76 -10.87 22.06 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.96 -25.61 48.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -105.04 161.55 14.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 66' ' ' ARG . 1.4 pp -118.84 -176.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.465 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 4.7 m-20 -73.92 -179.83 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.807 HD22 ' HB2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 172.91 152.68 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.543 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.51 144.35 18.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.2 tt -48.9 148.21 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 83.57 -7.34 69.38 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 1.001 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.0 m-20 -88.06 -175.25 5.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.001 HD12 ' C ' ' A' ' 28' ' ' ASP . 2.4 mp -137.5 146.6 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.918 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.6 mp -122.38 120.84 35.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.228 -0.92 . . . . 0.0 109.125 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.93 91.49 7.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.864 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.672 HG11 ' OH ' ' A' ' 8' ' ' TYR . 87.8 t -99.87 110.63 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.0 109.024 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 97.0 m-20 -63.4 147.77 50.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.789 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 161.66 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.353 -0.842 . . . . 0.0 109.573 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 -59.87 4.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 m -52.66 -24.98 9.54 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.216 -1.167 . . . . 0.0 109.184 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.866 HD23 ' O ' ' A' ' 37' ' ' LEU . 3.2 tt -90.27 -29.36 18.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.814 . . . . 0.0 109.347 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 38' ' ' VAL . 96.8 t -89.2 0.56 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.34 -8.33 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -91.99 -17.07 25.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.718 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.38 23.07 3.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.2 m-85 -57.36 -171.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -1.15 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.9 -173.67 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.377 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.36 87.36 7.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 -31.78 2.5 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -53.8 -20.38 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -49.97 -54.47 19.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -85.31 59.31 5.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.431 -0.793 . . . . 0.0 110.033 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -153.06 57.49 2.03 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 3.3 Cg_exo -49.85 -46.89 25.56 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.774 ' HA ' HG22 ' A' ' 72' ' ' THR . 8.4 pt-20 -60.2 -33.68 72.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.06 -1.025 . . . . 0.0 109.311 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' CD ' ' HG2' ' A' ' 49' ' ' ARG . 5.4 mt-10 -99.89 1.82 43.19 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 50' ' ' PRO . 2.5 mt -94.36 -34.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 108.895 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.39 -80.52 0.31 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -140.56 144.77 36.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -1.082 . . . . 0.0 109.083 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.816 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -128.77 159.83 34.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.4 t30 -118.41 114.47 22.96 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -135.9 -160.01 8.71 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.291 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 44.5 t80 -126.17 110.03 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.669 -0.901 . . . . 0.0 109.787 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 1.2 m-20 -79.29 85.49 5.13 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.128 -0.982 . . . . 0.0 109.371 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.49 -34.94 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.761 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.4 m -51.12 -33.82 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.639 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 65' ' ' GLU . 5.6 t -121.74 7.07 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.621 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.62 47.0 87.91 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 63' ' ' THR . 81.5 mm-40 -118.26 163.22 17.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -1.187 . . . . 0.0 109.379 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.655 ' O ' HG21 ' A' ' 22' ' ' ILE . 9.1 ttp180 -148.47 127.72 12.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 167.09 -159.42 32.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.603 -1.284 . . . . 0.0 109.952 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -96.08 167.38 11.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.804 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -165.57 159.71 13.67 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.231 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.1 Cg_exo -61.62 122.55 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.073 1.848 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -41.83 73.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.4 p -60.46 -12.18 8.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.316 . . . . 0.0 109.408 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.6 m-85 -98.56 22.12 10.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.127 -0.983 . . . . 0.0 110.533 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 71' ' ' GLY . 15.4 m -138.39 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 6.4 pt-20 -148.55 84.07 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CZ ' ' HB3' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -32.54 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.758 0.79 . . . . 0.0 112.155 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 15.1 mm -129.61 -9.69 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 79' ' ' ARG . . . 81.93 -151.79 30.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.629 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.33 141.44 42.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.606 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 18.5 m-85 -86.45 123.28 31.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -1.135 . . . . 0.0 109.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.542 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -127.72 138.86 52.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 109.712 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.703 ' CE2' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -137.29 179.64 6.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.967 . . . . 0.0 109.672 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.545 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 1.4 mtm-85 -111.42 161.85 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.68 102.19 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 110.502 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 75' ' ' GLU . 2.9 mt -75.14 -39.5 60.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.1 m-85 -128.01 172.47 10.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.882 . . . . 0.0 109.855 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 9.3 p-10 -99.6 146.63 26.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 109.677 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 70' ' ' PRO . 71.8 t80 -125.24 166.21 16.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -108.24 139.32 43.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 109.423 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 15.5 ttpp -83.3 72.87 10.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 108.928 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -90.27 153.71 20.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.152 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.41 -26.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 18' ' ' ARG . 2.0 mt-10 -53.94 -59.67 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.4 p30 -77.06 169.46 18.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.81 . . . . 0.0 109.571 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.3 pp -127.77 161.77 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 0.0 109.893 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 4.5 m-20 -74.17 126.44 30.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.574 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 69' ' ' PHE . 19.0 mt -115.46 160.51 19.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.538 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 4.7 m-70 -156.56 149.95 24.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -57.52 137.52 56.19 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 109.386 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.98 -31.11 5.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 9.7 t0 -59.48 131.55 51.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -1.107 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.8 mm -93.26 140.46 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.752 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 9.8 mp -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.134 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -111.5 87.09 2.47 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.437 -0.789 . . . . 0.0 109.372 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.703 HG21 ' CE2' ' A' ' 8' ' ' TYR . 37.7 t -82.85 96.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -50.44 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.385 -0.822 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -86.93 154.08 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.626 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 88.43 -50.8 3.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -26.19 63.33 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.283 -1.128 . . . . 0.0 109.821 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 37' ' ' LEU . 2.2 tt -90.14 -35.97 15.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 38' ' ' VAL . 48.5 t -87.32 0.29 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.85 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.24 -13.99 15.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -104.05 32.2 4.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.744 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.21 51.27 55.29 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.702 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -70.83 -176.67 1.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -116.58 158.43 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -73.51 82.91 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.25 -36.94 0.6 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.1 29.31 1.24 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -90.1 -31.3 17.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.734 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -107.28 42.07 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.763 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.8 tpt180 -138.41 73.42 42.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.723 ' CG ' HG23 ' A' ' 74' ' ' VAL . 6.1 Cg_exo -56.75 -48.35 19.09 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.688 2.259 . . . . 0.0 111.878 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -56.64 -16.31 6.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.848 -1.158 . . . . 0.0 109.811 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -120.17 -5.41 9.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 109.8 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -79.86 -43.52 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.013 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.41 -76.39 0.26 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 30.7 m95 -143.74 132.75 22.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -1.045 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.853 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -119.87 158.61 26.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 110.027 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 21.1 t-20 -119.3 111.36 18.1 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -135.15 -151.7 6.32 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 31.0 t80 -130.73 113.36 14.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.915 -0.756 . . . . 0.0 109.978 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.606 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -80.71 82.07 6.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.0 109.17 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -49.51 -37.12 25.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.946 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -53.0 -44.39 67.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.647 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.503 HG21 ' NE2' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -110.43 15.86 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.75 41.49 7.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -106.99 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -1.139 . . . . 0.0 109.558 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.572 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 10.8 ttt180 -156.85 130.29 8.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 161.33 -162.91 34.15 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -92.9 174.74 7.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.991 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.76 ' HB3' HD11 ' A' ' 22' ' ' ILE . 22.3 p90 178.98 157.47 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 109.333 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.72 115.52 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.021 1.814 . . . . 0.0 109.657 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.951 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.84 -30.0 74.08 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 18.7 p -49.49 -20.67 0.77 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.817 -1.402 . . . . 0.0 109.935 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 18.2 m-85 -97.54 33.76 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 111.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 71' ' ' GLY . 16.5 m -145.41 174.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.035 -1.041 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.728 ' HB3' HD11 ' A' ' 11' ' ' LEU . 4.9 pt-20 -148.66 93.01 2.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.8 t80 -37.34 119.57 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.372 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 77' ' ' ILE . 14.2 mm -144.99 15.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.32 100.72 0.46 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.417 -1.049 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 147.64 -119.22 1.08 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 28.5 m-85 -143.31 148.22 35.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.52 -0.988 . . . . 0.0 108.472 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' CG ' HG23 ' A' ' 31' ' ' THR . 9.9 mt-30 -137.63 107.58 6.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 110.074 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.668 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.47 172.87 6.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.114 -0.991 . . . . 0.0 108.651 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB2' HD11 ' A' ' 77' ' ' ILE . 23.1 ttt180 -109.22 166.3 10.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -0.972 . . . . 0.0 108.954 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -90.64 99.36 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.024 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.61 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -80.62 -35.1 34.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.147 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 26.0 m-85 -130.76 171.3 13.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.883 . . . . 0.0 109.822 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -97.88 -177.26 3.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 65.6 t80 173.6 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -80.02 143.17 34.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 16' ' ' LYS . 14.1 pttp -59.32 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -66.18 -70.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.4 mtt180 -75.89 164.39 26.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.69 1.48 10.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 1.1 tp10 -104.81 -6.08 20.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.038 -1.039 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.474 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -102.35 154.31 19.18 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 109.824 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -108.01 -171.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 0.0 109.391 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.824 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.97 142.19 33.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.0 HD11 HD21 ' A' ' 30' ' ' LEU . 1.6 mm? -131.97 138.1 48.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.481 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -153.13 136.79 16.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -49.0 135.58 15.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 96.28 -3.69 64.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 5.1 t70 -90.12 148.97 22.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.495 ' C ' HD12 ' A' ' 30' ' ' LEU . 17.6 mm -101.68 132.15 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.859 . . . . 0.0 108.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 24' ' ' LEU . 6.5 mp -114.21 111.72 22.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.44 96.01 10.28 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.222 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.664 HG11 ' OH ' ' A' ' 8' ' ' TYR . 78.4 t -98.32 101.1 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.0 m-80 -46.99 173.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 109.891 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 1.2 ttpm? -90.35 -27.46 19.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.04 -53.92 3.55 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -54.54 -24.51 21.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.217 -1.167 . . . . 0.0 109.664 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 47' ' ' GLU . 19.6 tp -90.28 -40.83 11.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.652 ' O ' HG12 ' A' ' 38' ' ' VAL . 47.4 t -79.93 0.38 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.907 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -68.24 -6.53 24.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.858 ' N ' HD22 ' A' ' 40' ' ' LEU . 2.1 mm? -102.85 8.41 39.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.705 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.63 32.24 38.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.721 ' HE2' HG23 ' A' ' 53' ' ' ILE . 24.6 m-85 -58.29 -168.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.39 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.07 167.89 14.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.539 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.0 107.67 7.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.55 19.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD11 ' A' ' 53' ' ' ILE . 11.7 mm-40 -82.19 -41.15 20.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.261 -1.14 . . . . 0.0 109.579 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.2 pm0 -42.51 -43.89 3.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.442 -0.786 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -85.54 43.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.469 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -151.53 62.63 5.01 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HB2' HG23 ' A' ' 74' ' ' VAL . 2.8 Cg_exo -54.64 -55.55 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.469 2.113 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.7 -23.45 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.032 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.0 mt-10 -121.44 48.37 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 42' ' ' PHE . 4.9 mt -133.08 -43.91 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -75.65 0.26 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 48.5 m95 -144.19 123.57 13.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.378 -1.072 . . . . 0.0 109.576 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.732 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -112.95 156.47 22.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' VAL . 14.5 t-20 -112.21 107.69 16.65 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.627 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.18 -163.94 11.21 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.0 t80 -122.32 113.27 19.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.767 -0.843 . . . . 0.0 110.147 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 1.2 m120 -78.96 82.71 5.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.192 -0.943 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -45.19 -41.93 8.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.067 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m -47.88 -69.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 t -79.76 4.91 14.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.963 . . . . 0.0 109.698 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.75 50.15 38.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -128.84 171.52 12.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -1.128 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' C ' HG21 ' A' ' 22' ' ' ILE . 12.2 ttp85 -143.21 143.8 31.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 162.88 -167.36 37.25 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.573 -1.298 . . . . 0.0 109.923 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.0 p30 -91.49 171.85 8.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -1.062 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 13.5 p90 -175.13 154.01 1.64 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.875 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -58.4 124.51 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.985 1.79 . . . . 0.0 109.765 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.732 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -71.62 -18.83 77.49 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -70.49 -13.85 62.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.694 -1.474 . . . . 0.0 109.68 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.598 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 10.7 m-30 -99.9 19.3 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 50' ' ' PRO . 2.7 m -132.39 -174.02 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.81 -1.181 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.53 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.8 pt-20 -158.19 88.02 0.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.557 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 14.2 t80 -43.13 133.31 3.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.907 . . . . 0.0 109.31 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.8 mp -129.06 -4.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.876 -1.14 . . . . 0.0 109.931 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 171.66 167.29 31.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.518 ' CA ' ' OH ' ' A' ' 76' ' ' TYR . 2.6 ptt-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.54 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.34 148.84 17.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.671 ' CD1' HD22 ' A' ' 37' ' ' LEU . 52.5 m-85 -84.57 121.35 27.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -1.076 . . . . 0.0 109.265 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 3.7 mt-30 -116.87 129.98 56.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.636 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -118.88 174.65 6.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.945 . . . . 0.0 109.926 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.826 ' HB2' HD11 ' A' ' 77' ' ' ILE . 1.8 ttp85 -117.11 126.71 53.26 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -54.4 133.22 45.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.573 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.7 mt -108.93 -38.79 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 3.8 m-85 -116.48 -160.43 0.76 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -124.52 146.6 48.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.909 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 24' ' ' LEU . 63.9 t80 -156.33 111.23 2.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.21 121.91 25.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -48.67 114.6 1.01 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG3' ' OD2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -90.57 -72.07 0.59 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.203 -0.936 . . . . 0.0 108.612 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.67 166.06 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 109.143 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -9.62 18.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 109.883 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.59 -23.04 40.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.095 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -108.55 158.4 17.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.8 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 60' ' ' ASN . 15.4 pt -111.29 -169.54 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.564 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -106.61 109.0 20.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.824 . . . . 0.0 109.527 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -113.58 148.08 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.18 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 2.0 m80 -154.01 141.49 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 109.39 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.5 tp -41.59 136.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.679 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.32 1.64 81.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.781 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.4 m-20 -90.42 169.18 11.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -1.156 . . . . 0.0 109.473 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.596 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mm -122.92 132.54 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.183 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.985 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.5 mp -115.61 128.59 56.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.066 -1.021 . . . . 0.0 109.116 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -110.42 79.77 1.24 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.392 -0.818 . . . . 0.0 109.149 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 37' ' ' LEU . 74.7 t -80.25 117.12 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -53.3 -173.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 37' ' ' LEU . 6.3 mtmt -90.17 -62.47 1.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.427 -0.796 . . . . 0.0 109.938 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.67 -54.49 37.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -19.7 3.56 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.213 -1.169 . . . . 0.0 109.32 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.75 HD21 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -84.57 -36.85 21.82 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 38' ' ' VAL . 21.9 t -85.02 -4.06 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.344 -0.848 . . . . 0.0 109.886 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.1 -24.1 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.055 -1.028 . . . . 0.0 108.605 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -88.78 33.19 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.624 -0.673 . . . . 0.0 109.848 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 47.51 29.55 5.61 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.658 ' CE1' HG23 ' A' ' 53' ' ' ILE . 6.8 m-30 -47.62 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.822 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -100.86 -174.35 2.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.181 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.98 103.92 16.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.787 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 12.59 77.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' SER . 6.8 tt0 -90.3 29.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -1.2 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.75 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -86.55 -13.12 46.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -79.08 4.52 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.094 -1.004 . . . . 0.0 109.396 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 mtt180 -131.28 63.2 69.11 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 108.943 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' CB ' HD11 ' A' ' 56' ' ' LEU . 4.7 Cg_exo -59.0 -24.68 74.51 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.25 1.967 . . . . 0.0 110.397 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.71 ' CA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -69.03 -43.34 74.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.121 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.0 mt-10 -79.79 -6.79 57.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.154 -0.966 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -79.71 -42.39 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 108.697 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.8 -74.34 0.26 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 21.7 m95 -147.67 122.75 10.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -1.031 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -104.9 153.78 20.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.028 -1.045 . . . . 0.0 108.983 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.666 ' O ' HG13 ' A' ' 32' ' ' VAL . 5.7 t-20 -122.01 121.95 38.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 32' ' ' VAL . . . -146.88 -146.98 4.46 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -123.57 110.16 14.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.54 -0.977 . . . . 0.0 110.131 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.965 ' HB3' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -78.32 82.38 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 108.539 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -53.02 -35.04 59.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 110.122 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 28' ' ' ASP . 19.7 m -53.38 -39.81 64.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 109.714 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.965 HG22 ' HB3' ' A' ' 60' ' ' ASN . 14.8 t -108.93 6.59 25.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.82 48.53 56.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 63' ' ' THR . 37.1 mm-40 -135.7 171.91 13.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -1.184 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 25.1 ttt180 -141.59 146.45 36.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 22' ' ' ILE . . . 159.85 -159.05 30.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -106.5 175.46 5.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.947 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.985 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -173.17 162.03 3.52 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 6.1 Cg_exo -58.35 119.14 6.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.929 1.753 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.14 -29.81 66.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.71 HG22 ' CA ' ' A' ' 51' ' ' GLU . 27.9 p -69.45 -7.02 34.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -1.233 . . . . 0.0 109.15 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -100.26 -5.37 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 110.194 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.5 m -111.29 172.87 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 6.0 pt-20 -136.25 87.55 2.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.237 -0.915 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.605 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 91.4 t80 -42.64 143.54 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 9' ' ' ARG . 3.6 mt -145.2 16.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 83.69 -122.57 5.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 109.495 179.977 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.45 156.69 5.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.617 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 46.0 m-85 -107.06 115.99 31.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -1.192 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.775 ' CG ' HG23 ' A' ' 31' ' ' THR . 28.3 mt-30 -93.39 127.85 39.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.45 177.32 4.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.795 -1.191 . . . . 0.0 111.315 -179.897 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -114.23 124.85 53.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.825 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -61.3 116.66 4.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.7 mt -82.73 -36.14 26.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.571 -0.706 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 3.3 m-85 -120.83 -137.68 0.33 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.396 -0.815 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -144.16 -177.01 5.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 1.6 t80 -170.03 135.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.69 8.08 45.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.912 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 4.7 tttt 61.52 108.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 0.0 109.893 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -61.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 32.1 mtm-85 -90.41 139.63 30.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' ARG . 46.0 tt0 -40.93 -35.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -54.51 -59.53 4.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -64.52 165.34 10.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 110.022 -179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.605 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.6 pt -129.53 172.33 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.65 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.2 m-20 -69.62 115.91 9.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.9 . . . . 0.0 109.921 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -104.94 157.88 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.677 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -160.1 143.14 13.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.665 -1.272 . . . . 0.0 110.204 -179.929 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -55.49 139.25 44.36 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.232 -0.918 . . . . 0.0 109.394 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 29' ' ' ILE . . . 89.59 -33.07 4.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 25' ' ' HIS . 7.6 t0 -68.38 121.25 15.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -1.066 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.962 ' C ' HD23 ' A' ' 30' ' ' LEU . 2.9 mp -88.37 165.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.78 147.43 42.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.049 -1.032 . . . . 0.0 108.235 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.775 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -108.25 93.21 4.41 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.679 -0.638 . . . . 0.0 109.764 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 47.3 t -92.89 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.117 -0.99 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -54.65 138.7 40.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.855 . . . . 0.0 109.682 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 6.5 pttt -59.01 144.54 44.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.295 -0.878 . . . . 0.0 108.995 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.14 -58.5 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 33' ' ' ASN . 2.6 p -46.6 -26.01 0.82 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.152 -1.205 . . . . 0.0 108.747 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.017 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -85.25 -40.61 16.43 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 38' ' ' VAL . 21.4 t -70.96 -4.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -82.53 -54.94 4.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.01 20.02 4.2 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.783 ' HE2' HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -56.77 -68.28 0.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.571 -1.546 . . . . 0.0 108.143 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 13.8 t -158.2 130.91 7.21 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.13 117.95 9.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 0.0 109.669 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.76 -1.47 55.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 1.8 tt0 -86.39 30.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.095 -1.238 . . . . 0.0 110.076 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.737 ' HA ' HD22 ' A' ' 37' ' ' LEU . 8.1 mt-10 -88.14 20.53 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -105.24 -21.8 13.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -113.72 82.01 6.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.881 ' HA ' HD12 ' A' ' 53' ' ' ILE . 4.2 Cg_exo -59.62 -52.58 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -44.79 -27.47 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -105.51 47.03 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.971 HD13 ' CD2' ' A' ' 37' ' ' LEU . 58.7 mt -144.18 -49.69 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.5 -70.33 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 31.6 m95 -143.84 152.65 41.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.94 144.29 45.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.465 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 16.9 t-20 -110.34 106.19 15.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.31 -163.88 10.82 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.036 -1.554 . . . . 0.0 111.296 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 122.161 -0.611 . . . . 0.0 109.857 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.91 ' OD1' HD22 ' A' ' 30' ' ' LEU . 4.3 m-80 -77.04 91.12 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.838 -1.164 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.38 -37.29 62.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.487 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 10.7 m -51.71 -45.36 63.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.197 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 60' ' ' ASN . 2.5 t -107.25 9.57 30.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.52 53.61 5.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -129.51 151.85 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -1.196 . . . . 0.0 109.806 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.38 124.91 43.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 108.948 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -179.2 -166.64 35.4 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.471 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -104.22 166.93 10.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.966 . . . . 0.0 109.852 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CE2' ' CD1' ' A' ' 30' ' ' LEU . 5.0 p90 -167.95 160.03 9.55 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -59.85 128.6 27.36 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.221 1.947 . . . . 0.0 110.61 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -36.26 60.24 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 2.7 p -64.85 -9.82 23.75 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.031 -1.276 . . . . 0.0 109.242 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.6 m-85 -96.41 15.36 21.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.968 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.6 m -139.74 -177.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HD21 ' A' ' 11' ' ' LEU . 15.5 pt-20 -156.43 89.92 1.15 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.7 t80 -36.9 132.92 0.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.619 -0.675 . . . . 0.0 109.527 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG21 ' NH1' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -119.13 -15.55 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.994 . . . . 0.0 109.509 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 -124.31 5.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.085 -1.244 . . . . 0.0 109.505 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 34' ' ' LYS . 2.2 mt-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.344 0.592 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.92 -179.92 52.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.643 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 2.5 m-85 -99.69 136.82 39.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -1.146 . . . . 0.0 109.392 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 78' ' ' GLY . 1.2 mt-30 -129.94 108.74 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 108.941 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -101.82 -178.94 3.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.001 -1.062 . . . . 0.0 110.483 -179.873 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -123.51 139.77 53.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . . . -64.31 98.67 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.016 -1.053 . . . . 0.0 110.562 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.661 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 4.6 mt -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 108.588 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.661 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 28.6 m-85 -140.11 -164.13 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -115.67 148.2 39.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' HD22 ' A' ' 24' ' ' LEU . 45.1 t80 -150.64 108.92 3.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 17' ' ' GLU . 19.4 tptt -79.8 149.37 31.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 2.1 tttp -52.55 89.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' LYS . 42.5 mm-40 -77.97 -68.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.0 mtt180 -89.6 164.65 14.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.277 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.48 2.2 10.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.232 -0.918 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -106.07 -2.71 22.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.067 -1.02 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 p-10 -115.17 167.64 10.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.977 -1.077 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.528 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -111.92 -171.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.663 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -103.4 98.38 8.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -0.814 . . . . 0.0 109.348 179.918 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.678 HD23 ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -96.87 161.99 13.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.54 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 5.7 m-70 -156.33 149.75 24.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.146 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 6.4 tt -54.02 140.77 30.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.933 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -30.25 6.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.866 ' OD1' ' HB2' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.73 166.72 12.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 109.606 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 28' ' ' ASP . 7.4 mm -119.29 141.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.953 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.4 mp -110.43 123.64 50.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.3 88.63 3.02 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.784 HG22 ' CA ' ' A' ' 58' ' ' GLY . 74.3 t -96.55 95.5 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.468 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' VAL . 2.2 m120 -42.0 165.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 109.948 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -87.26 150.69 23.72 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.338 -0.851 . . . . 0.0 109.408 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.27 -61.72 2.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -55.61 -19.52 10.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.299 -1.118 . . . . 0.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.604 ' CD1' HG11 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -89.71 -30.62 17.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.47 -0.769 . . . . 0.0 109.409 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.574 HG23 ' CG ' ' A' ' 47' ' ' GLU . 18.8 t -87.87 -2.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -3.93 20.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 42' ' ' PHE . 5.9 mt -84.26 -25.68 29.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 122.06 4.2 9.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.038 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 20.0 m-85 -53.08 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.602 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.536 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -116.58 118.36 32.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 43' ' ' SER . 11.1 t70 -24.3 88.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.303 0.573 . . . . 0.0 111.259 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 139.53 -7.73 3.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.907 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.1 tp60 -90.51 -0.89 57.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.296 . . . . 0.0 110.04 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 22.1 mt-10 -66.92 -10.0 44.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 0.0 109.57 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.892 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -114.36 19.2 16.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -128.72 61.69 56.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.0 Cg_exo -57.62 -38.96 91.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.228 1.952 . . . . 0.0 110.323 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -64.37 -28.33 69.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 16.9 mm-40 -101.64 -5.24 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.038 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 18.6 mt -83.44 -88.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.283 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.808 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 155.8 -55.05 0.41 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 29.2 m95 -153.27 138.4 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -1.046 . . . . 0.0 109.395 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -135.01 143.04 46.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.795 -179.964 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 1.4 t-20 -94.51 102.98 14.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.784 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.98 175.93 15.89 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.723 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.5 t80 -109.25 106.92 16.97 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.815 -0.815 . . . . 0.0 109.519 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' ND2' ' CD1' ' A' ' 22' ' ' ILE . 1.6 m-80 -78.12 89.31 4.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 108.971 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -57.63 -36.86 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.004 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m -49.47 -33.04 13.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 6.6 9.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.2 39.41 70.92 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -107.7 157.02 18.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 13.0 tpt180 -139.16 114.43 9.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 108.868 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -175.4 -165.35 31.39 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.046 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.556 ' OD2' ' CE3' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -97.81 164.31 12.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -1.01 . . . . 0.0 109.783 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.953 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.2 p90 -160.07 162.66 23.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.612 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.46 124.89 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.922 1.748 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.45 -33.73 63.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -68.09 -8.2 36.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.984 -1.304 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.0 m-85 -99.06 -7.75 26.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.114 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 71' ' ' GLY . 24.1 m -109.34 176.11 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 5.7 pt-20 -142.11 89.33 2.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.437 -0.79 . . . . 0.0 108.957 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.892 ' CD2' ' HB1' ' A' ' 48' ' ' ALA . 60.4 t80 -38.71 125.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.549 -0.72 . . . . 0.0 109.921 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -152.57 17.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -121.38 105.1 0.99 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 10.4 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 4.6 tm-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . -169.23 -51.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 21.6 m-85 -137.53 105.04 5.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.92 . . . . 0.0 108.691 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' CG ' HG23 ' A' ' 31' ' ' THR . 10.2 mt-30 -99.64 123.12 43.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 110.047 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.648 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -112.91 170.19 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.071 -1.018 . . . . 0.0 108.967 179.878 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.548 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 13.3 ttp180 -105.68 145.47 31.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 108.97 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -74.13 96.95 2.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.923 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 18.6 mt -64.26 -29.75 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.618 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 6.5 m-85 -130.01 -159.34 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.139 -0.976 . . . . 0.0 110.16 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -117.59 -167.81 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -176.44 156.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.893 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -119.33 27.11 9.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 0.0 110.399 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.532 ' CB ' ' OD1' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 42.26 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.105 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 18' ' ' ARG . 17.4 mt-10 -126.9 -50.2 1.46 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.053 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 55' ' ' TRP . 0.2 OUTLIER -39.79 161.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.542 -0.724 . . . . 0.0 110.274 179.97 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -28.99 -68.25 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.595 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 5.3 mm-40 -131.16 48.68 2.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.808 -1.182 . . . . 0.0 111.005 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 56.1 p-10 -95.85 154.99 16.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.164 . . . . 0.0 108.853 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 22' ' ' ILE . 1.2 pp -104.09 171.35 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 110.042 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -64.82 170.3 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.943 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -153.27 146.84 25.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.528 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -156.25 138.98 15.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.681 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -55.35 122.27 10.79 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.43 -5.36 28.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.695 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.2 m-20 -90.24 163.63 14.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -1.166 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.706 ' C ' HD12 ' A' ' 30' ' ' LEU . 14.1 mm -119.24 140.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 24' ' ' LEU . 5.8 mp -118.9 113.85 21.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.485 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -88.09 105.78 17.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.561 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 58' ' ' GLY . 71.7 t -115.75 91.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.699 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.519 ' HA ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t-20 -42.82 159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.931 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -83.75 145.43 28.72 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 98.79 -55.4 1.01 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -45.85 -27.36 0.85 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.267 -1.137 . . . . 0.0 108.877 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 42' ' ' PHE . 0.6 OUTLIER -90.06 -35.72 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.964 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.575 ' O ' HG12 ' A' ' 38' ' ' VAL . 42.0 t -79.23 3.89 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 109.659 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.35 -13.2 17.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.832 ' N ' HD22 ' A' ' 40' ' ' LEU . 1.2 mm? -96.85 -19.72 18.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.089 -1.007 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 117.77 25.32 3.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.703 ' HE2' HG23 ' A' ' 53' ' ' ILE . 5.9 m-85 -51.65 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -1.042 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -160.5 -162.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.147 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 11.4 t70 -90.14 62.39 5.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.177 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 34.68 2.57 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -82.42 6.66 16.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 109.557 -179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' OE2' ' CZ ' ' A' ' 8' ' ' TYR . 3.9 tm-20 -67.7 -7.01 23.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -84.99 16.96 3.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.988 -1.07 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -125.69 59.36 26.7 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.126 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.547 ' CB ' HG23 ' A' ' 74' ' ' VAL . 3.0 Cg_exo -50.13 -59.78 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.153 1.902 . . . . 0.0 110.337 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.639 ' HA ' HG22 ' A' ' 72' ' ' THR . 4.2 tt0 -66.65 -17.15 64.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 108.679 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.2 mm-40 -108.67 22.69 15.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.703 HG23 ' HE2' ' A' ' 42' ' ' PHE . 5.5 mt -118.39 -45.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 108.945 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.97 -74.32 0.29 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 18' ' ' ARG . 12.5 m95 -141.78 147.02 36.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -1.084 . . . . 0.0 109.121 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.764 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -136.89 159.58 41.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 32' ' ' VAL . 10.8 t30 -111.76 100.79 9.22 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -119.62 178.46 16.55 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CG ' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -112.43 113.27 25.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.654 -0.909 . . . . 0.0 109.893 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 37.0 m-80 -89.44 64.43 6.75 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 62' ' ' THR . 4.1 mt-10 -45.94 -28.3 1.1 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.023 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.695 HG21 ' CG ' ' A' ' 28' ' ' ASP . 8.3 m -47.19 -54.97 9.39 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.8 t -87.3 -10.21 52.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.67 40.29 11.04 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 8.2 mm-40 -138.89 164.88 28.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.057 -1.261 . . . . 0.0 109.257 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 52.2 ttp85 -145.69 115.3 7.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.63 -159.07 10.06 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -87.81 165.63 15.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.945 . . . . 0.0 110.091 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.7 p90 -172.13 159.23 4.33 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.802 . . . . 0.0 109.313 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.7 Cg_exo -61.44 126.05 18.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.176 1.918 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -71.68 -32.94 63.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -64.84 -9.94 24.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.083 -1.245 . . . . 0.0 109.43 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.9 m-85 -98.73 15.95 23.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.789 HG11 ' HE2' ' A' ' 69' ' ' PHE . 18.1 m -134.94 -177.94 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.085 -1.009 . . . . 0.0 110.534 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 4.5 pt-20 -147.03 89.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 33.3 t80 -49.65 123.88 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.58 -16.8 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.985 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 111.65 -160.48 13.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.56 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.577 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . 178.6 -143.39 5.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 47' ' ' GLU . 60.0 m-85 -158.75 141.21 14.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.494 -1.004 . . . . 0.0 108.959 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -154.81 114.36 3.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 109.43 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 1.085 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -109.8 170.93 7.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.758 ' CB ' HD11 ' A' ' 77' ' ' ILE . 1.6 tpp180 -112.83 116.7 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -43.44 158.02 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.68 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.62 HD21 ' OE1' ' A' ' 75' ' ' GLU . 14.5 mt -135.92 -41.17 0.67 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 12.3 m-85 -125.33 169.96 11.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.548 -0.72 . . . . 0.0 109.765 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p30 -102.87 139.39 38.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.559 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 34.4 t80 -134.78 131.33 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.213 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.99 120.43 24.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.556 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.1 pttt -56.29 91.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.824 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -55.72 -68.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.33 159.33 16.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.157 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.31 -12.98 10.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.075 -1.016 . . . . 0.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -31.24 62.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -96.01 149.29 21.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 109.5 -179.989 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.644 HD11 ' CG ' ' A' ' 60' ' ' ASN . 1.4 pp -105.37 175.84 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.579 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 4.0 m-20 -80.18 115.8 19.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 109.894 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -94.08 147.01 23.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 108.725 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.654 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER -152.49 127.57 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.536 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.674 HD23 ' C ' ' A' ' 26' ' ' LEU . 5.5 tt -43.64 141.19 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.97 1.11 88.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.581 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 12.5 t0 -82.32 152.45 26.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 6.4 mm -104.37 124.57 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.035 . . . . 0.0 109.071 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 24' ' ' LEU . 6.8 mp -111.81 106.78 15.63 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 109.555 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.49 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -88.93 95.82 10.47 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.262 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 40.7 t -93.65 116.02 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.467 -0.771 . . . . 0.0 109.451 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -87.36 -179.31 6.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 146.95 31.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.06 -62.38 2.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -21.07 29.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.28 -1.129 . . . . 0.0 108.949 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.588 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -90.09 -35.3 15.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.284 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 38' ' ' VAL . 40.0 t -77.17 2.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.486 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -60.89 -11.93 9.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.938 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -102.64 36.63 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.001 -1.062 . . . . 0.0 109.39 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 48.3 25.09 4.02 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.938 ' CE2' HD23 ' A' ' 40' ' ' LEU . 6.1 m-30 -48.4 -178.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.572 -0.957 . . . . 0.0 109.858 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -122.83 106.12 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 43' ' ' SER . 13.4 t0 -27.72 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.312 0.577 . . . . 0.0 110.97 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 147.46 -23.07 1.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.602 ' HG2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -89.96 -2.94 58.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.12 -1.224 . . . . 0.0 110.309 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -42.99 -49.79 5.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.435 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.26 46.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.09 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.548 ' CD ' ' HB3' ' A' ' 52' ' ' GLU . 55.5 ttt180 -151.34 59.37 3.25 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.078 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 3.0 Cg_endo -60.03 -47.49 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.268 1.979 . . . . 0.0 110.453 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 52' ' ' GLU . 24.1 pt-20 -47.89 -46.87 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HB3' ' CD ' ' A' ' 49' ' ' ARG . 1.4 tt0 -99.5 47.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.181 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.825 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -130.56 -39.58 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.953 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.4 -79.41 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -138.6 137.32 36.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.631 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -121.78 168.21 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 109.794 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.679 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.3 t-20 -119.6 119.49 33.9 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.43 -172.94 15.37 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.088 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 50.1 t80 -114.85 109.11 17.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.465 -1.021 . . . . 0.0 109.763 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.644 ' CG ' HD11 ' A' ' 22' ' ' ILE . 15.9 m120 -79.05 85.9 4.93 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.189 -0.944 . . . . 0.0 109.0 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.447 -0.783 . . . . 0.0 110.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 21.9 m -53.58 -35.88 61.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.654 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -116.87 10.52 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 42.44 53.95 4.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -141.93 115.32 8.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.24 136.77 32.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 109.247 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.599 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 176.96 -160.5 27.67 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.244 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 8.4 m-20 -96.33 163.98 12.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -1.06 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.642 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 p90 -164.36 158.99 15.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.879 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.3 Cg_exo -61.19 117.43 4.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.249 1.966 . . . . 0.0 109.981 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.848 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.12 -34.83 82.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 2.9 p -63.26 -19.99 65.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.971 -1.311 . . . . 0.0 110.03 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 7.2 m-30 -93.41 17.98 10.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.598 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 71' ' ' GLY . 30.7 m -131.02 170.12 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.097 -1.002 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' OE1' HD21 ' A' ' 11' ' ' LEU . 7.6 pt-20 -137.6 87.38 2.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.282 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CE2' ' N ' ' A' ' 78' ' ' GLY . 65.8 t80 -41.04 141.11 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.758 HD11 ' CB ' ' A' ' 9' ' ' ARG . 3.3 mt -139.36 8.99 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 97.33 -140.33 14.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.408 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.61 -168.13 19.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 28.7 m-85 -80.02 106.35 11.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -1.083 . . . . 0.0 109.753 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.753 ' HG2' HG23 ' A' ' 31' ' ' THR . 1.4 mt-30 -102.56 128.04 49.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.31 173.15 6.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 0.0 109.972 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.87 142.26 46.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -64.93 151.31 46.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.896 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.772 HD21 ' CD ' ' A' ' 75' ' ' GLU . 13.3 mt -134.2 -41.8 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.624 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.0 m-85 -118.77 -142.8 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.554 -0.717 . . . . 0.0 109.541 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -144.77 173.96 11.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.89 -1.132 . . . . 0.0 109.957 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 47.6 t80 -173.59 141.51 0.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.4 -0.813 . . . . 0.0 108.911 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' GLU . 1.4 mttt -101.94 133.44 46.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.03 -1.043 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 21' ' ' ASP . 3.7 ttpm? -58.63 88.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 109.528 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 15' ' ' LYS . 60.8 tt0 -90.1 -73.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.1 mtt180 -61.66 157.9 16.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 26.2 tp10 -74.75 1.95 11.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.117 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.418 ' HG2' ' OD2' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -111.38 -1.06 16.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.061 -1.024 . . . . 0.0 110.042 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 52.3 p30 -110.99 164.63 12.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.997 -1.064 . . . . 0.0 109.6 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.803 HD12 ' ND2' ' A' ' 60' ' ' ASN . 2.1 pt -126.38 -170.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 1.2 m-20 -84.9 134.5 34.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.634 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -128.12 138.28 52.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.076 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -153.46 138.75 17.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.062 -1.024 . . . . 0.0 109.62 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 tt -54.21 147.55 12.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.35 -0.844 . . . . 0.0 109.779 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 90.65 -9.89 76.29 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.892 ' O ' HD13 ' A' ' 29' ' ' ILE . 1.8 m-20 -86.54 178.12 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.163 . . . . 0.0 109.83 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 28' ' ' ASP . 5.7 mm -129.5 140.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.115 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -121.42 130.13 53.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.971 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.753 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -106.94 93.82 4.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.884 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.952 ' CG1' HD12 ' A' ' 37' ' ' LEU . 56.4 t -101.11 115.03 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -68.47 160.95 28.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.05 2.55 17.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.886 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.58 -49.6 0.47 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -54.84 -25.69 30.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -1.168 . . . . 0.0 109.641 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.952 HD12 ' CG1' ' A' ' 32' ' ' VAL . 1.3 tt -90.38 -34.08 15.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 38' ' ' VAL . 71.4 t -80.75 2.27 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.066 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.5 4.23 7.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 109.988 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -111.44 5.1 19.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.047 . . . . 0.0 109.975 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.09 34.26 6.87 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.774 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -69.88 -169.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.81 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.524 ' O ' ' C ' ' A' ' 44' ' ' ASP . 58.8 m -125.93 90.11 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.913 0.864 . . . . 0.0 109.198 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.74 87.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.409 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 148.61 -23.95 1.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.483 ' NE2' ' HB3' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -90.33 -12.39 37.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.058 -1.26 . . . . 0.0 110.01 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.825 ' OE1' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -43.37 -39.76 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.933 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.59 40.94 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -148.08 60.34 5.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 5.0 Cg_exo -59.0 -41.93 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.358 2.039 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HA ' HG22 ' A' ' 72' ' ' THR . 16.8 pt-20 -57.01 -16.5 7.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.7 mt-10 -120.07 -5.75 10.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.895 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.774 HG23 ' CE2' ' A' ' 42' ' ' PHE . 3.2 mt -79.6 -34.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 109.161 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 -71.6 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -141.5 124.93 16.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -1.046 . . . . 0.0 109.407 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -113.82 156.44 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.816 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.534 ' ND2' ' OD1' ' A' ' 68' ' ' ASP . 3.1 t-20 -113.05 106.92 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.604 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.52 -158.65 9.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.588 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 38.8 t80 -124.8 108.72 12.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.674 -0.897 . . . . 0.0 109.863 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.803 ' ND2' HD12 ' A' ' 22' ' ' ILE . 1.4 m-20 -79.4 90.83 5.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.302 -0.874 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.06 -37.93 67.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 96.5 m -57.51 -45.77 84.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.326 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.4 p -93.81 4.89 53.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.68 48.75 8.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -140.2 166.35 24.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.621 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 30.9 ttp180 -134.11 140.87 46.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 165.6 -163.24 36.51 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.232 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 43.6 m-20 -94.19 170.74 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.976 . . . . 0.0 109.784 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.652 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 9.9 p90 -172.77 158.59 3.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.354 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.83 121.39 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.15 1.9 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.782 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -72.08 -34.37 61.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 51' ' ' GLU . 17.0 p -66.3 -8.97 28.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.304 . . . . 0.0 109.048 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.624 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.54 9.56 39.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 30' ' ' LEU . 4.5 m -128.06 -174.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.772 ' CD ' HD21 ' A' ' 11' ' ' LEU . 15.9 pt-20 -160.21 92.74 1.01 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.604 -0.685 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 75' ' ' GLU . 5.1 t80 -33.19 115.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.569 0.7 . . . . 0.0 110.547 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 77' ' ' ILE . 10.4 mm -144.11 16.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -129.35 115.22 1.89 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.251 -1.147 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.93 163.1 11.88 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 26.3 m-85 -80.91 123.74 28.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -115.56 115.65 26.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.7 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -104.96 175.56 5.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.062 -1.024 . . . . 0.0 109.093 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -112.53 174.35 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 108.849 179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.37 152.42 21.01 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.2 mt -137.79 -38.56 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.577 ' HB2' ' CG ' ' A' ' 73' ' ' TYR . 4.5 m-85 -122.82 176.02 6.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.383 -0.823 . . . . 0.0 109.78 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -100.63 171.86 7.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 3.1 t80 -161.96 146.75 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.6 ttpt -107.99 17.95 21.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 21' ' ' ASP . 16.1 ttmt 59.5 71.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.806 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.5 tp10 -72.4 -73.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.7 mtp85 -53.8 144.23 18.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.35 -7.66 10.43 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -103.68 -22.76 13.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.006 -1.059 . . . . 0.0 110.441 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 16' ' ' LYS . 48.1 p30 -73.77 -179.82 3.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 0.0 109.82 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.622 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.3 pp -138.11 159.4 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.2 m-20 -60.24 145.0 48.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.786 HD11 ' CB ' ' A' ' 69' ' ' PHE . 10.2 mt -135.4 157.75 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.868 . . . . 0.0 109.37 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.838 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -160.01 128.87 5.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 109.151 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -47.94 124.77 7.92 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 109.737 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.33 -18.79 11.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.642 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -90.3 160.58 16.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.86 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 mt -115.96 157.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.92 HD23 ' CE2' ' A' ' 69' ' ' PHE . 3.2 mp -130.77 121.41 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.279 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 102.62 14.93 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.779 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.7 HG11 ' OH ' ' A' ' 8' ' ' TYR . 75.6 t -102.32 117.91 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -50.59 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 12.7 mtpt -90.29 -73.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -54.58 -24.21 30.96 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -58.82 -40.74 85.05 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.081 -1.246 . . . . 0.0 109.883 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.8 tp -90.09 -29.52 18.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 38' ' ' VAL . 58.3 t -90.15 3.16 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.908 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -66.53 -7.67 21.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.37 15.63 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.096 -1.003 . . . . 0.0 109.773 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.4 41.61 25.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.96 ' CE2' HG23 ' A' ' 53' ' ' ILE . 5.1 m-85 -64.77 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -139.27 156.21 47.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.34 120.75 10.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.61 -31.77 6.42 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.3 mp0 -76.48 -40.08 51.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -1.169 . . . . 0.0 109.462 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.79 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.86 -27.05 66.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -84.71 -19.7 32.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -113.55 77.87 3.44 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.329 179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.654 ' HG2' HG23 ' A' ' 74' ' ' VAL . 4.2 Cg_exo -57.73 -32.71 95.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.096 1.864 . . . . 0.0 110.238 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.7 tt0 -60.39 -32.43 71.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.018 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.37 -6.64 43.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.96 HG23 ' CE2' ' A' ' 42' ' ' PHE . 16.2 mt -79.71 -54.34 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.71 -69.69 0.52 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.421 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 23.9 m95 -144.18 141.27 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.55 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -138.68 139.83 38.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' VAL . 10.6 t30 -90.25 99.21 12.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -112.38 166.29 12.17 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.346 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -101.95 106.58 17.53 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.764 -0.845 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 2.6 m-80 -78.48 78.45 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -49.27 -36.56 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.814 . . . . 0.0 109.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.642 HG21 ' CG ' ' A' ' 28' ' ' ASP . 20.4 m -51.51 -61.08 2.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.379 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.838 HG21 ' CE1' ' A' ' 25' ' ' HIS . 1.9 p -91.69 13.18 18.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.53 54.35 4.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 18.4 pt-20 -139.23 121.81 16.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.646 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.64 128.43 43.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -174.39 -179.53 45.06 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -88.94 165.02 14.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 109.59 180.0 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.92 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.8 p90 -165.67 162.84 13.05 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.644 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 2.2 Cg_endo -63.71 120.55 7.98 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.86 1.707 . . . . 0.0 109.254 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.706 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -64.35 -19.18 64.03 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.514 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -72.57 -20.03 61.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.902 -1.352 . . . . 0.0 109.927 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.577 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 7.3 m-30 -92.92 7.36 44.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 0.0 110.584 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.654 HG23 ' HG2' ' A' ' 50' ' ' PRO . 13.3 m -118.4 -172.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.946 -1.097 . . . . 0.0 109.621 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HB3' HD11 ' A' ' 11' ' ' LEU . 10.5 pt-20 -155.74 86.16 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.4 t80 -40.37 136.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 9' ' ' ARG . 5.1 mt -119.78 -4.28 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 109.859 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 130.48 -162.48 23.27 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HD2' ' C ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.83 -165.63 11.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.603 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 56.4 m-85 -80.43 110.36 15.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.584 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.2 mt-30 -87.48 124.42 33.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HD2' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -104.58 -177.11 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.01 -1.057 . . . . 0.0 110.131 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 3.8 ttm180 -126.32 130.96 51.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -65.48 123.5 19.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.778 -1.201 . . . . 0.0 110.056 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.625 HD21 ' CD ' ' A' ' 75' ' ' GLU . 10.5 mt -99.79 -42.41 6.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 7.2 m-85 -124.12 -158.68 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.503 -0.748 . . . . 0.0 109.566 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 6.2 p-10 -123.37 171.97 9.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.686 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 26.1 t80 -167.76 113.54 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.8 mmtp -80.21 132.81 35.94 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.062 -1.024 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 4.4 mtpm? -41.87 106.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.853 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -133.2 -33.96 1.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -75.55 145.6 41.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.85 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.477 ' HG3' ' OE1' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -41.96 -33.63 0.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.697 -0.627 . . . . 0.0 110.743 -179.98 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.477 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -137.35 58.06 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.924 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 3.4 p-10 -119.2 173.48 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.916 -1.115 . . . . 0.0 108.92 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.684 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -126.0 179.05 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 109.95 179.982 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.577 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 1.2 m-20 -85.91 108.82 18.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.3 mm? -95.07 144.13 25.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.659 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -155.18 128.4 8.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.11 -0.994 . . . . 0.0 109.66 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 3.2 tt -52.14 137.93 26.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.741 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -18.52 39.46 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.925 ' OD1' HG21 ' A' ' 62' ' ' THR . 16.7 m-20 -90.21 172.35 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -1.191 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 19.2 mm -117.83 144.72 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.722 HD22 ' ND2' ' A' ' 60' ' ' ASN . 10.3 mt -108.53 146.79 32.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 87.19 2.49 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.757 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.023 HG11 HD23 ' A' ' 37' ' ' LEU . 29.5 t -97.51 116.25 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -57.19 122.36 12.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.44 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.527 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 144.18 -56.95 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -48.21 -51.28 26.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.141 . . . . 0.0 110.122 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.023 HD23 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -81.39 -15.76 54.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.115 -0.99 . . . . 0.0 109.195 -179.92 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.094 HG23 ' OE1' ' A' ' 47' ' ' GLU . 1.4 t -77.84 -10.79 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.773 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.55 -9.15 23.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.0 109.336 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.74 HD12 ' CE2' ' A' ' 42' ' ' PHE . 14.6 mt -67.92 -27.63 66.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.03 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.17 3.03 6.94 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 40' ' ' LEU . 19.8 m-85 -58.82 178.08 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -1.145 . . . . 0.0 109.631 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -119.53 135.74 54.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 108.75 179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 43' ' ' SER . 10.5 t70 -31.88 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.317 0.579 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 129.49 -3.64 6.2 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 53' ' ' ILE . 4.6 mt-30 -91.14 -25.02 19.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.102 -1.234 . . . . 0.0 109.632 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 1.094 ' OE1' HG23 ' A' ' 38' ' ' VAL . 1.1 tt0 -59.05 -47.97 83.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -56.19 -15.8 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.11 80.45 5.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 109.587 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.608 ' CG ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -65.04 -47.12 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.166 1.911 . . . . 0.0 110.451 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' PRO . 7.6 pt-20 -43.17 -42.15 4.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.25 51.71 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 1.3 mt -138.89 -41.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.72 -77.18 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.427 ' CZ2' ' HD2' ' A' ' 18' ' ' ARG . 34.4 m95 -137.91 147.13 44.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -1.037 . . . . 0.0 109.121 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -138.76 137.22 36.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.147 -0.971 . . . . 0.0 110.125 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.607 ' ND2' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -88.33 95.69 10.29 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.662 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -115.33 173.74 14.92 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.355 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -115.7 107.81 15.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.648 -0.913 . . . . 0.0 109.76 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.722 ' ND2' HD22 ' A' ' 30' ' ' LEU . 4.1 m-80 -77.97 96.7 5.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 108.873 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' OE1' ' HB ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -54.17 -39.5 66.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.001 -179.918 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.925 HG21 ' OD1' ' A' ' 28' ' ' ASP . 17.9 m -49.08 -64.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.659 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.9 p -85.41 6.95 24.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.554 -0.716 . . . . 0.0 109.66 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.86 54.16 5.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 63' ' ' THR . 56.4 mm-40 -131.88 142.25 49.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -1.098 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -113.47 135.43 53.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.493 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.684 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 174.07 -167.91 40.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.607 ' OD1' ' ND2' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -102.13 163.96 11.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.699 ' HE1' HD13 ' A' ' 56' ' ' LEU . 2.1 p90 -163.13 162.23 18.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 Cg_endo -62.14 123.89 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.867 1.712 . . . . 0.0 109.827 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.777 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -67.61 -32.92 79.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 72' ' ' THR . 1.7 p -66.97 -9.41 38.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.035 -1.274 . . . . 0.0 109.415 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.9 m-85 -95.8 -13.14 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.608 HG23 ' CG ' ' A' ' 50' ' ' PRO . 32.7 m -107.69 175.03 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.625 ' CD ' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -149.88 90.66 1.71 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.189 -0.944 . . . . 0.0 108.715 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.557 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 76.3 t80 -38.63 123.91 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.847 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 77' ' ' ILE . 9.7 mm -111.38 -2.6 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 132.87 -164.43 24.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.108 . . . . 0.0 109.503 179.996 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.67 150.41 7.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 66.8 m-85 -79.37 134.13 36.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.142 . . . . 0.0 108.459 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 3.3 mt-30 -143.65 117.84 9.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.054 -1.029 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.875 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.78 178.66 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.359 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.38 155.44 24.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -91.65 121.07 32.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.882 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -104.88 -24.62 12.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.015 . . . . 0.0 108.619 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.556 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -119.57 176.62 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 163.02 14.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.172 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -166.41 114.62 0.89 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.085 -1.009 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -79.46 107.41 12.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.931 . . . . 0.0 108.587 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -41.44 115.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.845 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -69.65 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.17 146.84 23.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.878 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.0 mt-10 -43.53 -24.79 0.12 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.131 -0.981 . . . . 0.0 110.038 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -60.7 -58.07 10.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.113 -0.992 . . . . 0.0 109.971 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 2.0 p30 -72.04 162.7 29.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.945 . . . . 0.0 109.87 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -122.16 162.06 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.377 -0.827 . . . . 0.0 109.378 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CD ' ' A' ' 16' ' ' LYS . 1.7 m-20 -79.22 103.69 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.901 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -102.28 153.46 19.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.625 ' HE1' HG21 ' A' ' 63' ' ' THR . 1.0 OUTLIER -150.79 141.21 22.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.048 . . . . 0.0 109.878 -179.955 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tp -42.56 143.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 82.04 0.61 89.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.1 m-20 -90.42 159.13 16.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 109.746 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 28.2 mm -113.34 128.74 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 0.0 109.175 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.9 mp -109.76 105.93 15.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.915 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.95 91.33 8.03 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.547 -0.72 . . . . 0.0 110.328 -179.931 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.875 HG21 ' OH ' ' A' ' 8' ' ' TYR . 29.0 t -86.76 96.85 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 33' ' ' ASN . 6.1 p30 -51.45 152.82 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 110.385 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 34' ' ' LYS . 6.0 pttp -69.19 113.6 6.7 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.56 -54.66 0.76 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 48.4 t -56.78 -26.34 57.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.175 -1.191 . . . . 0.0 108.93 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.919 HD11 HD13 ' A' ' 53' ' ' ILE . 15.4 tp -90.55 -33.57 15.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 38' ' ' VAL . 84.7 t -90.31 2.78 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.099 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.82 -11.81 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -107.94 34.99 3.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.708 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.1 52.4 40.26 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.897 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -71.95 -167.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.09 143.38 50.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.13 87.89 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.34 -43.08 0.57 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' GLU . 23.2 mm-40 -73.01 -30.22 63.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.242 -1.152 . . . . 0.0 109.409 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 37' ' ' LEU . 1.5 pt-20 -42.51 -41.99 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -85.39 44.53 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.518 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -159.85 62.72 1.96 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.6 Cg_exo -57.75 -13.61 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.341 2.027 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -70.77 -31.15 67.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.997 -1.065 . . . . 0.0 109.298 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 tp10 -110.71 1.72 18.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.9 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.919 HD13 HD11 ' A' ' 37' ' ' LEU . 6.6 mt -79.45 -31.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.108 -0.995 . . . . 0.0 109.082 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 -78.18 0.29 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.465 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 11.2 m95 -140.68 154.23 46.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -1.11 . . . . 0.0 109.033 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.809 HD23 HD13 ' A' ' 37' ' ' LEU . 1.5 mp -143.07 158.91 43.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.989 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 32' ' ' VAL . 1.6 t30 -117.79 117.68 29.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -138.93 -167.73 11.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 58.7 t80 -115.59 114.12 24.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -1.051 . . . . 0.0 109.96 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 17.6 m-20 -79.31 79.88 5.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 108.64 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.19 -39.38 13.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.52 -0.738 . . . . 0.0 109.833 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 18.7 m -48.51 -53.32 18.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.922 . . . . 0.0 109.658 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.625 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.5 p -108.15 17.02 22.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 41.33 54.61 3.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.47 111.9 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -1.214 . . . . 0.0 109.935 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -90.74 129.44 36.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 109.194 179.938 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' CA ' ' CG1' ' A' ' 22' ' ' ILE . . . -178.86 -165.5 33.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -95.35 168.24 10.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.376 -1.073 . . . . 0.0 109.742 179.984 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -168.51 158.57 8.41 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -60.05 125.4 17.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.253 1.969 . . . . 0.0 110.196 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.801 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -39.9 76.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 12.0 p -64.78 -11.02 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.249 . . . . 0.0 109.636 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.8 m-85 -95.49 15.54 19.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 109.83 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.882 ' O ' HD11 ' A' ' 11' ' ' LEU . 18.9 m -134.71 -169.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.83 . . . . 0.0 110.044 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.766 ' CD ' HD22 ' A' ' 11' ' ' LEU . 11.9 pt-20 -158.26 89.03 0.97 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 56.6 t80 -36.87 136.24 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.653 . . . . 0.0 110.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 75' ' ' GLU . 29.7 mm -126.32 -8.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 113.21 -109.0 2.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.43 ' O ' ' NE2' ' A' ' 7' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.247 -1.149 . . . . 0.0 109.61 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.53 150.66 20.88 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 4.0 m-85 -79.83 118.82 21.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -1.142 . . . . 0.0 109.098 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 3.7 mp0 -102.11 118.09 36.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 109.899 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.865 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -99.62 173.01 6.92 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 0.0 108.983 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -117.9 116.53 27.13 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.801 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 25' ' ' HIS . . . -47.54 109.93 0.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 110.299 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.9 mt -90.93 -38.39 12.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.7 m-85 -126.46 -161.02 1.03 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.592 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -123.68 -175.28 3.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 109.732 179.911 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 27.5 t80 167.81 123.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 108.943 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 15.3 mmtp -79.47 156.27 27.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.988 -1.07 . . . . 0.0 109.914 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 25.0 mtpt -70.06 88.77 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -71.82 -72.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.926 . . . . 0.0 109.291 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -69.81 156.52 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -77.56 70.4 3.94 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.947 0.88 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.79 -26.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 4.0 p30 -71.54 170.36 13.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -121.02 167.64 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.543 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.727 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 3.2 m-20 -73.56 111.38 8.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 2.9 mm? -97.96 144.49 27.45 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 0.0 109.086 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.727 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -159.99 138.18 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.035 -179.966 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -57.51 133.57 55.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.189 -0.945 . . . . 0.0 109.498 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.8 -25.99 24.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.581 ' OD2' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -74.54 171.56 13.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.634 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.97 ' C ' HD12 ' A' ' 30' ' ' LEU . 18.9 mm -123.53 155.15 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.2 mp -127.15 123.53 36.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.146 -0.971 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -101.69 92.71 4.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.412 179.975 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.865 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 77.9 t -90.82 118.5 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 108.979 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.516 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 9.1 m-80 -48.01 176.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 109.284 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -83.0 -72.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.016 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -61.61 -23.05 62.42 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.516 ' CB ' ' HB2' ' A' ' 33' ' ' ASN . 16.6 t -59.07 -29.05 67.04 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.135 -1.215 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 1.1 tt -90.74 -47.76 7.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.644 ' O ' HG12 ' A' ' 38' ' ' VAL . 95.7 t -80.0 4.42 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.93 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -64.28 -9.06 15.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.949 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.3 mt -104.62 -11.69 16.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 0.0 110.006 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 105.95 29.21 5.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.847 ' CE2' HG23 ' A' ' 53' ' ' ILE . 10.5 m-85 -50.97 -175.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.521 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.68 157.5 44.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 109.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -56.95 123.31 14.7 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.72 -36.28 4.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.783 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.6 mt-30 -81.25 -32.45 33.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.304 -1.115 . . . . 0.0 109.376 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.8 pt-20 -64.26 -15.78 60.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.883 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -106.5 -13.95 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.737 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.6 mmt180 -113.87 80.09 5.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.2 Cg_endo -61.05 -31.74 91.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.215 1.943 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 9.1 pt-20 -60.07 -25.86 65.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 6.7 tt0 -104.81 -5.46 21.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.847 HG23 ' CE2' ' A' ' 42' ' ' PHE . 9.5 mt -79.44 -28.97 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.182 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 99.86 -77.05 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 70' ' ' PRO . 25.7 m95 -144.18 143.37 31.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 109.412 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.874 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -129.64 158.32 39.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.26 112.1 23.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -134.49 -171.48 12.53 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.48 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -120.6 109.64 15.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.975 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 8.4 m-20 -79.31 97.97 6.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.907 -1.121 . . . . 0.0 108.89 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.41 -36.19 81.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.817 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' OD2' ' A' ' 28' ' ' ASP . 37.9 m -50.05 -21.8 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' ASN . 12.0 t -127.76 -3.3 5.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.523 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.44 46.42 93.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -136.63 161.01 37.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.498 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 4.9 ttm180 -132.52 153.79 50.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.421 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 162.68 -171.2 38.45 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.663 -1.256 . . . . 0.0 109.962 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' ASP . 4.8 p30 -91.14 169.55 10.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.992 . . . . 0.0 109.655 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.679 ' HE2' HG11 ' A' ' 74' ' ' VAL . 10.4 p90 -174.33 143.86 0.91 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.164 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 2.9 Cg_exo -55.45 118.19 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.801 1.668 . . . . 0.0 109.914 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.874 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -63.24 -23.84 66.71 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 p -58.57 -19.54 39.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.891 -1.358 . . . . 0.0 109.881 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 17.9 m-85 -102.57 29.11 5.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' HE2' ' A' ' 69' ' ' PHE . 3.0 m -141.32 168.05 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.567 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 5.9 pt-20 -138.87 88.7 2.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 109.985 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.578 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 57.5 t80 -38.53 124.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 109.772 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -122.67 5.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 82.56 -100.84 2.2 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.442 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 175.76 -127.77 1.3 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.61 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 5.2 m-30 -78.41 105.18 9.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.691 -0.888 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 1.6 mt-30 -106.01 114.52 28.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.763 ' OH ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -104.65 175.95 5.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 108.662 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.687 ' HB2' HD11 ' A' ' 77' ' ' ILE . 8.2 ttm180 -113.71 150.36 33.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.803 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -73.72 111.91 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 8.6 mt -89.1 -31.72 17.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.905 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 9.4 m-85 -132.61 -163.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.844 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 73' ' ' TYR . 12.2 p-10 -123.76 172.74 8.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 109.762 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 24.8 t80 -164.57 118.37 1.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' GLU . 29.6 tttp -80.11 136.38 36.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.882 -1.136 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 8.2 ttmt -42.94 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.499 -0.751 . . . . 0.0 109.734 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -95.55 -64.96 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -81.51 145.8 30.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.918 . . . . 0.0 109.517 -179.984 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.83 -13.6 6.65 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 11.2 pm0 -110.54 33.68 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.016 -1.052 . . . . 0.0 110.199 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -125.45 177.59 6.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.265 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 ' HA3' ' A' ' 67' ' ' GLY . 2.9 pt -136.08 157.63 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -70.23 113.81 7.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.811 . . . . 0.0 109.6 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 2.4 mm? -101.32 154.09 19.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.042 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.594 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -159.96 133.18 6.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 109.423 179.997 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -52.0 141.4 18.09 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.597 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 97.35 -17.55 58.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.948 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.73 174.54 10.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.7 mp -125.45 137.14 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 8.0 mp -109.28 119.43 39.48 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.22 -0.925 . . . . 0.0 109.138 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -97.76 100.19 11.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 43.2 t -116.43 109.63 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.551 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 m120 -45.64 171.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.49 -0.756 . . . . 0.0 109.78 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -71.88 -70.7 0.31 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.744 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.91 98.42 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 33' ' ' ASN . 46.3 m -44.58 -25.14 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -1.142 . . . . 0.0 109.863 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.815 HD23 ' O ' ' A' ' 37' ' ' LEU . 4.0 tt -90.28 -40.97 11.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 38' ' ' VAL . 62.6 t -74.66 0.0 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 0.0 109.887 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.29 -12.37 13.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 109.763 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.1 mt -91.58 17.43 8.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.983 . . . . 0.0 109.761 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 72.92 17.91 78.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.891 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -54.62 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.037 -1.272 . . . . 0.0 109.511 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -121.08 149.95 41.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.212 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -50.94 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.568 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 136.65 -46.04 1.04 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.23 -16.22 52.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.26 -38.15 88.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.566 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -91.11 26.6 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 109.673 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.6 mtp180 -128.67 64.84 70.5 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.309 -0.869 . . . . 0.0 108.875 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 6.3 Cg_exo -57.09 -38.68 95.08 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.267 1.978 . . . . 0.0 110.381 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.6 -27.09 68.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.503 ' N ' ' HG2' ' A' ' 51' ' ' GLU . 2.1 mt-10 -104.87 -2.81 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.891 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -82.28 -84.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.042 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.789 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 151.15 -61.32 0.41 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.462 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . 28.8 m95 -148.53 134.24 18.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -1.055 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.733 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -133.57 164.0 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 31.4 t-20 -115.72 115.64 26.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.06 -169.0 12.08 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 36.3 t80 -122.66 105.95 10.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.617 -0.931 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' HD12 ' A' ' 22' ' ' ILE . 4.5 m-80 -79.9 88.26 5.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.254 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.84 -36.77 67.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.86 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.67 HG21 ' OD1' ' A' ' 28' ' ' ASP . 6.2 m -52.33 -37.15 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.146 -0.971 . . . . 0.0 109.347 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.594 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -116.85 9.98 14.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.51 52.73 6.22 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.95 119.72 21.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -1.178 . . . . 0.0 109.724 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 2.8 ttt85 -101.63 134.51 44.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.16 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.65 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 170.44 -165.2 38.48 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.255 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -90.36 173.69 7.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.412 -1.052 . . . . 0.0 109.71 -179.936 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 18.1 p90 -177.58 159.57 1.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.858 . . . . 0.0 109.22 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -61.53 126.03 18.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.075 1.85 . . . . 0.0 110.015 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.61 -40.37 77.57 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 25.6 p -58.21 -14.0 6.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.029 -1.277 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.4 m-85 -93.15 23.21 4.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 110.155 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.9 m -142.59 -173.49 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.153 -0.967 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.6 pt-20 -156.42 87.32 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 109.577 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t80 -37.33 135.2 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.635 -0.666 . . . . 0.0 110.494 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.7 mp -131.56 -2.89 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 87.34 -139.77 16.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -1.189 . . . . 0.0 109.286 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 16.9 m-85 -137.71 145.98 43.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -1.157 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.627 HE21 HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -137.79 121.17 17.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.91 172.79 7.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.306 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 21.3 mtt180 -117.57 139.46 50.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . . . -83.17 105.28 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.737 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -71.73 -36.42 70.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.064 -1.023 . . . . 0.0 108.977 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 34.3 m-85 -106.07 -177.78 3.46 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -113.71 141.02 47.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.834 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.56 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 55.5 t80 -132.17 158.4 41.79 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -111.19 -63.66 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.773 -1.204 . . . . 0.0 110.13 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 15' ' ' LYS . 14.3 tttm 153.68 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 2.2 tt0 -93.57 -54.18 3.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.024 -1.047 . . . . 0.0 109.192 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -69.75 159.32 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.214 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.38 25.85 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.214 -0.929 . . . . 0.0 111.402 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 20' ' ' GLU . 3.6 mm-40 -149.05 13.98 0.89 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.669 -1.27 . . . . 0.0 109.539 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -91.17 161.74 14.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.675 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -117.56 143.8 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 7.9 m-20 -49.15 109.68 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.336 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -103.69 154.71 19.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -154.25 142.34 20.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.96 -1.088 . . . . 0.0 109.634 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.6 tt -47.32 135.08 10.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.71 5.9 73.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 0.4 OUTLIER -90.24 136.01 33.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 109.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.935 ' C ' HD12 ' A' ' 30' ' ' LEU . 7.3 mm -94.85 140.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.071 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.935 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -125.76 111.26 14.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.055 -1.028 . . . . 0.0 109.8 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 HE21 ' A' ' 7' ' ' GLN . 0.2 OUTLIER -85.52 93.34 8.76 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' CA ' ' A' ' 58' ' ' GLY . 89.5 t -99.89 115.92 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.083 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.8 167.21 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.99 . . . . 0.0 109.012 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' C ' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -90.03 0.6 57.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.5 -56.47 1.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.98 -31.85 1.44 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -1.105 . . . . 0.0 109.978 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.932 HD11 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.86 -39.98 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.079 -1.013 . . . . 0.0 109.98 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 38' ' ' VAL . 56.8 t -76.39 1.62 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.37 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.793 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -97.6 -25.71 15.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' PHE . . . 120.93 22.13 3.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.061 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.7 m-85 -44.49 147.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.251 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.56 165.37 23.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -67.0 118.79 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.12 53.1 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.21 -32.23 73.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.816 ' HG3' HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -67.91 -21.2 65.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -74.71 -9.57 58.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.34 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -119.14 75.8 15.32 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 108.897 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 53' ' ' ILE . 6.1 Cg_exo -56.67 -48.79 17.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.497 2.131 . . . . 0.0 110.73 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.88 -25.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.5 tt0 -114.12 50.48 0.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.061 HG23 ' CE2' ' A' ' 42' ' ' PHE . 7.5 mt -134.91 -45.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.56 -77.6 0.28 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.458 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 17.4 m95 -139.64 143.97 37.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.433 -1.039 . . . . 0.0 109.336 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.932 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -131.96 147.88 52.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.914 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 32' ' ' VAL . 17.8 t-20 -114.18 109.39 18.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.574 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.13 -158.1 8.87 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.601 -1.285 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 72.9 t80 -120.26 116.91 26.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.42 -1.047 . . . . 0.0 109.801 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.794 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.2 m-20 -79.45 76.67 6.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -48.28 -34.87 11.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.787 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 31.7 m -49.11 -48.48 44.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.794 HG22 ' HB3' ' A' ' 60' ' ' ASN . 9.4 t -101.7 2.92 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.689 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.83 45.83 95.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.577 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 17.8 mm-40 -138.62 -174.75 3.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.172 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 150.05 29.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.083 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 171.12 -164.77 37.86 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -100.44 166.31 11.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.984 . . . . 0.0 109.565 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 5.5 p90 -169.07 156.36 6.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.71 126.56 20.1 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.108 1.872 . . . . 0.0 109.806 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.822 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.74 -22.11 78.6 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.534 ' HG1' ' HD1' ' A' ' 73' ' ' TYR . 1.2 p -73.07 -4.93 35.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.242 . . . . 0.0 109.47 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.7 m-85 -101.93 -5.43 24.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.766 ' O ' HD11 ' A' ' 11' ' ' LEU . 1.7 m -116.48 -171.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.064 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD21 ' A' ' 11' ' ' LEU . 11.0 pt-20 -157.51 92.82 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.63 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 55.4 t80 -48.04 139.43 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 109.668 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -132.99 -0.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.982 . . . . 0.0 109.638 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.624 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 140.1 169.65 11.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 27.0 m-85 -78.92 139.15 38.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.986 . . . . 0.0 109.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HG2' HG23 ' A' ' 31' ' ' THR . 21.1 mt-30 -129.54 126.09 37.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.104 -0.997 . . . . 0.0 109.845 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.87 177.32 5.54 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.531 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -117.78 138.11 52.28 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -70.44 103.5 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.0 110.675 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -68.5 -32.24 72.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 108.586 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 5.9 m-85 -129.75 -169.02 2.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.64 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -117.95 171.19 8.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 109.933 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.736 ' HD2' HD21 ' A' ' 24' ' ' LEU . 54.8 t80 -173.42 118.17 0.29 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 3.6 tttm -79.64 117.53 20.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 18.0 pttt -42.7 109.26 0.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.676 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -67.13 -66.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.252 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' OD2' ' A' ' 21' ' ' ASP . 15.9 mtm180 -90.29 174.34 7.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 2.09 12.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.69 -6.45 29.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 109.891 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -105.11 166.31 10.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.158 -0.964 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.804 HD12 HD22 ' A' ' 60' ' ' ASN . 1.1 pt -114.94 163.15 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.0 m-20 -87.43 105.67 17.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.736 HD21 ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -102.75 154.6 19.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.632 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -152.49 154.6 35.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 26.5 tp -46.6 135.32 8.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.94 9.62 86.05 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 16.2 t0 -91.17 110.98 22.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -1.127 . . . . 0.0 109.966 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.936 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -79.68 141.85 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.936 -1.102 . . . . 0.0 109.79 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.936 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.9 mp -123.38 140.03 53.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -109.86 86.19 2.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 109.285 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.606 HG22 ' CA ' ' A' ' 58' ' ' GLY . 53.9 t -90.58 108.68 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 30.2 m120 -50.49 161.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 109.722 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 53.84 2.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.89 -59.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 m -61.73 -20.37 63.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.341 -1.093 . . . . 0.0 109.255 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 47' ' ' GLU . 8.2 tp -90.35 -24.14 20.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.715 HG23 ' OE2' ' A' ' 47' ' ' GLU . 5.0 t -90.81 -4.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.065 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.02 -4.14 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.989 HD12 ' CE2' ' A' ' 42' ' ' PHE . 7.4 mt -80.82 -30.17 35.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.49 7.35 5.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.989 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.1 m-85 -59.94 -172.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 109.751 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.62 -171.41 1.92 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 108.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.96 84.48 6.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.724 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.76 2.17 3.98 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.169 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.522 ' CB ' ' HB3' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -80.86 -14.94 57.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.962 -1.316 . . . . 0.0 109.851 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.715 ' OE2' HG23 ' A' ' 38' ' ' VAL . 26.5 mt-10 -62.58 -40.17 96.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -61.67 -9.57 6.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.208 -0.932 . . . . 0.0 110.367 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mmm180 -113.59 80.59 4.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.872 -1.142 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.593 ' CG ' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.63 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.325 2.017 . . . . 0.0 110.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.4 tt0 -41.06 -29.8 0.12 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.253 -0.905 . . . . 0.0 109.071 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -98.64 47.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.835 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.0 mt -146.89 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -63.0 0.28 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 33.7 m95 -146.91 148.9 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -1.11 . . . . 0.0 109.289 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.728 HD11 ' HA3' ' A' ' 71' ' ' GLY . 2.6 mp -137.42 152.3 49.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.696 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 1.2 t-20 -110.54 107.51 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.606 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.28 -160.04 9.07 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 49.2 t80 -116.54 117.55 30.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.526 -0.985 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.804 HD22 HD12 ' A' ' 22' ' ' ILE . 2.5 t-20 -79.4 76.38 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.531 -0.731 . . . . 0.0 109.234 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.94 -37.32 71.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.799 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 19.4 m -60.3 -33.45 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.019 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.632 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.2 OUTLIER -121.76 18.26 11.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 40.19 54.16 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.28 113.1 8.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -1.227 . . . . 0.0 109.486 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 9.1 ttp-105 -91.24 140.47 29.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.623 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 166.09 -165.19 38.01 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -93.57 166.22 12.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.484 -1.009 . . . . 0.0 109.779 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -168.1 153.91 6.91 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -58.11 116.58 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.195 1.93 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.6 -28.26 73.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -63.63 -28.0 69.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.576 -1.543 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 19.4 m-30 -85.41 24.91 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.02 -1.05 . . . . 0.0 110.419 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.5 m -140.36 172.93 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.135 -0.978 . . . . 0.0 109.347 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD11 ' A' ' 11' ' ' LEU . 13.0 pt-20 -148.95 89.65 1.69 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.835 . . . . 0.0 109.177 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 75.6 t80 -41.56 133.13 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.718 . . . . 0.0 109.133 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 77' ' ' ILE . 17.5 mm -123.37 -2.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 140.65 -174.01 22.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.355 -1.085 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 34.7 m-85 -79.88 115.17 19.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -1.086 . . . . 0.0 109.353 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.679 ' CG ' HG23 ' A' ' 31' ' ' THR . 3.2 mt-30 -98.67 128.12 44.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.18 176.06 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.034 -1.041 . . . . 0.0 109.692 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' C ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.0 117.6 29.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -61.94 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.559 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -46.12 -50.45 15.41 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.057 -1.027 . . . . 0.0 109.782 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.722 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -111.24 170.68 7.95 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.574 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.36 -170.41 3.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.387 -0.821 . . . . 0.0 109.879 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 7.2 t80 179.75 115.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.236 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' GLU . 8.2 pttp -79.46 109.42 13.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.144 -0.972 . . . . 0.0 109.036 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' O ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -39.69 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.255 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' LYS . 48.0 mt-10 -63.33 -59.92 4.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 63.1 mtp85 -90.1 155.2 19.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.346 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.98 -9.15 19.32 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -84.02 -21.75 31.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 0.0 109.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' CA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -100.11 156.98 16.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.404 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.35 175.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.933 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.432 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 1.8 m-20 -75.66 151.48 37.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.002 HD11 HD21 ' A' ' 30' ' ' LEU . 1.1 tp -136.91 150.07 48.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.353 -0.842 . . . . 0.0 109.096 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.534 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 146.13 16.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.99 . . . . 0.0 109.672 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 43.5 tp -51.11 136.06 24.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.49 -0.756 . . . . 0.0 109.973 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.26 -2.48 78.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.655 ' C ' HD12 ' A' ' 29' ' ' ILE . 11.4 t0 -90.05 144.92 25.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -1.169 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.934 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 mp -108.65 146.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 24' ' ' LEU . 6.6 mp -124.89 112.43 16.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 0.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.679 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.51 91.91 7.97 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 109.376 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 8' ' ' TYR . 53.8 t -93.81 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.703 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -57.24 156.61 7.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -76.2 -16.54 59.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.633 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.65 -50.51 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 p -54.52 -30.28 53.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -1.113 . . . . 0.0 110.025 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.813 HD21 ' HA ' ' A' ' 47' ' ' GLU . 8.7 tp -90.31 -32.32 16.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 38' ' ' VAL . 77.2 t -90.21 2.96 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.941 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.53 -7.46 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.827 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.867 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -105.36 17.55 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.69 42.88 45.29 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.933 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -67.26 -168.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 109.441 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.29 136.38 52.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 122.9 6.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.501 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -62.46 -25.29 67.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -1.144 . . . . 0.0 109.409 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.813 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.4 mp0 -61.86 -32.76 73.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.967 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 76' ' ' TYR . . . -87.41 20.54 2.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.1 tpp180 -138.78 74.86 37.74 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 53' ' ' ILE . 6.2 Cg_exo -55.67 -48.77 18.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.443 2.095 . . . . 0.0 111.15 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 4.7 pm0 -44.11 -26.96 0.34 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.031 -1.043 . . . . 0.0 109.218 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.75 51.53 0.85 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.398 -0.814 . . . . 0.0 109.066 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 42' ' ' PHE . 24.2 mt -141.49 -39.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.47 -78.47 0.24 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.426 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 24.3 m95 -137.66 144.82 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -1.091 . . . . 0.0 109.192 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.868 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -134.77 154.3 51.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.448 ' C ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.92 108.16 18.33 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -130.66 -171.21 12.86 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 68.8 t80 -116.35 118.32 32.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.545 -0.973 . . . . 0.0 110.026 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 6.2 m-80 -84.53 64.82 8.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.105 -0.997 . . . . 0.0 109.009 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -43.67 -30.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.419 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.454 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 16.5 m -49.35 -54.47 17.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.234 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.93 10.96 39.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.445 -0.784 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.71 47.11 91.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.21 178.46 5.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -1.176 . . . . 0.0 109.582 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -159.66 138.52 10.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.93 -162.19 35.99 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-20 -94.92 167.49 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.499 -1.001 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -169.84 158.89 6.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -62.13 125.37 16.27 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.187 1.924 . . . . 0.0 110.086 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.868 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.34 -26.3 70.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -69.65 -7.44 39.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.951 -1.323 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.5 m-85 -99.32 -0.73 40.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.987 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.669 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -124.98 164.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 121.714 0.769 . . . . 0.0 110.422 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.829 ' HB3' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -139.79 109.74 6.42 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 83.2 t80 -37.56 113.39 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -105.11 9.77 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.519 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 104.33 -149.01 16.95 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 79.2 m-85 -160.1 124.79 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.476 -1.014 . . . . 0.0 108.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 31' ' ' THR . 1.1 mt-30 -129.51 122.29 28.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.016 -1.052 . . . . 0.0 110.196 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -116.92 -178.08 3.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.06 -1.025 . . . . 0.0 109.51 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.36 165.29 13.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.83 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -88.79 123.6 33.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 11.8 mt -104.3 -33.19 8.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 10.6 m-85 -128.18 -158.72 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.814 . . . . 0.0 109.902 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -126.66 172.65 10.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.736 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 75.3 t80 -171.49 113.79 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.297 -0.877 . . . . 0.0 108.809 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -79.29 156.39 28.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.983 -1.073 . . . . 0.0 110.052 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.7 tttt -55.08 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 109.663 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mt-10 -88.73 -62.91 1.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.216 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 6.6 ttm-85 -90.16 157.44 17.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.95 -4.4 16.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.174 -0.954 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 -9.86 15.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.079 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -85.33 171.45 11.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 109.528 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.492 HD12 HD22 ' A' ' 60' ' ' ASN . 0.4 OUTLIER -130.62 158.19 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.795 ' O ' HD22 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -60.04 134.01 56.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 1.2 mm? -133.47 146.15 50.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.06 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.2 147.76 19.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 109.27 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 10' ' ' ALA . 50.4 tp -51.48 145.1 9.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.11 -10.63 67.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.711 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.98 147.68 26.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -1.176 . . . . 0.0 109.565 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.906 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.6 mp -107.38 146.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 6.3 mp -122.75 123.27 40.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.093 -1.004 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.513 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -98.64 92.05 5.42 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.622 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 8' ' ' TYR . 53.5 t -88.43 113.77 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.22 -165.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -0.925 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -70.98 0.62 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.23 -36.61 83.53 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -53.71 -30.35 43.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.028 -1.278 . . . . 0.0 110.064 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.821 ' O ' HD23 ' A' ' 37' ' ' LEU . 3.1 tt -90.73 -42.67 10.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.707 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 38' ' ' VAL . 99.2 t -79.27 1.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 110.029 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -63.04 -12.65 27.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.322 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -106.22 27.09 9.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.63 48.68 84.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.755 ' CE2' HD21 ' A' ' 37' ' ' LEU . 7.1 m-85 -67.21 -168.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.639 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.1 m -133.75 143.74 48.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.486 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -59.15 122.73 14.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.0 -33.3 6.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -78.36 -2.65 39.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -1.194 . . . . 0.0 109.712 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 1.3 pt-20 -69.52 -37.23 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -87.2 15.13 6.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -123.6 67.69 39.54 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 109.127 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.585 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.35 -51.01 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.219 1.946 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.4 tt0 -59.14 -33.36 70.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.012 . . . . 0.0 108.741 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HG2' ' A' ' 49' ' ' ARG . 7.2 tp10 -99.28 34.06 2.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 108.689 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.678 HG21 ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -119.32 -37.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.24 -76.8 0.24 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 74.9 m95 -142.74 139.71 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.092 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -129.74 153.32 48.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.767 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 2.7 t-20 -108.7 112.21 24.4 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -132.97 -169.25 12.16 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -120.29 107.98 13.62 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.897 -0.767 . . . . 0.0 109.725 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.657 ' ND2' HD21 ' A' ' 24' ' ' LEU . 6.9 m-80 -79.57 90.19 5.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -36.4 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.485 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 34.1 m -53.82 -36.92 63.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.478 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.3 p -111.44 5.61 19.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.74 45.67 24.55 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 63' ' ' THR . 33.1 mt-10 -129.38 155.6 45.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.694 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' C ' HG21 ' A' ' 22' ' ' ILE . 2.6 tpp180 -126.61 132.01 51.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 108.893 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 177.68 -158.48 23.71 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -104.59 166.03 10.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -1.028 . . . . 0.0 110.062 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.65 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.9 p90 -163.65 158.96 17.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.447 -0.783 . . . . 0.0 109.307 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.28 127.27 21.51 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.136 1.891 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.822 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -71.3 -36.42 63.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.552 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.4 p -65.2 -9.96 27.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -1.197 . . . . 0.0 109.265 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.605 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.6 m-85 -99.82 18.37 18.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.443 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 71' ' ' GLY . 34.8 m -134.08 -168.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.093 -1.004 . . . . 0.0 110.092 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 77' ' ' ILE . 10.3 pt-20 -154.84 87.15 1.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.537 -0.727 . . . . 0.0 109.818 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 81.8 t80 -45.73 139.64 3.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.174 -0.954 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.38 -4.99 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 109.127 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 116.29 -173.11 14.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.46 ' OXT' ' HA ' ' A' ' 6' ' ' TYR . 73.4 mtp180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLN . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 14.8 m-85 -79.81 102.57 9.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -1.124 . . . . 0.0 109.088 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -99.93 128.88 45.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.432 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.627 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -121.84 176.3 5.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.124 -0.985 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.2 mmm180 -118.35 122.53 43.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.706 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -70.97 93.02 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.793 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.944 HD21 ' CD ' ' A' ' 75' ' ' GLU . 64.2 mt -58.4 -49.4 77.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -104.12 176.77 5.05 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.432 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 43.1 p-10 -107.25 -173.86 2.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 14.0 t80 -162.31 140.22 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -91.89 132.91 36.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.983 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -55.8 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.718 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' LYS . 9.3 tp10 -95.43 -54.89 3.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.212 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.1 mmp_? -81.76 136.82 35.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.68 -19.3 0.89 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.109 -0.994 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 mm-40 -97.44 -33.34 11.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -66.36 157.97 30.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.67 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.667 HG21 ' O ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -120.32 169.85 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 109.375 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 2.9 m-20 -78.99 112.41 16.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.842 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.706 HD12 ' CB ' ' A' ' 10' ' ' ALA . 3.1 mm? -88.5 166.29 14.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 108.426 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.628 ' CE1' ' CG2' ' A' ' 63' ' ' THR . 0.0 OUTLIER -157.99 135.15 10.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.853 -1.154 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 11' ' ' LEU . 12.1 tp -50.57 140.15 14.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.512 -0.743 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 5.8 t0 -87.93 146.43 25.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.18 -1.188 . . . . 0.0 109.084 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.698 ' C ' HD22 ' A' ' 30' ' ' LEU . 24.2 mm -91.59 142.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 29' ' ' ILE . 3.8 mm? -122.11 129.47 52.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -117.24 82.75 1.86 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.806 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 ' OH ' ' A' ' 8' ' ' TYR . 40.8 t -92.69 115.08 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.148 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -56.21 -171.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.725 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 4.6 mtmp? -90.04 -52.15 5.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.267 -0.896 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 36' ' ' SER . . . -67.51 -46.94 65.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -42.3 -33.87 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -1.144 . . . . 0.0 109.833 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.784 ' O ' HD23 ' A' ' 37' ' ' LEU . 5.1 tt -90.33 -32.67 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.731 HG22 ' OE2' ' A' ' 47' ' ' GLU . 95.0 t -80.09 0.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -61.45 -12.96 16.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.856 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -105.99 27.71 8.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.44 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.19 48.93 83.69 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.866 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.0 m-85 -69.66 -168.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.3 p -126.4 158.51 35.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.323 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.07 119.15 12.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.4 -20.03 38.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.25 15.69 9.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' OE2' HG22 ' A' ' 38' ' ' VAL . 4.6 mm-40 -90.33 -35.44 15.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -89.88 28.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.477 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -128.41 65.08 70.0 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.5 Cg_exo -57.61 -46.64 25.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.424 2.083 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.8 -19.02 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.6 -3.47 10.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 0.0 110.028 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.866 HG23 ' CE2' ' A' ' 42' ' ' PHE . 14.1 mt -80.27 -50.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.079 -1.013 . . . . 0.0 109.128 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.72 -69.22 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.409 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 45.1 m95 -139.81 148.15 41.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -1.051 . . . . 0.0 109.509 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.901 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.9 t-20 -111.56 104.04 12.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 32' ' ' VAL . . . -138.75 -140.87 4.04 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 64' ' ' GLY . 72.2 t80 -131.2 125.78 33.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.981 . . . . 0.0 110.363 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.43 85.17 7.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -42.85 -48.44 5.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.795 . . . . 0.0 110.867 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.558 HG22 HG23 ' A' ' 63' ' ' THR . 4.0 m -41.26 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.0 110.234 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.628 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 39.8 p -83.3 13.09 4.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.068 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 59' ' ' TYR . . . 45.76 45.34 13.21 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -119.75 117.16 27.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 0.0 109.234 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.667 ' O ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.63 156.33 18.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 156.93 -163.71 32.4 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.122 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.2 p-10 -104.71 154.1 20.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.811 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -155.88 159.68 31.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.1 Cg_exo -59.72 130.12 33.77 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.17 1.914 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -73.6 -29.72 63.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -69.43 -5.75 25.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.5 m-85 -100.04 -4.3 30.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.66 -176.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.944 ' CD ' HD21 ' A' ' 11' ' ' LEU . 21.1 pt-20 -153.48 96.45 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' HD3' ' A' ' 79' ' ' ARG . 9.8 t80 -37.67 110.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -135.35 14.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 7' ' ' GLN . . . -130.65 110.41 1.01 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.562 ' HD3' ' CE1' ' A' ' 76' ' ' TYR . 3.3 ttp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 32' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 m-85 -78.6 119.8 22.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.121 -1.223 . . . . 0.0 108.617 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.571 ' NE2' HG23 ' A' ' 31' ' ' THR . 30.6 mt-30 -106.78 122.91 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.141 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.941 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -115.79 173.77 6.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 109.64 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 8.5 mpt_? -107.86 137.44 45.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.403 -0.811 . . . . 0.0 108.846 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -66.02 99.12 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 110.241 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.5 mt -65.39 -30.51 71.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.147 -0.971 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.5 m-85 -127.94 -163.59 1.28 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.78 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.04 122.95 26.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.751 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.531 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 4.1 t80 -103.39 139.68 38.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.286 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 pttt -95.53 15.95 18.41 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.995 -1.065 . . . . 0.0 109.619 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 ttmm 64.19 92.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.658 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 4.8 tp10 -86.02 -80.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.229 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.507 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 77.8 mtm-85 -67.93 165.33 17.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.311 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -74.73 2.21 10.57 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.41 2.46 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.033 . . . . 0.0 109.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -109.37 172.43 6.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.508 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 HG13 ' CD2' ' A' ' 24' ' ' LEU . 6.3 pt -125.23 175.95 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.583 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -84.75 105.31 15.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.686 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.054 HD11 HD21 ' A' ' 30' ' ' LEU . 1.7 mm? -91.81 152.64 20.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' HG21 ' A' ' 63' ' ' THR . 1.6 m80 -152.22 135.86 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.338 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.5 tt -55.02 137.5 46.14 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.157 -0.965 . . . . 0.0 109.605 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.66 -9.12 71.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -90.31 162.39 15.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.3 mm -115.62 147.82 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.054 HD21 HD11 ' A' ' 24' ' ' LEU . 7.4 mp -120.76 111.8 18.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.226 -0.921 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.571 HG23 ' NE2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -86.52 93.57 9.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.74 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.941 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 46.9 t -92.35 121.27 42.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.117 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 4.5 m-80 -47.79 178.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -87.4 -71.31 0.57 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.87 -30.33 59.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 45.5 t -47.68 -33.85 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.237 . . . . 0.0 110.156 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.74 -40.55 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 38' ' ' VAL . 88.6 t -78.57 3.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.82 20.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.866 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.3 mm? -107.8 -7.34 16.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.53 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 95.2 33.5 6.54 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.722 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -53.81 -168.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -1.048 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 29.3 p -139.76 160.93 38.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -59.58 115.27 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.61 -34.09 4.67 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 15.9 mm-40 -68.39 -33.16 73.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.183 -1.187 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -64.23 -31.44 72.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -82.67 -14.57 54.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.1 mmm180 -112.05 80.17 3.06 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.033 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.7 Cg_exo -54.48 -57.4 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.304 2.003 . . . . 0.0 110.434 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 72' ' ' THR . 15.5 tt0 -44.0 -36.08 2.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.733 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.7 43.92 1.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.722 HG23 ' CE2' ' A' ' 42' ' ' PHE . 21.8 mt -136.68 -40.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.122 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -78.72 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 14.6 m95 -145.02 143.83 30.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.101 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.765 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -130.82 160.92 32.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 109.669 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -110.99 117.24 32.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.28 -176.16 14.37 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.5 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 70.7 t80 -117.55 111.87 19.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.876 -0.779 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.8 m-80 -79.3 78.72 5.78 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 108.79 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -48.19 -38.41 18.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.85 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 16.0 m -48.01 -46.74 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.599 HG21 ' CE1' ' A' ' 25' ' ' HIS . 53.3 p -117.4 17.72 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.04 50.93 6.13 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' OE1' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.87 109.93 15.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.301 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.455 ' C ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.0 150.54 20.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 109.398 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 153.98 -160.05 29.15 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.07 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -99.29 166.3 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.36 -1.083 . . . . 0.0 109.61 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.765 ' HE2' HG11 ' A' ' 74' ' ' VAL . 5.1 p90 -164.63 158.93 15.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.1 Cg_exo -60.47 116.54 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.014 1.809 . . . . 0.0 109.798 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.044 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.16 -37.69 91.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 51' ' ' GLU . 18.5 p -56.31 -23.39 36.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.902 -1.352 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 6.9 m-30 -92.49 28.23 2.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.044 HG22 ' O ' ' A' ' 71' ' ' GLY . 32.7 m -137.27 170.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.101 -1.0 . . . . 0.0 109.921 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.765 ' HG3' HD12 ' A' ' 77' ' ' ILE . 8.1 pt-20 -138.66 89.66 2.39 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.501 -0.75 . . . . 0.0 109.054 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 50.6 t80 -37.75 115.78 0.44 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.641 -0.662 . . . . 0.0 110.639 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 77' ' ' ILE . 67.6 mt -149.37 28.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -136.79 125.67 3.5 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.074 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 8.5 tpt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 72.7 m-85 -140.32 121.46 14.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -1.009 . . . . 0.0 108.863 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.636 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.3 tt0 -130.28 133.56 46.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.085 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.707 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -128.66 178.57 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.906 ' HB2' HD11 ' A' ' 77' ' ' ILE . 15.9 ttp180 -118.99 121.29 39.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -44.92 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.871 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.654 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -74.39 -64.62 0.99 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.654 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -96.71 -160.63 0.81 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -123.14 126.06 46.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.217 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 15' ' ' LYS . 92.7 t80 -128.28 131.68 48.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 12.9 mmtt -79.69 178.43 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' CG ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -98.71 68.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.956 . . . . 0.0 109.243 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -68.23 -84.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 9.2 mtm-85 -43.61 145.65 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.62 -5.62 21.06 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.257 -0.902 . . . . 0.0 109.896 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.13 7.77 25.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 109.8 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 44.4 p30 -106.16 159.39 16.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.0 109.534 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -119.44 161.21 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.354 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD2' ' CG ' ' A' ' 16' ' ' LYS . 2.7 m-20 -56.16 154.25 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 109.7 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -152.66 137.96 17.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.79 137.77 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 26.4 tp -42.81 151.07 0.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.608 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 87.31 -16.12 50.39 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 3.1 t70 -90.2 160.69 16.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -1.094 . . . . 0.0 109.168 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.976 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.8 mm -118.91 149.74 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.133 HD23 ' CE2' ' A' ' 69' ' ' PHE . 8.3 mp -124.79 108.98 12.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 108.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.636 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -89.23 91.44 8.77 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.101 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.707 HG21 ' OH ' ' A' ' 8' ' ' TYR . 40.6 t -87.2 101.77 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.81 152.65 44.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 176.56 1.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -59.47 4.61 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -71.34 -31.74 67.72 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.357 -1.084 . . . . 0.0 109.022 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 47' ' ' GLU . 4.9 tp -89.51 -28.54 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 38' ' ' VAL . 55.0 t -90.17 -1.93 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.72 -12.87 18.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.555 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.85 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? -93.29 -28.24 16.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.472 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 120.83 19.1 3.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.944 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 75.6 m-85 -55.75 -168.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -1.199 . . . . 0.0 109.47 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -151.18 156.79 41.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.285 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.8 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.44 -37.0 1.67 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -87.92 -12.5 44.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.192 -1.181 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.779 ' CB ' HD21 ' A' ' 37' ' ' LEU . 28.2 mt-10 -83.72 12.3 6.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.898 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -107.81 -10.33 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.1 mmt180 -117.43 77.31 10.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.733 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.3 Cg_endo -61.24 -21.44 71.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.211 1.941 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -56.32 -20.55 19.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 109.357 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 mt-10 -123.83 1.42 8.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.705 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.944 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 9.6 mt -79.54 -30.27 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 107.62 -77.73 0.23 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 10.3 m95 -147.68 136.4 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -1.091 . . . . 0.0 109.527 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.748 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -124.03 138.3 54.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.514 ' C ' HG22 ' A' ' 32' ' ' VAL . 22.6 t-20 -93.66 109.7 21.34 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -123.99 -176.62 14.76 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.14 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -114.16 110.31 19.79 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.657 -0.907 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' HG22 ' A' ' 63' ' ' THR . 75.2 m-20 -78.03 82.8 4.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.983 -1.073 . . . . 0.0 108.909 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -53.36 -34.42 57.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.468 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 49.6 m -50.54 -41.67 54.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.425 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 60' ' ' ASN . 1.6 t -108.35 2.68 22.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.08 47.46 89.05 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 63' ' ' THR . 73.8 mm-40 -137.02 169.68 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -1.125 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HG21 ' A' ' 22' ' ' ILE . 1.1 ttt180 -140.15 156.94 46.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 22' ' ' ILE . . . 160.64 -173.18 37.14 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 5.3 t0 -97.07 160.4 14.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -1.083 . . . . 0.0 109.602 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 1.133 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.4 p90 -158.51 162.21 27.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -60.01 128.16 25.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.958 1.772 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.35 -32.79 64.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 51' ' ' GLU . 32.8 p -68.27 -7.79 33.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.985 -1.303 . . . . 0.0 109.533 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.1 m-85 -99.68 6.94 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.733 HG23 ' HG2' ' A' ' 50' ' ' PRO . 10.6 m -127.32 164.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.136 -0.978 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.1 pt-20 -129.22 89.0 2.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.554 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 51.8 t80 -41.02 142.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.509 -0.744 . . . . 0.0 109.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -135.25 3.73 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.456 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 135.87 -177.69 19.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.32 -1.106 . . . . 0.0 109.5 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 3.9 m-85 -79.69 81.65 5.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.335 -1.097 . . . . 0.0 108.827 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.654 ' CG ' HG23 ' A' ' 31' ' ' THR . 8.8 mt-30 -84.28 141.34 31.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.276 0.56 . . . . 0.0 110.04 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.841 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -120.51 173.0 7.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.03 120.93 41.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.653 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -48.74 133.05 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.897 . . . . 0.0 110.656 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.0 mt -117.86 -39.37 3.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 19.7 m-85 -123.75 -159.02 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.594 -0.691 . . . . 0.0 109.758 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -135.38 132.46 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 109.766 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 28.3 t80 -123.9 126.97 47.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.096 -1.002 . . . . 0.0 109.547 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 24.3 ttpp -66.05 86.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -77.57 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.338 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 50.8 mtt-85 -89.0 146.08 25.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.79 -19.65 6.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -0.922 . . . . 0.0 110.017 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 3.3 pt-20 -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -90.97 169.84 10.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.361 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 67' ' ' GLY . 1.9 pt -126.79 179.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 3.3 m-20 -78.83 164.83 24.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.616 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 14.5 mt -154.15 148.6 26.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 108.714 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.9 m80 -156.06 132.66 10.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 109.823 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.8 tt -50.8 139.27 17.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.55 -10.65 68.91 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.801 ' OD1' HG21 ' A' ' 62' ' ' THR . 67.2 m-20 -79.31 -175.78 4.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -1.09 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.8 mm -133.57 125.47 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 108.946 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 20.5 mt -101.96 148.69 25.05 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.17 -0.956 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.654 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -133.25 82.56 2.0 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.882 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.841 HG21 ' OH ' ' A' ' 8' ' ' TYR . 9.7 t -79.63 116.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.966 -1.084 . . . . 0.0 108.155 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.89 154.49 12.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.979 -1.075 . . . . 0.0 110.049 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -68.12 145.52 54.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.464 -0.772 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 -57.14 4.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -20.9 2.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.223 -1.163 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.613 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -90.11 -35.15 15.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 38' ' ' VAL . 38.5 t -90.28 1.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.07 4.53 9.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.913 . . . . 0.0 109.98 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.7 mt -96.36 -28.99 14.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.114 -0.991 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 125.34 9.11 5.16 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.898 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.2 m-85 -54.64 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -1.211 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 80.3 p -125.15 -165.25 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.22 69.75 7.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.556 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.09 -31.76 0.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CG ' ' OG ' ' A' ' 43' ' ' SER . 41.4 mm-40 -68.96 -30.28 68.68 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.219 -1.165 . . . . 0.0 109.832 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -43.8 -35.92 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.97 . . . . 0.0 109.54 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.57 40.9 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -143.77 64.93 13.77 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.167 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.82 -42.35 53.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.188 1.925 . . . . 0.0 110.436 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 10.1 pt-20 -61.09 -34.67 75.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -98.42 -3.52 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.802 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.3 mt -79.92 -50.42 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 108.998 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 121.62 -71.26 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.0 m95 -146.42 127.24 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.423 -1.045 . . . . 0.0 109.709 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.662 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -116.21 143.7 45.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -101.63 111.69 24.01 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.62 -162.52 9.2 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.652 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 64' ' ' GLY . 36.6 t80 -124.07 104.54 8.93 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.708 -0.877 . . . . 0.0 110.359 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -79.2 96.87 6.01 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -58.63 -33.64 70.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -0.871 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 ' OD1' ' A' ' 28' ' ' ASP . 11.6 m -49.01 -29.16 4.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 109.597 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' HB2' ' A' ' 65' ' ' GLU . 7.8 t -127.06 5.79 6.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 59' ' ' TYR . . . 52.08 49.6 48.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 63' ' ' THR . 35.3 mm-40 -124.98 145.43 49.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.575 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -126.1 125.59 42.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.258 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.581 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 176.88 -165.85 36.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -94.41 159.93 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -1.062 . . . . 0.0 109.529 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.8 p90 -164.51 160.34 15.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.0 Cg_exo -59.98 116.5 3.35 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.102 1.868 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.23 -21.63 70.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.553 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 1.7 p -64.95 -16.92 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.975 -1.309 . . . . 0.0 109.81 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 9.1 m-30 -99.75 18.09 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.013 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 71' ' ' GLY . 11.3 m -134.69 161.41 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 8.2 pt-20 -134.11 90.35 2.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.861 -1.15 . . . . 0.0 109.236 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 85.4 t80 -38.48 137.91 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -136.45 10.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 109.136 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 91.91 -106.15 3.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 0.0 109.386 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.485 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 22.5 m-85 -132.0 139.03 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -1.016 . . . . 0.0 109.039 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.17 122.47 18.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.57 177.11 4.95 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.114 -0.991 . . . . 0.0 109.854 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.1 123.09 45.94 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -49.02 106.21 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.5 mt -83.5 -29.52 27.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.888 . . . . 0.0 108.858 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -127.3 -175.48 3.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.455 -0.778 . . . . 0.0 109.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.28 179.49 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 18.0 t80 -175.0 113.1 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.353 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 146.72 30.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 18.4 tttp -53.14 112.47 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.62 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -114.5 -82.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -73.53 159.61 32.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.121 -0.987 . . . . 0.0 109.586 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -0.4 15.33 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.9 mt-10 -105.72 -4.96 20.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 18' ' ' ARG . 2.7 p-10 -112.14 167.6 10.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.623 HD12 HD22 ' A' ' 60' ' ' ASN . 7.2 pt -128.0 177.59 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.6 m-20 -69.28 163.85 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -161.15 147.71 14.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.362 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.6 m80 -156.87 146.12 20.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 10' ' ' ALA . 33.7 tp -53.04 143.2 18.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.765 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' H ' HD12 ' A' ' 26' ' ' LEU . . . 91.99 -31.8 5.74 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.2 t70 -58.52 158.76 7.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -1.088 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.839 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.5 mp -115.64 137.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 108.991 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.6 mp -117.45 125.99 51.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 109.907 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -102.46 92.94 4.89 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.752 HG22 ' CA ' ' A' ' 58' ' ' GLY . 91.0 t -101.57 112.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 9.4 p-10 -51.5 -177.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.159 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -86.88 -28.56 22.76 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . -67.66 -56.74 10.37 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 9.9 t -43.88 -25.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -1.183 . . . . 0.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -87.84 -40.11 14.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -0.972 . . . . 0.0 109.337 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 38' ' ' VAL . 77.3 t -77.91 -2.56 4.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.14 -34.67 14.73 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -81.14 -45.48 16.35 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.25 29.16 6.48 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.79 -79.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.714 -1.462 . . . . 0.0 108.099 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.61 157.07 24.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -84.34 68.73 10.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 108.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.03 -28.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG2' ' NE ' ' A' ' 49' ' ' ARG . 2.3 mt-30 -85.93 41.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -1.217 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 2.5 pm0 -90.1 1.87 55.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -113.15 39.81 2.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.658 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.49 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -160.2 62.78 1.87 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.9 -18.12 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.408 2.072 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.82 -35.81 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.607 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -101.49 -0.85 34.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.638 HD12 HD21 ' A' ' 56' ' ' LEU . 21.6 mt -79.87 -33.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -76.34 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.475 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 23.0 m95 -137.01 157.28 47.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -1.066 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 37' ' ' LEU . 3.4 mp -143.39 154.75 44.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.845 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 32' ' ' VAL . 17.9 t-20 -114.37 109.67 18.7 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.752 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.61 -161.32 9.68 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 52.6 t80 -120.9 112.63 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.657 -0.907 . . . . 0.0 110.027 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.623 HD22 HD12 ' A' ' 22' ' ' ILE . 37.3 m-20 -79.79 80.37 6.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -40.8 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 91.2 m -57.36 -43.03 83.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 3.7 p -93.35 0.96 57.09 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.312 -0.868 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.47 44.34 67.03 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 63' ' ' THR . 26.7 mt-10 -141.09 179.09 6.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -1.193 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 15.3 ptt85 -152.49 146.18 25.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 109.505 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 163.4 -159.6 32.2 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.972 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -92.43 166.14 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -1.046 . . . . 0.0 109.661 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.883 ' HE2' HG11 ' A' ' 74' ' ' VAL . 7.2 p90 -171.1 159.51 5.32 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.835 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.55 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -57.86 120.27 8.07 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.084 1.856 . . . . 0.0 110.116 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.973 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.67 -31.99 70.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -63.19 -18.99 64.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.908 -1.348 . . . . 0.0 109.372 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 10.7 m-30 -92.57 30.21 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.005 . . . . 0.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.3 m -143.8 167.32 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 5.9 pt-20 -140.49 87.53 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.25 -0.906 . . . . 0.0 109.745 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.601 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 42.1 t80 -47.88 137.66 9.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 108.746 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.712 HG22 ' O ' ' A' ' 77' ' ' ILE . 70.5 mt -144.23 9.06 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . 159.27 -172.41 35.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.464 ' OXT' ' HB2' ' A' ' 7' ' ' GLN . 7.3 mtp180 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -1.072 . . . . 0.0 109.437 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.635 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 25.7 m-85 -80.23 133.25 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 109.616 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.593 ' CG ' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -119.14 113.57 21.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -0.795 . . . . 0.0 109.389 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.748 ' CE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.07 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.078 -1.014 . . . . 0.0 108.963 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.7 mtt85 -120.55 137.89 54.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.0 108.871 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -56.77 109.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 110.241 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -93.68 -29.71 15.29 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -128.2 -169.64 2.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.952 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 57.3 p-10 -114.93 178.35 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 67.1 t80 172.92 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.279 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 7.0 tttp -79.76 153.39 29.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.471 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 2.3 pttt -77.51 78.16 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.562 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.02 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.202 -0.936 . . . . 0.0 109.249 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -54.97 142.74 28.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -57.72 -15.67 8.63 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.06 -32.49 33.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 109.9 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -88.29 146.54 25.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.109 -0.994 . . . . 0.0 109.274 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.855 HD11 ' ND2' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -107.59 -169.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.671 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -73.64 153.33 40.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.848 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.31 129.92 22.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.666 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -147.87 133.25 18.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.646 ' C ' HD23 ' A' ' 26' ' ' LEU . 3.8 tt -51.67 151.34 3.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.865 . . . . 0.0 109.721 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 26' ' ' LEU . . . 89.16 -10.95 71.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.744 ' CG ' HG21 ' A' ' 62' ' ' THR . 2.2 m-20 -90.27 -170.26 2.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.966 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.0 mt -148.53 151.32 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.966 HD12 ' C ' ' A' ' 29' ' ' ILE . 3.7 mp -134.67 130.24 36.03 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.049 -1.032 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -97.84 96.45 8.22 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 57' ' ' ASN . 51.3 t -101.46 116.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.884 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 8.1 t30 -53.12 147.41 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 108.95 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -2.77 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.138 -0.976 . . . . 0.0 109.797 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.94 -53.97 1.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 p -48.59 -22.5 0.77 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -1.132 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD13 ' A' ' 53' ' ' ILE . 5.4 tt -90.31 -34.86 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 0.0 109.557 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 38' ' ' VAL . 53.8 t -87.71 0.78 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.628 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.15 -13.75 13.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.1 mm? -96.12 -23.17 16.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.583 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 118.27 23.12 3.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.861 ' CE2' HG23 ' A' ' 53' ' ' ILE . 12.0 m-85 -46.97 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -1.096 . . . . 0.0 109.612 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 t -94.56 162.88 13.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.64 96.25 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.94 -8.13 9.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.92 0.19 57.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -1.183 . . . . 0.0 109.612 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.635 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 3.1 mp0 -90.4 21.02 4.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.56 -2.46 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -126.66 86.28 58.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.5 Cg_endo -61.2 -38.22 68.06 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.248 1.966 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.9 pm0 -59.15 -17.55 27.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.145 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.8 -11.39 14.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.076 HD13 HD11 ' A' ' 37' ' ' LEU . 32.6 mt -79.75 -50.17 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.43 -72.67 0.39 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 15.3 m95 -139.9 143.08 36.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -1.002 . . . . 0.0 109.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.865 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -135.86 152.27 50.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.732 ' O ' HG13 ' A' ' 32' ' ' VAL . 13.1 t-20 -115.28 111.2 20.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.723 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.88 -152.24 6.5 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.704 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 60.0 t80 -126.63 110.81 13.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.777 -0.837 . . . . 0.0 110.203 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.855 ' ND2' HD11 ' A' ' 22' ' ' ILE . 4.9 m-80 -78.53 82.95 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.919 -1.113 . . . . 0.0 108.822 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -52.17 -39.78 60.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.13 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.744 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.6 m -54.26 -46.33 72.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 109.787 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.666 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -105.93 13.29 29.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 39.81 54.43 2.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' HB3' HD13 ' A' ' 22' ' ' ILE . 2.8 mm-40 -136.9 120.17 16.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.503 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 22' ' ' ILE . 7.2 ttp180 -92.76 151.0 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.57 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 154.09 -168.98 32.54 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.249 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -93.09 175.7 6.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.565 -0.962 . . . . 0.0 109.668 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.8 p90 -179.24 152.04 0.67 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.245 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -59.05 123.01 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.058 1.839 . . . . 0.0 109.958 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.865 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -69.41 -29.61 71.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 4.1 p -58.53 -15.01 9.39 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.839 -1.389 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 7.5 m-30 -103.29 33.22 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.025 . . . . 0.0 110.378 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 71' ' ' GLY . 2.1 m -147.91 -179.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 9.6 pt-20 -151.06 90.37 1.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 49.7 t80 -52.66 123.15 10.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 109.044 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.825 HD12 ' CD ' ' A' ' 9' ' ' ARG . 8.6 mt -112.3 -14.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 147.96 177.62 22.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.715 ' CG ' ' OH ' ' A' ' 76' ' ' TYR . 24.2 m-85 -79.31 140.25 37.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.418 -1.048 . . . . 0.0 108.643 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 mt-30 -147.24 125.18 11.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -120.53 177.99 4.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.564 ' CB ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -114.17 170.55 8.2 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -86.52 146.57 26.33 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 109.893 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 74' ' ' VAL . 13.3 mt -126.84 -36.99 2.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 2.5 m-85 -118.4 -163.22 0.94 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.941 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.68 170.11 10.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -174.52 116.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -86.94 34.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.938 -1.102 . . . . 0.0 110.298 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 17.4 tttt 41.55 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 42.1 mm-40 -97.25 -49.56 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.81 149.96 36.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 41.8 tt0 -69.55 -4.11 17.65 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.161 -0.962 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE2' ' OD2' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -106.32 -15.12 14.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 110.201 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 51.4 p30 -99.09 165.56 11.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.771 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -121.29 177.07 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.515 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 1.7 m-20 -70.02 171.24 9.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.813 HD21 HD21 ' A' ' 30' ' ' LEU . 10.4 mt -164.76 144.97 7.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.048 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.927 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -158.95 125.0 4.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.43 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.02 129.96 12.17 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.16 -11.81 33.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.754 ' CG ' HG21 ' A' ' 62' ' ' THR . 4.4 m-20 -89.73 -170.87 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.88 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -143.81 138.23 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.211 HD23 ' CE2' ' A' ' 69' ' ' PHE . 6.2 mp -116.81 124.22 49.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.467 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -96.28 103.08 14.96 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 110.648 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 96.2 t -113.8 100.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 p30 -57.73 -166.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.005 -1.06 . . . . 0.0 109.089 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -84.04 -27.18 28.51 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.027 -1.045 . . . . 0.0 110.622 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' N ' ' HG2' ' A' ' 34' ' ' LYS . . . -81.39 -53.85 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 33' ' ' ASN . 7.1 t -50.31 -22.46 1.81 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.069 -1.254 . . . . 0.0 109.437 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.652 HD12 HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -88.98 -44.36 10.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 108.683 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 38' ' ' VAL . 97.2 t -83.33 6.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -44.9 -28.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.668 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -100.1 -29.0 12.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 136.81 -40.07 1.56 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.2 m-85 38.81 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.918 . . . . 0.0 109.453 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.48 145.17 31.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.877 -1.139 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -62.97 96.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 142.04 -28.23 2.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -90.41 -6.45 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -1.099 . . . . 0.0 109.32 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 2.7 mp0 -43.01 -60.03 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.361 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -84.92 46.7 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.501 -0.75 . . . . 0.0 109.859 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.02 61.51 21.73 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.8 Cg_exo -54.97 -48.62 20.16 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.44 2.093 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 72' ' ' THR . 1.1 mp0 -67.89 -34.62 76.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.158 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 1.66 56.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.958 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.834 HD13 HD21 ' A' ' 56' ' ' LEU . 2.7 mt -88.95 -45.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 117.06 -70.63 0.29 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 15.5 m95 -149.19 128.76 13.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -1.025 . . . . 0.0 109.078 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.834 HD21 HD13 ' A' ' 53' ' ' ILE . 1.4 mp -119.14 140.8 49.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -94.77 101.83 13.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.4 179.37 16.98 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.118 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.6 t80 -104.69 117.7 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.869 -0.783 . . . . 0.0 109.352 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -78.95 77.94 5.41 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.245 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -55.97 -36.12 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.754 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.9 m -62.95 -31.85 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 109.949 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.927 HG21 ' HE1' ' A' ' 25' ' ' HIS . 6.9 p -119.14 19.2 12.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 40.98 54.64 3.6 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.0 179.64 5.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -1.211 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 19.7 ttp85 -160.47 123.02 3.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.771 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 177.2 -167.67 39.01 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.277 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 63.1 m-20 -95.26 161.83 13.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.483 -1.01 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 1.211 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -162.31 162.99 19.12 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.619 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.9 Cg_exo -59.5 113.84 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.818 1.679 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -62.99 -35.26 91.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 51' ' ' GLU . 28.6 p -60.65 -13.68 16.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.788 -1.419 . . . . 0.0 110.118 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 7.7 m-30 -97.54 15.78 22.29 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.976 -1.077 . . . . 0.0 112.087 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.2 m -126.81 -179.73 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.633 -1.292 . . . . 0.0 109.951 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 11' ' ' LEU . 4.2 pt-20 -143.72 91.67 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 109.103 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' OH ' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -31.58 162.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.256 1.027 . . . . 0.0 112.961 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 77' ' ' ILE . 34.3 mm -155.01 14.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -118.33 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 mtt85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 31.1 m-85 -80.09 112.65 17.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -1.146 . . . . 0.0 109.548 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 2.6 mt-30 -98.98 121.34 40.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.68 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.67 175.58 5.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.016 . . . . 0.0 109.653 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 36.4 ttt180 -114.85 141.46 47.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -68.06 108.41 3.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.946 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.1 mt -82.0 -31.26 31.16 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.5 m-85 -129.77 -160.15 1.01 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.48 -0.763 . . . . 0.0 109.468 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -134.41 109.85 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB3' HD21 ' A' ' 24' ' ' LEU . 66.4 t80 -105.07 128.89 53.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.93 158.47 26.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.891 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' CE ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -80.83 72.63 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.033 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.0 108.821 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -90.51 159.09 16.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.132 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HA ' ' CE ' ' A' ' 16' ' ' LYS . 32.3 tp10 -55.3 -28.75 55.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -53.2 -40.6 64.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.999 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -99.93 162.5 12.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.816 HG21 ' C ' ' A' ' 66' ' ' ARG . 35.6 pt -114.75 -168.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.925 . . . . 0.0 110.176 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -99.24 99.31 10.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 0.0 109.379 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -110.17 147.1 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 108.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -145.91 148.23 32.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -48.5 136.32 13.05 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.354 -0.841 . . . . 0.0 109.785 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 93.49 -5.03 73.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 6.7 t0 -90.39 145.9 24.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -1.132 . . . . 0.0 109.514 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.8 mm -96.58 132.06 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -0.923 . . . . 0.0 109.211 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.4 mp -110.34 114.56 28.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.319 -0.863 . . . . 0.0 108.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -92.16 96.86 10.56 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.902 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.68 HG11 ' OH ' ' A' ' 8' ' ' TYR . 64.3 t -102.59 108.05 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.885 . . . . 0.0 109.375 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 4.8 t30 -47.6 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -71.81 -62.76 1.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.54 99.7 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 33' ' ' ASN . 34.7 m -52.21 -19.8 2.23 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.351 -1.088 . . . . 0.0 109.827 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.887 ' O ' HD23 ' A' ' 37' ' ' LEU . 5.6 tt -88.96 -36.08 16.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 38' ' ' VAL . 40.2 t -90.42 1.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.28 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.17 47.88 1.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.887 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.42 56.61 14.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.799 ' CE2' HG23 ' A' ' 53' ' ' ILE . 3.8 m-85 -89.04 -166.89 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 46' ' ' GLN . 7.2 t -133.65 141.9 47.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 108.984 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.35 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.63 -30.48 1.03 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.753 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -88.23 34.4 0.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.683 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' OE1' ' OH ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -90.14 -17.45 27.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 76' ' ' TYR . . . -126.16 14.77 7.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.2 mtt180 -121.66 74.8 34.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.609 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.45 -52.79 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.197 1.931 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -52.39 -28.21 18.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 49' ' ' ARG . 2.7 mt-10 -109.43 44.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.7 mt -130.98 -42.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 108.894 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 112.47 -76.52 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 32.7 m95 -147.35 131.33 17.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -1.068 . . . . 0.0 109.244 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.793 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -117.67 160.45 21.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 13.8 t-20 -113.0 111.19 21.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.17 -170.57 12.47 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.45 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 61.4 t80 -116.78 113.22 22.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.572 -0.958 . . . . 0.0 110.188 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.622 ' ND2' HD11 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -79.27 77.98 5.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 61' ' ' GLU . 3.7 tm-20 -52.92 -36.32 59.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.458 -0.776 . . . . 0.0 110.289 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 20.8 m -55.23 -38.48 68.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 109.982 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -113.01 20.48 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.48 53.88 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.79 172.08 13.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.816 ' C ' HG21 ' A' ' 22' ' ' ILE . 32.2 ttm-85 -156.19 144.6 19.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.564 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 159.78 -152.95 23.93 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.025 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 72.7 m-20 -100.65 162.46 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -1.025 . . . . 0.0 109.916 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.646 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.9 p90 -161.97 158.97 21.85 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -58.84 125.73 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.093 1.862 . . . . 0.0 110.146 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -68.26 -44.16 76.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 51' ' ' GLU . 33.5 p -61.68 -12.12 14.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.998 -1.296 . . . . 0.0 109.615 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.4 m-85 -92.95 18.58 8.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.996 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.4 m -140.02 -176.04 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.219 -0.926 . . . . 0.0 109.793 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 1.039 ' O ' HD12 ' A' ' 77' ' ' ILE . 7.8 pt-20 -155.1 89.28 1.21 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.51 ' CE1' ' HB3' ' A' ' 6' ' ' TYR . 48.8 t80 -46.14 120.68 2.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.039 HD12 ' O ' ' A' ' 75' ' ' GLU . 1.1 mp -152.36 20.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.56 111.57 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.46 ' NH1' ' HB2' ' A' ' 79' ' ' ARG . 12.1 mtm105 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.13 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 25.3 m-85 -79.55 93.35 5.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -1.12 . . . . 0.0 109.75 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.752 ' HG2' HG23 ' A' ' 31' ' ' THR . 1.9 mt-30 -89.69 129.97 36.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 0.0 108.622 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.35 179.05 4.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.924 -1.11 . . . . 0.0 109.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -117.38 136.33 53.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -76.31 137.76 40.07 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 110.436 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.975 HD21 ' C ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -122.94 -32.66 3.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.498 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 m-85 -112.74 -163.13 0.83 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -137.51 112.6 9.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.965 -1.084 . . . . 0.0 110.153 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 17.2 t80 -100.42 158.33 15.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.052 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.77 149.61 30.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 0.0 109.42 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 23' ' ' ASP . 14.9 tttp -82.23 70.77 9.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -55.94 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -79.76 142.28 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -64.08 -9.75 18.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.213 -0.93 . . . . 0.0 109.935 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 3.3 mm-40 -103.82 19.7 19.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.983 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 11.6 p-10 -124.71 172.51 9.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.881 HD12 HD21 ' A' ' 60' ' ' ASN . 0.5 OUTLIER -130.9 154.87 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -68.94 110.34 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.567 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -104.55 148.92 25.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.201 -0.937 . . . . 0.0 109.277 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -160.17 130.47 5.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.175 -0.953 . . . . 0.0 109.372 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -42.93 137.14 2.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.322 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -1.07 81.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.789 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 37.2 t0 -90.72 131.59 36.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.426 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 46.2 mm -87.99 132.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.973 -1.079 . . . . 0.0 109.284 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.671 HD23 ' CE2' ' A' ' 69' ' ' PHE . 9.0 mp -107.68 139.87 41.58 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.325 -0.86 . . . . 0.0 108.993 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.752 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -116.29 99.25 7.07 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.005 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 52.6 t -107.74 95.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 73.8 m-20 -45.42 136.1 5.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 109.953 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -70.14 160.77 31.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.44 -60.82 4.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -20.65 55.78 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.377 -1.072 . . . . 0.0 108.513 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 47' ' ' GLU . 4.5 tp -85.68 -29.32 24.08 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 38' ' ' VAL . 38.9 t -84.77 -1.23 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -73.71 -0.41 15.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -103.98 12.75 33.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 109.648 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.74 15.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 53' ' ' ILE . 17.2 m-85 -72.35 -168.92 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.662 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 94.9 p -125.51 166.04 17.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.835 . . . . 0.0 109.287 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -72.27 98.58 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.646 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.22 13.27 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.464 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.6 mt-30 -89.89 -21.91 22.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -1.22 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HA ' HD21 ' A' ' 37' ' ' LEU . 3.5 pt-20 -65.7 -8.27 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.274 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' C ' ' HD3' ' A' ' 50' ' ' PRO . . . -108.11 -4.97 17.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.981 -1.074 . . . . 0.0 110.036 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.501 ' O ' HG13 ' A' ' 53' ' ' ILE . 32.5 mmt-85 -117.96 72.33 8.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.9 Cg_exo -54.2 -33.19 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.279 1.986 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 72' ' ' THR . 3.0 pt-20 -64.21 -40.16 95.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.056 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 61.7 mt-10 -85.33 4.76 33.65 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 109.526 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 56' ' ' LEU . 8.6 mt -94.24 -52.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -77.04 0.3 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 14.2 m95 -134.09 147.2 50.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -1.028 . . . . 0.0 109.063 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.812 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -140.38 158.24 44.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 28.5 t-20 -113.9 109.35 18.37 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.74 -161.3 9.86 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.66 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 54.1 t80 -127.18 114.19 17.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 110.182 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.881 HD21 HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -79.75 96.35 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.121 -0.987 . . . . 0.0 108.615 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -60.35 -40.87 92.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.439 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 22.9 m -59.28 -22.12 60.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.988 -1.07 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.599 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -120.62 6.12 10.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 45.01 37.66 5.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' OE2' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -114.76 173.86 6.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.168 . . . . 0.0 109.462 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 1.6 ttp85 -153.25 130.87 11.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.137 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 169.55 -158.04 30.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.174 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-20 -92.79 165.46 12.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -1.013 . . . . 0.0 110.0 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.671 ' CE2' HD23 ' A' ' 30' ' ' LEU . 4.3 p90 -171.79 153.13 3.24 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.96 123.35 12.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.025 1.817 . . . . 0.0 110.063 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.812 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -30.3 65.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.604 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.3 p -67.02 -7.88 25.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -1.207 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.1 m-85 -98.67 10.88 40.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.975 ' C ' HD21 ' A' ' 11' ' ' LEU . 2.9 m -130.9 -165.96 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.755 0.788 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' HD23 ' A' ' 11' ' ' LEU . 8.2 pt-20 -160.05 90.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.577 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.8 t80 -38.16 120.6 0.89 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.506 -0.747 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.508 ' CG1' ' HB2' ' A' ' 9' ' ' ARG . 45.8 mm -106.62 -19.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.97 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.577 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 129.27 -130.32 6.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.26 -1.141 . . . . 0.0 109.449 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 39.1 m-85 -148.35 111.98 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -1.155 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.544 ' OE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -99.83 120.24 39.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.557 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -107.1 178.59 4.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.975 -1.078 . . . . 0.0 109.868 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.94 147.96 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . . . -75.51 106.64 7.16 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 110.126 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.7 mt -84.97 -26.34 27.21 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 23.5 m-85 -135.82 -160.71 1.08 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.538 -0.726 . . . . 0.0 109.711 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HA ' ' C ' ' A' ' 24' ' ' LEU . 10.1 p-10 -135.67 143.26 45.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.593 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 10.7 t80 -116.67 163.91 15.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.188 -0.945 . . . . 0.0 108.626 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 8.9 mmtt -104.57 -19.58 13.95 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.053 -1.03 . . . . 0.0 110.551 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER 75.24 81.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.068 . . . . 0.0 109.236 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -84.42 -54.96 4.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.731 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 1.1 tpt180 -87.97 162.35 16.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.71 -3.6 19.4 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 7.1 pt-20 -99.61 14.81 28.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.083 -1.011 . . . . 0.0 109.773 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -127.68 163.42 24.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.149 -0.969 . . . . 0.0 109.417 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -128.33 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 110.116 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.576 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -58.99 119.45 7.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 30' ' ' LEU . 2.2 mm? -97.28 159.38 14.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 109.169 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.1 m80 -159.44 125.38 4.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.865 . . . . 0.0 109.4 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 10' ' ' ALA . 2.8 tp -50.62 128.29 20.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.74 28.28 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.729 ' CG ' ' HB2' ' A' ' 10' ' ' ALA . 2.3 p30 -90.02 -179.9 5.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.272 . . . . 0.0 109.967 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.858 ' C ' HD12 ' A' ' 30' ' ' LEU . 33.5 mm -127.54 149.2 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.074 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.3 mp -123.84 123.34 40.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.013 -1.054 . . . . 0.0 110.387 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -99.7 86.61 3.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 57' ' ' ASN . 67.7 t -96.56 116.35 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -56.52 162.83 2.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 108.475 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.7 ptmt -90.5 -25.61 20.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.01 -1.056 . . . . 0.0 110.327 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.65 -58.83 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -50.19 -22.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -1.151 . . . . 0.0 110.05 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' OE1' ' A' ' 47' ' ' GLU . 4.1 tt -90.31 -32.73 16.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 109.707 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 38' ' ' VAL . 51.3 t -82.34 -0.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 109.751 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.2 -21.18 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.198 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.14 37.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.516 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.96 49.58 17.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 2.3 m-85 -59.38 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.177 -1.19 . . . . 0.0 109.267 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -128.56 150.79 50.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.138 -0.977 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.55 120.81 10.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.07 -33.41 6.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.504 ' O ' ' CG1' ' A' ' 53' ' ' ILE . 10.2 mt-30 -65.9 -11.93 50.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -1.147 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 1.015 ' OE1' HD13 ' A' ' 37' ' ' LEU . 14.9 mm-40 -81.13 -22.38 39.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.626 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.18 -4.96 58.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.1 mmp_? -117.14 74.13 7.27 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.7 Cg_exo -54.99 -32.17 77.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.2 1.934 . . . . 0.0 110.489 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 6.7 pt-20 -62.24 -35.98 80.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.942 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.3 mt-10 -95.57 -3.74 45.92 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.162 -0.961 . . . . 0.0 110.017 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.717 HD12 HD21 ' A' ' 56' ' ' LEU . 31.6 mt -79.6 -36.92 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 109.361 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 108.15 -76.52 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m95 -143.77 132.81 22.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -1.137 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -117.42 142.3 47.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.798 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.687 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -105.97 111.77 24.55 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.568 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -139.49 -161.27 8.66 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.413 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 67.2 t80 -115.5 114.22 24.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.626 -0.926 . . . . 0.0 110.553 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.1 m-20 -78.09 79.02 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -42.68 -44.69 4.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 3.4 m -46.57 -69.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.105 -0.997 . . . . 0.0 109.876 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.543 ' CG2' ' HG3' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -81.05 6.03 14.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.971 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.42 48.43 60.17 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.576 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 2.7 mt-10 -121.27 173.11 7.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.278 . . . . 0.0 109.282 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.58 118.0 6.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 109.341 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -176.4 -150.76 8.38 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 22' ' ' ILE . 7.5 m-20 -108.83 165.21 11.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -1.056 . . . . 0.0 109.829 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 1.074 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.9 p90 -165.87 161.82 13.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.385 -0.822 . . . . 0.0 109.011 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.595 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -57.92 126.92 23.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.936 1.757 . . . . 0.0 110.033 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.98 -33.97 62.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 72' ' ' THR . 2.0 p -65.48 -9.03 22.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.083 -1.245 . . . . 0.0 109.218 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -98.3 16.4 21.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.899 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 30' ' ' LEU . 6.1 m -136.49 -175.45 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.18 -0.95 . . . . 0.0 109.612 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 77' ' ' ILE . 11.3 pt-20 -156.61 87.26 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.87 . . . . 0.0 109.808 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.522 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 58.3 t80 -46.18 135.8 7.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.369 -0.832 . . . . 0.0 109.753 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -135.38 17.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.067 -1.021 . . . . 0.0 109.468 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.457 ' HA2' ' OH ' ' A' ' 76' ' ' TYR . . . 116.52 -147.17 18.91 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 87.9 m-85 -79.58 121.21 24.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.46 -1.024 . . . . 0.0 108.885 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.627 ' CG ' HG23 ' A' ' 31' ' ' THR . 1.3 mt-30 -118.87 115.67 24.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.883 -1.136 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.625 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -105.99 -178.98 3.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.905 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -121.64 132.43 54.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.731 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -57.65 164.43 2.05 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 109.932 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 74' ' ' VAL . 14.1 mt -138.49 -40.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.603 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -117.3 -159.66 0.74 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.128 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 11.5 p-10 -119.71 168.18 11.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 110.275 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CB ' ' CD2' ' A' ' 24' ' ' LEU . 2.0 t80 -171.91 119.22 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.509 -0.744 . . . . 0.0 109.195 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' LYS . 16.8 mttm -93.67 49.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.833 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 9.7 ttmt 42.2 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 3.2 mt-10 -73.23 -81.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.276 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 8.1 mmt180 -88.96 150.52 22.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.0 109.388 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -47.12 -23.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.823 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.77 -48.68 68.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.965 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 34.7 p30 -82.38 173.15 12.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -127.71 -171.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.0 m-20 -93.75 115.04 27.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -121.32 150.21 41.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.856 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -150.21 149.36 30.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.047 -1.033 . . . . 0.0 109.769 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.1 tp -42.47 136.46 2.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 85.62 2.28 87.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.731 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 13.5 t0 -90.41 117.25 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -1.174 . . . . 0.0 109.213 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.764 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.8 mp -79.97 134.98 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.025 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 6.9 mp -113.46 136.8 52.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -115.65 89.31 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 111.008 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 37' ' ' LEU . 1.5 t -89.4 106.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 108.841 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -50.75 157.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -73.3 156.28 38.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 -56.93 4.83 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -51.04 -23.28 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.218 -1.166 . . . . 0.0 109.66 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -90.49 -34.21 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 38' ' ' VAL . 52.5 t -89.13 1.79 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.746 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.502 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.62 -8.21 25.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.861 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.76 18.62 21.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.311 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.77 38.78 60.7 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.707 ' CE1' HD23 ' A' ' 40' ' ' LEU . 5.6 m-85 -57.8 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.525 ' O ' ' C ' ' A' ' 44' ' ' ASP . 27.2 t -125.08 97.69 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.72 93.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.297 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.03 -14.76 4.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' SER . 5.8 mt-30 -90.68 2.14 56.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.778 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 1.3 mp0 -65.7 -23.23 66.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -103.21 19.04 20.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.526 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mmt180 -130.93 65.2 76.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.212 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.38 -33.49 97.86 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.162 1.908 . . . . 0.0 110.342 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 21.1 pt-20 -58.61 -29.8 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 109.597 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 -0.13 24.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.704 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.2 mt -79.92 -39.22 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 111.66 -73.45 0.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 11.2 m95 -148.1 140.98 24.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.467 -1.02 . . . . 0.0 109.123 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -130.8 132.9 45.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.0 110.019 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -99.82 105.37 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 32' ' ' VAL . . . -131.6 -156.2 8.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.621 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -115.66 111.49 20.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.451 -1.029 . . . . 0.0 110.774 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' HD11 ' A' ' 30' ' ' LEU . 3.2 m-80 -79.59 80.4 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 108.603 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -44.56 -44.84 9.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -46.49 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.03 . . . . 0.0 109.957 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.856 HG21 ' CE1' ' A' ' 25' ' ' HIS . 14.7 p -83.36 12.71 5.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.87 43.31 6.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.91 117.14 25.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -1.141 . . . . 0.0 109.314 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 15.9 ttm180 -94.99 138.06 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.501 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 168.18 -174.0 43.01 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.248 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -90.02 152.82 21.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.72 -0.871 . . . . 0.0 109.859 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 1.025 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 2.5 p90 -155.36 161.16 30.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 0.0 109.121 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.67 127.42 23.54 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.929 1.753 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.12 -32.29 63.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -69.56 -8.66 49.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.239 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.69 -1.24 50.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.73 ' O ' HD12 ' A' ' 11' ' ' LEU . 5.9 m -122.73 -174.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 11' ' ' LEU . 2.5 pt-20 -156.75 88.66 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.59 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 81.9 t80 -34.48 128.94 0.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.242 0.544 . . . . 0.0 109.973 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -116.78 0.86 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.946 . . . . 0.0 109.396 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.59 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 97.95 -115.02 5.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 7.3 m-85 -81.76 141.74 33.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.438 -1.037 . . . . 0.0 108.975 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.635 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.9 mt-30 -144.88 116.81 8.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.803 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -110.94 179.78 3.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 12.6 mtm180 -114.83 168.72 9.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.328 -0.858 . . . . 0.0 108.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -90.2 97.77 11.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -67.51 -30.72 70.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.086 -1.008 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -129.47 -168.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.439 -0.788 . . . . 0.0 109.725 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -130.79 98.25 4.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.537 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 32.1 t80 -88.41 152.29 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.785 . . . . 0.0 109.323 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 151.69 20.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.953 . . . . 0.0 109.425 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.6 ttpt -72.92 85.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.408 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' CG ' ' OH ' ' A' ' 14' ' ' TYR . 1.7 pp20? -117.86 -35.22 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -71.99 138.38 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.1 tt0 -56.41 -15.89 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 3.5 tt0 -129.65 36.98 4.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 110.11 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 1.1 p-10 -122.53 161.66 23.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.062 -1.024 . . . . 0.0 109.531 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 24' ' ' LEU . 1.6 pt -116.11 170.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.92 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.574 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -79.51 100.8 7.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.218 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.9 HD11 HD21 ' A' ' 30' ' ' LEU . 3.5 mm? -88.06 133.42 33.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.8 m80 -135.08 139.2 44.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.6 tt -56.33 123.37 14.39 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.35 -0.844 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.93 -5.56 39.71 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -90.34 167.04 12.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 109.066 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.925 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -125.52 147.71 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 29' ' ' ILE . 5.9 mp -122.77 127.55 49.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.237 -0.914 . . . . 0.0 108.789 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.635 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -97.91 93.65 6.45 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 109.942 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 87.4 t -90.31 114.39 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -58.02 173.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -37.66 66.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.275 -0.89 . . . . 0.0 109.741 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.56 -44.09 8.81 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 79.2 p -51.83 -21.43 2.87 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 37' ' ' LEU . 1.6 tm? -85.21 -35.97 21.27 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 38' ' ' VAL . 79.5 t -85.68 4.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.768 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.83 -5.19 11.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.217 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.121 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -100.16 -45.21 5.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 109.166 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 123.95 17.16 3.13 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.121 ' CE2' HD23 ' A' ' 40' ' ' LEU . 10.0 m-85 -59.37 -151.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 108.969 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.58 166.62 16.36 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.311 -0.868 . . . . 0.0 108.854 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.65 87.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.03 -17.15 1.37 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.75 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -89.55 20.91 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.235 . . . . 0.0 109.629 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.646 ' OE2' HG23 ' A' ' 38' ' ' VAL . 13.1 mt-10 -89.75 -43.11 10.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.866 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.92 38.47 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 tpt180 -156.25 66.55 4.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HG2' HG23 ' A' ' 74' ' ' VAL . 3.1 Cg_exo -59.64 -46.43 20.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.244 1.963 . . . . 0.0 110.413 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -44.31 -26.69 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.244 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tt0 -111.64 50.57 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.178 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.75 HD11 ' O ' ' A' ' 46' ' ' GLN . 57.9 mt -141.85 -69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 142.03 -63.31 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 43.0 m95 -152.33 140.08 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -1.088 . . . . 0.0 109.38 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -131.66 159.87 37.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.938 . . . . 0.0 109.763 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.4 t-20 -114.29 110.38 19.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.18 -168.85 12.29 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.203 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 40.0 t80 -111.52 114.66 27.89 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.63 75.21 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.028 . . . . 0.0 108.952 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.22 -33.88 21.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 16.4 m -55.39 -45.22 76.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.559 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -113.99 18.0 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.65 39.48 4.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 11.5 mt-10 -123.7 109.04 13.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.146 . . . . 0.0 109.135 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 17.6 ptt180 -92.63 143.97 25.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.729 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 168.67 -162.24 36.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -93.87 163.4 13.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -1.042 . . . . 0.0 109.382 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.724 ' CE2' HG11 ' A' ' 74' ' ' VAL . 3.8 p90 -163.63 158.64 17.25 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.76 124.43 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.133 1.888 . . . . 0.0 109.973 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.74 -40.92 85.01 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p -65.08 -12.06 46.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -1.204 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.0 m-85 -94.2 15.25 17.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.782 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.1 m -132.37 179.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.4 pt-20 -151.5 88.43 1.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 38.1 t80 -45.08 122.64 3.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 77' ' ' ILE . 74.7 mt -148.36 27.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -150.19 120.68 1.16 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.268 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.501 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 20.2 mtt85 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.464 -1.021 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.717 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 23.5 m-85 -78.1 113.52 16.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.06 . . . . 0.0 109.384 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.1 mt-30 -108.99 123.75 49.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.67 179.23 4.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.963 -1.085 . . . . 0.0 108.657 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 1.3 mtt180 -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -58.31 122.9 14.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.037 -1.039 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.8 mt -99.31 -34.07 10.47 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.0 m-85 -123.23 -166.72 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -0.807 . . . . 0.0 109.902 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 45.8 p30 -108.38 165.44 11.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.915 . . . . 0.0 109.839 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.807 ' HB2' HD22 ' A' ' 24' ' ' LEU . 7.7 t80 -173.81 106.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.405 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 12.5 ptmm? -83.57 11.58 6.95 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.649 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 69.72 115.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.223 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -90.66 -64.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.29 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.17 162.09 15.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.76 -10.87 22.06 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.96 -25.61 48.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -105.04 161.55 14.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 66' ' ' ARG . 1.4 pp -118.84 -176.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.465 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 4.7 m-20 -73.92 -179.83 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.807 HD22 ' HB2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 172.91 152.68 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.543 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.51 144.35 18.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.2 tt -48.9 148.21 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 83.57 -7.34 69.38 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 1.001 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.0 m-20 -88.06 -175.25 5.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.001 HD12 ' C ' ' A' ' 28' ' ' ASP . 2.4 mp -137.5 146.6 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.918 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.6 mp -122.38 120.84 35.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.228 -0.92 . . . . 0.0 109.125 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.93 91.49 7.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.864 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.672 HG11 ' OH ' ' A' ' 8' ' ' TYR . 87.8 t -99.87 110.63 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.0 109.024 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 97.0 m-20 -63.4 147.77 50.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.789 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 161.66 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.353 -0.842 . . . . 0.0 109.573 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 -59.87 4.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 m -52.66 -24.98 9.54 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.216 -1.167 . . . . 0.0 109.184 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.866 ' O ' HD23 ' A' ' 37' ' ' LEU . 3.2 tt -90.27 -29.36 18.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.814 . . . . 0.0 109.347 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 38' ' ' VAL . 96.8 t -89.2 0.56 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.34 -8.33 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -91.99 -17.07 25.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.718 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.38 23.07 3.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.2 m-85 -57.36 -171.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -1.15 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.9 -173.67 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.377 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.36 87.36 7.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 -31.78 2.5 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -53.8 -20.38 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -49.97 -54.47 19.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -85.31 59.31 5.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.431 -0.793 . . . . 0.0 110.033 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -153.06 57.49 2.03 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 3.3 Cg_exo -49.85 -46.89 25.56 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.774 ' HA ' HG22 ' A' ' 72' ' ' THR . 8.4 pt-20 -60.2 -33.68 72.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.06 -1.025 . . . . 0.0 109.311 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' CD ' ' HG2' ' A' ' 49' ' ' ARG . 5.4 mt-10 -99.89 1.82 43.19 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 50' ' ' PRO . 2.5 mt -94.36 -34.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 108.895 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.39 -80.52 0.31 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -140.56 144.77 36.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -1.082 . . . . 0.0 109.083 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.816 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -128.77 159.83 34.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 15.6 t-20 -118.41 114.47 22.96 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -135.9 -160.01 8.71 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.291 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 44.5 t80 -126.17 110.03 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.669 -0.901 . . . . 0.0 109.787 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 1.2 m-20 -79.29 85.49 5.13 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.128 -0.982 . . . . 0.0 109.371 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.49 -34.94 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.761 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.4 m -51.12 -33.82 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.639 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 65' ' ' GLU . 5.6 t -121.74 7.07 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.621 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.62 47.0 87.91 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 63' ' ' THR . 81.5 mm-40 -118.26 163.22 17.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -1.187 . . . . 0.0 109.379 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.655 ' O ' HG21 ' A' ' 22' ' ' ILE . 9.1 ttp180 -148.47 127.72 12.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 167.09 -159.42 32.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.603 -1.284 . . . . 0.0 109.952 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -96.08 167.38 11.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.804 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -165.57 159.71 13.67 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.231 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.1 Cg_exo -61.62 122.55 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.073 1.848 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -41.83 73.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.4 p -60.46 -12.18 8.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.316 . . . . 0.0 109.408 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.6 m-85 -98.56 22.12 10.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.127 -0.983 . . . . 0.0 110.533 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 71' ' ' GLY . 15.4 m -138.39 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 6.4 pt-20 -148.55 84.07 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CZ ' ' HB3' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -32.54 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.758 0.79 . . . . 0.0 112.155 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 15.1 mm -129.61 -9.69 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 79' ' ' ARG . . . 81.93 -151.79 30.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.629 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.606 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 18.5 m-85 -86.45 123.28 31.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -1.135 . . . . 0.0 109.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.542 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -127.72 138.86 52.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 109.712 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.703 ' CE2' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -137.29 179.64 6.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.967 . . . . 0.0 109.672 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.545 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 1.4 mtm-85 -111.42 161.85 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.68 102.19 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 110.502 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 75' ' ' GLU . 2.9 mt -75.14 -39.5 60.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.1 m-85 -128.01 172.47 10.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.882 . . . . 0.0 109.855 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 9.3 p-10 -99.6 146.63 26.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 109.677 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 70' ' ' PRO . 71.8 t80 -125.24 166.21 16.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -108.24 139.32 43.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 109.423 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 15.5 ttpp -83.3 72.87 10.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 108.928 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -90.27 153.71 20.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.152 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.41 -26.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 18' ' ' ARG . 2.0 mt-10 -53.94 -59.67 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.4 p30 -77.06 169.46 18.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.81 . . . . 0.0 109.571 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.791 ' O ' HD12 ' A' ' 22' ' ' ILE . 1.3 pp -127.77 161.77 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 0.0 109.893 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 4.5 m-20 -74.17 126.44 30.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.574 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 69' ' ' PHE . 19.0 mt -115.46 160.51 19.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.696 ' CE1' HG21 ' A' ' 63' ' ' THR . 2.2 m80 -156.56 149.95 24.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -57.52 137.52 56.19 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 109.386 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.98 -31.11 5.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 9.7 t0 -59.48 131.55 51.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -1.107 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.8 mm -93.26 140.46 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.752 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 9.8 mp -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.134 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -111.5 87.09 2.47 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.437 -0.789 . . . . 0.0 109.372 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.703 HG21 ' CE2' ' A' ' 8' ' ' TYR . 37.7 t -82.85 96.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -50.44 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.385 -0.822 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -86.93 154.08 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.626 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 88.43 -50.8 3.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -26.19 63.33 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.283 -1.128 . . . . 0.0 109.821 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.899 ' O ' HD23 ' A' ' 37' ' ' LEU . 2.2 tt -90.14 -35.97 15.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 38' ' ' VAL . 48.5 t -87.32 0.29 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.85 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.24 -13.99 15.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -104.05 32.2 4.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.744 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.21 51.27 55.29 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.702 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -70.83 -176.67 1.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -116.58 158.43 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -73.51 82.91 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.25 -36.94 0.6 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.1 29.31 1.24 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -90.1 -31.3 17.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.734 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -107.28 42.07 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.763 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.8 tpt180 -138.41 73.42 42.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.723 ' CG ' HG23 ' A' ' 74' ' ' VAL . 6.1 Cg_exo -56.75 -48.35 19.09 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.688 2.259 . . . . 0.0 111.878 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -56.64 -16.31 6.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.848 -1.158 . . . . 0.0 109.811 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -120.17 -5.41 9.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 109.8 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -79.86 -43.52 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.013 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.41 -76.39 0.26 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 30.7 m95 -143.74 132.75 22.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -1.045 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.853 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -119.87 158.61 26.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 110.027 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 21.1 t-20 -119.3 111.36 18.1 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -135.15 -151.7 6.32 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 31.0 t80 -130.73 113.36 14.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.915 -0.756 . . . . 0.0 109.978 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.557 HD21 HD13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -80.71 82.07 6.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.0 109.17 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -49.51 -37.12 25.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.946 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -53.0 -44.39 67.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.647 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.696 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -110.43 15.86 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.75 41.49 7.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -106.99 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -1.139 . . . . 0.0 109.558 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.572 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 10.8 ttt180 -156.85 130.29 8.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 161.33 -162.91 34.15 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -92.9 174.74 7.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.991 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.76 ' HB3' HD11 ' A' ' 22' ' ' ILE . 22.3 p90 178.98 157.47 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 109.333 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.72 115.52 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.021 1.814 . . . . 0.0 109.657 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.951 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.84 -30.0 74.08 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 18.7 p -49.49 -20.67 0.77 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.817 -1.402 . . . . 0.0 109.935 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 18.2 m-85 -97.54 33.76 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 111.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 71' ' ' GLY . 16.5 m -145.41 174.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.035 -1.041 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.728 ' HB3' HD11 ' A' ' 11' ' ' LEU . 4.9 pt-20 -148.66 93.01 2.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.8 t80 -37.34 119.57 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.372 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 77' ' ' ILE . 14.2 mm -144.99 15.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.32 100.72 0.46 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.477 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.417 -1.049 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 28.5 m-85 -143.31 148.22 35.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.52 -0.988 . . . . 0.0 108.472 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' CG ' HG23 ' A' ' 31' ' ' THR . 9.9 mt-30 -137.63 107.58 6.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 110.074 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.668 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.47 172.87 6.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.114 -0.991 . . . . 0.0 108.651 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB2' HD11 ' A' ' 77' ' ' ILE . 23.1 ttt180 -109.22 166.3 10.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -0.972 . . . . 0.0 108.954 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -90.64 99.36 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.024 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.61 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -80.62 -35.1 34.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.147 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 26.0 m-85 -130.76 171.3 13.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.883 . . . . 0.0 109.822 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -97.88 -177.26 3.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 65.6 t80 173.6 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -80.02 143.17 34.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 14.1 pttp -59.32 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -66.18 -70.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.4 mtt180 -75.89 164.39 26.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.69 1.48 10.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.464 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 1.1 tp10 -104.81 -6.08 20.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.038 -1.039 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.474 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -102.35 154.31 19.18 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 109.824 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -108.01 -171.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 0.0 109.391 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.824 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.97 142.19 33.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.0 HD11 HD21 ' A' ' 30' ' ' LEU . 1.6 mm? -131.97 138.1 48.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.481 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -153.13 136.79 16.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -49.0 135.58 15.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 96.28 -3.69 64.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 5.1 t70 -90.12 148.97 22.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.495 ' C ' HD12 ' A' ' 30' ' ' LEU . 17.6 mm -101.68 132.15 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.859 . . . . 0.0 108.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 24' ' ' LEU . 6.5 mp -114.21 111.72 22.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.44 96.01 10.28 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.222 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.664 HG11 ' OH ' ' A' ' 8' ' ' TYR . 78.4 t -98.32 101.1 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.0 m-80 -46.99 173.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 109.891 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 1.2 ttpm? -90.35 -27.46 19.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.04 -53.92 3.55 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -54.54 -24.51 21.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.217 -1.167 . . . . 0.0 109.664 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 47' ' ' GLU . 19.6 tp -90.28 -40.83 11.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 38' ' ' VAL . 47.4 t -79.93 0.38 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.907 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.414 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -68.24 -6.53 24.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -102.85 8.41 39.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.705 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.63 32.24 38.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.721 ' HE2' HG23 ' A' ' 53' ' ' ILE . 24.6 m-85 -58.29 -168.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.39 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.07 167.89 14.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.539 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.0 107.67 7.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.55 19.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD11 ' A' ' 53' ' ' ILE . 11.7 mm-40 -82.19 -41.15 20.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.261 -1.14 . . . . 0.0 109.579 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.2 pm0 -42.51 -43.89 3.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.442 -0.786 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -85.54 43.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.469 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -151.53 62.63 5.01 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HB2' HG23 ' A' ' 74' ' ' VAL . 2.8 Cg_exo -54.64 -55.55 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.469 2.113 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.7 -23.45 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.032 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.0 mt-10 -121.44 48.37 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 42' ' ' PHE . 4.9 mt -133.08 -43.91 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -75.65 0.26 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 48.5 m95 -144.19 123.57 13.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.378 -1.072 . . . . 0.0 109.576 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.732 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -112.95 156.47 22.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' VAL . 14.5 t-20 -112.21 107.69 16.65 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.627 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.18 -163.94 11.21 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.0 t80 -122.32 113.27 19.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.767 -0.843 . . . . 0.0 110.147 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' ND2' ' N ' ' A' ' 60' ' ' ASN . 1.2 m120 -78.96 82.71 5.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.192 -0.943 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -45.19 -41.93 8.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.067 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m -47.88 -69.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 t -79.76 4.91 14.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.963 . . . . 0.0 109.698 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.75 50.15 38.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -128.84 171.52 12.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -1.128 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' C ' HG21 ' A' ' 22' ' ' ILE . 12.2 ttp85 -143.21 143.8 31.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 162.88 -167.36 37.25 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.573 -1.298 . . . . 0.0 109.923 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.0 p30 -91.49 171.85 8.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -1.062 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 13.5 p90 -175.13 154.01 1.64 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.875 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -58.4 124.51 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.985 1.79 . . . . 0.0 109.765 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.732 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -71.62 -18.83 77.49 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -70.49 -13.85 62.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.694 -1.474 . . . . 0.0 109.68 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.598 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 10.7 m-30 -99.9 19.3 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 50' ' ' PRO . 2.7 m -132.39 -174.02 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.81 -1.181 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.53 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.8 pt-20 -158.19 88.02 0.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.557 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 14.2 t80 -43.13 133.31 3.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.907 . . . . 0.0 109.31 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.8 mp -129.06 -4.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.876 -1.14 . . . . 0.0 109.931 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 171.66 167.29 31.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.518 ' CA ' ' OH ' ' A' ' 76' ' ' TYR . 2.6 ptt-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.54 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.671 ' CD1' HD22 ' A' ' 37' ' ' LEU . 52.5 m-85 -84.57 121.35 27.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -1.076 . . . . 0.0 109.265 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 3.7 mt-30 -116.87 129.98 56.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.636 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -118.88 174.65 6.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.945 . . . . 0.0 109.926 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.826 ' HB2' HD11 ' A' ' 77' ' ' ILE . 1.8 ttp85 -117.11 126.71 53.26 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -54.4 133.22 45.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.573 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.7 mt -108.93 -38.79 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 3.8 m-85 -116.48 -160.43 0.76 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -124.52 146.6 48.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.909 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 24' ' ' LEU . 63.9 t80 -156.33 111.23 2.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.21 121.91 25.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -48.67 114.6 1.01 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG3' ' OD2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -90.57 -72.07 0.59 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.203 -0.936 . . . . 0.0 108.612 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.67 166.06 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 109.143 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -9.62 18.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 109.883 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.59 -23.04 40.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.095 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -108.55 158.4 17.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.8 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 60' ' ' ASN . 15.4 pt -111.29 -169.54 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.564 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -106.61 109.0 20.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.824 . . . . 0.0 109.527 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -113.58 148.08 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.18 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 2.0 m80 -154.01 141.49 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 109.39 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.5 tp -41.59 136.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.679 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.32 1.64 81.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.781 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.4 m-20 -90.42 169.18 11.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -1.156 . . . . 0.0 109.473 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.596 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mm -122.92 132.54 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.183 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.985 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.5 mp -115.61 128.59 56.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.066 -1.021 . . . . 0.0 109.116 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -110.42 79.77 1.24 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.392 -0.818 . . . . 0.0 109.149 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 37' ' ' LEU . 74.7 t -80.25 117.12 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -53.3 -173.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 37' ' ' LEU . 6.3 mtmt -90.17 -62.47 1.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.427 -0.796 . . . . 0.0 109.938 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.67 -54.49 37.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -19.7 3.56 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.213 -1.169 . . . . 0.0 109.32 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.75 HD21 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -84.57 -36.85 21.82 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 38' ' ' VAL . 21.9 t -85.02 -4.06 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.344 -0.848 . . . . 0.0 109.886 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.1 -24.1 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.055 -1.028 . . . . 0.0 108.605 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -88.78 33.19 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.624 -0.673 . . . . 0.0 109.848 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 47.51 29.55 5.61 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.658 ' CE1' HG23 ' A' ' 53' ' ' ILE . 6.8 m-30 -47.62 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.822 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -100.86 -174.35 2.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.181 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.98 103.92 16.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.787 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 12.59 77.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' SER . 6.8 tt0 -90.3 29.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -1.2 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.75 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -86.55 -13.12 46.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -79.08 4.52 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.094 -1.004 . . . . 0.0 109.396 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 mtt180 -131.28 63.2 69.11 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 108.943 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' CB ' HD11 ' A' ' 56' ' ' LEU . 4.7 Cg_exo -59.0 -24.68 74.51 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.25 1.967 . . . . 0.0 110.397 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.71 ' CA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -69.03 -43.34 74.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.121 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.0 mt-10 -79.79 -6.79 57.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.154 -0.966 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -79.71 -42.39 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 108.697 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.8 -74.34 0.26 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 21.7 m95 -147.67 122.75 10.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -1.031 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -104.9 153.78 20.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.028 -1.045 . . . . 0.0 108.983 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.666 ' O ' HG13 ' A' ' 32' ' ' VAL . 5.7 t-20 -122.01 121.95 38.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 32' ' ' VAL . . . -146.88 -146.98 4.46 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -123.57 110.16 14.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.54 -0.977 . . . . 0.0 110.131 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.965 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -78.32 82.38 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 108.539 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -53.02 -35.04 59.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 110.122 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 28' ' ' ASP . 19.7 m -53.38 -39.81 64.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 109.714 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.965 HG22 ' HB3' ' A' ' 60' ' ' ASN . 14.8 t -108.93 6.59 25.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.82 48.53 56.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 63' ' ' THR . 37.1 mm-40 -135.7 171.91 13.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -1.184 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 25.1 ttt180 -141.59 146.45 36.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 22' ' ' ILE . . . 159.85 -159.05 30.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -106.5 175.46 5.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.947 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.985 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -173.17 162.03 3.52 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 6.1 Cg_exo -58.35 119.14 6.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.929 1.753 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.14 -29.81 66.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.71 HG22 ' CA ' ' A' ' 51' ' ' GLU . 27.9 p -69.45 -7.02 34.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -1.233 . . . . 0.0 109.15 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -100.26 -5.37 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 110.194 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.5 m -111.29 172.87 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 6.0 pt-20 -136.25 87.55 2.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.237 -0.915 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.605 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 91.4 t80 -42.64 143.54 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 9' ' ' ARG . 3.6 mt -145.2 16.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 83.69 -122.57 5.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 109.495 179.977 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.617 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 46.0 m-85 -107.06 115.99 31.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -1.192 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.775 ' CG ' HG23 ' A' ' 31' ' ' THR . 9.8 mt-30 -93.39 127.85 39.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.45 177.32 4.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.795 -1.191 . . . . 0.0 111.315 -179.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -114.23 124.85 53.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -61.3 116.66 4.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.7 mt -82.73 -36.14 26.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.571 -0.706 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 3.3 m-85 -120.83 -137.68 0.33 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.396 -0.815 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -144.16 -177.01 5.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 1.6 t80 -170.03 135.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.69 8.08 45.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 4.7 tttt 61.52 108.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 0.0 109.893 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -61.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 32.1 mtm-85 -90.41 139.63 30.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' ARG . 46.0 tt0 -40.93 -35.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -54.51 -59.53 4.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -64.52 165.34 10.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 110.022 -179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.605 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.6 pt -129.53 172.33 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.65 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.2 m-20 -69.62 115.91 9.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.9 . . . . 0.0 109.921 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -104.94 157.88 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.677 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -160.1 143.14 13.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.665 -1.272 . . . . 0.0 110.204 -179.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -55.49 139.25 44.36 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.232 -0.918 . . . . 0.0 109.394 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 29' ' ' ILE . . . 89.59 -33.07 4.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 25' ' ' HIS . 7.6 t0 -68.38 121.25 15.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -1.066 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.962 ' C ' HD23 ' A' ' 30' ' ' LEU . 2.9 mp -88.37 165.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.78 147.43 42.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.049 -1.032 . . . . 0.0 108.235 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.775 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -108.25 93.21 4.41 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.679 -0.638 . . . . 0.0 109.764 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 47.3 t -92.89 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.117 -0.99 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -54.65 138.7 40.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.855 . . . . 0.0 109.682 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 6.5 pttt -59.01 144.54 44.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.295 -0.878 . . . . 0.0 108.995 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.14 -58.5 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 33' ' ' ASN . 2.6 p -46.6 -26.01 0.82 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.152 -1.205 . . . . 0.0 108.747 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.017 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -85.25 -40.61 16.43 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 38' ' ' VAL . 21.4 t -70.96 -4.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -82.53 -54.94 4.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.01 20.02 4.2 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.783 ' HE2' HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -56.77 -68.28 0.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.571 -1.546 . . . . 0.0 108.143 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 13.8 t -158.2 130.91 7.21 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.13 117.95 9.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 0.0 109.669 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.76 -1.47 55.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 1.8 tt0 -86.39 30.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.095 -1.238 . . . . 0.0 110.076 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.737 ' HA ' HD22 ' A' ' 37' ' ' LEU . 8.1 mt-10 -88.14 20.53 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -105.24 -21.8 13.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -113.72 82.01 6.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.881 ' HA ' HD12 ' A' ' 53' ' ' ILE . 4.2 Cg_exo -59.62 -52.58 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -44.79 -27.47 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -105.51 47.03 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.971 HD13 ' CD2' ' A' ' 37' ' ' LEU . 58.7 mt -144.18 -49.69 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.5 -70.33 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 31.6 m95 -143.84 152.65 41.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.94 144.29 45.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.465 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 16.9 t-20 -110.34 106.19 15.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.31 -163.88 10.82 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.036 -1.554 . . . . 0.0 111.296 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 122.161 -0.611 . . . . 0.0 109.857 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.91 ' OD1' HD22 ' A' ' 30' ' ' LEU . 4.3 m-80 -77.04 91.12 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.838 -1.164 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.38 -37.29 62.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.487 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 10.7 m -51.71 -45.36 63.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.197 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 60' ' ' ASN . 2.5 t -107.25 9.57 30.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.52 53.61 5.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -129.51 151.85 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -1.196 . . . . 0.0 109.806 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.38 124.91 43.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 108.948 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -179.2 -166.64 35.4 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.471 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -104.22 166.93 10.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.966 . . . . 0.0 109.852 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CE2' ' CD1' ' A' ' 30' ' ' LEU . 5.0 p90 -167.95 160.03 9.55 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -59.85 128.6 27.36 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.221 1.947 . . . . 0.0 110.61 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -36.26 60.24 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 2.7 p -64.85 -9.82 23.75 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.031 -1.276 . . . . 0.0 109.242 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.6 m-85 -96.41 15.36 21.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.968 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.6 m -139.74 -177.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HD21 ' A' ' 11' ' ' LEU . 15.5 pt-20 -156.43 89.92 1.15 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.7 t80 -36.9 132.92 0.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.619 -0.675 . . . . 0.0 109.527 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG21 ' NH1' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -119.13 -15.55 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.994 . . . . 0.0 109.509 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 -124.31 5.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.481 ' O ' ' NE2' ' A' ' 7' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.085 -1.244 . . . . 0.0 109.505 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.643 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 2.5 m-85 -99.69 136.82 39.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -1.146 . . . . 0.0 109.392 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 78' ' ' GLY . 1.2 mt-30 -129.94 108.74 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 108.941 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -101.82 -178.94 3.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.001 -1.062 . . . . 0.0 110.483 -179.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -123.51 139.77 53.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . . . -64.31 98.67 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.016 -1.053 . . . . 0.0 110.562 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.661 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 4.6 mt -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 108.588 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.661 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 28.6 m-85 -140.11 -164.13 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -115.67 148.2 39.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' HD22 ' A' ' 24' ' ' LEU . 45.1 t80 -150.64 108.92 3.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 17' ' ' GLU . 19.4 tptt -79.8 149.37 31.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 2.1 tttp -52.55 89.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' LYS . 42.5 mm-40 -77.97 -68.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.0 mtt180 -89.6 164.65 14.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.277 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.48 2.2 10.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.232 -0.918 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -106.07 -2.71 22.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.067 -1.02 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 p-10 -115.17 167.64 10.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.977 -1.077 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.528 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -111.92 -171.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.663 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -103.4 98.38 8.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -0.814 . . . . 0.0 109.348 179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -96.87 161.99 13.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 3.0 m80 -156.33 149.75 24.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.146 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 6.4 tt -54.02 140.77 30.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.933 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -30.25 6.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.866 ' OD1' ' HB2' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.73 166.72 12.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 109.606 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 28' ' ' ASP . 7.4 mm -119.29 141.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.953 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.4 mp -110.43 123.64 50.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.3 88.63 3.02 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.784 HG22 ' CA ' ' A' ' 58' ' ' GLY . 74.3 t -96.55 95.5 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.468 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' VAL . 2.2 m120 -42.0 165.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 109.948 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.26 150.69 23.72 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.338 -0.851 . . . . 0.0 109.408 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.27 -61.72 2.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -55.61 -19.52 10.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.299 -1.118 . . . . 0.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.604 ' CD1' HG11 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -89.71 -30.62 17.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.47 -0.769 . . . . 0.0 109.409 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.574 HG23 ' CG ' ' A' ' 47' ' ' GLU . 18.8 t -87.87 -2.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -3.93 20.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 42' ' ' PHE . 5.9 mt -84.26 -25.68 29.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 122.06 4.2 9.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.038 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 20.0 m-85 -53.08 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.602 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.536 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -116.58 118.36 32.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 43' ' ' SER . 11.1 t70 -24.3 88.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.303 0.573 . . . . 0.0 111.259 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 139.53 -7.73 3.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.907 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.1 tp60 -90.51 -0.89 57.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.296 . . . . 0.0 110.04 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 22.1 mt-10 -66.92 -10.0 44.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 0.0 109.57 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.892 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -114.36 19.2 16.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -128.72 61.69 56.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.0 Cg_exo -57.62 -38.96 91.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.228 1.952 . . . . 0.0 110.323 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -64.37 -28.33 69.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 16.9 mm-40 -101.64 -5.24 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.038 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 18.6 mt -83.44 -88.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.283 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.808 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 155.8 -55.05 0.41 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 29.2 m95 -153.27 138.4 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -1.046 . . . . 0.0 109.395 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -135.01 143.04 46.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.795 -179.964 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -94.51 102.98 14.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.784 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.98 175.93 15.89 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.723 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.5 t80 -109.25 106.92 16.97 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.815 -0.815 . . . . 0.0 109.519 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.484 ' ND2' ' CD1' ' A' ' 22' ' ' ILE . 1.6 m-80 -78.12 89.31 4.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 108.971 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -57.63 -36.86 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.004 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m -49.47 -33.04 13.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 6.6 9.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.2 39.41 70.92 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -107.7 157.02 18.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 13.0 tpt180 -139.16 114.43 9.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 108.868 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -175.4 -165.35 31.39 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.046 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.556 ' OD2' ' CE3' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -97.81 164.31 12.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -1.01 . . . . 0.0 109.783 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.953 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.2 p90 -160.07 162.66 23.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.612 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.46 124.89 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.922 1.748 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.45 -33.73 63.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -68.09 -8.2 36.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.984 -1.304 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.0 m-85 -99.06 -7.75 26.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.114 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 71' ' ' GLY . 24.1 m -109.34 176.11 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 5.7 pt-20 -142.11 89.33 2.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.437 -0.79 . . . . 0.0 108.957 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.892 ' CD2' ' HB1' ' A' ' 48' ' ' ALA . 60.4 t80 -38.71 125.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.549 -0.72 . . . . 0.0 109.921 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -152.57 17.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -121.38 105.1 0.99 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 10.4 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 21.6 m-85 -137.53 105.04 5.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.92 . . . . 0.0 108.691 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.485 ' CG ' HG23 ' A' ' 31' ' ' THR . 10.2 mt-30 -99.64 123.12 43.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 110.047 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -112.91 170.19 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.071 -1.018 . . . . 0.0 108.967 179.878 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.548 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 13.3 ttp180 -105.68 145.47 31.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 108.97 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -74.13 96.95 2.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.923 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 18.6 mt -64.26 -29.75 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.618 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 6.5 m-85 -130.01 -159.34 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.139 -0.976 . . . . 0.0 110.16 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -117.59 -167.81 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -176.44 156.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -119.33 27.11 9.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 0.0 110.399 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.532 ' CB ' ' OD1' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 42.26 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.105 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 18' ' ' ARG . 17.4 mt-10 -126.9 -50.2 1.46 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.053 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 55' ' ' TRP . 0.2 OUTLIER -39.79 161.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.542 -0.724 . . . . 0.0 110.274 179.97 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -28.99 -68.25 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.595 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 5.3 mm-40 -131.16 48.68 2.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.808 -1.182 . . . . 0.0 111.005 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 56.1 p-10 -95.85 154.99 16.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.164 . . . . 0.0 108.853 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.594 ' O ' HD12 ' A' ' 22' ' ' ILE . 1.2 pp -104.09 171.35 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 110.042 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -64.82 170.3 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.943 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -153.27 146.84 25.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.528 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -156.25 138.98 15.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.681 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -55.35 122.27 10.79 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.43 -5.36 28.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.695 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.2 m-20 -90.24 163.63 14.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -1.166 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.706 ' C ' HD12 ' A' ' 30' ' ' LEU . 14.1 mm -119.24 140.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 24' ' ' LEU . 5.8 mp -118.9 113.85 21.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.485 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -88.09 105.78 17.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.561 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 58' ' ' GLY . 71.7 t -115.75 91.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.699 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.519 ' HA ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t-20 -42.82 159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.931 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -83.75 145.43 28.72 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 98.79 -55.4 1.01 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -45.85 -27.36 0.85 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.267 -1.137 . . . . 0.0 108.877 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 42' ' ' PHE . 0.6 OUTLIER -90.06 -35.72 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 38' ' ' VAL . 42.0 t -79.23 3.89 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 109.659 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.35 -13.2 17.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.832 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.2 mm? -96.85 -19.72 18.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.089 -1.007 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 117.77 25.32 3.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.703 ' HE2' HG23 ' A' ' 53' ' ' ILE . 5.9 m-85 -51.65 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -1.042 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -160.5 -162.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.147 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 11.4 t70 -90.14 62.39 5.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.177 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 34.68 2.57 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -82.42 6.66 16.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 109.557 -179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' OE2' ' CZ ' ' A' ' 8' ' ' TYR . 3.9 tm-20 -67.7 -7.01 23.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -84.99 16.96 3.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.988 -1.07 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -125.69 59.36 26.7 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.126 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.547 ' CB ' HG23 ' A' ' 74' ' ' VAL . 3.0 Cg_exo -50.13 -59.78 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.153 1.902 . . . . 0.0 110.337 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.639 ' HA ' HG22 ' A' ' 72' ' ' THR . 4.2 tt0 -66.65 -17.15 64.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 108.679 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.2 mm-40 -108.67 22.69 15.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.703 HG23 ' HE2' ' A' ' 42' ' ' PHE . 5.5 mt -118.39 -45.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 108.945 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.97 -74.32 0.29 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 18' ' ' ARG . 12.5 m95 -141.78 147.02 36.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -1.084 . . . . 0.0 109.121 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.764 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -136.89 159.58 41.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 32' ' ' VAL . 3.1 t-20 -111.76 100.79 9.22 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -119.62 178.46 16.55 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CG ' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -112.43 113.27 25.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.654 -0.909 . . . . 0.0 109.893 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 37.0 m-80 -89.44 64.43 6.75 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 62' ' ' THR . 4.1 mt-10 -45.94 -28.3 1.1 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.023 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.695 HG21 ' CG ' ' A' ' 28' ' ' ASP . 8.3 m -47.19 -54.97 9.39 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.8 t -87.3 -10.21 52.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.67 40.29 11.04 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 8.2 mm-40 -138.89 164.88 28.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.057 -1.261 . . . . 0.0 109.257 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 52.2 ttp85 -145.69 115.3 7.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . -162.63 -159.07 10.06 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -87.81 165.63 15.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.945 . . . . 0.0 110.091 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.7 p90 -172.13 159.23 4.33 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.802 . . . . 0.0 109.313 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.7 Cg_exo -61.44 126.05 18.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.176 1.918 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -71.68 -32.94 63.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -64.84 -9.94 24.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.083 -1.245 . . . . 0.0 109.43 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.9 m-85 -98.73 15.95 23.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.789 HG11 ' HE2' ' A' ' 69' ' ' PHE . 18.1 m -134.94 -177.94 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.085 -1.009 . . . . 0.0 110.534 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 4.5 pt-20 -147.03 89.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 33.3 t80 -49.65 123.88 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.58 -16.8 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.985 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 111.65 -160.48 13.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.56 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.577 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 47' ' ' GLU . 60.0 m-85 -158.75 141.21 14.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.494 -1.004 . . . . 0.0 108.959 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 1.1 tt0 -154.81 114.36 3.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 109.43 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 1.085 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -109.8 170.93 7.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.758 ' CB ' HD11 ' A' ' 77' ' ' ILE . 1.6 tpp180 -112.83 116.7 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -43.44 158.02 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.68 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.62 HD21 ' OE1' ' A' ' 75' ' ' GLU . 14.5 mt -135.92 -41.17 0.67 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 12.3 m-85 -125.33 169.96 11.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.548 -0.72 . . . . 0.0 109.765 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p30 -102.87 139.39 38.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.559 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 34.4 t80 -134.78 131.33 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.213 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.99 120.43 24.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.556 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.1 pttt -56.29 91.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.824 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -55.72 -68.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.33 159.33 16.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.157 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.31 -12.98 10.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.075 -1.016 . . . . 0.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -31.24 62.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -96.01 149.29 21.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 109.5 -179.989 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.644 HD11 ' CG ' ' A' ' 60' ' ' ASN . 1.4 pp -105.37 175.84 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.579 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 4.0 m-20 -80.18 115.8 19.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 109.894 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -94.08 147.01 23.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 108.725 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.654 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER -152.49 127.57 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.536 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.674 ' C ' HD23 ' A' ' 26' ' ' LEU . 5.5 tt -43.64 141.19 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.97 1.11 88.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.581 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 12.5 t0 -82.32 152.45 26.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 6.4 mm -104.37 124.57 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.035 . . . . 0.0 109.071 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 24' ' ' LEU . 6.8 mp -111.81 106.78 15.63 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 109.555 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.49 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -88.93 95.82 10.47 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.262 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 40.7 t -93.65 116.02 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.467 -0.771 . . . . 0.0 109.451 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -87.36 -179.31 6.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 146.95 31.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.06 -62.38 2.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -21.07 29.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.28 -1.129 . . . . 0.0 108.949 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.588 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -90.09 -35.3 15.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.284 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 38' ' ' VAL . 40.0 t -77.17 2.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.486 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -60.89 -11.93 9.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.938 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -102.64 36.63 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.001 -1.062 . . . . 0.0 109.39 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 48.3 25.09 4.02 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.938 ' CE2' HD23 ' A' ' 40' ' ' LEU . 6.1 m-30 -48.4 -178.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.572 -0.957 . . . . 0.0 109.858 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -122.83 106.12 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 43' ' ' SER . 13.4 t0 -27.72 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.312 0.577 . . . . 0.0 110.97 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 147.46 -23.07 1.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.602 ' HG2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -89.96 -2.94 58.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.12 -1.224 . . . . 0.0 110.309 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -42.99 -49.79 5.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.435 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.26 46.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.09 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.548 ' CD ' ' HB3' ' A' ' 52' ' ' GLU . 55.5 ttt180 -151.34 59.37 3.25 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.078 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 3.0 Cg_endo -60.03 -47.49 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.268 1.979 . . . . 0.0 110.453 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 52' ' ' GLU . 24.1 pt-20 -47.89 -46.87 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HB3' ' CD ' ' A' ' 49' ' ' ARG . 1.4 tt0 -99.5 47.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.181 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.825 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -130.56 -39.58 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.953 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.4 -79.41 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -138.6 137.32 36.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.631 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -121.78 168.21 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 109.794 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.679 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -119.6 119.49 33.9 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.43 -172.94 15.37 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.088 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 50.1 t80 -114.85 109.11 17.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.465 -1.021 . . . . 0.0 109.763 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.644 ' CG ' HD11 ' A' ' 22' ' ' ILE . 15.9 m120 -79.05 85.9 4.93 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.189 -0.944 . . . . 0.0 109.0 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.447 -0.783 . . . . 0.0 110.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 21.9 m -53.58 -35.88 61.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.654 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -116.87 10.52 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 42.44 53.95 4.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -141.93 115.32 8.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.24 136.77 32.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 109.247 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.599 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 176.96 -160.5 27.67 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.244 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 8.4 m-20 -96.33 163.98 12.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -1.06 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.642 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 p90 -164.36 158.99 15.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.879 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.3 Cg_exo -61.19 117.43 4.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.249 1.966 . . . . 0.0 109.981 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.848 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.12 -34.83 82.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 2.9 p -63.26 -19.99 65.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.971 -1.311 . . . . 0.0 110.03 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 7.2 m-30 -93.41 17.98 10.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.598 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 71' ' ' GLY . 30.7 m -131.02 170.12 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.097 -1.002 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' OE1' HD21 ' A' ' 11' ' ' LEU . 7.6 pt-20 -137.6 87.38 2.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.282 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CE2' ' N ' ' A' ' 78' ' ' GLY . 65.8 t80 -41.04 141.11 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.758 HD11 ' CB ' ' A' ' 9' ' ' ARG . 3.3 mt -139.36 8.99 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 97.33 -140.33 14.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.408 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 28.7 m-85 -80.02 106.35 11.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -1.083 . . . . 0.0 109.753 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.753 ' HG2' HG23 ' A' ' 31' ' ' THR . 1.3 mt-30 -102.56 128.04 49.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.31 173.15 6.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 0.0 109.972 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.87 142.26 46.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -64.93 151.31 46.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.896 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.772 HD21 ' CD ' ' A' ' 75' ' ' GLU . 13.3 mt -134.2 -41.8 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.624 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.0 m-85 -118.77 -142.8 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.554 -0.717 . . . . 0.0 109.541 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -144.77 173.96 11.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.89 -1.132 . . . . 0.0 109.957 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 47.6 t80 -173.59 141.51 0.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.4 -0.813 . . . . 0.0 108.911 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' GLU . 1.4 mttt -101.94 133.44 46.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.03 -1.043 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 21' ' ' ASP . 3.7 ttpm? -58.63 88.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 109.528 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 15' ' ' LYS . 60.8 tt0 -90.1 -73.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.1 mtt180 -61.66 157.9 16.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 26.2 tp10 -74.75 1.95 11.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.117 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.418 ' HG2' ' OD2' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -111.38 -1.06 16.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.061 -1.024 . . . . 0.0 110.042 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 52.3 p30 -110.99 164.63 12.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.997 -1.064 . . . . 0.0 109.6 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.803 HD12 ' ND2' ' A' ' 60' ' ' ASN . 2.1 pt -126.38 -170.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 1.2 m-20 -84.9 134.5 34.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.634 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -128.12 138.28 52.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.076 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -153.46 138.75 17.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.062 -1.024 . . . . 0.0 109.62 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 tt -54.21 147.55 12.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.35 -0.844 . . . . 0.0 109.779 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 90.65 -9.89 76.29 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.892 ' O ' HD13 ' A' ' 29' ' ' ILE . 1.8 m-20 -86.54 178.12 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.163 . . . . 0.0 109.83 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 28' ' ' ASP . 5.7 mm -129.5 140.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.115 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -121.42 130.13 53.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.971 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.753 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -106.94 93.82 4.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.952 ' CG1' HD12 ' A' ' 37' ' ' LEU . 56.4 t -101.11 115.03 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -68.47 160.95 28.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.05 2.55 17.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.886 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.58 -49.6 0.47 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -54.84 -25.69 30.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -1.168 . . . . 0.0 109.641 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.952 HD12 ' CG1' ' A' ' 32' ' ' VAL . 1.3 tt -90.38 -34.08 15.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 38' ' ' VAL . 71.4 t -80.75 2.27 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.066 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.5 4.23 7.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 109.988 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -111.44 5.1 19.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.047 . . . . 0.0 109.975 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.09 34.26 6.87 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.774 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -69.88 -169.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.81 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.524 ' O ' ' C ' ' A' ' 44' ' ' ASP . 58.8 m -125.93 90.11 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.913 0.864 . . . . 0.0 109.198 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.74 87.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.409 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 148.61 -23.95 1.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.483 ' NE2' ' HB3' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -90.33 -12.39 37.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.058 -1.26 . . . . 0.0 110.01 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.825 ' OE1' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -43.37 -39.76 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.933 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.59 40.94 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -148.08 60.34 5.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 5.0 Cg_exo -59.0 -41.93 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.358 2.039 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HA ' HG22 ' A' ' 72' ' ' THR . 16.8 pt-20 -57.01 -16.5 7.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.7 mt-10 -120.07 -5.75 10.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.895 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.774 HG23 ' CE2' ' A' ' 42' ' ' PHE . 3.2 mt -79.6 -34.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 109.161 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 -71.6 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -141.5 124.93 16.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -1.046 . . . . 0.0 109.407 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -113.82 156.44 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.816 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -113.05 106.92 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.604 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.52 -158.65 9.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.588 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 38.8 t80 -124.8 108.72 12.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.674 -0.897 . . . . 0.0 109.863 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.803 ' ND2' HD12 ' A' ' 22' ' ' ILE . 1.4 m-20 -79.4 90.83 5.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.302 -0.874 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.06 -37.93 67.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 96.5 m -57.51 -45.77 84.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.326 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.4 p -93.81 4.89 53.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.68 48.75 8.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -140.2 166.35 24.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.621 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.4 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 30.9 ttp180 -134.11 140.87 46.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 165.6 -163.24 36.51 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.232 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 43.6 m-20 -94.19 170.74 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.976 . . . . 0.0 109.784 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.652 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 9.9 p90 -172.77 158.59 3.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.354 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.83 121.39 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.15 1.9 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.782 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -72.08 -34.37 61.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 51' ' ' GLU . 17.0 p -66.3 -8.97 28.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.304 . . . . 0.0 109.048 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.624 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.54 9.56 39.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 30' ' ' LEU . 4.5 m -128.06 -174.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.772 ' CD ' HD21 ' A' ' 11' ' ' LEU . 15.9 pt-20 -160.21 92.74 1.01 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.604 -0.685 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 75' ' ' GLU . 5.1 t80 -33.19 115.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.569 0.7 . . . . 0.0 110.547 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 77' ' ' ILE . 10.4 mm -144.11 16.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -129.35 115.22 1.89 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.251 -1.147 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 26.3 m-85 -80.91 123.74 28.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -115.56 115.65 26.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.7 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -104.96 175.56 5.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.062 -1.024 . . . . 0.0 109.093 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -112.53 174.35 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 108.849 179.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.37 152.42 21.01 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.2 mt -137.79 -38.56 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.577 ' HB2' ' CG ' ' A' ' 73' ' ' TYR . 4.5 m-85 -122.82 176.02 6.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.383 -0.823 . . . . 0.0 109.78 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -100.63 171.86 7.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 3.1 t80 -161.96 146.75 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.6 ttpt -107.99 17.95 21.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 21' ' ' ASP . 16.1 ttmt 59.5 71.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.806 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.5 tp10 -72.4 -73.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.7 mtp85 -53.8 144.23 18.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.35 -7.66 10.43 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -103.68 -22.76 13.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.006 -1.059 . . . . 0.0 110.441 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 16' ' ' LYS . 48.1 p30 -73.77 -179.82 3.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 0.0 109.82 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.622 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.3 pp -138.11 159.4 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.2 m-20 -60.24 145.0 48.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 69' ' ' PHE . 10.2 mt -135.4 157.75 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.868 . . . . 0.0 109.37 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.838 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -160.01 128.87 5.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 109.151 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -47.94 124.77 7.92 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 109.737 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.33 -18.79 11.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.642 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -90.3 160.58 16.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.86 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 mt -115.96 157.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.92 HD23 ' CE2' ' A' ' 69' ' ' PHE . 3.2 mp -130.77 121.41 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.279 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 102.62 14.93 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.779 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.7 HG11 ' OH ' ' A' ' 8' ' ' TYR . 75.6 t -102.32 117.91 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -50.59 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 12.7 mtpt -90.29 -73.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -54.58 -24.21 30.96 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -58.82 -40.74 85.05 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.081 -1.246 . . . . 0.0 109.883 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.8 tp -90.09 -29.52 18.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 38' ' ' VAL . 58.3 t -90.15 3.16 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.908 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -66.53 -7.67 21.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.37 15.63 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.096 -1.003 . . . . 0.0 109.773 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.4 41.61 25.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.96 ' CE2' HG23 ' A' ' 53' ' ' ILE . 5.1 m-85 -64.77 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -139.27 156.21 47.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.34 120.75 10.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.61 -31.77 6.42 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.3 mp0 -76.48 -40.08 51.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -1.169 . . . . 0.0 109.462 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.79 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.86 -27.05 66.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -84.71 -19.7 32.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -113.55 77.87 3.44 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.329 179.968 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.654 ' HG2' HG23 ' A' ' 74' ' ' VAL . 4.2 Cg_exo -57.73 -32.71 95.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.096 1.864 . . . . 0.0 110.238 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.7 tt0 -60.39 -32.43 71.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.018 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.37 -6.64 43.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.96 HG23 ' CE2' ' A' ' 42' ' ' PHE . 16.2 mt -79.71 -54.34 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.71 -69.69 0.52 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.421 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 23.9 m95 -144.18 141.27 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.55 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -138.68 139.83 38.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -90.25 99.21 12.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.852 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -112.38 166.29 12.17 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.346 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -101.95 106.58 17.53 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.764 -0.845 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 3.2 m120 -78.48 78.45 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -49.27 -36.56 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.814 . . . . 0.0 109.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.642 HG21 ' CG ' ' A' ' 28' ' ' ASP . 20.4 m -51.51 -61.08 2.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.379 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.838 HG21 ' CE1' ' A' ' 25' ' ' HIS . 1.9 p -91.69 13.18 18.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.53 54.35 4.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 18.4 pt-20 -139.23 121.81 16.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.646 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.64 128.43 43.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -174.39 -179.53 45.06 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -88.94 165.02 14.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 109.59 180.0 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.92 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.8 p90 -165.67 162.84 13.05 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.644 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 2.2 Cg_endo -63.71 120.55 7.98 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.86 1.707 . . . . 0.0 109.254 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.706 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -64.35 -19.18 64.03 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.514 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -72.57 -20.03 61.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.902 -1.352 . . . . 0.0 109.927 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.577 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 7.3 m-30 -92.92 7.36 44.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 0.0 110.584 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.654 HG23 ' HG2' ' A' ' 50' ' ' PRO . 13.3 m -118.4 -172.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.946 -1.097 . . . . 0.0 109.621 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HB3' HD11 ' A' ' 11' ' ' LEU . 10.5 pt-20 -155.74 86.16 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.4 t80 -40.37 136.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 9' ' ' ARG . 5.1 mt -119.78 -4.28 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 109.859 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 130.48 -162.48 23.27 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' C ' ' HD2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.603 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 56.4 m-85 -80.43 110.36 15.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.584 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.2 mt-30 -87.48 124.42 33.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HD2' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -104.58 -177.11 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.01 -1.057 . . . . 0.0 110.131 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 3.8 ttm180 -126.32 130.96 51.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -65.48 123.5 19.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.778 -1.201 . . . . 0.0 110.056 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.625 HD21 ' CD ' ' A' ' 75' ' ' GLU . 10.5 mt -99.79 -42.41 6.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 7.2 m-85 -124.12 -158.68 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.503 -0.748 . . . . 0.0 109.566 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 6.2 p-10 -123.37 171.97 9.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.686 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 26.1 t80 -167.76 113.54 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.8 mmtp -80.21 132.81 35.94 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.062 -1.024 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 4.4 mtpm? -41.87 106.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.853 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -133.2 -33.96 1.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -75.55 145.6 41.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.85 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.477 ' HG3' ' OE1' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -41.96 -33.63 0.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.697 -0.627 . . . . 0.0 110.743 -179.98 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.477 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -137.35 58.06 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.924 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 3.4 p-10 -119.2 173.48 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.916 -1.115 . . . . 0.0 108.92 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.684 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -126.0 179.05 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 109.95 179.982 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.577 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 1.2 m-20 -85.91 108.82 18.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.3 mm? -95.07 144.13 25.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.659 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -155.18 128.4 8.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.11 -0.994 . . . . 0.0 109.66 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 3.2 tt -52.14 137.93 26.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.741 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -18.52 39.46 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.925 ' OD1' HG21 ' A' ' 62' ' ' THR . 16.7 m-20 -90.21 172.35 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -1.191 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 19.2 mm -117.83 144.72 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.722 HD22 ' ND2' ' A' ' 60' ' ' ASN . 10.3 mt -108.53 146.79 32.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 87.19 2.49 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.757 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.023 HG11 HD23 ' A' ' 37' ' ' LEU . 29.5 t -97.51 116.25 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -57.19 122.36 12.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.44 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.527 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 144.18 -56.95 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -48.21 -51.28 26.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.141 . . . . 0.0 110.122 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.023 HD23 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -81.39 -15.76 54.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.115 -0.99 . . . . 0.0 109.195 -179.92 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.094 HG23 ' OE1' ' A' ' 47' ' ' GLU . 1.4 t -77.84 -10.79 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.55 -9.15 23.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.0 109.336 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.74 HD12 ' CE2' ' A' ' 42' ' ' PHE . 14.6 mt -67.92 -27.63 66.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.03 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.17 3.03 6.94 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 40' ' ' LEU . 19.8 m-85 -58.82 178.08 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -1.145 . . . . 0.0 109.631 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -119.53 135.74 54.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 108.75 179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 43' ' ' SER . 10.5 t70 -31.88 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.317 0.579 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 129.49 -3.64 6.2 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 53' ' ' ILE . 4.6 mt-30 -91.14 -25.02 19.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.102 -1.234 . . . . 0.0 109.632 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 1.094 ' OE1' HG23 ' A' ' 38' ' ' VAL . 1.1 tt0 -59.05 -47.97 83.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -56.19 -15.8 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.11 80.45 5.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 109.587 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.608 ' CG ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -65.04 -47.12 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.166 1.911 . . . . 0.0 110.451 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' PRO . 7.6 pt-20 -43.17 -42.15 4.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.25 51.71 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.602 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 1.3 mt -138.89 -41.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.72 -77.18 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.427 ' CZ2' ' HD2' ' A' ' 18' ' ' ARG . 34.4 m95 -137.91 147.13 44.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -1.037 . . . . 0.0 109.121 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -138.76 137.22 36.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.147 -0.971 . . . . 0.0 110.125 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -88.33 95.69 10.29 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.662 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -115.33 173.74 14.92 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.355 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -115.7 107.81 15.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.648 -0.913 . . . . 0.0 109.76 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.722 ' ND2' HD22 ' A' ' 30' ' ' LEU . 4.1 m-80 -77.97 96.7 5.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 108.873 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' OE1' ' HB ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -54.17 -39.5 66.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.001 -179.918 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.925 HG21 ' OD1' ' A' ' 28' ' ' ASP . 17.9 m -49.08 -64.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.659 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.9 p -85.41 6.95 24.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.554 -0.716 . . . . 0.0 109.66 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.86 54.16 5.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 63' ' ' THR . 56.4 mm-40 -131.88 142.25 49.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -1.098 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -113.47 135.43 53.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.493 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.684 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 174.07 -167.91 40.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -102.13 163.96 11.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.699 ' HE1' HD13 ' A' ' 56' ' ' LEU . 2.1 p90 -163.13 162.23 18.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 Cg_endo -62.14 123.89 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.867 1.712 . . . . 0.0 109.827 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.777 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -67.61 -32.92 79.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 72' ' ' THR . 1.7 p -66.97 -9.41 38.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.035 -1.274 . . . . 0.0 109.415 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.9 m-85 -95.8 -13.14 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.608 HG23 ' CG ' ' A' ' 50' ' ' PRO . 32.7 m -107.69 175.03 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.625 ' CD ' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -149.88 90.66 1.71 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.189 -0.944 . . . . 0.0 108.715 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.557 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 76.3 t80 -38.63 123.91 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.847 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 77' ' ' ILE . 9.7 mm -111.38 -2.6 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 132.87 -164.43 24.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.108 . . . . 0.0 109.503 179.996 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 66.8 m-85 -79.37 134.13 36.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.142 . . . . 0.0 108.459 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 3.3 mt-30 -143.65 117.84 9.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.054 -1.029 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.875 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.78 178.66 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.359 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.38 155.44 24.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -91.65 121.07 32.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.882 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -104.88 -24.62 12.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.015 . . . . 0.0 108.619 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.556 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -119.57 176.62 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 163.02 14.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.172 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -166.41 114.62 0.89 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.085 -1.009 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -79.46 107.41 12.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.931 . . . . 0.0 108.587 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -41.44 115.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.845 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -69.65 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.457 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.17 146.84 23.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.878 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.0 mt-10 -43.53 -24.79 0.12 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.131 -0.981 . . . . 0.0 110.038 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -60.7 -58.07 10.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.113 -0.992 . . . . 0.0 109.971 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 2.0 p30 -72.04 162.7 29.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.945 . . . . 0.0 109.87 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -122.16 162.06 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.377 -0.827 . . . . 0.0 109.378 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CD ' ' A' ' 16' ' ' LYS . 1.7 m-20 -79.22 103.69 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.901 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' O ' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -102.28 153.46 19.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.625 ' HE1' HG21 ' A' ' 63' ' ' THR . 1.0 OUTLIER -150.79 141.21 22.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.048 . . . . 0.0 109.878 -179.955 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tp -42.56 143.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 82.04 0.61 89.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.1 m-20 -90.42 159.13 16.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 109.746 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 28.2 mm -113.34 128.74 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 0.0 109.175 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.9 mp -109.76 105.93 15.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.915 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.95 91.33 8.03 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.547 -0.72 . . . . 0.0 110.328 -179.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.875 HG21 ' OH ' ' A' ' 8' ' ' TYR . 29.0 t -86.76 96.85 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 33' ' ' ASN . 6.1 p30 -51.45 152.82 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 110.385 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 34' ' ' LYS . 6.0 pttp -69.19 113.6 6.7 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.56 -54.66 0.76 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 48.4 t -56.78 -26.34 57.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.175 -1.191 . . . . 0.0 108.93 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.919 HD11 HD13 ' A' ' 53' ' ' ILE . 15.4 tp -90.55 -33.57 15.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 38' ' ' VAL . 84.7 t -90.31 2.78 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.099 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.82 -11.81 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -107.94 34.99 3.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.708 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.1 52.4 40.26 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.897 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -71.95 -167.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.09 143.38 50.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.13 87.89 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.34 -43.08 0.57 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' GLU . 23.2 mm-40 -73.01 -30.22 63.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.242 -1.152 . . . . 0.0 109.409 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 37' ' ' LEU . 1.5 pt-20 -42.51 -41.99 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -85.39 44.53 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.518 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -159.85 62.72 1.96 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.6 Cg_exo -57.75 -13.61 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.341 2.027 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -70.77 -31.15 67.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.997 -1.065 . . . . 0.0 109.298 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 tp10 -110.71 1.72 18.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.9 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.919 HD13 HD11 ' A' ' 37' ' ' LEU . 6.6 mt -79.45 -31.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.108 -0.995 . . . . 0.0 109.082 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 -78.18 0.29 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.465 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 11.2 m95 -140.68 154.23 46.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -1.11 . . . . 0.0 109.033 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.809 HD23 HD13 ' A' ' 37' ' ' LEU . 1.5 mp -143.07 158.91 43.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.989 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 32' ' ' VAL . 6.6 t-20 -117.79 117.68 29.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -138.93 -167.73 11.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 58.7 t80 -115.59 114.12 24.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -1.051 . . . . 0.0 109.96 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 17.6 m-20 -79.31 79.88 5.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 108.64 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.19 -39.38 13.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.52 -0.738 . . . . 0.0 109.833 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 18.7 m -48.51 -53.32 18.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.922 . . . . 0.0 109.658 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.625 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.5 p -108.15 17.02 22.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 41.33 54.61 3.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.47 111.9 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -1.214 . . . . 0.0 109.935 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -90.74 129.44 36.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 109.194 179.938 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' CA ' ' CG1' ' A' ' 22' ' ' ILE . . . -178.86 -165.5 33.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -95.35 168.24 10.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.376 -1.073 . . . . 0.0 109.742 179.984 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -168.51 158.57 8.41 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -60.05 125.4 17.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.253 1.969 . . . . 0.0 110.196 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.801 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -39.9 76.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 12.0 p -64.78 -11.02 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.249 . . . . 0.0 109.636 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.8 m-85 -95.49 15.54 19.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 109.83 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.882 ' O ' HD11 ' A' ' 11' ' ' LEU . 18.9 m -134.71 -169.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.83 . . . . 0.0 110.044 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.766 ' CD ' HD22 ' A' ' 11' ' ' LEU . 11.9 pt-20 -158.26 89.03 0.97 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 56.6 t80 -36.87 136.24 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.653 . . . . 0.0 110.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 75' ' ' GLU . 29.7 mm -126.32 -8.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 113.21 -109.0 2.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.417 ' OXT' ' HG3' ' A' ' 79' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.247 -1.149 . . . . 0.0 109.61 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 4.0 m-85 -79.83 118.82 21.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -1.142 . . . . 0.0 109.098 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 3.7 mp0 -102.11 118.09 36.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 109.899 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.865 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -99.62 173.01 6.92 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 0.0 108.983 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -117.9 116.53 27.13 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.801 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 25' ' ' HIS . . . -47.54 109.93 0.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 110.299 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.9 mt -90.93 -38.39 12.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.7 m-85 -126.46 -161.02 1.03 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.592 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -123.68 -175.28 3.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 109.732 179.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 27.5 t80 167.81 123.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 108.943 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 15.3 mmtp -79.47 156.27 27.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.988 -1.07 . . . . 0.0 109.914 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 25.0 mtpt -70.06 88.77 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -71.82 -72.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.926 . . . . 0.0 109.291 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -69.81 156.52 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -77.56 70.4 3.94 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.947 0.88 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.79 -26.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 4.0 p30 -71.54 170.36 13.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -121.02 167.64 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.543 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 3.2 m-20 -73.56 111.38 8.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 2.9 mm? -97.96 144.49 27.45 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 0.0 109.086 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.699 ' CD2' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -159.99 138.18 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.035 -179.966 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -57.51 133.57 55.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.189 -0.945 . . . . 0.0 109.498 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.8 -25.99 24.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 25' ' ' HIS . 1.1 m-20 -74.54 171.56 13.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.634 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.97 ' C ' HD12 ' A' ' 30' ' ' LEU . 18.9 mm -123.53 155.15 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.2 mp -127.15 123.53 36.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.146 -0.971 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -101.69 92.71 4.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.412 179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.865 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 77.9 t -90.82 118.5 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 108.979 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 9.1 m-80 -48.01 176.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 109.284 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -83.0 -72.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.016 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -61.61 -23.05 62.42 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.516 ' CB ' ' HB2' ' A' ' 33' ' ' ASN . 16.6 t -59.07 -29.05 67.04 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.135 -1.215 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 1.1 tt -90.74 -47.76 7.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 38' ' ' VAL . 95.7 t -80.0 4.42 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.93 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -64.28 -9.06 15.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.949 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.3 mt -104.62 -11.69 16.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 0.0 110.006 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 105.95 29.21 5.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.847 ' CE2' HG23 ' A' ' 53' ' ' ILE . 10.5 m-85 -50.97 -175.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.521 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.68 157.5 44.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 109.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -56.95 123.31 14.7 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.72 -36.28 4.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.783 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.6 mt-30 -81.25 -32.45 33.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.304 -1.115 . . . . 0.0 109.376 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.8 pt-20 -64.26 -15.78 60.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.883 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -106.5 -13.95 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.737 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.6 mmt180 -113.87 80.09 5.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.2 Cg_endo -61.05 -31.74 91.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.215 1.943 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 9.1 pt-20 -60.07 -25.86 65.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 6.7 tt0 -104.81 -5.46 21.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.847 HG23 ' CE2' ' A' ' 42' ' ' PHE . 9.5 mt -79.44 -28.97 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.182 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 99.86 -77.05 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 70' ' ' PRO . 25.7 m95 -144.18 143.37 31.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 109.412 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.874 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -129.64 158.32 39.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -113.26 112.1 23.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -134.49 -171.48 12.53 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.48 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -120.6 109.64 15.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.975 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 8.4 m-20 -79.31 97.97 6.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.907 -1.121 . . . . 0.0 108.89 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.41 -36.19 81.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.817 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' OD2' ' A' ' 28' ' ' ASP . 37.9 m -50.05 -21.8 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' ASN . 12.0 t -127.76 -3.3 5.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.523 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.44 46.42 93.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -136.63 161.01 37.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.498 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 4.9 ttm180 -132.52 153.79 50.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 162.68 -171.2 38.45 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.663 -1.256 . . . . 0.0 109.962 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' ASP . 4.8 p30 -91.14 169.55 10.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.992 . . . . 0.0 109.655 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.679 ' HE2' HG11 ' A' ' 74' ' ' VAL . 10.4 p90 -174.33 143.86 0.91 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.164 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 2.9 Cg_exo -55.45 118.19 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.801 1.668 . . . . 0.0 109.914 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.874 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -63.24 -23.84 66.71 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 p -58.57 -19.54 39.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.891 -1.358 . . . . 0.0 109.881 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 17.9 m-85 -102.57 29.11 5.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' HE2' ' A' ' 69' ' ' PHE . 3.0 m -141.32 168.05 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.567 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 5.9 pt-20 -138.87 88.7 2.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 109.985 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.578 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 57.5 t80 -38.53 124.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 109.772 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -122.67 5.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 82.56 -100.84 2.2 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.442 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.61 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 5.2 m-30 -78.41 105.18 9.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.691 -0.888 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 1.6 mt-30 -106.01 114.52 28.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.763 ' OH ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -104.65 175.95 5.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 108.662 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.687 ' HB2' HD11 ' A' ' 77' ' ' ILE . 8.2 ttm180 -113.71 150.36 33.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.803 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -73.72 111.91 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 8.6 mt -89.1 -31.72 17.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.905 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 9.4 m-85 -132.61 -163.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.844 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 73' ' ' TYR . 12.2 p-10 -123.76 172.74 8.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 109.762 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 24.8 t80 -164.57 118.37 1.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' GLU . 29.6 tttp -80.11 136.38 36.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.882 -1.136 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 8.2 ttmt -42.94 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.499 -0.751 . . . . 0.0 109.734 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -95.55 -64.96 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -81.51 145.8 30.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.918 . . . . 0.0 109.517 -179.984 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.83 -13.6 6.65 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 11.2 pm0 -110.54 33.68 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.016 -1.052 . . . . 0.0 110.199 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -125.45 177.59 6.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.265 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 ' HA3' ' A' ' 67' ' ' GLY . 2.9 pt -136.08 157.63 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -70.23 113.81 7.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.811 . . . . 0.0 109.6 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 2.4 mm? -101.32 154.09 19.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.042 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.594 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -159.96 133.18 6.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 109.423 179.997 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -52.0 141.4 18.09 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.597 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 97.35 -17.55 58.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.948 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.73 174.54 10.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.7 mp -125.45 137.14 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 8.0 mp -109.28 119.43 39.48 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.22 -0.925 . . . . 0.0 109.138 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -97.76 100.19 11.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 43.2 t -116.43 109.63 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.551 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 m120 -45.64 171.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.49 -0.756 . . . . 0.0 109.78 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -71.88 -70.7 0.31 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.744 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.91 98.42 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 33' ' ' ASN . 46.3 m -44.58 -25.14 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -1.142 . . . . 0.0 109.863 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.815 ' O ' HD23 ' A' ' 37' ' ' LEU . 4.0 tt -90.28 -40.97 11.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 38' ' ' VAL . 62.6 t -74.66 0.0 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 0.0 109.887 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.29 -12.37 13.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 109.763 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.1 mt -91.58 17.43 8.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.983 . . . . 0.0 109.761 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 72.92 17.91 78.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.891 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -54.62 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.037 -1.272 . . . . 0.0 109.511 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -121.08 149.95 41.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.212 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -50.94 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.568 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 136.65 -46.04 1.04 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.23 -16.22 52.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.26 -38.15 88.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.566 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -91.11 26.6 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 109.673 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.6 mtp180 -128.67 64.84 70.5 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.309 -0.869 . . . . 0.0 108.875 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 6.3 Cg_exo -57.09 -38.68 95.08 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.267 1.978 . . . . 0.0 110.381 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.6 -27.09 68.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.503 ' N ' ' HG2' ' A' ' 51' ' ' GLU . 2.1 mt-10 -104.87 -2.81 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.891 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -82.28 -84.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.042 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.789 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 151.15 -61.32 0.41 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.462 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . 28.8 m95 -148.53 134.24 18.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -1.055 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.733 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -133.57 164.0 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 31.4 t-20 -115.72 115.64 26.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.06 -169.0 12.08 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 36.3 t80 -122.66 105.95 10.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.617 -0.931 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' HD12 ' A' ' 22' ' ' ILE . 4.5 m-80 -79.9 88.26 5.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.254 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.84 -36.77 67.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.86 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.67 HG21 ' OD1' ' A' ' 28' ' ' ASP . 6.2 m -52.33 -37.15 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.146 -0.971 . . . . 0.0 109.347 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.594 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -116.85 9.98 14.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.51 52.73 6.22 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.95 119.72 21.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -1.178 . . . . 0.0 109.724 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 2.8 ttt85 -101.63 134.51 44.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.16 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.65 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 170.44 -165.2 38.48 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.255 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -90.36 173.69 7.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.412 -1.052 . . . . 0.0 109.71 -179.936 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 18.1 p90 -177.58 159.57 1.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.858 . . . . 0.0 109.22 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -61.53 126.03 18.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.075 1.85 . . . . 0.0 110.015 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.61 -40.37 77.57 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 25.6 p -58.21 -14.0 6.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.029 -1.277 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.4 m-85 -93.15 23.21 4.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 110.155 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.9 m -142.59 -173.49 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.153 -0.967 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.6 pt-20 -156.42 87.32 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 109.577 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t80 -37.33 135.2 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.635 -0.666 . . . . 0.0 110.494 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.7 mp -131.56 -2.89 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 87.34 -139.77 16.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -1.189 . . . . 0.0 109.286 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' O ' ' CG ' ' A' ' 34' ' ' LYS . 1.5 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.568 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . -104.81 -159.15 23.62 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 16.9 m-85 -137.71 145.98 43.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -1.157 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.627 HE21 HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -137.79 121.17 17.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.727 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.91 172.79 7.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.306 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 21.3 mtt180 -117.57 139.46 50.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . . . -83.17 105.28 14.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.737 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.922 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -71.73 -36.42 70.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.064 -1.023 . . . . 0.0 108.977 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 34.3 m-85 -106.07 -177.78 3.46 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -113.71 141.02 47.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.834 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.56 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 55.5 t80 -132.17 158.4 41.79 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -111.19 -63.66 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.773 -1.204 . . . . 0.0 110.13 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 15' ' ' LYS . 14.3 tttm 153.68 95.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 2.2 tt0 -93.57 -54.18 3.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.024 -1.047 . . . . 0.0 109.192 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -69.75 159.32 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.214 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.38 25.85 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.214 -0.929 . . . . 0.0 111.402 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 20' ' ' GLU . 3.6 mm-40 -149.05 13.98 0.89 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.669 -1.27 . . . . 0.0 109.539 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.536 ' OD1' ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -91.17 161.74 14.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.004 -1.06 . . . . 0.0 109.675 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG12 ' CA ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -117.56 143.8 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 0.0 109.306 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 7.9 m-20 -49.15 109.68 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.336 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -103.69 154.71 19.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -154.25 142.34 20.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.96 -1.088 . . . . 0.0 109.634 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.6 tt -47.32 135.08 10.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.71 5.9 73.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 0.4 OUTLIER -90.24 136.01 33.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -1.2 . . . . 0.0 109.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.935 ' C ' HD12 ' A' ' 30' ' ' LEU . 7.3 mm -94.85 140.58 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.071 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.935 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -125.76 111.26 14.69 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.055 -1.028 . . . . 0.0 109.8 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 HE21 ' A' ' 7' ' ' GLN . 0.2 OUTLIER -85.52 93.34 8.76 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG22 ' CA ' ' A' ' 58' ' ' GLY . 89.5 t -99.89 115.92 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.083 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.8 167.21 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.99 . . . . 0.0 109.012 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' C ' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -90.03 0.6 57.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.935 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.5 -56.47 1.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.98 -31.85 1.44 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.322 -1.105 . . . . 0.0 109.978 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.932 HD11 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.86 -39.98 12.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.079 -1.013 . . . . 0.0 109.98 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 38' ' ' VAL . 56.8 t -76.39 1.62 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.37 6.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.793 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -97.6 -25.71 15.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' PHE . . . 120.93 22.13 3.03 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.061 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.7 m-85 -44.49 147.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.251 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.56 165.37 23.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -67.0 118.79 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.89 -18.12 53.1 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.21 -32.23 73.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.816 ' HG3' HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -67.91 -21.2 65.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -74.71 -9.57 58.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 109.34 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -119.14 75.8 15.32 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 108.897 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 53' ' ' ILE . 6.1 Cg_exo -56.67 -48.79 17.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.497 2.131 . . . . 0.0 110.73 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.88 -25.79 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.5 tt0 -114.12 50.48 0.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.061 HG23 ' CE2' ' A' ' 42' ' ' PHE . 7.5 mt -134.91 -45.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.56 -77.6 0.28 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.458 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 17.4 m95 -139.64 143.97 37.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.433 -1.039 . . . . 0.0 109.336 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.932 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -131.96 147.88 52.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.914 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' C ' HG22 ' A' ' 32' ' ' VAL . 17.8 t-20 -114.18 109.39 18.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.574 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.13 -158.1 8.87 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.601 -1.285 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 72.9 t80 -120.26 116.91 26.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.42 -1.047 . . . . 0.0 109.801 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.794 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.2 m-20 -79.45 76.67 6.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -48.28 -34.87 11.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.787 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 31.7 m -49.11 -48.48 44.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.823 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.794 HG22 ' HB3' ' A' ' 60' ' ' ASN . 9.4 t -101.7 2.92 39.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.689 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.83 45.83 95.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.577 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 17.8 mm-40 -138.62 -174.75 3.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.172 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.65 150.05 29.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.083 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 171.12 -164.77 37.86 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -100.44 166.31 11.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.984 . . . . 0.0 109.565 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 5.5 p90 -169.07 156.36 6.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.71 126.56 20.1 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.108 1.872 . . . . 0.0 109.806 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.822 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.74 -22.11 78.6 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.534 ' HG1' ' HD1' ' A' ' 73' ' ' TYR . 1.2 p -73.07 -4.93 35.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.088 -1.242 . . . . 0.0 109.47 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.7 m-85 -101.93 -5.43 24.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.212 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.766 ' O ' HD11 ' A' ' 11' ' ' LEU . 1.7 m -116.48 -171.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 110.064 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD21 ' A' ' 11' ' ' LEU . 11.0 pt-20 -157.51 92.82 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.63 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 55.4 t80 -48.04 139.43 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 109.668 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -132.99 -0.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.982 . . . . 0.0 109.638 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.624 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 140.1 169.65 11.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 101.65 -152.97 18.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 27.0 m-85 -78.92 139.15 38.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.986 . . . . 0.0 109.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.511 ' HG2' HG23 ' A' ' 31' ' ' THR . 21.1 mt-30 -129.54 126.09 37.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.104 -0.997 . . . . 0.0 109.845 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -122.87 177.32 5.54 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.531 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -117.78 138.11 52.28 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -70.44 103.5 2.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.072 -1.018 . . . . 0.0 110.675 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.4 mt -68.5 -32.24 72.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 108.586 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 5.9 m-85 -129.75 -169.02 2.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.64 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -117.95 171.19 8.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 109.933 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.736 ' HD2' HD21 ' A' ' 24' ' ' LEU . 54.8 t80 -173.42 118.17 0.29 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 3.6 tttm -79.64 117.53 20.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 18.0 pttt -42.7 109.26 0.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.676 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -67.13 -66.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 0.0 109.252 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' O ' ' OD2' ' A' ' 21' ' ' ASP . 15.9 mtm180 -90.29 174.34 7.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 2.09 12.47 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -98.69 -6.45 29.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 109.891 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -105.11 166.31 10.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.158 -0.964 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.804 HD12 HD22 ' A' ' 60' ' ' ASN . 1.1 pt -114.94 163.15 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.0 m-20 -87.43 105.67 17.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.736 HD21 ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -102.75 154.6 19.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.573 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.632 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -152.49 154.6 35.81 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 26.5 tp -46.6 135.32 8.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.94 9.62 86.05 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 25' ' ' HIS . 16.2 t0 -91.17 110.98 22.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.284 -1.127 . . . . 0.0 109.966 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.936 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -79.68 141.85 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.936 -1.102 . . . . 0.0 109.79 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.936 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.9 mp -123.38 140.03 53.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -109.86 86.19 2.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 109.285 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.606 HG22 ' CA ' ' A' ' 58' ' ' GLY . 53.9 t -90.58 108.68 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 30.2 m120 -50.49 161.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 109.722 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 53.84 2.57 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.326 -0.859 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.89 -59.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.7 m -61.73 -20.37 63.44 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.341 -1.093 . . . . 0.0 109.255 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 47' ' ' GLU . 8.2 tp -90.35 -24.14 20.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.715 HG23 ' OE2' ' A' ' 47' ' ' GLU . 5.0 t -90.81 -4.49 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.065 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.02 -4.14 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.989 HD12 ' CE2' ' A' ' 42' ' ' PHE . 7.4 mt -80.82 -30.17 35.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.49 7.35 5.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.989 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.1 m-85 -59.94 -172.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -1.189 . . . . 0.0 109.751 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.62 -171.41 1.92 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.423 -0.798 . . . . 0.0 108.975 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.96 84.48 6.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.724 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.76 2.17 3.98 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.169 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.522 ' CB ' ' HB3' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -80.86 -14.94 57.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.962 -1.316 . . . . 0.0 109.851 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.715 ' OE2' HG23 ' A' ' 38' ' ' VAL . 26.5 mt-10 -62.58 -40.17 96.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -61.67 -9.57 6.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.208 -0.932 . . . . 0.0 110.367 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mmm180 -113.59 80.59 4.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.872 -1.142 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.593 ' CG ' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.63 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.325 2.017 . . . . 0.0 110.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.4 tt0 -41.06 -29.8 0.12 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.253 -0.905 . . . . 0.0 109.071 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -98.64 47.06 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.835 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.0 mt -146.89 -42.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -63.0 0.28 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 33.7 m95 -146.91 148.9 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -1.11 . . . . 0.0 109.289 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.728 HD11 ' HA3' ' A' ' 71' ' ' GLY . 2.6 mp -137.42 152.3 49.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.696 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 1.2 t-20 -110.54 107.51 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.606 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.28 -160.04 9.07 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 49.2 t80 -116.54 117.55 30.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.526 -0.985 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.804 HD22 HD12 ' A' ' 22' ' ' ILE . 2.5 t-20 -79.4 76.38 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.531 -0.731 . . . . 0.0 109.234 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -56.94 -37.32 71.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.799 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 19.4 m -60.3 -33.45 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.019 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.632 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.2 OUTLIER -121.76 18.26 11.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 40.19 54.16 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -140.28 113.1 8.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -1.227 . . . . 0.0 109.486 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 9.1 ttp-105 -91.24 140.47 29.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.623 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 166.09 -165.19 38.01 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.164 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -93.57 166.22 12.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.484 -1.009 . . . . 0.0 109.779 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 5.1 p90 -168.1 153.91 6.91 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -58.11 116.58 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.195 1.93 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.6 -28.26 73.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -63.63 -28.0 69.61 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.576 -1.543 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 19.4 m-30 -85.41 24.91 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.02 -1.05 . . . . 0.0 110.419 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.5 m -140.36 172.93 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.135 -0.978 . . . . 0.0 109.347 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' HD11 ' A' ' 11' ' ' LEU . 13.0 pt-20 -148.95 89.65 1.69 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.835 . . . . 0.0 109.177 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 75.6 t80 -41.56 133.13 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.551 -0.718 . . . . 0.0 109.133 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 77' ' ' ILE . 17.5 mm -123.37 -2.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.099 -1.001 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 140.65 -174.01 22.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.355 -1.085 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 167.85 136.72 2.09 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 34.7 m-85 -79.88 115.17 19.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -1.086 . . . . 0.0 109.353 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.679 ' CG ' HG23 ' A' ' 31' ' ' THR . 3.2 mt-30 -98.67 128.12 44.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -115.18 176.06 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.034 -1.041 . . . . 0.0 109.692 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' C ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -118.0 117.6 29.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -61.94 85.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.559 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -46.12 -50.45 15.41 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.057 -1.027 . . . . 0.0 109.782 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.722 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -111.24 170.68 7.95 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.574 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.36 -170.41 3.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.387 -0.821 . . . . 0.0 109.879 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 7.2 t80 179.75 115.58 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.236 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' GLU . 8.2 pttp -79.46 109.42 13.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.144 -0.972 . . . . 0.0 109.036 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' O ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -39.69 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 110.255 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' LYS . 48.0 mt-10 -63.33 -59.92 4.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.072 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 63.1 mtp85 -90.1 155.2 19.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.346 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.98 -9.15 19.32 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -84.02 -21.75 31.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 0.0 109.843 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' CA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -100.11 156.98 16.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.404 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.35 175.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.933 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' CG ' ' HG3' ' A' ' 16' ' ' LYS . 1.8 m-20 -75.66 151.48 37.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.002 HD11 HD21 ' A' ' 30' ' ' LEU . 1.1 tp -136.91 150.07 48.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.353 -0.842 . . . . 0.0 109.096 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.534 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 146.13 16.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.99 . . . . 0.0 109.672 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 43.5 tp -51.11 136.06 24.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.49 -0.756 . . . . 0.0 109.973 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.26 -2.48 78.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.655 ' C ' HD12 ' A' ' 29' ' ' ILE . 11.4 t0 -90.05 144.92 25.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -1.169 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.934 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.9 mp -108.65 146.25 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 24' ' ' LEU . 6.6 mp -124.89 112.43 16.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 0.0 109.303 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.679 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.51 91.91 7.97 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.485 -0.759 . . . . 0.0 109.376 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG11 ' OH ' ' A' ' 8' ' ' TYR . 53.8 t -93.81 114.98 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.703 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -57.24 156.61 7.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -76.2 -16.54 59.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.633 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.65 -50.51 3.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 p -54.52 -30.28 53.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -1.113 . . . . 0.0 110.025 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.813 HD21 ' HA ' ' A' ' 47' ' ' GLU . 8.7 tp -90.31 -32.32 16.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 109.571 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 38' ' ' VAL . 77.2 t -90.21 2.96 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.941 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.53 -7.46 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.827 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.867 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -105.36 17.55 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.145 -0.972 . . . . 0.0 109.513 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.69 42.88 45.29 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.933 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -67.26 -168.32 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -1.162 . . . . 0.0 109.441 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.29 136.38 52.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.176 -0.952 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.76 122.9 6.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.8 -47.89 1.0 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.501 ' CA ' ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -62.46 -25.29 67.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -1.144 . . . . 0.0 109.409 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.813 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.4 mp0 -61.86 -32.76 73.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.967 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.521 ' HB1' ' CG ' ' A' ' 76' ' ' TYR . . . -87.41 20.54 2.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.1 tpp180 -138.78 74.86 37.74 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HA ' HD12 ' A' ' 53' ' ' ILE . 6.2 Cg_exo -55.67 -48.77 18.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.443 2.095 . . . . 0.0 111.15 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 4.7 pm0 -44.11 -26.96 0.34 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.031 -1.043 . . . . 0.0 109.218 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.75 51.53 0.85 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.398 -0.814 . . . . 0.0 109.066 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 42' ' ' PHE . 24.2 mt -141.49 -39.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.36 -0.837 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.47 -78.47 0.24 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.426 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 24.3 m95 -137.66 144.82 42.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.345 -1.091 . . . . 0.0 109.192 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.868 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -134.77 154.3 51.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.978 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' C ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.92 108.16 18.33 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -130.66 -171.21 12.86 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 68.8 t80 -116.35 118.32 32.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.545 -0.973 . . . . 0.0 110.026 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 6.2 m-80 -84.53 64.82 8.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.105 -0.997 . . . . 0.0 109.009 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -43.67 -30.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.419 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.454 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 16.5 m -49.35 -54.47 17.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.234 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.93 10.96 39.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.445 -0.784 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.71 47.11 91.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.21 178.46 5.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -1.176 . . . . 0.0 109.582 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -159.66 138.52 10.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 109.364 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 166.93 -162.19 35.99 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-20 -94.92 167.49 11.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.499 -1.001 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.669 ' HE2' HG21 ' A' ' 74' ' ' VAL . 6.5 p90 -169.84 158.89 6.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -62.13 125.37 16.27 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.187 1.924 . . . . 0.0 110.086 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.868 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -73.34 -26.3 70.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.3 p -69.65 -7.44 39.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.951 -1.323 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.5 m-85 -99.32 -0.73 40.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.987 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.669 HG21 ' HE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -124.98 164.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 121.714 0.769 . . . . 0.0 110.422 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.829 ' HB3' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -139.79 109.74 6.42 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 83.2 t80 -37.56 113.39 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -105.11 9.77 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.519 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 104.33 -149.01 16.95 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.214 -1.168 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . -71.98 -153.88 1.84 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 79.2 m-85 -160.1 124.79 3.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.476 -1.014 . . . . 0.0 108.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 31' ' ' THR . 1.1 mt-30 -129.51 122.29 28.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.016 -1.052 . . . . 0.0 110.196 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -116.92 -178.08 3.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.06 -1.025 . . . . 0.0 109.51 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.36 165.29 13.66 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.83 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -88.79 123.6 33.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 11.8 mt -104.3 -33.19 8.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 10.6 m-85 -128.18 -158.72 0.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.814 . . . . 0.0 109.902 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -126.66 172.65 10.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.736 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 75.3 t80 -171.49 113.79 0.37 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.297 -0.877 . . . . 0.0 108.809 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -79.29 156.39 28.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.983 -1.073 . . . . 0.0 110.052 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.7 tttt -55.08 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 109.663 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mt-10 -88.73 -62.91 1.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.216 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 6.6 ttm-85 -90.16 157.44 17.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -68.95 -4.4 16.52 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.174 -0.954 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 -9.86 15.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.079 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -85.33 171.45 11.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.078 -1.014 . . . . 0.0 109.528 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.492 HD12 HD22 ' A' ' 60' ' ' ASN . 0.4 OUTLIER -130.62 158.19 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 109.574 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.795 ' O ' HD22 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -60.04 134.01 56.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 1.2 mm? -133.47 146.15 50.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 0.0 109.06 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -158.2 147.76 19.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 109.27 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 10' ' ' ALA . 50.4 tp -51.48 145.1 9.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.11 -10.63 67.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.711 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -85.98 147.68 26.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -1.176 . . . . 0.0 109.565 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.906 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.6 mp -107.38 146.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 6.3 mp -122.75 123.27 40.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.093 -1.004 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.513 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -98.64 92.05 5.42 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.622 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 8' ' ' TYR . 53.5 t -88.43 113.77 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.22 -165.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -0.925 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -70.98 0.62 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.23 -36.61 83.53 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -53.71 -30.35 43.45 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.028 -1.278 . . . . 0.0 110.064 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.821 ' O ' HD23 ' A' ' 37' ' ' LEU . 3.1 tt -90.73 -42.67 10.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.707 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 38' ' ' VAL . 99.2 t -79.27 1.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 110.029 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -63.04 -12.65 27.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.322 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -106.22 27.09 9.01 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.63 48.68 84.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.755 ' CE2' HD21 ' A' ' 37' ' ' LEU . 7.1 m-85 -67.21 -168.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.639 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.1 m -133.75 143.74 48.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.486 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -59.15 122.73 14.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.0 -33.3 6.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -78.36 -2.65 39.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -1.194 . . . . 0.0 109.712 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 6' ' ' TYR . 1.3 pt-20 -69.52 -37.23 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -87.2 15.13 6.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -123.6 67.69 39.54 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.25 -0.906 . . . . 0.0 109.127 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.585 ' CB ' ' CG2' ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.35 -51.01 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.219 1.946 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.4 tt0 -59.14 -33.36 70.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.012 . . . . 0.0 108.741 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HG2' ' A' ' 49' ' ' ARG . 7.2 tp10 -99.28 34.06 2.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 108.689 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.678 HG21 ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -119.32 -37.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.24 -76.8 0.24 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 74.9 m95 -142.74 139.71 31.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.092 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.822 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -129.74 153.32 48.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.767 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 2.7 t-20 -108.7 112.21 24.4 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -132.97 -169.25 12.16 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.682 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -120.29 107.98 13.62 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.897 -0.767 . . . . 0.0 109.725 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.657 ' ND2' HD21 ' A' ' 24' ' ' LEU . 6.9 m-80 -79.57 90.19 5.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.184 -0.947 . . . . 0.0 108.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.82 -36.4 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.595 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.485 ' HB ' ' OD2' ' A' ' 28' ' ' ASP . 34.1 m -53.82 -36.92 63.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.478 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.3 p -111.44 5.61 19.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 47.74 45.67 24.55 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 63' ' ' THR . 33.1 mt-10 -129.38 155.6 45.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.694 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' C ' HG21 ' A' ' 22' ' ' ILE . 2.6 tpp180 -126.61 132.01 51.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 108.893 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 177.68 -158.48 23.71 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.249 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -104.59 166.03 10.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.452 -1.028 . . . . 0.0 110.062 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.65 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.9 p90 -163.65 158.96 17.39 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.447 -0.783 . . . . 0.0 109.307 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.584 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.28 127.27 21.51 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.136 1.891 . . . . 0.0 110.191 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.822 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -71.3 -36.42 63.42 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.552 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.4 p -65.2 -9.96 27.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -1.197 . . . . 0.0 109.265 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.605 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.6 m-85 -99.82 18.37 18.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.443 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 71' ' ' GLY . 34.8 m -134.08 -168.06 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.093 -1.004 . . . . 0.0 110.092 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 77' ' ' ILE . 10.3 pt-20 -154.84 87.15 1.14 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.537 -0.727 . . . . 0.0 109.818 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 81.8 t80 -45.73 139.64 3.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.174 -0.954 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.38 -4.99 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 109.127 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 116.29 -173.11 14.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.46 ' OXT' ' HA ' ' A' ' 6' ' ' TYR . 73.4 mtp180 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 7' ' ' GLN . 1.3 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLN . . . 95.01 173.25 37.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 14.8 m-85 -79.81 102.57 9.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -1.124 . . . . 0.0 109.088 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -99.93 128.88 45.97 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.432 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.627 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -121.84 176.3 5.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.124 -0.985 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 3.2 mmm180 -118.35 122.53 43.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.706 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -70.97 93.02 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 110.793 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.944 HD21 ' CD ' ' A' ' 75' ' ' GLU . 64.2 mt -58.4 -49.4 77.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -104.12 176.77 5.05 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.432 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 43.1 p-10 -107.25 -173.86 2.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 14.0 t80 -162.31 140.22 8.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -91.89 132.91 36.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.983 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -55.8 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 109.718 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 15' ' ' LYS . 9.3 tp10 -95.43 -54.89 3.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.212 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.1 mmp_? -81.76 136.82 35.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.68 -19.3 0.89 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.109 -0.994 . . . . 0.0 110.086 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' O ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 mm-40 -97.44 -33.34 11.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -66.36 157.97 30.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.67 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.667 HG21 ' O ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -120.32 169.85 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 109.375 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 2.9 m-20 -78.99 112.41 16.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.842 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.706 HD12 ' CB ' ' A' ' 10' ' ' ALA . 3.1 mm? -88.5 166.29 14.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 108.426 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.628 ' CE1' ' CG2' ' A' ' 63' ' ' THR . 0.0 OUTLIER -157.99 135.15 10.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.853 -1.154 . . . . 0.0 110.29 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 11' ' ' LEU . 12.1 tp -50.57 140.15 14.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.512 -0.743 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.72 14.23 72.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 5.8 t0 -87.93 146.43 25.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.18 -1.188 . . . . 0.0 109.084 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.698 ' C ' HD22 ' A' ' 30' ' ' LEU . 24.2 mm -91.59 142.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.195 -0.941 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 29' ' ' ILE . 3.8 mm? -122.11 129.47 52.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -117.24 82.75 1.86 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.806 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 ' OH ' ' A' ' 8' ' ' TYR . 40.8 t -92.69 115.08 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.148 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 0.8 OUTLIER -56.21 -171.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.725 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 4.6 mtmp? -90.04 -52.15 5.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.267 -0.896 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 36' ' ' SER . . . -67.51 -46.94 65.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -42.3 -33.87 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.256 -1.144 . . . . 0.0 109.833 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.784 ' O ' HD23 ' A' ' 37' ' ' LEU . 5.1 tt -90.33 -32.67 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.731 HG22 ' OE2' ' A' ' 47' ' ' GLU . 95.0 t -80.09 0.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -61.45 -12.96 16.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.856 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.7 OUTLIER -105.99 27.71 8.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.44 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.19 48.93 83.69 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.866 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.0 m-85 -69.66 -168.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.3 p -126.4 158.51 35.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.323 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.07 119.15 12.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.562 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.4 -20.03 38.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.25 15.69 9.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -1.166 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' OE2' HG22 ' A' ' 38' ' ' VAL . 4.6 mm-40 -90.33 -35.44 15.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.781 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -89.88 28.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.477 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -128.41 65.08 70.0 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.5 Cg_exo -57.61 -46.64 25.78 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.424 2.083 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.8 -19.02 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.6 -3.47 10.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.98 . . . . 0.0 110.028 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.866 HG23 ' CE2' ' A' ' 42' ' ' PHE . 14.1 mt -80.27 -50.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.079 -1.013 . . . . 0.0 109.128 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.72 -69.22 0.4 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.409 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 45.1 m95 -139.81 148.15 41.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -1.051 . . . . 0.0 109.509 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.901 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -130.81 138.83 50.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.368 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.9 t-20 -111.56 104.04 12.41 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 32' ' ' VAL . . . -138.75 -140.87 4.04 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 64' ' ' GLY . 72.2 t80 -131.2 125.78 33.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.981 . . . . 0.0 110.363 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -86.43 85.17 7.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -42.85 -48.44 5.76 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.795 . . . . 0.0 110.867 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.558 HG22 HG23 ' A' ' 63' ' ' THR . 4.0 m -41.26 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.0 110.234 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.628 ' CG2' ' CE1' ' A' ' 25' ' ' HIS . 39.8 p -83.3 13.09 4.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.068 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 59' ' ' TYR . . . 45.76 45.34 13.21 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -119.75 117.16 27.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 0.0 109.234 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.667 ' O ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -89.63 156.33 18.65 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.26 -0.9 . . . . 0.0 109.29 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 156.93 -163.71 32.4 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.122 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.2 p-10 -104.71 154.1 20.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.811 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HB3' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -155.88 159.68 31.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.1 Cg_exo -59.72 130.12 33.77 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.17 1.914 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.901 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -73.6 -29.72 63.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -69.43 -5.75 25.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.066 -1.255 . . . . 0.0 109.364 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.5 m-85 -100.04 -4.3 30.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG21 HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -116.66 -176.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.141 -0.974 . . . . 0.0 110.184 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.944 ' CD ' HD21 ' A' ' 11' ' ' LEU . 21.1 pt-20 -153.48 96.45 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' HD3' ' A' ' 79' ' ' ARG . 9.8 t80 -37.67 110.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.323 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -135.35 14.09 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 7' ' ' GLN . . . -130.65 110.41 1.01 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.562 ' HD3' ' CE1' ' A' ' 76' ' ' TYR . 3.3 ttp180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.465 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 32' ' ' VAL . . . 108.0 -168.89 14.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 32' ' ' VAL . 5.1 m-85 -78.6 119.8 22.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.121 -1.223 . . . . 0.0 108.617 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.571 ' NE2' HG23 ' A' ' 31' ' ' THR . 30.6 mt-30 -106.78 122.91 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.141 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.941 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -115.79 173.77 6.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.13 -0.981 . . . . 0.0 109.64 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 8.5 mpt_? -107.86 137.44 45.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.403 -0.811 . . . . 0.0 108.846 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -66.02 99.12 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 110.241 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.5 mt -65.39 -30.51 71.34 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.147 -0.971 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.5 m-85 -127.94 -163.59 1.28 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.78 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.04 122.95 26.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.751 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.531 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 4.1 t80 -103.39 139.68 38.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.286 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.7 pttt -95.53 15.95 18.41 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.995 -1.065 . . . . 0.0 109.619 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 ttmm 64.19 92.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.658 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 4.8 tp10 -86.02 -80.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.229 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 77.8 mtm-85 -67.93 165.33 17.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.311 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -74.73 2.21 10.57 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.212 -0.93 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.41 2.46 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.033 . . . . 0.0 109.87 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -109.37 172.43 6.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.508 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 HG13 ' CD2' ' A' ' 24' ' ' LEU . 6.3 pt -125.23 175.95 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.665 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.583 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -84.75 105.31 15.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.686 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.054 HD11 HD21 ' A' ' 30' ' ' LEU . 1.7 mm? -91.81 152.64 20.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.091 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' HG21 ' A' ' 63' ' ' THR . 1.6 m80 -152.22 135.86 16.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.338 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 11' ' ' LEU . 4.5 tt -55.02 137.5 46.14 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.157 -0.965 . . . . 0.0 109.605 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.66 -9.12 71.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HB ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -90.31 162.39 15.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.34 -1.094 . . . . 0.0 109.262 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 30' ' ' LEU . 3.3 mm -115.62 147.82 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.054 HD21 HD11 ' A' ' 24' ' ' LEU . 7.4 mp -120.76 111.8 18.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.226 -0.921 . . . . 0.0 109.263 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.571 HG23 ' NE2' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -86.52 93.57 9.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.74 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.941 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 46.9 t -92.35 121.27 42.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.117 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 4.5 m-80 -47.79 178.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -87.4 -71.31 0.57 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.87 -30.33 59.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 45.5 t -47.68 -33.85 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.098 -1.237 . . . . 0.0 110.156 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -90.74 -40.55 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.029 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 38' ' ' VAL . 88.6 t -78.57 3.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.82 20.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.866 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.3 mm? -107.8 -7.34 16.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.53 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 95.2 33.5 6.54 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.722 ' CE2' HG23 ' A' ' 53' ' ' ILE . 9.8 m-85 -53.81 -168.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.418 -1.048 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 29.3 p -139.76 160.93 38.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.935 . . . . 0.0 109.561 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -59.58 115.27 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.61 -34.09 4.67 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 15.9 mm-40 -68.39 -33.16 73.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.183 -1.187 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -64.23 -31.44 72.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -82.67 -14.57 54.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.1 mmm180 -112.05 80.17 3.06 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.881 . . . . 0.0 109.033 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.7 Cg_exo -54.48 -57.4 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.304 2.003 . . . . 0.0 110.434 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 72' ' ' THR . 15.5 tt0 -44.0 -36.08 2.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 108.733 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.7 43.92 1.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.722 HG23 ' CE2' ' A' ' 42' ' ' PHE . 21.8 mt -136.68 -40.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.122 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 110.75 -78.72 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 14.6 m95 -145.02 143.83 30.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.101 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.765 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -130.82 160.92 32.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 109.669 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -110.99 117.24 32.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.28 -176.16 14.37 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.5 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 70.7 t80 -117.55 111.87 19.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.876 -0.779 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' HG ' ' A' ' 30' ' ' LEU . 1.8 m-80 -79.3 78.72 5.78 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.073 -1.017 . . . . 0.0 108.79 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -48.19 -38.41 18.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.85 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 16.0 m -48.01 -46.74 33.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 0.0 109.713 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.599 HG21 ' CE1' ' A' ' 25' ' ' HIS . 53.3 p -117.4 17.72 14.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.04 50.93 6.13 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' OE1' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.87 109.93 15.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.301 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' C ' HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -96.0 150.54 20.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 109.398 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 22' ' ' ILE . . . 153.98 -160.05 29.15 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.07 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -99.29 166.3 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.36 -1.083 . . . . 0.0 109.61 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.765 ' HE2' HG11 ' A' ' 74' ' ' VAL . 5.1 p90 -164.63 158.93 15.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.1 Cg_exo -60.47 116.54 3.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.014 1.809 . . . . 0.0 109.798 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.044 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.16 -37.69 91.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 51' ' ' GLU . 18.5 p -56.31 -23.39 36.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.902 -1.352 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 6.9 m-30 -92.49 28.23 2.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.044 HG22 ' O ' ' A' ' 71' ' ' GLY . 32.7 m -137.27 170.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.101 -1.0 . . . . 0.0 109.921 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.765 ' HG3' HD12 ' A' ' 77' ' ' ILE . 8.1 pt-20 -138.66 89.66 2.39 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.501 -0.75 . . . . 0.0 109.054 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 50.6 t80 -37.75 115.78 0.44 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.641 -0.662 . . . . 0.0 110.639 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 77' ' ' ILE . 67.6 mt -149.37 28.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -136.79 125.67 3.5 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.074 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 78' ' ' GLY . 8.5 tpt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.477 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.43 -170.22 31.99 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 72.7 m-85 -140.32 121.46 14.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.484 -1.009 . . . . 0.0 108.863 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.636 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.3 tt0 -130.28 133.56 46.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 110.085 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.707 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -128.66 178.57 6.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.345 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.906 ' HB2' HD11 ' A' ' 77' ' ' ILE . 15.9 ttp180 -118.99 121.29 39.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -44.92 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.871 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.654 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 0.6 OUTLIER -74.39 -64.62 0.99 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.654 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -96.71 -160.63 0.81 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.35 -0.844 . . . . 0.0 109.481 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -123.14 126.06 46.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.217 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 15' ' ' LYS . 92.7 t80 -128.28 131.68 48.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.467 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 12.9 mmtt -79.69 178.43 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' CG ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -98.71 68.16 1.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.956 . . . . 0.0 109.243 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -68.23 -84.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 109.29 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 9.2 mtm-85 -43.61 145.65 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.62 -5.62 21.06 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.257 -0.902 . . . . 0.0 109.896 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.13 7.77 25.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 109.8 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 44.4 p30 -106.16 159.39 16.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.0 109.534 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -119.44 161.21 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.354 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD2' ' CG ' ' A' ' 16' ' ' LYS . 2.7 m-20 -56.16 154.25 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.877 . . . . 0.0 109.7 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.76 HD11 HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -152.66 137.96 17.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.79 137.77 10.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 26.4 tp -42.81 151.07 0.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.608 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 87.31 -16.12 50.39 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 3.1 t70 -90.2 160.69 16.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -1.094 . . . . 0.0 109.168 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.976 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.8 mm -118.91 149.74 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.133 HD23 ' CE2' ' A' ' 69' ' ' PHE . 8.3 mp -124.79 108.98 12.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.195 -0.941 . . . . 0.0 108.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.636 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -89.23 91.44 8.77 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.101 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.707 HG21 ' OH ' ' A' ' 8' ' ' TYR . 40.6 t -87.2 101.77 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 0.0 109.14 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.81 152.65 44.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 176.56 1.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.53 -59.47 4.61 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 m -71.34 -31.74 67.72 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.357 -1.084 . . . . 0.0 109.022 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.779 HD21 ' CB ' ' A' ' 47' ' ' GLU . 4.9 tp -89.51 -28.54 19.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 38' ' ' VAL . 55.0 t -90.17 -1.93 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.72 -12.87 18.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -0.974 . . . . 0.0 109.555 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.85 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? -93.29 -28.24 16.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.472 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 120.83 19.1 3.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.944 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 75.6 m-85 -55.75 -168.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -1.199 . . . . 0.0 109.47 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -151.18 156.79 41.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.285 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -57.8 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.44 -37.0 1.67 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -87.92 -12.5 44.51 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.192 -1.181 . . . . 0.0 109.55 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.779 ' CB ' HD21 ' A' ' 37' ' ' LEU . 28.2 mt-10 -83.72 12.3 6.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.325 -0.859 . . . . 0.0 109.898 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.582 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -107.81 -10.33 15.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.1 mmt180 -117.43 77.31 10.21 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 0.0 109.265 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.733 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.3 Cg_endo -61.24 -21.44 71.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.211 1.941 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -56.32 -20.55 19.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 109.357 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 mt-10 -123.83 1.42 8.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.705 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.944 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 9.6 mt -79.54 -30.27 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 107.62 -77.73 0.23 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 10.3 m95 -147.68 136.4 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -1.091 . . . . 0.0 109.527 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.748 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -124.03 138.3 54.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.514 ' C ' HG22 ' A' ' 32' ' ' VAL . 22.6 t-20 -93.66 109.7 21.34 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -123.99 -176.62 14.76 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.14 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -114.16 110.31 19.79 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.657 -0.907 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' HG22 ' A' ' 63' ' ' THR . 75.2 m-20 -78.03 82.8 4.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.983 -1.073 . . . . 0.0 108.909 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -53.36 -34.42 57.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.468 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 49.6 m -50.54 -41.67 54.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.425 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 60' ' ' ASN . 1.6 t -108.35 2.68 22.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.08 47.46 89.05 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 63' ' ' THR . 73.8 mm-40 -137.02 169.68 17.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.287 -1.125 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HG21 ' A' ' 22' ' ' ILE . 1.1 ttt180 -140.15 156.94 46.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.476 ' HA3' HG13 ' A' ' 22' ' ' ILE . . . 160.64 -173.18 37.14 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 5.3 t0 -97.07 160.4 14.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -1.083 . . . . 0.0 109.602 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 1.133 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.4 p90 -158.51 162.21 27.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -60.01 128.16 25.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.958 1.772 . . . . 0.0 109.734 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.575 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.35 -32.79 64.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 51' ' ' GLU . 32.8 p -68.27 -7.79 33.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.985 -1.303 . . . . 0.0 109.533 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.1 m-85 -99.68 6.94 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.733 HG23 ' HG2' ' A' ' 50' ' ' PRO . 10.6 m -127.32 164.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.136 -0.978 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 15.1 pt-20 -129.22 89.0 2.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.554 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 51.8 t80 -41.02 142.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.509 -0.744 . . . . 0.0 109.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -135.25 3.73 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.456 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 135.87 -177.69 19.3 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.32 -1.106 . . . . 0.0 109.5 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 2.8 pp20? . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.59 145.21 7.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 3.9 m-85 -79.69 81.65 5.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.335 -1.097 . . . . 0.0 108.827 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.654 ' CG ' HG23 ' A' ' 31' ' ' THR . 8.8 mt-30 -84.28 141.34 31.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.276 0.56 . . . . 0.0 110.04 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.841 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -120.51 173.0 7.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.03 120.93 41.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.653 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -48.74 133.05 17.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.897 . . . . 0.0 110.656 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.0 mt -117.86 -39.37 3.12 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 19.7 m-85 -123.75 -159.02 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.594 -0.691 . . . . 0.0 109.758 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -135.38 132.46 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 109.766 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 28.3 t80 -123.9 126.97 47.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 144.97 32.94 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.096 -1.002 . . . . 0.0 109.547 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 24.3 ttpp -66.05 86.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -77.57 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.338 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 50.8 mtt-85 -89.0 146.08 25.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.79 -19.65 6.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -0.922 . . . . 0.0 110.017 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 3.3 pt-20 -72.35 -37.3 68.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -90.97 169.84 10.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.361 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 67' ' ' GLY . 1.9 pt -126.79 179.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 3.3 m-20 -78.83 164.83 24.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.616 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 14.5 mt -154.15 148.6 26.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 108.714 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.9 m80 -156.06 132.66 10.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 109.823 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.8 tt -50.8 139.27 17.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.55 -10.65 68.91 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.801 ' OD1' HG21 ' A' ' 62' ' ' THR . 67.2 m-20 -79.31 -175.78 4.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -1.09 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.8 mm -133.57 125.47 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.457 -0.777 . . . . 0.0 108.946 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 20.5 mt -101.96 148.69 25.05 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.17 -0.956 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.654 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -133.25 82.56 2.0 Allowed 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.882 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.841 HG21 ' OH ' ' A' ' 8' ' ' TYR . 9.7 t -79.63 116.89 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.966 -1.084 . . . . 0.0 108.155 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.89 154.49 12.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.979 -1.075 . . . . 0.0 110.049 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -68.12 145.52 54.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.464 -0.772 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.86 -57.14 4.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -20.9 2.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.223 -1.163 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.613 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -90.11 -35.15 15.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 38' ' ' VAL . 38.5 t -90.28 1.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.753 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.07 4.53 9.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.913 . . . . 0.0 109.98 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.7 mt -96.36 -28.99 14.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.114 -0.991 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 125.34 9.11 5.16 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.898 ' CE2' HD12 ' A' ' 40' ' ' LEU . 23.2 m-85 -54.64 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.142 -1.211 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 80.3 p -125.15 -165.25 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.22 69.75 7.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 109.556 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.09 -31.76 0.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CG ' ' OG ' ' A' ' 43' ' ' SER . 41.4 mm-40 -68.96 -30.28 68.68 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.219 -1.165 . . . . 0.0 109.832 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -43.8 -35.92 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.97 . . . . 0.0 109.54 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.57 40.9 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -143.77 64.93 13.77 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.167 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.82 -42.35 53.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.188 1.925 . . . . 0.0 110.436 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 10.1 pt-20 -61.09 -34.67 75.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -98.42 -3.52 36.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.802 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 4.3 mt -79.92 -50.42 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 108.998 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 121.62 -71.26 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 29.0 m95 -146.42 127.24 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.423 -1.045 . . . . 0.0 109.709 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.662 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -116.21 143.7 45.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -101.63 111.69 24.01 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -138.62 -162.52 9.2 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.652 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 64' ' ' GLY . 36.6 t80 -124.07 104.54 8.93 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.708 -0.877 . . . . 0.0 110.359 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -79.2 96.87 6.01 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -58.63 -33.64 70.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -0.871 . . . . 0.0 110.94 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.801 HG21 ' OD1' ' A' ' 28' ' ' ASP . 11.6 m -49.01 -29.16 4.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 109.597 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' HB2' ' A' ' 65' ' ' GLU . 7.8 t -127.06 5.79 6.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 59' ' ' TYR . . . 52.08 49.6 48.85 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 63' ' ' THR . 35.3 mm-40 -124.98 145.43 49.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.182 -1.187 . . . . 0.0 109.575 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -126.1 125.59 42.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.321 -0.862 . . . . 0.0 109.258 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.581 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 176.88 -165.85 36.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -94.41 159.93 14.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -1.062 . . . . 0.0 109.529 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 56' ' ' LEU . 2.8 p90 -164.51 160.34 15.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.0 Cg_exo -59.98 116.5 3.35 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.102 1.868 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -66.23 -21.63 70.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.553 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 1.7 p -64.95 -16.92 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.975 -1.309 . . . . 0.0 109.81 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 9.1 m-30 -99.75 18.09 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.013 . . . . 0.0 110.414 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 71' ' ' GLY . 11.3 m -134.69 161.41 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 8.2 pt-20 -134.11 90.35 2.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.861 -1.15 . . . . 0.0 109.236 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 85.4 t80 -38.48 137.91 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -136.45 10.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -0.854 . . . . 0.0 109.136 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 91.91 -106.15 3.36 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -1.134 . . . . 0.0 109.386 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.485 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 178.37 -146.92 7.66 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 22.5 m-85 -132.0 139.03 48.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -1.016 . . . . 0.0 109.039 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.53 ' OE1' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.17 122.47 18.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.884 . . . . 0.0 109.479 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -118.57 177.11 4.95 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.114 -0.991 . . . . 0.0 109.854 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.46 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -117.1 123.09 45.94 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -49.02 106.21 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.421 -0.799 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 6.5 mt -83.5 -29.52 27.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.28 -0.888 . . . . 0.0 108.858 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -127.3 -175.48 3.45 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.455 -0.778 . . . . 0.0 109.67 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.28 179.49 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 18.0 t80 -175.0 113.1 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.353 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 146.72 30.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 18.4 tttp -53.14 112.47 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.62 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -114.5 -82.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -73.53 159.61 32.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.121 -0.987 . . . . 0.0 109.586 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -0.4 15.33 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 5.9 mt-10 -105.72 -4.96 20.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 18' ' ' ARG . 2.7 p-10 -112.14 167.6 10.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.969 -1.082 . . . . 0.0 109.643 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.623 HD12 HD22 ' A' ' 60' ' ' ASN . 7.2 pt -128.0 177.59 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.6 m-20 -69.28 163.85 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.433 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -161.15 147.71 14.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.362 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 1.6 m80 -156.87 146.12 20.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 10' ' ' ALA . 33.7 tp -53.04 143.2 18.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.253 -0.904 . . . . 0.0 109.765 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' H ' HD12 ' A' ' 26' ' ' LEU . . . 91.99 -31.8 5.74 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.2 t70 -58.52 158.76 7.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -1.088 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.839 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.5 mp -115.64 137.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 108.991 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' C ' ' A' ' 29' ' ' ILE . 8.6 mp -117.45 125.99 51.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 109.907 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -102.46 92.94 4.89 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.752 HG22 ' CA ' ' A' ' 58' ' ' GLY . 91.0 t -101.57 112.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.101 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 9.4 p-10 -51.5 -177.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.159 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -86.88 -28.56 22.76 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.95 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . -67.66 -56.74 10.37 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 9.9 t -43.88 -25.32 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -1.183 . . . . 0.0 109.995 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.729 HD12 HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -87.84 -40.11 14.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -0.972 . . . . 0.0 109.337 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 38' ' ' VAL . 77.3 t -77.91 -2.56 4.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.14 -34.67 14.73 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CB ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -81.14 -45.48 16.35 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.25 29.16 6.48 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CE1' ' CB ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.79 -79.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.714 -1.462 . . . . 0.0 108.099 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.61 157.07 24.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -84.34 68.73 10.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 108.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.03 -28.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG2' ' NE ' ' A' ' 49' ' ' ARG . 2.3 mt-30 -85.93 41.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -1.217 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 2.5 pm0 -90.1 1.87 55.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.311 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -113.15 39.81 2.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.658 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.49 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -160.2 62.78 1.87 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -61.9 -18.12 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.408 2.072 . . . . 0.0 110.371 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.82 -35.81 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.0 109.607 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -101.49 -0.85 34.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 109.722 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.638 HD12 HD21 ' A' ' 56' ' ' LEU . 21.6 mt -79.87 -33.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -76.34 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.475 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 23.0 m95 -137.01 157.28 47.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -1.066 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 37' ' ' LEU . 3.4 mp -143.39 154.75 44.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.845 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' O ' HG13 ' A' ' 32' ' ' VAL . 17.9 t-20 -114.37 109.67 18.7 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.752 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.61 -161.32 9.68 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.492 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 52.6 t80 -120.9 112.63 19.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.657 -0.907 . . . . 0.0 110.027 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.623 HD22 HD12 ' A' ' 22' ' ' ILE . 37.3 m-20 -79.79 80.37 6.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.87 -40.8 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 91.2 m -57.36 -43.03 83.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 3.7 p -93.35 0.96 57.09 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.312 -0.868 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.47 44.34 67.03 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 63' ' ' THR . 26.7 mt-10 -141.09 179.09 6.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.172 -1.193 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 15.3 ptt85 -152.49 146.18 25.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 109.505 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 163.4 -159.6 32.2 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.972 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -92.43 166.14 12.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.422 -1.046 . . . . 0.0 109.661 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.883 ' HE2' HG11 ' A' ' 74' ' ' VAL . 7.2 p90 -171.1 159.51 5.32 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.835 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.55 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -57.86 120.27 8.07 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.084 1.856 . . . . 0.0 110.116 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.973 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.67 -31.99 70.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 1.4 p -63.19 -18.99 64.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.908 -1.348 . . . . 0.0 109.372 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 10.7 m-30 -92.57 30.21 1.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.005 . . . . 0.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 71' ' ' GLY . 35.3 m -143.8 167.32 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 109.455 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 5.9 pt-20 -140.49 87.53 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.25 -0.906 . . . . 0.0 109.745 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.601 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 42.1 t80 -47.88 137.66 9.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 108.746 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.712 HG22 ' O ' ' A' ' 77' ' ' ILE . 70.5 mt -144.23 9.06 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.078 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . 159.27 -172.41 35.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.464 ' OXT' ' HB2' ' A' ' 7' ' ' GLN . 7.3 mtp180 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -1.072 . . . . 0.0 109.437 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.3 0.572 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 79' ' ' ARG . . . -89.52 -178.01 45.46 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.635 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 25.7 m-85 -80.23 133.25 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -1.122 . . . . 0.0 109.616 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.593 ' CG ' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -119.14 113.57 21.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.429 -0.795 . . . . 0.0 109.389 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.748 ' CE2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -105.07 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.078 -1.014 . . . . 0.0 108.963 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.825 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.7 mtt85 -120.55 137.89 54.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.0 108.871 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -56.77 109.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 110.241 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.605 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -93.68 -29.71 15.29 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -128.2 -169.64 2.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.952 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 57.3 p-10 -114.93 178.35 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 67.1 t80 172.92 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.279 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 7.0 tttp -79.76 153.39 29.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.471 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 2.3 pttt -77.51 78.16 4.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.562 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.02 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.202 -0.936 . . . . 0.0 109.249 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -54.97 142.74 28.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -57.72 -15.67 8.63 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.157 -0.964 . . . . 0.0 109.838 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.06 -32.49 33.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 109.9 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -88.29 146.54 25.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.109 -0.994 . . . . 0.0 109.274 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.855 HD11 ' ND2' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -107.59 -169.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.671 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -73.64 153.33 40.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.848 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.31 129.92 22.73 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.666 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -147.87 133.25 18.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.646 ' C ' HD23 ' A' ' 26' ' ' LEU . 3.8 tt -51.67 151.34 3.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.865 . . . . 0.0 109.721 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 26' ' ' LEU . . . 89.16 -10.95 71.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.744 ' CG ' HG21 ' A' ' 62' ' ' THR . 2.2 m-20 -90.27 -170.26 2.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.966 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.0 mt -148.53 151.32 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.966 HD12 ' C ' ' A' ' 29' ' ' ILE . 3.7 mp -134.67 130.24 36.03 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.049 -1.032 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -97.84 96.45 8.22 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 57' ' ' ASN . 51.3 t -101.46 116.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.884 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 8.1 t30 -53.12 147.41 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.322 -0.861 . . . . 0.0 108.95 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -2.77 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.138 -0.976 . . . . 0.0 109.797 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.94 -53.97 1.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 p -48.59 -22.5 0.77 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -1.132 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD13 ' A' ' 53' ' ' ILE . 5.4 tt -90.31 -34.86 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 0.0 109.557 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 38' ' ' VAL . 53.8 t -87.71 0.78 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.628 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.15 -13.75 13.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.805 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.1 mm? -96.12 -23.17 16.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.583 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 118.27 23.12 3.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.861 ' CE2' HG23 ' A' ' 53' ' ' ILE . 12.0 m-85 -46.97 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -1.096 . . . . 0.0 109.612 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.46 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 t -94.56 162.88 13.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.64 96.25 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.94 -8.13 9.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.92 0.19 57.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -1.183 . . . . 0.0 109.612 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.635 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 3.1 mp0 -90.4 21.02 4.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -114.56 -2.46 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -126.66 86.28 58.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.125 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.5 Cg_endo -61.2 -38.22 68.06 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.248 1.966 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.9 pm0 -59.15 -17.55 27.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.145 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -109.8 -11.39 14.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.076 HD13 HD11 ' A' ' 37' ' ' LEU . 32.6 mt -79.75 -50.17 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.43 -72.67 0.39 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 15.3 m95 -139.9 143.08 36.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -1.002 . . . . 0.0 109.472 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.865 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -135.86 152.27 50.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.88 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.732 ' O ' HG13 ' A' ' 32' ' ' VAL . 13.1 t-20 -115.28 111.2 20.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.723 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -134.88 -152.24 6.5 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.704 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 60.0 t80 -126.63 110.81 13.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.777 -0.837 . . . . 0.0 110.203 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.855 ' ND2' HD11 ' A' ' 22' ' ' ILE . 4.9 m-80 -78.53 82.95 4.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.919 -1.113 . . . . 0.0 108.822 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -52.17 -39.78 60.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.468 -0.77 . . . . 0.0 110.13 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.744 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.6 m -54.26 -46.33 72.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 109.787 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.666 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -105.93 13.29 29.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 39.81 54.43 2.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' HB3' HD13 ' A' ' 22' ' ' ILE . 2.8 mm-40 -136.9 120.17 16.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -1.185 . . . . 0.0 109.503 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 22' ' ' ILE . 7.2 ttp180 -92.76 151.0 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.57 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 154.09 -168.98 32.54 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.249 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -93.09 175.7 6.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.565 -0.962 . . . . 0.0 109.668 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.8 p90 -179.24 152.04 0.67 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.245 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.574 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -59.05 123.01 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.058 1.839 . . . . 0.0 109.958 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.865 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -69.41 -29.61 71.65 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.584 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 4.1 p -58.53 -15.01 9.39 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.839 -1.389 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.584 ' CE1' ' OG1' ' A' ' 72' ' ' THR . 7.5 m-30 -103.29 33.22 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.025 . . . . 0.0 110.378 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 71' ' ' GLY . 2.1 m -147.91 -179.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.102 -0.999 . . . . 0.0 109.495 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.552 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 9.6 pt-20 -151.06 90.37 1.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 49.7 t80 -52.66 123.15 10.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 109.044 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.825 HD12 ' CD ' ' A' ' 9' ' ' ARG . 8.6 mt -112.3 -14.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.584 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.56 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 147.96 177.62 22.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.313 -1.11 . . . . 0.0 109.449 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 119.45 -138.67 13.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.715 ' CG ' ' OH ' ' A' ' 76' ' ' TYR . 24.2 m-85 -79.31 140.25 37.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.418 -1.048 . . . . 0.0 108.643 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 mt-30 -147.24 125.18 11.99 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -120.53 177.99 4.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.564 ' CB ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -114.17 170.55 8.2 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -86.52 146.57 26.33 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.936 -1.103 . . . . 0.0 109.893 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 74' ' ' VAL . 13.3 mt -126.84 -36.99 2.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 2.5 m-85 -118.4 -163.22 0.94 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.941 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.68 170.11 10.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -174.52 116.69 0.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -86.94 34.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.938 -1.102 . . . . 0.0 110.298 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 17.4 tttt 41.55 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.88 . . . . 0.0 109.613 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 42.1 mm-40 -97.25 -49.56 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -76.81 149.96 36.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 41.8 tt0 -69.55 -4.11 17.65 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.161 -0.962 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' OE2' ' OD2' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -106.32 -15.12 14.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 110.201 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 51.4 p30 -99.09 165.56 11.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.974 -1.079 . . . . 0.0 109.671 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.771 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -121.29 177.07 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.709 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.515 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 1.7 m-20 -70.02 171.24 9.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.813 HD21 HD21 ' A' ' 30' ' ' LEU . 10.4 mt -164.76 144.97 7.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 109.048 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.927 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -158.95 125.0 4.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.43 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.02 129.96 12.17 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.16 -11.81 33.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.754 ' CG ' HG21 ' A' ' 62' ' ' THR . 4.4 m-20 -89.73 -170.87 2.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -1.131 . . . . 0.0 109.492 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.88 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -143.81 138.23 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.211 HD23 ' CE2' ' A' ' 69' ' ' PHE . 6.2 mp -116.81 124.22 49.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.467 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -96.28 103.08 14.96 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 110.648 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 96.2 t -113.8 100.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.808 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 p30 -57.73 -166.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.005 -1.06 . . . . 0.0 109.089 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -84.04 -27.18 28.51 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.027 -1.045 . . . . 0.0 110.622 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' N ' ' HG2' ' A' ' 34' ' ' LYS . . . -81.39 -53.85 3.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 33' ' ' ASN . 7.1 t -50.31 -22.46 1.81 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.069 -1.254 . . . . 0.0 109.437 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.652 HD12 HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -88.98 -44.36 10.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.31 -0.869 . . . . 0.0 108.683 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 38' ' ' VAL . 97.2 t -83.33 6.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -44.9 -28.08 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.668 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -100.1 -29.0 12.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 136.81 -40.07 1.56 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' A' ' 53' ' ' ILE . 8.2 m-85 38.81 -163.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.918 . . . . 0.0 109.453 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.48 145.17 31.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.877 -1.139 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -62.97 96.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 142.04 -28.23 2.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.481 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -90.41 -6.45 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -1.099 . . . . 0.0 109.32 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 2.7 mp0 -43.01 -60.03 1.79 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.361 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -84.92 46.7 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.501 -0.75 . . . . 0.0 109.859 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.02 61.51 21.73 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.8 Cg_exo -54.97 -48.62 20.16 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.44 2.093 . . . . 0.0 110.897 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 72' ' ' THR . 1.1 mp0 -67.89 -34.62 76.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.158 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 1.66 56.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.958 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.834 HD13 HD21 ' A' ' 56' ' ' LEU . 2.7 mt -88.95 -45.17 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 117.06 -70.63 0.29 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 15.5 m95 -149.19 128.76 13.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -1.025 . . . . 0.0 109.078 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.834 HD21 HD13 ' A' ' 53' ' ' ILE . 1.4 mp -119.14 140.8 49.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -94.77 101.83 13.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.4 179.37 16.98 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.118 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.6 t80 -104.69 117.7 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.869 -0.783 . . . . 0.0 109.352 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -78.95 77.94 5.41 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.245 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -55.97 -36.12 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.754 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.9 m -62.95 -31.85 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 109.949 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.927 HG21 ' HE1' ' A' ' 25' ' ' HIS . 6.9 p -119.14 19.2 12.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 40.98 54.64 3.6 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -130.0 179.64 5.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.141 -1.211 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 19.7 ttp85 -160.47 123.02 3.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.771 ' N ' HD13 ' A' ' 22' ' ' ILE . . . 177.2 -167.67 39.01 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.277 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 63.1 m-20 -95.26 161.83 13.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.483 -1.01 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 1.211 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -162.31 162.99 19.12 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.619 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.573 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 5.9 Cg_exo -59.5 113.84 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.818 1.679 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -62.99 -35.26 91.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 51' ' ' GLU . 28.6 p -60.65 -13.68 16.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.788 -1.419 . . . . 0.0 110.118 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.573 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 7.7 m-30 -97.54 15.78 22.29 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.976 -1.077 . . . . 0.0 112.087 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.2 m -126.81 -179.73 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.633 -1.292 . . . . 0.0 109.951 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.568 ' OE1' HD21 ' A' ' 11' ' ' LEU . 4.2 pt-20 -143.72 91.67 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.453 -0.779 . . . . 0.0 109.103 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' OH ' ' CG ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -31.58 162.58 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.256 1.027 . . . . 0.0 112.961 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 77' ' ' ILE . 34.3 mm -155.01 14.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.438 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -118.33 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 mtt85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 7.0 pt-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.442 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . -178.61 -166.96 35.61 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 31.1 m-85 -80.09 112.65 17.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -1.146 . . . . 0.0 109.548 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 2.6 mt-30 -98.98 121.34 40.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.68 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.67 175.58 5.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.075 -1.016 . . . . 0.0 109.653 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 36.4 ttt180 -114.85 141.46 47.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -68.06 108.41 3.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.946 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.613 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.1 mt -82.0 -31.26 31.16 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.5 m-85 -129.77 -160.15 1.01 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.48 -0.763 . . . . 0.0 109.468 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -134.41 109.85 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB3' HD21 ' A' ' 24' ' ' LEU . 66.4 t80 -105.07 128.89 53.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.93 158.47 26.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.891 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' CE ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -80.83 72.63 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.033 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.016 . . . . 0.0 108.821 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -90.51 159.09 16.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.132 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HA ' ' CE ' ' A' ' 16' ' ' LYS . 32.3 tp10 -55.3 -28.75 55.7 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -53.2 -40.6 64.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.019 -1.051 . . . . 0.0 109.999 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -99.93 162.5 12.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.816 HG21 ' C ' ' A' ' 66' ' ' ARG . 35.6 pt -114.75 -168.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.925 . . . . 0.0 110.176 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -99.24 99.31 10.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 0.0 109.379 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -110.17 147.1 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 108.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -145.91 148.23 32.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.573 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -48.5 136.32 13.05 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.354 -0.841 . . . . 0.0 109.785 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 93.49 -5.03 73.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 6.7 t0 -90.39 145.9 24.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -1.132 . . . . 0.0 109.514 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.8 mm -96.58 132.06 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -0.923 . . . . 0.0 109.211 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.646 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 8.4 mp -110.34 114.56 28.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.319 -0.863 . . . . 0.0 108.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -92.16 96.86 10.56 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.902 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.68 HG11 ' OH ' ' A' ' 8' ' ' TYR . 64.3 t -102.59 108.05 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.885 . . . . 0.0 109.375 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 4.8 t30 -47.6 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -71.81 -62.76 1.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.39 -42.54 99.7 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 33' ' ' ASN . 34.7 m -52.21 -19.8 2.23 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.351 -1.088 . . . . 0.0 109.827 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.887 ' O ' HD23 ' A' ' 37' ' ' LEU . 5.6 tt -88.96 -36.08 16.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 38' ' ' VAL . 40.2 t -90.42 1.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.28 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.17 47.88 1.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.887 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 51.42 56.61 14.44 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.799 ' CE2' HG23 ' A' ' 53' ' ' ILE . 3.8 m-85 -89.04 -166.89 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 46' ' ' GLN . 7.2 t -133.65 141.9 47.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 108.984 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -59.35 90.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.63 -30.48 1.03 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.753 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -88.23 34.4 0.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.683 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' OE1' ' OH ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -90.14 -17.45 27.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 76' ' ' TYR . . . -126.16 14.77 7.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.2 mtt180 -121.66 74.8 34.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.609 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.1 Cg_exo -54.45 -52.79 7.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.197 1.931 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -52.39 -28.21 18.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 49' ' ' ARG . 2.7 mt-10 -109.43 44.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.7 mt -130.98 -42.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -0.844 . . . . 0.0 108.894 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 112.47 -76.52 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 32.7 m95 -147.35 131.33 17.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -1.068 . . . . 0.0 109.244 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.793 HD11 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -117.67 160.45 21.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 0.0 109.852 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 13.8 t-20 -113.0 111.19 21.75 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.593 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.17 -170.57 12.47 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.45 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 61.4 t80 -116.78 113.22 22.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.572 -0.958 . . . . 0.0 110.188 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.622 ' ND2' HD11 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -79.27 77.98 5.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 61' ' ' GLU . 3.7 tm-20 -52.92 -36.32 59.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.458 -0.776 . . . . 0.0 110.289 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 20.8 m -55.23 -38.48 68.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 109.982 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.6 OUTLIER -113.01 20.48 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 109.948 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.48 53.88 4.94 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.79 172.08 13.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.816 ' C ' HG21 ' A' ' 22' ' ' ILE . 32.2 ttm-85 -156.19 144.6 19.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.564 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 159.78 -152.95 23.93 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.025 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 72.7 m-20 -100.65 162.46 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -1.025 . . . . 0.0 109.916 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.646 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 1.9 p90 -161.97 158.97 21.85 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.2 Cg_exo -58.84 125.73 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.093 1.862 . . . . 0.0 110.146 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.793 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -68.26 -44.16 76.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 51' ' ' GLU . 33.5 p -61.68 -12.12 14.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.998 -1.296 . . . . 0.0 109.615 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.4 m-85 -92.95 18.58 8.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.996 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 71' ' ' GLY . 12.4 m -140.02 -176.04 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.219 -0.926 . . . . 0.0 109.793 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 1.039 ' O ' HD12 ' A' ' 77' ' ' ILE . 7.8 pt-20 -155.1 89.28 1.21 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.51 ' CE1' ' HB3' ' A' ' 6' ' ' TYR . 48.8 t80 -46.14 120.68 2.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.039 HD12 ' O ' ' A' ' 75' ' ' GLU . 1.1 mp -152.36 20.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.56 111.57 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.46 ' NH1' ' HB2' ' A' ' 79' ' ' ARG . 12.1 mtm105 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.13 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 120.82 -167.69 13.96 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' TYR . 25.3 m-85 -79.55 93.35 5.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -1.12 . . . . 0.0 109.75 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.752 ' HG2' HG23 ' A' ' 31' ' ' THR . 1.9 mt-30 -89.69 129.97 36.03 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 0.0 108.622 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -102.35 179.05 4.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.924 -1.11 . . . . 0.0 109.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -117.38 136.33 53.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -76.31 137.76 40.07 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 110.436 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.975 HD21 ' C ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -122.94 -32.66 3.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.498 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 m-85 -112.74 -163.13 0.83 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -137.51 112.6 9.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.965 -1.084 . . . . 0.0 110.153 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 17.2 t80 -100.42 158.33 15.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.052 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -110.77 149.61 30.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 0.0 109.42 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 23' ' ' ASP . 14.9 tttp -82.23 70.77 9.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -55.94 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -79.76 142.28 35.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -0.892 . . . . 0.0 109.416 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -64.08 -9.75 18.22 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.213 -0.93 . . . . 0.0 109.935 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 3.3 mm-40 -103.82 19.7 19.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.983 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 11.6 p-10 -124.71 172.51 9.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.881 HD12 HD21 ' A' ' 60' ' ' ASN . 0.5 OUTLIER -130.9 154.87 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 2.9 m-20 -68.94 110.34 4.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.567 HD11 HD21 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -104.55 148.92 25.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.201 -0.937 . . . . 0.0 109.277 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -160.17 130.47 5.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.175 -0.953 . . . . 0.0 109.372 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -42.93 137.14 2.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.322 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.59 -1.07 81.12 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.789 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 37.2 t0 -90.72 131.59 36.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.426 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 46.2 mm -87.99 132.96 31.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.973 -1.079 . . . . 0.0 109.284 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.671 HD23 ' CE2' ' A' ' 69' ' ' PHE . 9.0 mp -107.68 139.87 41.58 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.325 -0.86 . . . . 0.0 108.993 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.752 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -116.29 99.25 7.07 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.468 -0.77 . . . . 0.0 110.005 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 52.6 t -107.74 95.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 73.8 m-20 -45.42 136.1 5.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 109.953 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -70.14 160.77 31.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.44 -60.82 4.5 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -20.65 55.78 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.377 -1.072 . . . . 0.0 108.513 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 47' ' ' GLU . 4.5 tp -85.68 -29.32 24.08 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 38' ' ' VAL . 38.9 t -84.77 -1.23 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.468 -0.77 . . . . 0.0 109.733 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -73.71 -0.41 15.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -103.98 12.75 33.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 109.648 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.03 39.74 15.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 53' ' ' ILE . 17.2 m-85 -72.35 -168.92 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.662 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HG3' ' A' ' 46' ' ' GLN . 94.9 p -125.51 166.04 17.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.365 -0.835 . . . . 0.0 109.287 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -72.27 98.58 2.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.646 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.22 13.27 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.464 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.6 mt-30 -89.89 -21.91 22.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -1.22 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.658 ' HA ' HD21 ' A' ' 37' ' ' LEU . 3.5 pt-20 -65.7 -8.27 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.274 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' C ' ' HD3' ' A' ' 50' ' ' PRO . . . -108.11 -4.97 17.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.981 -1.074 . . . . 0.0 110.036 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.501 ' O ' HG13 ' A' ' 53' ' ' ILE . 32.5 mmt-85 -117.96 72.33 8.7 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 5.9 Cg_exo -54.2 -33.19 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.279 1.986 . . . . 0.0 110.459 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 72' ' ' THR . 3.0 pt-20 -64.21 -40.16 95.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.115 -0.99 . . . . 0.0 109.056 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.489 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 61.7 mt-10 -85.33 4.76 33.65 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 109.526 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.642 HD12 HD21 ' A' ' 56' ' ' LEU . 8.6 mt -94.24 -52.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -77.04 0.3 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.435 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 14.2 m95 -134.09 147.2 50.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -1.028 . . . . 0.0 109.063 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.812 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -140.38 158.24 44.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.981 . . . . 0.0 110.09 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 28.5 t-20 -113.9 109.35 18.37 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -132.74 -161.3 9.86 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.66 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 54.1 t80 -127.18 114.19 17.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.764 -0.845 . . . . 0.0 110.182 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.881 HD21 HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -79.75 96.35 6.24 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.121 -0.987 . . . . 0.0 108.615 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -60.35 -40.87 92.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.439 ' HB ' ' CG ' ' A' ' 28' ' ' ASP . 22.9 m -59.28 -22.12 60.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.988 -1.07 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.599 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -120.62 6.12 10.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 45.01 37.66 5.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' OE2' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -114.76 173.86 6.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.168 . . . . 0.0 109.462 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 1.6 ttp85 -153.25 130.87 11.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.137 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 169.55 -158.04 30.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.174 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-20 -92.79 165.46 12.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.478 -1.013 . . . . 0.0 110.0 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.671 ' CE2' HD23 ' A' ' 30' ' ' LEU . 4.3 p90 -171.79 153.13 3.24 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.503 -0.748 . . . . 0.0 109.125 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.599 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.3 Cg_exo -60.96 123.35 12.76 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.025 1.817 . . . . 0.0 110.063 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.812 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -30.3 65.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.604 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.3 p -67.02 -7.88 25.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -1.207 . . . . 0.0 109.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.1 m-85 -98.67 10.88 40.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.975 ' C ' HD21 ' A' ' 11' ' ' LEU . 2.9 m -130.9 -165.96 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.755 0.788 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.583 ' CD ' HD23 ' A' ' 11' ' ' LEU . 8.2 pt-20 -160.05 90.84 0.92 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.577 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 49.8 t80 -38.16 120.6 0.89 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.506 -0.747 . . . . 0.0 109.582 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.508 ' CG1' ' HB2' ' A' ' 9' ' ' ARG . 45.8 mm -106.62 -19.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.97 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.577 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 129.27 -130.32 6.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.26 -1.141 . . . . 0.0 109.449 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' OE1' ' HD3' ' A' ' 34' ' ' LYS . 6.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.58 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 137.98 -170.52 23.73 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 39.1 m-85 -148.35 111.98 5.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -1.155 . . . . 0.0 109.419 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.544 ' OE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -99.83 120.24 39.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.557 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -107.1 178.59 4.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.975 -1.078 . . . . 0.0 109.868 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.94 147.96 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . . . -75.51 106.64 7.16 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 110.126 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 8.7 mt -84.97 -26.34 27.21 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 23.5 m-85 -135.82 -160.71 1.08 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.538 -0.726 . . . . 0.0 109.711 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HA ' ' C ' ' A' ' 24' ' ' LEU . 10.1 p-10 -135.67 143.26 45.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.593 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CZ ' ' OE2' ' A' ' 17' ' ' GLU . 10.7 t80 -116.67 163.91 15.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.188 -0.945 . . . . 0.0 108.626 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 8.9 mmtt -104.57 -19.58 13.95 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.053 -1.03 . . . . 0.0 110.551 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER 75.24 81.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.068 . . . . 0.0 109.236 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' OE2' ' CZ ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -84.42 -54.96 4.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.881 . . . . 0.0 109.731 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' ' HG2' ' A' ' 20' ' ' GLU . 1.1 tpt180 -87.97 162.35 16.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.71 -3.6 19.4 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' ARG . 7.1 pt-20 -99.61 14.81 28.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.083 -1.011 . . . . 0.0 109.773 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.531 ' O ' ' CG ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -127.68 163.42 24.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.149 -0.969 . . . . 0.0 109.417 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -128.33 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.128 -0.983 . . . . 0.0 110.116 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.576 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -58.99 119.45 7.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 30' ' ' LEU . 2.2 mm? -97.28 159.38 14.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 109.169 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.1 m80 -159.44 125.38 4.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.865 . . . . 0.0 109.4 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 10' ' ' ALA . 2.8 tp -50.62 128.29 20.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.74 28.28 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.941 -1.123 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.729 ' CG ' ' HB2' ' A' ' 10' ' ' ALA . 2.3 p30 -90.02 -179.9 5.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.272 . . . . 0.0 109.967 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.858 ' C ' HD12 ' A' ' 30' ' ' LEU . 33.5 mm -127.54 149.2 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.074 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.3 mp -123.84 123.34 40.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.013 -1.054 . . . . 0.0 110.387 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -99.7 86.61 3.36 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 57' ' ' ASN . 67.7 t -96.56 116.35 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -56.52 162.83 2.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -0.939 . . . . 0.0 108.475 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD3' ' OE1' ' A' ' 4' ' ' GLU . 11.7 ptmt -90.5 -25.61 20.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.01 -1.056 . . . . 0.0 110.327 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.65 -58.83 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -50.19 -22.97 1.92 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -1.151 . . . . 0.0 110.05 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.015 HD13 ' OE1' ' A' ' 47' ' ' GLU . 4.1 tt -90.31 -32.73 16.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 109.707 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 38' ' ' VAL . 51.3 t -82.34 -0.39 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 109.751 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.2 -21.18 3.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 109.198 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.14 37.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 109.516 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.96 49.58 17.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.558 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 2.3 m-85 -59.38 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.177 -1.19 . . . . 0.0 109.267 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -128.56 150.79 50.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.138 -0.977 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.55 120.81 10.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.07 -33.41 6.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.504 ' O ' ' CG1' ' A' ' 53' ' ' ILE . 10.2 mt-30 -65.9 -11.93 50.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -1.147 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 1.015 ' OE1' HD13 ' A' ' 37' ' ' LEU . 14.9 mm-40 -81.13 -22.38 39.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.626 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.18 -4.96 58.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.1 mmp_? -117.14 74.13 7.27 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' CB ' HG23 ' A' ' 74' ' ' VAL . 5.7 Cg_exo -54.99 -32.17 77.7 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.2 1.934 . . . . 0.0 110.489 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 6.7 pt-20 -62.24 -35.98 80.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.942 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.3 mt-10 -95.57 -3.74 45.92 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.162 -0.961 . . . . 0.0 110.017 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.717 HD12 HD21 ' A' ' 56' ' ' LEU . 31.6 mt -79.6 -36.92 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 109.361 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 108.15 -76.52 0.22 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m95 -143.77 132.81 22.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -1.137 . . . . 0.0 109.326 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -117.42 142.3 47.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.798 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.687 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -105.97 111.77 24.55 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.568 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -139.49 -161.27 8.66 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.413 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 65' ' ' GLU . 67.2 t80 -115.5 114.22 24.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.626 -0.926 . . . . 0.0 110.553 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' OD1' ' CD1' ' A' ' 30' ' ' LEU . 2.1 m-20 -78.09 79.02 4.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.182 -0.949 . . . . 0.0 108.477 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -42.68 -44.69 4.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.458 -0.776 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 3.4 m -46.57 -69.82 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.105 -0.997 . . . . 0.0 109.876 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.543 ' CG2' ' HG3' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -81.05 6.03 14.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.971 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.42 48.43 60.17 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.576 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 2.7 mt-10 -121.27 173.11 7.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.027 -1.278 . . . . 0.0 109.282 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.58 118.0 6.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 109.341 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . -176.4 -150.76 8.38 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 22' ' ' ILE . 7.5 m-20 -108.83 165.21 11.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -1.056 . . . . 0.0 109.829 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 1.074 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.9 p90 -165.87 161.82 13.02 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.385 -0.822 . . . . 0.0 109.011 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.595 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.8 Cg_exo -57.92 126.92 23.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.936 1.757 . . . . 0.0 110.033 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.98 -33.97 62.24 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 72' ' ' THR . 2.0 p -65.48 -9.03 22.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.083 -1.245 . . . . 0.0 109.218 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.595 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -98.3 16.4 21.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.899 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.652 HG11 HD22 ' A' ' 30' ' ' LEU . 6.1 m -136.49 -175.45 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.18 -0.95 . . . . 0.0 109.612 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 77' ' ' ILE . 11.3 pt-20 -156.61 87.26 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.87 . . . . 0.0 109.808 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.522 ' N ' ' HB3' ' A' ' 8' ' ' TYR . 58.3 t80 -46.18 135.8 7.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.369 -0.832 . . . . 0.0 109.753 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -135.38 17.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.067 -1.021 . . . . 0.0 109.468 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' HA2' ' OH ' ' A' ' 76' ' ' TYR . . . 116.52 -147.17 18.91 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.236 -1.155 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 124.85 178.56 15.37 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 87.9 m-85 -79.58 121.21 24.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.46 -1.024 . . . . 0.0 108.885 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.627 ' CG ' HG23 ' A' ' 31' ' ' THR . 1.3 mt-30 -118.87 115.67 24.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.883 -1.136 . . . . 0.0 110.154 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -105.99 -178.98 3.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.905 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -121.64 132.43 54.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.731 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -57.65 164.43 2.05 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 109.932 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 74' ' ' VAL . 14.1 mt -138.49 -40.3 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.603 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -117.3 -159.66 0.74 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.128 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 11.5 p-10 -119.71 168.18 11.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 110.275 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CB ' ' CD2' ' A' ' 24' ' ' LEU . 2.0 t80 -171.91 119.22 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.509 -0.744 . . . . 0.0 109.195 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' LYS . 16.8 mttm -93.67 49.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.833 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 9.7 ttmt 42.2 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 3.2 mt-10 -73.23 -81.7 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.276 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 8.1 mmt180 -88.96 150.52 22.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.876 . . . . 0.0 109.388 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -47.12 -23.35 0.49 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.823 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.77 -48.68 68.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.965 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 34.7 p30 -82.38 173.15 12.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -127.71 -171.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 109.81 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.0 m-20 -93.75 115.04 27.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -121.32 150.21 41.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.856 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -150.21 149.36 30.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.047 -1.033 . . . . 0.0 109.769 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.1 tp -42.47 136.46 2.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 85.62 2.28 87.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.731 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 13.5 t0 -90.41 117.25 28.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -1.174 . . . . 0.0 109.213 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.764 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.8 mp -79.97 134.98 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.025 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 6.9 mp -113.46 136.8 52.39 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -115.65 89.31 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 111.008 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.894 HG11 HD12 ' A' ' 37' ' ' LEU . 1.5 t -89.4 106.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 108.841 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -50.75 157.94 0.72 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HG3' ' HA2' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -73.3 156.28 38.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 -56.93 4.83 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -51.04 -23.28 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.218 -1.166 . . . . 0.0 109.66 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.894 HD12 HG11 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -90.49 -34.21 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 38' ' ' VAL . 52.5 t -89.13 1.79 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.746 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.502 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.62 -8.21 25.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.861 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -105.76 18.62 21.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.311 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.77 38.78 60.7 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.707 ' CE1' HD23 ' A' ' 40' ' ' LEU . 5.6 m-85 -57.8 -168.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.525 ' O ' ' C ' ' A' ' 44' ' ' ASP . 27.2 t -125.08 97.69 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.72 93.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.297 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.03 -14.76 4.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 43' ' ' SER . 5.8 mt-30 -90.68 2.14 56.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -1.156 . . . . 0.0 109.778 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 1.3 mp0 -65.7 -23.23 66.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -103.21 19.04 20.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 109.526 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HG13 ' A' ' 53' ' ' ILE . 7.1 mmt180 -130.93 65.2 76.16 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.212 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 5.1 Cg_exo -58.38 -33.49 97.86 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.162 1.908 . . . . 0.0 110.342 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 21.1 pt-20 -58.61 -29.8 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 109.597 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.57 -0.13 24.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.704 HG23 ' CE2' ' A' ' 42' ' ' PHE . 6.2 mt -79.92 -39.22 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.362 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 111.66 -73.45 0.21 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.583 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 11.2 m95 -148.1 140.98 24.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.467 -1.02 . . . . 0.0 109.123 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.642 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -130.8 132.9 45.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.049 -1.032 . . . . 0.0 110.019 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -99.82 105.37 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.554 ' HA3' HG23 ' A' ' 32' ' ' VAL . . . -131.6 -156.2 8.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.621 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -115.66 111.49 20.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.451 -1.029 . . . . 0.0 110.774 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' HD11 ' A' ' 30' ' ' LEU . 3.2 m-80 -79.59 80.4 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 108.603 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -44.56 -44.84 9.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 110.568 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -46.49 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.03 . . . . 0.0 109.957 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.856 HG21 ' CE1' ' A' ' 25' ' ' HIS . 14.7 p -83.36 12.71 5.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.87 43.31 6.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' OE1' HG22 ' A' ' 22' ' ' ILE . 0.9 OUTLIER -121.91 117.14 25.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -1.141 . . . . 0.0 109.314 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 15.9 ttm180 -94.99 138.06 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.633 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.501 ' CA ' HG12 ' A' ' 22' ' ' ILE . . . 168.18 -174.0 43.01 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.248 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -90.02 152.82 21.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.72 -0.871 . . . . 0.0 109.859 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 1.025 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 2.5 p90 -155.36 161.16 30.06 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.473 -0.767 . . . . 0.0 109.121 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.67 127.42 23.54 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 121.929 1.753 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.12 -32.29 63.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -69.56 -8.66 49.2 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.239 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.69 -1.24 50.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.73 ' O ' HD12 ' A' ' 11' ' ' LEU . 5.9 m -122.73 -174.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 11' ' ' LEU . 2.5 pt-20 -156.75 88.66 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.59 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 81.9 t80 -34.48 128.94 0.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.242 0.544 . . . . 0.0 109.973 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -116.78 0.86 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.187 -0.946 . . . . 0.0 109.396 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.59 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 97.95 -115.02 5.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . -160.79 156.28 27.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 7.3 m-85 -81.76 141.74 33.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.438 -1.037 . . . . 0.0 108.975 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.635 ' CG ' HG23 ' A' ' 31' ' ' THR . 2.9 mt-30 -144.88 116.81 8.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.803 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -110.94 179.78 3.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.301 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.544 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 12.6 mtm180 -114.83 168.72 9.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.328 -0.858 . . . . 0.0 108.889 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -90.2 97.77 11.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.924 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.1 mt -67.51 -30.72 70.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.086 -1.008 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.9 m-85 -129.47 -168.11 1.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.439 -0.788 . . . . 0.0 109.725 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -130.79 98.25 4.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.537 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 32.1 t80 -88.41 152.29 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.785 . . . . 0.0 109.323 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 151.69 20.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.953 . . . . 0.0 109.425 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 30.6 ttpt -72.92 85.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.408 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' CG ' ' OH ' ' A' ' 14' ' ' TYR . 1.7 pp20? -117.86 -35.22 3.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.675 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -71.99 138.38 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.588 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.1 tt0 -56.41 -15.89 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 3.5 tt0 -129.65 36.98 4.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 110.11 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 18' ' ' ARG . 1.1 p-10 -122.53 161.66 23.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.062 -1.024 . . . . 0.0 109.531 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.823 HG13 HD21 ' A' ' 24' ' ' LEU . 1.6 pt -116.11 170.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.92 . . . . 0.0 109.021 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.574 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -79.51 100.8 7.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 0.0 109.218 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.9 HD11 HD21 ' A' ' 30' ' ' LEU . 3.5 mm? -88.06 133.42 33.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 1.8 m80 -135.08 139.2 44.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.895 . . . . 0.0 109.543 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 2.6 tt -56.33 123.37 14.39 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.35 -0.844 . . . . 0.0 109.916 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.93 -5.56 39.71 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -90.34 167.04 12.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 109.066 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.925 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mp -125.52 147.71 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.925 HD12 ' C ' ' A' ' 29' ' ' ILE . 5.9 mp -122.77 127.55 49.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.237 -0.914 . . . . 0.0 108.789 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.635 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -97.91 93.65 6.45 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 109.942 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 87.4 t -90.31 114.39 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -58.02 173.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 109.751 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -37.66 66.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.275 -0.89 . . . . 0.0 109.741 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.56 -44.09 8.81 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 79.2 p -51.83 -21.43 2.87 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.998 HD13 ' O ' ' A' ' 37' ' ' LEU . 1.6 tm? -85.21 -35.97 21.27 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.341 -0.849 . . . . 0.0 109.457 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 38' ' ' VAL . 79.5 t -85.68 4.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.193 -0.942 . . . . 0.0 109.768 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -66.83 -5.19 11.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.264 -0.897 . . . . 0.0 110.217 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.121 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -100.16 -45.21 5.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 0.0 109.166 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 123.95 17.16 3.13 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.121 ' CE2' HD23 ' A' ' 40' ' ' LEU . 10.0 m-85 -59.37 -151.22 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 108.969 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.58 166.62 16.36 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.311 -0.868 . . . . 0.0 108.854 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -65.65 87.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.03 -17.15 1.37 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.75 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -89.55 20.91 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.235 . . . . 0.0 109.629 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.646 ' OE2' HG23 ' A' ' 38' ' ' VAL . 13.1 mt-10 -89.75 -43.11 10.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.866 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -88.92 38.47 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 tpt180 -156.25 66.55 4.33 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.924 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HG2' HG23 ' A' ' 74' ' ' VAL . 3.1 Cg_exo -59.64 -46.43 20.53 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.244 1.963 . . . . 0.0 110.413 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -44.31 -26.69 0.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.244 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tt0 -111.64 50.57 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.178 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.75 HD11 ' O ' ' A' ' 46' ' ' GLN . 57.9 mt -141.85 -69.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 142.03 -63.31 0.51 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 43.0 m95 -152.33 140.08 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -1.088 . . . . 0.0 109.38 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.714 HD21 HD12 ' A' ' 53' ' ' ILE . 0.6 OUTLIER -131.66 159.87 37.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.938 . . . . 0.0 109.763 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 3.4 t-20 -114.29 110.38 19.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.18 -168.85 12.29 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.203 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 66' ' ' ARG . 40.0 t80 -111.52 114.66 27.89 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.754 HD21 HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.63 75.21 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.028 . . . . 0.0 108.952 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.22 -33.88 21.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.401 -0.812 . . . . 0.0 109.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 16.4 m -55.39 -45.22 76.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.559 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -113.99 18.0 17.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.657 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.65 39.48 4.67 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 60' ' ' ASN . 11.5 mt-10 -123.7 109.04 13.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.146 . . . . 0.0 109.135 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 59' ' ' TYR . 17.6 ptt180 -92.63 143.97 25.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.729 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 168.67 -162.24 36.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -93.87 163.4 13.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -1.042 . . . . 0.0 109.382 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.724 ' CE2' HG11 ' A' ' 74' ' ' VAL . 3.8 p90 -163.63 158.64 17.25 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.76 124.43 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.133 1.888 . . . . 0.0 109.973 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.74 -40.92 85.01 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p -65.08 -12.06 46.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -1.204 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.0 m-85 -94.2 15.25 17.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.782 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.1 m -132.37 179.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 8.4 pt-20 -151.5 88.43 1.43 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 38.1 t80 -45.08 122.64 3.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 77' ' ' ILE . 74.7 mt -148.36 27.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -150.19 120.68 1.16 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.268 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.501 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 20.2 mtt85 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.464 -1.021 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 79' ' ' ARG . . . -163.57 -161.54 12.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.717 ' HB3' ' CZ ' ' A' ' 76' ' ' TYR . 23.5 m-85 -78.1 113.52 16.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.06 . . . . 0.0 109.384 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.1 mt-30 -108.99 123.75 49.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.153 -0.967 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.67 179.23 4.33 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.963 -1.085 . . . . 0.0 108.657 179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 1.3 mtt180 -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -58.31 122.9 14.36 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.037 -1.039 . . . . 0.0 109.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.586 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 6.8 mt -99.31 -34.07 10.47 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.0 m-85 -123.23 -166.72 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -0.807 . . . . 0.0 109.902 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 25' ' ' HIS . 45.8 p30 -108.38 165.44 11.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.915 . . . . 0.0 109.839 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.807 ' HB2' HD22 ' A' ' 24' ' ' LEU . 7.7 t80 -173.81 106.89 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.405 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 12.5 ptmm? -83.57 11.58 6.95 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.649 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 69.72 115.69 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.223 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -90.66 -64.07 1.18 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.29 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.17 162.09 15.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.76 -10.87 22.06 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -77.96 -25.61 48.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -105.04 161.55 14.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 66' ' ' ARG . 1.4 pp -118.84 -176.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.465 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 4.7 m-20 -73.92 -179.83 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.807 HD22 ' HB2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 172.91 152.68 0.08 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.543 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.51 144.35 18.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 11' ' ' LEU . 2.2 tt -48.9 148.21 2.36 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.923 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 83.57 -7.34 69.38 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 1.001 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.0 m-20 -88.06 -175.25 5.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.001 HD12 ' C ' ' A' ' 28' ' ' ASP . 2.4 mp -137.5 146.6 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.186 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.918 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.6 mp -122.38 120.84 35.18 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.228 -0.92 . . . . 0.0 109.125 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.93 91.49 7.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.864 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.672 HG11 ' OH ' ' A' ' 8' ' ' TYR . 87.8 t -99.87 110.63 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.0 109.024 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 97.0 m-20 -63.4 147.77 50.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.789 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 161.66 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.353 -0.842 . . . . 0.0 109.573 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 -59.87 4.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.4 m -52.66 -24.98 9.54 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.216 -1.167 . . . . 0.0 109.184 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.866 ' O ' HD23 ' A' ' 37' ' ' LEU . 3.2 tt -90.27 -29.36 18.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.397 -0.814 . . . . 0.0 109.347 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 38' ' ' VAL . 96.8 t -89.2 0.56 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.872 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.34 -8.33 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.9 OUTLIER -91.99 -17.07 25.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 109.718 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.38 23.07 3.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 37' ' ' LEU . 5.2 m-85 -57.36 -171.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -1.15 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.9 -173.67 2.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.377 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.36 87.36 7.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 -31.78 2.5 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -53.8 -20.38 5.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.51 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.61 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -49.97 -54.47 19.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HA ' ' CD1' ' A' ' 76' ' ' TYR . . . -85.31 59.31 5.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.431 -0.793 . . . . 0.0 110.033 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -153.06 57.49 2.03 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 3.3 Cg_exo -49.85 -46.89 25.56 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.774 ' HA ' HG22 ' A' ' 72' ' ' THR . 8.4 pt-20 -60.2 -33.68 72.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.06 -1.025 . . . . 0.0 109.311 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' CD ' ' HG2' ' A' ' 49' ' ' ARG . 5.4 mt-10 -99.89 1.82 43.19 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 50' ' ' PRO . 2.5 mt -94.36 -34.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 108.895 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.39 -80.52 0.31 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -140.56 144.77 36.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -1.082 . . . . 0.0 109.083 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.816 HD23 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -128.77 159.83 34.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 15.6 t-20 -118.41 114.47 22.96 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -135.9 -160.01 8.71 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.291 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 44.5 t80 -126.17 110.03 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.669 -0.901 . . . . 0.0 109.787 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 1.2 m-20 -79.29 85.49 5.13 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.128 -0.982 . . . . 0.0 109.371 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.49 -34.94 69.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.911 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.761 HG21 ' CG ' ' A' ' 28' ' ' ASP . 24.4 m -51.12 -33.82 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.639 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 65' ' ' GLU . 5.6 t -121.74 7.07 9.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.621 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.62 47.0 87.91 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 63' ' ' THR . 81.5 mm-40 -118.26 163.22 17.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -1.187 . . . . 0.0 109.379 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.655 ' O ' HG21 ' A' ' 22' ' ' ILE . 9.1 ttp180 -148.47 127.72 12.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 167.09 -159.42 32.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.603 -1.284 . . . . 0.0 109.952 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER -96.08 167.38 11.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.804 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 4.3 p90 -165.57 159.71 13.67 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.231 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.1 Cg_exo -61.62 122.55 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.073 1.848 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -41.83 73.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 51' ' ' GLU . 2.4 p -60.46 -12.18 8.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.316 . . . . 0.0 109.408 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.6 m-85 -98.56 22.12 10.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.127 -0.983 . . . . 0.0 110.533 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 71' ' ' GLY . 15.4 m -138.39 -172.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 6.4 pt-20 -148.55 84.07 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CZ ' ' HB3' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -32.54 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.758 0.79 . . . . 0.0 112.155 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 15.1 mm -129.61 -9.69 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 79' ' ' ARG . . . 81.93 -151.79 30.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 117.786 -1.102 . . . . 0.0 110.629 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.33 141.44 42.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.606 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 18.5 m-85 -86.45 123.28 31.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -1.135 . . . . 0.0 109.271 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.542 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -127.72 138.86 52.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.495 -0.753 . . . . 0.0 109.712 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.703 ' CE2' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -137.29 179.64 6.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.967 . . . . 0.0 109.672 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.545 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 1.4 mtm-85 -111.42 161.85 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.68 102.19 14.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 110.502 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 75' ' ' GLU . 2.9 mt -75.14 -39.5 60.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 5.1 m-85 -128.01 172.47 10.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.882 . . . . 0.0 109.855 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' CB ' ' HA ' ' A' ' 25' ' ' HIS . 9.3 p-10 -99.6 146.63 26.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.162 -0.961 . . . . 0.0 109.677 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 70' ' ' PRO . 71.8 t80 -125.24 166.21 16.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 109.257 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -108.24 139.32 43.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 109.423 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 15.5 ttpp -83.3 72.87 10.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.832 . . . . 0.0 109.557 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 108.928 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -90.27 153.71 20.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.152 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.41 -26.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 18' ' ' ARG . 2.0 mt-10 -53.94 -59.67 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.693 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.4 p30 -77.06 169.46 18.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.81 . . . . 0.0 109.571 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.791 ' O ' HD12 ' A' ' 22' ' ' ILE . 1.3 pp -127.77 161.77 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 0.0 109.893 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 4.5 m-20 -74.17 126.44 30.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.574 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 69' ' ' PHE . 19.0 mt -115.46 160.51 19.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.214 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.696 ' CE1' HG21 ' A' ' 63' ' ' THR . 2.2 m80 -156.56 149.95 24.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -57.52 137.52 56.19 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 109.386 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 89.98 -31.11 5.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 9.7 t0 -59.48 131.55 51.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.319 -1.107 . . . . 0.0 109.329 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.8 mm -93.26 140.46 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.752 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 9.8 mp -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.134 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -111.5 87.09 2.47 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.437 -0.789 . . . . 0.0 109.372 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.703 HG21 ' CE2' ' A' ' 8' ' ' TYR . 37.7 t -82.85 96.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -50.44 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.385 -0.822 . . . . 0.0 109.739 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -86.93 154.08 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.626 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' HD3' ' A' ' 34' ' ' LYS . . . 88.43 -50.8 3.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -26.19 63.33 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.283 -1.128 . . . . 0.0 109.821 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.899 ' O ' HD23 ' A' ' 37' ' ' LEU . 2.2 tt -90.14 -35.97 15.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.423 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 38' ' ' VAL . 48.5 t -87.32 0.29 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.85 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.24 -13.99 15.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -104.05 32.2 4.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.744 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.21 51.27 55.29 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.702 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -70.83 -176.67 1.39 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 m -116.58 158.43 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.729 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -73.51 82.91 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.25 -36.94 0.6 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.1 29.31 1.24 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -1.153 . . . . 0.0 109.414 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -90.1 -31.3 17.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.734 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -107.28 42.07 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.763 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.506 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.8 tpt180 -138.41 73.42 42.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.723 ' CG ' HG23 ' A' ' 74' ' ' VAL . 6.1 Cg_exo -56.75 -48.35 19.09 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.688 2.259 . . . . 0.0 111.878 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -56.64 -16.31 6.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.848 -1.158 . . . . 0.0 109.811 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -120.17 -5.41 9.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 109.8 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -79.86 -43.52 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.08 -1.013 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.41 -76.39 0.26 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 30.7 m95 -143.74 132.75 22.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -1.045 . . . . 0.0 109.138 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.853 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -119.87 158.61 26.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 110.027 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 21.1 t-20 -119.3 111.36 18.1 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -135.15 -151.7 6.32 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 31.0 t80 -130.73 113.36 14.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.915 -0.756 . . . . 0.0 109.978 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.557 HD21 HD13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -80.71 82.07 6.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.0 109.17 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -49.51 -37.12 25.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.946 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 23.6 m -53.0 -44.39 67.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.647 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.696 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -110.43 15.86 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.476 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.75 41.49 7.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -106.99 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -1.139 . . . . 0.0 109.558 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.572 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 10.8 ttt180 -156.85 130.29 8.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 161.33 -162.91 34.15 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.064 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -92.9 174.74 7.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.991 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.76 ' HB3' HD11 ' A' ' 22' ' ' ILE . 22.3 p90 178.98 157.47 0.64 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 109.333 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.579 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -61.72 115.52 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.021 1.814 . . . . 0.0 109.657 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.951 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -67.84 -30.0 74.08 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 18.7 p -49.49 -20.67 0.77 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.817 -1.402 . . . . 0.0 109.935 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 18.2 m-85 -97.54 33.76 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 111.362 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.951 HG22 ' O ' ' A' ' 71' ' ' GLY . 16.5 m -145.41 174.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.035 -1.041 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.728 ' HB3' HD11 ' A' ' 11' ' ' LEU . 4.9 pt-20 -148.66 93.01 2.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.8 t80 -37.34 119.57 0.71 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.372 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 77' ' ' ILE . 14.2 mm -144.99 15.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.32 100.72 0.46 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.417 -1.049 . . . . 0.0 109.485 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.576 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . 147.64 -119.22 1.08 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 28.5 m-85 -143.31 148.22 35.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.52 -0.988 . . . . 0.0 108.472 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' CG ' HG23 ' A' ' 31' ' ' THR . 9.9 mt-30 -137.63 107.58 6.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 110.074 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.668 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -103.47 172.87 6.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.114 -0.991 . . . . 0.0 108.651 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB2' HD11 ' A' ' 77' ' ' ILE . 23.1 ttt180 -109.22 166.3 10.96 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.144 -0.972 . . . . 0.0 108.954 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -90.64 99.36 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 110.024 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.61 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 10.5 mt -80.62 -35.1 34.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.147 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 26.0 m-85 -130.76 171.3 13.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.883 . . . . 0.0 109.822 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -97.88 -177.26 3.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.442 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 65.6 t80 173.6 119.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -80.02 143.17 34.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.256 -0.902 . . . . 0.0 109.43 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 14.1 pttp -59.32 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -66.18 -70.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 5.4 mtt180 -75.89 164.39 26.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.69 1.48 10.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 1.1 tp10 -104.81 -6.08 20.6 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.038 -1.039 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.474 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -102.35 154.31 19.18 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 109.824 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -108.01 -171.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 0.0 109.391 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.824 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -80.97 142.19 33.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.0 HD11 HD21 ' A' ' 30' ' ' LEU . 1.6 mm? -131.97 138.1 48.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.481 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -153.13 136.79 16.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -49.0 135.58 15.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 96.28 -3.69 64.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.61 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 5.1 t70 -90.12 148.97 22.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 109.706 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.495 ' C ' HD12 ' A' ' 30' ' ' LEU . 17.6 mm -101.68 132.15 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.859 . . . . 0.0 108.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 24' ' ' LEU . 6.5 mp -114.21 111.72 22.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -91.44 96.01 10.28 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.222 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.664 HG11 ' OH ' ' A' ' 8' ' ' TYR . 78.4 t -98.32 101.1 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.658 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 32' ' ' VAL . 4.0 m-80 -46.99 173.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.391 -0.818 . . . . 0.0 109.891 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 1.2 ttpm? -90.35 -27.46 19.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.04 -53.92 3.55 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -54.54 -24.51 21.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.217 -1.167 . . . . 0.0 109.664 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 47' ' ' GLU . 19.6 tp -90.28 -40.83 11.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.327 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 38' ' ' VAL . 47.4 t -79.93 0.38 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.907 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' C ' HD22 ' A' ' 40' ' ' LEU . . . -68.24 -6.53 24.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 40' ' ' LEU . 2.1 mm? -102.85 8.41 39.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 109.705 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.63 32.24 38.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.721 ' HE2' HG23 ' A' ' 53' ' ' ILE . 24.6 m-85 -58.29 -168.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.39 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.07 167.89 14.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.539 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -75.0 107.67 7.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.55 19.33 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD11 ' A' ' 53' ' ' ILE . 11.7 mm-40 -82.19 -41.15 20.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.261 -1.14 . . . . 0.0 109.579 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HA ' HD21 ' A' ' 37' ' ' LEU . 2.2 pm0 -42.51 -43.89 3.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.442 -0.786 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -85.54 43.63 1.04 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.469 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -151.53 62.63 5.01 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HB2' HG23 ' A' ' 74' ' ' VAL . 2.8 Cg_exo -54.64 -55.55 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.469 2.113 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.7 -23.45 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.032 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 4.0 mt-10 -121.44 48.37 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 42' ' ' PHE . 4.9 mt -133.08 -43.91 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.82 -75.65 0.26 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 48.5 m95 -144.19 123.57 13.09 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.378 -1.072 . . . . 0.0 109.576 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.732 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -112.95 156.47 22.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' C ' HG22 ' A' ' 32' ' ' VAL . 14.5 t-20 -112.21 107.69 16.65 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.627 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.18 -163.94 11.21 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.814 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.0 t80 -122.32 113.27 19.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.767 -0.843 . . . . 0.0 110.147 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' ND2' ' N ' ' A' ' 60' ' ' ASN . 1.2 m120 -78.96 82.71 5.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.192 -0.943 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -45.19 -41.93 8.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.067 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 5.9 m -47.88 -69.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 t -79.76 4.91 14.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.963 . . . . 0.0 109.698 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.75 50.15 38.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -128.84 171.52 12.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -1.128 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' C ' HG21 ' A' ' 22' ' ' ILE . 12.2 ttp85 -143.21 143.8 31.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.86 . . . . 0.0 109.362 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 162.88 -167.36 37.25 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.573 -1.298 . . . . 0.0 109.923 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 4.0 p30 -91.49 171.85 8.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -1.062 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 13.5 p90 -175.13 154.01 1.64 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.875 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.598 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 6.2 Cg_exo -58.4 124.51 16.02 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.985 1.79 . . . . 0.0 109.765 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.732 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -71.62 -18.83 77.49 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.509 ' OG1' ' CE1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -70.49 -13.85 62.29 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.694 -1.474 . . . . 0.0 109.68 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.598 ' CD2' ' HG2' ' A' ' 70' ' ' PRO . 10.7 m-30 -99.9 19.3 16.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.701 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 50' ' ' PRO . 2.7 m -132.39 -174.02 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.81 -1.181 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.53 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.8 pt-20 -158.19 88.02 0.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.557 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 14.2 t80 -43.13 133.31 3.93 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.248 -0.907 . . . . 0.0 109.31 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.8 mp -129.06 -4.0 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.876 -1.14 . . . . 0.0 109.931 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 171.66 167.29 31.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.518 ' CA ' ' OH ' ' A' ' 76' ' ' TYR . 2.6 ptt-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.54 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.34 148.84 17.68 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.671 ' CD1' HD22 ' A' ' 37' ' ' LEU . 52.5 m-85 -84.57 121.35 27.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -1.076 . . . . 0.0 109.265 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 3.7 mt-30 -116.87 129.98 56.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.636 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -118.88 174.65 6.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.945 . . . . 0.0 109.926 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.826 ' HB2' HD11 ' A' ' 77' ' ' ILE . 1.8 ttp85 -117.11 126.71 53.26 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -54.4 133.22 45.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.012 -1.055 . . . . 0.0 109.736 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.573 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 7.7 mt -108.93 -38.79 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 3.8 m-85 -116.48 -160.43 0.76 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.556 -0.715 . . . . 0.0 109.915 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -124.52 146.6 48.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 0.0 109.909 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 24' ' ' LEU . 63.9 t80 -156.33 111.23 2.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.21 121.91 25.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -48.67 114.6 1.01 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.416 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG3' ' OD2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -90.57 -72.07 0.59 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.203 -0.936 . . . . 0.0 108.612 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.67 166.06 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 109.143 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -9.62 18.9 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 109.883 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -80.59 -23.04 40.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.095 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -108.55 158.4 17.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.156 -0.965 . . . . 0.0 109.8 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 60' ' ' ASN . 15.4 pt -111.29 -169.54 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.564 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -106.61 109.0 20.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.381 -0.824 . . . . 0.0 109.527 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -113.58 148.08 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.18 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 2.0 m80 -154.01 141.49 19.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 109.39 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 11' ' ' LEU . 2.5 tp -41.59 136.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.679 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.32 1.64 81.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.781 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.4 m-20 -90.42 169.18 11.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -1.156 . . . . 0.0 109.473 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.596 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mm -122.92 132.54 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.183 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.985 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.5 mp -115.61 128.59 56.05 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.066 -1.021 . . . . 0.0 109.116 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' OE1' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -110.42 79.77 1.24 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.392 -0.818 . . . . 0.0 109.149 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.726 HG12 ' HB2' ' A' ' 37' ' ' LEU . 74.7 t -80.25 117.12 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -53.3 -173.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 37' ' ' LEU . 6.3 mtmt -90.17 -62.47 1.46 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.427 -0.796 . . . . 0.0 109.938 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.67 -54.49 37.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -19.7 3.56 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.213 -1.169 . . . . 0.0 109.32 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.75 HD21 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -84.57 -36.85 21.82 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 38' ' ' VAL . 21.9 t -85.02 -4.06 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.344 -0.848 . . . . 0.0 109.886 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.1 -24.1 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.055 -1.028 . . . . 0.0 108.605 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -88.78 33.19 0.78 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.624 -0.673 . . . . 0.0 109.848 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 47.51 29.55 5.61 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.658 ' CE1' HG23 ' A' ' 53' ' ' ILE . 6.8 m-30 -47.62 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.822 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -100.86 -174.35 2.6 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.181 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.98 103.92 16.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.787 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 12.59 77.79 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' SER . 6.8 tt0 -90.3 29.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -1.2 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.75 ' HG2' HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -86.55 -13.12 46.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -79.08 4.52 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.094 -1.004 . . . . 0.0 109.396 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 3.5 mtt180 -131.28 63.2 69.11 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 108.943 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' CB ' HD11 ' A' ' 56' ' ' LEU . 4.7 Cg_exo -59.0 -24.68 74.51 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.25 1.967 . . . . 0.0 110.397 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.71 ' CA ' HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -69.03 -43.34 74.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.121 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 49' ' ' ARG . 4.0 mt-10 -79.79 -6.79 57.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.154 -0.966 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.658 HG23 ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -79.71 -42.39 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 108.697 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 115.8 -74.34 0.26 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 54' ' ' GLY . 21.7 m95 -147.67 122.75 10.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -1.031 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -104.9 153.78 20.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.028 -1.045 . . . . 0.0 108.983 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.666 ' O ' HG13 ' A' ' 32' ' ' VAL . 5.7 t-20 -122.01 121.95 38.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 32' ' ' VAL . . . -146.88 -146.98 4.46 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -123.57 110.16 14.68 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.54 -0.977 . . . . 0.0 110.131 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.965 ' HB3' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -78.32 82.38 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.075 -1.016 . . . . 0.0 108.539 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -53.02 -35.04 59.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.373 -0.829 . . . . 0.0 110.122 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 28' ' ' ASP . 19.7 m -53.38 -39.81 64.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.032 -1.042 . . . . 0.0 109.714 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.965 HG22 ' HB3' ' A' ' 60' ' ' ASN . 14.8 t -108.93 6.59 25.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.82 48.53 56.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 63' ' ' THR . 37.1 mm-40 -135.7 171.91 13.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -1.184 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 58' ' ' GLY . 25.1 ttt180 -141.59 146.45 36.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 22' ' ' ILE . . . 159.85 -159.05 30.31 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER -106.5 175.46 5.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.086 . . . . 0.0 109.947 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.985 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.7 p90 -173.17 162.03 3.52 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.593 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 6.1 Cg_exo -58.35 119.14 6.2 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.929 1.753 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -72.14 -29.81 66.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.71 HG22 ' CA ' ' A' ' 51' ' ' GLU . 27.9 p -69.45 -7.02 34.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -1.233 . . . . 0.0 109.15 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 4.2 m-85 -100.26 -5.37 27.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 110.194 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 71' ' ' GLY . 28.5 m -111.29 172.87 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 6.0 pt-20 -136.25 87.55 2.31 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.237 -0.915 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.605 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 91.4 t80 -42.64 143.54 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 9' ' ' ARG . 3.6 mt -145.2 16.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 83.69 -122.57 5.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.249 -1.148 . . . . 0.0 109.495 179.977 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.289 0.566 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.45 156.69 5.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.617 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 46.0 m-85 -107.06 115.99 31.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -1.192 . . . . 0.0 110.032 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.775 ' CG ' HG23 ' A' ' 31' ' ' THR . 9.8 mt-30 -93.39 127.85 39.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.45 177.32 4.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.795 -1.191 . . . . 0.0 111.315 -179.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -114.23 124.85 53.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 25' ' ' HIS . . . -61.3 116.66 4.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 9.7 mt -82.73 -36.14 26.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.571 -0.706 . . . . 0.0 109.161 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 3.3 m-85 -120.83 -137.68 0.33 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.396 -0.815 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -144.16 -177.01 5.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 1.6 t80 -170.03 135.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.69 8.08 45.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 4.7 tttt 61.52 108.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 0.0 109.893 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -61.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 32.1 mtm-85 -90.41 139.63 30.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.436 -0.79 . . . . 0.0 108.997 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' ARG . 46.0 tt0 -40.93 -35.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.819 . . . . 0.0 110.088 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -54.51 -59.53 4.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -64.52 165.34 10.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 110.022 -179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.605 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.6 pt -129.53 172.33 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.65 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 2.2 m-20 -69.62 115.91 9.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.9 . . . . 0.0 109.921 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -104.94 157.88 16.92 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.677 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -160.1 143.14 13.71 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.665 -1.272 . . . . 0.0 110.204 -179.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -55.49 139.25 44.36 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.232 -0.918 . . . . 0.0 109.394 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 29' ' ' ILE . . . 89.59 -33.07 4.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 25' ' ' HIS . 7.6 t0 -68.38 121.25 15.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -1.066 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.962 ' C ' HD23 ' A' ' 30' ' ' LEU . 2.9 mp -88.37 165.55 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.872 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -138.78 147.43 42.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.049 -1.032 . . . . 0.0 108.235 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.775 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -108.25 93.21 4.41 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.679 -0.638 . . . . 0.0 109.764 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CB ' ' OH ' ' A' ' 8' ' ' TYR . 47.3 t -92.89 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.117 -0.99 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -54.65 138.7 40.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.855 . . . . 0.0 109.682 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 6.5 pttt -59.01 144.54 44.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.295 -0.878 . . . . 0.0 108.995 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.14 -58.5 0.46 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 33' ' ' ASN . 2.6 p -46.6 -26.01 0.82 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.152 -1.205 . . . . 0.0 108.747 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.017 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -85.25 -40.61 16.43 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 38' ' ' VAL . 21.4 t -70.96 -4.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.571 -0.705 . . . . 0.0 109.599 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -82.53 -54.94 4.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.01 20.02 4.2 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.783 ' HE2' HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -56.77 -68.28 0.23 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.571 -1.546 . . . . 0.0 108.143 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 46' ' ' GLN . 13.8 t -158.2 130.91 7.21 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.13 117.95 9.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.187 -0.945 . . . . 0.0 109.669 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.76 -1.47 55.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 1.8 tt0 -86.39 30.9 0.68 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.095 -1.238 . . . . 0.0 110.076 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.737 ' HA ' HD22 ' A' ' 37' ' ' LEU . 8.1 mt-10 -88.14 20.53 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 109.489 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -105.24 -21.8 13.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.634 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -113.72 82.01 6.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.881 ' HA ' HD12 ' A' ' 53' ' ' ILE . 4.2 Cg_exo -59.62 -52.58 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.234 1.956 . . . . 0.0 110.119 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -44.79 -27.47 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -105.51 47.03 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.632 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.971 HD13 ' CD2' ' A' ' 37' ' ' LEU . 58.7 mt -144.18 -49.69 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.5 -70.33 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.584 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 31.6 m95 -143.84 152.65 41.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -1.103 . . . . 0.0 109.751 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.017 HD23 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.94 144.29 45.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.465 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 16.9 t-20 -110.34 106.19 15.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.31 -163.88 10.82 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.036 -1.554 . . . . 0.0 111.296 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -121.46 104.68 9.85 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 122.161 -0.611 . . . . 0.0 109.857 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.91 ' OD1' HD22 ' A' ' 30' ' ' LEU . 4.3 m-80 -77.04 91.12 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.838 -1.164 . . . . 0.0 108.729 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -53.38 -37.29 62.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.574 -0.704 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.487 ' HB ' ' OD1' ' A' ' 28' ' ' ASP . 10.7 m -51.71 -45.36 63.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.197 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 60' ' ' ASN . 2.5 t -107.25 9.57 30.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.52 53.61 5.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -129.51 151.85 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -1.196 . . . . 0.0 109.806 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.38 124.91 43.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 108.948 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -179.2 -166.64 35.4 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.235 -1.46 . . . . 0.0 110.471 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -104.22 166.93 10.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.558 -0.966 . . . . 0.0 109.852 -179.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.687 ' CE2' ' CD1' ' A' ' 30' ' ' LEU . 5.0 p90 -167.95 160.03 9.55 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -59.85 128.6 27.36 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.221 1.947 . . . . 0.0 110.61 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' A' ' 56' ' ' LEU . . . -72.18 -36.26 60.24 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 72' ' ' THR . 2.7 p -64.85 -9.82 23.75 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.031 -1.276 . . . . 0.0 109.242 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.6 m-85 -96.41 15.36 21.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.968 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.6 m -139.74 -177.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HD21 ' A' ' 11' ' ' LEU . 15.5 pt-20 -156.43 89.92 1.15 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.575 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 5.7 t80 -36.9 132.92 0.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.619 -0.675 . . . . 0.0 109.527 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG21 ' NH1' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -119.13 -15.55 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.994 . . . . 0.0 109.509 -179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 -124.31 5.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.481 ' O ' ' NE2' ' A' ' 7' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.085 -1.244 . . . . 0.0 109.505 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' OE2' ' NZ ' ' A' ' 34' ' ' LYS . 2.2 mt-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.344 0.592 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.92 -179.92 52.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.643 ' CE2' ' CB ' ' A' ' 47' ' ' GLU . 2.5 m-85 -99.69 136.82 39.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -1.146 . . . . 0.0 109.392 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 78' ' ' GLY . 1.2 mt-30 -129.94 108.74 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 108.941 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -101.82 -178.94 3.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.001 -1.062 . . . . 0.0 110.483 -179.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.482 ' HB3' ' OE2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -123.51 139.77 53.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . . . -64.31 98.67 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.016 -1.053 . . . . 0.0 110.562 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.661 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 4.6 mt -67.69 -25.09 65.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 108.588 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.661 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 28.6 m-85 -140.11 -164.13 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -115.67 148.2 39.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' HD22 ' A' ' 24' ' ' LEU . 45.1 t80 -150.64 108.92 3.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 17' ' ' GLU . 19.4 tptt -79.8 149.37 31.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 2.1 tttp -52.55 89.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' LYS . 42.5 mm-40 -77.97 -68.2 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 3.0 mtt180 -89.6 164.65 14.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.277 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.48 2.2 10.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.232 -0.918 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -106.07 -2.71 22.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.067 -1.02 . . . . 0.0 110.196 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.9 p-10 -115.17 167.64 10.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.977 -1.077 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.528 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -111.92 -171.86 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 109.663 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.567 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.5 OUTLIER -103.4 98.38 8.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.397 -0.814 . . . . 0.0 109.348 179.918 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -96.87 161.99 13.61 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 23' ' ' ASP . 3.0 m80 -156.33 149.75 24.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.146 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 6.4 tt -54.02 140.77 30.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.933 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -30.25 6.79 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.866 ' OD1' ' HB2' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.73 166.72 12.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 109.606 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 28' ' ' ASP . 7.4 mm -119.29 141.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.953 HD23 ' CZ ' ' A' ' 69' ' ' PHE . 10.4 mp -110.43 123.64 50.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.089 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.3 88.63 3.02 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.784 HG22 ' CA ' ' A' ' 58' ' ' GLY . 74.3 t -96.55 95.5 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.468 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 32' ' ' VAL . 2.2 m120 -42.0 165.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.534 -0.729 . . . . 0.0 109.948 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -87.26 150.69 23.72 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.338 -0.851 . . . . 0.0 109.408 179.934 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.27 -61.72 2.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -55.61 -19.52 10.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.299 -1.118 . . . . 0.0 109.101 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.604 ' CD1' HG11 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -89.71 -30.62 17.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.47 -0.769 . . . . 0.0 109.409 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.574 HG23 ' CG ' ' A' ' 47' ' ' GLU . 18.8 t -87.87 -2.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -3.93 20.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 42' ' ' PHE . 5.9 mt -84.26 -25.68 29.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.563 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 122.06 4.2 9.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.038 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 20.0 m-85 -53.08 -170.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.602 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.536 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -116.58 118.36 32.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 43' ' ' SER . 11.1 t70 -24.3 88.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.303 0.573 . . . . 0.0 111.259 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 139.53 -7.73 3.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.907 ' O ' HD11 ' A' ' 53' ' ' ILE . 1.1 tp60 -90.51 -0.89 57.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.296 . . . . 0.0 110.04 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' CB ' ' CE2' ' A' ' 6' ' ' TYR . 22.1 mt-10 -66.92 -10.0 44.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.021 -1.049 . . . . 0.0 109.57 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.892 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -114.36 19.2 16.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.529 ' CG ' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -128.72 61.69 56.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 4.0 Cg_exo -57.62 -38.96 91.77 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.228 1.952 . . . . 0.0 110.323 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -64.37 -28.33 69.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 16.9 mm-40 -101.64 -5.24 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.272 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.038 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 18.6 mt -83.44 -88.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.283 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.808 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 155.8 -55.05 0.41 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.576 ' CZ3' ' HA ' ' A' ' 69' ' ' PHE . 29.2 m95 -153.27 138.4 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -1.046 . . . . 0.0 109.395 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -135.01 143.04 46.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.795 -179.964 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -94.51 102.98 14.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.784 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -118.98 175.93 15.89 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.723 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 33.5 t80 -109.25 106.92 16.97 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.815 -0.815 . . . . 0.0 109.519 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' ND2' ' CD1' ' A' ' 22' ' ' ILE . 1.6 m-80 -78.12 89.31 4.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 108.971 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -57.63 -36.86 72.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 110.004 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m -49.47 -33.04 13.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 6.6 9.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.2 39.41 70.92 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -107.7 157.02 18.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 13.0 tpt180 -139.16 114.43 9.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 108.868 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -175.4 -165.35 31.39 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.046 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.556 ' OD2' ' CE3' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -97.81 164.31 12.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.482 -1.01 . . . . 0.0 109.783 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.953 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 1.2 p90 -160.07 162.66 23.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.612 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -59.46 124.89 16.47 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.922 1.748 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -71.45 -33.73 63.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -68.09 -8.2 36.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.984 -1.304 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 5.0 m-85 -99.06 -7.75 26.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.114 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 71' ' ' GLY . 24.1 m -109.34 176.11 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 5.7 pt-20 -142.11 89.33 2.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.437 -0.79 . . . . 0.0 108.957 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.892 ' CD2' ' HB1' ' A' ' 48' ' ' ALA . 60.4 t80 -38.71 125.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.549 -0.72 . . . . 0.0 109.921 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -152.57 17.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLN . . . -121.38 105.1 0.99 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 10.4 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 4.6 tm-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 6' ' ' TYR . . . -169.23 -51.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 21.6 m-85 -137.53 105.04 5.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.92 . . . . 0.0 108.691 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' CG ' HG23 ' A' ' 31' ' ' THR . 10.2 mt-30 -99.64 123.12 43.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.988 -1.07 . . . . 0.0 110.047 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.648 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -112.91 170.19 8.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.071 -1.018 . . . . 0.0 108.967 179.878 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.548 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 13.3 ttp180 -105.68 145.47 31.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.263 -0.898 . . . . 0.0 108.97 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -74.13 96.95 2.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.923 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.618 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 18.6 mt -64.26 -29.75 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.114 -0.991 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.618 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 6.5 m-85 -130.01 -159.34 0.95 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.139 -0.976 . . . . 0.0 110.16 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -117.59 -167.81 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -176.44 156.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -119.33 27.11 9.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 0.0 110.399 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.532 ' CB ' ' OD1' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 42.26 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.189 -0.944 . . . . 0.0 110.105 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 18' ' ' ARG . 17.4 mt-10 -126.9 -50.2 1.46 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.247 -0.908 . . . . 0.0 109.053 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 55' ' ' TRP . 0.2 OUTLIER -39.79 161.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.542 -0.724 . . . . 0.0 110.274 179.97 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -28.99 -68.25 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.595 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OD2' ' A' ' 68' ' ' ASP . 5.3 mm-40 -131.16 48.68 2.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.808 -1.182 . . . . 0.0 111.005 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.56 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 56.1 p-10 -95.85 154.99 16.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.164 . . . . 0.0 108.853 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.594 ' O ' HD12 ' A' ' 22' ' ' ILE . 1.2 pp -104.09 171.35 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.089 -1.007 . . . . 0.0 110.042 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -64.82 170.3 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.943 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -153.27 146.84 25.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.528 ' CG ' ' C ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -156.25 138.98 15.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.681 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -55.35 122.27 10.79 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.363 -0.836 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.43 -5.36 28.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.695 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.2 m-20 -90.24 163.63 14.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -1.166 . . . . 0.0 109.542 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.706 ' C ' HD12 ' A' ' 30' ' ' LEU . 14.1 mm -119.24 140.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 24' ' ' LEU . 5.8 mp -118.9 113.85 21.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.038 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.485 HG23 ' CG ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -88.09 105.78 17.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.561 -179.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.715 HG22 ' CA ' ' A' ' 58' ' ' GLY . 71.7 t -115.75 91.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.699 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.519 ' HA ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t-20 -42.82 159.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.931 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -83.75 145.43 28.72 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 98.79 -55.4 1.01 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -45.85 -27.36 0.85 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.267 -1.137 . . . . 0.0 108.877 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD21 ' CD2' ' A' ' 42' ' ' PHE . 0.6 OUTLIER -90.06 -35.72 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 38' ' ' VAL . 42.0 t -79.23 3.89 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 109.659 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.35 -13.2 17.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.832 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.2 mm? -96.85 -19.72 18.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.089 -1.007 . . . . 0.0 109.476 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 117.77 25.32 3.12 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.703 ' HE2' HG23 ' A' ' 53' ' ' ILE . 5.9 m-85 -51.65 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -1.042 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.46 ' CB ' ' HB2' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -160.5 -162.08 0.92 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 0.0 109.147 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 11.4 t70 -90.14 62.39 5.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.177 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.72 34.68 2.57 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' HB2' ' CB ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -82.42 6.66 16.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 109.557 -179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' OE2' ' CZ ' ' A' ' 8' ' ' TYR . 3.9 tm-20 -67.7 -7.01 23.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.249 -0.907 . . . . 0.0 109.765 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.566 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -84.99 16.96 3.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.988 -1.07 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -125.69 59.36 26.7 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.126 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.547 ' CB ' HG23 ' A' ' 74' ' ' VAL . 3.0 Cg_exo -50.13 -59.78 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.153 1.902 . . . . 0.0 110.337 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.639 ' HA ' HG22 ' A' ' 72' ' ' THR . 4.2 tt0 -66.65 -17.15 64.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 108.679 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.2 mm-40 -108.67 22.69 15.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.703 HG23 ' HE2' ' A' ' 42' ' ' PHE . 5.5 mt -118.39 -45.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 108.945 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.97 -74.32 0.29 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 18' ' ' ARG . 12.5 m95 -141.78 147.02 36.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -1.084 . . . . 0.0 109.121 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.764 HD11 ' HA3' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -136.89 159.58 41.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 32' ' ' VAL . 3.1 t-20 -111.76 100.79 9.22 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.715 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -119.62 178.46 16.55 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CG ' ' HB2' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -112.43 113.27 25.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.654 -0.909 . . . . 0.0 109.893 179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 37.0 m-80 -89.44 64.43 6.75 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 62' ' ' THR . 4.1 mt-10 -45.94 -28.3 1.1 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.023 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.695 HG21 ' CG ' ' A' ' 28' ' ' ASP . 8.3 m -47.19 -54.97 9.39 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.8 t -87.3 -10.21 52.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.67 40.29 11.04 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' A' ' 59' ' ' TYR . 8.2 mm-40 -138.89 164.88 28.51 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.057 -1.261 . . . . 0.0 109.257 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.594 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 52.2 ttp85 -145.69 115.3 7.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . -162.63 -159.07 10.06 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.014 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -87.81 165.63 15.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.945 . . . . 0.0 110.091 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HE2' HG11 ' A' ' 74' ' ' VAL . 2.7 p90 -172.13 159.23 4.33 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.802 . . . . 0.0 109.313 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 3.7 Cg_exo -61.44 126.05 18.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.176 1.918 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -71.68 -32.94 63.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 51' ' ' GLU . 1.6 p -64.84 -9.94 24.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.083 -1.245 . . . . 0.0 109.43 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.9 m-85 -98.73 15.95 23.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.789 HG11 ' HE2' ' A' ' 69' ' ' PHE . 18.1 m -134.94 -177.94 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.085 -1.009 . . . . 0.0 110.534 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 4.5 pt-20 -147.03 89.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 33.3 t80 -49.65 123.88 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.589 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.58 -16.8 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.985 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 111.65 -160.48 13.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.56 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.577 ' O ' ' CG ' ' A' ' 6' ' ' TYR . . . 178.6 -143.39 5.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 47' ' ' GLU . 60.0 m-85 -158.75 141.21 14.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.494 -1.004 . . . . 0.0 108.959 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' CG ' ' HA ' ' A' ' 31' ' ' THR . 1.1 tt0 -154.81 114.36 3.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.324 -0.86 . . . . 0.0 109.43 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 1.085 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -109.8 170.93 7.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.758 ' CB ' HD11 ' A' ' 77' ' ' ILE . 1.6 tpp180 -112.83 116.7 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' H ' ' A' ' 28' ' ' ASP . . . -43.44 158.02 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.68 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.62 HD21 ' OE1' ' A' ' 75' ' ' GLU . 14.5 mt -135.92 -41.17 0.67 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.607 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 12.3 m-85 -125.33 169.96 11.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.548 -0.72 . . . . 0.0 109.765 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 1.3 p30 -102.87 139.39 38.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.559 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 34.4 t80 -134.78 131.33 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.213 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.99 120.43 24.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.556 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.1 pttt -56.29 91.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.824 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -55.72 -68.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.33 159.33 16.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 109.157 179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.31 -12.98 10.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.075 -1.016 . . . . 0.0 110.0 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.23 -31.24 62.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -96.01 149.29 21.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 109.5 -179.989 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.644 HD11 ' CG ' ' A' ' 60' ' ' ASN . 1.4 pp -105.37 175.84 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.818 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.579 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 4.0 m-20 -80.18 115.8 19.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 109.894 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.674 HD11 HD21 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -94.08 147.01 23.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 108.725 -179.973 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.654 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER -152.49 127.57 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 109.536 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.674 ' C ' HD23 ' A' ' 26' ' ' LEU . 5.5 tt -43.64 141.19 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.31 -0.869 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.97 1.11 88.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.581 ' H ' ' HB3' ' A' ' 10' ' ' ALA . 12.5 t0 -82.32 152.45 26.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 6.4 mm -104.37 124.57 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.035 . . . . 0.0 109.071 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.674 HD21 HD11 ' A' ' 24' ' ' LEU . 6.8 mp -111.81 106.78 15.63 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.135 -0.978 . . . . 0.0 109.555 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.49 ' HA ' ' CG ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -88.93 95.82 10.47 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.262 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 40.7 t -93.65 116.02 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.467 -0.771 . . . . 0.0 109.451 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -87.36 -179.31 6.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.33 146.95 31.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.333 -0.854 . . . . 0.0 109.891 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.06 -62.38 2.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -21.07 29.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.28 -1.129 . . . . 0.0 108.949 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.588 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -90.09 -35.3 15.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.284 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 38' ' ' VAL . 40.0 t -77.17 2.36 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.486 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -60.89 -11.93 9.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.938 HD23 ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -102.64 36.63 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.001 -1.062 . . . . 0.0 109.39 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 48.3 25.09 4.02 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.938 ' CE2' HD23 ' A' ' 40' ' ' LEU . 6.1 m-30 -48.4 -178.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.572 -0.957 . . . . 0.0 109.858 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -122.83 106.12 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 43' ' ' SER . 13.4 t0 -27.72 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.312 0.577 . . . . 0.0 110.97 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 147.46 -23.07 1.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.602 ' HG2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -89.96 -2.94 58.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.12 -1.224 . . . . 0.0 110.309 -179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -42.99 -49.79 5.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.186 -0.946 . . . . 0.0 109.435 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.26 46.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 109.09 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.548 ' CD ' ' HB3' ' A' ' 52' ' ' GLU . 55.5 ttt180 -151.34 59.37 3.25 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.078 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 3.0 Cg_endo -60.03 -47.49 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.268 1.979 . . . . 0.0 110.453 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CG ' ' N ' ' A' ' 52' ' ' GLU . 24.1 pt-20 -47.89 -46.87 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HB3' ' CD ' ' A' ' 49' ' ' ARG . 1.4 tt0 -99.5 47.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.181 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.825 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -130.56 -39.58 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.953 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.4 -79.41 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -138.6 137.32 36.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.631 HD11 ' HA3' ' A' ' 71' ' ' GLY . 1.2 mp -121.78 168.21 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 109.794 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.679 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -119.6 119.49 33.9 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.43 -172.94 15.37 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.088 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 50.1 t80 -114.85 109.11 17.65 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.465 -1.021 . . . . 0.0 109.763 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.644 ' CG ' HD11 ' A' ' 22' ' ' ILE . 15.9 m120 -79.05 85.9 4.93 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.189 -0.944 . . . . 0.0 109.0 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -55.72 -36.76 67.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.447 -0.783 . . . . 0.0 110.022 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 21.9 m -53.58 -35.88 61.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.654 HG21 ' HE1' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -116.87 10.52 14.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 60' ' ' ASN . . . 42.44 53.95 4.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -141.93 115.32 8.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.24 136.77 32.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 109.247 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.599 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 176.96 -160.5 27.67 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.244 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 8.4 m-20 -96.33 163.98 12.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -1.06 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.642 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 p90 -164.36 158.99 15.95 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.879 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 69' ' ' PHE . 3.3 Cg_exo -61.19 117.43 4.21 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.249 1.966 . . . . 0.0 109.981 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.848 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -68.12 -34.83 82.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 2.9 p -63.26 -19.99 65.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.971 -1.311 . . . . 0.0 110.03 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 7.2 m-30 -93.41 17.98 10.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.598 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 71' ' ' GLY . 30.7 m -131.02 170.12 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.097 -1.002 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' OE1' HD21 ' A' ' 11' ' ' LEU . 7.6 pt-20 -137.6 87.38 2.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.804 . . . . 0.0 109.282 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CE2' ' N ' ' A' ' 78' ' ' GLY . 65.8 t80 -41.04 141.11 0.67 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.789 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.758 HD11 ' CB ' ' A' ' 9' ' ' ARG . 3.3 mt -139.36 8.99 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 97.33 -140.33 14.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.408 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.61 -168.13 19.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 28.7 m-85 -80.02 106.35 11.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.36 -1.083 . . . . 0.0 109.753 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.753 ' HG2' HG23 ' A' ' 31' ' ' THR . 1.3 mt-30 -102.56 128.04 49.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 108.975 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -110.31 173.15 6.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 0.0 109.972 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -113.87 142.26 46.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -64.93 151.31 46.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.896 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.772 HD21 ' CD ' ' A' ' 75' ' ' GLU . 13.3 mt -134.2 -41.8 0.81 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.624 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.0 m-85 -118.77 -142.8 0.36 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.554 -0.717 . . . . 0.0 109.541 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 p30 -144.77 173.96 11.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.89 -1.132 . . . . 0.0 109.957 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 47.6 t80 -173.59 141.51 0.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.4 -0.813 . . . . 0.0 108.911 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' GLU . 1.4 mttt -101.94 133.44 46.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.03 -1.043 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HG3' ' OD1' ' A' ' 21' ' ' ASP . 3.7 ttpm? -58.63 88.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 109.528 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 15' ' ' LYS . 60.8 tt0 -90.1 -73.42 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 1.1 mtt180 -61.66 157.9 16.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 26.2 tp10 -74.75 1.95 11.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.203 -0.936 . . . . 0.0 110.117 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.418 ' HG2' ' OD2' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -111.38 -1.06 16.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.061 -1.024 . . . . 0.0 110.042 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' ARG . 52.3 p30 -110.99 164.63 12.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.997 -1.064 . . . . 0.0 109.6 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.803 HD12 ' ND2' ' A' ' 60' ' ' ASN . 2.1 pt -126.38 -170.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 109.648 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 25' ' ' HIS . 1.2 m-20 -84.9 134.5 34.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.835 . . . . 0.0 109.634 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -128.12 138.28 52.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.076 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -153.46 138.75 17.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.062 -1.024 . . . . 0.0 109.62 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 tt -54.21 147.55 12.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.35 -0.844 . . . . 0.0 109.779 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 90.65 -9.89 76.29 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.892 ' O ' HD13 ' A' ' 29' ' ' ILE . 1.8 m-20 -86.54 178.12 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.163 . . . . 0.0 109.83 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 28' ' ' ASP . 5.7 mm -129.5 140.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.115 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -121.42 130.13 53.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.971 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.753 HG23 ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -106.94 93.82 4.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.952 ' CG1' HD12 ' A' ' 37' ' ' LEU . 56.4 t -101.11 115.03 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.9 . . . . 0.0 109.721 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -68.47 160.95 28.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.928 . . . . 0.0 109.292 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.05 2.55 17.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.886 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.58 -49.6 0.47 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -54.84 -25.69 30.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -1.168 . . . . 0.0 109.641 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.952 HD12 ' CG1' ' A' ' 32' ' ' VAL . 1.3 tt -90.38 -34.08 15.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 38' ' ' VAL . 71.4 t -80.75 2.27 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 110.066 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.5 4.23 7.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 109.988 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -111.44 5.1 19.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.047 . . . . 0.0 109.975 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.09 34.26 6.87 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.774 ' CE2' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -69.88 -169.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -1.187 . . . . 0.0 109.81 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.524 ' O ' ' C ' ' A' ' 44' ' ' ASP . 58.8 m -125.93 90.11 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.913 0.864 . . . . 0.0 109.198 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -19.74 87.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.409 179.828 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 148.61 -23.95 1.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.483 ' NE2' ' HB3' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -90.33 -12.39 37.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.058 -1.26 . . . . 0.0 110.01 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.825 ' OE1' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -43.37 -39.76 3.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.933 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.59 40.94 0.87 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -148.08 60.34 5.14 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 5.0 Cg_exo -59.0 -41.93 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.358 2.039 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HA ' HG22 ' A' ' 72' ' ' THR . 16.8 pt-20 -57.01 -16.5 7.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 49' ' ' ARG . 2.7 mt-10 -120.07 -5.75 10.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.895 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.774 HG23 ' CE2' ' A' ' 42' ' ' PHE . 3.2 mt -79.6 -34.22 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 109.161 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 -71.6 0.46 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -141.5 124.93 16.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.423 -1.046 . . . . 0.0 109.407 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.782 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -113.82 156.44 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.816 -179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -113.05 106.92 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.604 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -130.52 -158.65 9.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.588 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 38.8 t80 -124.8 108.72 12.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.674 -0.897 . . . . 0.0 109.863 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.803 ' ND2' HD12 ' A' ' 22' ' ' ILE . 1.4 m-20 -79.4 90.83 5.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.302 -0.874 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -55.06 -37.93 67.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.622 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 96.5 m -57.51 -45.77 84.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.326 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 64' ' ' GLY . 1.4 p -93.81 4.89 53.25 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 44.68 48.75 8.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -140.2 166.35 24.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.621 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 30.9 ttp180 -134.11 140.87 46.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 57' ' ' ASN . . . 165.6 -163.24 36.51 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.232 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 43.6 m-20 -94.19 170.74 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.976 . . . . 0.0 109.784 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.652 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 9.9 p90 -172.77 158.59 3.63 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.354 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 5.3 Cg_exo -58.83 121.39 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.15 1.9 . . . . 0.0 110.111 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.782 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -72.08 -34.37 61.65 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 51' ' ' GLU . 17.0 p -66.3 -8.97 28.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.304 . . . . 0.0 109.048 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.624 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 3.0 m-85 -95.54 9.56 39.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 110.064 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HD22 ' A' ' 30' ' ' LEU . 4.5 m -128.06 -174.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.772 ' CD ' HD21 ' A' ' 11' ' ' LEU . 15.9 pt-20 -160.21 92.74 1.01 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.604 -0.685 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 75' ' ' GLU . 5.1 t80 -33.19 115.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.569 0.7 . . . . 0.0 110.547 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 77' ' ' ILE . 10.4 mm -144.11 16.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' CZ ' ' A' ' 76' ' ' TYR . . . -129.35 115.22 1.89 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.251 -1.147 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.93 163.1 11.88 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 26.3 m-85 -80.91 123.74 28.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -1.15 . . . . 0.0 109.412 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -115.56 115.65 26.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.7 ' OH ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -104.96 175.56 5.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.062 -1.024 . . . . 0.0 109.093 179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -112.53 174.35 5.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 108.849 179.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASP . . . -90.37 152.42 21.01 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.834 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 14.2 mt -137.79 -38.56 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.577 ' HB2' ' CG ' ' A' ' 73' ' ' TYR . 4.5 m-85 -122.82 176.02 6.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.383 -0.823 . . . . 0.0 109.78 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -100.63 171.86 7.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -0.93 . . . . 0.0 109.866 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 24' ' ' LEU . 3.1 t80 -161.96 146.75 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 1.6 ttpt -107.99 17.95 21.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 109.998 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 21' ' ' ASP . 16.1 ttmt 59.5 71.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.806 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 1.5 tp10 -72.4 -73.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.035 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.7 mtp85 -53.8 144.23 18.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.35 -7.66 10.43 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -103.68 -22.76 13.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.006 -1.059 . . . . 0.0 110.441 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 16' ' ' LYS . 48.1 p30 -73.77 -179.82 3.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 0.0 109.82 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.622 HG23 ' HA3' ' A' ' 67' ' ' GLY . 1.3 pp -138.11 159.4 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 16' ' ' LYS . 2.2 m-20 -60.24 145.0 48.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.456 -0.777 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 69' ' ' PHE . 10.2 mt -135.4 157.75 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.868 . . . . 0.0 109.37 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.838 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -160.01 128.87 5.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 109.151 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -47.94 124.77 7.92 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.273 -0.892 . . . . 0.0 109.737 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.33 -18.79 11.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.642 ' CG ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -90.3 160.58 16.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.86 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 mt -115.96 157.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.92 HD23 ' CE2' ' A' ' 69' ' ' PHE . 3.2 mp -130.77 121.41 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.279 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.16 102.62 14.93 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.779 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.7 HG11 ' OH ' ' A' ' 8' ' ' TYR . 75.6 t -102.32 117.91 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.332 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -50.59 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 6' ' ' TYR . 12.7 mtpt -90.29 -73.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -54.58 -24.21 30.96 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -58.82 -40.74 85.05 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.081 -1.246 . . . . 0.0 109.883 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.8 tp -90.09 -29.52 18.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 38' ' ' VAL . 58.3 t -90.15 3.16 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.908 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -66.53 -7.67 21.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.37 15.63 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.096 -1.003 . . . . 0.0 109.773 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.4 41.61 25.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.96 ' CE2' HG23 ' A' ' 53' ' ' ILE . 5.1 m-85 -64.77 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -139.27 156.21 47.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -60.34 120.75 10.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.61 -31.77 6.42 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.3 mp0 -76.48 -40.08 51.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -1.169 . . . . 0.0 109.462 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.79 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -59.86 -27.05 66.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -84.71 -19.7 32.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -113.55 77.87 3.44 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.329 179.968 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.654 ' HG2' HG23 ' A' ' 74' ' ' VAL . 4.2 Cg_exo -57.73 -32.71 95.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.096 1.864 . . . . 0.0 110.238 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HA ' ' CA ' ' A' ' 72' ' ' THR . 24.7 tt0 -60.39 -32.43 71.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 109.018 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -94.37 -6.64 43.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.96 HG23 ' CE2' ' A' ' 42' ' ' PHE . 16.2 mt -79.71 -54.34 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.71 -69.69 0.52 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.421 ' C ' ' HG ' ' A' ' 56' ' ' LEU . 23.9 m95 -144.18 141.27 29.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.55 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.751 HD21 HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -138.68 139.83 38.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.483 ' O ' HG22 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -90.25 99.21 12.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.852 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.516 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -112.38 166.29 12.17 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.346 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -101.95 106.58 17.53 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.764 -0.845 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 3.2 m120 -78.48 78.45 4.94 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.151 -0.968 . . . . 0.0 109.205 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -49.27 -36.56 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.397 -0.814 . . . . 0.0 109.463 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.642 HG21 ' CG ' ' A' ' 28' ' ' ASP . 20.4 m -51.51 -61.08 2.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.829 . . . . 0.0 109.379 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.838 HG21 ' CE1' ' A' ' 25' ' ' HIS . 1.9 p -91.69 13.18 18.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.44 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.53 54.35 4.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 18.4 pt-20 -139.23 121.81 16.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 109.646 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.64 128.43 43.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . -174.39 -179.53 45.06 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -88.94 165.02 14.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.51 -0.994 . . . . 0.0 109.59 180.0 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.92 ' CE2' HD23 ' A' ' 30' ' ' LEU . 1.8 p90 -165.67 162.84 13.05 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.644 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.569 ' HG2' ' CD2' ' A' ' 73' ' ' TYR . 2.2 Cg_endo -63.71 120.55 7.98 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.86 1.707 . . . . 0.0 109.254 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.706 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -64.35 -19.18 64.03 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.514 ' CA ' ' HA ' ' A' ' 51' ' ' GLU . 1.7 p -72.57 -20.03 61.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.902 -1.352 . . . . 0.0 109.927 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.577 ' CG ' ' HB2' ' A' ' 12' ' ' TYR . 7.3 m-30 -92.92 7.36 44.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.127 -0.983 . . . . 0.0 110.584 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.654 HG23 ' HG2' ' A' ' 50' ' ' PRO . 13.3 m -118.4 -172.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.946 -1.097 . . . . 0.0 109.621 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HB3' HD11 ' A' ' 11' ' ' LEU . 10.5 pt-20 -155.74 86.16 1.05 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.571 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.4 t80 -40.37 136.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.467 -0.771 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 9' ' ' ARG . 5.1 mt -119.78 -4.28 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 109.859 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 130.48 -162.48 23.27 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' C ' ' HD2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.274 -1.133 . . . . 0.0 109.391 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.83 -165.63 11.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.603 ' CD2' ' HB3' ' A' ' 47' ' ' GLU . 56.4 m-85 -80.43 110.36 15.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.584 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.2 mt-30 -87.48 124.42 33.42 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.291 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HD2' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -104.58 -177.11 3.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.01 -1.057 . . . . 0.0 110.131 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 3.8 ttm180 -126.32 130.96 51.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 25' ' ' HIS . . . -65.48 123.5 19.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.778 -1.201 . . . . 0.0 110.056 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.625 HD21 ' CD ' ' A' ' 75' ' ' GLU . 10.5 mt -99.79 -42.41 6.84 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 11' ' ' LEU . 7.2 m-85 -124.12 -158.68 0.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.503 -0.748 . . . . 0.0 109.566 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 6.2 p-10 -123.37 171.97 9.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 109.686 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 26.1 t80 -167.76 113.54 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.8 mmtp -80.21 132.81 35.94 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.062 -1.024 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 4.4 mtpm? -41.87 106.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.853 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -133.2 -33.96 1.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -75.55 145.6 41.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.85 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.477 ' HG3' ' OE1' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -41.96 -33.63 0.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.697 -0.627 . . . . 0.0 110.743 -179.98 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.477 ' OE1' ' HG3' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -137.35 58.06 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.761 -1.212 . . . . 0.0 110.924 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 3.4 p-10 -119.2 173.48 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.916 -1.115 . . . . 0.0 108.92 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.684 HG23 ' HA3' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -126.0 179.05 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 109.95 179.982 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.577 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 1.2 m-20 -85.91 108.82 18.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' O ' ' CD2' ' A' ' 25' ' ' HIS . 2.3 mm? -95.07 144.13 25.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.659 ' HE1' HG21 ' A' ' 63' ' ' THR . 0.1 OUTLIER -155.18 128.4 8.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.11 -0.994 . . . . 0.0 109.66 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 3.2 tt -52.14 137.93 26.82 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.741 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -18.52 39.46 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.925 ' OD1' HG21 ' A' ' 62' ' ' THR . 16.7 m-20 -90.21 172.35 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -1.191 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' OE1' ' A' ' 61' ' ' GLU . 19.2 mm -117.83 144.72 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.722 HD22 ' ND2' ' A' ' 60' ' ' ASN . 10.3 mt -108.53 146.79 32.7 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 87.19 2.49 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.757 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.023 HG11 HD23 ' A' ' 37' ' ' LEU . 29.5 t -97.51 116.25 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -57.19 122.36 12.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.44 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.527 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA2' ' HB ' ' A' ' 38' ' ' VAL . . . 144.18 -56.95 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -48.21 -51.28 26.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.141 . . . . 0.0 110.122 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.023 HD23 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -81.39 -15.76 54.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.115 -0.99 . . . . 0.0 109.195 -179.92 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.094 HG23 ' OE1' ' A' ' 47' ' ' GLU . 1.4 t -77.84 -10.79 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.55 -9.15 23.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.0 109.336 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.74 HD12 ' CE2' ' A' ' 42' ' ' PHE . 14.6 mt -67.92 -27.63 66.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.03 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.17 3.03 6.94 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.74 ' CE2' HD12 ' A' ' 40' ' ' LEU . 19.8 m-85 -58.82 178.08 0.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -1.145 . . . . 0.0 109.631 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -119.53 135.74 54.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 108.75 179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 43' ' ' SER . 10.5 t70 -31.88 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.317 0.579 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 129.49 -3.64 6.2 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 53' ' ' ILE . 4.6 mt-30 -91.14 -25.02 19.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.102 -1.234 . . . . 0.0 109.632 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 1.094 ' OE1' HG23 ' A' ' 38' ' ' VAL . 1.1 tt0 -59.05 -47.97 83.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB1' ' CD2' ' A' ' 76' ' ' TYR . . . -56.19 -15.8 4.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.11 80.45 5.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 109.587 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.608 ' CG ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -65.04 -47.12 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.166 1.911 . . . . 0.0 110.451 179.987 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' PRO . 7.6 pt-20 -43.17 -42.15 4.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.259 -0.901 . . . . 0.0 109.25 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.25 51.71 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 1.3 mt -138.89 -41.36 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.72 -77.18 0.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.427 ' CZ2' ' HD2' ' A' ' 18' ' ' ARG . 34.4 m95 -137.91 147.13 44.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.437 -1.037 . . . . 0.0 109.121 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -138.76 137.22 36.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.147 -0.971 . . . . 0.0 110.125 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -88.33 95.69 10.29 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.662 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -115.33 173.74 14.92 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.355 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -115.7 107.81 15.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.648 -0.913 . . . . 0.0 109.76 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.722 ' ND2' HD22 ' A' ' 30' ' ' LEU . 4.1 m-80 -77.97 96.7 5.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 108.873 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' OE1' ' HB ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -54.17 -39.5 66.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.396 -0.815 . . . . 0.0 110.001 -179.918 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.925 HG21 ' OD1' ' A' ' 28' ' ' ASP . 17.9 m -49.08 -64.53 0.78 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.659 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.9 p -85.41 6.95 24.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.554 -0.716 . . . . 0.0 109.66 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 42.86 54.16 5.16 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 63' ' ' THR . 56.4 mm-40 -131.88 142.25 49.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -1.098 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -113.47 135.43 53.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.344 -0.847 . . . . 0.0 109.493 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.684 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 174.07 -167.91 40.52 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -102.13 163.96 11.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.699 ' HE1' HD13 ' A' ' 56' ' ' LEU . 2.1 p90 -163.13 162.23 18.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.6 Cg_endo -62.14 123.89 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.867 1.712 . . . . 0.0 109.827 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.777 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -67.61 -32.92 79.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 72' ' ' THR . 1.7 p -66.97 -9.41 38.4 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.035 -1.274 . . . . 0.0 109.415 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.9 m-85 -95.8 -13.14 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.608 HG23 ' CG ' ' A' ' 50' ' ' PRO . 32.7 m -107.69 175.03 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.625 ' CD ' HD21 ' A' ' 11' ' ' LEU . 18.6 pt-20 -149.88 90.66 1.71 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.189 -0.944 . . . . 0.0 108.715 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.557 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 76.3 t80 -38.63 123.91 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.435 -0.791 . . . . 0.0 109.847 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 77' ' ' ILE . 9.7 mm -111.38 -2.6 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 132.87 -164.43 24.1 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.317 -1.108 . . . . 0.0 109.503 179.996 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.67 150.41 7.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 66.8 m-85 -79.37 134.13 36.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -1.142 . . . . 0.0 108.459 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 3.3 mt-30 -143.65 117.84 9.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.054 -1.029 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.875 ' OH ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -113.78 178.66 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.359 179.953 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HB3' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -112.38 155.44 24.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -91.65 121.07 32.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.882 HD11 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -104.88 -24.62 12.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.015 . . . . 0.0 108.619 179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.556 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 5.2 m-85 -119.57 176.62 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 163.02 14.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.172 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -166.41 114.62 0.89 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.085 -1.009 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -79.46 107.41 12.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.931 . . . . 0.0 108.587 179.896 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -41.44 115.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.457 -0.777 . . . . 0.0 109.932 -179.845 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -69.65 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -90.17 146.84 23.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.878 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.0 mt-10 -43.53 -24.79 0.12 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.131 -0.981 . . . . 0.0 110.038 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -60.7 -58.07 10.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.113 -0.992 . . . . 0.0 109.971 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 2.0 p30 -72.04 162.7 29.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.945 . . . . 0.0 109.87 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -122.16 162.06 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.377 -0.827 . . . . 0.0 109.378 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' OD1' ' CD ' ' A' ' 16' ' ' LYS . 1.7 m-20 -79.22 103.69 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.901 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' O ' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -102.28 153.46 19.97 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.625 ' HE1' HG21 ' A' ' 63' ' ' THR . 1.0 OUTLIER -150.79 141.21 22.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.048 . . . . 0.0 109.878 -179.955 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tp -42.56 143.53 0.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 82.04 0.61 89.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 62' ' ' THR . 1.1 m-20 -90.42 159.13 16.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 109.746 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 28.2 mm -113.34 128.74 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.813 . . . . 0.0 109.175 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.9 mp -109.76 105.93 15.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.915 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -84.95 91.33 8.03 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.547 -0.72 . . . . 0.0 110.328 -179.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.875 HG21 ' OH ' ' A' ' 8' ' ' TYR . 29.0 t -86.76 96.85 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 33' ' ' ASN . 6.1 p30 -51.45 152.82 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.407 -0.808 . . . . 0.0 110.385 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 34' ' ' LYS . 6.0 pttp -69.19 113.6 6.7 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.56 -54.66 0.76 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 48.4 t -56.78 -26.34 57.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.175 -1.191 . . . . 0.0 108.93 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.919 HD11 HD13 ' A' ' 53' ' ' ILE . 15.4 tp -90.55 -33.57 15.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.767 . . . . 0.0 109.451 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 38' ' ' VAL . 84.7 t -90.31 2.78 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.099 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.82 -11.81 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -107.94 34.99 3.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.708 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.1 52.4 40.26 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.897 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 5.5 m-85 -71.95 -167.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.09 143.38 50.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.13 87.89 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.34 -43.08 0.57 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' GLU . 23.2 mm-40 -73.01 -30.22 63.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.242 -1.152 . . . . 0.0 109.409 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.655 ' HA ' HD21 ' A' ' 37' ' ' LEU . 1.5 pt-20 -42.51 -41.99 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -85.39 44.53 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.518 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -159.85 62.72 1.96 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.914 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 4.6 Cg_exo -57.75 -13.61 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.341 2.027 . . . . 0.0 110.943 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -70.77 -31.15 67.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.997 -1.065 . . . . 0.0 109.298 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.5 tp10 -110.71 1.72 18.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.9 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.919 HD13 HD11 ' A' ' 37' ' ' LEU . 6.6 mt -79.45 -31.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.108 -0.995 . . . . 0.0 109.082 179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.65 -78.18 0.29 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.465 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 11.2 m95 -140.68 154.23 46.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -1.11 . . . . 0.0 109.033 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.809 HD23 HD13 ' A' ' 37' ' ' LEU . 1.5 mp -143.07 158.91 43.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.989 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' HG22 ' A' ' 32' ' ' VAL . 6.6 t-20 -117.79 117.68 29.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 108.911 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -138.93 -167.73 11.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 58.7 t80 -115.59 114.12 24.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -1.051 . . . . 0.0 109.96 -179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 17.6 m-20 -79.31 79.88 5.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 108.64 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.19 -39.38 13.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.52 -0.738 . . . . 0.0 109.833 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 28' ' ' ASP . 18.7 m -48.51 -53.32 18.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.922 . . . . 0.0 109.658 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.625 HG21 ' HE1' ' A' ' 25' ' ' HIS . 1.5 p -108.15 17.02 22.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 41.33 54.61 3.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.47 111.9 12.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -1.214 . . . . 0.0 109.935 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -90.74 129.44 36.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 109.194 179.938 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' CA ' ' CG1' ' A' ' 22' ' ' ILE . . . -178.86 -165.5 33.39 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -95.35 168.24 10.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.376 -1.073 . . . . 0.0 109.742 179.984 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 6.5 p90 -168.51 158.57 8.41 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.539 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 4.6 Cg_exo -60.05 125.4 17.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.253 1.969 . . . . 0.0 110.196 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.801 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.7 -39.9 76.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 12.0 p -64.78 -11.02 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.249 . . . . 0.0 109.636 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 70' ' ' PRO . 3.8 m-85 -95.49 15.54 19.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.157 -0.964 . . . . 0.0 109.83 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.882 ' O ' HD11 ' A' ' 11' ' ' LEU . 18.9 m -134.71 -169.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -0.83 . . . . 0.0 110.044 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.766 ' CD ' HD22 ' A' ' 11' ' ' LEU . 11.9 pt-20 -158.26 89.03 0.97 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 56.6 t80 -36.87 136.24 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.653 . . . . 0.0 110.07 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 75' ' ' GLU . 29.7 mm -126.32 -8.16 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.694 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 76' ' ' TYR . . . 113.21 -109.0 2.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.417 ' OXT' ' HG3' ' A' ' 79' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.247 -1.149 . . . . 0.0 109.61 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.53 150.66 20.88 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 47' ' ' GLU . 4.0 m-85 -79.83 118.82 21.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -1.142 . . . . 0.0 109.098 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 31' ' ' THR . 3.7 mp0 -102.11 118.09 36.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 109.899 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.865 ' CZ ' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -99.62 173.01 6.92 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.071 -1.018 . . . . 0.0 108.983 179.859 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.567 ' HB2' ' CG ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -117.9 116.53 27.13 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.801 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 25' ' ' HIS . . . -47.54 109.93 0.26 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 110.299 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.9 mt -90.93 -38.39 12.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 4.7 m-85 -126.46 -161.02 1.03 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.592 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -123.68 -175.28 3.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.966 . . . . 0.0 109.732 179.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 15' ' ' LYS . 27.5 t80 167.81 123.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 108.943 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 14' ' ' TYR . 15.3 mmtp -79.47 156.27 27.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.988 -1.07 . . . . 0.0 109.914 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HD2' ' OD1' ' A' ' 23' ' ' ASP . 25.0 mtpt -70.06 88.77 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.411 -0.806 . . . . 0.0 109.665 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -71.82 -72.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.926 . . . . 0.0 109.291 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -69.81 156.52 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -77.56 70.4 3.94 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.947 0.88 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.79 -26.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 17' ' ' GLU . 4.0 p30 -71.54 170.36 13.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CG2' ' C ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -121.02 167.64 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.543 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 25' ' ' HIS . 3.2 m-20 -73.56 111.38 8.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 2.9 mm? -97.96 144.49 27.45 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.378 -0.826 . . . . 0.0 109.086 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.699 ' CD2' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -159.99 138.18 10.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.035 -179.966 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -57.51 133.57 55.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.189 -0.945 . . . . 0.0 109.498 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.8 -25.99 24.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.585 ' OD2' ' CD2' ' A' ' 25' ' ' HIS . 1.1 m-20 -74.54 171.56 13.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.634 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.97 ' C ' HD12 ' A' ' 30' ' ' LEU . 18.9 mm -123.53 155.15 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.2 mp -127.15 123.53 36.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.146 -0.971 . . . . 0.0 109.392 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -101.69 92.71 4.98 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.412 179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.865 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 77.9 t -90.82 118.5 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 108.979 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.516 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 9.1 m-80 -48.01 176.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 109.284 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -83.0 -72.58 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.016 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 39' ' ' ALA . . . -61.61 -23.05 62.42 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.516 ' CB ' ' HB2' ' A' ' 33' ' ' ASN . 16.6 t -59.07 -29.05 67.04 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.135 -1.215 . . . . 0.0 110.07 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 1.1 tt -90.74 -47.76 7.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.063 -1.023 . . . . 0.0 109.334 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 38' ' ' VAL . 95.7 t -80.0 4.42 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.93 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 35' ' ' GLY . . . -64.28 -9.06 15.06 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 109.949 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' HE1' ' A' ' 42' ' ' PHE . 1.3 mt -104.62 -11.69 16.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 0.0 110.006 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 105.95 29.21 5.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.847 ' CE2' HG23 ' A' ' 53' ' ' ILE . 10.5 m-85 -50.97 -175.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -1.086 . . . . 0.0 109.521 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.68 157.5 44.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 109.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -56.95 123.31 14.7 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.72 -36.28 4.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.783 ' O ' HD11 ' A' ' 53' ' ' ILE . 2.6 mt-30 -81.25 -32.45 33.33 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.304 -1.115 . . . . 0.0 109.376 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 2.8 pt-20 -64.26 -15.78 60.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.883 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -106.5 -13.95 15.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.737 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.6 mmt180 -113.87 80.09 5.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 2.2 Cg_endo -61.05 -31.74 91.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.215 1.943 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 9.1 pt-20 -60.07 -25.86 65.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 6.7 tt0 -104.81 -5.46 21.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 109.488 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.847 HG23 ' CE2' ' A' ' 42' ' ' PHE . 9.5 mt -79.44 -28.97 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.182 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 55' ' ' TRP . . . 99.86 -77.05 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CH2' ' HD3' ' A' ' 70' ' ' PRO . 25.7 m95 -144.18 143.37 31.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 109.412 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.874 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -129.64 158.32 39.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.475 ' ND2' ' C ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -113.26 112.1 23.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 66' ' ' ARG . . . -134.49 -171.48 12.53 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.48 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -120.6 109.64 15.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.975 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 63' ' ' THR . 8.4 m-20 -79.31 97.97 6.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.907 -1.121 . . . . 0.0 108.89 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.41 -36.19 81.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.817 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' OD2' ' A' ' 28' ' ' ASP . 37.9 m -50.05 -21.8 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' ASN . 12.0 t -127.76 -3.3 5.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.523 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.44 46.42 93.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -136.63 161.01 37.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.498 ' C ' ' CG2' ' A' ' 22' ' ' ILE . 4.9 ttm180 -132.52 153.79 50.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 57' ' ' ASN . . . 162.68 -171.2 38.45 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.663 -1.256 . . . . 0.0 109.962 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 68' ' ' ASP . 4.8 p30 -91.14 169.55 10.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.992 . . . . 0.0 109.655 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.679 ' HE2' HG11 ' A' ' 74' ' ' VAL . 10.4 p90 -174.33 143.86 0.91 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.837 . . . . 0.0 109.164 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 2.9 Cg_exo -55.45 118.19 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.801 1.668 . . . . 0.0 109.914 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.874 ' CA ' HD11 ' A' ' 56' ' ' LEU . . . -63.24 -23.84 66.71 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 p -58.57 -19.54 39.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.891 -1.358 . . . . 0.0 109.881 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 70' ' ' PRO . 17.9 m-85 -102.57 29.11 5.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' HE2' ' A' ' 69' ' ' PHE . 3.0 m -141.32 168.05 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.567 ' CG ' ' HB2' ' A' ' 9' ' ' ARG . 5.9 pt-20 -138.87 88.7 2.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 109.985 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.578 ' CZ ' ' HA2' ' A' ' 78' ' ' GLY . 57.5 t80 -38.53 124.98 1.35 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.716 -0.615 . . . . 0.0 109.772 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -122.67 5.97 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 76' ' ' TYR . . . 82.56 -100.84 2.2 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.174 -1.192 . . . . 0.0 109.442 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 33' ' ' ASN . . . 175.76 -127.77 1.3 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.61 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 5.2 m-30 -78.41 105.18 9.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.691 -0.888 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 31' ' ' THR . 1.6 mt-30 -106.01 114.52 28.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.193 -0.942 . . . . 0.0 109.756 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.763 ' OH ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -104.65 175.95 5.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 0.0 108.662 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.687 ' HB2' HD11 ' A' ' 77' ' ' ILE . 8.2 ttm180 -113.71 150.36 33.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.803 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 26' ' ' LEU . . . -73.72 111.91 9.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.869 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.616 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 8.6 mt -89.1 -31.72 17.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.905 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 9.4 m-85 -132.61 -163.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.844 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 73' ' ' TYR . 12.2 p-10 -123.76 172.74 8.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 109.762 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 24' ' ' LEU . 24.8 t80 -164.57 118.37 1.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.16 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' GLU . 29.6 tttp -80.11 136.38 36.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.882 -1.136 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' OD2' ' A' ' 21' ' ' ASP . 8.2 ttmt -42.94 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.499 -0.751 . . . . 0.0 109.734 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -95.55 -64.96 1.01 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -81.51 145.8 30.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.918 . . . . 0.0 109.517 -179.984 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.83 -13.6 6.65 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 11.2 pm0 -110.54 33.68 4.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.016 -1.052 . . . . 0.0 110.199 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -125.45 177.59 6.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.265 179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.65 HG23 ' HA3' ' A' ' 67' ' ' GLY . 2.9 pt -136.08 157.63 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' CE1' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -70.23 113.81 7.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.811 . . . . 0.0 109.6 -179.993 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.927 HD11 HD21 ' A' ' 30' ' ' LEU . 2.4 mm? -101.32 154.09 19.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.042 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.594 ' CE1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -159.96 133.18 6.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 109.423 179.997 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -52.0 141.4 18.09 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.265 -0.897 . . . . 0.0 109.597 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' HG ' ' A' ' 26' ' ' LEU . . . 97.35 -17.55 58.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.948 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.7 m-20 -83.73 174.54 10.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.948 HD12 ' C ' ' A' ' 28' ' ' ASP . 1.7 mp -125.45 137.14 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 24' ' ' LEU . 8.0 mp -109.28 119.43 39.48 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.22 -0.925 . . . . 0.0 109.138 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -97.76 100.19 11.56 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 ' CA ' ' A' ' 58' ' ' GLY . 43.2 t -116.43 109.63 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.551 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 1.7 m120 -45.64 171.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.49 -0.756 . . . . 0.0 109.78 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' CG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -71.88 -70.7 0.31 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.929 . . . . 0.0 109.744 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.91 98.42 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 33' ' ' ASN . 46.3 m -44.58 -25.14 0.24 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -1.142 . . . . 0.0 109.863 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.815 ' O ' HD23 ' A' ' 37' ' ' LEU . 4.0 tt -90.28 -40.97 11.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 -179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 38' ' ' VAL . 62.6 t -74.66 0.0 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.238 -0.914 . . . . 0.0 109.887 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.29 -12.37 13.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 109.763 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 42' ' ' PHE . 3.1 mt -91.58 17.43 8.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.983 . . . . 0.0 109.761 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 42' ' ' PHE . . . 72.92 17.91 78.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.891 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 14.9 m-85 -54.62 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.037 -1.272 . . . . 0.0 109.511 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -121.08 149.95 41.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.212 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -50.94 90.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.568 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' SER . . . 136.65 -46.04 1.04 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.23 -16.22 52.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -1.161 . . . . 0.0 109.704 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -62.26 -38.15 88.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.566 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -91.11 26.6 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 109.673 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' HG13 ' A' ' 53' ' ' ILE . 2.6 mtp180 -128.67 64.84 70.5 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.309 -0.869 . . . . 0.0 108.875 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 6.3 Cg_exo -57.09 -38.68 95.08 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.267 1.978 . . . . 0.0 110.381 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.6 -27.09 68.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.503 ' N ' ' HG2' ' A' ' 51' ' ' GLU . 2.1 mt-10 -104.87 -2.81 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.891 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 12.0 mt -82.28 -84.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.042 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.789 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 151.15 -61.32 0.41 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.462 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . 28.8 m95 -148.53 134.24 18.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -1.055 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.733 HD11 ' CA ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -133.57 164.0 28.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 31.4 t-20 -115.72 115.64 26.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.793 ' CA ' HG22 ' A' ' 32' ' ' VAL . . . -133.06 -169.0 12.08 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 66' ' ' ARG . 36.3 t80 -122.66 105.95 10.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.617 -0.931 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' HD12 ' A' ' 22' ' ' ILE . 4.5 m-80 -79.9 88.26 5.3 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.254 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.84 -36.77 67.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.86 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.67 HG21 ' OD1' ' A' ' 28' ' ' ASP . 6.2 m -52.33 -37.15 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.146 -0.971 . . . . 0.0 109.347 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.594 HG21 ' CE1' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -116.85 9.98 14.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.34 -0.85 . . . . 0.0 109.461 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' THR . . . 43.51 52.73 6.22 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.95 119.72 21.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -1.178 . . . . 0.0 109.724 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 2.8 ttt85 -101.63 134.51 44.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.862 . . . . 0.0 109.16 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.65 ' HA3' HG23 ' A' ' 22' ' ' ILE . . . 170.44 -165.2 38.48 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.255 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -90.36 173.69 7.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.412 -1.052 . . . . 0.0 109.71 -179.936 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 18.1 p90 -177.58 159.57 1.33 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.858 . . . . 0.0 109.22 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HB2' ' CD1' ' A' ' 73' ' ' TYR . 2.7 Cg_endo -61.53 126.03 18.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.075 1.85 . . . . 0.0 110.015 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -69.61 -40.37 77.57 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 25.6 p -58.21 -14.0 6.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.029 -1.277 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.611 ' CD2' ' HB2' ' A' ' 12' ' ' TYR . 4.4 m-85 -93.15 23.21 4.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.195 -0.941 . . . . 0.0 110.155 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 71' ' ' GLY . 29.9 m -142.59 -173.49 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.153 -0.967 . . . . 0.0 109.898 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 10.6 pt-20 -156.42 87.32 1.03 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 109.577 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 6' ' ' TYR . 10.2 t80 -37.33 135.2 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.635 -0.666 . . . . 0.0 110.494 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.687 HD11 ' HB2' ' A' ' 9' ' ' ARG . 2.7 mp -131.56 -2.89 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' N ' ' CE1' ' A' ' 76' ' ' TYR . . . 87.34 -139.77 16.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -1.189 . . . . 0.0 109.286 179.999 . . . . . . . . 0 0 . 1 stop_ save_